Citrus Sinensis ID: 041073

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430------
Protein Sequence
MSSDEASIFSTFLFCLLMFVFSPREIEARKLAVKMCSSSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVVDVNLAYGSCSFPSTSFSPPGLSFSYSFDYNLNSYANYVNCSSDIVDQVSAKVPCLSNNQLNVYVYVGYDLIATSISHLPDSCAFISKVPVVLNRSVDKLSYEDLRKSLESGFDLTWLDWSWSLSMPRYCMYNAGVVATIICYPYYIRFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI
Secondary Structure (PSIPRED)
ccccHHHHHHHHHHHHHHHHHcccHHHHccccccccccccccccccccccccccccccccccccEEEEcccccEEEEcccEEEEEEEEEcccEEEEEccccccccccccccccccccccccccccccccccccEEcccccccccccccccccccccccEEEEEccccccccccccccccEEEEEEEEccccccccccHHHHHHHHccccEEEEEccccccccccccccccccEEEEEEccccEEEcEEEEHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHcccccccEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHcccccccEEEEEEEccccEEEEEEEccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccEEccccccccccccEEEEEccccEEEEEcccEEEEEEEEccccEEEEEcccccccccccccccccccccccccccccccccEEEEEEcccccccccccccccccccccEEEEEEccccccccHHHcccccEEEEEEEcccccccccccHHHHHHHHHcccEEEcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHcccccccEEcHHHHHHHHHHcccEEEEccccEEEEEEEcccEEEEEEcccccccccccHHHHHHHHcccccccEccEEEEccccccccEEEEcccccEHHHHHccccccccHccHHHHHHHHHHHHHHHHHHHcccccEEEEEEcccccc
Coil and Loop (DISEMBL)
MSSDEASIFSTFLFCLLMFVFSPREIEARKLAVKMCssscgdvknisypfrlkgdparcghpelelscesnktifefnsgkyyvkrisydkctISVVDVNlaygscsfpstsfsppglsfsysfdynlnsyanyvncssdivdqvsakvpclsnnqlnVYVYVGYDLIATsishlpdscafiskvPVVLNRSVDKLSYEDLRKSLEsgfdltwldwswslsmprycmynAGVVATIIcypyyirfpVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNVEKFLHNqqswmpkrysypeiIAMTNHfthklgqggfgsvykgqlhtgGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGfcsegskrAVVYeympngsldrhifpkesrgqsfswEKLHEVALGTARGIeylhngcdvcilhfdikphni
Flexible Loop (DISEMBL)
MSSDEASIFSTFLFCLLMFVFSPREIEARKLAVKMCSSSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVVDVNLAYGSCSFPSTSFSPPGLSFSYSFDYNLNSYANYVNCSSDIVDQVSAKVPCLSNNQLNVYVYVGYDLIATSISHLPDSCAFISKVPVVLNRSVDKLSYEDLRKSLESGFDLTWLDWSWSLSMPRYCMYNAGVVATIICYPYYIRFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI
Low Complexity Region (SEG)
MSSDEASIFSTFLFCLLMFVFSPREIEARKLAVKMCSSSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVVDVNLAYGscsfpstsfsppglsfsYSFDYNLNSYANYVNCSSDIVDQVSAKVPCLSNNQLNVYVYVGYDLIATSISHLPDSCAFISKVPVVLNRSVDKLSYEDLRKSLESGFDLTWLDWSWSLSMPRYCMYNAGVVATIICYPYYIRFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI
Disordered region (IsUnstruct)
*******IFSTFLFCLLMFVFSPREIEARKLAVKMCSSSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVVDVNLAYGSCSFPSTSFSPPGLSFSYSFDYNLNSYANYVNCSSDIVDQVSAKVPCLSNNQLNVYVYVGYDLIATSISHLPDSCAFISKVPVVLNRSVDKLSYEDLRKSLESGFDLTWLDWSWSLSMPRYCMYNAGVVATIICYPYYIRFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDI*****
Disordered Region (DISOPRED)
*****AS**STFLFCLLMFVFSPREIEARKLAVKMCSSSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVVDVNLAYGSCSFPSTSFSPPGLSFSYSFDYNLNSYANYVNCSSDIVDQVSAKVPCLSNNQLNVYVYVGYDLIATSISHLPDSCAFISKVPVVLNRSVDKLSYEDLRKSLESGFDLTWLDWSWSLSMPRYCMYNAGVVATIICYPYYIRFPVDVLIIGRFILAPIVFLVFLIHKYRT*************NQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN*
Disordered Region (DISEMBL)
MSSDEASIFSTFLFCLLMFVFSPREIEARKLAVKMCSSSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVVDVNLAYGSCSFPSTSFSPPGLSFSYSFDYNLNSYANYVNCSSDIVDQVSAKVPCLSNNQLNVYVYVGYDLIATSISHLPDSCAFISKVPVVLNRSVDKLSYEDLRKSLESGFDLTWLDWSWSLSMPRYCMYNAGVVATIICYPYYIRFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI
Disordered Region (DISPRO)
**SDEASIFSTFLFCLLMFVFSPREIEARKLAVKMCSSSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVVDVNLAYGSCSFPSTSFSPPGLSFSYSFDYNLNSYANYVNCSSDIVDQVSAKVPCLSNNQLNVYVYVGYDLIATSISHLPDSCAFISKVPVVLNRSVDKLSYEDLRKSLESGFDLTWLDWSWSLSMPRYCMYNAGVVATIICYPYYIRFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP***
Transmembrane Helix (TMHMM)
ooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSSDEASIFSTFLFCLLMFVFSPREIEARKLAVKMCSSSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVVDVNLAYGSCSFPSTSFSPPGLSFSYSFDYNLNSYANYVNCSSDIVDQVSAKVPCLSNNQLNVYVYVGYDLIATSISHLPDSCAFISKVPVVLNRSVDKLSYEDLRKSLESGFDLTWLDWSWSLSMPRYCMYNAGVVATIICYPYYIRFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	436	2.2.26 [Sep-21-2011]
Q3ECH2	892	Probable receptor-like pr	no	no	0.440	0.215	0.433	7e-40
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.403	0.214	0.453	3e-39
Q9FID5	806	Probable receptor-like pr	no	no	0.316	0.171	0.534	5e-38
Q9FID6	813	Probable receptor-like pr	no	no	0.321	0.172	0.506	6e-37
O64477	828	G-type lectin S-receptor-	no	no	0.325	0.171	0.524	3e-36
Q9XID3	829	G-type lectin S-receptor-	no	no	0.337	0.177	0.472	1e-33
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.417	0.208	0.405	2e-33
Q39203	797	G-type lectin S-receptor-	no	no	0.410	0.224	0.412	1e-32
O65238	872	G-type lectin S-receptor-	no	no	0.330	0.165	0.448	2e-32
Q9FZB8	871	Probable LRR receptor-lik	no	no	0.327	0.164	0.448	6e-31

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  165 bits (417), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 91/210 (43%), Positives = 131/210 (62%), Gaps = 18/210 (8%)

Query: 233 VATIICYPYYIRFPVDVLIIGRFILAPIVFLVFLIHKYRTTL----QTVDNVEKFLHNQQ 288
           +AT++ Y +        + +G      IVFLV L   +R  +    +T D V   L   +
Sbjct: 489 IATLVRYTF--------IALGALTGVVIVFLVLLCPCFRVQIFRKRKTSDEVR--LQKLK 538

Query: 289 SWMP-KRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS-AEEFI 346
           + +P K Y+Y E+  MT  FT  +G+GGFG VY G L    ++AVK+LK+SK +  E+FI
Sbjct: 539 ALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFI 598

Query: 347 NEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE 406
           NEV+++ +  HVN+V LLGFC EGS+RA++YE++ NGSLD+ I  K S   +   + L+ 
Sbjct: 599 NEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDKSS--VNLDLKTLYG 656

Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           +ALG ARG+EYLH GC   I+HFDIKP N+
Sbjct: 657 IALGVARGLEYLHYGCKTRIVHFDIKPQNV 686

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  163 bits (412), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 82/181 (45%), Positives = 115/181 (63%), Gaps = 5/181 (2%)

Query: 260 IVFLVFLIHKYRTTL----QTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGG 315
           ++F+ F IHK +  +    Q     + FL N  S MP R++Y ++ + TN+F+ KLGQGG
Sbjct: 445 LIFVAFRIHKRKKMILEAPQESSEEDNFLENL-SGMPIRFAYKDLQSATNNFSVKLGQGG 503

Query: 316 FGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV 375
           FGSVY+G L  G  +AVK L+      +EF  EVS IG IHH+++V+L GFC+EG+ R +
Sbjct: 504 FGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLL 563

Query: 376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN 435
            YE++  GSL+R IF K+       W+    +ALGTA+G+ YLH  CD  I+H DIKP N
Sbjct: 564 AYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPEN 623

Query: 436 I 436
           I
Sbjct: 624 I 624

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  159 bits (401), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 77/144 (53%), Positives = 106/144 (73%), Gaps = 6/144 (4%)

Query: 295 YSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGR 354
           Y+Y E+  +T  F++ +G+GGFG+VY G L  G  +AVK+LK+ K SAE+FINEV+++ +
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQ 547

Query: 355 IHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE--KLHEVALGTA 412
             HVN+V LLGFC EGSKRA+VYE++ NGSLD+ +    SR +S + +   L+ +ALG A
Sbjct: 548 TSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFM----SRNKSLTQDVTTLYGIALGIA 603

Query: 413 RGIEYLHNGCDVCILHFDIKPHNI 436
           RG+EYLH GC   I+HFDIKP NI
Sbjct: 604 RGLEYLHYGCKTRIVHFDIKPQNI 627

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  155 bits (392), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 74/146 (50%), Positives = 105/146 (71%), Gaps = 6/146 (4%)

Query: 293 KRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTI 352
           K+Y Y E+  +T  F+H +G+GGFG+VY+G L  G  +AVK+LK+ K + ++FINEV+++
Sbjct: 484 KQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSM 543

Query: 353 GRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFS--WEKLHEVALG 410
            +  HVN+V LLGFC EGSKRA++ E++ +GSLD+ I    SR +S +     L+ +ALG
Sbjct: 544 SQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFI----SRNKSLTPNVTTLYGIALG 599

Query: 411 TARGIEYLHNGCDVCILHFDIKPHNI 436
            ARG+EYLH GC   I+HFDIKP NI
Sbjct: 600 IARGLEYLHYGCKTRIVHFDIKPQNI 625

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  152 bits (385), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 75/143 (52%), Positives = 97/143 (67%), Gaps = 1/143 (0%)

Query: 295 YSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGR 354
           +SY E+   T +F+ KLG GGFGSV+KG L     IAVK L+      ++F  EV TIG 
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGT 542

Query: 355 IHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQ-SFSWEKLHEVALGTAR 413
           I HVN+V+L GFCSEGSK+ +VY+YMPNGSLD H+F  +   +    W+   ++ALGTAR
Sbjct: 543 IQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTAR 602

Query: 414 GIEYLHNGCDVCILHFDIKPHNI 436
           G+ YLH+ C  CI+H DIKP NI
Sbjct: 603 GLAYLHDECRDCIIHCDIKPENI 625

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  144 bits (363), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 70/148 (47%), Positives = 97/148 (65%), Gaps = 1/148 (0%)

Query: 289 SWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINE 348
           S  P +++Y E+   T  F  KLG GGFG+VY+G L    ++AVK L+  +   ++F  E
Sbjct: 468 SGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRME 527

Query: 349 VSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVA 408
           V+TI   HH+N+V+L+GFCS+G  R +VYE+M NGSLD  +F  +S  +  +WE    +A
Sbjct: 528 VATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDS-AKFLTWEYRFNIA 586

Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
           LGTA+GI YLH  C  CI+H DIKP NI
Sbjct: 587 LGTAKGITYLHEECRDCIVHCDIKPENI 614

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  144 bits (362), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 77/190 (40%), Positives = 110/190 (57%), Gaps = 8/190 (4%)

Query: 250 LIIGRFILAPIV--FLVFLIHKYRTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHF 307
           +++G  +L  ++   L + + + RT  +   N      +     P  ++Y ++   TN+F
Sbjct: 478 IVVGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDS-----PVSFTYRDLQNCTNNF 532

Query: 308 THKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAE-EFINEVSTIGRIHHVNVVQLLGF 366
           +  LG GGFG+VYKG +    L+AVK L  +    E EFI EV+TIG +HH+N+V+L G+
Sbjct: 533 SQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGY 592

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           CSE S R +VYEYM NGSLD+ IF  E       W    E+A+ TA+GI Y H  C   I
Sbjct: 593 CSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRI 652

Query: 427 LHFDIKPHNI 436
           +H DIKP NI
Sbjct: 653 IHCDIKPENI 662

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  140 bits (354), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 78/189 (41%), Positives = 108/189 (57%), Gaps = 10/189 (5%)

Query: 249 VLIIGRFILAPIVFLVFLIHKYRTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFT 308
           + ++G  +L P++ L     + +T  Q  D              K +S+ E+ + TN F+
Sbjct: 412 ISVLGFTLLVPLILLKRSRKRKKTRKQDEDGFAVLNL-------KVFSFKELQSATNGFS 464

Query: 309 HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
            K+G GGFG+V+KG L  +   +AVK L+       EF  EV TIG I HVN+V+L GFC
Sbjct: 465 DKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVCTIGNIQHVNLVRLRGFC 524

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           SE   R +VY+YMP GSL  ++    +  +  SWE    +ALGTA+GI YLH GC  CI+
Sbjct: 525 SENLHRLLVYDYMPQGSLSSYL--SRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCII 582

Query: 428 HFDIKPHNI 436
           H DIKP NI
Sbjct: 583 HCDIKPENI 591

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  140 bits (353), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 66/147 (44%), Positives = 96/147 (65%), Gaps = 3/147 (2%)

Query: 291 MPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA-EEFINEV 349
           +P+++ + E+   T +F  ++G GGFGSVYKG L    LIAVK + N      +EF  E+
Sbjct: 501 LPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEI 560

Query: 350 STIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVAL 409
           + IG I H N+V+L GFC+ G +  +VYEYM +GSL++ +F     G    W++  ++AL
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF--SGNGPVLEWQERFDIAL 618

Query: 410 GTARGIEYLHNGCDVCILHFDIKPHNI 436
           GTARG+ YLH+GCD  I+H D+KP NI
Sbjct: 619 GTARGLAYLHSGCDQKIIHCDVKPENI 645

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1

 Score =  135 bits (340), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 65/145 (44%), Positives = 94/145 (64%), Gaps = 2/145 (1%)

Query: 293 KRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA-EEFINEVST 351
           K+++Y E++ MTN+F   LG+GGFG VY G ++    +AVKML +S     ++F  EV  
Sbjct: 565 KKFTYAEVLTMTNNFQKILGKGGFGIVYYGSVNGTEQVAVKMLSHSSAQGYKQFKAEVEL 624

Query: 352 IGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGT 411
           + R+HH N+V L+G+C EG K A++YEYM NG LD H+  K   G   +W    ++AL  
Sbjct: 625 LLRVHHKNLVGLVGYCEEGDKLALIYEYMANGDLDEHMSGKRG-GSILNWGTRLKIALEA 683

Query: 412 ARGIEYLHNGCDVCILHFDIKPHNI 436
           A+G+EYLHNGC   ++H D+K  NI
Sbjct: 684 AQGLEYLHNGCKPLMVHRDVKTTNI 708

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	436
255570697	631	kinase, putative [Ricinus communis] gi|2	0.915	0.632	0.505	1e-106
115434122	659	Os01g0113300 [Oryza sativa Japonica Grou	0.901	0.596	0.422	2e-85
359490872	753	PREDICTED: probable receptor-like protei	0.887	0.513	0.434	1e-83
359495102	603	PREDICTED: probable receptor-like protei	0.862	0.623	0.435	2e-82
147801082	590	hypothetical protein VITISV_037666 [Viti	0.926	0.684	0.428	1e-81
359495100	651	PREDICTED: probable receptor-like protei	0.892	0.597	0.419	2e-81
225455116	608	PREDICTED: probable receptor-like protei	0.889	0.638	0.427	6e-81
255545008	662	kinase, putative [Ricinus communis] gi|2	0.912	0.601	0.415	1e-80
242053327	681	hypothetical protein SORBIDRAFT_03g02563	0.899	0.575	0.406	2e-80
359490671	584	PREDICTED: probable receptor-like protei	0.876	0.654	0.422	4e-80

>gi|255570697|ref|XP_002526303.1| kinase, putative [Ricinus communis] gi|223534384|gb|EEF36092.1| kinase, putative [Ricinus communis]

 Score =  392 bits (1008), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 220/435 (50%), Positives = 287/435 (65%), Gaps = 36/435 (8%)

Query: 25  EIEARKLAVKMCSSSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYV 84
           E+E+R L   +CSSSCG +K ISYPFRL  DPA CG P  E+SC  NK I EF+SGKYYV
Sbjct: 27  EVESRILQ-DICSSSCGYIK-ISYPFRLNNDPATCGDPGYEISCNDNKPILEFHSGKYYV 84

Query: 85  KRISYDKCTISVVDVNLAYGSCSFPSTSFSPPGLSFSYSFDYNLNS-YANYVNCSSDIVD 143
            +ISYDK  I +VDVNLA GSC+ P  S S   +     +   ++S + ++  CSS+I D
Sbjct: 85  NQISYDKHIIRLVDVNLANGSCNLPYISVSVDEVRGDSRYRGLVSSTFTSFFRCSSEIND 144

Query: 144 QVSAKVPCLSNNQLNVYVYVGYDLIATSISHLPDSCAFISKVPVVLNRSVDKLSYEDLRK 203
           Q    VPC S N    +VYV Y      IS L  SC+FIS+VP +  ++V   SY+ + +
Sbjct: 145 QAYRDVPCFSGN--GSHVYVSYSTYV--ISDLQGSCSFISRVPTIY-QNVLYPSYQSILQ 199

Query: 204 SLESGFDLTWLDWSWSLSMPRYCMYNAGVVA--------TIICYPYYIRFPV-------- 247
            +  GFDL      WS+   R C+ + G+ +           CY   I  P         
Sbjct: 200 LMALGFDL-----EWSVEC-RDCIADGGICSLSSVGTPNVYECYYSGIYIPAAVSLIFAA 253

Query: 248 --DVL----IIGRFILAPIVFLVFLIHKYRTTLQTVDNVEKFLHNQQSWMPKRYSYPEII 301
             D+L    +I RF++APIV + FLIHKYRT  +T ++ E  L N+ S MP+RYSY +II
Sbjct: 254 IWDILLAINLIARFVVAPIVIVGFLIHKYRTQKKTEESKENLLPNEPSMMPRRYSYSDII 313

Query: 302 AMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVV 361
           A+TN+F  K+G+GGFG+VYKGQL  G L+AVKML +SKFS ++FI+EVSTIG+IHH NVV
Sbjct: 314 AITNNFKDKIGKGGFGTVYKGQLPDGFLVAVKMLGDSKFSDKDFIDEVSTIGKIHHANVV 373

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
           QL+GFCSEGS  A+++EY+  GSLD+HIF +E+  Q FSWEK  ++A+GTARGIE+LH G
Sbjct: 374 QLVGFCSEGSYHALLFEYIARGSLDKHIFSREAEFQPFSWEKRLQIAIGTARGIEHLHVG 433

Query: 422 CDVCILHFDIKPHNI 436
           CDVCILHFDIKPHN+
Sbjct: 434 CDVCILHFDIKPHNV 448

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115434122|ref|NP_001041819.1| Os01g0113300 [Oryza sativa Japonica Group] gi|52076279|dbj|BAD45064.1| putative rust resistance kinase Lr10 [Oryza sativa Japonica Group] gi|113531350|dbj|BAF03733.1| Os01g0113300 [Oryza sativa Japonica Group] gi|125568759|gb|EAZ10274.1| hypothetical protein OsJ_00109 [Oryza sativa Japonica Group] gi|215767081|dbj|BAG99309.1| unnamed protein product [Oryza sativa Japonica Group]

 Score =  322 bits (826), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 186/440 (42%), Positives = 254/440 (57%), Gaps = 47/440 (10%)

Query: 39  SCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVVD 98
           SCG ++ I YPFRL+GDP  CG    EL C   + I   N+GKY+VK ISY++    VVD
Sbjct: 44  SCGHLEGIRYPFRLQGDPLGCGDEAYELVCRDGRAIIHINTGKYFVKDISYNESRFWVVD 103

Query: 99  VNLAYGSCSFPSTSFSPPGLSFSYSFDYNLNSYANYVNCSSDIVDQVSAKVPCLSNNQLN 158
            NL   SC  P  +  P           +   +A ++NCS  I + +   V CLS N   
Sbjct: 104 ANLDNSSCPLPLWNNLPYFNDMGTKLYTSAVRWATFLNCSRAINNGMYMPVACLSGN--T 161

Query: 159 VYVYVGYDLIATSISHLPDSCAFISKVPV--VLNRSVDKLSYEDLRKSLESGFDLTW--- 213
            +VYV     +  + ++  SC +++ +PV        D  SY D+ K + +GF +++   
Sbjct: 162 SFVYVLTTSSSYYVQNIEPSCGYLAVIPVDDRTKNVPDYASYADVVKFMRNGFPVSFPRV 221

Query: 214 -----------------------------LDWSWSLSMPRY----CMYNAGVVATIICYP 240
                                         +W+ ++         C+ N    AT +   
Sbjct: 222 ESPSHSPVIKACARDTFQNFKEQMYSRNIQNWTSAIIGTELQFLGCVINYYSSATQVWVT 281

Query: 241 YYIRFPVDV----LIIGRFILAPIVFLVFLIHKYRTTLQTVDNVEKFLHNQQSWMPKRYS 296
             + F V++    +++ RFILAP+  L FL +KYR T  ++D VEKFL  QQ+  PKRY+
Sbjct: 282 LVLVFAVEIVKCIIVLCRFILAPLTVLTFLGYKYRKTRISIDAVEKFLRMQQAHGPKRYA 341

Query: 297 YPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH 356
           Y EI A+T HF  KLGQGG+GSVYKG L   G +A+KML NS  + EEFI+EVSTI RIH
Sbjct: 342 YTEITAITGHFREKLGQGGYGSVYKGFLPGDGHVAIKMLSNSMCNGEEFISEVSTISRIH 401

Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
           HVNVV+L+GFCSE  +RA+VYEYMP GSLD++IF  E   +S SW+KL+E+ALG ARGI+
Sbjct: 402 HVNVVRLVGFCSEELRRALVYEYMPCGSLDKYIFSPE---KSLSWDKLNEIALGIARGID 458

Query: 417 YLHNGCDVCILHFDIKPHNI 436
           YLH+GCD+ I+HFDIKPHNI
Sbjct: 459 YLHHGCDMQIMHFDIKPHNI 478

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359490872|ref|XP_003634180.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  317 bits (811), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 188/433 (43%), Positives = 257/433 (59%), Gaps = 46/433 (10%)

Query: 38  SSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVV 97
           SSCGD++NISYPFRLKGDP  CG PE EL CE+N T+     GKYYV  I+YD  TI VV
Sbjct: 33  SSCGDIQNISYPFRLKGDPFWCGDPEYELVCENNHTMVNLEYGKYYVADINYDHSTIRVV 92

Query: 98  DVNLAYGSC-SFPSTSFSPPGLSFSYSFDYNLNSYAN-----YVNCSSDIVDQVSAKV-P 150
           D  +  G+C S P  S +       +   Y LN Y        +NC   I D     + P
Sbjct: 93  DPGVEKGNCFSTPLRSLTVDQFDSFFDSAYYLNPYEATNTTVLMNCEQPISDGNYIPITP 152

Query: 151 CLSNNQLN----VYVYV----GYDLIATSISHLPDSCAFISKVPVVLNRSVD--KLSYED 200
           C  +N+ +     YVY     G  L+   I +   SC  +   P ++ R +    LS  D
Sbjct: 153 CNRSNETSSSSQAYVYALVGGGDSLLVNDIMY---SCTIL---PTIVTRFMKPGNLSMSD 206

Query: 201 LRKSLESGFDLTWLDW--------SWSLSMPRYCMYNAGVVATIICYPYYIRFPVD---- 248
           L++ L  G DL++L +         W    P +   NA     + C  +++ +  D    
Sbjct: 207 LQEMLLLGVDLSFLRFRCKSKCGKKWPSCSPDFAK-NA-----VKCGHWFVDWFSDFLQS 260

Query: 249 ----VLIIGRFILAPIVFLVFLIHKY-RTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIAM 303
               ++IIGR  L  +  LV+LI+K+ R  L   D++E+FLH+  +    +YSY E+  M
Sbjct: 261 LIVMIIIIGRTALGILCLLVYLIYKFQRRHLSLDDDIEEFLHSHNNLQLIKYSYSEVKKM 320

Query: 304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQL 363
           T++F +KLGQGGFGSVYKG+L +G ++AVKML  SK + ++F+NEV+TIGRIHHVNVV+L
Sbjct: 321 THNFKNKLGQGGFGSVYKGRLRSGHIVAVKMLVMSKANGQDFVNEVATIGRIHHVNVVRL 380

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
           +GFC +GSK A+VY++MPNGSLD+ +F         SWE+L+++ALG  RGIEYLH GCD
Sbjct: 381 IGFCIQGSKWALVYDFMPNGSLDKFVFLDRGNNIPLSWERLYKIALGVGRGIEYLHQGCD 440

Query: 424 VCILHFDIKPHNI 436
           + ILHFDIKPHNI
Sbjct: 441 MQILHFDIKPHNI 453

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359495102|ref|XP_002263106.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  312 bits (800), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 183/420 (43%), Positives = 248/420 (59%), Gaps = 44/420 (10%)

Query: 34  KMCSSSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCT 93
           ++C+SSCG++ NISYPFRLK DP  CG  E EL+CE+N+TI    SGKY V+ I+Y+  T
Sbjct: 32  RVCTSSCGNIHNISYPFRLKDDPRSCGESEYELACETNRTILYLYSGKYKVEEINYEIFT 91

Query: 94  ISVVDVNLAYGSCS-FPSTSFSPPGLSFSYSFDY---NLNSYANYVNCSSDIVDQVSAKV 149
           I +VD  L    CS  P  S +    +      Y   + NS  N+++C + I   +   +
Sbjct: 92  IRIVDTGLQKDDCSSLPLHSLTYRNFTSQRPIRYWRSSENSALNFIDCEAPISSSIYMDM 151

Query: 150 -PC---------LSNNQLNVYVYVGYDLIATSISHLPDSCAFISKVPV-VLNRSVDKLSY 198
            PC         LS+ Q   YV VGY     S+S L +SC    +V V    + +D  S 
Sbjct: 152 APCSKNSSAHFSLSSIQTYSYVVVGY----MSLSDLQNSCRIDLEVSVSTRGQKIDNSSC 207

Query: 199 EDLRKSLESGFDLTWLDWSWSLSMPRYCMYNAGVVATIICYPYYIRFPVDVLIIGRFILA 258
             +   +  G DL W            C+       + +C P      V ++ +     +
Sbjct: 208 SGIHDGMLYGTDLQWCK----------CL-------SSVCPPC-----VAIVAVRTLFGS 245

Query: 259 PIVFLVFLIHKYRT-TLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFG 317
           P V ++FLI+K+R   L     +E+F+  Q +  P RYSY  I  MT  F  KLG+GG+G
Sbjct: 246 PCV-VIFLIYKWRRRNLSMYHAIEEFIQAQNNLTPIRYSYSNIKKMTKGFMEKLGEGGYG 304

Query: 318 SVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY 377
           SVYKG+L +G  +AVKM+ NSK + ++FINEV+TIGRIHHVNVVQL+GFC+EGSKRA+VY
Sbjct: 305 SVYKGKLRSGHFVAVKMMANSKANGQDFINEVATIGRIHHVNVVQLIGFCAEGSKRALVY 364

Query: 378 EYMPNGSLDRHIFP-KESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           ++MPNGSLD++IFP KE      S EK++E++LG A GIEYLH GCD  ILHFDIKPHNI
Sbjct: 365 DFMPNGSLDKYIFPEKEGNISLLSLEKMYEISLGVAYGIEYLHRGCDTQILHFDIKPHNI 424

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147801082|emb|CAN71175.1| hypothetical protein VITISV_037666 [Vitis vinifera]

 Score =  309 bits (792), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 186/434 (42%), Positives = 254/434 (58%), Gaps = 30/434 (6%)

Query: 16  LLMFVFSPREIEARKLAVKMCSSSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIF 75
           + + +  P   +A KL   +C SSCG++ +ISYPFRLK D  RCG  + EL+CE+N+TI 
Sbjct: 13  IFLLLLRPTTCKA-KLNHHLCHSSCGNIPDISYPFRLKDDRPRCGERKYELACENNRTIL 71

Query: 76  EFNSGKYYVKRISYDKCTISVVDVNLAYGSCS-FPSTSFSPPGLSFSYSFDYNLN---SY 131
           + NSG+YYV+ I+Y + TI VVD  L    CS  P  S +    +FSY   Y L+   S 
Sbjct: 72  QLNSGRYYVEEINYTRETIRVVDTGLKKDDCSSLPLHSLTYA--NFSYGDPYRLSXETSD 129

Query: 132 ANYVNCSSDIVDQVSAKV-PCLSNNQ-------LNVYVYVGYDLIATSISHLPDSCAFIS 183
            N+++C + I   +   + PC  N+        +  Y YV    +A  +  L DSC+   
Sbjct: 130 VNFIDCEAPINSPLYIDMAPCSRNSSSNSSLSSMQTYSYVVVRHMA--LLDLEDSCSVGL 187

Query: 184 KVPVVLNRSVDKLSYEDLRKSLESGFDLTWLDWSWSLSMPRYCMYNAGVVATIICYPYYI 243
            V           S  D+      G DL W +    L  P   +       T++     I
Sbjct: 188 VVGFSTRGQKIDNSLPDIHNRXLYGVDLRWFNCFGFLLCPSCDLVEFVSQLTVLAVAAKI 247

Query: 244 RFPVDVLIIGRFILAPIVFLVFLIHKY-RTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIA 302
            F V           P V L+FLI+K+ R +L     +E+F+    +  P R SY  I  
Sbjct: 248 FFGV-----------PCV-LIFLIYKWKRRSLSMYHAIEEFIQTHNNLKPIRXSYSNIKK 295

Query: 303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQ 362
           MT  FT KLG+GG+GSVYKG+L +G L+AVKML NSK + ++FINEV+TIGRIHH NVVQ
Sbjct: 296 MTKGFTEKLGEGGYGSVYKGKLXSGHLVAVKMLANSKANGQDFINEVATIGRIHHFNVVQ 355

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           L+GFC EGSKRA+VY++MPNGSLD++IFP++    S S+EK+++++LG A GIEYLH GC
Sbjct: 356 LIGFCVEGSKRALVYDFMPNGSLDKYIFPEKEEXISLSFEKMYQISLGVAHGIEYLHRGC 415

Query: 423 DVCILHFDIKPHNI 436
           D+ ILHFDIKPHNI
Sbjct: 416 DMQILHFDIKPHNI 429

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359495100|ref|XP_002265444.2| PREDICTED: probable receptor-like protein kinase At5g39020-like [Vitis vinifera]

 Score =  309 bits (792), Expect = 2e-81,   Method: Compositional matrix adjust.
 Identities = 187/446 (41%), Positives = 257/446 (57%), Gaps = 57/446 (12%)

Query: 38  SSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVV 97
           SSCGDVK IS PFRLKGDP+ CG P+ EL CE+N+T+    +GKYYV  I+YD  TI VV
Sbjct: 33  SSCGDVKKISNPFRLKGDPSGCGDPDYELVCENNRTMVNLENGKYYVADINYDNYTIRVV 92

Query: 98  DVNLAYGSCSFPSTSFSPPGLSFSYSF------DYNLNSYAN-----YVNCSSDIVDQVS 146
           D  +  G+C      FS P  S +          Y LN +        +NC   I D   
Sbjct: 93  DPGVEKGNC------FSAPLYSLTREIFRSDKRAYFLNPHEATNTTVLMNCEQPISDGNY 146

Query: 147 AKV-PCLSNN------QLNVYVYVGY--DLIATSISHLPDSCAFISKVPVVLNRSVDKLS 197
             + PC  +N      Q  VY  VG    L+   I +   SC  IS+  +        LS
Sbjct: 147 IPITPCNRSNVTSSSSQAYVYALVGGGDSLLVNDIKY---SCT-ISRTIITQFLKPGNLS 202

Query: 198 YEDLRKSLESGFDLTWL---------------DWSWSLSMPR-------YCMYNAGVVAT 235
             DL++ L  G D+++L               D  W+ +  +       +  Y   +   
Sbjct: 203 MSDLQEILLQGLDISFLPFRCKSECHMKGPYCDLDWTKNTVKWYSFGYWFSEYLESLRGV 262

Query: 236 IICYPYYIRFP----VDVLIIGRFILAPIVFLVFLIHKYRTT-LQTVDNVEKFLHNQQSW 290
              Y YY  +     + ++IIGR I   +  LV+LI+K+R   L   D++E+FLH+ ++ 
Sbjct: 263 RERYNYYYHYETALYLGMIIIGRAIPGILCLLVYLIYKFRQRHLSLDDDIEEFLHSHKNL 322

Query: 291 MPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVS 350
            P +YSY EI  MT++F +KLGQGGFGS+YKG+L +G ++AVKML  SK + ++FINEV+
Sbjct: 323 QPIKYSYSEIKKMTHNFKNKLGQGGFGSMYKGKLQSGRIVAVKMLVMSKANGQDFINEVA 382

Query: 351 TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALG 410
           TIGRIHHVNVV+L+GFC + SK A+VY++MPNGSLD+ +F  +      +WE+L+++ALG
Sbjct: 383 TIGRIHHVNVVRLVGFCIQRSKWALVYDFMPNGSLDKFVFLDQGNNIPLNWERLYKIALG 442

Query: 411 TARGIEYLHNGCDVCILHFDIKPHNI 436
             RGIEYLH GCD+ ILHFDIKPHNI
Sbjct: 443 VGRGIEYLHQGCDMQILHFDIKPHNI 468

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225455116|ref|XP_002268775.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  307 bits (787), Expect = 6e-81,   Method: Compositional matrix adjust.
 Identities = 181/423 (42%), Positives = 249/423 (58%), Gaps = 35/423 (8%)

Query: 30  KLAVKMCSSSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISY 89
           KL  K C SSCG++ +I  PFRLK DP  CG  E EL+CE+N+TI   NS KYYV+ I+Y
Sbjct: 26  KLNDKACHSSCGNIHDIRGPFRLKDDPLSCGDSEYELACENNRTILHLNSRKYYVEEINY 85

Query: 90  DKCTISVVDVNLAYGSCSFPSTSFSPPGLSFSYSFDYNLN---SYANYVNCSSDIVDQVS 146
              TI VVD  L    CS      S    +F   + Y L    +  N+++C + I     
Sbjct: 86  KHETIRVVDTALRKDDCS-TLLLHSLNDENFGDEYLYILRDKYTAINFIDCEAPISSPFY 144

Query: 147 AKVP-CLSNN---------QLNVYVYVGYDLIATSISHLPDSCAFISKVPVVLNRS--VD 194
             +P C  N+         Q   YV VG       +S L DSC+ I++V  + +R   +D
Sbjct: 145 VDMPFCSKNSSSNFSLSSIQTYSYVVVG----DMKVSDLRDSCS-IARVVRISSRGPKID 199

Query: 195 KLSYEDLRKSLESGFDLTWLDWSWSLSMPRYCMYNAGVVATIICYPYYIRFPVDVLIIGR 254
           K S   ++  L  G DL W D+   L      +  +G +             + +++  R
Sbjct: 200 KSSLSSIQDGLLYGTDLIW-DFKAYLRWFAPAILESGSLL------------IGLIVALR 246

Query: 255 FILAPIVFLVFLIHKYRT-TLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQ 313
            +      L+FL++K+R   L     +E+F+      MP RYSY  I  MT  F  KLG+
Sbjct: 247 TLFGTPCVLIFLVYKWRRRNLSMYQAIEEFIQTHNKLMPIRYSYSNIKKMTKGFNEKLGE 306

Query: 314 GGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR 373
           GG+GSVYKG+L +G L+AVK++ NSK + ++FINEV+TIG+IHHVNVVQLLGFC EGSKR
Sbjct: 307 GGYGSVYKGKLRSGHLVAVKLMTNSKSNGQDFINEVATIGKIHHVNVVQLLGFCVEGSKR 366

Query: 374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP 433
           A+VY++MPNGSLD++IFP++    S S+EK+++++LG A GIEYLH GCD+ ILHFDIKP
Sbjct: 367 ALVYDFMPNGSLDKYIFPEKEGNISLSFEKMYQISLGVAHGIEYLHRGCDMQILHFDIKP 426

Query: 434 HNI 436
           HNI
Sbjct: 427 HNI 429

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545008|ref|XP_002513565.1| kinase, putative [Ricinus communis] gi|223547473|gb|EEF48968.1| kinase, putative [Ricinus communis]

 Score =  306 bits (785), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 181/436 (41%), Positives = 263/436 (60%), Gaps = 38/436 (8%)

Query: 32  AVKMCS-SSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYD 90
             ++C+ SSCGDVKNI  PFRL+ D   CG+P  ELSCE+N+TI    SG+Y V  I++ 
Sbjct: 37  GTRLCAPSSCGDVKNIRLPFRLRTDSKNCGYPVYELSCENNETILYLFSGRYRVLSINHH 96

Query: 91  KCTISVVDVNLAYGSCSFPSTSFSPPGLSFS-----YSFDYNL-NSYANYVNCSSDIVDQ 144
             T+ VVD  +  G+CS     FS  G +F+     + +DY +  +   ++NC++ +   
Sbjct: 97  NSTVRVVDAAVEKGNCS-SVPQFSLSGANFTDAKHWFGYDYEVPKAMIVFMNCANPVNST 155

Query: 145 VSAKVPCLSNNQLNVYVYVGYDLIATSISHLPDSCA--FISKVPVVLNRSVDKLSYEDLR 202
           +       +N + + ++ V  D     +S++ + C    ++   ++L R   KLSY D+ 
Sbjct: 156 LYGDATSCTNGRYS-HIMVSRD----EMSNVENLCTIELVAMSSLLLQRHGKKLSYMDIH 210

Query: 203 KSLESGFDLTWLDWSWSLSMPRYCMY---------NAGVVATIICY-----------PYY 242
             L  GF+L W D +          Y         + GV  ++I +            + 
Sbjct: 211 NQLAFGFELRWFDITCEFCHGDEKYYPVGSTSPCNSHGVFDSLISHIKSFLSQLKYLSWL 270

Query: 243 IRFPVDVLIIGRFILAPIVFLVFLIHKYRTT-LQTVDNVEKFLHNQQSWMPKRYSYPEII 301
           I   + +L   +F+       VFLI+K+R   L   DN+E+FL +Q ++MP RYSY +I 
Sbjct: 271 ILLILALLPAAKFVFCSPFAFVFLIYKWRKRHLSMYDNIEEFLESQNNFMPIRYSYLDIR 330

Query: 302 AMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS-AEEFINEVSTIGRIHHVNV 360
            MTN+F  KLG+GG+GSVYKG+L +G L AVK+L  SK +  +EF+NEV+TIGRIHH+NV
Sbjct: 331 KMTNNFKDKLGEGGYGSVYKGKLRSGCLAAVKILGKSKAANGQEFMNEVATIGRIHHINV 390

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+L+GFC EGSKRA+VYE+MPNGSLD++IF +E    S SW K++E++LG ARGIEYLH 
Sbjct: 391 VRLVGFCFEGSKRALVYEFMPNGSLDKYIFYEEGYA-SLSWRKMYEISLGVARGIEYLHR 449

Query: 421 GCDVCILHFDIKPHNI 436
           GC++ ILHFDIKPHNI
Sbjct: 450 GCEMQILHFDIKPHNI 465

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242053327|ref|XP_002455809.1| hypothetical protein SORBIDRAFT_03g025630 [Sorghum bicolor] gi|241927784|gb|EES00929.1| hypothetical protein SORBIDRAFT_03g025630 [Sorghum bicolor]

 Score =  306 bits (783), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 188/462 (40%), Positives = 255/462 (55%), Gaps = 70/462 (15%)

Query: 39  SCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVVD 98
           SCGD+ NIS PFR  GDP  CG    ELSC  +K     N+  Y+V  I+Y   +  VVD
Sbjct: 45  SCGDLHNISSPFRRPGDPPECGVQAYELSCSRSKATIRINTETYFVTSINYTDLSFGVVD 104

Query: 99  VNL-AYGSCSFP-----------STSFSPPGLSFSY--SFDYNLNSYANYVNCSSDIVDQ 144
            NL  + SC  P           + S+   GL   Y   FDY+ N++A ++NCS    + 
Sbjct: 105 ANLDMHSSCPLPRPDQFRYNDDYTGSYLESGLHSHYDLGFDYS-NNWACFINCSQSKTNS 163

Query: 145 VSAK-VPCLSNNQLNVYVYVGYDLIATSISHLPDSCAFISKVP-----VVLNRSVDKLSY 198
              K V CLS N  N +VYV  D    ++S L  SC +++ +P      + +  ++  SY
Sbjct: 164 SWYKPVNCLSAN--NSFVYVMVDYSDCTVSSLEPSCGYLAMIPFGNWRTITDPDLENASY 221

Query: 199 EDLRKSLESGFDL------------TW----------------------LDWS----WSL 220
            D+   +  GF +            +W                      L+W+    WS 
Sbjct: 222 TDIIDYVRKGFSVQFPHDYYSGRNASWIFKTCRNNSISYFHEQLFGTSILNWTRAFFWSE 281

Query: 221 SMPRYCMY-----NAGVVATIICYPYYIRFPVDVLIIGRFILAPIVFLVFLIHKYRTTLQ 275
           S    C+Y     N      +I     +       ++ R +L  +V   FL +KY  T  
Sbjct: 282 SHFAQCVYSYYTPNLMFQRVVIAIVSAVNVAKLYFVLCRLVLPALVVFTFLAYKYWKTRI 341

Query: 276 TVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGL-IAVKM 334
           T+D VEKFL  QQ   P R++Y +I A+T+HF  KLGQGG+GSVYKG L  G + +A+KM
Sbjct: 342 TIDAVEKFLQMQQMLGPMRFAYTDITAITSHFRDKLGQGGYGSVYKGVLLPGNVHVAIKM 401

Query: 335 LKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKES 394
           L NS  + +EFI+EVSTIGRIHH+NVV+L+GFC+E  +RA+VYEYMP+GSLD++IF  E 
Sbjct: 402 LGNSNCNGDEFISEVSTIGRIHHINVVRLVGFCAEEMRRALVYEYMPHGSLDKYIFSAE- 460

Query: 395 RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
             +SFSW+KL+E+ALG ARGI YLH GCD+ ILHFDIKPHNI
Sbjct: 461 --RSFSWDKLNEIALGIARGINYLHLGCDMQILHFDIKPHNI 500

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359490671|ref|XP_003634135.1| PREDICTED: probable receptor-like protein kinase At5g39020-like [Vitis vinifera]

 Score =  305 bits (780), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 184/435 (42%), Positives = 254/435 (58%), Gaps = 53/435 (12%)

Query: 38  SSCGDVKNISYPFRLKGDPARCGHPELELSCESNKTIFEFNSGKYYVKRISYDKCTISVV 97
           SSCGD+K IS PFRLKGDP+ CG P+ EL CE+N+T+   + GKYYV  I+YD  TI +V
Sbjct: 33  SSCGDIKKISNPFRLKGDPSGCGDPDYELVCENNRTMVNLDHGKYYVADINYDNYTIRIV 92

Query: 98  DVNLAYGSCSFPSTSFSPPGLSFSYSF------DYNLNSYAN-----YVNCSSDIVDQVS 146
           D  +  G+C      FS P  S +          Y LN +        +NC   I D   
Sbjct: 93  DPGVEKGNC------FSAPLYSLTREIFRSDKRAYFLNPHEATNTTVLMNCEQSISDGNY 146

Query: 147 AKV-PCLSNN------QLNVYVYVGY--DLIATSISHLPDSCAFISKVPVVLNRSVDKLS 197
             + PC  +N      Q  VY  VG    L+   I +   SC  IS+  +        LS
Sbjct: 147 IPITPCNRSNVTSSSSQAYVYALVGGGDSLLVNDIKY---SCT-ISRTIITQFLKPGNLS 202

Query: 198 YEDLRKSLESGFDLTWL---------------DWSWSLSMPRYCMYNAGVVATIICYPYY 242
             DL++ L  G D+++L               D  W+ +  ++  Y+ G       +  Y
Sbjct: 203 MSDLQEILLQGLDISFLPFRCKSECHVKGPYCDLDWTKNTVKW--YSFGY-----WFSEY 255

Query: 243 IRFPVDVLIIGRFILAPIVFLVFLIHKYRTT-LQTVDNVEKFLHNQQSWMPKRYSYPEII 301
           +     ++IIGR I   +  LV+LI+K+R   L   D +E+FLH+ ++  P +YSY EI 
Sbjct: 256 LESLRGMIIIGRAIPGILCLLVYLIYKFRRRHLSLDDGIEEFLHSHKNLQPIKYSYSEIK 315

Query: 302 AMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVV 361
            MT++F +KLGQGGFGSVYKG+L +G ++AVKML  SK + ++FINEV+TIGRIHHVNVV
Sbjct: 316 KMTHNFKNKLGQGGFGSVYKGKLQSGHIVAVKMLVMSKANGQDFINEVATIGRIHHVNVV 375

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
           +L+GFC + SK A+VY++MPNGSLD+ +F  +      +WE+L+++ALG  RGIEYLH G
Sbjct: 376 RLVGFCIQRSKWALVYDFMPNGSLDKFVFLDQGNNIPLNWERLYKIALGVGRGIEYLHQG 435

Query: 422 CDVCILHFDIKPHNI 436
            D+ ILHFDIKPHNI
Sbjct: 436 YDMQILHFDIKPHNI 450

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	436
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.405	0.265	0.459	4e-49
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.954	0.652	0.317	9.8e-48
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.580	0.375	0.395	2.8e-46
TAIR|locus:2019713	892	AT1G67000 [Arabidopsis thalian	0.419	0.205	0.455	2.2e-44
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.419	0.275	0.492	1.2e-41
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.396	0.202	0.473	2.1e-39
TAIR|locus:2116525	821	SD2-5 "S-domain-2 5" [Arabidop	0.438	0.232	0.444	3.9e-39
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.417	0.227	0.442	1.4e-36
TAIR|locus:2177142	813	AT5G39020 [Arabidopsis thalian	0.415	0.222	0.434	4.1e-36
TAIR|locus:2176697	588	AT5G38240 [Arabidopsis thalian	0.270	0.200	0.539	6.7e-36

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 435 (158.2 bits), Expect = 4.0e-49, Sum P(2) = 4.0e-49
 Identities = 86/187 (45%), Positives = 128/187 (68%)

Query:   256 ILAPIVFLVFLIHKYRTTL-----QTVDNVEKFLHNQQSWMP-KRYSYPEIIAMTNHFTH 309
             ++  +  L  LI + R TL     +T D+  +   N ++ +P K YSY ++ ++T  F  
Sbjct:   295 VILVVTCLNCLIRRQRKTLNDPRMRTSDDSRQ--QNLKALIPLKHYSYAQVTSITKSFAE 352

Query:   310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
              +G+GGFG+VY+G L+ G  +AVK+LK S+ + E+FINEV+++ +  HVN+V LLGFCSE
Sbjct:   353 VIGKGGFGTVYRGTLYDGRSVAVKVLKESQGNGEDFINEVASMSQTSHVNIVTLLGFCSE 412

Query:   370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
             G KRA++YE+M NGSLD+ I  K+S   +  W +L+ +ALG ARG+EYLH+GC   I+HF
Sbjct:   413 GYKRAIIYEFMENGSLDKFISSKKS--STMDWRELYGIALGVARGLEYLHHGCRTRIVHF 470

Query:   430 DIKPHNI 436
             DIKP N+
Sbjct:   471 DIKPQNV 477

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 499 (180.7 bits), Expect = 9.8e-48, P = 9.8e-48
 Identities = 144/454 (31%), Positives = 228/454 (50%)

Query:     7 SIFSTFLFCLLMFVFSPREIEARKLAVKMCSSS--CGDVKNISYPFRLKGDPARCGHPEL 64
             S+  T ++ L +       ++ R+   K CS +  CG   ++ YPF    D   CGHP  
Sbjct:    11 SLSYTIIWMLFVIPSCVLSVDERQ---KHCSPTFRCGKQTDLYYPF-WSPDREECGHPVF 66

Query:    65 ELSCESNKTIFEFNSGKYYVKRISYDKCTISVVDVNLAYGXXXXXXXXXXXXXXXXXYSF 124
             +++C  +   F  ++ K++V  ++Y+   I +V                        +  
Sbjct:    67 KVNCSGDFAEFTISTVKFHVLEMNYESRIIRLVRTEYLNNLCPWHPENRSINQEVLPFLQ 126

Query:   125 DYNLNSYANYVNCSSDIVDQVS-AKVPCLS-NNQLNVYVYV----GYDLIATSISHLPDS 178
             D  L ++  Y NCS   VD+++   +  L  + ++    Y      +      +  L  S
Sbjct:   127 DTELGTF--YYNCSGPTVDELANGYIRQLGCDEEVGGKSYFVSSPSHPGNRAILDGLSAS 184

Query:   179 CAFISKVPV---VLNRSVDKLSYEDLRKSLESGFDLTW-LDWSWSLSMPRYCMYNAGVVA 234
             C     +PV    +  +    S E ++K L+ GF+L +  D S  ++    C +N    A
Sbjct:   185 CERNVDIPVSRSAMETTATNQSLEAIKKVLDVGFELGFNSDCSLCVASKGACGFNQSSKA 244

Query:   235 TIICY----PYYI---RFPVDVLIIGRFILAPIV---FLVFLIHKYRTT--LQTVDNVEK 282
               +CY    P+     +  + + +   F+ A ++    L F   K RT+  L+  DN  K
Sbjct:   245 -FVCYCKDEPHEHTCGKMGIGIGLGCGFLGATLITVCLLCFFFQKRRTSHHLRPRDNNLK 303

Query:   283 FLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA 342
              L        K+YSY E+  +T  F+H LG+GGFG+VY G L  G  +AVK+LK+ K + 
Sbjct:   304 GLVQL-----KQYSYAEVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAVKILKDFKSNG 358

Query:   343 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE 402
             E+FINEV+++ +  HVN+V LLGFC EGSKRA+VYE++ NGSLD+ +  K+S     S  
Sbjct:   359 EDFINEVASMSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFLSEKKSLNLDVS-- 416

Query:   403 KLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
              L+ +ALG ARG++YLH+GC   I+HFDIKP NI
Sbjct:   417 TLYRIALGVARGLDYLHHGCKTRIVHFDIKPQNI 450

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 414 (150.8 bits), Expect = 2.8e-46, Sum P(2) = 2.8e-46
 Identities = 108/273 (39%), Positives = 154/273 (56%)

Query:   172 ISHLPDSCAFISKVPV---VLNRSVDKLSYEDLRKSLESGFDLTW-LDWSWSLSMPRYCM 227
             +++L + C     VP     LN      +  +L+ +LE GF+L    + S  +     C 
Sbjct:   216 LNNLREMCKRKVSVPASGPALNTLQTNPNSNNLKMALEHGFELQDNSNCSMCVLSGGSCG 275

Query:   228 YNAGVVATIICYPYYIRFPVDVLIIGRFILAPIVFLVFLIH--KYRTTLQTVDNVEKFLH 285
             YN   +A II       F V +  IG FI     FLV L    K R       + ++   
Sbjct:   276 YNQNSMAIIIGI-----F-VALCTIGGFI----AFLVLLCPCCKVRIFRNRKTSDDRRQE 325

Query:   286 NQQSWMP-KRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS-AE 343
               ++ +P K Y+Y ++  MT  F   +G+GGFG VY+G L  G ++AVK+LK SK + +E
Sbjct:   326 KLKALIPLKHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSE 385

Query:   344 EFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK 403
             +FINEVS++ +  HVN+V LLGFCSEGS+RA++YE++ NGSLD+ I  K S         
Sbjct:   386 DFINEVSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFISEKTS--VILDLTA 443

Query:   404 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
             L+ +ALG ARG+EYLH GC   I+HFDIKP N+
Sbjct:   444 LYGIALGVARGLEYLHYGCKTRIVHFDIKPQNV 476

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)]

 Score = 413 (150.4 bits), Expect = 2.2e-44, Sum P(2) = 2.2e-44
 Identities = 88/193 (45%), Positives = 124/193 (64%)

Query:   250 LIIGRFILAPIVFLVFLIHKYRTTL----QTVDNVEKFLHNQQSWMP-KRYSYPEIIAMT 304
             + +G      IVFLV L   +R  +    +T D V   L   ++ +P K Y+Y E+  MT
Sbjct:   498 IALGALTGVVIVFLVLLCPCFRVQIFRKRKTSDEVR--LQKLKALIPLKHYTYAEVKKMT 555

Query:   305 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS-AEEFINEVSTIGRIHHVNVVQL 363
               FT  +G+GGFG VY G L    ++AVK+LK+SK +  E+FINEV+++ +  HVN+V L
Sbjct:   556 KSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSHVNIVSL 615

Query:   364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
             LGFC EGS+RA++YE++ NGSLD+ I  K S   +   + L+ +ALG ARG+EYLH GC 
Sbjct:   616 LGFCCEGSRRAIIYEFLGNGSLDKFISDKSS--VNLDLKTLYGIALGVARGLEYLHYGCK 673

Query:   424 VCILHFDIKPHNI 436
               I+HFDIKP N+
Sbjct:   674 TRIVHFDIKPQNV 686

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 444 (161.4 bits), Expect = 1.2e-41, P = 1.2e-41
 Identities = 93/189 (49%), Positives = 128/189 (67%)

Query:   250 LIIGRFILAPIVFLVFLIHKYRTTLQTVDNVEKFLHNQQSW-MPKRYSYPEIIAMTNHFT 308
             LI+G      ++ L+ ++   RT  + + N E    N ++  M KRYSY  +  MTN F 
Sbjct:   277 LIVGVSAALTLMILIVVVIIVRT--KNMRNSEWNDQNVEAVAMLKRYSYTRVKKMTNSFA 334

Query:   309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
             H LG+GGFG+VYKG+L   G  +AVK+LK S+ + EEFINEV+++ R  HVN+V LLGFC
Sbjct:   335 HVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGNGEEFINEVASMSRTSHVNIVSLLGFC 394

Query:   368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
              E +KRA++YE+MPNGSLD++I    S      WE+L++VA+G +RG+EYLHN C   I+
Sbjct:   395 YEKNKRAIIYEFMPNGSLDKYISANMST--KMEWERLYDVAVGISRGLEYLHNRCVTRIV 452

Query:   428 HFDIKPHNI 436
             HFDIKP NI
Sbjct:   453 HFDIKPQNI 461

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 429 (156.1 bits), Expect = 2.1e-39, P = 2.1e-39
 Identities = 88/186 (47%), Positives = 123/186 (66%)

Query:   256 ILAPIVFLVFLI---HKYRTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLG 312
             +L  IV +  ++   H  R +    +N+E  +      M KRYS+ ++  MTN F H +G
Sbjct:   473 VLISIVVIALVVRARHAKRKSELNDENIEAVV------MLKRYSFEKVKKMTNSFDHVIG 526

Query:   313 QGGFGSVYKGQLH--TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 370
             +GGFG+VYKG+L   +G  IA+K+LK SK + EEFINE+ ++ R  HVN+V L GFC EG
Sbjct:   527 KGGFGTVYKGKLPDASGRDIALKILKESKGNGEEFINELVSMSRASHVNIVSLFGFCYEG 586

Query:   371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFD 430
             S+RA++YE+MPNGSLD+ I   E+      W+ L+ +A+G ARG+EYLHN C   I+HFD
Sbjct:   587 SQRAIIYEFMPNGSLDKFI--SENMSTKIEWKTLYNIAVGVARGLEYLHNSCVSKIVHFD 644

Query:   431 IKPHNI 436
             IKP NI
Sbjct:   645 IKPQNI 650

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 426 (155.0 bits), Expect = 3.9e-39, P = 3.9e-39
 Identities = 88/198 (44%), Positives = 126/198 (63%)

Query:   245 FP--VDVLIIGRFILAPIVFLVFLIHKYRTTL----QTVDNVEKFLHNQQSWMPKRYSYP 298
             FP  V ++++  FI+A ++F+ F IHK +  +    Q     + FL N  S MP R++Y 
Sbjct:   428 FPYVVIIVVVTVFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENL-SGMPIRFAYK 486

Query:   299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
             ++ + TN+F+ KLGQGGFGSVY+G L  G  +AVK L+      +EF  EVS IG IHH+
Sbjct:   487 DLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHL 546

Query:   359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
             ++V+L GFC+EG+ R + YE++  GSL+R IF K+       W+    +ALGTA+G+ YL
Sbjct:   547 HLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYL 606

Query:   419 HNGCDVCILHFDIKPHNI 436
             H  CD  I+H DIKP NI
Sbjct:   607 HEDCDARIVHCDIKPENI 624

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 402 (146.6 bits), Expect = 1.4e-36, P = 1.4e-36
 Identities = 84/190 (44%), Positives = 124/190 (65%)

Query:   250 LIIG-RFILAPIVFLVFLIHKYRTT-LQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHF 307
             LI+G   +LA ++ +V ++ K R   ++  D  EK +  +   M KR+SY ++  MT  F
Sbjct:   405 LILGVSSVLATMIIIV-IVGKVRANNMRKSDLNEKNM--EAVVMLKRFSYVQVKKMTKSF 461

Query:   308 THKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
              + LG+GGFG+VYKG+L  G   +AVK+LK S    E+FINE++++ R  H N+V LLGF
Sbjct:   462 ENVLGKGGFGTVYKGKLPDGSRDVAVKILKESNEDGEDFINEIASMSRTSHANIVSLLGF 521

Query:   367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
             C EG K+A++YE MPNGSLD+ I   ++      W+ L+ +A+G + G+EYLH+ C   I
Sbjct:   522 CYEGRKKAIIYELMPNGSLDKFI--SKNMSAKMEWKTLYNIAVGVSHGLEYLHSHCVSRI 579

Query:   427 LHFDIKPHNI 436
             +HFDIKP NI
Sbjct:   580 VHFDIKPQNI 589

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)]

 Score = 386 (140.9 bits), Expect = 4.1e-36, Sum P(2) = 4.1e-36
 Identities = 83/191 (43%), Positives = 125/191 (65%)

Query:   249 VLIIGRFI-LAP-IVFLVFLIHKYRTTLQTVDN-VEKFLHNQQSWMPKRYSYPEIIAMTN 305
             ++++G  I LA  IV ++ LI + +      +N V  F       + K+Y Y E+  +T 
Sbjct:   442 LIVVGSVIGLATFIVIIMLLIRQMKRKKNKKENSVIMF-----KLLLKQYIYAELKKITK 496

Query:   306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
              F+H +G+GGFG+VY+G L  G  +AVK+LK+ K + ++FINEV+++ +  HVN+V LLG
Sbjct:   497 SFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVSLLG 556

Query:   366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
             FC EGSKRA++ E++ +GSLD+ I   +S   + +   L+ +ALG ARG+EYLH GC   
Sbjct:   557 FCYEGSKRAIISEFLEHGSLDQFISRNKSLTPNVT--TLYGIALGIARGLEYLHYGCKTR 614

Query:   426 ILHFDIKPHNI 436
             I+HFDIKP NI
Sbjct:   615 IVHFDIKPQNI 625

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)]

 Score = 343 (125.8 bits), Expect = 6.7e-36, Sum P(2) = 6.7e-36
 Identities = 68/126 (53%), Positives = 89/126 (70%)

Query:   311 LGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 370
             +G+GGFG+VYKG L  G  +AVK+LK+S  + E+FINEV++I +  HVN+V LLGFC E 
Sbjct:   287 VGRGGFGTVYKGNLRDGRKVAVKILKDSNGNCEDFINEVASISQTSHVNIVSLLGFCFEK 346

Query:   371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFD 430
             SKRA+VYE++ NGSLD+          +     L+ +ALG ARGIEYLH GC   I+HFD
Sbjct:   347 SKRAIVYEFLENGSLDQ--------SSNLDVSTLYGIALGVARGIEYLHFGCKKRIVHFD 398

Query:   431 IKPHNI 436
             IKP N+
Sbjct:   399 IKPQNV 404

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00030422001 SubName- Full=Chromosome chr1 scaffold_5, whole genome shotgun sequence; (728 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	436
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-26
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-25
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-24
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-24
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-18
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-17
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-14
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-14
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-13
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-12
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-11
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-11
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-10
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-10
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-10
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-10
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-10
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-09
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-09
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-09
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-09
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-09
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-09
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-08
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-08
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-08
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-08
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-08
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-08
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-08
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-08
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-07
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-07
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-07
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-07
pfam13947	106	pfam13947, GUB_WAK_bind, Wall-associated receptor	4e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-07
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-06
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-06
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-06
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-06
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-06
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-06
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-06
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-05
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-05
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-05
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-05
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-05
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-05
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-05
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-04
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-04
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-04
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-04
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-04
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-04
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-04
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-04
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-04
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-04
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-04
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	0.001
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	0.001
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	0.001
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	0.001
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	0.001
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	0.001
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	0.001
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	0.001
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	0.002
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	0.002
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	0.002
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	0.002
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	0.003
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	0.003
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.003
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	0.004
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	0.004
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	0.004
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	0.004
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	0.004
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	0.004

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  115 bits (290), Expect = 1e-29
 Identities = 49/137 (35%), Positives = 68/137 (49%), Gaps = 12/137 (8%)

Query: 307 FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSKFSA--EEFINEVSTIGRIHHVN 359
              KLG+G FG VYKG L          +AVK LK        EEF+ E   + ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           +V+LLG C+E     +V EYMP G L  ++  +++R +  S   L   AL  ARG+EYL 
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 420 NGCDVCILHFDIKPHNI 436
                  +H D+   N 
Sbjct: 121 ---SKNFIHRDLAARNC 134

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  110 bits (278), Expect = 6e-28
 Identities = 49/137 (35%), Positives = 68/137 (49%), Gaps = 13/137 (9%)

Query: 307 FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSKFSA--EEFINEVSTIGRIHHVN 359
              KLG+G FG VYKG+L          +AVK LK        EEF+ E   + ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           VV+LLG C+E     +V EYM  G L  ++  +++R +  S   L   AL  ARG+EYL 
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPK-LSLSDLLSFALQIARGMEYLE 119

Query: 420 NGCDVCILHFDIKPHNI 436
                  +H D+   N 
Sbjct: 120 ---SKNFIHRDLAARNC 133

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  107 bits (269), Expect = 1e-26
 Identities = 48/133 (36%), Positives = 69/133 (51%), Gaps = 13/133 (9%)

Query: 306 HFTHKLGQGGFGSVYKGQLH-----TGGLIAVKMLKNSKFSA--EEFINEVSTIGRIHHV 358
               KLG+G FG VYKG L      T   +AVK LK        EEF+ E S + ++ H 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           N+V+LLG C++G    +V EYMP G L   +      G+  + + L ++AL  A+G+EYL
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 419 HNGCDVCILHFDI 431
                   +H D+
Sbjct: 119 E---SKNFVHRDL 128

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  104 bits (261), Expect = 2e-25
 Identities = 48/136 (35%), Positives = 73/136 (53%), Gaps = 13/136 (9%)

Query: 306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFI---NEVSTIGRIHHVNVV 361
               KLG G FG+VYK +   TG ++AVK+LK     +++      E+  + R+ H N+V
Sbjct: 2   ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-N 420
           +L+    +     +V EY   G L  ++    SRG   S ++  ++AL   RG+EYLH N
Sbjct: 62  RLIDAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 421 GCDVCILHFDIKPHNI 436
           G    I+H D+KP NI
Sbjct: 118 G----IIHRDLKPENI 129

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  100 bits (251), Expect = 1e-24
 Identities = 42/129 (32%), Positives = 71/129 (55%), Gaps = 9/129 (6%)

Query: 311 LGQGGFGSVYKGQLH-TGGLIAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           LG+GGFG+VY  +   TG  +A+K++K  +S    EE + E+  + +++H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
            + +   +V EY   GSL   +   +      S +++  + L    G+EYLH+     I+
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHS---NGII 114

Query: 428 HFDIKPHNI 436
           H D+KP NI
Sbjct: 115 HRDLKPENI 123

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =   99 bits (250), Expect = 5e-24
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 10/130 (7%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS--AEEFINEVSTIGRIHHVNVVQLLGF 366
           KLG+G FG VY  +   TG L+A+K++K  K     E  + E+  + ++ H N+V+L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
             +  K  +V EY   G L   +     +    S ++           +EYLH      I
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLH---SKGI 118

Query: 427 LHFDIKPHNI 436
           +H D+KP NI
Sbjct: 119 VHRDLKPENI 128

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 99.5 bits (249), Expect = 8e-24
 Identities = 48/139 (34%), Positives = 69/139 (49%), Gaps = 16/139 (11%)

Query: 310 KLGQGGFGSVYKGQLHTGG----LIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQL 363
           KLG+G FG VYKG+L         +AVK LK      E  +F+ E   + ++ H NVV+L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 364 LGFCSEGSKRAVVYEYMPNGSLD------RHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           LG C+E     +V EYM  G L       R +FP   +  + S + L   A+  A+G+EY
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEK-STLSLKDLLSFAIQIAKGMEY 120

Query: 418 LHNGCDVCILHFDIKPHNI 436
           L +      +H D+   N 
Sbjct: 121 LAS---KKFVHRDLAARNC 136

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 5e-18
 Identities = 42/132 (31%), Positives = 72/132 (54%), Gaps = 12/132 (9%)

Query: 311 LGQGGFGSVYKGQLHTGG----LIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQLL 364
           +G G FG V +G+L   G     +A+K LK      +  +F+ E S +G+  H N+++L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     ++ EYM NGSLD+  F +E+ G+ F+  +L  +  G A G++YL    ++
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDK--FLRENDGK-FTVGQLVGMLRGIASGMKYL---SEM 125

Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 126 NYVHRDLAARNI 137

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 81.8 bits (203), Expect = 1e-17
 Identities = 46/142 (32%), Positives = 64/142 (45%), Gaps = 29/142 (20%)

Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
             LG+G FGSVY      TG L+AVK ++   +S+   E    E+  +  + H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 365 GFCSEGSKRAVVY----EYMPNGSLDRHIFPKESRGQSFSWEKLHE--VALGTA---RGI 415
           G  SE  +         EY+  GSL   +   +  G      KL E  +   T     G+
Sbjct: 66  G--SERDEEKNTLNIFLEYVSGGSLSSLL---KKFG------KLPEPVIRKYTRQILEGL 114

Query: 416 EYLH-NGCDVCILHFDIKPHNI 436
            YLH NG    I+H DIK  NI
Sbjct: 115 AYLHSNG----IVHRDIKGANI 132

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 46/131 (35%), Positives = 71/131 (54%), Gaps = 10/131 (7%)

Query: 309 HKLGQGGFGSVYKG-QLHTGGLIAVKMLK-NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
            K+G+GGFG VYK     TG  +A+K++K  SK   E+ INE+  + +  H N+V+  G 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGCDVC 425
             +  +  +V E+   GSL   +   +S  Q+ +  ++  V     +G+EYLH NG    
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSNG---- 118

Query: 426 ILHFDIKPHNI 436
           I+H DIK  NI
Sbjct: 119 IIHRDIKAANI 129

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 39/129 (30%), Positives = 65/129 (50%), Gaps = 6/129 (4%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
              ++G G FG V+ G       +A+K ++    S E+FI E   + ++ H  +VQL G 
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C+E S   +V+E+M +G L  ++  +  RG  FS E L  + L    G+ YL +     +
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYL--RAQRG-KFSQETLLGMCLDVCEGMAYLESS---NV 121

Query: 427 LHFDIKPHN 435
           +H D+   N
Sbjct: 122 IHRDLAARN 130

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 37/132 (28%), Positives = 62/132 (46%), Gaps = 20/132 (15%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG------LIAVKMLKN--SKFSAEEFINEVSTIGRIHH 357
               +LG+G FG V+ G+ +         L+AVK LK   S  + ++F  E   +    H
Sbjct: 8   VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRH-----------IFPKESRGQSFSWEKLHE 406
            N+V+  G C+EG    +V+EYM +G L++              P    G+  +  +L +
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQ 126

Query: 407 VALGTARGIEYL 418
           +A+  A G+ YL
Sbjct: 127 IAVQIASGMVYL 138

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 39/128 (30%), Positives = 61/128 (47%), Gaps = 6/128 (4%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLK-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 368
           KLG G FG V++G       +A+K+LK +     ++F  EV  + R+ H +++ L   CS
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 369 EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILH 428
            G    ++ E M  GSL    F +   GQ      L ++A   A G+ YL    +   +H
Sbjct: 73  VGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127

Query: 429 FDIKPHNI 436
            D+   NI
Sbjct: 128 RDLAARNI 135

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 13/132 (9%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAE---EFINEVSTIGRIHHVNVVQLLG 365
            +G+G FG VYKG  L TG  +A+K +   K   E     + E+  +  + H N+V+ +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN-GCDV 424
                    ++ EY  NGSL + I       +S     +++V     +G+ YLH  G   
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV----LQGLAYLHEQG--- 119

Query: 425 CILHFDIKPHNI 436
            ++H DIK  NI
Sbjct: 120 -VIHRDIKAANI 130

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 42/128 (32%), Positives = 69/128 (53%), Gaps = 8/128 (6%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA--EEFINEVSTIGRIHHVNVVQLLGFC 367
           K+G+G FG VYKG L     +AVK  +++       +F+ E   + +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
            +     +V E +P GSL   +  K++R    + +KL +++L  A G+EYL +    CI 
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLESKN--CI- 115

Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 116 HRDLAARN 123

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 8/132 (6%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
                +G+G FG V  G  + G  +AVK LK+   +A+ F+ E S +  + H N+VQLLG
Sbjct: 9   KLGATIGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQS-FSWEKLHEVALGTARGIEYLHNGCDV 424
              +G+   +V EYM  GSL  ++    SRG++  +  +    AL    G+EYL      
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK--- 121

Query: 425 CILHFDIKPHNI 436
             +H D+   N+
Sbjct: 122 NFVHRDLAARNV 133

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 37/129 (28%), Positives = 65/129 (50%), Gaps = 6/129 (4%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  +LG G FG V+ G+      +A+KM++    S ++FI E   + ++ H N+VQL G 
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C++     +V EYM NG L  ++  ++ +  +   E L ++       +EYL +      
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGT---EWLLDMCSDVCEAMEYLESN---GF 121

Query: 427 LHFDIKPHN 435
           +H D+   N
Sbjct: 122 IHRDLAARN 130

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 15/125 (12%)

Query: 311 LGQGGFGSVYKGQLH----TGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQL 363
           LG+G FGSV +GQL     +   +AVK +K    +    EEF++E + +    H NV++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 364 LGFCSEGSKRA------VVYEYMPNGSLDRHIFPKESRGQS--FSWEKLHEVALGTARGI 415
           +G C E S         V+  +M +G L   +      G       + L +  +  A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 416 EYLHN 420
           EYL N
Sbjct: 127 EYLSN 131

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 40/109 (36%), Positives = 54/109 (49%), Gaps = 2/109 (1%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLG G FG V+ G  +    +AVK LK    S E F+ E   + ++ H  +VQL   CSE
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
                +V EYM  GSL    F K   G+     +L ++A   A G+ YL
Sbjct: 73  EEPIYIVTEYMSKGSLLD--FLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 39/111 (35%), Positives = 58/111 (52%), Gaps = 3/111 (2%)

Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL
Sbjct: 72  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL 120

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 31/162 (19%)

Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGG------LIAVKMLKNSKFSA--EEFINEVS 350
           EI      F  +LG+G FG VYKG+L           +A+K LK +      +EF  E  
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 351 TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIF--------------PKESRG 396
            +  + H N+V LLG C++     +++EY+ +G L  H F                E+  
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL--HEFLVRNSPHSDVGAESGDETVK 118

Query: 397 QSFSWEKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNI 436
            S        +A+  A G+EYL  H+      +H D+   N 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNC 155

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 69.0 bits (167), Expect = 9e-13
 Identities = 42/132 (31%), Positives = 61/132 (46%), Gaps = 11/132 (8%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS----AEEFINEVSTIGRI-HHVNVVQLL 364
           KLG+G FG VY  +     L+A+K+L     S     E F+ E+  +  + H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
            F  +     +V EY+  GSL   +  K  R    S  +   +       +EYLH     
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYLH---SK 120

Query: 425 CILHFDIKPHNI 436
            I+H DIKP NI
Sbjct: 121 GIIHRDIKPENI 132

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 38/140 (27%), Positives = 65/140 (46%), Gaps = 9/140 (6%)

Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           EI   +     KLG G FG V++G  +    +AVK LK      ++F+ E   + ++ H 
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61

Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            ++QL   C+      +V E M  GSL  ++  +   G++    +L ++A   A G+ YL
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYL--QGGAGRALKLPQLIDMAAQVASGMAYL 119

Query: 419 --HNGCDVCILHFDIKPHNI 436
              N      +H D+   N+
Sbjct: 120 EAQN-----YIHRDLAARNV 134

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 43/140 (30%), Positives = 78/140 (55%), Gaps = 14/140 (10%)

Query: 305 NHFTHK--LGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIH 356
           +H T +  +G G FG V++G L   G     +A+K LK   ++   ++F++E S +G+  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
           H N+++L G  ++     ++ EYM NG+LD+  + ++  G+ FS  +L  +  G A G++
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDK--YLRDHDGE-FSSYQLVGMLRGIAAGMK 121

Query: 417 YLHNGCDVCILHFDIKPHNI 436
           YL    D+  +H D+   NI
Sbjct: 122 YL---SDMNYVHRDLAARNI 138

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 14/133 (10%)

Query: 311 LGQGGFGSVYKGQLHTGGLIAVKMLK---NSKFSAE----EFINEVSTIGRIHHVNVVQL 363
           LG+G +G+VY G  + G LIAVK ++   ++  +AE    +   EV  +  + HVN+VQ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
           LG C + +  ++  E++P GS+   +    +R          +       G+ YLHN   
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNN-- 121

Query: 424 VCILHFDIKPHNI 436
            C++H DIK +N+
Sbjct: 122 -CVVHRDIKGNNV 133

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 67.1 bits (165), Expect = 2e-12
 Identities = 41/136 (30%), Positives = 64/136 (47%), Gaps = 21/136 (15%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEF----INEVSTIGRIHHVNVVQLL 364
           KLG+G +G VYK +   TG ++A+K ++      E      + E+S +  + H N+V+LL
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 365 GFCSEGSKRAVVYEYMPN---GSLDRHIFP-KESRGQSFSWEKLHEVALGTARGIEYLHN 420
                  K  +V+EY        LD+   P   +  +S  ++ L        RG+ Y H 
Sbjct: 65  DVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLL--------RGLAYCH- 115

Query: 421 GCDVCILHFDIKPHNI 436
                ILH D+KP NI
Sbjct: 116 --SHRILHRDLKPQNI 129

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 37/140 (26%), Positives = 66/140 (47%), Gaps = 17/140 (12%)

Query: 307 FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVN 359
           F  +LG+G FG V   +      +TG  +AVK L +S  +    +F  E+  +  + H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 360 VVQLLGFCSEGSKRA--VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           +V+  G C +   R+  ++ EY+P+GSL R    +     +    +L   +    +G++Y
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSL-RDYLQRHRDQINLK--RLLLFSSQICKGMDY 124

Query: 418 LHN-GCDVCILHFDIKPHNI 436
           L +       +H D+   NI
Sbjct: 125 LGSQRY----IHRDLAARNI 140

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 45/140 (32%), Positives = 61/140 (43%), Gaps = 27/140 (19%)

Query: 309 HKLGQGGFGSVYKGQLH--TGGLIAVKMLKNSKFSAEEF----INEVSTIGRIHHVNVVQ 362
             LGQG  G VYK + H  TG + A+K +       EEF    + E+ T+       VV+
Sbjct: 7   KVLGQGSSGVVYKVR-HKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCESPYVVK 63

Query: 363 LLG-FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTA-----RGIE 416
             G F  EG    +V EYM  GSL   +             K+ E  L        +G++
Sbjct: 64  CYGAFYKEGEIS-IVLEYMDGGSLADLLKKV---------GKIPEPVLAYIARQILKGLD 113

Query: 417 YLHNGCDVCILHFDIKPHNI 436
           YLH      I+H DIKP N+
Sbjct: 114 YLHT--KRHIIHRDIKPSNL 131

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 38/123 (30%), Positives = 54/123 (43%), Gaps = 14/123 (11%)

Query: 311 LGQGGFGSVYKGQLHT------GGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQ 362
           LGQG FG VY+G             +A+K +  +    E  EF+NE S +   +  +VV+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKE---SRGQSFSWEKLHEVALGTARGIE 416
           LLG  S G    VV E M  G L    R   P+          + +K  ++A   A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 417 YLH 419
           YL 
Sbjct: 134 YLA 136

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 3/112 (2%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  +LG G FG V  G+      +A+KM+K    S +EFI E   + ++ H  +VQL G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           C++     +V EYM NG L  ++      G+ F   +L E+      G+ YL
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYL 116

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 65.6 bits (161), Expect = 5e-12
 Identities = 43/132 (32%), Positives = 72/132 (54%), Gaps = 12/132 (9%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN--EVSTIGRI-HHVNVVQLLG 365
           +LG G FGSVY  +   TG L+A+K +K   +S EE +N  EV ++ ++  H N+V+L  
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGCDV 424
              E  +   V+EYM  G+L  +   K+ +G+ FS   +  +     +G+ ++H +G   
Sbjct: 66  VFRENDELYFVFEYM-EGNL--YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--- 119

Query: 425 CILHFDIKPHNI 436
              H D+KP N+
Sbjct: 120 -FFHRDLKPENL 130

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 44/141 (31%), Positives = 71/141 (50%), Gaps = 30/141 (21%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE-----FINEVSTIGRIHHVNVVQL 363
           KLG+G + +VYKG+   TG ++A   LK     AEE      I E+S +  + H N+V+L
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVA---LKEIHLDAEEGTPSTAIREISLMKELKHENIVRL 63

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRG-------QSFSWEKLHEVALGTARGIE 416
                  +K  +V+EYM +  L +++     RG       +SF+++ L        +GI 
Sbjct: 64  HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLL--------KGIA 114

Query: 417 YLH-NGCDVCILHFDIKPHNI 436
           + H N     +LH D+KP N+
Sbjct: 115 FCHENR----VLHRDLKPQNL 131

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 6/127 (4%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLG G FG V+ G  +    +AVK LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  GSL    F K+  G++     L ++A   A G+ Y+     +  +H 
Sbjct: 73  -EPIYIVTEYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126

Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 127 DLRSANI 133

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 65.3 bits (160), Expect = 9e-12
 Identities = 42/140 (30%), Positives = 68/140 (48%), Gaps = 24/140 (17%)

Query: 309 HKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFS-AEEFIN-----EVSTIGRIHHVNVV 361
            KLG+G +  VYK     TG ++A+K +K  +   A++ IN     E+  +  + H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSL-----DRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
            LL      S   +V+E+M    L     D+ I    +  +S+    L        RG+E
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL--------RGLE 116

Query: 417 YLHNGCDVCILHFDIKPHNI 436
           YLH+     ILH D+KP+N+
Sbjct: 117 YLHSN---WILHRDLKPNNL 133

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 43/130 (33%), Positives = 66/130 (50%), Gaps = 10/130 (7%)

Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG-FC 367
             +G+G FG V  G  + G  +AVK +KN   +A+ F+ E S + ++ H N+VQLLG   
Sbjct: 12  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQS-FSWEKLHEVALGTARGIEYLHNGCDVCI 426
            E     +V EYM  GSL  ++    SRG+S    + L + +L     +EYL        
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123

Query: 427 LHFDIKPHNI 436
           +H D+   N+
Sbjct: 124 VHRDLAARNV 133

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 42/132 (31%), Positives = 59/132 (44%), Gaps = 9/132 (6%)

Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
              K+G+G  G VYK     TG  +A+K ++  K + E  INE+  +    H N+V    
Sbjct: 23  NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGCDV 424
               G +  VV EYM  GSL   I     R    +  ++  V     +G+EYLH      
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVR---MNEPQIAYVCREVLQGLEYLHSQNV-- 137

Query: 425 CILHFDIKPHNI 436
             +H DIK  NI
Sbjct: 138 --IHRDIKSDNI 147

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 40/132 (30%), Positives = 73/132 (55%), Gaps = 12/132 (9%)

Query: 311 LGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V +G+L   G     +A+K LK+  ++    +F++E S +G+  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     ++ E+M NG+LD   F +++ GQ F+  +L  +  G A G++YL    ++
Sbjct: 72  GVVTKSRPVMIITEFMENGALDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---SEM 125

Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 126 NYVHRDLAARNI 137

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 62.2 bits (151), Expect = 7e-11
 Identities = 44/132 (33%), Positives = 70/132 (53%), Gaps = 12/132 (9%)

Query: 311 LGQGGFGSVYKGQLHTGG----LIAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G+L   G     +A+K LK   ++    +F++E S +G+  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     +V EYM NGSLD   F ++  GQ F+  +L  +  G A G++YL    D+
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDA--FLRKHDGQ-FTVIQLVGMLRGIASGMKYL---SDM 125

Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 126 GYVHRDLAARNI 137

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 61.7 bits (151), Expect = 9e-11
 Identities = 40/131 (30%), Positives = 66/131 (50%), Gaps = 7/131 (5%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
           ++G+G FG VY  +    G L  +K +  S  S +E    +NEV  + +++H N+++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
              E  K  +V EY   G L + I  ++  G+ F  E++ +  +     ++YLH      
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRK 123

Query: 426 ILHFDIKPHNI 436
           ILH DIKP NI
Sbjct: 124 ILHRDIKPQNI 134

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 37/137 (27%), Positives = 62/137 (45%), Gaps = 25/137 (18%)

Query: 307 FTHKLGQGGFGSVY---------------KGQLHTGGLIAVKMLKN--SKFSAEEFINEV 349
              KLG+G FG V+                       L+AVKML+   +K +  +F+ E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 350 STIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQ--------SFSW 401
             + R+ + N+++LLG C       ++ EYM NG L++ +  +E            S S 
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 402 EKLHEVALGTARGIEYL 418
             L  +A+  A G++YL
Sbjct: 129 ANLLYMAVQIASGMKYL 145

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 9/114 (7%)

Query: 311 LGQGGFGSVYKGQLHTGG----LIAVKMLKNSKFSAEE--FINEVSTIGRIHHVNVVQLL 364
           LG G FG + +G L         +A+  L+      +   F+ E  T+G+  H N+V+L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           G  + G+   +V EYM NG+LD   F ++  GQ     +L  +  G A G++YL
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQ-LVAGQLMGMLPGLASGMKYL 123

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 37/128 (28%), Positives = 67/128 (52%), Gaps = 8/128 (6%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 368
           KLG+G +GSVYK     TG ++A+K++   +   +E I E+S + +     +V+  G   
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68

Query: 369 EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILH 428
           + +   +V EY   GS+   +   +   ++ + E++  +   T +G+EYLH+      +H
Sbjct: 69  KNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIH 122

Query: 429 FDIKPHNI 436
            DIK  NI
Sbjct: 123 RDIKAGNI 130

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 20/136 (14%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKML------KNSKFSAEEFINEVSTIGRIHHVNVVQL 363
           LG G FGSVY+G  L  G   AVK +      +  + + ++   E++ + ++ H N+VQ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR---GIEYLHN 420
           LG   E     +  E +P GSL           + +       + L T +   G+EYLH+
Sbjct: 68  LGTEREEDNLYIFLELVPGGSL-------AKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 421 GCDVCILHFDIKPHNI 436
                 +H DIK  NI
Sbjct: 121 R---NTVHRDIKGANI 133

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 43/138 (31%), Positives = 61/138 (44%), Gaps = 16/138 (11%)

Query: 311 LGQGGFGSVYKGQ-LHTGGL-----IAVKMLKNSKFSAEE--FINEVSTIGRIHHVNVVQ 362
           LG G FG VY+G      G      +AVK L  S    +E  F+ E   + + +H N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           L+G   E   R ++ E M  G L    R   P+  R  S + + L   A   A+G +YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 420 -NGCDVCILHFDIKPHNI 436
            N      +H DI   N 
Sbjct: 134 ENH----FIHRDIAARNC 147

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 36/138 (26%), Positives = 66/138 (47%), Gaps = 24/138 (17%)

Query: 311 LGQGGFGSVYKGQLHTGG-----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQL 363
           LG G FG+VYKG     G      +A+K+L+   S  + +E ++E   +  + H +VV+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRG-----QSFSWEKLHEVALGTARGIEYL 418
           LG C   S+  ++ + MP G L  ++  +  +         +W       +  A+G+ YL
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNW------CVQIAKGMSYL 125

Query: 419 HNGCDVCILHFDIKPHNI 436
               +  ++H D+   N+
Sbjct: 126 E---EKRLVHRDLAARNV 140

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 3/112 (2%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  +LG G FG V+ G+      +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           C++     +V E+M NG L  ++  ++ +G+  S + L  +      G+EYL
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYL--RQRQGK-LSKDMLLSMCQDVCEGMEYL 116

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 42/134 (31%), Positives = 62/134 (46%), Gaps = 15/134 (11%)

Query: 309 HKLGQGGFGSVYKG-QLHTGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +K+G G FG VY    L TG L+AVK ++   N   + +E  +E+  +  + H N+V+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEV-ALGTARGIEYLH-NGC 422
           G      K  +  EY   G+L+               E +  V  L    G+ YLH +G 
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEEL-----LEHGRILDEHVIRVYTLQLLEGLAYLHSHG- 119

Query: 423 DVCILHFDIKPHNI 436
              I+H DIKP NI
Sbjct: 120 ---IVHRDIKPANI 130

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 60.3 bits (147), Expect = 4e-10
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 23/139 (16%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEF----INEVSTIGRIHHVNVVQL 363
            ++G+G +G VYK +   TG L+A+K ++      E F    I E+  + ++ H N+V+L
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 364 LGFCSEGSKRAV--VYEYMP---NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
               +   K ++  V+EYM     G LD            F+  ++         G++YL
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTGLLDSP-------EVKFTESQIKCYMKQLLEGLQYL 116

Query: 419 H-NGCDVCILHFDIKPHNI 436
           H NG    ILH DIK  NI
Sbjct: 117 HSNG----ILHRDIKGSNI 131

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 6/127 (4%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 73  -EPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126

Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 127 DLRAANI 133

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 58.8 bits (142), Expect = 7e-10
 Identities = 41/128 (32%), Positives = 72/128 (56%), Gaps = 10/128 (7%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
            +G+G FG+V +G+ +TG  +AVK +K    +A+ F+ E + + ++HH N+V+LLG    
Sbjct: 13  IIGEGEFGAVLQGE-YTGQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSF-SWEKLHEVALGTARGIEYLHNGCDVCILH 428
                +V E M  G+L   +    +RG++  S  +L + +L  A G+EYL +     ++H
Sbjct: 71  NGLY-IVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 429 FDIKPHNI 436
            D+   NI
Sbjct: 124 RDLAARNI 131

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 35/140 (25%), Positives = 64/140 (45%), Gaps = 16/140 (11%)

Query: 311 LGQGGFGSVYKGQLHTGG--LIAVKML-----------KNSKFSAEEFINEVSTIG-RIH 356
           LG G FG VYK +    G  L+A+K +           +    S  + ++EV+ I  ++ 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
           H N+V+      E  +  +V + +    L  H    + + Q F+ E++  + +     + 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 417 YLHNGCDVCILHFDIKPHNI 436
           YLH   +  I+H D+ P+NI
Sbjct: 128 YLHK--EKRIVHRDLTPNNI 145

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 43/141 (30%), Positives = 67/141 (47%), Gaps = 26/141 (18%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSA----------EEFINEVSTIGRIHHVN 359
           +G G FGSVY G    +G L+AVK ++    SA          +    E++ +  + H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGS----LDRHIFPKESRGQSFSWEKLHEVALGTARGI 415
           +VQ LG   +     +  EY+P GS    L+ +   +E+  ++F  + L        +G+
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL--------KGL 119

Query: 416 EYLHNGCDVCILHFDIKPHNI 436
            YLHN     I+H DIK  NI
Sbjct: 120 NYLHNR---GIIHRDIKGANI 137

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 38/131 (29%), Positives = 68/131 (51%), Gaps = 7/131 (5%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQLLG 365
           KLG+G +GSVYK + L      A+K +     S    E+ +NE+  +  ++H N++    
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
              +G+K  +V EY P G L + I  ++ + +    +++  + +   RG++ LH   +  
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQK 123

Query: 426 ILHFDIKPHNI 436
           ILH D+K  NI
Sbjct: 124 ILHRDLKSANI 134

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 27/140 (19%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLL 364
             +G+G +G V K +   TG ++A+K  K S   +   +  + EV  + ++ H N+V L 
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRG-------QSFSWEKLHEVALGTARGIEY 417
                  +  +V+EY+    L+     + S G       +S+ W+ L        + I Y
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLE---LLEASPGGLPPDAVRSYIWQLL--------QAIAY 115

Query: 418 LH-NGCDVCILHFDIKPHNI 436
            H +     I+H DIKP NI
Sbjct: 116 CHSHN----IIHRDIKPENI 131

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 6/127 (4%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK      E F+ E   + ++ H  +V L    SE
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V E+M  GSL    F KE  G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 73  -EPIYIVTEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126

Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 127 DLRAANI 133

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 34/134 (25%), Positives = 65/134 (48%), Gaps = 15/134 (11%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA-------EEFINEVSTIGRIHHVNVVQ 362
           LG G F S Y+ + + TG L+AVK +   + ++       E    E+  + R++H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           +LG   E S   +  E+M  GS+   +    +  ++       ++     RG+ YLH   
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL----LRGLSYLH--- 120

Query: 423 DVCILHFDIKPHNI 436
           +  I+H D+K  N+
Sbjct: 121 ENQIIHRDVKGANL 134

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 39/139 (28%), Positives = 67/139 (48%), Gaps = 19/139 (13%)

Query: 311 LGQGGFGSVYKGQL------HTGGL-IAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVV 361
           LG G FG VY+G         +G + +AVK L+      E  EF+ E   +   +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSF-----SWEKLHEVALGTARGIE 416
           +LLG C     + ++ E M  G L  ++  +++R + F     + ++L ++ L  A+G  
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 417 YLHNGCDVCILHFDIKPHN 435
           YL     +  +H D+   N
Sbjct: 121 YLE---QMHFIHRDLAARN 136

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 39/139 (28%), Positives = 64/139 (46%), Gaps = 26/139 (18%)

Query: 310 KLGQGGFGSVYKGQLHT------GGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNVVQ 362
           +LG+G FG V+  + H         L+AVK LK +  SA ++F  E   +  + H ++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDR---------HIFPKESRGQS---FSWEKLHEVALG 410
             G C+EG    +V+EYM +G L+R          I        +    +  ++  +A  
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKIL-AGGEDVAPGQLTLGQMLAIASQ 130

Query: 411 TARGIEYLHNGCDVCILHF 429
            A G+ YL +      LHF
Sbjct: 131 IASGMVYLAS------LHF 143

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 23/150 (15%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGG-----LIAVKMLK--NSKFSAEEFINEVSTIGRIHHVN 359
           F  +LG+  FG +YKG L+  G     L+A+K LK  N+     EF  E S +  +HH N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIF---PKESRG----------QSFSWEKLHE 406
           +V LLG  ++     +++EY+  G L   +    P    G           S        
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           +A+  A G+EYL +      +H D+   NI
Sbjct: 129 IAIQIAAGMEYLSSH---FFVHKDLAARNI 155

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 37/116 (31%), Positives = 57/116 (49%), Gaps = 11/116 (9%)

Query: 309 HKLGQGGFGSVYKGQLHTGGL----IAVKMLKNSKFSA--EEFINEVSTIGRIHHVNVVQ 362
            +LG G FGSV KG           +AVK LK    +A  +EF+ E S + ++ H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           L+G C +G    +V E  P G L +++  +    +      L E+A   A G+ YL
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYL 111

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 24/149 (16%)

Query: 309 HKLGQGGFGSVYKGQL-----HTGGL-IAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
             LG+G FG V K +            +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSL------DRHIFPKESR------GQSFSWEKLHEV 407
           ++ LLG C++     VV EY  +G+L       R      S        ++ + + L   
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+E+L +    CI H D+   N+
Sbjct: 138 AYQVARGMEFLAS--KKCI-HRDLAARNV 163

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 14/134 (10%)

Query: 310 KLGQGGFGSVYKGQLHTGGL----IAVKMLKNSKFSA--EEFINEVSTIGRIHHVNVVQL 363
           KLG G FG V +G+  T G     +AVK LK+ K S   ++F+ E + +  + H N+++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 364 LGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
            G         +V E  P GSL DR    ++     F    L + A+  A G+ YL +  
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIANGMRYLESK- 116

Query: 423 DVCILHFDIKPHNI 436
               +H D+   NI
Sbjct: 117 --RFIHRDLAARNI 128

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 19/128 (14%)

Query: 311 LGQGGFGSVYK--------GQLHTGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNV 360
           +GQG FG V++         +  T  ++AVKMLK   S     +F  E + +    H N+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+LLG C+ G    +++EYM  G L+  +     R +S        ++  T+   +   N
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFL-----RHRSPRA--QCSLSHSTSSARKCGLN 123

Query: 421 GCDVCILH 428
              +    
Sbjct: 124 PLPLSCTE 131

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 7e-09
 Identities = 43/133 (32%), Positives = 64/133 (48%), Gaps = 8/133 (6%)

Query: 306 HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQL 363
               ++G G +G VYK + + TG L+A+K++K       E I  E+S +    H N+V  
Sbjct: 6   ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G      K  +V EY   GSL   I+ + +RG   S  ++  V   T +G+ YLH    
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQ-DIY-QVTRG-PLSELQIAYVCRETLKGLAYLHE--- 119

Query: 424 VCILHFDIKPHNI 436
              +H DIK  NI
Sbjct: 120 TGKIHRDIKGANI 132

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 56.1 bits (136), Expect = 8e-09
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 23/137 (16%)

Query: 310 KLGQGGFGSVYK-GQLHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLG 365
           ++G+G  G V+K     TG  +A+K +   +       + + E+  +    H  VV+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 366 FCSEGSKRAVVYEYMPNGSLD-----RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH- 419
               GS   +V EYMP+   +         P E++ +S+    L        +G+ Y+H 
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERPLP-EAQVKSYMRMLL--------KGVAYMHA 117

Query: 420 NGCDVCILHFDIKPHNI 436
           NG    I+H D+KP N+
Sbjct: 118 NG----IMHRDLKPANL 130

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 36/127 (28%), Positives = 58/127 (45%), Gaps = 5/127 (3%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLG G FG V+ G  +    +AVK LK    S + F+ E + +  + H  +V+L    ++
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                ++ EYM  GSL    F K   G      KL + +   A G+ Y+        +H 
Sbjct: 73  EEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 127

Query: 430 DIKPHNI 436
           D++  N+
Sbjct: 128 DLRAANV 134

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.1 bits (136), Expect = 9e-09
 Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 31/143 (21%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN--EVSTIGRI-HHVNVVQLL 364
            K+G+G F  V K Q   TG   A+K +K    S E+  N  E+  + R+  H N+++L+
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 365 G--FCSEGSKRAVV--------YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARG 414
              F  +  + A+V        YE +      +   P E R +S+ ++ L          
Sbjct: 65  EVLFDRKTGRLALVFELMDMNLYELIKG---RKRPLP-EKRVKSYMYQLLK--------S 112

Query: 415 IEYLH-NGCDVCILHFDIKPHNI 436
           ++++H NG    I H DIKP NI
Sbjct: 113 LDHMHRNG----IFHRDIKPENI 131

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 14/138 (10%)

Query: 307 FTHKLGQGGFGSVYKG-----QLHTGGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S      +F  E+  +  + H N+
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 361 VQLLGFCSEGSKRA--VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   +V EY+P GSL  ++     R       KL   A    +G+EYL
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL 124

Query: 419 HNGCDVCILHFDIKPHNI 436
             G    + H D+   NI
Sbjct: 125 --GSKRYV-HRDLATRNI 139

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 39/128 (30%), Positives = 63/128 (49%), Gaps = 8/128 (6%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLG G FG V+ G  +    +A+K LK    S E F+ E + + ++ H  +V+L    ++
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 370 GSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILH 428
                ++ EYM NGSL D   F K   G   +  KL ++A   A G+ ++        +H
Sbjct: 73  -EPIYIITEYMENGSLVD---FLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIH 125

Query: 429 FDIKPHNI 436
            D++  NI
Sbjct: 126 RDLRAANI 133

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 42/133 (31%), Positives = 63/133 (47%), Gaps = 10/133 (7%)

Query: 310 KLGQGGFGSVYKGQLHTGGLI-AVK--MLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG- 365
           +LG+G  GSV K +L   G+I A+K      +    ++ + E+          +V+  G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 366 FCSEGSKR-AVVYEYMPNGSLDRHIFPK-ESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
           F  E S    +  EY   GSLD  I+ K + RG     + L ++A    +G+ YLH    
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---S 123

Query: 424 VCILHFDIKPHNI 436
             I+H DIKP NI
Sbjct: 124 RKIIHRDIKPSNI 136

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 22/137 (16%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKML---KNSKFSAEE---FINEVSTIGRIHHVNVVQL 363
           LGQG FG VY    + TG  +AVK +    +S  + +E      E+  +  + H  +VQ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFP----KESRGQSFSWEKLHEVALGTARGIEYLH 419
            G   +    ++  EYMP GS+   +       E+  + ++ + L         G+EYLH
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE--------GVEYLH 121

Query: 420 NGCDVCILHFDIKPHNI 436
                 I+H DIK  NI
Sbjct: 122 ---SNMIVHRDIKGANI 135

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 46/142 (32%), Positives = 68/142 (47%), Gaps = 22/142 (15%)

Query: 311 LGQGGFGSVYKGQLH----TGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQL 363
           LG+G FGSV + QL     +   +AVKMLK   FS+   EEF+ E + +    H NV++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 364 LGFC--SEGSKR----AVVYEYMPNGSLDRHIFPKESR-GQ---SFSWEKLHEVALGTAR 413
           +G    S    R     V+  +M +G L  H F   SR G+   +   + L    +  A 
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 414 GIEYLHNGCDVCILHFDIKPHN 435
           G+EYL +      +H D+   N
Sbjct: 125 GMEYLSSK---NFIHRDLAARN 143

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 36/134 (26%), Positives = 57/134 (42%), Gaps = 19/134 (14%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
            +G+G FG VYK     T  ++A+K+  L+ ++   E+   E+  + +     + +  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 367 CSEGSKRAVVYEYMPNGS----LDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
             +GSK  ++ EY   GS    L      +           L EV      G+EYLH   
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIA-----FILREV----LLGLEYLHEEG 118

Query: 423 DVCILHFDIKPHNI 436
            +   H DIK  NI
Sbjct: 119 KI---HRDIKAANI 129

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 39/131 (29%), Positives = 63/131 (48%), Gaps = 10/131 (7%)

Query: 310 KLGQGGFGSVYKGQLH--TGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQLLG 365
           +LG G  G V K   H  TG ++AVK ++     A   + + E+  + + +   +V   G
Sbjct: 8   ELGAGNSGVVSKVL-HRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                   ++  EYM  GSLD+    KE +G+      L ++A+   +G+ YLH      
Sbjct: 67  AFYNNGDISICMEYMDGGSLDK--ILKEVQGR-IPERILGKIAVAVLKGLTYLHE--KHK 121

Query: 426 ILHFDIKPHNI 436
           I+H D+KP NI
Sbjct: 122 IIHRDVKPSNI 132

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 39/138 (28%), Positives = 62/138 (44%), Gaps = 26/138 (18%)

Query: 307 FTHKLGQGGFGSV----------YKGQLHTGG-------LIAVKMLK--NSKFSAEEFIN 347
           F  KLG+G FG V          +  +            L+AVK+L+   S  + E+F+ 
Sbjct: 9   FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68

Query: 348 EVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLD----RHIFPKESR---GQSFS 400
           EV  + R+   N+ +LLG C+      ++ EYM NG L+    +H+          +S S
Sbjct: 69  EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128

Query: 401 WEKLHEVALGTARGIEYL 418
           +  L  +A   A G+ YL
Sbjct: 129 FSTLLYMATQIASGMRYL 146

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 35/129 (27%), Positives = 65/129 (50%), Gaps = 21/129 (16%)

Query: 310 KLGQGGFGSVYKGQLHTGG------LIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNVVQ 362
           +LG+G FG V+  + +         L+AVK LK+   +A ++F  E   +  + H ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIF-------------PKESRGQSFSWEKLHEVAL 409
             G C +G    +V+EYM +G L++ +              P++++G+    + LH +A 
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH-IAS 130

Query: 410 GTARGIEYL 418
             A G+ YL
Sbjct: 131 QIASGMVYL 139

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 36/118 (30%), Positives = 56/118 (47%), Gaps = 14/118 (11%)

Query: 311 LGQGGFGSVY-----KGQLHTGGLIAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQL 363
           LG+G FG V           TG ++AVK LK    + +   +  E++ +  ++H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 364 LGFCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            G CSE   + +  + EY+P GSL R   PK     +    +L   A     G+ YLH
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL-RDYLPKHKLNLA----QLLLFAQQICEGMAYLH 124

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 41/136 (30%), Positives = 64/136 (47%), Gaps = 22/136 (16%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKML--KNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           LG+G +G VY  + L T   IA+K +  ++S++  +    E++    + H N+VQ LG  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE--KLHEVALG-----TARGIEYLHN 420
           SE     +  E +P GSL   +  K        W   K +E  +         G++YLH 
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSK--------WGPLKDNEQTIIFYTKQILEGLKYLH- 125

Query: 421 GCDVCILHFDIKPHNI 436
             D  I+H DIK  N+
Sbjct: 126 --DNQIVHRDIKGDNV 139

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 34/146 (23%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGG-----------------LIAVKMLK--NSKFSAEEFIN 347
           F  KLG+G FG V+  ++                     L+AVK+L+   +K +  +F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 348 EVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLD-----RHIFPKESRGQ----- 397
           EV  + R+   N+++LLG C +     ++ EYM NG L+      H+  KE  G      
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 398 -----SFSWEKLHEVALGTARGIEYL 418
                + S+  L  VAL  A G++YL
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL 154

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 27/142 (19%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEE-----------FINEVSTIGRIHHV 358
           +G+G +G VY    + TG ++AVK ++     A               +E+ T+  + H+
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGS----LDRHIFPKESRGQSFSWEKLHEVALGTARG 414
           N+VQ LGF +     ++  EY+P GS    L  +   +E   + F+ + L         G
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL--------EG 120

Query: 415 IEYLHNGCDVCILHFDIKPHNI 436
           + YLH+     ILH D+K  N+
Sbjct: 121 LAYLHSK---GILHRDLKADNL 139

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 26/138 (18%)

Query: 307 FTHKLGQGGFGSVY----KGQL-------------HTGGLIAVKMLKN--SKFSAEEFIN 347
           F  KLG+G FG V+    +G               +   L+AVKML+   +K +  +F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 348 EVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLD----RHIFPK---ESRGQSFS 400
           E+  + R+   N+++LL  C       ++ EYM NG L+    RH   +   ++   + S
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 401 WEKLHEVALGTARGIEYL 418
           +  L  +A   A G++YL
Sbjct: 129 YSTLIFMATQIASGMKYL 146

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 52.9 bits (127), Expect = 8e-08
 Identities = 36/131 (27%), Positives = 61/131 (46%), Gaps = 9/131 (6%)

Query: 310 KLGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G FG V+K        + A+K +  SK +    EE I+E   + ++    +++   
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
              +  K  +V EY  NG L  H   K  RG+    +++    +    G+ +LH+     
Sbjct: 67  SFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---K 121

Query: 426 ILHFDIKPHNI 436
           ILH DIK  N+
Sbjct: 122 ILHRDIKSLNL 132

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 9e-08
 Identities = 32/134 (23%), Positives = 61/134 (45%), Gaps = 17/134 (12%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G VYK +   TG ++A+K +K    S    +  + E+  +  ++H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQS--FSWEKLHEVALGTARGIEYLH-NGC 422
                    +V+E+M           K  + +        +        +G+ + H +G 
Sbjct: 66  VFRHKGDLYLVFEFM------DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG- 118

Query: 423 DVCILHFDIKPHNI 436
              ILH D+KP N+
Sbjct: 119 ---ILHRDLKPENL 129

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 41/124 (33%), Positives = 61/124 (49%), Gaps = 13/124 (10%)

Query: 311 LGQGGFGSVY----KGQLHTGG--LIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQ 362
           LG+G FG V+    KG    GG  L+ VK L+ +K      EF  E+    ++ H NVV+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKL---HEVALGT--ARGIEY 417
           LLG C E     ++ EY   G L + +   +S+ +      L    +VAL T  A G+++
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 418 LHNG 421
           L N 
Sbjct: 133 LSNA 136

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 30/127 (23%), Positives = 63/127 (49%), Gaps = 11/127 (8%)

Query: 311 LGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           + +G  G+ YKG+    G+   VK + +        I +   +G++ H N+V+L+G C  
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQHPNIVKLIGLCRS 754

Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +++EY+   +L   +       ++ SWE+  ++A+G A+ + +LH  C   ++  
Sbjct: 755 EKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807

Query: 430 DIKPHNI 436
           ++ P  I
Sbjct: 808 NLSPEKI 814

Length = 968

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 21/158 (13%)

Query: 297 YPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGL---IAVKMLKN--SKFSAEEFINEVST 351
           YP +      F   +G+G FG V K ++   GL    A+K +K   SK    +F  E+  
Sbjct: 1   YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60

Query: 352 IGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPNGSL------------DRHIFPKESRGQS 398
           + ++ HH N++ LLG C       +  EY P+G+L            D       S   +
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 399 FSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            S ++L   A   ARG++YL        +H D+   NI
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 155

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 52.1 bits (126), Expect = 1e-07
 Identities = 44/137 (32%), Positives = 68/137 (49%), Gaps = 24/137 (17%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG V   +   TG L A+K+LK  K       E  + E + + RI+H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 366 FCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEKLH----EVALGTARGIEYLH 419
             +  ++  +  V EY P G L  H+    S+   FS E+      E+ L     +EYLH
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHL----SKEGRFSEERARFYAAEIVLA----LEYLH 110

Query: 420 NGCDVCILHFDIKPHNI 436
           +   + I++ D+KP NI
Sbjct: 111 S---LGIIYRDLKPENI 124

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 39/128 (30%), Positives = 62/128 (48%), Gaps = 10/128 (7%)

Query: 311 LGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAE---EFINEVSTIGRIHHVNVVQLLGFC 367
           LG+G FG V+KG L     +AVK  K      E   +F++E   + +  H N+V+L+G C
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           ++     +V E +P G     +  K+        ++L + AL  A G+ YL +    CI 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLES--KNCI- 115

Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 116 HRDLAARN 123

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 10/93 (10%)

Query: 311 LGQGGFGSVYKG-QLHTGGL-----IAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQ 362
           LG+G FG V K       G      +AVKMLK +  S+E  + ++E + + +++H +V++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESR 395
           L G CS+     ++ EY   GSL    F +ESR
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRS--FLRESR 98

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 39/134 (29%), Positives = 59/134 (44%), Gaps = 15/134 (11%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA--EEFINEVSTIGRIHHVNVVQLLGF 366
            +G G    VY    L     +A+K +   K     +E   EV  + + +H NVV+    
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 367 CSEGSKRAVVYEYMPNGS-LD--RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGC 422
              G +  +V  Y+  GS LD  +  +P+    ++     L EV     +G+EYLH NG 
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV----LKGLEYLHSNG- 122

Query: 423 DVCILHFDIKPHNI 436
               +H DIK  NI
Sbjct: 123 ---QIHRDIKAGNI 133

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 47/150 (31%), Positives = 69/150 (46%), Gaps = 33/150 (22%)

Query: 306 HFTHKLGQGGFGSVYKG-QLHTGGLIAVK--MLKNSKFSAEEF----INEVSTIGRIHHV 358
               KLG+G FG VYK  Q+ TG ++A+K  ++ N K   + F    + E+  + ++ H 
Sbjct: 11  EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK---DGFPITALREIKILKKLKHP 67

Query: 359 NVVQLLGFCSEGS-----KRAVVYEYMP------NGSLDR-HIFPKESRGQSFSWEKLHE 406
           NVV L+    E       KR  VY   P      +G L+   +   ES+ + +  + L  
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE- 126

Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
                  GI YLH   +  ILH DIK  NI
Sbjct: 127 -------GINYLH---ENHILHRDIKAANI 146

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 41/116 (35%), Positives = 54/116 (46%), Gaps = 12/116 (10%)

Query: 311 LGQGGFGSVYKGQLHTGGLI----AVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G+G FG VY G L          AVK L         E+F+ E   +    H NV+ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 365 GFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           G C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G+EYL
Sbjct: 63  GICLPSEGSP-LVVLPYMKHGDL-RNFIRSETHNPTV--KDLIGFGLQVAKGMEYL 114

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 32/132 (24%), Positives = 64/132 (48%), Gaps = 8/132 (6%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLL 364
           K+G+G F  VYK   L  G ++A+K ++  +       ++ + E+  + ++ H NV++ L
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
               E ++  +V E    G L R I   + + +      + +  +     +E++H+    
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK--- 125

Query: 425 CILHFDIKPHNI 436
            I+H DIKP N+
Sbjct: 126 RIMHRDIKPANV 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 29/81 (35%), Positives = 41/81 (50%), Gaps = 5/81 (6%)

Query: 310 KLGQGGFGSVYKGQLHTG---GLIAVKMLKNSKFSAEE--FINEVSTIGRIHHVNVVQLL 364
           ++G G FG V  G+ H G     + VK L+ S    E+  F+ EV     ++H NV+Q L
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 365 GFCSEGSKRAVVYEYMPNGSL 385
           G C E     +V E+ P G L
Sbjct: 62  GQCIESIPYLLVLEFCPLGDL 82

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 39/145 (26%), Positives = 68/145 (46%), Gaps = 38/145 (26%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE------FINEVSTIGRIHHVNVVQ 362
           K+G+G +G VYK +   TG ++A   LK  +   E+       I E+S +  ++H N+V+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVA---LKKIRLETEDEGVPSTAIREISLLKELNHPNIVR 62

Query: 363 LLGFCSEGSKRAVVYEYM-----------PNGSLDRHIFPKESRGQSFSWEKLHEVALGT 411
           LL      +K  +V+E++           P   LD  +       +S+ ++ L       
Sbjct: 63  LLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI------KSYLYQLL------- 109

Query: 412 ARGIEYLHNGCDVCILHFDIKPHNI 436
            +GI Y H+     +LH D+KP N+
Sbjct: 110 -QGIAYCHSH---RVLHRDLKPQNL 130

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 37/135 (27%), Positives = 68/135 (50%), Gaps = 19/135 (14%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKML---KNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
            +G+G +G V K +   TG ++A+K     ++ K   +  + E+  + ++ H N+V L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 366 FCSEGSKRAVVYEYMPNGSLDR-HIFP---KESRGQSFSWEKLHEVALGTARGIEYLHNG 421
                 +  +V+E++ +  LD    +P    ESR + + ++ L        RGIE+ H+ 
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL--------RGIEFCHSH 119

Query: 422 CDVCILHFDIKPHNI 436
               I+H DIKP NI
Sbjct: 120 ---NIIHRDIKPENI 131

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 39/124 (31%), Positives = 60/124 (48%), Gaps = 18/124 (14%)

Query: 311 LGQGGFGSVYKGQLHTGGLI---AVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           LG+G FGSV +GQL+    I   AVK +K    ++   E+F++E   +    H NV++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 365 GFCSEGSKR------AVVYEYMPNGSLDRHIFPKESR----GQSFSWEKLHEVALGTARG 414
           G C +  +        V+  +M +G L  H F   SR     Q    + L +     A G
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDL--HSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 415 IEYL 418
           +EYL
Sbjct: 125 MEYL 128

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding

 Score = 48.0 bits (115), Expect = 4e-07
 Identities = 25/91 (27%), Positives = 37/91 (40%), Gaps = 6/91 (6%)

Query: 36  CSSSCGDVKNISYPFRLKGDPARCGHPELELSCE--SNKTIFEFNSGKYYVKRISYDKCT 93
           C   CG+V +I YPF +    AR   P  EL+C   ++       +G Y V  IS    T
Sbjct: 4   CPDRCGNV-SIPYPFGIGPGCAR--DPGFELTCNNTTSPPRLLLGNGNYEVLSISLANGT 60

Query: 94  ISVVDVNLAYGSCSFPSTSFSPPGLSFSYSF 124
           + V+D  ++    +          LS    F
Sbjct: 61  VRVLD-PISSNCYNSSGKRTDNGSLSLGGPF 90

This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 40/125 (32%), Positives = 65/125 (52%), Gaps = 16/125 (12%)

Query: 310 KLGQGGFGSVYKGQLHTGGL-------IAVKMLKNSKFSAE--EFINEVSTIGRIHHVNV 360
           +LGQG FG VY+G +  G +       +A+K +  +    E  EF+NE S +   +  +V
Sbjct: 13  ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKE--SRGQSF-SWEKLHEVALGTARG 414
           V+LLG  S+G    V+ E M  G L    R + P+   +  Q+  S +K+ ++A   A G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 415 IEYLH 419
           + YL+
Sbjct: 132 MAYLN 136

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 36/133 (27%), Positives = 68/133 (51%), Gaps = 14/133 (10%)

Query: 311 LGQGGFGSVYKGQLHTGG-----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQL 363
           LG G FG+V+KG     G      +A+K +++   + + +E  + +  +G + H  +V+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
           LG C  G+   +V +  P GSL  H+  ++ R  S   ++L    +  A+G+ YL    +
Sbjct: 75  LGICP-GASLQLVTQLSPLGSLLDHV--RQHRD-SLDPQRLLNWCVQIAKGMYYLE---E 127

Query: 424 VCILHFDIKPHNI 436
             ++H ++   NI
Sbjct: 128 HRMVHRNLAARNI 140

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 37/129 (28%), Positives = 68/129 (52%), Gaps = 8/129 (6%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           +LG G FG VYK +   TG L A K+++  S+   E+++ E+  +   +H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
               K  ++ E+ P G++D  I  +  RG   +  ++  +       ++YLH+   + I+
Sbjct: 79  YWDGKLWIMIEFCPGGAVDA-IMLELDRG--LTEPQIQVICRQMLEALQYLHS---MKII 132

Query: 428 HFDIKPHNI 436
           H D+K  N+
Sbjct: 133 HRDLKAGNV 141

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 50.5 bits (120), Expect = 7e-07
 Identities = 27/87 (31%), Positives = 49/87 (56%), Gaps = 7/87 (8%)

Query: 310 KLGQGGFGSVYKGQLHT------GGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNVVQ 362
           +LG+G FG V+  + +         L+AVK LK++  +A ++F  E   +  + H ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHI 389
             G C EG    +V+EYM +G L++ +
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFL 98

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 50.2 bits (121), Expect = 7e-07
 Identities = 40/135 (29%), Positives = 62/135 (45%), Gaps = 20/135 (14%)

Query: 311 LGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLG 365
           LG G FG V   +   +G   A+K+L  +K       E  +NE   +  I H  +V L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFS--WEKLH--EVALGTARGIEYLHNG 421
              + S   +V EY+P G L  H+     +   F     + +  +V L     +EYLH+ 
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVL----ALEYLHS- 119

Query: 422 CDVCILHFDIKPHNI 436
            D  I++ D+KP N+
Sbjct: 120 LD--IVYRDLKPENL 132

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 50.3 bits (120), Expect = 8e-07
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 18/120 (15%)

Query: 311 LGQGGFGSVY------KGQLHTGGLIAVKMLKNSKFSAEEFIN----EVSTIGRIHHVNV 360
           LG+G FG V       +G  +TG  +AVK LK    S    I     E+  +  ++H N+
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENI 68

Query: 361 VQLLGFCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C+E     +  + E++P+GSL  ++ P+       + ++  + A+   +G++YL
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNK--NKINLKQQLKYAVQICKGMDYL 125

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 21/148 (14%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGL---IAVKMLKN--SKFSAEEFINEVSTIGRI-HHVNV 360
           F   +G+G FG V +  +   GL    A+KMLK   S+    +F  E+  + ++ HH N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHI-----------FPKE-SRGQSFSWEKLHEVA 408
           + LLG C       +  EY P G+L   +           F KE     + + ++L + A
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
              A G++YL    +   +H D+   N+
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNV 150

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 36/139 (25%), Positives = 69/139 (49%), Gaps = 18/139 (12%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLK---NSKFSAEEFINEVSTIGRIH---HVNVVQ 362
           ++G G +G+VYK +  H+G  +A+K ++   N        + EV+ + R+    H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 363 LLGFCS-----EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           L+  C+       +K  +V+E++     D   +  +        E + ++     RG+++
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 418 LHNGCDVCILHFDIKPHNI 436
           LH  C   I+H D+KP NI
Sbjct: 124 LHANC---IVHRDLKPENI 139

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 18/137 (13%)

Query: 311 LGQGGFGSVYKGQLHTGG-----------LIAVKMLKNSKFSAEEFINEVSTIGRIHHVN 359
           LGQG F ++YKG L                + +K+L +    +  F    S + ++ H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           +V+L G C    +  +V EY+  G LD  +  +E    S  W KL +VA   A  + YL 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFL-HREKNNVSLHW-KL-DVAKQLASALHYLE 118

Query: 420 NGCDVCILHFDIKPHNI 436
              D  ++H ++   NI
Sbjct: 119 ---DKKLVHGNVCGKNI 132

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 26/149 (17%)

Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S++             L   
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 143 TYQVARGMEYL--ASQKCI-HRDLAARNV 168

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 35/141 (24%), Positives = 68/141 (48%), Gaps = 24/141 (17%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE------FINEVSTIGRI---HHVNV 360
           +G+G +G+VYK + L+TG  +A+K +   +    E       + E++ + ++    H N+
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV---RVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 361 VQLLGFC-----SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGI 415
           V+LL  C         K  +V+E++     D   +  +        E + ++     RG+
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLPPETIKDLMRQLLRGV 120

Query: 416 EYLHNGCDVCILHFDIKPHNI 436
           ++LH+     I+H D+KP NI
Sbjct: 121 DFLHSH---RIVHRDLKPQNI 138

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 33/129 (25%), Positives = 61/129 (47%), Gaps = 9/129 (6%)

Query: 310 KLGQGGFGSVYKGQLHTGG-LIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           ++G+G FG V+ G+L      +AVK  + +       +F+ E   + +  H N+V+L+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C++     +V E +  G     +    + G     ++L ++    A G+EYL +    CI
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLESKH--CI 116

Query: 427 LHFDIKPHN 435
            H D+   N
Sbjct: 117 -HRDLAARN 124

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 40/142 (28%), Positives = 67/142 (47%), Gaps = 28/142 (19%)

Query: 308 THKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE------FINEVSTIGRIHHVNV 360
             K+G+G +G VYK +   T   IA   LK  +   E+       I E+S +  + H N+
Sbjct: 7   VEKIGEGTYGVVYKARDRVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHI-----FPKESRG-QSFSWEKLHEVALGTARG 414
           V+L        +  +V+EY+ +  L +H+     F K  R  +++ ++ L        RG
Sbjct: 64  VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL--------RG 114

Query: 415 IEYLHNGCDVCILHFDIKPHNI 436
           I Y H+     +LH D+KP N+
Sbjct: 115 IAYCHSH---RVLHRDLKPQNL 133

Length = 294

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 21/144 (14%)

Query: 311 LGQGGFGSVYKGQLHTGGL---IAVKMLKN--SKFSAEEFINEVSTIGRI-HHVNVVQLL 364
           +G+G FG V K ++   GL    A+K +K   SK    +F  E+  + ++ HH N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 365 GFCSEGSKRAVVYEYMPNGSL------------DRHIFPKESRGQSFSWEKLHEVALGTA 412
           G C       +  EY P+G+L            D       S   + S ++L   A   A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 413 RGIEYLHNGCDVCILHFDIKPHNI 436
           RG++YL        +H D+   NI
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNI 143

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 26/149 (17%)

Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K + +    +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK------------LHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S++             L   
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+EYL      CI H D+   N+
Sbjct: 140 AYQVARGMEYL--ASQKCI-HRDLAARNV 165

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 36/150 (24%), Positives = 63/150 (42%), Gaps = 32/150 (21%)

Query: 306 HFTHKLGQGGFGSVYKGQL---HTGGLIAVKMLKNSKFSAEEF----INEVSTIGRIHHV 358
                +G+G +G VYK +      G   A+K  K  K            E++ +  + H 
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62

Query: 359 NVVQLLGFCSEGSKRAV--VYEYMPNGSLDRHI--FPKESRGQSFS--------WEKLHE 406
           NVV L+    E + ++V  +++Y  +      I  F ++++  S          W+ L+ 
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAEHDLW--QIIKFHRQAKRVSIPPSMVKSLLWQILN- 119

Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
                  G+ YLH+     +LH D+KP NI
Sbjct: 120 -------GVHYLHSNW---VLHRDLKPANI 139

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 34/143 (23%), Positives = 65/143 (45%), Gaps = 35/143 (24%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFI-----NEVSTIGRIHHVNVVQL 363
           K+G+G +G+V+K +   T  ++A+K ++      +E +      E+  +  + H N+V+L
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVRL 64

Query: 364 LGFCSEGSKRAVVYEYMP----------NGSLDRHIFPKESRGQSFSWEKLHEVALGTAR 413
                   K  +V+EY            NG +D  I       +SF ++ L        +
Sbjct: 65  YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV------KSFMFQLL--------K 110

Query: 414 GIEYLHNGCDVCILHFDIKPHNI 436
           G+ + H+     +LH D+KP N+
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNL 130

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 38/130 (29%), Positives = 59/130 (45%), Gaps = 14/130 (10%)

Query: 310 KLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSA--EEFINEVSTIGRIHHVNVVQLLGF 366
           ++G G  G+VYK     TG L A+K++  +       +   E+  +  ++H NVV+    
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
                +  V+ E+M  GSL+      E        + L +VA     GI YLH      I
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADE--------QFLADVARQILSGIAYLHRR---HI 189

Query: 427 LHFDIKPHNI 436
           +H DIKP N+
Sbjct: 190 VHRDIKPSNL 199

Length = 353

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 36/135 (26%), Positives = 60/135 (44%), Gaps = 9/135 (6%)

Query: 306 HFTHKLGQGGFGSVY--KGQLHTGGLI--AVKMLKNSKFSAEEFINEVSTIGRIHHVNVV 361
               K+G+G FG +Y  K +  +   +   + + K      E    EV  + ++ H N+V
Sbjct: 3   EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
                  E  +  +V EY   G L + I     RG  FS +++    +  + G++++H  
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIH-- 118

Query: 422 CDVCILHFDIKPHNI 436
            D  ILH DIK  NI
Sbjct: 119 -DRKILHRDIKSQNI 132

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 48.7 bits (117), Expect = 2e-06
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 17/134 (12%)

Query: 311 LGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVS----TIGRI-HHVNVVQLL 364
           +G+G F +V   +   T    A+K+L   +   E+ +  V      + R+  H  +++L 
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68

Query: 365 G-FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGC 422
             F  E      V EY PNG L ++I    S  +  +     E+ L     +EYLH  G 
Sbjct: 69  YTFQDE-ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL----ALEYLHSKG- 122

Query: 423 DVCILHFDIKPHNI 436
              I+H D+KP NI
Sbjct: 123 ---IIHRDLKPENI 133

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 39/135 (28%), Positives = 70/135 (51%), Gaps = 17/135 (12%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE-----FINEVSTIGRIHHVNVVQL 363
           K+G+G +G VYKG+   TG ++A+K ++    S EE      I E+S +  + H N+V L
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIREISLLKELQHPNIVCL 64

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHI--FPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
                + S+  +++E++ +  L +++   PK   GQ    E +        +GI + H+ 
Sbjct: 65  QDVLMQESRLYLIFEFL-SMDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSR 120

Query: 422 CDVCILHFDIKPHNI 436
               +LH D+KP N+
Sbjct: 121 ---RVLHRDLKPQNL 132

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 36/137 (26%), Positives = 62/137 (45%), Gaps = 19/137 (13%)

Query: 313 QGGFGSVYKGQLHTGGL-----IAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           +G FG ++ G L          + VK +K+  S+      + E   +  + H N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 366 FCSEGS-KRAVVYEYMPNGSLDRHIFPKESR------GQSFSWEKLHEVALGTARGIEYL 418
            C E      V+Y YM  G+L   +F ++ R       Q+ S ++L  +A+  A G+ YL
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133

Query: 419 HNGCDVCILHFDIKPHN 435
           H      ++H DI   N
Sbjct: 134 HK---RGVIHKDIAARN 147

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 42/133 (31%), Positives = 56/133 (42%), Gaps = 19/133 (14%)

Query: 313 QGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV-----NVVQLLGF 366
           +G FGSVY  +   TG   A+K+LK S   A+  +  V     I  +      V +L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK--LHEVALGTARGIEYLH-NGCD 423
                   +V EY+  G     I  K   G    W K  + EV LG    +E LH  G  
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLG----VEDLHQRG-- 117

Query: 424 VCILHFDIKPHNI 436
             I+H DIKP N+
Sbjct: 118 --IIHRDIKPENL 128

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 25/159 (15%)

Query: 286 NQQSW-MPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLK---NSKF 340
           N+  W +P+RY+             ++G G +GSV       TG  +A+K L     S+ 
Sbjct: 7   NKTVWELPERYTSL----------KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI 56

Query: 341 SAEEFINEVSTIGRIHHVNVVQLLG-FCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQ 397
            A+    E++ +  + H NV+ LL  F S  S       Y  MP    D     ++  G 
Sbjct: 57  FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL----QKIMGH 112

Query: 398 SFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
             S +K+  +      G++Y+H+     I+H D+KP N+
Sbjct: 113 PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNL 148

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 41/142 (28%), Positives = 64/142 (45%), Gaps = 30/142 (21%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAV-KMLKNSKFSAEEF---INEVSTIGRIHHVNVVQL 363
            ++G G FG+VY  + + T  ++A+ KM  + K S E++   I EV  + ++ H N ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 364 LGFCSEGSKRAVVYEYMPNGS----LDRHIFPKESRGQSFSWEKLHEVAL-----GTARG 414
            G         +V EY   GS    L+ H  P            L EV +     G  +G
Sbjct: 81  KGCYLREHTAWLVMEYCL-GSASDILEVHKKP------------LQEVEIAAICHGALQG 127

Query: 415 IEYLHNGCDVCILHFDIKPHNI 436
           + YLH+      +H DIK  NI
Sbjct: 128 LAYLHS---HERIHRDIKAGNI 146

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 34/90 (37%), Positives = 46/90 (51%), Gaps = 12/90 (13%)

Query: 310 KLGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           +LGQG FG VY        KG+  T   +AVK +  S    E  EF+NE S +      +
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAET--RVAVKTVNESASLRERIEFLNEASVMKGFTCHH 70

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHI 389
           VV+LLG  S+G    VV E M +G L  ++
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYL 100

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 26/149 (17%)

Query: 311 LGQGGFGSVYKGQLH--------TGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V + + +            +AVKMLK++    +  + I+E+  +  I  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE--KLHE----------V 407
           ++ LLG C++     V+ EY   G+L   +  +   G  ++++  K+ E           
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+EYL +    CI H D+   N+
Sbjct: 140 AYQVARGMEYLES--RRCI-HRDLAARNV 165

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 8/95 (8%)

Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKFSA--EEFINEVS 350
           EI   T  F  +LG+  FG VYKG L           +A+K LK+       EEF +E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 351 TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL 385
              R+ H N+V LLG  ++    ++++ Y  +  L
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 37/128 (28%), Positives = 61/128 (47%), Gaps = 8/128 (6%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLK-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 368
           LG G FG VYK Q   TG   A K+++  S+   E+F+ E+  +    H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 369 EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILH 428
             +K  ++ E+   G+LD  I  +  RG   +  ++  V       + +LH+     ++H
Sbjct: 73  YENKLWILIEFCDGGALD-SIMLELERG--LTEPQIRYVCRQMLEALNFLHSH---KVIH 126

Query: 429 FDIKPHNI 436
            D+K  NI
Sbjct: 127 RDLKAGNI 134

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 26/149 (17%)

Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKN--SKFSAEEFINEVSTIGRI-HHVN 359
           LG+G FG V         K + +    +AVKMLK+  ++    + I+E+  +  I  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRG------------QSFSWEKLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G            +  S++ L   
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+EYL      CI H D+   N+
Sbjct: 146 AYQVARGMEYL--ASKKCI-HRDLAARNV 171

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)

Query: 310 KLGQGGFGSV-YKGQLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 367
           K+G+G  G V    + HTG  +AVK +   K    E + NEV  +   HH NVV +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
             G +  VV E++  G+L   +    +R    + E++  V L   R + YLHN     ++
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV--THTR---MNEEQIATVCLSVLRALSYLHNQ---GVI 140

Query: 428 HFDIKPHNI 436
           H DIK  +I
Sbjct: 141 HRDIKSDSI 149

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 8/129 (6%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           +LG G FG VYK Q   TG L A K++   S+   E+++ E+  +    H N+V+LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
              +   ++ E+   G++D  +   E   +  +  ++  V   T   + YLH   +  I+
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH---ENKII 125

Query: 428 HFDIKPHNI 436
           H D+K  NI
Sbjct: 126 HRDLKAGNI 134

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 35/129 (27%), Positives = 59/129 (45%), Gaps = 10/129 (7%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 367
           K+G+G  G V       TG  +AVK +   K    E + NEV  +    H N+V++    
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
             G +  VV E++  G+L   +    +R    + E++  V L   + + +LH      ++
Sbjct: 86  LVGDELWVVMEFLEGGALTDIV--THTR---MNEEQIATVCLAVLKALSFLHAQ---GVI 137

Query: 428 HFDIKPHNI 436
           H DIK  +I
Sbjct: 138 HRDIKSDSI 146

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 22/136 (16%)

Query: 310 KLGQGGFGSVYKGQLHTGG-LIAVKMLKNSKFSAEEF--INEVSTIGRIHHVNVVQLLGF 366
           KLG+G + +VYKG+    G L+A+K+++  +     F  I E S +  + H N+V L   
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 367 CSEGSKRAVVYEYMPNG---SLDRH---IFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
                   +V+EY+       +D+H   + P+  +   F ++ L        RG+ Y+H 
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVK--LFLFQLL--------RGLSYIHQ 121

Query: 421 GCDVCILHFDIKPHNI 436
                ILH D+KP N+
Sbjct: 122 R---YILHRDLKPQNL 134

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 34/131 (25%), Positives = 67/131 (51%), Gaps = 10/131 (7%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +K  +V+E++ +  L + +      G      K +   L   +G+ + H+     
Sbjct: 67  VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCHSH---R 120

Query: 426 ILHFDIKPHNI 436
           +LH D+KP N+
Sbjct: 121 VLHRDLKPQNL 131

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 40/130 (30%), Positives = 60/130 (46%), Gaps = 12/130 (9%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 367
           K+GQG  G+VY    + TG  +A+K +   +   +E I NE+  +    H N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 368 SEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
             G +  VV EY+  GSL D         GQ      +  V     + +E+LH+     +
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLHSN---QV 136

Query: 427 LHFDIKPHNI 436
           +H DIK  NI
Sbjct: 137 IHRDIKSDNI 146

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 10/130 (7%)

Query: 310 KLGQGGFGSVYKGQLH-TGGLIAVK--MLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           KLG+G + +V+KG+   T  L+A+K   L++ + +    I EVS +  + H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
                   +V+EY+ +  L +++   ++ G   S   +        RG+ Y H      I
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124

Query: 427 LHFDIKPHNI 436
           LH D+KP N+
Sbjct: 125 LHRDLKPQNL 134

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 45.5 bits (107), Expect = 2e-05
 Identities = 37/134 (27%), Positives = 65/134 (48%), Gaps = 13/134 (9%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLG-FC 367
           +G G +G VYKG+ + TG L A+K++  +    EE   E++ + +  HH N+    G F 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 368 SEG-----SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
            +       +  +V E+   GS+   I  K ++G +   E +  +     RG+ +LH   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQH- 130

Query: 423 DVCILHFDIKPHNI 436
              ++H DIK  N+
Sbjct: 131 --KVIHRDIKGQNV 142

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 32/135 (23%), Positives = 59/135 (43%), Gaps = 8/135 (5%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            +G+G FG+V K +    G ++  K +     + +E    ++EV+ +  + H N+V+   
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 366 FCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
              + S + +  V EY   G L + I   +   +    E +  +       +   HN  D
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 424 V--CILHFDIKPHNI 436
               +LH D+KP NI
Sbjct: 127 PGNTVLHRDLKPANI 141

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 34/127 (26%), Positives = 57/127 (44%), Gaps = 6/127 (4%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLG G FG V+    +    +AVK +K    S E F+ E + +  + H  +V+L    ++
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                ++ E+M  GSL    F K   G      KL + +   A G+ ++        +H 
Sbjct: 73  -EPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 126

Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 127 DLRAANI 133

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 18/141 (12%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGL--------IAVKMLKNSKFSAEE--FINEVSTIGRI- 355
           F   LG G FG V +   +  GL        +AVKMLK +  S+E    ++E+  +  + 
Sbjct: 39  FGKTLGAGAFGKVVEATAY--GLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96

Query: 356 HHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGI 415
           +H N+V LLG C+ G    V+ EY   G L    F +  R    + E L   +   A+G+
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLN--FLRRKRESFLTLEDLLSFSYQVAKGM 154

Query: 416 EYLHNGCDVCILHFDIKPHNI 436
            +L +    CI H D+   N+
Sbjct: 155 AFLAS--KNCI-HRDLAARNV 172

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 14/133 (10%)

Query: 311 LGQGGFGSVYKGQLHTGGL-----IAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQL 363
           LG G FG+VYKG     G      +A+K+L+   S  + +E ++E   +  +    V +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
           LG C   S   +V + MP G L  ++  +E++ +  S + L    +  A+G+ YL    +
Sbjct: 75  LGICLT-STVQLVTQLMPYGCLLDYV--RENKDRIGS-QDLLNWCVQIAKGMSYLE---E 127

Query: 424 VCILHFDIKPHNI 436
           V ++H D+   N+
Sbjct: 128 VRLVHRDLAARNV 140

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 41/137 (29%), Positives = 59/137 (43%), Gaps = 22/137 (16%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE-----FINEVSTIGRIHHVNVVQ 362
            KLG+G + +VYKG+   TG L+A   LK  +   EE      I E S +  + H N+V 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVA---LKEIRLEHEEGAPFTAIREASLLKDLKHANIVT 67

Query: 363 LLGFCSEGSKRAVVYEYMPNG---SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           L           +V+EY+       +D         G S    +L    L   RG+ Y H
Sbjct: 68  LHDIIHTKKTLTLVFEYLDTDLKQYMDDC-----GGGLSMHNVRLFLFQL--LRGLAYCH 120

Query: 420 NGCDVCILHFDIKPHNI 436
                 +LH D+KP N+
Sbjct: 121 ---QRRVLHRDLKPQNL 134

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 7/117 (5%)

Query: 309 HKLGQGGFGSVYKGQLHTGGLIA---VKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQL 363
            ++G G FG V   +++T   +A   VK LK +  S E  EF+ +      + H N++Q 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKE-SRGQSFSWEKLHEVALGTARGIEYLH 419
           LG C E     +V+EY   G L  ++  ++  R  S     L  +A   A G+ ++H
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL-LQRMACEIAAGVTHMH 116

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 16/133 (12%)

Query: 310 KLGQGGFGSVYKGQLH-TGGLIAVK--MLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           KLG+G + +VYKG+   T  L+A+K   L++ + +    I EVS +  + H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVAL---GTARGIEYLHNGCD 423
                   +V+EY     LD+ +  K+      +   +H V L      RG+ Y H    
Sbjct: 73  IHTEKSLTLVFEY-----LDKDL--KQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR-- 123

Query: 424 VCILHFDIKPHNI 436
             +LH D+KP N+
Sbjct: 124 -KVLHRDLKPQNL 135

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 35/134 (26%), Positives = 65/134 (48%), Gaps = 13/134 (9%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS 368
           +G G +G VYKG+ + TG L A+K++  ++   EE   E++ + +  HH N+    G   
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 369 EGSKRA------VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           + S         +V E+   GS+   +  K ++G +   + +  +     RG+ +LH   
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYICREILRGLAHLHAH- 140

Query: 423 DVCILHFDIKPHNI 436
              ++H DIK  N+
Sbjct: 141 --KVIHRDIKGQNV 152

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 26/143 (18%)

Query: 307 FTHKLGQGGFGSVYKGQLH--TGGLIAVK----MLKNSKFSAEEFINEVSTIGRIHHVNV 360
              +LG+G +GSVYK  LH  TG  +A+K     L  SKF+  + I E+  + +     +
Sbjct: 5   VLDELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFN--QIIMELDILHKAVSPYI 61

Query: 361 VQLLG-FCSEGSKRAVVY---EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
           V   G F  EG+    VY   EYM  GSLD+ ++      +    + L  +     +G++
Sbjct: 62  VDFYGAFFIEGA----VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLK 116

Query: 417 YL---HNGCDVCILHFDIKPHNI 436
           +L   HN     I+H D+KP N+
Sbjct: 117 FLKEEHN-----IIHRDVKPTNV 134

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 44.7 bits (106), Expect = 5e-05
 Identities = 36/133 (27%), Positives = 58/133 (43%), Gaps = 13/133 (9%)

Query: 310 KLGQGGFGSVYKG--QLHTGGLI--AVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQL 363
            +G+G FG VY+G         I  AVK  KN  S    E+F+ E   + +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
           +G  +E +   +V E  P G L  ++   +    S     L   +   +  + YL +   
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLESKRF 128

Query: 424 VCILHFDIKPHNI 436
           V   H DI   N+
Sbjct: 129 V---HRDIAARNV 138

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 38/133 (28%), Positives = 64/133 (48%), Gaps = 16/133 (12%)

Query: 310 KLGQGGFGSVYKGQLH-TGGLIAVK--MLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           KLG+G + +V+KG+   T  L+A+K   L++ + +    I EVS +  + H N+V L   
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVAL---GTARGIEYLHNGCD 423
                   +V+EY     LD+ +  K+      +   +H V +      RG+ Y H    
Sbjct: 73  VHTDKSLTLVFEY-----LDKDL--KQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR-- 123

Query: 424 VCILHFDIKPHNI 436
             +LH D+KP N+
Sbjct: 124 -KVLHRDLKPQNL 135

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 9/88 (10%)

Query: 307 FTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HH 357
           F   LG G FG V +   +          +AVKMLK S    E    ++E+  +  + +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSL 385
           +N+V LLG C+ G    V+ EY   G L
Sbjct: 99  INIVNLLGACTVGGPTLVITEYCCYGDL 126

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 35/133 (26%), Positives = 61/133 (45%), Gaps = 12/133 (9%)

Query: 309 HKLGQGGFGSVY-KGQLHTGGLIAVKML----KNSKFSAEEFINEVSTIGRIHHVNVVQL 363
           H++G G FG+VY     HT  ++AVK +    K +    ++ I EV  + ++ H N ++ 
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G   +     +V EY    + D      E   +     ++  +  G  +G+ YLH+   
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDL----LEVHKKPLQEVEIAAITHGALQGLAYLHSH-- 140

Query: 424 VCILHFDIKPHNI 436
             ++H DIK  NI
Sbjct: 141 -NMIHRDIKAGNI 152

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 26/85 (30%), Positives = 45/85 (52%), Gaps = 5/85 (5%)

Query: 310 KLGQGGFGSVYKGQLHTG---GLIAVKMLKNSKFSAEE--FINEVSTIGRIHHVNVVQLL 364
           ++G G FG V  G++++G     + VK L+ S    E+  F+ E      + H N++Q L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHI 389
           G C+E +   +V E+ P G L  ++
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYL 86

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 44.3 bits (104), Expect = 6e-05
 Identities = 33/130 (25%), Positives = 66/130 (50%), Gaps = 11/130 (8%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           ++G+G FG VYKG    T  ++A+K+  L+ ++   E+   E++ + +     + +  G 
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
             +G+K  ++ EY+  GS    + P     +++    L E+     +G++YLH+   +  
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLKPGPLE-ETYIATILREI----LKGLDYLHSERKI-- 123

Query: 427 LHFDIKPHNI 436
            H DIK  N+
Sbjct: 124 -HRDIKAANV 132

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 10/94 (10%)

Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRHIFPKES 394
            LLG C++ G    V+ E+   G+L  ++  K  
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRG 108

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 43.9 bits (103), Expect = 8e-05
 Identities = 43/134 (32%), Positives = 60/134 (44%), Gaps = 17/134 (12%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            ++G G +G VYK + LHTG L AVK++K      FS  +   E+  +    H N+V   
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ--QEIFMVKECKHCNIVAYF 72

Query: 365 GFCSEGSKRAVVYEYMPNGSLDR--HIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           G      K  +  EY   GSL    H+    S  Q      +  V   T +G+ YLH+  
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ------IAYVCRETLQGLAYLHSKG 126

Query: 423 DVCILHFDIKPHNI 436
               +H DIK  NI
Sbjct: 127 K---MHRDIKGANI 137

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 15/135 (11%)

Query: 311 LGQGGFGSVYKG---------QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVV 361
           LGQG F  ++KG         +LH   ++   + K+ +  +E F    S + ++ H ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
              G C  G +  +V EY+  GSLD ++  K     + SW KL EVA   A  + +L   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISW-KL-EVAKQLAWALHFLE-- 117

Query: 422 CDVCILHFDIKPHNI 436
            D  + H ++   N+
Sbjct: 118 -DKGLTHGNVCAKNV 131

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 30/88 (34%), Positives = 42/88 (47%), Gaps = 9/88 (10%)

Query: 307 FTHKLGQGGFGSVYK------GQLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HH 357
           F   LG G FG V +      G+      +AVKMLK S  + E    ++E+  +  +  H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSL 385
            N+V LLG C+ G    V+ EY   G L
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDL 129

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 36/146 (24%), Positives = 58/146 (39%), Gaps = 32/146 (21%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEF---------------INEVSTIGR 354
           LG+G +G V K     TG ++A+K +K  + S +                 + E+  +  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 355 IHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL----DRHIFPKESRGQSFSWEKLHEVALG 410
           I H N++ L+    EG    +V + M    L    DR I   ES+ +    + L      
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQIL------ 129

Query: 411 TARGIEYLHNGCDVCILHFDIKPHNI 436
              G+  LH       +H D+ P NI
Sbjct: 130 --NGLNVLHK---WYFMHRDLSPANI 150

Length = 335

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 11/134 (8%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGF-- 366
           +G+G +G VYK     TG L+A+K++   +   EE   E + + +  +H N+    G   
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73

Query: 367 ----CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
                    +  +V E    GS+   +     +G+    E +  +   T RG+ YLH   
Sbjct: 74  KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN- 132

Query: 423 DVCILHFDIKPHNI 436
              ++H DIK  NI
Sbjct: 133 --KVIHRDIKGQNI 144

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 16/96 (16%)

Query: 311 LGQGGFGSVYK------GQLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  +   +AVKMLK    ++E    + E+  +  I HH+NVV
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLD------RHIF 390
            LLG C++ G    V+ EY   G+L       R  F
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECF 110

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 36/140 (25%), Positives = 66/140 (47%), Gaps = 30/140 (21%)

Query: 311 LGQGGFGSVY---KGQLHTGGLIAVKMLKNSKFSAEEFINEVST----IGRIHHVNVVQL 363
           + +G +G V+   K    TG + A+K++K +    +  +++V T    + +     VV+L
Sbjct: 1   ISKGAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 364 LGFCSEGSKRAV--VYEYMPNG---SLDRHI--FPKESRGQSFSWEKLHEVALGTARGIE 416
             + S   K+ +  V EY+P G   SL  ++    ++      +     E+ L     +E
Sbjct: 59  --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVLA----LE 107

Query: 417 YLHNGCDVCILHFDIKPHNI 436
           YLH+     I+H D+KP NI
Sbjct: 108 YLHS---NGIIHRDLKPDNI 124

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 19/97 (19%)

Query: 311 LGQGGFGSVYKGQLHTGGL--------IAVKMLKNSKFSAEE--FINEVSTIGRIH-HVN 359
           LG G FG V +   H  GL        +AVKMLK++  S+E+   ++E+  +  +  H+N
Sbjct: 45  LGSGAFGRVVEATAH--GLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLN 102

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSL------DRHIF 390
           +V LLG C++G    ++ EY   G L      ++H F
Sbjct: 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 42/133 (31%), Positives = 59/133 (44%), Gaps = 18/133 (13%)

Query: 312 GQGGFGSVYKGQL-HTGGLIAVK-MLKN---SKFSAEEFINEVSTIGRIHHVNVVQL-LG 365
           G+G FG V   Q   T  + A+K M K     K S    +NE   +  ++H  +V L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE--KLHEVALGTARGIEYLHNGCD 423
           F  E     +V + +  G L  H+    S+   FS E  K     +  A  +EYLH+   
Sbjct: 69  FQDE-ENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLA--LEYLHSKG- 120

Query: 424 VCILHFDIKPHNI 436
             I+H DIKP NI
Sbjct: 121 --IIHRDIKPDNI 131

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 36/129 (27%), Positives = 63/129 (48%), Gaps = 10/129 (7%)

Query: 310 KLGQGGFGSV-YKGQLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 367
           K+G+G  G V    + H+G  +AVKM+   K    E + NEV  +    H NVV++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
             G +  V+ E++  G+L   +   ++R    + E++  V     + + YLH+     ++
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV--SQTR---LNEEQIATVCESVLQALCYLHSQ---GVI 139

Query: 428 HFDIKPHNI 436
           H DIK  +I
Sbjct: 140 HRDIKSDSI 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 16/135 (11%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAE--EFIN----EVSTIGRIHHVNVVQL 363
           LGQG FG VY      TG  +AVK ++    S E  + +N    E+  +  + H  +VQ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 364 LGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
            G   +  +R  ++  E+MP GS+   +    +  ++ + +   ++      G+ YLH+ 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI----LEGVSYLHSN 125

Query: 422 CDVCILHFDIKPHNI 436
               I+H DIK  NI
Sbjct: 126 ---MIVHRDIKGANI 137

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 40/131 (30%), Positives = 64/131 (48%), Gaps = 11/131 (8%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQLLG- 365
           +LG G  G V K Q    GLI  + L + +       + I E+  +   +   +V   G 
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           F S+G + ++  E+M  GSLD+ +  KE++      E L +V++   RG+ YL       
Sbjct: 72  FYSDG-EISICMEHMDGGSLDQVL--KEAK--RIPEEILGKVSIAVLRGLAYLREKHQ-- 124

Query: 426 ILHFDIKPHNI 436
           I+H D+KP NI
Sbjct: 125 IMHRDVKPSNI 135

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 33/131 (25%), Positives = 56/131 (42%), Gaps = 11/131 (8%)

Query: 311 LGQGGFGS--VYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
           LG+G FG   +Y+ +     L+  K +  ++ S +E    +NE+  +  + H N++    
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
              + +   +  EY   G+L   I     +GQ F  E +          + Y+H      
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAG 121

Query: 426 ILHFDIKPHNI 436
           ILH DIK  NI
Sbjct: 122 ILHRDIKTLNI 132

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 42/146 (28%), Positives = 57/146 (39%), Gaps = 40/146 (27%)

Query: 311 LGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFI---NEVS----------TIGRIH 356
           LG+G FG V   +   TG L A+K LK      +  I   +EV           T     
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALK------KGDIIARDEVESLMCEKRIFETANSER 60

Query: 357 HVNVVQLLGFCSEGSKRA-VVYEYMPNGSLDRHI----FPKESRGQSFSWEKLHEVALGT 411
           H  +V L   C +       V EY   G L  HI    F  E R   ++      V L  
Sbjct: 61  HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYA----ACVVL-- 112

Query: 412 ARGIEYLH-NGCDVCILHFDIKPHNI 436
             G++YLH N     I++ D+K  N+
Sbjct: 113 --GLQYLHENK----IVYRDLKLDNL 132

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 44/146 (30%), Positives = 63/146 (43%), Gaps = 33/146 (22%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKM--LKNSKFSAEEF----INEVSTIGRIHHVNVVQL 363
           +G+G +G VYK +   TG L+A+K   L N K   E F    I E+  + +++H N+V L
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNL 71

Query: 364 ----------LGFCSEGSKRAVVYEYMPN---GSLDRHIFPKESRGQSFSWEKLHEVALG 410
                     L F  +     +V+EYM +   G L       ES    FS + +      
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-------ESGLVHFSEDHIKSFMKQ 124

Query: 411 TARGIEYLHNGCDVCILHFDIKPHNI 436
              G+ Y H       LH DIK  NI
Sbjct: 125 LLEGLNYCHKK---NFLHRDIKCSNI 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 38/137 (27%), Positives = 64/137 (46%), Gaps = 20/137 (14%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKMLK--------NSKFSAEEFINEVSTIGRIHHVNVV 361
           LGQG FG VY    + TG  +A K ++        + + SA E   E+  +  + H  +V
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC--EIQLLKNLQHERIV 67

Query: 362 QLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           Q  G   + +++   +  EYMP GS+   +    +  +S + +   ++      G+ YLH
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI----LEGMSYLH 123

Query: 420 NGCDVCILHFDIKPHNI 436
           +     I+H DIK  NI
Sbjct: 124 SN---MIVHRDIKGANI 137

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 35/143 (24%), Positives = 65/143 (45%), Gaps = 35/143 (24%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE--------FINEVSTIGRIHHVNV 360
           K+G+G +G V+K +   TG ++A+K     KF   E         + E+  + ++ H N+
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLKHPNL 62

Query: 361 VQLLGFCSEGSKRAVVYEYMPN---GSLDRHIFPK---ESRGQSFSWEKLHEVALGTARG 414
           V L+       K  +V+EY  +     L+++  P+   E   +   W+        T + 
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQ--------TLQA 112

Query: 415 IEYLH-NGCDVCILHFDIKPHNI 436
           + + H + C    +H D+KP NI
Sbjct: 113 VNFCHKHNC----IHRDVKPENI 131

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 16/134 (11%)

Query: 311 LGQGGFGSVYKGQLHTGGL-----IAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQL 363
           LG G FG+VYKG     G      +A+K+L  +       EF++E   +  + H ++V+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFP-KESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           LG C   + + +V + MP+G L  ++   K++ G       L    +  A+G+ YL    
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQL----LLNWCVQIAKGMMYLE--- 126

Query: 423 DVCILHFDIKPHNI 436
           +  ++H D+   N+
Sbjct: 127 ERRLVHRDLAARNV 140

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 17/134 (12%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFI---NEVSTIGRIHHVNVVQLL 364
            ++G G +G VYK + ++TG L A+K++K      E+F     E+  +    H N+V   
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYF 72

Query: 365 GFCSEGSKRAVVYEYMPNGSLDR--HIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           G      K  +  E+   GSL    H+    S  Q      +  V+  T +G+ YLH+  
Sbjct: 73  GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ------IAYVSRETLQGLYYLHSKG 126

Query: 423 DVCILHFDIKPHNI 436
               +H DIK  NI
Sbjct: 127 K---MHRDIKGANI 137

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 36/149 (24%), Positives = 66/149 (44%), Gaps = 37/149 (24%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE------FINEVSTIGRIHHVN-VV 361
           K+G+G +G VYK +  +TG L+A   LK ++   +E       + E+S +  +     +V
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVA---LKKTRLEMDEEGIPPTALREISLLQMLSESIYIV 64

Query: 362 QLLGFCSEGSKRA-----VVYEYMP---------NGSLDRHIFPKESRGQSFSWEKLHEV 407
           +LL       K       +V+EY+          NG       P ++  +SF ++ L   
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKT-IKSFMYQLL--- 120

Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
                +G+ + H      ++H D+KP N+
Sbjct: 121 -----KGVAHCHK---HGVMHRDLKPQNL 141

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 34/131 (25%), Positives = 65/131 (49%), Gaps = 13/131 (9%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           ++G+G FG V+KG    T  ++A+K+  L+ ++   E+   E++ + +     V +  G 
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 367 CSEGSKRAVVYEYMPNGS-LDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
             +G+K  ++ EY+  GS LD        R   F   ++  +     +G++YLH+   + 
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDL------LRAGPFDEFQIATMLKEILKGLDYLHSEKKI- 123

Query: 426 ILHFDIKPHNI 436
             H DIK  N+
Sbjct: 124 --HRDIKAANV 132

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 35/142 (24%), Positives = 63/142 (44%), Gaps = 23/142 (16%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI---------HHVN 359
           ++G+G +G V+K + L  GG      LK  +    E    +STI  +          H N
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65

Query: 360 VVQLLGFCS-----EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARG 414
           VV+L   C+       +K  +V+E++     D   +  +        E + ++     RG
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDMMFQLLRG 122

Query: 415 IEYLHNGCDVCILHFDIKPHNI 436
           +++LH+     ++H D+KP NI
Sbjct: 123 LDFLHSH---RVVHRDLKPQNI 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 35/133 (26%), Positives = 63/133 (47%), Gaps = 14/133 (10%)

Query: 311 LGQGGFGSVYKGQLHTGGL-----IAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQL 363
           LG G FG+VYKG     G      +A+K L+   S  + +E ++E   +  + + +V +L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
           LG C   S   ++ + MP G L  ++   +    S   + L    +  A+G+ YL    +
Sbjct: 75  LGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMNYLE---E 127

Query: 424 VCILHFDIKPHNI 436
             ++H D+   N+
Sbjct: 128 RRLVHRDLAARNV 140

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 40.5 bits (94), Expect = 0.001
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 12/130 (9%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 367
           K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPK-ESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
             G +  VV EY+  GSL   +       GQ      +  V     + +E+LH+     +
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLHSN---QV 137

Query: 427 LHFDIKPHNI 436
           +H DIK  NI
Sbjct: 138 IHRDIKSDNI 147

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 37/134 (27%), Positives = 67/134 (50%), Gaps = 14/134 (10%)

Query: 311 LGQGGFGSVYKGQLH--TGGLIAVKMLK--NSKFSAEEFINEVSTIGRIHH-VNVVQLLG 365
           +G+G FG+V K  LH  +G ++AVK ++    +   +  + ++  + R      +V+  G
Sbjct: 12  IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 366 --FCSEGSKRAVVYEYMPNGSLDR-HIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
             F  EG    +  E M + SLD+ + +  E        E L ++A+ T + + YL    
Sbjct: 71  ALF-REGDC-WICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-- 125

Query: 423 DVCILHFDIKPHNI 436
           ++ I+H D+KP NI
Sbjct: 126 ELKIIHRDVKPSNI 139

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 39/133 (29%), Positives = 56/133 (42%), Gaps = 16/133 (12%)

Query: 310 KLGQGGFGSVYKGQLHTGG-LIAVKMLKNSKFSAEEF--INEVSTIGRIHHVNVVQLLGF 366
           KLG+G + +VYKG     G L+A+K++         F  I E S +  + H N+V L   
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVAL---GTARGIEYLHNGCD 423
                    V+EYM       H    +   Q       + V L      RG+ Y+H    
Sbjct: 72  IHTKETLTFVFEYM-------HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ-- 122

Query: 424 VCILHFDIKPHNI 436
             ILH D+KP N+
Sbjct: 123 -HILHRDLKPQNL 134

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 18/135 (13%)

Query: 310 KLGQGGFGSVYKG---QLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQL 363
           +LG G FG+V KG      +   +AVK+LKN        +E + E + + ++ +  +V++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL--HNG 421
           +G C E     +V E    G L++ +   +   +    E +H+V++    G++YL   N 
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM----GMKYLEETN- 115

Query: 422 CDVCILHFDIKPHNI 436
                +H D+   N+
Sbjct: 116 ----FVHRDLAARNV 126

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 40.5 bits (94), Expect = 0.001
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 12/130 (9%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 367
           K+GQG  G+VY    + TG  +A+K +   +   +E I NE+  +    + N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPK-ESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
             G +  VV EY+  GSL   +       GQ      +  V     + +++LH+     +
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALDFLHSN---QV 136

Query: 427 LHFDIKPHNI 436
           +H DIK  NI
Sbjct: 137 IHRDIKSDNI 146

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 40.5 bits (94), Expect = 0.001
 Identities = 35/132 (26%), Positives = 60/132 (45%), Gaps = 12/132 (9%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKML----KNSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           ++G G FG+VY  + + T  ++A+K +    K S    ++ I EV  + RI H N ++  
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G         +V EY    + D      E   +     ++  +  G  +G+ YLH+    
Sbjct: 92  GCYLREHTAWLVMEYCLGSASDL----LEVHKKPLQEVEIAAITHGALQGLAYLHSH--- 144

Query: 425 CILHFDIKPHNI 436
            ++H DIK  NI
Sbjct: 145 NMIHRDIKAGNI 156

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 40.1 bits (93), Expect = 0.001
 Identities = 35/129 (27%), Positives = 59/129 (45%), Gaps = 10/129 (7%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 367
           K+GQG  G+V+    + TG  +A+K +   K   +E I NE+  +  + + N+V  L   
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
             G +  VV EY+  GSL   +             ++  V     + +E+LH      ++
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVI 137

Query: 428 HFDIKPHNI 436
           H DIK  N+
Sbjct: 138 HRDIKSDNV 146

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 35/131 (26%), Positives = 54/131 (41%), Gaps = 10/131 (7%)

Query: 311 LGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEE----FINEVSTIGRIHHVNVVQLLG 365
           LG+GGFG V   Q+  TG + A K L   +    +     +NE   + ++    +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                    +V   M  G L  HI+     G  F   +    A     G+E+LH      
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--FPEARAIFYAAQIICGLEHLHQ---RR 115

Query: 426 ILHFDIKPHNI 436
           I++ D+KP N+
Sbjct: 116 IVYRDLKPENV 126

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 9/131 (6%)

Query: 311 LGQGGFGSVYKGQLH--TGGLIAVKMLKNSKFSAEE--FINEVSTIGR-IHHVNVVQLLG 365
           LG+G +G V K + H  TG ++AVK ++ +  S E+   + ++    R +     V   G
Sbjct: 9   LGRGAYGVVDKMR-HVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                    +  E M + SLD+       +G +   + L ++A+   + +EYLH+   V 
Sbjct: 68  ALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV- 125

Query: 426 ILHFDIKPHNI 436
            +H D+KP N+
Sbjct: 126 -IHRDVKPSNV 135

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 25/138 (18%)

Query: 311 LGQGGFGSVY------KGQLHTGGLIAV-KMLKNSKFSAEEFINEVSTIGRIHHVNVVQL 363
           +G+G FG V+        +L     I V +M K+ + +A+   NE   +  + H N+++ 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK--LH---EVALGTARGIEYL 418
                E     +V EY P G+L  +I   + R  S   E   LH   ++ L     + ++
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDTILHFFVQILL----ALHHV 117

Query: 419 HNGCDVCILHFDIKPHNI 436
           H      ILH D+K  NI
Sbjct: 118 HTK---LILHRDLKTQNI 132

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 36/129 (27%), Positives = 60/129 (46%), Gaps = 10/129 (7%)

Query: 310 KLGQGGFGSVYKGQLHTGG-LIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 367
           K+G+G  G V    + + G L+AVK +   K    E + NEV  +    H NVV++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
             G +  VV E++  G+L   +    +R    + E++  V L   + +  LH      ++
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV--THTR---MNEEQIAAVCLAVLKALSVLHAQ---GVI 138

Query: 428 HFDIKPHNI 436
           H DIK  +I
Sbjct: 139 HRDIKSDSI 147

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 44/132 (33%), Positives = 65/132 (49%), Gaps = 15/132 (11%)

Query: 311 LGQGGFGSVYK-GQLHTGGLIAVK-MLKNSKFSAEEFINEVSTIGRIHHVN---VVQLLG 365
           LG G  GSV K   + TG ++A K +   +K S  + I  +  +  +H      +V   G
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECRSPYIVSFYG 70

Query: 366 -FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
            F +E +   +  E+M  GSLDR I+ K   G     E L ++A+    G+ YL+N    
Sbjct: 71  AFLNENNI-CMCMEFMDCGSLDR-IYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VH 123

Query: 425 CILHFDIKPHNI 436
            I+H DIKP NI
Sbjct: 124 RIMHRDIKPSNI 135

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 35/131 (26%), Positives = 54/131 (41%), Gaps = 8/131 (6%)

Query: 311 LGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+GGFG V   Q+  TG L A K L   +       E  + E   + ++H   +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +   +V   M  G L  HI+  +     F   +          G+E+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117

Query: 426 ILHFDIKPHNI 436
           I++ D+KP N+
Sbjct: 118 IIYRDLKPENV 128

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 20/137 (14%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKMLK---NSKFSAEEFIN----EVSTIGRIHHVNVVQ 362
           LG+G FG VY      TG  +AVK +    +S+ +++E +N    E+  +  + H  +VQ
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68

Query: 363 LLGFC---SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
             G C    E  K ++  EYMP GS+   +    +  ++ +     ++     +G+ YLH
Sbjct: 69  YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI----LQGVSYLH 123

Query: 420 NGCDVCILHFDIKPHNI 436
           +     I+H DIK  NI
Sbjct: 124 SN---MIVHRDIKGANI 137

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 13/104 (12%)

Query: 311 LGQGGFGSVYKGQLHTGGL--------IAVKMLKNSKFSAEE--FINEVSTIGRI-HHVN 359
           LG G FG V +G  +  GL        +AVKMLK +  S+E+   ++E+  +  +  H+N
Sbjct: 45  LGSGAFGKVVEGTAY--GLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK 403
           +V LLG C++     ++ EY   G L  ++        S   EK
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEK 146

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 39.0 bits (91), Expect = 0.004
 Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 26/139 (18%)

Query: 311 LGQGGFGSVY-----KGQLHTGGLIAVKMLKNSKFSAEEFI---NEVSTIGRIHHVNVVQ 362
           LGQG FG V+      G    G L A+K+LK +     + +    E   +  ++H  +V+
Sbjct: 4   LGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 363 L-LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK----LHEVALGTARGIEY 417
           L   F +EG K  ++ +++  G L    F + S+   F+ E     L E+AL     +++
Sbjct: 63  LHYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELAL----ALDH 113

Query: 418 LHNGCDVCILHFDIKPHNI 436
           LH+   + I++ D+KP NI
Sbjct: 114 LHS---LGIIYRDLKPENI 129

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 34/135 (25%), Positives = 63/135 (46%), Gaps = 21/135 (15%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           K+G+G FG V+KG    T  ++A+K+  L+ ++   E+   E++ + +     V +  G 
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTA-----RGIEYLHNG 421
             + +K  ++ EY+  GS    + P            L E  + T      +G++YLH+ 
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLEPG----------PLDETQIATILREILKGLDYLHSE 120

Query: 422 CDVCILHFDIKPHNI 436
             +   H DIK  N+
Sbjct: 121 KKI---HRDIKAANV 132

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 37/131 (28%), Positives = 59/131 (45%), Gaps = 9/131 (6%)

Query: 310 KLGQGGFG-SVYKGQLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G FG ++       G    +K +  SK S    EE   EV+ +  + H N+VQ   
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
              E     +V +Y   G L + I     RG  F  +++ +  +     ++++H   D  
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVH---DRK 121

Query: 426 ILHFDIKPHNI 436
           ILH DIK  NI
Sbjct: 122 ILHRDIKSQNI 132

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 38.9 bits (91), Expect = 0.004
 Identities = 33/139 (23%), Positives = 68/139 (48%), Gaps = 23/139 (16%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLK--NSK----FSAEEFINEVSTIGRIHHVNVV 361
           +++G+G +G VY+ +   +G ++A+K ++  N +     S+   + E++ +  + H N+V
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS---LREITLLLNLRHPNIV 69

Query: 362 QLLGFCSEGSKRAV--VYEYMPN--GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           +L          ++  V EY      SL       ++    FS  ++  + L   RG++Y
Sbjct: 70  ELKEVVVGKHLDSIFLVMEYCEQDLASL------LDNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 418 LHNGCDVCILHFDIKPHNI 436
           LH   +  I+H D+K  N+
Sbjct: 124 LH---ENFIIHRDLKVSNL 139

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 37/131 (28%), Positives = 56/131 (42%), Gaps = 10/131 (7%)

Query: 311 LGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEE----FINEVSTIGRIHHVNVVQLLG 365
           LG+GGFG V   Q+  TG + A K L+  +    +     +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                    +V   M  G L  HI+   + G  F  E+    A     G+E LH      
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLHRE---N 122

Query: 426 ILHFDIKPHNI 436
            ++ D+KP NI
Sbjct: 123 TVYRDLKPENI 133

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 32/132 (24%), Positives = 64/132 (48%), Gaps = 14/132 (10%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHV---NVVQLL 364
           +G+G +G+VY+G  + TG ++A+K+  L        +   EV+ + ++      N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G   +G +  ++ EY   GS+ R +       + +    + EV +     ++Y+H    V
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLV----ALKYIHK---V 120

Query: 425 CILHFDIKPHNI 436
            ++H DIK  NI
Sbjct: 121 GVIHRDIKAANI 132

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	436
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.96
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.94
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.92
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.91
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.91
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.9
KOG3653	534	consensus Transforming growth factor beta/activin	99.9
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.89
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.88
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.88
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.88
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.88
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.88
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.87
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.87
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.87
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.87
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.86
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.86
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.86
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.86
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.86
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.85
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.85
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.85
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.85
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.85
KOG0198	313	consensus MEKK and related serine/threonine protei	99.85
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.84
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.84
KOG0610	459	consensus Putative serine/threonine protein kinase	99.84
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.84
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.84
KOG0605	550	consensus NDR and related serine/threonine kinases	99.84
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.83
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.83
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.83
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.83
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.83
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.83
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.83
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.83
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.83
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.83
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.83
KOG0578	550	consensus p21-activated serine/threonine protein k	99.83
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.83
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.83
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.83
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.83
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.82
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.82
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.82
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.82
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.82
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.82
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.82
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.82
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.82
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.82
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.82
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.82
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.81
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.81
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.81
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.81
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.81
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.81
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.81
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.81
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.81
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.81
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.81
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.81
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.81
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.81
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.81
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.8
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.8
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.8
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.8
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.8
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.8
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.8
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.8
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.8
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.8
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.8
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.8
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.8
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.8
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.8
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.8
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.8
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.8
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.8
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.8
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.8
PTZ00267	478	NIMA-related protein kinase; Provisional	99.8
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.8
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.79
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.79
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.79
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.79
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.79
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.79
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.79
KOG0589	426	consensus Serine/threonine protein kinase [General	99.79
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.79
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.79
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.79
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.79
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.79
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.79
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.79
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.79
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.79
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.79
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.79
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.79
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.79
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.79
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.79
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.79
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.79
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.79
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.79
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.79
KOG0586	596	consensus Serine/threonine protein kinase [General	99.79
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.79
PF13947	106	GUB_WAK_bind: Wall-associated receptor kinase gala	99.79
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.78
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.78
PHA03212	391	serine/threonine kinase US3; Provisional	99.78
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.78
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.78
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.78
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.78
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.78
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.78
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.78
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.78
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.78
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.78
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.78
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.78
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.78
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.78
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.78
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.78
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.78
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.78
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.78
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.78
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.78
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.78
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.78
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.78
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.78
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.78
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.78
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.78
KOG0584	632	consensus Serine/threonine protein kinase [General	99.78
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.78
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.78
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.78
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.78
PHA02988	283	hypothetical protein; Provisional	99.78
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.77
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.77
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.77
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.77
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.77
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.77
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.77
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.77
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.77
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.77
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.77
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.77
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.77
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.77
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.77
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.77
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.77
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.77
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.76
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.76
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.76
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.76
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.76
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.76
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.76
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.76
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.76
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.76
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.76
PTZ00283	496	serine/threonine protein kinase; Provisional	99.76
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.76
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.76
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.76
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.76
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.76
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.76
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.76
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.76
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.76
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.76
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.76
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.76
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.76
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.76
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.76
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.76
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.76
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.76
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.76
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.76
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.76
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.76
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.76
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.76
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.76
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.75
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.75
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.75
PTZ00036	440	glycogen synthase kinase; Provisional	99.75
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.75
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.75
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.75
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.75
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.75
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.75
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.75
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.75
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.75
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.75
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.75
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.75
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.75
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.75
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.75
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.75
PHA03211	461	serine/threonine kinase US3; Provisional	99.75
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.75
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.75
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.75
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.75
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.75
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.74
PHA03209	357	serine/threonine kinase US3; Provisional	99.74
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.74
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.74
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.74
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.74
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.74
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.74
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.74
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.74
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.74
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.74
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.74
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.74
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.74
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.74
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.74
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.73
PHA03207	392	serine/threonine kinase US3; Provisional	99.73
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.73
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.73
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.73
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.73
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.73
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.73
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.73
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.73
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.73
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.73
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.73
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.73
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.73
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.73
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.73
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.73
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.72
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.72
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.72
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.72
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.72
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.72
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.72
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.72
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.72
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.72
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.72
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.72
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.72
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.72
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.72
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.72
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.72
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.72
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.72
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.72
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.72
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.72
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.72
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.72
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.71
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.71
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.71
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.71
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.71
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.71
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.71
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.71
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.71
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.71
PTZ00284	467	protein kinase; Provisional	99.71
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.71
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.71
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.71
PLN00009	294	cyclin-dependent kinase A; Provisional	99.71
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.71
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.71
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.71
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.71
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.7
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.7
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.7
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.7
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.7
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.7
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.7
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.69
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.69
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.69
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.69
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.69
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.69
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.69
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.69
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.69
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.69
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.69
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.69
PRK10345	210	hypothetical protein; Provisional	99.68
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.68
PHA03210	501	serine/threonine kinase US3; Provisional	99.68
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.68
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.68
KOG1152	772	consensus Signal transduction serine/threonine kin	99.68
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.68
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.68
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.68
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.67
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.67
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.67
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.67
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.67
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.67
PRK09188	365	serine/threonine protein kinase; Provisional	99.66
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.66
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.66
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.66
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.66
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.66
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.65
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.65
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.65
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.65
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.65
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.64
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.64
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.64
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.64
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.63
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.63
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.63
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.63
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.63
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.62
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.62
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.62
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.61
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.59
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.59
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.58
PHA02882	294	putative serine/threonine kinase; Provisional	99.58
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.58
smart00090	237	RIO RIO-like kinase.	99.57
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.56
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.55
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.54
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.54
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.54
PRK14879	211	serine/threonine protein kinase; Provisional	99.53
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.53
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.53
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.52
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.51
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.5
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.5
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.5
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.49
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.48
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.48
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.46
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.46
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.45
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.45
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.45
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.44
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.44
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.43
PRK12274	218	serine/threonine protein kinase; Provisional	99.4
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.34
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.32
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.29
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.27
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.25
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.23
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.2
PF14380	94	WAK_assoc: Wall-associated receptor kinase C-termi	99.14
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	98.95
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.93
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.85
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.79
PLN00181	793	protein SPA1-RELATED; Provisional	98.78
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.75
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.54
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	98.54
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.42
KOG3087	229	consensus Serine/threonine protein kinase [General	98.39
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	98.38
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	98.36
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.24
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.15
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.11
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.09
KOG1243	690	consensus Protein kinase [General function predict	98.01
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	97.98
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	97.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	97.82
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.77
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	97.73
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.58
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	97.58
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.54
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.51
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.36
PRK09902	216	hypothetical protein; Provisional	97.31
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.28
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.13
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.0
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	96.91
PRK10593	297	hypothetical protein; Provisional	96.85
PLN02876	822	acyl-CoA dehydrogenase	96.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	96.55
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.5
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	96.41
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.4
PF01636	239	APH: Phosphotransferase enzyme family This family	96.06
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	95.5
KOG2270	520	consensus Serine/threonine protein kinase involved	95.42
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	95.35
PRK09550	401	mtnK methylthioribose kinase; Reviewed	93.57
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	92.76
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	92.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	92.33
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	90.8
KOG0576	829	consensus Mitogen-activated protein kinase kinase	90.14
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	88.86
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	88.82
PLN02756	418	S-methyl-5-thioribose kinase	87.7
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	86.58
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	86.49
PF02009	299	Rifin_STEVOR: Rifin/stevor family; InterPro: IPR00	85.38
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	84.01
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	83.86
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	82.7

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.4e-29  Score=239.49  Aligned_cols=144  Identities=48%  Similarity=0.891  Sum_probs=131.3

Q ss_pred             CCCccChHHHHHHhhhhh--cccCCCCCeEEEEEEEcCCCEEEEEEecCcccC-HHHHHHHHHHHcCCCcCcccceeEEE
Q 041073          291 MPKRYSYPEIIAMTNHFT--HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS-AEEFINEVSTIGRIHHVNVVQLLGFC  367 (436)
Q Consensus       291 ~~~~~~~~~i~~~~~~~~--~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~  367 (436)
                      ....|++.++..+|.+|.  +.||+|+||.||+|.+.++..||||.+...... ..+|.+|+.++.+++|||+|+++|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            556799999999999998  689999999999999998899999988775443 56699999999999999999999999


Q ss_pred             EeCC-eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          368 SEGS-KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       368 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+.+ ...||+|||++|+|.++++.....  .++|..+++||.++|+||+|||+.+.++||||||||+||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI  208 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI  208 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence            9988 599999999999999999765422  899999999999999999999999888999999999998

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=3.3e-27  Score=218.91  Aligned_cols=125  Identities=28%  Similarity=0.496  Sum_probs=112.0

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |.+.+.||+|+|++||+|+++ ++..||||.+.+...   ..+.+..|+.+|+.++|||||+++++...++..+||||||
T Consensus        12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC   91 (429)
T KOG0595|consen   12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC   91 (429)
T ss_pred             ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence            445567999999999999954 678899999977543   3355889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+|+|.+|++    +.+.+++..++.++.|+|.||++||++   +||||||||+||
T Consensus        92 ~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNi  140 (429)
T KOG0595|consen   92 NGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNI  140 (429)
T ss_pred             CCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceE
Confidence            9999999994    345799999999999999999999998   999999999997

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=2.7e-25  Score=206.10  Aligned_cols=129  Identities=26%  Similarity=0.398  Sum_probs=113.0

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCccc--------CHHHHHHHHHHHcCCCcCcccceeEEEEeCC
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKF--------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS  371 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  371 (436)
                      ....|-+.+.||+|+||.|-+|. .++|+.||||++++.+.        ......+|+++|++++|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            44566677899999999999997 56899999999976322        1233679999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..||||||++||+|.+++.    ..+.+.+..-..++.|++.|+.|||++   +|+||||||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNI  307 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENI  307 (475)
T ss_pred             ceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceE
Confidence            9999999999999999994    345677888899999999999999998   999999999997

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=9.3e-25  Score=209.74  Aligned_cols=137  Identities=30%  Similarity=0.490  Sum_probs=125.5

Q ss_pred             cChHHHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          295 YSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       295 ~~~~~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ....++.+...++.+.||+|.||.||.|.++....||+|.++......+.|.+|+++|++++|+|||+++|++..++.++
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            34457777888899999999999999999987778999999988778889999999999999999999999999988999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||||+.|+|.+||..  ..+..+...+.+.++.|||+||+||+++   ++|||||.++||
T Consensus       278 IVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNi  334 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNI  334 (468)
T ss_pred             EEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---Cccchhhhhhhe
Confidence            99999999999999954  2456789999999999999999999998   999999999997

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.91  E-value=3.3e-24  Score=205.94  Aligned_cols=132  Identities=37%  Similarity=0.633  Sum_probs=113.9

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCC-eeeE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS-KRAV  375 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~l  375 (436)
                      +......+.+.||+|+||+||+|.++....||||.+......   .++|.+|+.+|.+++|||||+++|++.+.. ...|
T Consensus        38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            333444455679999999999999885555999999864332   458999999999999999999999999887 7899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc-eEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC-ILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~-iiHrDlkp~NI  436 (436)
                      ||||+++|+|.++++..  +...+++..+++++.|||+||.|||++   + ||||||||+||
T Consensus       118 VtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~Ni  174 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNI  174 (362)
T ss_pred             EEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhE
Confidence            99999999999999653  357899999999999999999999998   6 99999999997

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.6e-23  Score=203.59  Aligned_cols=127  Identities=27%  Similarity=0.417  Sum_probs=116.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecC----cccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKN----SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      .+|...+.||+|+|+.+|.++. .+|..||+|++.+    .....+.+.+||++.+.|+|||||++++++++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4567778999999999999996 7899999999987    3445677999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|++++|..++    ++...+++.+++.++.||+.||.|||++   +|||||||..||
T Consensus        98 ELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNl  149 (592)
T KOG0575|consen   98 ELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNL  149 (592)
T ss_pred             EecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhc---Cceecccchhhe
Confidence            999999999988    3557899999999999999999999998   999999999996

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=1.4e-23  Score=197.80  Aligned_cols=125  Identities=32%  Similarity=0.554  Sum_probs=106.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHc--CCCcCcccceeEEEEeCC----eeeEEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIG--RIHHVNVVQLLGFCSEGS----KRAVVY  377 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~----~~~lv~  377 (436)
                      ..++.++||+|+||.||+|++. ++.||||+++..  +.+.|.+|-++.+  .++|+||+++++.-....    .++||+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            3456788999999999999986 589999998653  3456777766655  568999999999877655    789999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc------CCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN------GCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~------~~~~~iiHrDlkp~NI  436 (436)
                      ||.++|+|.+||     ....++|....+++..+++||+|||+      +.+|+|+|||||++||
T Consensus       288 ~fh~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNV  347 (534)
T KOG3653|consen  288 EFHPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNV  347 (534)
T ss_pred             eeccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccce
Confidence            999999999999     34679999999999999999999997      3467999999999997

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.89  E-value=2.6e-23  Score=191.33  Aligned_cols=124  Identities=29%  Similarity=0.424  Sum_probs=109.6

Q ss_pred             hhcccCCCCCeEEEEEEEc-CCCEEEEEEecC--cccCHHHHHHHHHHHcCCCcCcccceeEEEEeCC-eeeEEEecCCC
Q 041073          307 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-KRAVVYEYMPN  382 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~~~~  382 (436)
                      ..+.||+|..|+||++.++ +++.+|+|++..  +....+++.+|++++++.+||+||+++|.+.... ...|+||||.+
T Consensus        83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg  162 (364)
T KOG0581|consen   83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG  162 (364)
T ss_pred             hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence            4578999999999999965 788899999954  3334578999999999999999999999999988 49999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|++++    ...+.+++....+++.++++||.|||+.  ++||||||||+||
T Consensus       163 GSLd~~~----k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNl  210 (364)
T KOG0581|consen  163 GSLDDIL----KRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNL  210 (364)
T ss_pred             CCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHe
Confidence            9999998    2346799999999999999999999963  3999999999997

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.88  E-value=1e-22  Score=179.11  Aligned_cols=126  Identities=29%  Similarity=0.511  Sum_probs=111.9

Q ss_pred             hhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +|.-.+.||+|.||.||+|+ ..+|+.||||.++..+..   .....+|++.|+.++|+||+.+++++...+...||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            45566889999999999998 568999999999874332   35688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+. +|+..+.+   +...++..++..++.++++|++|+|++   .|+||||||.|+
T Consensus        83 m~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNL  132 (318)
T KOG0659|consen   83 MPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNL  132 (318)
T ss_pred             ccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccce
Confidence            965 99999943   446799999999999999999999998   999999999996

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.88  E-value=2.9e-23  Score=205.78  Aligned_cols=132  Identities=30%  Similarity=0.495  Sum_probs=115.1

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  372 (436)
                      ||......+.+.||.|.||.|++|+++    ....||||.++...  ..+.+|+.|+.+|.++.||||++|.|+......
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            444455566788999999999999965    23469999998843  345679999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+||+|||++|+|+.||+.   +.+.+++.++..++++|+.||+||.+.   ++|||||.++||
T Consensus       705 vMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNI  762 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNI  762 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhe
Confidence            9999999999999999954   336699999999999999999999876   999999999997

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=1.9e-22  Score=191.69  Aligned_cols=127  Identities=29%  Similarity=0.459  Sum_probs=110.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeC--CeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  376 (436)
                      ..|.-.++||+|+||.||+++ ..+|+.||+|.++....   ...-..+||.+|+++.||||+++.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            445556889999999999998 56899999999976432   344578999999999999999999988775  689999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|||+. +|.-++.   ...-.+++.++..++.|+++||+|+|++   +|+|||||.+||
T Consensus       197 FeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNi  249 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNI  249 (560)
T ss_pred             Eecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---Ceeeccccccce
Confidence            999976 8888773   3446799999999999999999999998   999999999997

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.9e-23  Score=197.09  Aligned_cols=129  Identities=29%  Similarity=0.495  Sum_probs=115.0

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcccCHHH--HHHHHHHHcCCC-cCcccceeEEEEeCC-eeeE
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRIH-HVNVVQLLGFCSEGS-KRAV  375 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  375 (436)
                      ...+|.+.++||.|+||.||+|+ ..++..||||.+++.-...++  -++|++.|++++ ||||+++.+.+.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            45688899999999999999998 568899999999876555554  468999999999 999999999998887 8999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||| ..+|.+.+..   ++..+++..++.|+.||++||+|+|.+   |+.|||+||+||
T Consensus        88 VfE~M-d~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENi  141 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENI  141 (538)
T ss_pred             eHHhh-hhhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhhe
Confidence            99999 5599999943   467899999999999999999999998   999999999997

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.88  E-value=9.6e-23  Score=187.57  Aligned_cols=128  Identities=27%  Similarity=0.399  Sum_probs=115.0

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ...+.+.+.||+|+||+|+.++. .+++.+|+|++++..    .+.+...+|..+|.+++||.||+++-.+.+.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            34566789999999999999984 578899999998733    3456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||+.||.|...|    ++.+.+++..++-++.+|+.||.|||++   +||||||||+||
T Consensus       104 ld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENI  156 (357)
T KOG0598|consen  104 LDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENI  156 (357)
T ss_pred             EeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHe
Confidence            9999999999999    4557899999999999999999999998   999999999997

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.87  E-value=1.9e-22  Score=186.65  Aligned_cols=130  Identities=23%  Similarity=0.372  Sum_probs=117.5

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      -.+.+|.+.+.||+|.||+|-++. ...|+.||||.+++++.    +.-.+.+|+++|..++||||++++.+++..+.+.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            345778888999999999999998 46899999999987443    3345889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||||..+|.|.+|+    ...+.+++.+++++++||..|+.|+|.+   +++|||||.+||
T Consensus       130 ivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENI  184 (668)
T KOG0611|consen  130 IVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENI  184 (668)
T ss_pred             EEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhhe
Confidence            999999999999999    4557899999999999999999999998   999999999998

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.5e-22  Score=197.32  Aligned_cols=133  Identities=33%  Similarity=0.478  Sum_probs=113.3

Q ss_pred             HHHHHHhhhhhcccCCCCCeEEEEEEEcC--C--CE-EEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEE
Q 041073          298 PEIIAMTNHFTHKLGQGGFGSVYKGQLHT--G--GL-IAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCS  368 (436)
Q Consensus       298 ~~i~~~~~~~~~~lg~G~fg~V~~~~~~~--~--~~-vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  368 (436)
                      +++...+..+.++||+|+||.||+|+++.  +  .. ||+|..+.+    +....++++|+++|+.++|||||+++|+..
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            44555555667999999999999998542  2  23 899988752    234467999999999999999999999999


Q ss_pred             eCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          369 EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       369 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...+++||||++++|+|.++|..   ....++..+...++.++|.||+|||++   ++|||||.++|.
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNc  293 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNC  293 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHh
Confidence            99999999999999999999943   233699999999999999999999998   999999999984

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=3.5e-23  Score=183.26  Aligned_cols=134  Identities=26%  Similarity=0.386  Sum_probs=113.9

Q ss_pred             HHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeE-EEEeCCe-eeE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLG-FCSEGSK-RAV  375 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l  375 (436)
                      ...|++.++||+|+||.||++. ..+|..+|.|.++-..   ...+++..|+.+|++++|||||++++ .+.++.. ++|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            3567788999999999999998 6689999999887533   33467999999999999999999998 4444444 799


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NI  436 (436)
                      |||++..|+|.+.+..-++..+.+++..+++++.|++.||.++|++. ++  |+||||||.||
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNI  159 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANI  159 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchhe
Confidence            99999999999998655556678999999999999999999999842 24  99999999997

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.87  E-value=2.3e-22  Score=194.89  Aligned_cols=132  Identities=31%  Similarity=0.551  Sum_probs=116.8

Q ss_pred             ChHHHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCe
Q 041073          296 SYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       296 ~~~~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  372 (436)
                      .++|+......+.+.||+|+||+||+|.+.  ..||||+++....   ..+.|.+|+..+++.+|.||+-+.|++..++.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            556777777778899999999999999976  3599999987443   34679999999999999999999999988776


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       .||+.+|++.+|+.+++..+   .++...+.+.|+.||++||.|||.+   +|||||||..||
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNI  519 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNI  519 (678)
T ss_pred             -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccce
Confidence             99999999999999997643   5788999999999999999999998   999999999998

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.9e-22  Score=174.83  Aligned_cols=127  Identities=25%  Similarity=0.444  Sum_probs=112.5

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +++.+.||+|.||.||.++. +++-.||+|++.++.    ...+++.+|+++-..++||||+++++++.+....||++||
T Consensus        24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy  103 (281)
T KOG0580|consen   24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY  103 (281)
T ss_pred             ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence            34678999999999999984 567789999997643    2346799999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++|.|...+..  ++...+++.....++.|+|.||.|+|.+   ++|||||||+|+
T Consensus       104 a~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenl  155 (281)
T KOG0580|consen  104 APRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENL  155 (281)
T ss_pred             cCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHh
Confidence            999999999842  3456789999999999999999999987   999999999996

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.86  E-value=3.5e-22  Score=201.36  Aligned_cols=135  Identities=31%  Similarity=0.551  Sum_probs=116.4

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeC
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEG  370 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  370 (436)
                      ++......+.+.||+|+||+||+|+..      +...||||.++....  ..++|++|++++..++|||||+++|.|..+
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            555666678899999999999999832      445799999987443  456799999999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCC----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESR----------GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++.++|+|||..|||.+||+.....          ..+++..+.+.||.|||.||+||-++   .+|||||..+|.
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNC  634 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNC  634 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhc
Confidence            9999999999999999999753211          23489999999999999999999988   999999999994

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.86  E-value=4.6e-22  Score=190.59  Aligned_cols=126  Identities=29%  Similarity=0.388  Sum_probs=111.1

Q ss_pred             hhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCccc----CHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKF----SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      .+.|.+.||+|+|++|++++ ..+++.+|||++.+...    .......|-.+|..| .||.|++|+-.+.+...+|+|+
T Consensus        74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL  153 (604)
T KOG0592|consen   74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL  153 (604)
T ss_pred             hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence            34577889999999999998 55889999999976322    233466788888888 7999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.++|    .+-+.+++..++.++.||+.||+|||++   +||||||||+||
T Consensus       154 e~A~nGdll~~i----~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENI  205 (604)
T KOG0592|consen  154 EYAPNGDLLDLI----KKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENI  205 (604)
T ss_pred             EecCCCcHHHHH----HHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhhe
Confidence            999999999999    3457899999999999999999999998   999999999997

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.86  E-value=7.9e-22  Score=190.01  Aligned_cols=133  Identities=27%  Similarity=0.463  Sum_probs=116.2

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      |..+....+.++||+|.||.|.+++...+..||||+++....  ...+|.+|+++|.+++||||++++|+|..++.+++|
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            566667778899999999999999988789999999987433  346899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|||++|+|.+|+...+..  .+.-....+|+.||+.||+||.+.   ++|||||.++|+
T Consensus       614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNc  668 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNC  668 (807)
T ss_pred             HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccce
Confidence            9999999999999544322  245566778999999999999987   999999999995

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.6e-21  Score=182.75  Aligned_cols=127  Identities=25%  Similarity=0.415  Sum_probs=105.3

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHc--CCCcCcccceeEEEEeCC----eeeE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIG--RIHHVNVVQLLGFCSEGS----KRAV  375 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~----~~~l  375 (436)
                      +.+..+.+.||+|.||.||+|.++ |+.||||++....  .+.+.+|.++..  .++|+||+.+++.-..+.    .++|
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            344566789999999999999998 7889999996543  344566666655  469999999998664432    4789


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN-----GCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-----~~~~~iiHrDlkp~NI  436 (436)
                      |++|.|.|||.|||     +...++.+..++++..+|.||+|||.     +.+|.|.|||||+.||
T Consensus       287 vTdYHe~GSL~DyL-----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI  347 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYL-----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  347 (513)
T ss_pred             eeecccCCcHHHHH-----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence            99999999999999     33679999999999999999999996     4478999999999998

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.85  E-value=8.3e-22  Score=176.26  Aligned_cols=125  Identities=26%  Similarity=0.407  Sum_probs=106.9

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |....++|+|+||.|++++.+ +|+.||||.+..+..+   .+-.++|+++|++++|+|+|.+++++.....++||+||+
T Consensus         4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~   83 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC   83 (396)
T ss_pred             HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence            444567999999999999954 8999999999775543   245789999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..-|.+ +   +.....++.+.+.+++.|+++|+.|+|++   ++|||||||+||
T Consensus        84 dhTvL~e-L---e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENI  132 (396)
T KOG0593|consen   84 DHTVLHE-L---ERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENI  132 (396)
T ss_pred             chHHHHH-H---HhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhhe
Confidence            7744443 4   23345689999999999999999999998   999999999997

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.85  E-value=7.5e-22  Score=189.60  Aligned_cols=125  Identities=30%  Similarity=0.464  Sum_probs=112.1

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      .|.+.+.||+|+||.||||+. .+.+.||+|.+.+...   +.+.+.+|++++++++||||+.+++++++..+.++|+||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            466778999999999999984 4778899999977433   345689999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +.+ +|..++    ...+.++++.+..++.+++.||.|||++   +|+|||+||+||
T Consensus        83 a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqni  131 (808)
T KOG0597|consen   83 AVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNI  131 (808)
T ss_pred             hhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCccee
Confidence            966 999999    3457899999999999999999999998   999999999997

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.85  E-value=3.4e-21  Score=181.86  Aligned_cols=127  Identities=28%  Similarity=0.460  Sum_probs=106.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---------------CHHHHHHHHHHHcCCCcCcccceeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---------------SAEEFINEVSTIGRIHHVNVVQLLGF  366 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l~~~  366 (436)
                      ..|.+.+.||+|.||.|-++.. .+++.||||++.+.+.               ..+...+|+.+|++++|+|||+|+++
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            3456678899999999999984 4788999999965321               12468899999999999999999999


Q ss_pred             EEe--CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          367 CSE--GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       367 ~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..+  .+.+|||+||+..|.+...-    .....+++.++++++++++.||+|||.+   +||||||||+|+
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNL  241 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNL  241 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhhe
Confidence            876  45789999999998875432    1223399999999999999999999998   999999999996

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.85  E-value=7.9e-21  Score=174.76  Aligned_cols=130  Identities=28%  Similarity=0.465  Sum_probs=110.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCc-ccceeEEEEeCC------
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVN-VVQLLGFCSEGS------  371 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------  371 (436)
                      ..+...++||+|+||+||+|+ ..+|+.||+|.++....   ......+|+.++++++|+| |+++++++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            445556779999999999999 45888999999987433   3456789999999999999 999999998877      


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..++|+||+ .-+|.+++.........++...++.++.|+++||+|||++   +|+||||||+||
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNl  151 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNL  151 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceE
Confidence            789999999 5599999954332224577789999999999999999998   999999999997

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.9e-21  Score=186.29  Aligned_cols=128  Identities=27%  Similarity=0.400  Sum_probs=112.4

Q ss_pred             HHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCc----cc--CHHHHHHHHHHHcCCC-cCcccceeEEEEeCCee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNS----KF--SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~----~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  373 (436)
                      ...|.+.+.||+|+||+|+.+. ..++..||+|++++.    ..  ..+.+.+|+.+++.++ ||||++++.+.......
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            3456677899999999999997 457899999977653    11  2345678999999999 99999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+.+|+|.+++.    +.+.+.+..+..++.|++.|++|+|++   +|+||||||+||
T Consensus        96 ~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENi  151 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENI  151 (370)
T ss_pred             EEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHE
Confidence            99999999999999994    346789999999999999999999998   999999999997

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.85  E-value=6e-21  Score=178.21  Aligned_cols=128  Identities=34%  Similarity=0.491  Sum_probs=108.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCC--eeeEEEe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRAVVYE  378 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~E  378 (436)
                      .++...+.||+|+||.||++... +|...|||.+.... ...+.+.+|+.+|.+++|||||+++|......  ..+++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34556688999999999999854 58899999986531 12566899999999999999999999855444  6899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++...   +..+++..++.+..||++||+|||++   +||||||||+||
T Consensus        97 y~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~Ni  148 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANI  148 (313)
T ss_pred             ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceE
Confidence            99999999999322   22799999999999999999999998   999999999997

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.84  E-value=4.1e-21  Score=171.46  Aligned_cols=126  Identities=29%  Similarity=0.375  Sum_probs=112.3

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .+++.+.||.|+||+|.+++.+ ++..+|+|++.+.+    ...+...+|..+|+.+.||.++++++.+.+...++||||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            3456688999999999999854 67889999997633    234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|.|..+++    +.+++++..++.++.||+.||+|||+.   .|++|||||+||
T Consensus       125 yv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENi  175 (355)
T KOG0616|consen  125 YVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENL  175 (355)
T ss_pred             ccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHe
Confidence            999999999993    456899999999999999999999998   999999999997

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.84  E-value=2.1e-21  Score=191.61  Aligned_cols=125  Identities=29%  Similarity=0.497  Sum_probs=109.6

Q ss_pred             hcccCCCCCeEEEEEE-EcCCCEEEEEEecC--cccCHHHHHHHHHHHcCCCcCcccceeEEEEeCC------eeeEEEe
Q 041073          308 THKLGQGGFGSVYKGQ-LHTGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRAVVYE  378 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~E  378 (436)
                      .+.||+|+||.||+|+ ..+|+.||||.++.  .....+...+|+++|++++|+|||++++.-++..      ...++||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            4679999999999999 56899999999987  3345677899999999999999999998776543      4579999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||.+|||...+.+.+ +...|++.+.+.+...++.||.|||++   +|+||||||.||
T Consensus        98 yC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NI  151 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNI  151 (732)
T ss_pred             ecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcE
Confidence            999999999996554 345699999999999999999999988   999999999998

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.84  E-value=1.2e-20  Score=175.67  Aligned_cols=132  Identities=26%  Similarity=0.335  Sum_probs=115.0

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      +.-...++.+.||+|.-|+||+++.+ ++..+|+|++.+...    ...+...|-++|+.+.||.+++++..++.+...+
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            33445567789999999999999966 558899999977332    2345778889999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+||+|...++  ++.++.+++..++.++.+++-||+|||..   |||.|||||+||
T Consensus       154 l~meyCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENI  210 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENI  210 (459)
T ss_pred             EEEecCCCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCccee
Confidence            9999999999998773  34667899999999999999999999987   999999999997

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.84  E-value=7.3e-21  Score=178.03  Aligned_cols=130  Identities=27%  Similarity=0.442  Sum_probs=112.1

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ....+++.+.||+|+||.||+|..+    .+..+|+|.++....  ..+.+.+|+..+++++||||+++++.+..++..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3456778899999999999999743    355799999876422  2356889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++|+|.+++..   ....+++..++.++.|++.||+|||++   +++||||||+||
T Consensus        83 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~ni  138 (266)
T cd05064          83 IVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKV  138 (266)
T ss_pred             EEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhE
Confidence            99999999999999843   234689999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.84  E-value=1.7e-20  Score=206.21  Aligned_cols=131  Identities=24%  Similarity=0.528  Sum_probs=109.6

Q ss_pred             cChHHHHHHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          295 YSYPEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       295 ~~~~~i~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      +++.++.. .++..+.||+|+||.||+|.. .++..||+|.++.....   ..+|++.+++++||||++++|++.+.+..
T Consensus       683 ~~~~~~~~-~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        683 ITINDILS-SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             hhHHHHHh-hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            34444432 234456899999999999986 57889999998653322   23568899999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++|+|.+++.       .++|..+.+++.|+++||+|||..++++|+||||||+||
T Consensus       759 ~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Ni  814 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKI  814 (968)
T ss_pred             EEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhE
Confidence            99999999999999992       489999999999999999999976667999999999997

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.84  E-value=7.4e-21  Score=182.38  Aligned_cols=126  Identities=25%  Similarity=0.351  Sum_probs=113.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .+.+.++||+|+||.||+++. .+|..+|+|+++++.    ...+....|-.+|....+++||+++-.+.+.+.+|||||
T Consensus       142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME  221 (550)
T KOG0605|consen  142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME  221 (550)
T ss_pred             cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence            345678999999999999984 589999999998843    344568889999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|||++..+|    .+...|++..++.++.+++.|++-||+.   ++|||||||+|+
T Consensus       222 ylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNl  272 (550)
T KOG0605|consen  222 YLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNL  272 (550)
T ss_pred             ecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhhe
Confidence            99999999998    3557899999999999999999999998   999999999995

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=1.2e-20  Score=185.77  Aligned_cols=125  Identities=26%  Similarity=0.312  Sum_probs=109.9

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      |.+.+.||+|+||.||++.. .+++.||+|++....    ...+.+.+|+++++.++||||+++++.+.+....++||||
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~   82 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF   82 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence            55678999999999999985 478899999986532    1235678899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++.    +...+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        83 ~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NI  132 (377)
T cd05629          83 LPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNI  132 (377)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHE
Confidence            99999999983    335688999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.83  E-value=1.2e-20  Score=185.87  Aligned_cols=125  Identities=25%  Similarity=0.278  Sum_probs=109.8

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +.+.+.||+|+||+||++.. .+++.+|+|+++...    ...+.+.+|+++++.++|+||+++++.+.+.+..++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~   82 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence            45668899999999999985 477899999997532    2234688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++.    +...+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        83 ~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Ni  132 (381)
T cd05626          83 IPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNI  132 (381)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHE
Confidence            99999999983    335688999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.83  E-value=1.7e-20  Score=179.03  Aligned_cols=132  Identities=30%  Similarity=0.503  Sum_probs=110.4

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEcC-----------------CCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccc
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLHT-----------------GGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQ  362 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~  362 (436)
                      ...+.+.+.||+|+||.||++..+.                 +..||+|.++....  ...++.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4567778999999999999997432                 23699999876322  2356899999999999999999


Q ss_pred             eeEEEEeCCeeeEEEecCCCCChhhhccCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceE
Q 041073          363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKES---------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL  427 (436)
Q Consensus       363 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ii  427 (436)
                      +++++...+..+++|||+++|+|.+++.....               ....+++..+.+++.|++.||+|||+.   +|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            99999999999999999999999998853211               113478889999999999999999988   999


Q ss_pred             ecCCCCCCC
Q 041073          428 HFDIKPHNI  436 (436)
Q Consensus       428 HrDlkp~NI  436 (436)
                      ||||||+||
T Consensus       161 H~dlkp~Ni  169 (304)
T cd05096         161 HRDLATRNC  169 (304)
T ss_pred             ccCcchhhe
Confidence            999999997

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.83  E-value=1e-20  Score=183.34  Aligned_cols=134  Identities=28%  Similarity=0.447  Sum_probs=109.6

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEE------cCCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEEeC
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEG  370 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  370 (436)
                      +...++++.+.||+|+||.||+|..      .+++.||+|+++....  ..+.+.+|+.++..+ +||||+++++.+...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            3456778889999999999999973      2346799999875322  235688999999999 899999999988654


Q ss_pred             -CeeeEEEecCCCCChhhhccCCCCC------------------------------------------------------
Q 041073          371 -SKRAVVYEYMPNGSLDRHIFPKESR------------------------------------------------------  395 (436)
Q Consensus       371 -~~~~lv~E~~~~gsL~~~l~~~~~~------------------------------------------------------  395 (436)
                       +..+++|||+++|+|.+++......                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4578999999999999988542110                                                      


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          396 ----GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       396 ----~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                          ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Ni  205 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNI  205 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceE
Confidence                13478889999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.83  E-value=1.5e-20  Score=184.12  Aligned_cols=125  Identities=22%  Similarity=0.319  Sum_probs=110.2

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +++.+.||+|+||+||++... +++.+|+|+++...    .....+.+|+.++.+++|+||+++++.+.+....++||||
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~   82 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF   82 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence            456788999999999999854 68899999997532    2234678899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 ~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NI  132 (363)
T cd05628          83 LPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNL  132 (363)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHe
Confidence            99999999983    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.83  E-value=2.2e-20  Score=183.85  Aligned_cols=125  Identities=25%  Similarity=0.288  Sum_probs=110.2

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      |.+.+.||+|+||.||+++. .+++.+|+|++....    ...+.+.+|++++++++|+||+++++.+.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            56678999999999999985 468899999986522    2345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 ~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Ni  132 (376)
T cd05598          83 IPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNI  132 (376)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHE
Confidence            99999999983    335688999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.83  E-value=2.6e-20  Score=179.40  Aligned_cols=121  Identities=25%  Similarity=0.299  Sum_probs=106.9

Q ss_pred             cccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          309 HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      +.||+|+||.||++.. .+++.+|+|+++...    .....+.+|+.++++++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999985 478899999987532    22345788999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NI  126 (323)
T cd05571          81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENL  126 (323)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHE
Confidence            9999883    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=1.5e-20  Score=184.23  Aligned_cols=125  Identities=25%  Similarity=0.333  Sum_probs=110.4

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      |++.+.||+|+||.||+++.. +++.||+|++....    .....+.+|+.++..++|+||+++++.+.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY   82 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence            556789999999999999854 68899999997532    2234578899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 ~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NI  132 (364)
T cd05599          83 LPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNL  132 (364)
T ss_pred             CCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHe
Confidence            99999999984    234689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.83  E-value=3.3e-20  Score=172.43  Aligned_cols=128  Identities=28%  Similarity=0.483  Sum_probs=114.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      ..+++.+.||+|+||.||++..+++..+|+|.++......+++.+|+.++++++||||+++++++...+..+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            34567788999999999999988777899999876655667899999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        84 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni  131 (256)
T cd05114          84 GCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNC  131 (256)
T ss_pred             CcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceE
Confidence            9999998432   24589999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.83  E-value=7.5e-21  Score=189.57  Aligned_cols=124  Identities=27%  Similarity=0.478  Sum_probs=106.8

Q ss_pred             hhhcccCCCCCeEEEEEEE-cCCC----EEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          306 HFTHKLGQGGFGSVYKGQL-HTGG----LIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~-~~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      +-.++||+|+||+||+|.+ ..++    +||+|++...  .....++.+|+..|.+++|||+++++|++.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3457899999999999984 3333    6899998763  334578999999999999999999999998765 889999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||.|.|.+|++.   .+..+..+..+.+..|||+||.|||.+   +++||||.++||
T Consensus       778 ~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNV  829 (1177)
T KOG1025|consen  778 LMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNV  829 (1177)
T ss_pred             hcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhhe
Confidence            9999999999954   346788899999999999999999988   999999999996

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=1.3e-20  Score=178.88  Aligned_cols=126  Identities=23%  Similarity=0.261  Sum_probs=110.6

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|++.+.||+|+||.||++... +++.+|+|++....    ...+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            3556788999999999999854 78899999986532    223568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NI  132 (291)
T cd05612          82 YVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENI  132 (291)
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHe
Confidence            999999999983    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.2e-20  Score=182.13  Aligned_cols=125  Identities=30%  Similarity=0.457  Sum_probs=111.8

Q ss_pred             hhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcccCH-HHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .|.-.++||+|+.|.||.+. ..+++.||||.+....+.. +-+.+|+.+|+..+|+|||.+++.+...+.+|+|||||+
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            34445789999999999998 5678899999998865544 458899999999999999999999998999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|+|.+.+     ....+++.++..|++++++||+|||.+   +|+|||||.+||
T Consensus       354 ggsLTDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnI  400 (550)
T KOG0578|consen  354 GGSLTDVV-----TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNI  400 (550)
T ss_pred             CCchhhhh-----hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeecccccee
Confidence            99999988     335699999999999999999999998   999999999997

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.83  E-value=2.6e-20  Score=179.92  Aligned_cols=127  Identities=24%  Similarity=0.345  Sum_probs=111.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|.+.+.||+|+||.||+++.. +++.+|+|+++...    ...+.+.+|+.++++++||||+++++.+..++..+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            45667789999999999999964 67899999987532    23456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        98 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NI  149 (329)
T PTZ00263         98 EFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENL  149 (329)
T ss_pred             cCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHE
Confidence            9999999999983    335688999999999999999999998   999999999997

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.83  E-value=2.2e-20  Score=169.34  Aligned_cols=125  Identities=26%  Similarity=0.376  Sum_probs=105.4

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEe--CCeeeEEEe
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAVVYE  378 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E  378 (436)
                      |...+.|++|+||.||+|+. ++++.||+|.++..+..   .-.-.+||.+|.+++|||||.+..+...  -+.+|||||
T Consensus        78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe  157 (419)
T KOG0663|consen   78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME  157 (419)
T ss_pred             HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence            44557899999999999994 58889999999875421   1235799999999999999999888764  356899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |++. +|...+..   -.+++...++..++.|+++|++|||.+   .|+|||||++|+
T Consensus       158 ~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNL  208 (419)
T KOG0663|consen  158 YVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNL  208 (419)
T ss_pred             HHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhhe
Confidence            9976 89888843   336789999999999999999999998   999999999996

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.83  E-value=3.6e-20  Score=178.39  Aligned_cols=121  Identities=26%  Similarity=0.319  Sum_probs=106.5

Q ss_pred             cccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          309 HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      +.||+|+||.||++.. .++..||+|+++...    .....+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3689999999999985 478899999987532    23345778999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NI  126 (323)
T cd05595          81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENL  126 (323)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHE
Confidence            9998883    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.83  E-value=6.3e-21  Score=171.70  Aligned_cols=121  Identities=31%  Similarity=0.482  Sum_probs=110.4

Q ss_pred             cccCCCCCeEEEEEE-EcCCCEEEEEEecCccc-CHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKF-SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      +.||+|+++.|-.+. +.++..+|||++.+... .+.+..+|++++...+ |+||++++++++++...|||||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            679999999999887 77899999999987543 4567899999999886 99999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...|.    +...+++.++.++..+|+.||.|||.+   +|.||||||+||
T Consensus       164 LshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENi  207 (463)
T KOG0607|consen  164 LSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENI  207 (463)
T ss_pred             HHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccce
Confidence            99994    446799999999999999999999998   999999999998

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.82  E-value=4.6e-20  Score=178.05  Aligned_cols=121  Identities=26%  Similarity=0.340  Sum_probs=106.9

Q ss_pred             cccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          309 HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      +.||+|+||.||++.. .+++.+|+|++....    .....+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999985 478899999997532    23356788999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NI  126 (328)
T cd05593          81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENL  126 (328)
T ss_pred             CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHe
Confidence            9998883    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.82  E-value=3e-20  Score=182.60  Aligned_cols=135  Identities=30%  Similarity=0.468  Sum_probs=112.6

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEE------cCCCEEEEEEecCcc--cCHHHHHHHHHHHcCC-CcCcccceeEEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSE  369 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  369 (436)
                      ++....+.+.+.||+|+||.||++..      .++..||+|+++...  ...+.+.+|+.++..+ +||||+++++.+..
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            33455677889999999999999963      245579999987533  2345688999999999 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCC-------------------------------------------------------
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKES-------------------------------------------------------  394 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------  394 (436)
                      ++..++||||+++|+|.+++.....                                                       
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            9999999999999999998853211                                                       


Q ss_pred             ----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          395 ----------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       395 ----------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                                      ....+++..+.+++.|+++||+|||++   +|+||||||+||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  245 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNI  245 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhE
Confidence                            012578899999999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.82  E-value=4.5e-20  Score=178.89  Aligned_cols=129  Identities=24%  Similarity=0.281  Sum_probs=111.7

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc-C-CCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH-T-GGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~-~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ....+++.+.||+|+||.||+|..+ . +..+|+|.+...    ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3456778899999999999999854 3 357999998652    223456889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       108 lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NI  162 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENL  162 (340)
T ss_pred             EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHE
Confidence            9999999999999983    335689999999999999999999998   999999999997

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.82  E-value=3e-20  Score=183.22  Aligned_cols=125  Identities=24%  Similarity=0.289  Sum_probs=109.7

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +.+.+.||+|+||.||+++. .+++.+|+|++....    ...+.+.+|+++++.++|+||+++++.+.+.+..++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            45678899999999999985 467889999987532    2234688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 ~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NI  132 (382)
T cd05625          83 IPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNI  132 (382)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            99999999883    234688999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.82  E-value=7.7e-20  Score=170.45  Aligned_cols=132  Identities=27%  Similarity=0.462  Sum_probs=117.6

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +...++++.+.||+|++|.||++...+++.+|+|.++......+++.+|+.++++++|+||+++++++...+..+++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            44566778899999999999999977778899999987665667899999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||
T Consensus        83 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Ni  134 (261)
T cd05068          83 MKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNV  134 (261)
T ss_pred             ccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceE
Confidence            9999999998432  234689999999999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.82  E-value=6.7e-20  Score=175.66  Aligned_cols=119  Identities=22%  Similarity=0.327  Sum_probs=105.5

Q ss_pred             cCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          311 LGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       311 lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      ||+|+||.||++... +++.+|+|+++..    ......+.+|+.++++++||||+++++.+...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999854 6788999998752    22345678899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Ni  124 (312)
T cd05585          81 FHHLQ----REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENI  124 (312)
T ss_pred             HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHe
Confidence            99983    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.82  E-value=3.8e-20  Score=181.42  Aligned_cols=127  Identities=22%  Similarity=0.277  Sum_probs=111.0

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ...|++.+.||+|+||.||+++.. +++.+|+|++....    ...+.+.+|+.+++.++||||+++++.+..+...++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            356777889999999999999864 67889999986521    2334578999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       122 ~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NI  173 (370)
T cd05621         122 MEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNM  173 (370)
T ss_pred             EcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHE
Confidence            99999999999883     23588999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.82  E-value=6.9e-20  Score=170.74  Aligned_cols=132  Identities=27%  Similarity=0.454  Sum_probs=116.8

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +....+++.++||+|+||.||+|...++..+|+|.+.......+.+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            34566778899999999999999987788899999876555567899999999999999999999999988999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++...  ....+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~ni  134 (261)
T cd05072          83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANV  134 (261)
T ss_pred             CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhE
Confidence            9999999998532  235688999999999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.82  E-value=1.2e-19  Score=174.91  Aligned_cols=121  Identities=25%  Similarity=0.308  Sum_probs=105.9

Q ss_pred             cccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          309 HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      +.||+|+||.||++.. .+++.+|+|+++...    .....+.+|++++..++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999985 478899999997532    22345788999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~iiHrDlkp~NI  436 (436)
                      +|.+++.    +...+++..+..++.|++.||+|||+ +   +|+||||||+||
T Consensus        81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NI  127 (325)
T cd05594          81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENL  127 (325)
T ss_pred             cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeE
Confidence            9998883    33568999999999999999999996 5   899999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.82  E-value=9.6e-20  Score=169.43  Aligned_cols=128  Identities=31%  Similarity=0.514  Sum_probs=113.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      ..+.+.+.||+|+||.||++....+..+|+|.++......+++.+|+.++++++||||+++++++......+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            34567789999999999999877667799999886655667899999999999999999999999988889999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||||+||
T Consensus        84 ~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni  131 (256)
T cd05113          84 GCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNC  131 (256)
T ss_pred             CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceE
Confidence            9999998432   23689999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.82  E-value=7.2e-20  Score=173.14  Aligned_cols=127  Identities=28%  Similarity=0.344  Sum_probs=109.2

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      |+..+.||+|+||.||++.. .+++.+|+|.+....    .....+.+|+.+++.++|+||+++++.+.+.+..+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            44568899999999999985 578899999986532    1223578899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Ni  133 (285)
T cd05631          82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENI  133 (285)
T ss_pred             cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHE
Confidence            9999998877432  234689999999999999999999998   999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.82  E-value=5.7e-20  Score=177.80  Aligned_cols=125  Identities=22%  Similarity=0.333  Sum_probs=110.7

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      |.+.+.||+|+||.||++... +++.||+|+++...    ...+.+.+|++++..++||||+++++.+...+..++||||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            556789999999999999965 68899999987532    2335688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 ~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Ni  132 (333)
T cd05600          83 VPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENF  132 (333)
T ss_pred             CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHE
Confidence            99999999983    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.81  E-value=1.1e-19  Score=168.90  Aligned_cols=128  Identities=29%  Similarity=0.478  Sum_probs=113.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      ..+.+.+.||+|+||.||++..+++..+|+|.+.........+.+|+++++.++|+||+++++.+...+..+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            34567789999999999999877777899999876555667788999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        84 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni  131 (256)
T cd05059          84 GCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNC  131 (256)
T ss_pred             CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhE
Confidence            9999998432   24689999999999999999999998   999999999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.81  E-value=7.8e-20  Score=179.36  Aligned_cols=127  Identities=21%  Similarity=0.263  Sum_probs=110.8

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ...+.+.+.||+|+||.||+++.. +++.+|+|++....    ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            456677899999999999999854 68899999986522    2334578899999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       122 ~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NI  173 (370)
T cd05596         122 MEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNM  173 (370)
T ss_pred             EcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence            99999999999883     23578899999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.81  E-value=9.8e-20  Score=171.76  Aligned_cols=123  Identities=28%  Similarity=0.421  Sum_probs=106.6

Q ss_pred             cCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          311 LGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       311 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      ||+|+||+||++... +++.+|+|.+.....    ..+.+..|+++++.++|+||+++.+.+......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999854 788999999865322    224577899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++.........+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  128 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENV  128 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            988754333445789999999999999999999998   999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.81  E-value=8e-20  Score=171.82  Aligned_cols=121  Identities=26%  Similarity=0.403  Sum_probs=103.0

Q ss_pred             ccCCCCCeEEEEEEEcC-------------------------CCEEEEEEecCccc-CHHHHHHHHHHHcCCCcCcccce
Q 041073          310 KLGQGGFGSVYKGQLHT-------------------------GGLIAVKMLKNSKF-SAEEFINEVSTIGRIHHVNVVQL  363 (436)
Q Consensus       310 ~lg~G~fg~V~~~~~~~-------------------------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l  363 (436)
                      .||+|+||.||+|....                         ...|++|++..... ....+.+|+.+++.++|+||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997421                         12488888865332 23568889999999999999999


Q ss_pred             eEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       364 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++......++||||+++|+|..++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni  148 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI  148 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence            9999999999999999999999998842   235688999999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.81  E-value=1.4e-19  Score=168.61  Aligned_cols=132  Identities=29%  Similarity=0.480  Sum_probs=116.8

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ++...++++.++||+|+||.||++...+++.+|+|.+.......+++.+|+.++++++|+||+++++... .+..+++||
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            4566788889999999999999999888899999999876667788999999999999999999998864 456899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++...  .+..+++.++..++.|++.||+|||+.   +++||||||+||
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni  133 (260)
T cd05067          81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANI  133 (260)
T ss_pred             cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhE
Confidence            99999999988432  335689999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1e-19  Score=170.80  Aligned_cols=131  Identities=24%  Similarity=0.325  Sum_probs=116.1

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ....|.+.+.||.|.-++||+|. ...+..||||+++..+.  +.+.+.+|+..|+.++||||++++..+..+..+|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            34567788999999999999998 56789999999976443  3578999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .||.+|++.+.+...-.  ..+++..+..|.+++++||.|||++   +.||||||+.||
T Consensus       104 pfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnI  157 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNI  157 (516)
T ss_pred             hhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccE
Confidence            99999999999854322  3489999999999999999999998   999999999998

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.81  E-value=1.4e-19  Score=173.99  Aligned_cols=121  Identities=26%  Similarity=0.339  Sum_probs=106.3

Q ss_pred             cccCCCCCeEEEEEEE----cCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          309 HKLGQGGFGSVYKGQL----HTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      +.||+|+||.||++..    .+++.+|+|+++...   .....+.+|++++++++||||+++++.+..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    367899999997632   233457789999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|+|.+++.    +...+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        82 ~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  129 (318)
T cd05582          82 GGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENI  129 (318)
T ss_pred             CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHe
Confidence            999999883    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=8.5e-20  Score=176.43  Aligned_cols=127  Identities=20%  Similarity=0.227  Sum_probs=110.6

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|++.+.||+|+||.||++... +++.+|+|++.+.    ....+.+.+|+.++..++|+||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            3567789999999999999854 6889999998652    2233458889999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Ni  133 (331)
T cd05597          82 YYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNV  133 (331)
T ss_pred             cCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHE
Confidence            9999999999832   235689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.81  E-value=9.2e-20  Score=178.29  Aligned_cols=125  Identities=23%  Similarity=0.325  Sum_probs=110.0

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +++.+.||+|+||.||++... +++.+|+|+++..    ......+.+|+.++..++|+||+++++.+.+.+..++||||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~   82 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF   82 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            456688999999999999854 6889999998752    22345688899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 ~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NI  132 (360)
T cd05627          83 LPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNL  132 (360)
T ss_pred             CCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHE
Confidence            99999999983    335689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.81  E-value=1.6e-19  Score=174.66  Aligned_cols=131  Identities=24%  Similarity=0.348  Sum_probs=113.1

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      +....|++.+.||+|+||.||++... ++..+|+|.+.....  ....+.+|+++++.++|+||+++++++...+..++|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            44567788899999999999999865 678899998865322  235688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++.    ....+++..+..++.|++.||+|||+.  .+|+||||||+||
T Consensus        82 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Ni  135 (333)
T cd06650          82 MEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNI  135 (333)
T ss_pred             EecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhE
Confidence            99999999999983    234688999999999999999999974  2699999999997

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.81  E-value=1.2e-19  Score=171.98  Aligned_cols=126  Identities=29%  Similarity=0.454  Sum_probs=108.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .|.+.+.||+|+||.||+|..+ ++..||+|.++...  .....+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL   85 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence            4667789999999999999854 78899999987532  23456789999999999999999999999988999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      + ++|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        86 ~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Ni  134 (288)
T cd07871          86 D-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNL  134 (288)
T ss_pred             C-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHE
Confidence            7 599988832   234578999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.81  E-value=1.2e-19  Score=175.85  Aligned_cols=130  Identities=28%  Similarity=0.423  Sum_probs=115.6

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCCC-cCcccceeEEEEeCCe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSK  372 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  372 (436)
                      +-....|.+.+.||+|.||.||+++.+ +|+.+|+|.+.+...    ..+.+.+|+.+|+++. |||||++.+.+++...
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            344566778899999999999999955 699999999977433    3467999999999998 9999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++|||++.+|.|.+.+...     .+++..+..++.|++.+++|||+.   +|+||||||+|+
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~  166 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENL  166 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHe
Confidence            99999999999999999533     399999999999999999999997   999999999996

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.81  E-value=3.9e-20  Score=193.10  Aligned_cols=137  Identities=30%  Similarity=0.539  Sum_probs=117.5

Q ss_pred             hHHHHHHhhhhhcccCCCCCeEEEEEEEc--CC----CEEEEEEecC--cccCHHHHHHHHHHHcCCCcCcccceeEEEE
Q 041073          297 YPEIIAMTNHFTHKLGQGGFGSVYKGQLH--TG----GLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCS  368 (436)
Q Consensus       297 ~~~i~~~~~~~~~~lg~G~fg~V~~~~~~--~~----~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  368 (436)
                      ++++.....++.+.||+|.||.||.|...  .+    ..||+|.+++  +..+..+|.+|..+|++++|||||+++|.+.
T Consensus       686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            34455666777889999999999999854  23    2489999987  3455678999999999999999999999999


Q ss_pred             eCCeeeEEEecCCCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          369 EGSKRAVVYEYMPNGSLDRHIFPKES---RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       369 ~~~~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +....+|++|||++|+|..||+..+.   ....++..+.+.++.+||+|++||+++   ++|||||.++|.
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNC  833 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNC  833 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhhe
Confidence            99999999999999999999964321   145689999999999999999999998   999999999994

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.81  E-value=1.5e-19  Score=172.39  Aligned_cols=127  Identities=28%  Similarity=0.447  Sum_probs=109.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ..|++.+.||+|+||.||+++.. +++.+|+|+++...  .....+.+|+.+++.++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            35667789999999999999965 78899999987532  2234578899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++ ++|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        85 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Ni  134 (303)
T cd07869          85 VH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNL  134 (303)
T ss_pred             CC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            95 688887732   235688999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.81  E-value=1.8e-19  Score=174.06  Aligned_cols=121  Identities=21%  Similarity=0.284  Sum_probs=105.7

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||++... +++.||+|+++...    ...+.+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999854 68899999997632    2234578899999888 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Ni  127 (329)
T cd05588          81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNV  127 (329)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHe
Confidence            99998883    335799999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.80  E-value=1.6e-19  Score=174.50  Aligned_cols=129  Identities=26%  Similarity=0.354  Sum_probs=111.7

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ...|.+.+.||+|+||.||+++.. ++..+|+|.+....  ...+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            455667789999999999999855 67889999987532  223568999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++.    ....+++..+..++.|++.||.|||++  .+|+||||||+||
T Consensus        84 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Ni  135 (331)
T cd06649          84 HMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNI  135 (331)
T ss_pred             cCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhE
Confidence            999999999983    234689999999999999999999975  2699999999997

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.80  E-value=1.1e-19  Score=179.68  Aligned_cols=134  Identities=25%  Similarity=0.398  Sum_probs=111.2

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCC-cCcccceeEEEEeC
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIH-HVNVVQLLGFCSEG  370 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  370 (436)
                      .....+.+.+.||+|+||.||+|...      .+..||+|+++....  ..+.+.+|+++++++. ||||+++++++...
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            33556777899999999999999742      234699999975322  3457899999999996 99999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCC--------------------------------------------------------
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKES--------------------------------------------------------  394 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------  394 (436)
                      +..+|||||+++|+|.+++.....                                                        
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            999999999999999998754210                                                        


Q ss_pred             ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          395 ------------------------------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       395 ------------------------------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                                                          ....+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni  268 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence                                                012478888999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.80  E-value=1.2e-19  Score=175.26  Aligned_cols=126  Identities=24%  Similarity=0.271  Sum_probs=110.6

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      |.+.+.||+|+||.||++... +++.+|+|+++....    ..+.+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            567789999999999999854 788999999976322    335588899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NI  133 (330)
T cd05601          83 QPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENV  133 (330)
T ss_pred             CCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHhe
Confidence            9999999998432   25689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.80  E-value=1.3e-19  Score=177.84  Aligned_cols=129  Identities=22%  Similarity=0.266  Sum_probs=111.7

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      +....+.+.+.||+|+||.||+++.. +++.+|+|++....    ...+.+.+|+.+++.++||||+++++.+..+...+
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            33467778899999999999999854 67889999986522    22345788999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++|+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       120 lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NI  173 (371)
T cd05622         120 MVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNM  173 (371)
T ss_pred             EEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHE
Confidence            9999999999999883     23578899999999999999999998   999999999997

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.80  E-value=2.3e-19  Score=167.53  Aligned_cols=130  Identities=31%  Similarity=0.466  Sum_probs=114.1

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ...+.+.+.||+|++|.||++..+ .++.+|+|.+........++.+|+++++.++|+||+++++.+...+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            345667789999999999999854 6788999998766555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++...  ....+++..++.++.|+++||+|||++   +++||||||+||
T Consensus        85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~ni  135 (263)
T cd05052          85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNC  135 (263)
T ss_pred             CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceE
Confidence            999999998432  234689999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.80  E-value=1.8e-20  Score=172.42  Aligned_cols=123  Identities=33%  Similarity=0.476  Sum_probs=100.3

Q ss_pred             hhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCC-----eeeEEEecC
Q 041073          307 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRAVVYEYM  380 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~E~~  380 (436)
                      -.+.+|.|+||.||+|... +++.||||..-.++.   --.+|+++|+.+.|||||++.-++....     ...+|||||
T Consensus        28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            3478999999999999954 678999998755332   2236899999999999999988775422     235899999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |. +|.++++.....+..++...++-+..|+.+||+|||+.   +|+||||||+||
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNl  156 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNL  156 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheE
Confidence            87 99998854333456788888999999999999999987   999999999996

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.80  E-value=8.9e-20  Score=177.64  Aligned_cols=126  Identities=25%  Similarity=0.329  Sum_probs=111.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      +|.+.+.||+|+||.||++... +++.||+|+++...    .....+.+|++++..++|+||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            3566789999999999999954 78899999987532    234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NI  132 (350)
T cd05573          82 YMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNI  132 (350)
T ss_pred             CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHe
Confidence            9999999999842    25789999999999999999999997   999999999997

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.80  E-value=3.2e-19  Score=166.16  Aligned_cols=130  Identities=29%  Similarity=0.501  Sum_probs=116.0

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCccc-CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ...|++.++||+|+||.||+|....++.+++|.+..... ..+++.+|+.+++.++|+||+++++++......+++|||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            456778899999999999999987788999999876543 4567899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~ni  135 (261)
T cd05148          85 EKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNI  135 (261)
T ss_pred             ccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceE
Confidence            999999999543  335689999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.80  E-value=3.4e-19  Score=166.00  Aligned_cols=132  Identities=33%  Similarity=0.517  Sum_probs=118.0

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +....+.+.+.||+|+||.||++...++..+|+|.+.......+++.+|+.++++++|+||+++++.+......+++|||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            45567778899999999999999977778899999987666677899999999999999999999999988899999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++...  ....+++..+..++.|++.||+|||++   +++|+||||+||
T Consensus        83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~ni  134 (261)
T cd05034          83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNI  134 (261)
T ss_pred             cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheE
Confidence            9999999998532  234689999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.80  E-value=2.3e-19  Score=172.87  Aligned_cols=121  Identities=28%  Similarity=0.411  Sum_probs=105.6

Q ss_pred             cccCCCCCeEEEEEEE----cCCCEEEEEEecCcc-----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          309 HKLGQGGFGSVYKGQL----HTGGLIAVKMLKNSK-----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +.||+|+||.||++..    .+++.+|+|+++...     .....+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999974    357789999987532     2234578899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++.    +...+.+..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Ni  131 (323)
T cd05584          82 LSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENI  131 (323)
T ss_pred             CCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHe
Confidence            99999999883    335688899999999999999999998   999999999997

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.80  E-value=1.3e-19  Score=178.09  Aligned_cols=134  Identities=28%  Similarity=0.450  Sum_probs=111.4

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEEeC
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEG  370 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  370 (436)
                      .....+++.+.||+|+||.||++...      ++..||+|+++....  ..+.+.+|+++++.+ +|+||+++++.+...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            44556778899999999999998732      335799999975332  235688999999999 899999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCC--------------------------------------------------------
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKES--------------------------------------------------------  394 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------  394 (436)
                      +..++||||+++|+|.+++.....                                                        
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            999999999999999998843210                                                        


Q ss_pred             ----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          395 ----------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       395 ----------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                                ....+++..+.+++.|+++||+|||++   +|+||||||+||
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Ni  243 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNV  243 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheE
Confidence                      113478899999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.80  E-value=2.9e-20  Score=180.22  Aligned_cols=136  Identities=29%  Similarity=0.420  Sum_probs=122.5

Q ss_pred             cChHHHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          295 YSYPEIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       295 ~~~~~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      .+-+|+.+.......+||-|.||.||.|.++ -.-.||||.++.+....++|+.|+.+|+.++|||+|+++|+|......
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3556777778888899999999999999976 455799999999888899999999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      |||+|||.+|+|.+||+..  +...++.-.++.++.||+.||+||..+   ++|||||.++|
T Consensus       339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARN  395 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARN  395 (1157)
T ss_pred             EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhh
Confidence            9999999999999999543  345678888899999999999999987   99999999998

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.80  E-value=1.7e-19  Score=174.39  Aligned_cols=127  Identities=19%  Similarity=0.195  Sum_probs=110.0

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|.+.+.||+|+||.||+++.. +++.+|+|++....    ...+.+.+|..++..++|+||+++++.+...+..++|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            3567789999999999999854 67889999986521    223457889999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 y~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Ni  133 (331)
T cd05624          82 YYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNV  133 (331)
T ss_pred             CCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHE
Confidence            9999999999943   234689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.80  E-value=3.7e-19  Score=165.77  Aligned_cols=131  Identities=31%  Similarity=0.482  Sum_probs=114.6

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +....+++.+.||+|+||.||++....+..+|+|.++......+.+.+|+.++++++|+|++++++.+. ....+++|||
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            345667888999999999999999877888999999876666678999999999999999999999875 4567899999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Ni  133 (260)
T cd05070          82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANI  133 (260)
T ss_pred             cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceE
Confidence            9999999998532  234589999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.80  E-value=3.1e-19  Score=166.60  Aligned_cols=130  Identities=30%  Similarity=0.455  Sum_probs=112.7

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ...++.+.++||+|+||.||+|...+...+|+|.++......+++.+|+++++.++|+||+++++... ....+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            34567888999999999999998776677999999875556678999999999999999999999874 45578999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++...  ....+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Ni  133 (262)
T cd05071          83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANI  133 (262)
T ss_pred             CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccE
Confidence            999999999432  234578999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.80  E-value=2.7e-19  Score=172.45  Aligned_cols=123  Identities=29%  Similarity=0.386  Sum_probs=105.1

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHH---cCCCcCcccceeEEEEeCCeeeEEE
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTI---GRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ++.+.||+|+||.||++... +++.||+|+++...    ...+.+.+|++++   +.++||||+++++++...+..++||
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            45688999999999999854 68899999997532    2234566676554   5678999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|..++.     ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Ni  132 (324)
T cd05589          82 EYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNL  132 (324)
T ss_pred             cCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHe
Confidence            9999999998872     24689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.80  E-value=3.5e-19  Score=171.88  Aligned_cols=125  Identities=18%  Similarity=0.244  Sum_probs=107.7

Q ss_pred             hhcccCCC--CCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          307 FTHKLGQG--GFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       307 ~~~~lg~G--~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      +.++||+|  +|++||++.. .+++.||+|.++....   ..+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  6789999985 5788999999876432   2345778999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Ni  132 (327)
T cd08227          82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHI  132 (327)
T ss_pred             CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhE
Confidence            999999998432  224589999999999999999999988   999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=9.3e-20  Score=178.48  Aligned_cols=125  Identities=26%  Similarity=0.371  Sum_probs=112.2

Q ss_pred             hhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +++.+.||.|+.|.|-+|+ ..+|+.+|||++.+.    ......+.+|+.+|+-+.|||++++++.+++...+|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            3456789999999999998 458999999999764    22345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|.|.+++.    +.+.+++.++.+++.||+.|+.|+|..   +|+||||||+|+
T Consensus        94 v~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENl  143 (786)
T KOG0588|consen   94 VPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENL  143 (786)
T ss_pred             cCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhh
Confidence            99999999994    457899999999999999999999998   999999999996

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.80  E-value=2e-19  Score=170.15  Aligned_cols=127  Identities=29%  Similarity=0.378  Sum_probs=109.4

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      |+..+.||+|+||.||++.. .+++.||+|.+.....    ....+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            45668899999999999985 4688999999865321    224577899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Ni  133 (285)
T cd05605          82 MNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENI  133 (285)
T ss_pred             cCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHE
Confidence            9999999887432  234689999999999999999999998   999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.80  E-value=3.2e-19  Score=171.68  Aligned_cols=121  Identities=25%  Similarity=0.319  Sum_probs=104.6

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||+|+.. +++.+|+|+++...    ...+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36899999999999854 67899999987532    2334577888888765 799999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|..++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Ni  127 (321)
T cd05591          81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNI  127 (321)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHe
Confidence            99998883    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.80  E-value=3.6e-19  Score=171.93  Aligned_cols=121  Identities=23%  Similarity=0.297  Sum_probs=104.6

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||++... +++.+|+|+++...    ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36899999999999854 67889999987632    2234577888888766 799999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|..++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Ni  127 (329)
T cd05618          81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNV  127 (329)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHE
Confidence            99998873    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.80  E-value=2.4e-19  Score=181.70  Aligned_cols=130  Identities=15%  Similarity=0.196  Sum_probs=110.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-C-CCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-T-GGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .|.+.+.||+|+||.||++... + +..||+|.+.... .....+.+|+.+++.++||||+++++.+...+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3667889999999999999843 3 5678888765432 22345788999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++.........+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NI  200 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANI  200 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhE
Confidence            99999988754333445689999999999999999999988   999999999997

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.80  E-value=3.3e-19  Score=173.86  Aligned_cols=122  Identities=30%  Similarity=0.436  Sum_probs=105.1

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .+++.+.||+|+||.||++... +++.||+|++.....  ..+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3445688999999999999854 688999999865322  2356889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+..        ...+..+..++.|++.||+|||++   +|+||||||+||
T Consensus       155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  199 (353)
T PLN00034        155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNL  199 (353)
T ss_pred             CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHE
Confidence            999986533        346778889999999999999988   999999999997

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.79  E-value=4.1e-19  Score=166.04  Aligned_cols=128  Identities=30%  Similarity=0.497  Sum_probs=110.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ..+++.+.||+|+||.||+|...    +...+|+|.++....  ...++.+|+.++++++|+||+++++.+...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            45667889999999999999864    235799999875432  235688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++++|.+++..   ....+++..+.+++.|++.||+|||++   +|+||||||+||
T Consensus        84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~ni  137 (266)
T cd05033          84 TEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNI  137 (266)
T ss_pred             EEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceE
Confidence            999999999999843   224689999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.79  E-value=4.7e-19  Score=165.44  Aligned_cols=122  Identities=24%  Similarity=0.378  Sum_probs=103.5

Q ss_pred             cccCCCCCeEEEEEEEcC-------------CCEEEEEEecCccc-CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          309 HKLGQGGFGSVYKGQLHT-------------GGLIAVKMLKNSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~-------------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      +.||+|+||.||+|....             ...+++|.+..... ....+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997432             22588888765432 2346888999999999999999999999888899


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|||+++|+|..++..   ....+++..+.+++.|+++||+|||++   +|+||||||+||
T Consensus        81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Ni  136 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNI  136 (262)
T ss_pred             EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccE
Confidence            99999999999988742   235689999999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.79  E-value=7.8e-20  Score=185.21  Aligned_cols=132  Identities=19%  Similarity=0.256  Sum_probs=110.2

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEcCC-CEEEEEEecC-cccCHHHHHHHHHHHcCCC-cCcccceeEEE-Ee------CC
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLHTG-GLIAVKMLKN-SKFSAEEFINEVSTIGRIH-HVNVVQLLGFC-SE------GS  371 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~~~-~~vavK~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~------~~  371 (436)
                      ..+.++.+.|.+|||+.||.++...+ ..+|+|++-. ++...+.+.+|+++|+.|+ |+|||.+++.. ..      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34456678899999999999996655 8999998654 4555677999999999997 99999999932 21      13


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..+|.||||++|+|-+++..+.+  ..|++.++++|+.++++|+++||.. +++|||||||.|||
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENv  177 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENV  177 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhhe
Confidence            46799999999999999965443  3499999999999999999999996 78899999999997

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.79  E-value=2.9e-19  Score=166.53  Aligned_cols=132  Identities=26%  Similarity=0.438  Sum_probs=115.2

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ++...++++.+.||+|+||.||++....+..+|+|.+.......+.+.+|+.++++++|+||+++++.+.. ...+++||
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            34566778889999999999999987777789999987655556789999999999999999999998877 67899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni  133 (260)
T cd05073          81 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANI  133 (260)
T ss_pred             eCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceE
Confidence            99999999998432  234678899999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.79  E-value=4.5e-19  Score=170.81  Aligned_cols=121  Identities=28%  Similarity=0.389  Sum_probs=102.8

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHH-HHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||++... +++.||+|++....    ....++.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36899999999999964 78899999987532    12234555554 56789999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.    +...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NI  127 (323)
T cd05575          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENI  127 (323)
T ss_pred             CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHe
Confidence            99999883    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.79  E-value=3.9e-19  Score=171.03  Aligned_cols=121  Identities=27%  Similarity=0.375  Sum_probs=104.8

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||++..+ +++.||+|+++..    ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999854 6789999998753    22345577888888766 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NI  127 (320)
T cd05590          81 GDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNV  127 (320)
T ss_pred             chHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHe
Confidence            99999883    335689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.79  E-value=4.6e-19  Score=170.18  Aligned_cols=121  Identities=26%  Similarity=0.338  Sum_probs=102.6

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcC-CCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGR-IHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||++... +++.||+|+++...    ...+.+..|..++.. .+||||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999854 67889999987532    223445667666664 4799999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Ni  127 (316)
T cd05592          81 GDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNV  127 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHe
Confidence            99999883    334689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.79  E-value=1e-19  Score=174.54  Aligned_cols=129  Identities=25%  Similarity=0.387  Sum_probs=112.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCe-eeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-RAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  377 (436)
                      ..|.+.+++|+|+||.++..+.+ +++.+++|.++....   .++...+|+.++++++|||||.+.+.+..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            34667789999999999988744 677899999976433   34568899999999999999999999998888 89999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|++||+|.+.|...  ++..++++.+..++.|++.|++|||++   +|+|||||+.||
T Consensus        84 ~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Ni  137 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANI  137 (426)
T ss_pred             eecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhh
Confidence            999999999998543  457799999999999999999999987   999999999997

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.79  E-value=3.7e-19  Score=171.44  Aligned_cols=125  Identities=27%  Similarity=0.288  Sum_probs=107.1

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCc-CcccceeEEEEeCCeeeEEEe
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E  378 (436)
                      |.+.+.||+|+||.||+|... +++.||+|+++..    ....+.+..|.+++..++| ++|+++++++...+..++|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            456789999999999999854 6778999998753    2234567889999998876 468889999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Ni  132 (324)
T cd05587          82 YVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNV  132 (324)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHe
Confidence            999999999883    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.79  E-value=2.9e-20  Score=162.08  Aligned_cols=135  Identities=29%  Similarity=0.351  Sum_probs=117.3

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEe-----CCee
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSE-----GSKR  373 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~  373 (436)
                      ...+|.+.+.||+|||+.|+.++ ..+++.+|+|++.... .+.+..++|++..++++|||++++++....     ....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34577888999999999999998 6788999999987644 556778999999999999999999876543     3458


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||++.|...|+|.+.+...+.++..+++.+.+.++.++++||++||+. .+++.||||||.||
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NI  160 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANI  160 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCccee
Confidence            999999999999999977666677899999999999999999999997 45799999999997

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.79  E-value=4.5e-19  Score=170.62  Aligned_cols=121  Identities=28%  Similarity=0.383  Sum_probs=102.3

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHH-HHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||+++.. +++.+|+|++....    .....+.+|.. +++.++|+||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999964 67889999986532    12234555554 57889999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+.+.    +...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NI  127 (321)
T cd05603          81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENI  127 (321)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHe
Confidence            99988873    335688999999999999999999987   999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.79  E-value=5e-19  Score=164.01  Aligned_cols=122  Identities=25%  Similarity=0.498  Sum_probs=106.8

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      +.||+|+||.||++... +++.+|+|.+....  .....+.+|++++++++|+||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999854 78889999876432  2245689999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++..   ....+++..+..++.|+++||+|||++   +++||||||+||
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~ni  125 (252)
T cd05084          81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNC  125 (252)
T ss_pred             HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheE
Confidence            999842   234689999999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.79  E-value=5.1e-19  Score=169.88  Aligned_cols=121  Identities=27%  Similarity=0.355  Sum_probs=103.9

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcC-CCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGR-IHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||+|+.. +++.||+|+++...    ...+....|..++.. ++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999964 67889999987632    233456677777775 4899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Ni  127 (316)
T cd05619          81 GDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNI  127 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHE
Confidence            99999883    234688999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.79  E-value=4.9e-19  Score=170.66  Aligned_cols=121  Identities=27%  Similarity=0.351  Sum_probs=102.8

Q ss_pred             cccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHH-HHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||++.. .+++.+|+|++....    .....+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4689999999999985 478899999986532    12234555554 56789999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|..++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NI  127 (325)
T cd05604          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENI  127 (325)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHe
Confidence            99998883    345689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.79  E-value=3.6e-19  Score=170.94  Aligned_cols=128  Identities=25%  Similarity=0.451  Sum_probs=107.3

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCC----EEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ...++..+.||+|+||.||+|... ++.    .||+|.++...  ...+++.+|+.+++.++|+||++++|++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            445667789999999999999853 333    38999986532  2345788999999999999999999998764 567


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++||+++|+|.+++...   ...+++..+.+++.|++.||+|||++   +|+||||||+||
T Consensus        85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Ni  140 (316)
T cd05108          85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNV  140 (316)
T ss_pred             eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhhe
Confidence            999999999999998432   34688999999999999999999998   999999999997

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.79  E-value=4.2e-19  Score=171.68  Aligned_cols=125  Identities=24%  Similarity=0.332  Sum_probs=108.0

Q ss_pred             hhhhcccCCCCCeEEEEEEE----cCCCEEEEEEecCcc-----cCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeee
Q 041073          305 NHFTHKLGQGGFGSVYKGQL----HTGGLIAVKMLKNSK-----FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  374 (436)
                      |.+.+.||+|+||.||+++.    .+++.+|+|++....     ...+.+.+|+.++..++ |+||+++++.+...+..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            45678899999999999874    367889999986521     12345788999999994 999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Ni  136 (332)
T cd05614          82 LILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENI  136 (332)
T ss_pred             EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHe
Confidence            9999999999999984    235689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.79  E-value=6.2e-19  Score=163.87  Aligned_cols=121  Identities=27%  Similarity=0.464  Sum_probs=103.5

Q ss_pred             cccCCCCCeEEEEEEEcCCC-----------EEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          309 HKLGQGGFGSVYKGQLHTGG-----------LIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      +.||+|+||.||+|......           .+++|.+.........+.+|+.+++.++|+||+++++.+.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46899999999999865332           47788776544336778999999999999999999999887 7789999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        80 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Ni  132 (259)
T cd05037          80 EYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNI  132 (259)
T ss_pred             EcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceE
Confidence            999999999998432   22689999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.4e-19  Score=172.31  Aligned_cols=129  Identities=25%  Similarity=0.385  Sum_probs=115.2

Q ss_pred             HHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ...|++.+.||+|.|+.|-+++ .-+|..||||++.+.+.+   ...+.+|++.|+.++|||||++|++..+...+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            3456777889999999999988 458999999999875543   456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |.=.+|+|.+||...+   ..+.+..+.+++.||+.|+.|+|+.   .+|||||||+||
T Consensus        97 ELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENV  149 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENV  149 (864)
T ss_pred             EecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCccee
Confidence            9999999999996543   5689999999999999999999987   899999999996

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.79  E-value=3.5e-19  Score=172.28  Aligned_cols=127  Identities=20%  Similarity=0.217  Sum_probs=109.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .+++.+.||+|+||.||++..+ +++.+|+|++.+.    ......+.+|+.++..++|+||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            3566789999999999999865 5778999998642    1223457889999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        82 y~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Ni  133 (332)
T cd05623          82 YYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNI  133 (332)
T ss_pred             ccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHE
Confidence            9999999999942   234689999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.79  E-value=3.9e-19  Score=168.09  Aligned_cols=126  Identities=25%  Similarity=0.363  Sum_probs=108.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +|.+.+.||+|+||.||+++.+ +++.+|+|+++...   ...+.+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            3567789999999999999965 67889999987532   2345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++.+..+.    .....+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        82 ~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Ni  131 (287)
T cd07848          82 VEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENL  131 (287)
T ss_pred             CCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            9988776554    2234689999999999999999999987   999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.79  E-value=5.2e-19  Score=174.73  Aligned_cols=136  Identities=26%  Similarity=0.454  Sum_probs=113.5

Q ss_pred             HHHHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCC-cCcccceeEEEE
Q 041073          298 PEIIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIH-HVNVVQLLGFCS  368 (436)
Q Consensus       298 ~~i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~  368 (436)
                      .++....+.+.+.||+|+||.||++..+      .++.||+|+++....  ..+.+.+|++++.++. |+||+++++.+.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4566667778899999999999999853      345799999976422  2346889999999997 999999999999


Q ss_pred             eCCeeeEEEecCCCCChhhhccCCCC------------------------------------------------------
Q 041073          369 EGSKRAVVYEYMPNGSLDRHIFPKES------------------------------------------------------  394 (436)
Q Consensus       369 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------  394 (436)
                      ..+..++||||+++|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            98999999999999999999864311                                                      


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCC
Q 041073          395 ----------------------------------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPH  434 (436)
Q Consensus       395 ----------------------------------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~  434 (436)
                                                              ....+++..++.++.|++.||+|||+.   +|+||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                    112467888899999999999999987   9999999999


Q ss_pred             CC
Q 041073          435 NI  436 (436)
Q Consensus       435 NI  436 (436)
                      ||
T Consensus       269 Ni  270 (401)
T cd05107         269 NV  270 (401)
T ss_pred             eE
Confidence            96

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.79  E-value=5.9e-19  Score=169.43  Aligned_cols=121  Identities=26%  Similarity=0.317  Sum_probs=104.1

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcC-CCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGR-IHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||+++.+ +++.||+|.++...    ...+....|..++.. .+|+||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46899999999999865 67899999987632    233456778777765 4899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        81 g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Ni  127 (316)
T cd05620          81 GDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNV  127 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHe
Confidence            99999883    235689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.79  E-value=9.1e-19  Score=163.16  Aligned_cols=131  Identities=28%  Similarity=0.436  Sum_probs=112.6

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +...++.+.+.||+|++|.||++....+..+|+|.+.......+.+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            334567788899999999999999776778999998765555677899999999999999999998875 4567899999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Ni  133 (260)
T cd05069          82 MGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANI  133 (260)
T ss_pred             CCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceE
Confidence            9999999998532  234588999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.79  E-value=5.2e-19  Score=170.64  Aligned_cols=121  Identities=21%  Similarity=0.275  Sum_probs=105.3

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||++... +++.+|+|+++...    ...+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999854 67889999997632    2234578899988888 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Ni  127 (327)
T cd05617          81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNV  127 (327)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence            99998883    335699999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.79  E-value=7.3e-19  Score=165.52  Aligned_cols=132  Identities=30%  Similarity=0.536  Sum_probs=113.2

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCcccC--HHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      ..++.+.+.||+|+||.||+|...      ++..+|+|.++.....  .+.+.+|++++++++|+||+++++.+......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            456778899999999999999753      3468999998764332  45789999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKE----------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|||+++++|.+++....          .....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~ni  153 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNC  153 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceE
Confidence            99999999999999985432          1224578999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.79  E-value=2.3e-19  Score=167.26  Aligned_cols=125  Identities=36%  Similarity=0.658  Sum_probs=105.5

Q ss_pred             hhcccCCCCCeEEEEEEEc-----CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          307 FTHKLGQGGFGSVYKGQLH-----TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +.+.||.|.||.||+|.+.     .+..|+||.++....  ..+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999966     345799999965322  356799999999999999999999999988889999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++...  ....+++..+..++.|+++||+|||++   +++|+||+++||
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~ni  134 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNI  134 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGE
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccc
Confidence            9999999999543  245789999999999999999999998   899999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.79  E-value=9.8e-19  Score=163.52  Aligned_cols=128  Identities=30%  Similarity=0.399  Sum_probs=112.1

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ...|++.+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.++++++|+||+++++.+...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            34567789999999999999985 477889999987533 3345678999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        88 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~ni  137 (267)
T cd06646          88 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANI  137 (267)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHE
Confidence            99999999883    234689999999999999999999987   999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.79  E-value=5.6e-19  Score=165.25  Aligned_cols=128  Identities=30%  Similarity=0.497  Sum_probs=109.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-C---CCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-T---GGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      .++++.+.||+|+||.||+|... +   +..+|+|.++....  ..+.+.+|+.++++++||||+++++++..++..+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            45667789999999999999853 2   33689998865332  235689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++++|.+++..   ....+++.++..++.|++.||+|||++   +++||||||+||
T Consensus        84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~ni  137 (267)
T cd05066          84 TEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNI  137 (267)
T ss_pred             EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcE
Confidence            999999999999843   234689999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.79  E-value=3.9e-19  Score=173.30  Aligned_cols=127  Identities=22%  Similarity=0.355  Sum_probs=112.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ..|.+.+.||+|.|+.|.++.. .++..||+|.+.++..+   .+.+.+|+++|+.++|||||+++.+.+....+++|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            3455678999999999999984 47899999999885443   3558899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+.+|.+.+++.    +.+.+.+..+..++.|+.+|++|+|++   .|+|||||++||
T Consensus       136 ya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNi  186 (596)
T KOG0586|consen  136 YASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENI  186 (596)
T ss_pred             eccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhc
Confidence            999999999994    445677788999999999999999998   999999999997

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.79  E-value=6.5e-19  Score=164.66  Aligned_cols=130  Identities=21%  Similarity=0.349  Sum_probs=111.3

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ++.+.+.||+|+||.||+|.. .+++.+|+|.++...    .....+.+|+++++.++||||+++++.+...+..++++|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            456778899999999999985 478899999876421    123468899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++.........+++..+..++.|+++||+|||++   +++||||||+||
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni  137 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANV  137 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHE
Confidence            9999999988854333345688999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding

Probab=99.79  E-value=4.3e-19  Score=141.30  Aligned_cols=65  Identities=43%  Similarity=0.785  Sum_probs=59.9

Q ss_pred             ccccCCCCCCCCCcCCCccCCCCCCCCC-CCcEEEecCC--ccEEEEcCceeEEEEEeeCCceeEEEeCCCC
Q 041073           34 KMCSSSCGDVKNISYPFRLKGDPARCGH-PELELSCESN--KTIFEFNSGKYYVKRISYDKCTISVVDVNLA  102 (436)
Q Consensus        34 ~~C~~~CG~~~~I~yPF~~~~~p~~CG~-p~f~l~C~~~--~~~l~~~~~~y~V~~I~y~~~~i~v~~~~~~  102 (436)
                      +.|+.+|||+. |+||||++.   +||+ |+|+|+|+++  .+.|.+.++.|+|++|+|++++++|.++...
T Consensus         2 ~~C~~~CGnv~-IpYPFgi~~---~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~~~~i~v~~~~~~   69 (106)
T PF13947_consen    2 PGCPSSCGNVS-IPYPFGIGP---GCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYENGTIRVSDPISS   69 (106)
T ss_pred             CCCCCccCCEe-ecCCCccCC---CCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecCCCEEEEEecccc
Confidence            46999999995 999999988   8999 9999999988  6888889999999999999999999998764

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.78  E-value=6.7e-19  Score=166.18  Aligned_cols=131  Identities=31%  Similarity=0.556  Sum_probs=110.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-----cCCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      ..+++.+.||+|+||.||+|..     ..+..+++|.+.....  ....+.+|+.++++++|+||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4566778999999999999973     2456899999875322  23568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKES-------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|||+++++|.+++..+..             ....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ni  155 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNI  155 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceE
Confidence            9999999999999843210             123578999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.78  E-value=5.9e-19  Score=168.43  Aligned_cols=122  Identities=28%  Similarity=0.432  Sum_probs=107.3

Q ss_pred             cccCCCCCeEEEEEEE-cCCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCC
Q 041073          309 HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGS  384 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  384 (436)
                      +.||.|.||+||-|.. ++|+.||||++.+.   .....++++|+.+|.+++||.||.+.-.+++.+..++|||-+ +|+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence            7899999999999984 58999999999763   334467999999999999999999999999999999999999 556


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          385 LDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +.+.|.+.  ..+.+++.....++.||+.||.|||.+   +|+|+||||+||
T Consensus       649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENV  695 (888)
T KOG4236|consen  649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENV  695 (888)
T ss_pred             HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchhe
Confidence            66666543  346799999999999999999999998   999999999997

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.78  E-value=4.3e-19  Score=175.12  Aligned_cols=121  Identities=19%  Similarity=0.223  Sum_probs=105.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      ..|.+.+.||+|+||.||++.. .+++.||+|...     ...+.+|++++++++||||+++++++......++++|++.
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            3467789999999999999985 478899999653     2356789999999999999999999999999999999994


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       ++|..++.    ....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus       167 -~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NI  213 (391)
T PHA03212        167 -TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENI  213 (391)
T ss_pred             -CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhE
Confidence             68888873    234689999999999999999999998   999999999997

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.78  E-value=7.6e-19  Score=168.83  Aligned_cols=121  Identities=30%  Similarity=0.379  Sum_probs=105.1

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||++... +++.+|+|+++...    .....+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999865 67889999997532    2334577888888877 699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|..++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Ni  127 (318)
T cd05570          81 GDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNV  127 (318)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHe
Confidence            99998883    334689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.78  E-value=5e-19  Score=171.44  Aligned_cols=124  Identities=23%  Similarity=0.401  Sum_probs=105.1

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeC-----CeeeE
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRAV  375 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  375 (436)
                      |++.+.||+|+||.||+|.. .++..||+|.++..   .....++.+|+++++.++||||+++++++...     ...++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            55678999999999999985 47889999998752   22335688999999999999999999987543     24799


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||++ ++|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        82 v~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NI  134 (338)
T cd07859          82 VFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNI  134 (338)
T ss_pred             EEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHe
Confidence            999995 68998883    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.78  E-value=2.8e-19  Score=175.84  Aligned_cols=132  Identities=27%  Similarity=0.415  Sum_probs=115.7

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC-c-----CcccceeEEEEeCC
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-H-----VNVVQLLGFCSEGS  371 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~  371 (436)
                      |....+|.+.+.||+|+||.|.+|. .++++.||||+++..+.-.++...|+.+|..++ |     -|+|++++++...+
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            4444577889999999999999998 457999999999987766677888999999886 4     38999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +.+||+|.+ ..+|.+++..+  +-..++...++.|+.||+.||.+||+.   +|||+|||||||
T Consensus       262 HlciVfELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENI  320 (586)
T KOG0667|consen  262 HLCIVFELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENI  320 (586)
T ss_pred             ceeeeehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhhe
Confidence            999999999 55999999543  345689999999999999999999987   999999999998

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.78  E-value=5.5e-19  Score=170.17  Aligned_cols=125  Identities=26%  Similarity=0.284  Sum_probs=106.8

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEe
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      +++.+.||+|+||.||++... +++.||+|+++...    ...+.+..|..++..+. |++|+++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            456788999999999999854 78899999987532    22345778888888875 5778889999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 y~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Ni  132 (323)
T cd05615          82 YVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNV  132 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHe
Confidence            999999999883    335689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.78  E-value=8.8e-19  Score=164.08  Aligned_cols=125  Identities=30%  Similarity=0.444  Sum_probs=103.3

Q ss_pred             cccCCCCCeEEEEEEEcC---CCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          309 HKLGQGGFGSVYKGQLHT---GGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      +.||+|+||.||+|....   ...+++|.+.....  ....+.+|+..++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997432   34678887754322  2346889999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKES-RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.+++..... .....++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Ni  131 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNC  131 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhhe
Confidence            99999854322 123456788899999999999999998   999999999997

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.78  E-value=1.3e-18  Score=163.04  Aligned_cols=124  Identities=27%  Similarity=0.394  Sum_probs=103.1

Q ss_pred             ccCCCCCeEEEEEEEcCCC---EEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCC
Q 041073          310 KLGQGGFGSVYKGQLHTGG---LIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGS  384 (436)
Q Consensus       310 ~lg~G~fg~V~~~~~~~~~---~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  384 (436)
                      .||+|+||.||+++..++.   .+++|.+....  ...+.+.+|+..++.++||||+++++.+......+++|||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5899999999999754333   45666665432  234578999999999999999999999999889999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          385 LDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |.+++..........++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~ni  130 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNC  130 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceE
Confidence            9999864333334567778889999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.78  E-value=8.6e-19  Score=164.64  Aligned_cols=131  Identities=27%  Similarity=0.442  Sum_probs=110.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCcccC--HHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ..+...+.||+|+||.||++..+      +.+.+++|.+......  .+.+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            45556788999999999999853      3457899988654332  457899999999999999999999998888899


Q ss_pred             EEEecCCCCChhhhccCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESR-----GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|||+++|+|.+++......     ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Ni  148 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNC  148 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceE
Confidence            999999999999998543211     12689999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.78  E-value=1e-18  Score=165.08  Aligned_cols=128  Identities=25%  Similarity=0.439  Sum_probs=109.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-----cCCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeC--Cee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKR  373 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  373 (436)
                      .+++..+.||+|+||.||++..     .++..+|+|.++...  ...+.+.+|+.+++.++|+||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4566778999999999999973     357789999987532  2345789999999999999999999988764  567


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|||+++++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        84 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Ni  140 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNV  140 (284)
T ss_pred             EEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheE
Confidence            899999999999999832   224589999999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.78  E-value=1e-18  Score=165.48  Aligned_cols=133  Identities=26%  Similarity=0.491  Sum_probs=111.9

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      ++..+.+.+.||+|+||.||++...      ++..+|+|.+.... ...+.+.+|++++++++|+||+++++++...+..
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            3456677889999999999999742      34568999887533 2345689999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKE---------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|||+++++|.+++....         .+...+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Ni  151 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNC  151 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceE
Confidence            99999999999999985322         1223589999999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.78  E-value=4.3e-19  Score=187.16  Aligned_cols=143  Identities=22%  Similarity=0.328  Sum_probs=116.3

Q ss_pred             ccChHHHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEe
Q 041073          294 RYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE  369 (436)
Q Consensus       294 ~~~~~~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~  369 (436)
                      .+...+.....|.+.+.||+|+||.||++... ++..+|+|.+.....   ....+..|+.+++.++||||+++++.+..
T Consensus         4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d   83 (1021)
T PTZ00266          4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN   83 (1021)
T ss_pred             cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence            34445555567888899999999999999854 667889998875322   24568899999999999999999998754


Q ss_pred             --CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC----CceEecCCCCCCC
Q 041073          370 --GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD----VCILHFDIKPHNI  436 (436)
Q Consensus       370 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~----~~iiHrDlkp~NI  436 (436)
                        ....+|||||+++|+|.++|.........+++..++.|+.||+.||+|||+...    .+||||||||+||
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNI  156 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNI  156 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHe
Confidence              456899999999999999985432334579999999999999999999998421    2599999999997

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.78  E-value=1.6e-18  Score=162.15  Aligned_cols=127  Identities=28%  Similarity=0.377  Sum_probs=111.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ..+.+.+.||+|+||.||++.. .+++.+|+|.++... .....+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4667788999999999999985 468899999987643 23356788999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++.    ....+++.++..++.|++.||+|||+.   +++||||||+||
T Consensus        89 ~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~ni  137 (267)
T cd06645          89 GGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANI  137 (267)
T ss_pred             CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            9999999883    335689999999999999999999998   999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.78  E-value=1.5e-18  Score=160.60  Aligned_cols=122  Identities=29%  Similarity=0.501  Sum_probs=107.4

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCChh
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLD  386 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  386 (436)
                      +.||+|+||.||+|...+++.+|+|.++....  ....+.+|+++++.++|+||+++++.+...+..+++|||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999987888999999876332  2346889999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          387 RHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       387 ~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++..   ....+++..+..++.|++.||.|||++   +++||||||+||
T Consensus        81 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~ni  124 (250)
T cd05085          81 SFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNC  124 (250)
T ss_pred             HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheE
Confidence            98843   234588999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.78  E-value=6.6e-19  Score=171.10  Aligned_cols=134  Identities=30%  Similarity=0.472  Sum_probs=109.6

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEE------cCCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEEe-
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSE-  369 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  369 (436)
                      ....++++.+.||+|+||.||+|..      .+++.||||+++....  ....+.+|+.++.++ +|+||+++++.+.. 
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            3456788899999999999999963      3567899999976432  234688999999999 68999999998765 


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCC-------------------------------------------------------
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKES-------------------------------------------------------  394 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------  394 (436)
                      +...+++|||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            4567899999999999998854211                                                       


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          395 --------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       395 --------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                              ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Ni  210 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNI  210 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeE
Confidence                    012468888999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.78  E-value=8.9e-19  Score=167.61  Aligned_cols=126  Identities=29%  Similarity=0.459  Sum_probs=107.9

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      +|.+.+.||+|+||.||++..+ +++.+|+|.++...  .....+.+|+.++++++|+||+++++++..++..++||||+
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   86 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL   86 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence            4566789999999999999854 67889999987532  23346788999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++ +|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        87 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Ni  135 (309)
T cd07872          87 DK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNL  135 (309)
T ss_pred             CC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            75 88887732   234588999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.78  E-value=9.2e-19  Score=162.65  Aligned_cols=128  Identities=31%  Similarity=0.508  Sum_probs=113.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      ..+++.+.||+|+||.||++... ++.+|+|.++......+++.+|+.++++++|+||+++++.+...+..+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            45667889999999999999865 78899999987554567899999999999999999999999988899999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++...  ....+++..+..++.|++.||.|||++   +++||||||+||
T Consensus        85 ~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Ni  133 (256)
T cd05039          85 GSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNV  133 (256)
T ss_pred             CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceE
Confidence            9999998432  223689999999999999999999998   999999999997

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.78  E-value=8.5e-19  Score=164.18  Aligned_cols=128  Identities=29%  Similarity=0.522  Sum_probs=110.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CC---CEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TG---GLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ..+++.+.||+|+||.||+|... ++   ..||+|.+....  ....++..|+.+++.++||||+++++.+..+...+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            34667889999999999999854 33   359999987532  2345799999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++++|.+++..   ....+++.+++.++.|++.||+|||++   +++||||||+||
T Consensus        84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~ni  137 (269)
T cd05065          84 TEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNI  137 (269)
T ss_pred             EecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheE
Confidence            999999999999843   234689999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.78  E-value=1.4e-18  Score=162.16  Aligned_cols=130  Identities=24%  Similarity=0.383  Sum_probs=113.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|++.+.||+|+||.||+|... +++.+|+|.++..    ....+.+.+|++++++++|+|++++++.+...+..+++||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            4567789999999999999965 7889999988642    1224578899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++.........+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni  137 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANV  137 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhE
Confidence            9999999998854333445689999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.78  E-value=1.8e-19  Score=173.29  Aligned_cols=114  Identities=29%  Similarity=0.549  Sum_probs=102.3

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCChhhh
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRH  388 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~  388 (436)
                      +=||.|+.|.||+|+++ ++.||||+++.-+      ..+|+.|++|+|+||+++.|+|.....++||||||+.|-|...
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            45899999999999987 6789999875422      3578899999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          389 IFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       389 l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |    +.+..++......+..+||.||.|||.+   .|||||||.-||
T Consensus       203 L----ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNi  243 (904)
T KOG4721|consen  203 L----KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNI  243 (904)
T ss_pred             H----hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCce
Confidence            9    3456789999999999999999999998   999999999987

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.78  E-value=7.9e-19  Score=165.17  Aligned_cols=134  Identities=28%  Similarity=0.436  Sum_probs=111.4

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCC
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS  371 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  371 (436)
                      +...++++.+.||+|+||.||+|...      .+..+|+|.+....  ....++.+|+.+++.++|+||+++++.+..+.
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            44567788899999999999998743      34579999886532  23346889999999999999999999999889


Q ss_pred             eeeEEEecCCCCChhhhccCCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESR------GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..++||||+++++|.+++......      ...+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Ni  150 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC  150 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheE
Confidence            999999999999999998542211      23467888999999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.78  E-value=1.1e-18  Score=168.18  Aligned_cols=121  Identities=26%  Similarity=0.359  Sum_probs=101.5

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHH-HHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||+++.. +++.+|+|++....    .....+..|.. +++.++|+||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36899999999999855 67789999987532    12233444444 56788999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.    ....+.+..+..++.|+++||+|||++   +|+||||||+||
T Consensus        81 ~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Ni  127 (325)
T cd05602          81 GELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENI  127 (325)
T ss_pred             CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHe
Confidence            99999883    335678889999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.78  E-value=6.7e-19  Score=167.32  Aligned_cols=133  Identities=29%  Similarity=0.478  Sum_probs=110.4

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEcC---------------CCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccce
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLHT---------------GGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQL  363 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~~---------------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l  363 (436)
                      ...++.+.+.||+|+||.||++....               ...||+|.++....  ..+.+.+|++++++++|+|++++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            34567788999999999999986431               23589999875322  23568899999999999999999


Q ss_pred             eEEEEeCCeeeEEEecCCCCChhhhccCCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKES--------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       364 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      ++++...+..++||||+++++|.+++.....        ....+++..+..++.|++.||+|||++   +++||||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence            9999999999999999999999998853221        112478899999999999999999988   99999999999


Q ss_pred             C
Q 041073          436 I  436 (436)
Q Consensus       436 I  436 (436)
                      |
T Consensus       160 i  160 (295)
T cd05097         160 C  160 (295)
T ss_pred             E
Confidence            7

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.78  E-value=1.8e-18  Score=162.91  Aligned_cols=121  Identities=26%  Similarity=0.396  Sum_probs=103.9

Q ss_pred             cCCCCCeEEEEEEE-cCCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          311 LGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       311 lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      ||+|+||.||++.. .+++.+|+|.+.....    ....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999985 4688999999865221    223456799999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Ni  126 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENV  126 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhE
Confidence            9887432  234588999999999999999999987   999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.78  E-value=7.4e-19  Score=167.73  Aligned_cols=134  Identities=29%  Similarity=0.496  Sum_probs=110.4

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCC--EEEEEEecCc--ccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCee
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGG--LIAVKMLKNS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  373 (436)
                      +....+.+.+.||+|+||.||+|..+ ++.  .+++|.++..  ....+.+.+|++++.++ +|+||+++++++...+..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            34456678899999999999999854 444  3577776542  22335688999999999 899999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKE------------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|||+++++|.+++....            .....+++..++.++.|++.||+|||++   +++||||||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Ni  155 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI  155 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheE
Confidence            99999999999999985432            1123688999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.78  E-value=9.4e-19  Score=168.59  Aligned_cols=125  Identities=26%  Similarity=0.272  Sum_probs=106.1

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEe
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      +++.+.||+|+||.||++... +++.+|+|+++...    ...+.+..|..++..+ +|++|+++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            456788999999999999854 67789999987532    1233466777887776 58999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Ni  132 (323)
T cd05616          82 YVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNV  132 (323)
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHe
Confidence            999999998883    335689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.78  E-value=1.4e-18  Score=163.66  Aligned_cols=128  Identities=26%  Similarity=0.400  Sum_probs=112.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ..|.+.+.||+|++|.||++... ++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+..+...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            45778899999999999999864 67889999986532 23456889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        85 ~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni  134 (280)
T cd06611          85 DGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNI  134 (280)
T ss_pred             CCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhE
Confidence            99999998842   234689999999999999999999998   999999999996

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.78  E-value=1.5e-18  Score=161.16  Aligned_cols=127  Identities=29%  Similarity=0.549  Sum_probs=113.3

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      .+++.+.||+|+||.||++....+..+|+|.+........++.+|++++++++|+|++++++.+......+++|||++++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG   84 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence            45677899999999999998776788999998776556678999999999999999999999999889999999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.+++..   ....++++.+..++.|++.||+|||+.   +++||||||+||
T Consensus        85 ~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni  131 (256)
T cd05112          85 CLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNC  131 (256)
T ss_pred             cHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceE
Confidence            99999843   224588999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.78  E-value=1.5e-18  Score=162.49  Aligned_cols=125  Identities=27%  Similarity=0.394  Sum_probs=104.8

Q ss_pred             cccCCCCCeEEEEEEEc---CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          309 HKLGQGGFGSVYKGQLH---TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      +.||+|+||.||+|...   ++..+|+|.++....  ....+.+|+.++++++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999854   345789998876432  2346888999999999999999999999888899999999999


Q ss_pred             ChhhhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKES-RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.+++..... .....++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~ni  131 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNC  131 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceE
Confidence            99999854322 223467788889999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.78  E-value=1.1e-18  Score=164.66  Aligned_cols=127  Identities=31%  Similarity=0.506  Sum_probs=107.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-----cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEe--CCeeeE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAV  375 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  375 (436)
                      .+++.+.||+|+||.||++..     .++..+|+|.+.... ...+.+.+|+++++.++|+||+++++++..  ....++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            456678899999999999974     257789999987543 234578899999999999999999997754  346789


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++++|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        85 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~ni  139 (284)
T cd05081          85 VMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNI  139 (284)
T ss_pred             EEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhE
Confidence            9999999999999842   224589999999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.78  E-value=2e-19  Score=175.63  Aligned_cols=126  Identities=25%  Similarity=0.386  Sum_probs=105.8

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCCEEE---EEEecC--cccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCe--eeEEE
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGGLIA---VKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK--RAVVY  377 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~~va---vK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  377 (436)
                      ++...||+|+|-+||+|... +|..||   ||.-+.  +....++|.+|+.+|+.|+|+||++++..|.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            45678999999999999854 555665   332111  23344789999999999999999999999987655  77999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |.+..|+|..|+    .+.+.++...+..|++||++||.|||++ +|+|||||||-+||
T Consensus       123 EL~TSGtLr~Y~----kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNI  176 (632)
T KOG0584|consen  123 ELFTSGTLREYR----KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNI  176 (632)
T ss_pred             ecccCCcHHHHH----HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceE
Confidence            999999999999    3456788899999999999999999998 88999999999997

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.78  E-value=1.1e-18  Score=165.20  Aligned_cols=135  Identities=30%  Similarity=0.436  Sum_probs=111.5

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeC
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEG  370 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  370 (436)
                      ++...++++.+.||+|+||.||+|..+      .+..+|+|.++....  ....+.+|+.+++.++|+||+++++.+...
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            345567888899999999999998643      244799998865432  234578899999999999999999999988


Q ss_pred             CeeeEEEecCCCCChhhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKES------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...+++|||+++|+|.+++.....      .....++..+..++.|++.||.|||++   +|+||||||+||
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~ni  150 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNC  150 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheE
Confidence            899999999999999999854221      123457788899999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.78  E-value=1.1e-18  Score=163.04  Aligned_cols=130  Identities=22%  Similarity=0.362  Sum_probs=112.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .+++.+.||+|++|.||++.. .+++.+|+|.+....    ....++.+|+.+++.++|+||+++++.+..++..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            456778899999999999984 578899999876522    123568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++.........+++..+..++.|++.||+|||++   +++|+||||+||
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~ni  137 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANV  137 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            9999999998853333345689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.78  E-value=1.7e-18  Score=165.71  Aligned_cols=126  Identities=25%  Similarity=0.344  Sum_probs=109.0

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      +++.+.||+|+||.||++... ++..+|+|.+....  ....++.+|++++++++||||+++++.+..++..+++|||++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~   82 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD   82 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence            456788999999999999854 67788999886532  223568899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|.+++.    +...+++..+..++.|+++||.|||+.  .+++||||||+||
T Consensus        83 ~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~ni  131 (308)
T cd06615          83 GGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNI  131 (308)
T ss_pred             CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHE
Confidence            999999983    235689999999999999999999973  2899999999996

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.78  E-value=2.7e-19  Score=148.78  Aligned_cols=123  Identities=24%  Similarity=0.435  Sum_probs=107.7

Q ss_pred             hhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          307 FTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      -.++||+|.||+|++++ ..+++.||+|.++.+.   .-.....+|+-+++.++|.|||++++....+....+|+||+ .
T Consensus         6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-d   84 (292)
T KOG0662|consen    6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-D   84 (292)
T ss_pred             HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-h
Confidence            34789999999999998 4578899999987633   33467889999999999999999999999999999999999 5


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+|..+..   .-++.++.+..+.++.|+++||.|.|++   ++.|||+||+|+
T Consensus        85 qdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnl  132 (292)
T KOG0662|consen   85 QDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNL  132 (292)
T ss_pred             HHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceE
Confidence            58988883   3457799999999999999999999998   999999999984

>PHA02988 hypothetical protein; Provisional

Probab=99.78  E-value=1.4e-18  Score=164.10  Aligned_cols=121  Identities=17%  Similarity=0.278  Sum_probs=103.9

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccC----HHHHHHHHHHHcCCCcCcccceeEEEEe----CCeeeEEEecC
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRAVVYEYM  380 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~  380 (436)
                      ..||+|+++.||+|.. +++.||||.++.....    .+.+.+|+.+|++++||||++++|++.+    ....+++|||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            4689999999999987 5889999999764332    3567899999999999999999999876    34678999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++..    ...+++....+++.|++.||+|||+.  .+++||||||+||
T Consensus       105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~ni  154 (283)
T PHA02988        105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSF  154 (283)
T ss_pred             CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhE
Confidence            99999999942    34688999999999999999999973  2688999999996

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.77  E-value=1e-18  Score=183.53  Aligned_cols=130  Identities=22%  Similarity=0.356  Sum_probs=110.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      +|.+.++||+|+||.||+|... +++.||+|+++....    ..+++.+|++++++++||||+++++.+.+++..+++||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            4566789999999999999854 688999999875321    23568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKE-------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~-------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++....       .....+++..+++++.|+++||+|||++   +|+||||||+||
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNI  144 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNI  144 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheE
Confidence            999999999885311       1123467788899999999999999998   999999999997

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.77  E-value=1.2e-18  Score=165.75  Aligned_cols=132  Identities=29%  Similarity=0.485  Sum_probs=110.2

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-----------------CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccc
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-----------------TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQ  362 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-----------------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~  362 (436)
                      ..++++.+.||+|+||.||++...                 ++..+|+|+++...  ....++.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            345678899999999999998522                 23468999987532  23457899999999999999999


Q ss_pred             eeEEEEeCCeeeEEEecCCCCChhhhccCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKES-------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       363 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      +++++...+..+++|||+++++|.+++.....       ....+++..+..++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            99999999999999999999999999854321       123478889999999999999999988   99999999999


Q ss_pred             C
Q 041073          436 I  436 (436)
Q Consensus       436 I  436 (436)
                      |
T Consensus       161 i  161 (296)
T cd05095         161 C  161 (296)
T ss_pred             E
Confidence            6

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.77  E-value=1.3e-18  Score=164.55  Aligned_cols=127  Identities=28%  Similarity=0.356  Sum_probs=108.8

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ++..+.||+|+||+||++.. .+++.+|+|.+.....    ....+.+|+++++.++|+||+.+.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            34557899999999999985 4788999999865322    223578899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Ni  133 (285)
T cd05632          82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENI  133 (285)
T ss_pred             ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHE
Confidence            9999999888432  234689999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.77  E-value=5.6e-19  Score=164.43  Aligned_cols=122  Identities=26%  Similarity=0.397  Sum_probs=103.5

Q ss_pred             cccCCCCCeEEEEEEEcC--------CCEEEEEEecCccc-CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          309 HKLGQGGFGSVYKGQLHT--------GGLIAVKMLKNSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +.||+|+||.||+|....        ...+++|.+..... ..+.+.+|+.+++.++|||++++++.+..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999997531        22477887755322 235688899999999999999999999998899999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~ni  131 (258)
T cd05078          81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNV  131 (258)
T ss_pred             CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence            9999999998432   34689999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.77  E-value=2.5e-18  Score=160.00  Aligned_cols=120  Identities=24%  Similarity=0.469  Sum_probs=102.2

Q ss_pred             ccCCCCCeEEEEEEEc---CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCC
Q 041073          310 KLGQGGFGSVYKGQLH---TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGS  384 (436)
Q Consensus       310 ~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  384 (436)
                      .||+|+||.||+|..+   .+..+|+|++.....  ..+.+.+|+.++++++|+||+++++.+. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999753   345699999876432  2356889999999999999999999875 456789999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          385 LDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |.+++..   ....+++..+++++.|++.||+|||++   +++||||||+||
T Consensus        81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~ni  126 (257)
T cd05115          81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNV  126 (257)
T ss_pred             HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheE
Confidence            9999843   235689999999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.77  E-value=1.4e-18  Score=166.12  Aligned_cols=135  Identities=29%  Similarity=0.464  Sum_probs=113.0

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc--------CCCEEEEEEecCcc--cCHHHHHHHHHHHcCC-CcCcccceeEEE
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLKNSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFC  367 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~  367 (436)
                      ++....+.+.+.||+|+||.||++...        +...+|+|.++...  ....++.+|+.+++++ +|+||+++++.+
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            444567888899999999999999742        23469999987532  2335688899999999 799999999999


Q ss_pred             EeCCeeeEEEecCCCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          368 SEGSKRAVVYEYMPNGSLDRHIFPKES------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       368 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      ...+..+++|||+++|+|.+++..+..            ....+++.++++++.|++.||+|||+.   +++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence            999999999999999999999964321            123589999999999999999999987   99999999999


Q ss_pred             C
Q 041073          436 I  436 (436)
Q Consensus       436 I  436 (436)
                      |
T Consensus       171 i  171 (307)
T cd05098         171 V  171 (307)
T ss_pred             e
Confidence            7

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.77  E-value=1.9e-18  Score=164.97  Aligned_cols=135  Identities=27%  Similarity=0.469  Sum_probs=112.8

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc--------CCCEEEEEEecCcc--cCHHHHHHHHHHHcCC-CcCcccceeEEE
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLKNSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFC  367 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~  367 (436)
                      ++....+.+.+.||+|+||.||+++..        ++..+|+|.+....  ...+++.+|+.+++.+ +|+||+++++.+
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            355667778899999999999999731        23468999886532  2345788999999999 799999999999


Q ss_pred             EeCCeeeEEEecCCCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          368 SEGSKRAVVYEYMPNGSLDRHIFPKES------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       368 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      ......+++|||+++|+|.+++.....            ....+++..+..++.|+++||+|||++   +++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence            999999999999999999999864321            123578899999999999999999988   99999999999


Q ss_pred             C
Q 041073          436 I  436 (436)
Q Consensus       436 I  436 (436)
                      |
T Consensus       168 i  168 (304)
T cd05101         168 V  168 (304)
T ss_pred             E
Confidence            7

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.77  E-value=1.5e-20  Score=163.56  Aligned_cols=128  Identities=23%  Similarity=0.347  Sum_probs=111.9

Q ss_pred             HHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      .+.|++.+.||+|.|+.|+++. ..+|+.+|+|+++..   ....+++.+|+.+.+.++||||+++.......+..+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            3456777899999999999987 457888999988653   335578999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.|++|..-|..+    ...++..+-..++||+++|.|.|.+   +|||||+||+|+
T Consensus        90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nl  141 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENL  141 (355)
T ss_pred             ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhhe
Confidence            999999998777332    5678999999999999999999998   999999999995

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.77  E-value=1.9e-18  Score=167.02  Aligned_cols=119  Identities=28%  Similarity=0.346  Sum_probs=100.6

Q ss_pred             cCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCC---CcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          311 LGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRI---HHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       311 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      ||+|+||.||+++.. +++.+|+|++.....    .......|..++...   +||||+++++.+......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999854 688999999865321    223355566666554   699999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.    +...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Ni  127 (330)
T cd05586          81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENI  127 (330)
T ss_pred             ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHe
Confidence            99998883    345689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.77  E-value=1.9e-18  Score=163.48  Aligned_cols=127  Identities=28%  Similarity=0.361  Sum_probs=108.4

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ++..+.||+|+||.||++... +++.+|+|.+.....    ....+.+|+.+++.++|++++.+++.+...+..+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            345578999999999999854 788999999865321    123577899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||
T Consensus        82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Ni  133 (285)
T cd05630          82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENI  133 (285)
T ss_pred             cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHE
Confidence            9999999988432  224589999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.77  E-value=2.5e-18  Score=162.47  Aligned_cols=131  Identities=28%  Similarity=0.374  Sum_probs=112.9

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      +....+++.+.||+|+||.||++... +++.+|+|++....  .....+.+|+++++.++|+||+++++.+...+..++|
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            34567788899999999999999854 67889999876532  2346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++++|.+++.    ..+.+++..+..++.+++.||.|||+.  .+++||||||+||
T Consensus        82 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~ni  135 (284)
T cd06620          82 MEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNI  135 (284)
T ss_pred             EecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHE
Confidence            99999999999883    235689999999999999999999963  2799999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.77  E-value=2.4e-18  Score=162.28  Aligned_cols=131  Identities=30%  Similarity=0.570  Sum_probs=110.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcC------CCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHT------GGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ..+++.+.||+|+||.||+|....      ...+|+|.++....  ..+.+.+|+..+.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            356678999999999999998532      24689998865332  2356889999999999999999999999888999


Q ss_pred             EEEecCCCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKES------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|||+++++|.+++.....            ....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Ni  155 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNC  155 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceE
Confidence            99999999999999854311            114588999999999999999999998   999999999997

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.77  E-value=2e-18  Score=161.44  Aligned_cols=128  Identities=30%  Similarity=0.514  Sum_probs=110.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCC---EEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGG---LIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~---~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ..++..+.||+|+||.||+|... +++   .+|+|.++...  ...+.+.+|++++++++|+|++++.+.+...+..+++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            45566788999999999999854 333   68999886542  2345688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++++|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Ni  138 (268)
T cd05063          85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNI  138 (268)
T ss_pred             EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhE
Confidence            999999999999843   235689999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=4.9e-19  Score=162.65  Aligned_cols=121  Identities=25%  Similarity=0.461  Sum_probs=105.2

Q ss_pred             hcccCCCCCeEEEEEEE-cCCCEEEEEEecC---cccCHHHHHHHHHHHcCCCcCcccceeEEEEe-----CCeeeEEEe
Q 041073          308 THKLGQGGFGSVYKGQL-HTGGLIAVKMLKN---SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-----GSKRAVVYE  378 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~E  378 (436)
                      .+.||+|+||.|..+.. .+++.||||.+..   .....++..+|+++|+.++|+||+.+.+....     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            57799999999999984 5889999999874   34456778999999999999999999998865     456899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +| +.+|.+.+.    .++.++...+..++.|+++||+|+|+.   +|+||||||+|+
T Consensus       107 lM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNl  156 (359)
T KOG0660|consen  107 LM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNL  156 (359)
T ss_pred             HH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhhe
Confidence            99 669999993    334599999999999999999999998   999999999996

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.77  E-value=3.1e-18  Score=159.91  Aligned_cols=125  Identities=32%  Similarity=0.545  Sum_probs=109.4

Q ss_pred             hhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCccc-------CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          305 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ++..+.||+|+||.||+|...+++.+|+|.++....       ..+.+.+|+++++.++|+||+++++++...+..++++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            345678999999999999887888999998865321       1245889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++.    +...+++..+..++.|++.||+|||+.   +|+|+||||+||
T Consensus        82 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~ni  133 (265)
T cd06631          82 EFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNV  133 (265)
T ss_pred             ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhE
Confidence            9999999999983    234688999999999999999999987   899999999996

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.77  E-value=2.9e-18  Score=161.82  Aligned_cols=123  Identities=29%  Similarity=0.449  Sum_probs=105.5

Q ss_pred             hhhcccCCCCCeEEEEEEE-----cCCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeC--CeeeEE
Q 041073          306 HFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAVV  376 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  376 (436)
                      ++.+.||+|+||+||++..     .++..+|+|.++....  ....+.+|++++++++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6778999999999988652     3577899999876432  345688999999999999999999987653  457899


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++++|.+++.     ...+++.++..++.|++.||+|||++   +|+||||||+||
T Consensus        87 ~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Ni  138 (283)
T cd05080          87 MEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNV  138 (283)
T ss_pred             ecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheE
Confidence            99999999999983     23589999999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.77  E-value=2.4e-18  Score=161.95  Aligned_cols=132  Identities=29%  Similarity=0.449  Sum_probs=111.1

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      ...+.+.+.||+|++|.||++...      .+..+|+|.++....  ....+.+|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            345667789999999999999864      356789998865322  234688999999999999999999999888889


Q ss_pred             eEEEecCCCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKES---RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|||+++++|.+++.....   ....+++..+++++.|++.||+|||++   +++||||||+||
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~ni  147 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNC  147 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheE
Confidence            999999999999999854321   123589999999999999999999998   999999999997

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.77  E-value=1.9e-18  Score=167.44  Aligned_cols=134  Identities=31%  Similarity=0.488  Sum_probs=109.5

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEE------cCCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEEe-
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSE-  369 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  369 (436)
                      +...++++.+.||+|+||.||+|..      .+++.||+|+++....  ..+.+.+|+.++.++ +|+||+++++++.. 
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            3456788899999999999999963      2346899999875332  234578899999999 79999999998764 


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCCC------------------------------------------------------
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKESR------------------------------------------------------  395 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~~------------------------------------------------------  395 (436)
                      +...+++|||+++++|.+++......                                                      
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            45678999999999999988532110                                                      


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          396 ---GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       396 ---~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                         ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Ni  204 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNI  204 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence               13689999999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.76  E-value=2e-18  Score=162.25  Aligned_cols=134  Identities=28%  Similarity=0.421  Sum_probs=112.5

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCC
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS  371 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  371 (436)
                      +....+.+.+.||+|+||.||++...      ++..+|+|.+.....  ....+.+|+.+++.++|+||+++++++....
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            44566778899999999999999853      236799999865432  2346889999999999999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKES------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..+++|||+++|+|.+++.....      ....+++..+..++.|++.||.|||+.   +++||||||+||
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~ni  150 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNC  150 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheE
Confidence            99999999999999999854321      123478999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.76  E-value=2.8e-18  Score=161.87  Aligned_cols=132  Identities=27%  Similarity=0.479  Sum_probs=110.8

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCcccC--HHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      ..++.+.+.||+|+||.||+|...      .+..+|+|.++.....  .+.+.+|+.++..++|+||+++++.+...+..
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            345778899999999999999843      2467999998754322  35688999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKE------------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++||+++++|.+++..+.            .....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Ni  155 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNV  155 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhhe
Confidence            99999999999999984221            1123588899999999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.76  E-value=2e-18  Score=169.58  Aligned_cols=123  Identities=29%  Similarity=0.410  Sum_probs=105.6

Q ss_pred             hhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCC-----eeeEE
Q 041073          306 HFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRAVV  376 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  376 (436)
                      ++.+.||+|+||.||++.. .+++.||+|.+....   ...+++.+|+++++.++|+||+++++++...+     ..++|
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   82 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV   82 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence            4568899999999999985 478899999986532   23356889999999999999999999998766     78999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||++ ++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 ~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Ni  134 (372)
T cd07853          83 TELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNL  134 (372)
T ss_pred             eeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHE
Confidence            99996 58888773    335689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.76  E-value=1.9e-18  Score=163.26  Aligned_cols=131  Identities=26%  Similarity=0.336  Sum_probs=109.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEE-----eCCeeeE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS-----EGSKRAV  375 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~~~l  375 (436)
                      .++.+.+.||+|+||.||++.. .+++.+|+|.+.........+.+|+.+++++ +|+||+++++.+.     .++..++
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            4566778999999999999985 4678899998876444456788999999999 6999999999874     3456899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|||+++++|.+++.........+++..+..++.|+++||.|||+.   +|+||||||+||
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~ni  155 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNI  155 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhE
Confidence            9999999999988753323345689999999999999999999987   999999999996

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.76  E-value=2.9e-18  Score=161.56  Aligned_cols=133  Identities=26%  Similarity=0.410  Sum_probs=111.5

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEcC-----CCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEe-CCe
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLHT-----GGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSK  372 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  372 (436)
                      ...++.+.+.||+|+||.||+|....     +..|++|.+....  ...+.+.+|+.++++++|+||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45667788999999999999998654     6789999886532  234568899999999999999999998766 467


Q ss_pred             eeEEEecCCCCChhhhccCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESR----GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++++||+++++|.+++......    ...+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~ni  148 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNC  148 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhE
Confidence            88999999999999998543211    15689999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.76  E-value=2.7e-18  Score=162.74  Aligned_cols=126  Identities=31%  Similarity=0.440  Sum_probs=110.8

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|++.+.||+|++|.||++... +++.+|+|++....    ...+.+.+|++++++++||||+++++.+..++..+++||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            3566789999999999999854 67899999986532    234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++.    ....+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        82 ~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~ni  132 (290)
T cd05580          82 YVPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENL  132 (290)
T ss_pred             cCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHE
Confidence            999999999983    335789999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.76  E-value=6.7e-18  Score=159.29  Aligned_cols=127  Identities=28%  Similarity=0.444  Sum_probs=110.1

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .|++.+.||+|+||.||++... ++..+++|.+.... ...+.+.+|+++++.++|+|++++++.+...+..++++||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3567788999999999999865 56778899886532 334568899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|..++..   ....+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        86 ~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~ni  134 (282)
T cd06643          86 GGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNI  134 (282)
T ss_pred             CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccE
Confidence            9999988742   235689999999999999999999998   999999999996

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.76  E-value=2.5e-18  Score=163.98  Aligned_cols=132  Identities=29%  Similarity=0.452  Sum_probs=111.5

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEEeC
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEG  370 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  370 (436)
                      +...++.+.+.||+|+||.||++...      .+..+|+|.++....  ..+.+.+|+.+++++ +|+||+++++.+...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            44556778899999999999999731      345799998875322  235688999999999 799999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..+++|||+++|+|.+++...  ....+++.++..++.|++.||+|||++   +|+|+||||+||
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Ni  172 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNV  172 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceE
Confidence            9999999999999999998432  223489999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.76  E-value=4.6e-18  Score=157.86  Aligned_cols=127  Identities=24%  Similarity=0.344  Sum_probs=110.4

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      |++.+.||+|+||.||++... +++.+|+|.++..  ....+.+.+|+.+++.++|+||+++++.+.+.+..+++|||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            456788999999999999854 7888999998643  2234678899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|.+++...  ....+++..+..++.|++.||.|||++   +|+|+||||+||
T Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~ni  131 (255)
T cd08219          82 GGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNI  131 (255)
T ss_pred             CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceE
Confidence            99999988432  335688999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.76  E-value=5.8e-19  Score=164.11  Aligned_cols=125  Identities=37%  Similarity=0.632  Sum_probs=109.2

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHH---HHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAE---EFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |++.+.||+|+||+||++... +++.+|+|.+........   ...+|+..+++++|+||+++++........+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            356788999999999999965 556899999987543322   3456999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++.    ....+++..+..++.|+++||++||+.   +|+||||||+||
T Consensus        81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NI  129 (260)
T PF00069_consen   81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENI  129 (260)
T ss_dssp             TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGE
T ss_pred             cccccccccc----ccccccccccccccccccccccccccc---cccccccccccc
Confidence            9999999994    345689999999999999999999998   999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.76  E-value=4.3e-18  Score=160.46  Aligned_cols=128  Identities=28%  Similarity=0.503  Sum_probs=110.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-----CCCEEEEEEecCcccC--HHHHHHHHHHHcCCCcCcccceeEEEEe--CCee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-----TGGLIAVKMLKNSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKR  373 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  373 (436)
                      ..+++.+.||+|+||.||++...     ++..+|+|.++.....  .+.+.+|+++++.++|+||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45567789999999999999843     4678999999865443  5679999999999999999999998877  5578


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni  140 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNI  140 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhE
Confidence            9999999999999999432   23589999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=1.7e-18  Score=175.76  Aligned_cols=131  Identities=20%  Similarity=0.268  Sum_probs=110.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCC-------
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-------  371 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  371 (436)
                      .+|.+.+.||+|+||.||++.. .+++.||+|++.....   ....+.+|+..+..++|+||+++++.+....       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            4677889999999999999984 5788999999876432   2345788999999999999999887664322       


Q ss_pred             -eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 -KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 -~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       ..++||||+++|+|.+++..+......+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NI  174 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANI  174 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHE
Confidence             36799999999999999865444456789999999999999999999998   999999999997

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.76  E-value=2.3e-18  Score=180.80  Aligned_cols=126  Identities=24%  Similarity=0.344  Sum_probs=110.6

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|.+.+.||+|+||.||+|... +++.||+|+++....    ....+.+|+.+++.++|+||+++++.+......++|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            4567789999999999999965 788999999875321    23568889999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++.    ....+++..++.++.||+.||+|||++   +|+||||||+||
T Consensus        85 y~~g~~L~~li~----~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NI  135 (669)
T cd05610          85 YLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNM  135 (669)
T ss_pred             CCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHE
Confidence            999999999983    234688999999999999999999987   999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.76  E-value=3.9e-18  Score=160.42  Aligned_cols=126  Identities=23%  Similarity=0.385  Sum_probs=110.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ..|...+.||+|+||.||+|... ++..+|+|.+....  ...+.+.+|++++++++|+||+++++.+..++..++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45666788999999999999854 67789999987532  2335688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++.     ...+++..+..++.|+++||.|||++   +++|+||+|+||
T Consensus        84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni  132 (277)
T cd06642          84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANV  132 (277)
T ss_pred             cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheE
Confidence            99999999882     24688999999999999999999987   999999999996

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.76  E-value=2.4e-18  Score=163.18  Aligned_cols=134  Identities=28%  Similarity=0.483  Sum_probs=111.9

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEEeC
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEG  370 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  370 (436)
                      +....+++.+.||+|+||.||++...      ....+|+|.+.....  ...++.+|+.++.++ +|+||+++++.+...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34456677789999999999999853      235789999875322  234688999999999 799999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKE------------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..+++|||+++|+|.+++....            .....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni  163 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV  163 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence            99999999999999999985321            2235689999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.7e-18  Score=170.79  Aligned_cols=126  Identities=27%  Similarity=0.378  Sum_probs=110.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  376 (436)
                      ..+.+.++||+|+||+|++++.+ +++.+|||++++.    ..+.+..+.|.+++.... ||.++.++.++.+.++++.|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            44567799999999999999965 7789999999873    345677888888877664 99999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+.||++..++     ....+++..+.-++..++.||+|||++   +||+||||.+||
T Consensus       448 mey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNi  499 (694)
T KOG0694|consen  448 MEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNL  499 (694)
T ss_pred             EEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---Cceeeecchhhe
Confidence            9999999965544     346799999999999999999999998   999999999997

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.76  E-value=6.4e-18  Score=156.98  Aligned_cols=125  Identities=35%  Similarity=0.580  Sum_probs=109.5

Q ss_pred             cccCCCCCeEEEEEEEcC----CCEEEEEEecCcccC--HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLHT----GGLIAVKMLKNSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||++....    +..+++|.++.....  .+.+.+|++.+..++|+||+++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998653    778999999774433  56789999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESR-----GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++......     ...+++..+..++.|+++||+|||++   +++||||||+||
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~ni  136 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNC  136 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceE
Confidence            9999998543211     36789999999999999999999998   999999999997

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.76  E-value=3e-18  Score=165.83  Aligned_cols=136  Identities=27%  Similarity=0.460  Sum_probs=112.9

Q ss_pred             HHHHHHhhhhhcccCCCCCeEEEEEEEc--------CCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEE
Q 041073          298 PEIIAMTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGF  366 (436)
Q Consensus       298 ~~i~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~  366 (436)
                      .++...++++.+.||+|+||.||++...        ....+|+|.++....  ..+++.+|+++++++ +|+||+++++.
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            3455567888899999999999999732        123689998875322  345788999999999 79999999999


Q ss_pred             EEeCCeeeEEEecCCCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCC
Q 041073          367 CSEGSKRAVVYEYMPNGSLDRHIFPKES------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPH  434 (436)
Q Consensus       367 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~  434 (436)
                      +...+..++++||+++|+|.+++.....            ....+++..+..++.|++.||+|||++   +|+||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence            9998899999999999999999854321            224588999999999999999999987   9999999999


Q ss_pred             CC
Q 041073          435 NI  436 (436)
Q Consensus       435 NI  436 (436)
                      ||
T Consensus       164 Ni  165 (334)
T cd05100         164 NV  165 (334)
T ss_pred             eE
Confidence            97

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.76  E-value=1.2e-18  Score=169.25  Aligned_cols=131  Identities=28%  Similarity=0.467  Sum_probs=111.7

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc---CCC--EEEEEEecC--cccCHHHHHHHHHHHcCCCcCcccceeEEEEeCC
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH---TGG--LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS  371 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~---~~~--~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  371 (436)
                      ++.++...+.+.||+|-||.||+|.+.   .|+  .||||.-+.  ...+.+.|+.|..+|++++||||++++|.|.+. 
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            455666667889999999999999843   232  488898766  334567899999999999999999999999754 


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +.|||||.++.|.|..|+.   .+...++......++.||+.||+|||++   ++|||||.++||
T Consensus       464 P~WivmEL~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNi  522 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQ---QNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNI  522 (974)
T ss_pred             ceeEEEecccchhHHHHHH---hccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhhe
Confidence            6899999999999999994   3446788999999999999999999998   999999999997

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.76  E-value=6.3e-18  Score=160.32  Aligned_cols=128  Identities=26%  Similarity=0.460  Sum_probs=111.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ..|++.+.||+|+||.||+|+.. ++..+++|.+.... ...+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            45677889999999999999864 57889999987533 23456889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|..++..   ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        92 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Ni  141 (292)
T cd06644          92 PGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNV  141 (292)
T ss_pred             CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceE
Confidence            99999887732   234689999999999999999999987   999999999996

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.76  E-value=3.9e-18  Score=162.56  Aligned_cols=127  Identities=29%  Similarity=0.462  Sum_probs=109.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      .+|.+.+.||+|+||.||++... +++.||+|.++..  ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            34567788999999999999854 6788999998653  22345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++ ++|.+++..   ....+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        86 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Ni  135 (301)
T cd07873          86 LD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNL  135 (301)
T ss_pred             cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHE
Confidence            96 589888843   234688999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.76  E-value=2.5e-18  Score=160.75  Aligned_cols=125  Identities=28%  Similarity=0.455  Sum_probs=109.1

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc-------CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      |+..+.||+|++|.||++.. .+++.+|+|++.....       ..+.+.+|++.+++++|+||+++++.+...+..+++
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            34557899999999999984 5788999999865321       135688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||+++++|.+++.    +...+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        82 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~ni  134 (268)
T cd06630          82 VEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANL  134 (268)
T ss_pred             EeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            99999999999983    234688999999999999999999998   999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.76  E-value=2.8e-18  Score=162.92  Aligned_cols=131  Identities=31%  Similarity=0.517  Sum_probs=110.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcC-----------------CCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccce
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHT-----------------GGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQL  363 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l  363 (436)
                      ..+.+.+.||+|+||.||++....                 +..+|+|.+....  ...+.+.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            456778999999999999987431                 2458999987643  234578899999999999999999


Q ss_pred             eEEEEeCCeeeEEEecCCCCChhhhccCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKES-------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       364 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++...+..+++|||+++++|.+++.....       ....+++..++.++.|++.||+|||+.   +|+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence            9999998999999999999999999854321       113689999999999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.76  E-value=3.9e-18  Score=160.63  Aligned_cols=128  Identities=27%  Similarity=0.487  Sum_probs=108.6

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCC----EEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ...+++.+.||+|+||.||+|..+ +++    .+|+|.+.....  ....+.+|+..+++++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            355677789999999999999853 333    589998866432  23568899999999999999999999887 7889


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|||+++|+|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        85 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~ni  140 (279)
T cd05057          85 LITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNV  140 (279)
T ss_pred             EEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceE
Confidence            99999999999999843   234589999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.76  E-value=4.4e-18  Score=161.79  Aligned_cols=125  Identities=31%  Similarity=0.512  Sum_probs=108.5

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC------HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      |++.+.||+|++|.||+|... +++.+|+|.++.....      ...+.+|++++++++|+||+++++++.+.+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            456678999999999999854 6889999998764322      245778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+ +++|.+++...   ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        82 e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~ni  133 (298)
T cd07841          82 EFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNL  133 (298)
T ss_pred             ccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhE
Confidence            999 89999998432   13689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.76  E-value=4.1e-18  Score=162.10  Aligned_cols=126  Identities=28%  Similarity=0.386  Sum_probs=111.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .+|.+.+.||+|++|.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5666778999999999999985 578899999987533 33456889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++.     ...+++..+..++.|++.||.|||+.   +++||||||+||
T Consensus        99 ~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Ni  146 (297)
T cd06656          99 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNI  146 (297)
T ss_pred             CCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            9999999983     24578999999999999999999987   999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.76  E-value=4.6e-18  Score=159.34  Aligned_cols=127  Identities=29%  Similarity=0.510  Sum_probs=103.5

Q ss_pred             hhcccCCCCCeEEEEEEEcCC-C--EEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeC------Ceee
Q 041073          307 FTHKLGQGGFGSVYKGQLHTG-G--LIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRA  374 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~~~~~-~--~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  374 (436)
                      +.+.||+|+||.||+|..... .  .+|+|.++...   ...+.+.+|+++++.++|+||+++++.+...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            557899999999999986533 2  58999886532   2345688999999999999999999977432      2468


Q ss_pred             EEEecCCCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKE--SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|||+++|+|.+++....  .....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Ni  143 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNC  143 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccchhhe
Confidence            9999999999998874321  2234589999999999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.76  E-value=2.7e-18  Score=162.50  Aligned_cols=132  Identities=27%  Similarity=0.487  Sum_probs=111.0

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      ...+++.+.||+|+||.||++...      ++..+|+|.+.....  ...++.+|+.++++++|+||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            345667789999999999999853      467899999875322  235688999999999999999999999998899


Q ss_pred             eEEEecCCCCChhhhccCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKE------------------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      ++++||+++|+|.+++....                  .....+++..++.++.|++.||+|||++   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            99999999999999985321                  1123478889999999999999999988   99999999999


Q ss_pred             C
Q 041073          436 I  436 (436)
Q Consensus       436 I  436 (436)
                      |
T Consensus       161 i  161 (288)
T cd05050         161 C  161 (288)
T ss_pred             e
Confidence            6

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.76  E-value=3.6e-18  Score=161.01  Aligned_cols=132  Identities=27%  Similarity=0.496  Sum_probs=110.8

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ..++.+.++||+|+||.||++...      ++..+|+|.+.... ...+.+.+|+++++.++|+||+++++.+...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            445667789999999999999632      35578999876532 23457999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKES-----------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|||+++++|.+++.....           ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~ni  153 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNC  153 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhE
Confidence            99999999999999854321           113588999999999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.76  E-value=3.8e-18  Score=161.81  Aligned_cols=131  Identities=25%  Similarity=0.504  Sum_probs=110.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc-CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      ..+.+.+.||+|+||.||+++..      ++..+++|.+..... ..+.+.+|+..+++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            44566788999999999999732      345688898865432 23568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKE------------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++++|.+++....            .....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  154 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNC  154 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceE
Confidence            999999999999985432            1224589999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.76  E-value=6.8e-18  Score=156.98  Aligned_cols=119  Identities=25%  Similarity=0.521  Sum_probs=102.2

Q ss_pred             ccCCCCCeEEEEEEE---cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          310 KLGQGGFGSVYKGQL---HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       310 ~lg~G~fg~V~~~~~---~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      .||+|+||.||+|.+   .++..+|+|+++....   ..+++.+|+.+++.++|+||+++++.+. .+..+++|||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999964   3567899999865332   2356889999999999999999999875 45678999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~ni  126 (257)
T cd05116          81 PLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNV  126 (257)
T ss_pred             cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhE
Confidence            9999983    234689999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.76  E-value=4.8e-18  Score=160.01  Aligned_cols=127  Identities=27%  Similarity=0.456  Sum_probs=106.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCC----EEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGG----LIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      ..+++.+.||+|+||.||+|.. .++.    .||+|+++...  ...+.+.+|+.+++.++|+||+++++.+.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            4556678999999999999984 3444    47999986532  224568899999999999999999998865 45679


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||+++|+|.+++..   ....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        86 ~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Ni  140 (279)
T cd05109          86 VTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNV  140 (279)
T ss_pred             EEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence            9999999999999843   234689999999999999999999998   999999999997

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.76  E-value=4.7e-18  Score=157.79  Aligned_cols=125  Identities=31%  Similarity=0.447  Sum_probs=109.3

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc------cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ++..+.||+|++|.||+|... +++.+++|.+....      ...+.+.+|+.+++.++|+||+++++.+......++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            445678999999999999865 78899999986532      12356889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++.    +...+++..+..++.|+++||+|||+.   +++|+||||+||
T Consensus        82 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni  133 (258)
T cd06632          82 ELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANI  133 (258)
T ss_pred             EecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            9999999999983    334688999999999999999999988   999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.76  E-value=4.3e-18  Score=157.90  Aligned_cols=127  Identities=26%  Similarity=0.407  Sum_probs=110.9

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      +.+.+.||+|++|.||++... +++.+++|.+...   ....+.+.+|+++++.++||||+++++.+...+..+++|||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            446688999999999999854 6888999998653   223456889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||
T Consensus        82 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~ni  132 (256)
T cd08529          82 ENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNL  132 (256)
T ss_pred             CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceE
Confidence            999999998542  235689999999999999999999987   999999999997

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.76  E-value=4.5e-18  Score=161.75  Aligned_cols=125  Identities=28%  Similarity=0.396  Sum_probs=110.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      +|.+.+.||+|++|.||++.. .+++.+++|.+.... ...+.+.+|+.+++.+.|+|++++++.+..+...++||||++
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~  100 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence            556678899999999999984 467899999987633 334678899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|.+++.     ...+++.++..++.|++.||+|||+.   +|+||||||+||
T Consensus       101 ~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Ni  147 (296)
T cd06654         101 GGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNI  147 (296)
T ss_pred             CCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            999999883     23578999999999999999999988   999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.76  E-value=5.5e-18  Score=157.34  Aligned_cols=127  Identities=24%  Similarity=0.355  Sum_probs=110.6

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |++.+.||+|+||.||.++. .+++.+++|.+....   ....++.+|++++++++|+||+++++++...+..+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            56778999999999998884 468889999876532   23456889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++...  ....+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni  132 (256)
T cd08221          82 NGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNI  132 (256)
T ss_pred             CCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhE
Confidence            999999998432  235689999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.76  E-value=5.8e-18  Score=159.79  Aligned_cols=126  Identities=23%  Similarity=0.406  Sum_probs=109.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +|++.+.||+|++|.||++..+ +++.+|+|.+....   ...+.+.+|+.+++.++|+|++++++.+......+++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            3566788999999999999865 68899999886532   1235678999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++.|..++.    ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~ni  131 (286)
T cd07847          82 CDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENI  131 (286)
T ss_pred             cCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhE
Confidence            99988887762    334689999999999999999999997   999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.75  E-value=8e-18  Score=157.75  Aligned_cols=125  Identities=30%  Similarity=0.533  Sum_probs=104.5

Q ss_pred             cccCCCCCeEEEEEEEc-CCC--EEEEEEecCc--ccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGG--LIAVKMLKNS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||+|... ++.  .+++|.++..  ....+.+.+|++++.++ +||||+++++.+...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999865 333  4688887642  22345688999999999 799999999999999999999999999


Q ss_pred             CChhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKE------------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++....            .....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~ni  143 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI  143 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceE
Confidence            99999985432            1123578999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.75  E-value=4.9e-18  Score=160.95  Aligned_cols=129  Identities=26%  Similarity=0.453  Sum_probs=107.6

Q ss_pred             hhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      +++.+.||+|+||.||+|...      ....+++|.+.....  ..+++.+|+.+++.++||||+++++.+...+..+++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            356688999999999999742      224688888865332  245688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKE--------------------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||+++++|.+++....                    .....+++..++.++.|++.||+|||+.   +++||||||+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni  158 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV  158 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence            99999999999875321                    1123588999999999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.75  E-value=7.3e-18  Score=158.00  Aligned_cols=129  Identities=27%  Similarity=0.420  Sum_probs=110.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEeC------Ceee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG------SKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~~~  374 (436)
                      ..|.+.+.||+|+||.||+|... +++.+|+|.+.........+.+|+.++.++ +|+||+++++.+...      ...+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            44666788999999999999854 678899999877655667788999999998 699999999988653      4578


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|||+++++|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~ni  142 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNV  142 (272)
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHE
Confidence            999999999999988432  235689999999999999999999988   999999999996

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.75  E-value=3.3e-18  Score=171.48  Aligned_cols=126  Identities=21%  Similarity=0.379  Sum_probs=102.8

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeC--------Ceee
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--------SKRA  374 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~  374 (436)
                      .|.+.+.||+|+||.||+|.. .+++.||+|.+....   ....+|+.+++.++|+||+++++++...        ...+
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            466778999999999999985 467899999885432   2345799999999999999998876432        2467


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++ +|.+++.........+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NI  201 (440)
T PTZ00036        144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNL  201 (440)
T ss_pred             EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHE
Confidence            99999975 77776643333446789999999999999999999998   999999999997

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.75  E-value=7.3e-18  Score=158.86  Aligned_cols=121  Identities=26%  Similarity=0.392  Sum_probs=105.8

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      +++.+.||+|+||.||++.. .+++.+|+|.+....  ...+.+.+|++++++++||||+++++.+...+..+++|||++
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD   82 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence            45678899999999999984 578889999986532  223568899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|..+.        .+++..+..++.|++.||+|||+.   +|+|+||||+||
T Consensus        83 ~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  126 (279)
T cd06619          83 GGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNM  126 (279)
T ss_pred             CCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHE
Confidence            99996543        467888999999999999999988   999999999996

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.75  E-value=5.9e-18  Score=158.54  Aligned_cols=128  Identities=31%  Similarity=0.530  Sum_probs=106.4

Q ss_pred             hhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCe------
Q 041073          306 HFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------  372 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  372 (436)
                      ++.+.||+|+||.||+|...    .+..+|+|.++.....   .+.+.+|++.++.++|+||+++++.+.....      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            45688999999999999854    2367999998754322   3568899999999999999999998866544      


Q ss_pred             eeEEEecCCCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKE--SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++++||+++|+|..++....  .....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Ni  144 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNC  144 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheE
Confidence            789999999999998885432  1234689999999999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.75  E-value=5.3e-18  Score=162.65  Aligned_cols=134  Identities=28%  Similarity=0.483  Sum_probs=111.2

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc--------CCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCS  368 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~  368 (436)
                      +...++.+.+.||+|+||.||+++..        ....+|+|.++....  ....+.+|+.+++.+ +|+||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34456778899999999999999731        234689998875332  235688999999999 5999999999999


Q ss_pred             eCCeeeEEEecCCCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          369 EGSKRAVVYEYMPNGSLDRHIFPKES------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       369 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..+..+++|||+++|+|.+++.....            ....+++.++.+++.|++.||+|||++   +++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence            88899999999999999999854321            124589999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.75  E-value=2.8e-19  Score=159.87  Aligned_cols=127  Identities=30%  Similarity=0.416  Sum_probs=113.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .-+++.++||+|+||.||++.. .+|+.+|+|.+... .+.+++..|+.+|.+...+++|+++|.+-....+++|||||.
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3456778999999999999974 47899999988653 367889999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .|++.+.++   .+++.++++++..++...++||+|||..   .-||||||+.||
T Consensus       112 AGSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNI  160 (502)
T KOG0574|consen  112 AGSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNI  160 (502)
T ss_pred             CCcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccE
Confidence            999999994   4557899999999999999999999976   789999999997

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.75  E-value=6.3e-18  Score=157.54  Aligned_cols=126  Identities=29%  Similarity=0.400  Sum_probs=109.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc------CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      .+...+.||+|++|.||++.. .+++.+|+|.++....      ..+.+.+|++++++++||||+++++++...+..+++
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            355678899999999999985 4688999999865321      234688899999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||+++++|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        83 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~ni  135 (263)
T cd06625          83 MEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANI  135 (263)
T ss_pred             EEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            99999999999883    234688999999999999999999988   999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.75  E-value=4.9e-18  Score=161.58  Aligned_cols=130  Identities=27%  Similarity=0.505  Sum_probs=107.8

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCC--EEEEEEecCc--ccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGG--LIAVKMLKNS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      .+++.+.||+|+||.||+|..+ ++.  .+++|.++..  ....+.+.+|+.++.++ +||||+++++.+...+..++++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~   82 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI   82 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence            4567789999999999999864 332  4688887642  22345688999999999 7999999999999988999999


Q ss_pred             ecCCCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKES------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++.....            ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Ni  150 (297)
T cd05089          83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNV  150 (297)
T ss_pred             EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceE
Confidence            99999999999854221            123588999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.75  E-value=6.1e-18  Score=159.39  Aligned_cols=126  Identities=28%  Similarity=0.479  Sum_probs=103.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCC----EEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      .+++.+.||+|+||.||+|... ++.    .+++|.+....  ....++..|+..++++.|+||+++++++. ....+++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i   86 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV   86 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence            4456688999999999999853 444    36777775422  22356778888999999999999999875 4457889


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||+++|+|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        87 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~ni  140 (279)
T cd05111          87 TQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNI  140 (279)
T ss_pred             EEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceE
Confidence            999999999999943   235689999999999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.75  E-value=4.7e-18  Score=159.25  Aligned_cols=129  Identities=26%  Similarity=0.380  Sum_probs=108.0

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEcC----CCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLHT----GGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ...++.+.+.||+|+||.||+|...+    ...+++|......  ...+.+.+|+.++++++|+||+++++.+.. +..+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            34556778899999999999998542    2468999876532  234578999999999999999999998865 4578


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|||+++|+|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        83 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~ni  138 (270)
T cd05056          83 IVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNV  138 (270)
T ss_pred             EEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheE
Confidence            99999999999999843   234589999999999999999999987   999999999997

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.75  E-value=7.5e-18  Score=159.58  Aligned_cols=127  Identities=25%  Similarity=0.475  Sum_probs=101.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-c-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCC---CcCcccceeEEEE-----eC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-H-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRI---HHVNVVQLLGFCS-----EG  370 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~  370 (436)
                      +|.+.+.||+|+||.||+++. . ++..+|+|.++...   .....+.+|+.+++.+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            456778999999999999985 3 46789999986532   2234566777766655   6999999999875     24


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...+++|||++ ++|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Ni  141 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNI  141 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHE
Confidence            56899999996 6899988432  234589999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.75  E-value=8.9e-18  Score=158.53  Aligned_cols=127  Identities=27%  Similarity=0.451  Sum_probs=108.8

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |.+.+.||+|++|.||+|... ++..+|+|.++...   .....+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            456688999999999999854 68899999986532   23456889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      + ++|.+++.... ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        82 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~ni  132 (285)
T cd07861          82 S-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNL  132 (285)
T ss_pred             C-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHE
Confidence            7 68888874322 235689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.75  E-value=1.1e-17  Score=157.53  Aligned_cols=126  Identities=23%  Similarity=0.368  Sum_probs=110.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ..+++.+.||+|+||.||+|.. .++..+|+|.+....  .....+.+|+..+++++|+||+++++.+..++..++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            4456778899999999999985 467889999876532  2335688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++.     ...+++..+..++.|++.||.|||++   +++|+||||+||
T Consensus        84 ~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni  132 (277)
T cd06641          84 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANV  132 (277)
T ss_pred             CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhE
Confidence            99999999882     24689999999999999999999988   999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.75  E-value=1.1e-17  Score=155.87  Aligned_cols=127  Identities=31%  Similarity=0.415  Sum_probs=111.6

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .+.+.+.||+|+||.||++... +++.+++|.+.... ...+.+.+|+.++++++||||+++++.+...+..+++|||++
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~   83 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG   83 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence            4567788999999999999854 67789999987633 245678999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        84 ~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni  132 (262)
T cd06613          84 GGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANI  132 (262)
T ss_pred             CCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhE
Confidence            9999998843   225689999999999999999999987   999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.75  E-value=4.5e-18  Score=160.76  Aligned_cols=130  Identities=25%  Similarity=0.377  Sum_probs=111.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .+++.+.||+|+||.||++... ++..+|+|.++...  .....+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            4667889999999999999865 78899999886532  22356889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|..++.... ....+++..+..++.|++.||.|||++  .+|+||||||+||
T Consensus        82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~ni  134 (286)
T cd06622          82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNV  134 (286)
T ss_pred             CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHE
Confidence            9999999884321 134689999999999999999999963  2899999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.75  E-value=4.9e-18  Score=158.92  Aligned_cols=122  Identities=29%  Similarity=0.373  Sum_probs=106.0

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCChh
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLD  386 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  386 (436)
                      ..||+|+||.||+|... ++..+++|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++++||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            57999999999999854 67789999887643 23457899999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          387 RHIFPKESRGQSF--SWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       387 ~~l~~~~~~~~~l--~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++...   ...+  ++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        94 ~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~ni  139 (268)
T cd06624          94 ALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNV  139 (268)
T ss_pred             HHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHE
Confidence            998432   1234  7888889999999999999988   999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.75  E-value=1e-17  Score=155.63  Aligned_cols=128  Identities=30%  Similarity=0.500  Sum_probs=108.8

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEE-eCCeeeEEEecC
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRAVVYEYM  380 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~  380 (436)
                      ...+++.+.||+|+||.||++... +..+|+|.++... ..+.+.+|+.++++++|+|++++++++. .++..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            345677789999999999999765 7789999886533 3467899999999999999999999764 456789999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~ni  133 (256)
T cd05082          83 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNV  133 (256)
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheE
Confidence            999999998432  224588999999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.75  E-value=1.3e-17  Score=156.85  Aligned_cols=126  Identities=24%  Similarity=0.393  Sum_probs=110.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ..|+..+.||+|+||.||+|... ++..+|+|.+....  .....+.+|+.+++++.|+||+++++.+..+...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34566788999999999999854 67889999987532  2345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++.     ...+++..+..++.|++.||+|||+.   +++|+||+|+||
T Consensus        84 ~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Ni  132 (277)
T cd06640          84 LGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANV  132 (277)
T ss_pred             CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhE
Confidence            99999999883     24588999999999999999999988   999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.75  E-value=5.8e-18  Score=169.53  Aligned_cols=122  Identities=22%  Similarity=0.270  Sum_probs=105.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      ..+.+.+.||+|+||.||++... .++.||+|...     ...+.+|++++++++|+||+++++++..++..+++||++ 
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-
Confidence            34667789999999999999854 57789999532     234678999999999999999999999999999999999 


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++|.+++..   ....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus       243 ~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NI  291 (461)
T PHA03211        243 RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENV  291 (461)
T ss_pred             CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHE
Confidence            4788888732   234699999999999999999999998   999999999997

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.75  E-value=7.4e-18  Score=158.01  Aligned_cols=125  Identities=28%  Similarity=0.447  Sum_probs=107.2

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc-----------CHHHHHHHHHHHcCCCcCcccceeEEEEeCCe
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF-----------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  372 (436)
                      |...+.||+|+||.||+|.. .+++.+|+|.++....           ..+.+.+|+.+++.++|+|++++++.+...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            34557899999999999984 4688999998754211           02357889999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+++++|.+++.    +...+++..+..++.|++.||.|||++   +++||||||+||
T Consensus        83 ~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~ni  139 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNL  139 (272)
T ss_pred             eEEEEecCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhE
Confidence            999999999999999983    225689999999999999999999987   999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.75  E-value=2.9e-18  Score=159.44  Aligned_cols=125  Identities=28%  Similarity=0.375  Sum_probs=110.6

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      |++.+.||.|+||.||++... +++.+|+|.+....    ...+.+.+|++++++++||||+++++.+..+...++++||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            456789999999999999865 68899999987532    2346789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++..    ...+++..+..++.|+++||.|||++   +++|+||||+||
T Consensus        82 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~ni  131 (258)
T cd05578          82 LLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNI  131 (258)
T ss_pred             CCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHe
Confidence            999999999832    25789999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.75  E-value=7.5e-18  Score=157.03  Aligned_cols=125  Identities=30%  Similarity=0.473  Sum_probs=110.7

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |+..+.||+|+||.||++... +++.+++|.++....   ..+.+.+|+.+++.++|+||+++++.....+..++++||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            556788999999999999854 688999999876443   3467899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+||||+||
T Consensus        82 ~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~ni  130 (264)
T cd06626          82 SGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANI  130 (264)
T ss_pred             CCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            9999999983    234578999999999999999999988   999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.75  E-value=6.7e-18  Score=161.23  Aligned_cols=125  Identities=21%  Similarity=0.263  Sum_probs=109.3

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      |++.+.||+|+||.||++... +++.|++|.+....    ...+.+.+|+++++.++|+||+++++.+..++..+++|||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY   82 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence            456788999999999999854 67889999987532    1234678999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++.    ....+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        83 ~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NI  132 (305)
T cd05609          83 VEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNL  132 (305)
T ss_pred             CCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHE
Confidence            99999999983    235689999999999999999999987   999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.75  E-value=7.5e-18  Score=157.47  Aligned_cols=125  Identities=31%  Similarity=0.485  Sum_probs=107.9

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC----------HHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS----------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      +.+.+.||+|++|.||+|.. .+++.+|+|.+......          .+.+.+|+.++++++|+||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            34567899999999999985 46788999988653211          13578899999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|||+++++|.+++.    +...+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        82 ~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~ni  137 (267)
T cd06628          82 NIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANI  137 (267)
T ss_pred             EEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHE
Confidence            99999999999999983    335688999999999999999999987   999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.74  E-value=9e-18  Score=155.76  Aligned_cols=127  Identities=21%  Similarity=0.281  Sum_probs=110.5

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |.+.+.||+|++|.||++.. .+++.+|+|.+....   ...+.+.+|+++++.++|+|++++++.+..++..++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            45678899999999999985 477889999986532   23456889999999999999999999999899999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++...  ....+++..+..++.|+++||+|||++   +++||||||+||
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~ni  132 (256)
T cd08220          82 PGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNI  132 (256)
T ss_pred             CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            999999999432  234589999999999999999999998   999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.74  E-value=6.1e-18  Score=165.21  Aligned_cols=121  Identities=18%  Similarity=0.276  Sum_probs=104.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      .|.+.+.||+|+||.||+|... ++..||+|+....     ....|+.++++++|+||+++++++...+..++|+|++ .
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~  140 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-S  140 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-C
Confidence            4667789999999999999864 5678999975432     2356899999999999999999999999999999999 5


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       141 ~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Ni  188 (357)
T PHA03209        141 SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENI  188 (357)
T ss_pred             CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            688888742   335689999999999999999999998   999999999997

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.74  E-value=1.3e-17  Score=154.61  Aligned_cols=127  Identities=29%  Similarity=0.452  Sum_probs=112.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      ..|.+.+.||+|+||.||++... ++..+++|.++.... .+++.+|++++++++|+||+++++.+......++++||++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            34667788999999999999965 478899999876433 6789999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|.+++..   ....+++..+..++.|++.||.|||+.   +++||||+|+||
T Consensus        82 ~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni  130 (256)
T cd06612          82 AGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNI  130 (256)
T ss_pred             CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceE
Confidence            9999999842   235689999999999999999999987   999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.74  E-value=1.4e-17  Score=154.74  Aligned_cols=120  Identities=33%  Similarity=0.546  Sum_probs=103.0

Q ss_pred             cccCCCCCeEEEEEEEc-C---CCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-T---GGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||+|... .   +..+|+|.+.....  ..+++.+|+.+++.+.|+||+++++++. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46899999999999743 2   26799999876543  3457899999999999999999999875 4567999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~ni  126 (257)
T cd05060          80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNV  126 (257)
T ss_pred             CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceE
Confidence            999999942    23689999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=2.6e-18  Score=168.79  Aligned_cols=121  Identities=27%  Similarity=0.409  Sum_probs=106.3

Q ss_pred             ccCCCCCeEEEEEEEc-CCCEEEEEEecCc-ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCChhh
Q 041073          310 KLGQGGFGSVYKGQLH-TGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDR  387 (436)
Q Consensus       310 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~  387 (436)
                      .||+|.||+||-|+.. +...+|||.+... ....+.+.+|+...+.++|.|||+++|.+.+++..-|.||-+|||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            5999999999999954 5567899998763 3345679999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          388 HIFPKESRGQSF--SWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       388 ~l~~~~~~~~~l--~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++   .-+++  ++..+-.+..||++||.|||++   .|||||||-+||
T Consensus       662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNV  706 (1226)
T KOG4279|consen  662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNV  706 (1226)
T ss_pred             HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcE
Confidence            9943   34556  7788888999999999999998   999999999996

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.74  E-value=1.2e-17  Score=160.29  Aligned_cols=127  Identities=28%  Similarity=0.376  Sum_probs=110.9

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      |++.+.||+|++|.||++... +++.+|+|.+.....    ..+.+.+|+++++.++|+||+++++.+......+++|||
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   82 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY   82 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence            456688999999999999865 588999999876432    235688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++..  .....+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        83 ~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  134 (316)
T cd05574          83 CPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENI  134 (316)
T ss_pred             cCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHe
Confidence            999999998842  2335689999999999999999999987   999999999997

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.74  E-value=8.7e-18  Score=159.21  Aligned_cols=126  Identities=29%  Similarity=0.482  Sum_probs=108.1

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .|.+.+.||+|++|.||++..+ +++.||+|.+.....  ....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL   85 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence            4556788999999999999865 678999999865322  2345778999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      + ++|.+++..   ....+++..+..++.|+++||.|||+.   +|+||||||+||
T Consensus        86 ~-~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~ni  134 (291)
T cd07844          86 D-TDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNL  134 (291)
T ss_pred             C-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHE
Confidence            7 499988843   224689999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.74  E-value=1.2e-17  Score=161.17  Aligned_cols=123  Identities=25%  Similarity=0.379  Sum_probs=105.5

Q ss_pred             cccCCC--CCeEEEEEEE-cCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQG--GFGSVYKGQL-HTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G--~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      ..||+|  +||+||++.. .+++.||+|++......   .+.+.+|+.+++.++||||+++++++..++..++++||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  8999999985 47899999998754322   35688999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        84 ~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Ni  132 (328)
T cd08226          84 GSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHI  132 (328)
T ss_pred             CCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            9999988432  123589999999999999999999987   999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.74  E-value=7.8e-18  Score=163.55  Aligned_cols=125  Identities=26%  Similarity=0.361  Sum_probs=105.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeC------Ce
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  372 (436)
                      .+|.+.+.||+|+||.||++.. .+++.||+|.+.....   ..+.+.+|+.+++.++|+||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            4577778999999999999985 4778999999875322   235577899999999999999999877532      34


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++++|++ +++|.+++.     ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        95 ~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Ni  149 (343)
T cd07878          95 VYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNV  149 (343)
T ss_pred             EEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhE
Confidence            68999988 789988872     34689999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.74  E-value=1.4e-17  Score=159.80  Aligned_cols=123  Identities=24%  Similarity=0.390  Sum_probs=101.0

Q ss_pred             cccCCCCCeEEEEEEEc---CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEe--CCeeeEEEecCCCC
Q 041073          309 HKLGQGGFGSVYKGQLH---TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAVVYEYMPNG  383 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~~g  383 (436)
                      ++||+|+||.||+|...   +++.+|+|.+..... ...+.+|+.++++++||||+++++.+..  +...+++|||++ +
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H   84 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence            57999999999999854   457899999875432 3457889999999999999999998854  456789999985 5


Q ss_pred             ChhhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKE-----SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.+++....     .....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Ni  139 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANI  139 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHE
Confidence            8877764221     1223589999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.74  E-value=1.7e-17  Score=153.61  Aligned_cols=122  Identities=32%  Similarity=0.552  Sum_probs=107.8

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCChh
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLD  386 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  386 (436)
                      ++||+|+||.||++....++.+|+|.+.....  ....+.+|++++++++|+||+++++++......+++|||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999999976689999998876433  3457899999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          387 RHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       387 ~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++...   ...+++..+..++.+++.||+|||++   +++||||||+||
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~ni  124 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNC  124 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceE
Confidence            998432   34678999999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.74  E-value=1.4e-17  Score=154.62  Aligned_cols=122  Identities=32%  Similarity=0.507  Sum_probs=105.2

Q ss_pred             cccCCCCCeEEEEEEEcC--C--CEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLHT--G--GLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~--~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|++|.||++....  +  ..+|+|.+.....  ..+.+.+|+..+++++|+||+++++.+.. ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998542  2  2589999877443  34578999999999999999999999888 888999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++.....  ..+++..+..++.|+++||+|||++   +++||||||+||
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~ni  128 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNI  128 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccE
Confidence            999999854321  4689999999999999999999988   999999999996

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.74  E-value=1.1e-17  Score=158.61  Aligned_cols=131  Identities=29%  Similarity=0.391  Sum_probs=110.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEeC-----CeeeE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG-----SKRAV  375 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~l  375 (436)
                      .++.+.+.||+|+||.||++.. .+++.+|+|.+.........+.+|+.++.++ +|+|++++++.+...     +..++
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l  101 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL  101 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence            3456678899999999999985 4688899999876544456788899999988 799999999988653     35799


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++++|.+++.........+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus       102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~ni  159 (291)
T cd06639         102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNI  159 (291)
T ss_pred             EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHE
Confidence            9999999999998753333445789999999999999999999987   999999999996

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.74  E-value=9.5e-18  Score=159.21  Aligned_cols=121  Identities=33%  Similarity=0.459  Sum_probs=106.5

Q ss_pred             hcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          308 THKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      ...||+|+||.||++.. .++..+|+|.+.... ...+.+.+|+..++.++|+||+++++.+..++..+++|||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            46799999999999985 468899999986533 2345688999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++.     ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       107 ~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Ni  149 (292)
T cd06658         107 TDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSI  149 (292)
T ss_pred             HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHE
Confidence            99872     24588999999999999999999998   999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.74  E-value=1.2e-17  Score=155.90  Aligned_cols=125  Identities=27%  Similarity=0.381  Sum_probs=105.6

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc------cCHHHHHHHHHHHcCCCcCcccceeEEEEeC--CeeeE
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAV  375 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  375 (436)
                      +.+.+.||+|+||.||++.. .++..||+|.+....      ...+.+.+|+.++++++|+||+++++++.+.  ...++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            45668899999999999985 468899999875421      1234688899999999999999999988653  46789


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|||+++++|.+++.    +...+++..+..++.|++.||+|||++   +++|+||||+||
T Consensus        84 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~ni  137 (265)
T cd06652          84 FMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANI  137 (265)
T ss_pred             EEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHE
Confidence            999999999999883    224578899999999999999999988   999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.74  E-value=1.2e-17  Score=158.85  Aligned_cols=125  Identities=28%  Similarity=0.412  Sum_probs=110.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      +|++.+.||.|++|.||++.. .+++.+++|.+.... ...+.+.+|+..++.++|+||+++++.+...+..++|+||++
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   99 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA   99 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence            356678899999999999984 578899999986533 334678899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|.+++.     ...+++.++..++.|++.||+|||+.   +++||||||+||
T Consensus       100 ~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Ni  146 (296)
T cd06655         100 GGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNV  146 (296)
T ss_pred             CCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            999999882     23589999999999999999999998   999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.74  E-value=1.5e-17  Score=155.76  Aligned_cols=131  Identities=27%  Similarity=0.418  Sum_probs=112.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCC------eee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGS------KRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~~~  374 (436)
                      .+|++.+.||+|++|.||++... +++.+++|++.......+++.+|+.+++++ +|+||+++++++....      ..+
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            45677889999999999999964 677899999887655567799999999998 6999999999987644      479


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|||+++++|.+++.........+++..+..++.|+++||+|||+.   +++|+||+|+||
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni  144 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNI  144 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHE
Confidence            99999999999998854332346789999999999999999999988   999999999997

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.73  E-value=1.7e-17  Score=154.13  Aligned_cols=127  Identities=27%  Similarity=0.373  Sum_probs=110.0

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |++.+.||+|+||.+|++.. .+++.+|+|.+...   .....++.+|+.++++++|+||+++++.+...+..++|+||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            55678999999999999985 46788999998653   223457899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++...  ....+++..+..++.|++.||+|||++   +++|+||+|+||
T Consensus        82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~ni  132 (256)
T cd08218          82 EGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNI  132 (256)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHE
Confidence            999999988432  234578999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.73  E-value=7e-18  Score=166.85  Aligned_cols=124  Identities=21%  Similarity=0.273  Sum_probs=106.3

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc---CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH---TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ...+|.+.+.||+|+||.||++...   .+..||+|.+...    ....+|+++++.++|+||+++++.+......+++|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            3445778899999999999999743   4567899987643    23568999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |++. ++|.+++    .....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus       166 e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Ni  216 (392)
T PHA03207        166 PKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENI  216 (392)
T ss_pred             hhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHE
Confidence            9995 6888888    2345789999999999999999999998   999999999997

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.73  E-value=1.5e-17  Score=158.02  Aligned_cols=126  Identities=29%  Similarity=0.401  Sum_probs=110.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc-ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .++.+.+.||+|+||.||++.. .+++.+|+|.+... ....+.+.+|+.++++++|||++++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            4667778999999999999984 46788999998653 233466889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++.     ...+++..+..++.|++.||.|||++   +++||||||+||
T Consensus        99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Ni  146 (293)
T cd06647          99 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNI  146 (293)
T ss_pred             CCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHE
Confidence            9999999983     23578999999999999999999988   999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.73  E-value=1.6e-17  Score=156.82  Aligned_cols=125  Identities=25%  Similarity=0.421  Sum_probs=109.9

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |++.+.||+|++|.||+|... +++.+|+|.+....   .....+.+|+.++++++|+||+++++.+..+...++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            556788999999999999854 68899999987633   22457899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       +++|.+++...   ...+++..+..++.|+++||+|||+.   +++|+||||+||
T Consensus        82 -~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni  130 (286)
T cd07832          82 -PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANL  130 (286)
T ss_pred             -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHE
Confidence             99999988432   25689999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.73  E-value=8.1e-18  Score=157.42  Aligned_cols=125  Identities=28%  Similarity=0.475  Sum_probs=105.7

Q ss_pred             cccCCCCCeEEEEEEEcC-------CCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          309 HKLGQGGFGSVYKGQLHT-------GGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +.||+|+||.||+|+..+       +..+|+|.+....  .....+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            358999999999998532       2468999876533  3456788999999999999999999999988899999999


Q ss_pred             CCCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKES---RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++.....   ....+++..+..++.|++.||+|||+.   +++|+||||+||
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~ni  137 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNC  137 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheE
Confidence            999999999854321   224578999999999999999999987   899999999996

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.73  E-value=2e-17  Score=157.36  Aligned_cols=120  Identities=28%  Similarity=0.409  Sum_probs=106.3

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCChh
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLD  386 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  386 (436)
                      ..||+|+||.||++... +++.+|+|.+.... ...+.+.+|+.+++.++||||+++++.+..++..++++||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            46999999999999854 68899999986532 33456889999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          387 RHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       387 ~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++.     ...+++..+..++.|++.||+|||++   +++||||||+||
T Consensus       107 ~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Ni  148 (297)
T cd06659         107 DIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSI  148 (297)
T ss_pred             HHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHe
Confidence            8772     24589999999999999999999988   999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.73  E-value=1.1e-17  Score=163.58  Aligned_cols=125  Identities=26%  Similarity=0.308  Sum_probs=104.2

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCC------
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------  371 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  371 (436)
                      ..+|.+.+.||+|+||.||++.. .++..+|+|.+....   .....+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            35677789999999999999985 468899999986532   23456789999999999999999999886443      


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..++||||+++ +|.+.+.      ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       100 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NI  154 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI  154 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHE
Confidence            47899999965 6666652      2478899999999999999999998   999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.73  E-value=2.1e-17  Score=153.32  Aligned_cols=126  Identities=37%  Similarity=0.599  Sum_probs=109.1

Q ss_pred             hhhcccCCCCCeEEEEEEEcC-----CCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          306 HFTHKLGQGGFGSVYKGQLHT-----GGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .+.+.||+|+||.||++....     +..+|+|.++....  ..+.+.+|+..+..++|+||+++++.+...+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            356789999999999998542     37899999976443  45678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~ni  134 (258)
T smart00219       82 YMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNC  134 (258)
T ss_pred             ccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceE
Confidence            999999999984321  12289999999999999999999998   999999999997

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.73  E-value=1.9e-17  Score=156.16  Aligned_cols=127  Identities=27%  Similarity=0.457  Sum_probs=109.0

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      |++.+.||+|++|.||+|+.. ++..+|+|.++...  ...+.+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            456788999999999999964 68889999987632  234567889999999999999999999999999999999997


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      + +|.+++.... ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        82 ~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni  131 (284)
T cd07836          82 K-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNL  131 (284)
T ss_pred             c-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHE
Confidence            5 8888874332 234689999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=8.5e-19  Score=164.47  Aligned_cols=125  Identities=26%  Similarity=0.413  Sum_probs=110.5

Q ss_pred             hhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          305 NHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      |+-.+.||+|+||.||+|. ..+++.||+|++...  +...+++.+|+.++..++++||.+++|.+..+..++++|||+.
T Consensus        15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~   94 (467)
T KOG0201|consen   15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG   94 (467)
T ss_pred             cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence            3444789999999999998 458889999999874  3345789999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|++.+.+    +.+..+.+..+.-++++++.||.|||.+   +.+|||||+.||
T Consensus        95 gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaani  142 (467)
T KOG0201|consen   95 GGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANI  142 (467)
T ss_pred             Ccchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccce
Confidence            99999988    3344558888888999999999999998   999999999997

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.73  E-value=7.5e-18  Score=159.13  Aligned_cols=126  Identities=25%  Similarity=0.406  Sum_probs=109.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +|++.+.||+|+||.||++..+ +++.+|+|.+.....   ..+.+.+|+++++.++|+||+++++++..++..++++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            3556789999999999999965 688999998765322   235688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.++..    ....+++..+..++.|+++||+|||+.   +++||||+|+||
T Consensus        82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni  131 (286)
T cd07846          82 VDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENI  131 (286)
T ss_pred             CCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHE
Confidence            99999988762    234589999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.73  E-value=2.2e-17  Score=153.25  Aligned_cols=126  Identities=31%  Similarity=0.509  Sum_probs=107.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      ..+++.+.||+|+||.||++.. .++.+|+|.++... ..+.+.+|+.++++++|+|++++++.+... ..+++|||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~   82 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK   82 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence            4567788999999999999874 57789999986532 346788999999999999999999988654 47899999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        83 ~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~ni  131 (254)
T cd05083          83 GNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNI  131 (254)
T ss_pred             CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceE
Confidence            9999998532  234588999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.73  E-value=2.5e-17  Score=153.49  Aligned_cols=122  Identities=32%  Similarity=0.475  Sum_probs=100.9

Q ss_pred             cccCCCCCeEEEEEEEc----CCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEE-eCCeeeEEEecCC
Q 041073          309 HKLGQGGFGSVYKGQLH----TGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRAVVYEYMP  381 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~~  381 (436)
                      +.||+|+||.||+|...    ....+|+|.+...  ....+.+.+|+.+++.++||||+++++.+. .++..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999843    2346899987542  223457889999999999999999999765 4556789999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|+|.+++..   ....+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        81 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~ni  129 (262)
T cd05058          81 HGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNC  129 (262)
T ss_pred             CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceE
Confidence            9999999843   224467888899999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.73  E-value=1.3e-17  Score=154.68  Aligned_cols=127  Identities=27%  Similarity=0.428  Sum_probs=110.2

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      +.+.+.||+|+||.||++... ++..+|+|.+...   ....+.+.+|+.+++.++|+||+++++.+...+..++++||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            456788999999999999854 6788999998653   223456889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++...  ....+++..+..++.|+++||+|||+.   +++|+||||+||
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni  132 (257)
T cd08225          82 DGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNI  132 (257)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHE
Confidence            999999988432  234579999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.73  E-value=2.5e-17  Score=154.80  Aligned_cols=124  Identities=22%  Similarity=0.418  Sum_probs=108.5

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc--ccCHHHHHHHHHHHcCCC---cCcccceeEEEEeCCeeeEEEe
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS--KFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      |++.+.||+|+||.||+|.. .+++.+|+|.++..  .....++.+|+.+++.++   |+|++++++.+..+...+++||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            45668899999999999995 57889999998653  233456888999998886   9999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++.     ...+++..+..++.|++.||.|||+.   +|+||||+|+||
T Consensus        83 ~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni  132 (277)
T cd06917          83 YAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANI  132 (277)
T ss_pred             cCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHE
Confidence            999999999882     23689999999999999999999988   999999999996

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.73  E-value=2.7e-17  Score=152.69  Aligned_cols=127  Identities=21%  Similarity=0.324  Sum_probs=107.7

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEe-CCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~  379 (436)
                      |.+.+.||+|++|.||++... +++.+|+|.+....   ...+.+.+|++++++++|+|++++.+.+.. ....+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            567789999999999999854 57789999986532   234568899999999999999999988764 4467899999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++...  ....+++.++..++.|++.|++|||++   +++||||||+||
T Consensus        82 ~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~ni  133 (257)
T cd08223          82 CEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNV  133 (257)
T ss_pred             cCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhE
Confidence            9999999998432  234689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.73  E-value=3.8e-18  Score=167.81  Aligned_cols=129  Identities=25%  Similarity=0.475  Sum_probs=111.9

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc--CCC--EEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH--TGG--LIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~--~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      +....+-++||+|.||.|++|.+.  .|+  .||||.++....  ...+|++|+.+|.+|+|+|++++||...+ ....|
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            345566789999999999999865  333  589999987543  46789999999999999999999999987 67889


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.++.|+|.+.|+.  .....|-...+..++.|||.||.||.++   ++|||||.++||
T Consensus       188 V~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNl  243 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNL  243 (1039)
T ss_pred             HhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhh
Confidence            9999999999999965  3446788888999999999999999998   999999999996

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.73  E-value=2.3e-17  Score=156.36  Aligned_cols=126  Identities=28%  Similarity=0.430  Sum_probs=106.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .|.+.+.||+|+||.||+|.. .+++.+|+|.+....  .....+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM   85 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence            455678899999999999985 468899999986532  22345788999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      + ++|.+++..   ....+.+..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        86 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Ni  134 (291)
T cd07870          86 H-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNL  134 (291)
T ss_pred             c-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHE
Confidence            5 677777632   224578888999999999999999988   999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.72  E-value=2.7e-17  Score=154.76  Aligned_cols=121  Identities=28%  Similarity=0.388  Sum_probs=104.8

Q ss_pred             cCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          311 LGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       311 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      ||+|+||.||++... +++.+|+|.+....    ...+.+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999844 68899999986532    2234567899999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Ni  126 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENV  126 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHE
Confidence            99885332  24689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.72  E-value=1.9e-17  Score=156.67  Aligned_cols=129  Identities=29%  Similarity=0.402  Sum_probs=108.7

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEe--CCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~  379 (436)
                      +...+.||.|++|.||++... +++.+|+|.+.....  ...++.+|+++++.++|+||+++++.+..  .+..+++|||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   82 (287)
T cd06621           3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY   82 (287)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence            345678999999999999964 678899999875332  34568999999999999999999998854  3468999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++.........+++..+..++.|+++||+|||+.   +++|+||+|+||
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~ni  136 (287)
T cd06621          83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNI  136 (287)
T ss_pred             cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            999999988743333446689999999999999999999988   999999999996

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.72  E-value=2.3e-17  Score=156.62  Aligned_cols=128  Identities=23%  Similarity=0.411  Sum_probs=106.4

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCC-cCcccceeEEEEeCCe-----ee
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSK-----RA  374 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~~  374 (436)
                      |++.+.||+|+||.||++... +++.||+|.++....   ....+.+|+.+++.++ |+||+++++.+...+.     .+
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            556688999999999999854 688999998865322   2356888999999995 6999999998877655     79


Q ss_pred             EEEecCCCCChhhhccCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESR-GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|||+++ +|.+++...... ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~ni  141 (295)
T cd07837          83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNL  141 (295)
T ss_pred             EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHE
Confidence            99999975 898887543222 35689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.72  E-value=1.8e-17  Score=154.33  Aligned_cols=132  Identities=22%  Similarity=0.343  Sum_probs=108.6

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEe--CCeeeEEEe
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAVVYE  378 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E  378 (436)
                      |++.+.||.|+||.||++.. .++..+|+|.+.....   ..+++.+|+++++.++|+||+++++.+..  +...+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            45668899999999999984 4778899999865322   33568889999999999999999987753  456799999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC--DVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~--~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++.........+++..++.++.|++.||+|||..+  +.+++||||||+||
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ni  141 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANI  141 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHE
Confidence            99999999998543333567999999999999999999999321  23999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.72  E-value=2.9e-17  Score=153.58  Aligned_cols=125  Identities=27%  Similarity=0.385  Sum_probs=106.0

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc------CHHHHHHHHHHHcCCCcCcccceeEEEEe--CCeeeE
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF------SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAV  375 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  375 (436)
                      ++..+.||+|+||.||++.. .++..+++|.+.....      ..+.+.+|+.+++.++|+||+++++.+..  +...++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            45668899999999999985 4688999998864221      22458889999999999999999998865  356789


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||+++++|.+++.    +...+++.....++.|++.||+|||+.   +|+||||||+||
T Consensus        84 ~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~ni  137 (266)
T cd06651          84 FMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANI  137 (266)
T ss_pred             EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHE
Confidence            999999999999983    234588999999999999999999987   999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.72  E-value=1.9e-17  Score=156.04  Aligned_cols=129  Identities=23%  Similarity=0.394  Sum_probs=105.4

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHH-HcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVST-IGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      +++.+.||+|+||.||++... +++.||+|.++....  ...++..|+.. ++..+|+||+++++.+...+..+++|||+
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~   82 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM   82 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence            456788999999999999854 688999999876432  23345566664 56678999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      + |+|.+++.........+++..+..++.|++.||+|||++  .+++||||||+||
T Consensus        83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~ni  135 (283)
T cd06617          83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNV  135 (283)
T ss_pred             c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHE
Confidence            6 688887754333345789999999999999999999974  3799999999996

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.72  E-value=3.1e-17  Score=155.60  Aligned_cols=126  Identities=25%  Similarity=0.380  Sum_probs=107.3

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeC--CeeeEEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAVVY  377 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  377 (436)
                      .|.+.+.||+|+||.||+|... +++.+++|.++....   ....+.+|+.++++++||||+++++++...  ...+++|
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            5667789999999999999965 678899999875322   223567899999999999999999998877  8899999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||++ ++|.+++...   ...+++..+..++.|+++||+|||++   +++||||||+||
T Consensus        86 e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~ni  137 (293)
T cd07843          86 EYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNL  137 (293)
T ss_pred             hhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHE
Confidence            9996 5998887432   23689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.72  E-value=3.5e-17  Score=153.68  Aligned_cols=125  Identities=26%  Similarity=0.366  Sum_probs=110.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      +|.+.+.||.|++|.||++... +++.+|+|.+....  .....+.+|+++++.++|+||+++.+.+..+...++++||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            4567788999999999999854 67889999986532  23456889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++..     ..+++..+..++.|++.||.|||++   +++||||+|+||
T Consensus        82 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni  129 (274)
T cd06609          82 GGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANI  129 (274)
T ss_pred             CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHE
Confidence            99999999832     3789999999999999999999987   999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.72  E-value=5.1e-17  Score=153.58  Aligned_cols=127  Identities=32%  Similarity=0.422  Sum_probs=112.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      .+.+.+.||+|++|.||++... ++..+++|++.......+.+.+|++.++.++|+|++++++.+...+..++++||+++
T Consensus        20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   99 (286)
T cd06614          20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG   99 (286)
T ss_pred             cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence            3556678999999999999865 688899999976544556789999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||
T Consensus       100 ~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni  147 (286)
T cd06614         100 GSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNI  147 (286)
T ss_pred             CcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhE
Confidence            9999999432   13799999999999999999999987   999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.72  E-value=1.3e-17  Score=147.43  Aligned_cols=120  Identities=17%  Similarity=0.206  Sum_probs=91.7

Q ss_pred             hcccCCCCCeEEEEEEEcCCCEEEEEEecCccc---C-------H-----------------HHHHHHHHHHcCCCcCcc
Q 041073          308 THKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF---S-------A-----------------EEFINEVSTIGRIHHVNV  360 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---~-------~-----------------~~~~~E~~~l~~l~h~ni  360 (436)
                      ...||+|+||.||+|...+|+.||+|+++....   .       .                 ....+|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            357999999999999977899999999975321   1       0                 112348999999988776


Q ss_pred             cceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCceEecCCCCCCC
Q 041073          361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL-HNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       361 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yL-H~~~~~~iiHrDlkp~NI  436 (436)
                      ........  ...+|||||++++++...+.    ....+++..+..++.|++.+|+|+ |+.   +|+||||||+||
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NI  149 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNL  149 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHE
Confidence            54433222  22389999999877755431    234688999999999999999999 676   999999999997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.72  E-value=3.2e-17  Score=152.79  Aligned_cols=119  Identities=25%  Similarity=0.299  Sum_probs=105.3

Q ss_pred             cCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          311 LGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       311 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      ||.|++|.||++... +++.+|+|.+....    ...+.+.+|+.+++.++|+||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999964 58899999987532    2335688999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++.    +...+++..+..++.|+++||+|||++   +++|+||||+||
T Consensus        81 ~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~ni  124 (262)
T cd05572          81 WTILR----DRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENL  124 (262)
T ss_pred             HHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHE
Confidence            99983    234589999999999999999999987   999999999997

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.72  E-value=1.1e-17  Score=157.80  Aligned_cols=125  Identities=22%  Similarity=0.412  Sum_probs=107.1

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |.+.+.||+|+||.||++... +|+.+|+|.++....   ....+.+|++++++++|+||+++++.+.+....++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            456688999999999999854 788999999865321   2345788999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      + ++|.+++..   ....+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        82 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~ni  130 (284)
T cd07839          82 D-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNL  130 (284)
T ss_pred             C-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHE
Confidence            6 588887732   235689999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.8e-18  Score=167.15  Aligned_cols=122  Identities=25%  Similarity=0.428  Sum_probs=105.9

Q ss_pred             hcccCCCCCeEEEEEE-EcCCCEEEEEEecCcc-c---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          308 THKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK-F---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~-~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      .+.||.|+||.||.++ .++...||||.+.-+. .   ..++++.|+..|.+++|||++.+-|++......||||||| -
T Consensus        31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l  109 (948)
T KOG0577|consen   31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L  109 (948)
T ss_pred             HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence            4679999999999998 4577889999986532 2   2457999999999999999999999999999999999999 5


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+-.+.+.   -..+++.+.++..|..+.+.||+|||+.   +.||||||+.||
T Consensus       110 GSAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNI  157 (948)
T KOG0577|consen  110 GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNI  157 (948)
T ss_pred             ccHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccce
Confidence            67777773   2346788999999999999999999998   899999999998

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.72  E-value=3e-17  Score=155.50  Aligned_cols=125  Identities=25%  Similarity=0.319  Sum_probs=107.7

Q ss_pred             hhhhcccCCCCCeEEEEEEE----cCCCEEEEEEecCcc-----cCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeee
Q 041073          305 NHFTHKLGQGGFGSVYKGQL----HTGGLIAVKMLKNSK-----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  374 (436)
                      +++.+.||+|+||.||++..    .++..+|+|+++...     ...+.+.+|++++.++ +|+||+++++.+..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            45668899999999999985    367889999987522     2235678899999999 5999999999999888999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++++|.+++..    ...+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        82 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~ni  136 (290)
T cd05613          82 LILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENI  136 (290)
T ss_pred             EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHe
Confidence            99999999999999842    34688999999999999999999987   999999999997

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.72  E-value=2.4e-17  Score=157.23  Aligned_cols=126  Identities=28%  Similarity=0.490  Sum_probs=104.0

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCC----EEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      .++..+.||+|+||.||++... ++.    .+|+|.+.....  ....+.+|+.+++.++|+||+++++.+... ...++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v   86 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV   86 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence            3455678999999999999853 443    478888765332  224688999999999999999999988654 46799


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||+++|+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        87 ~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Ni  140 (303)
T cd05110          87 TQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNV  140 (303)
T ss_pred             ehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---Ceecccccccee
Confidence            999999999999843   234688999999999999999999988   999999999997

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.72  E-value=4.3e-17  Score=156.42  Aligned_cols=123  Identities=24%  Similarity=0.393  Sum_probs=100.5

Q ss_pred             cccCCCCCeEEEEEEEc---CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEe--CCeeeEEEecCCCC
Q 041073          309 HKLGQGGFGSVYKGQLH---TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAVVYEYMPNG  383 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~~g  383 (436)
                      .+||+|+||.||+|...   ++..+|+|.+..... ...+.+|++++++++||||+++++++..  +...++++||++ +
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence            57999999999999854   456899998875432 3457889999999999999999998853  557799999986 4


Q ss_pred             ChhhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKE-----SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.+++....     .....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Ni  139 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANI  139 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHE
Confidence            7777763211     1234588999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.72  E-value=2.8e-18  Score=154.30  Aligned_cols=129  Identities=25%  Similarity=0.384  Sum_probs=105.9

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-c--C--CCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEe-CCeee
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-H--T--GGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRA  374 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~--~--~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  374 (436)
                      .|+....||+|.||.||++.. +  +  ...+|+|.++..+.   -.....+|+.+++.++|+|++++..++.. +...+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            355667899999999999952 2  2  23689999876421   23457899999999999999999988877 77899


Q ss_pred             EEEecCCCCChhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKE-SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++||.+. +|.+.|+-.+ .+...++...+..|+.||+.|+.|||++   -|+||||||.||
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNI  163 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANI  163 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceE
Confidence            99999977 8888775432 3345788999999999999999999998   899999999998

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.72  E-value=2.2e-17  Score=153.69  Aligned_cols=119  Identities=25%  Similarity=0.432  Sum_probs=105.5

Q ss_pred             cCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          311 LGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       311 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      ||+|+||.||+++.. +++.+++|.+.....    ..+.+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999965 588999999876432    345688999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++..    ...+++..+..++.|+++||+|||+.   +++||||+|+||
T Consensus        81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~ni  124 (265)
T cd05579          81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNI  124 (265)
T ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHe
Confidence            999842    24689999999999999999999987   999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.72  E-value=3.4e-17  Score=152.94  Aligned_cols=126  Identities=28%  Similarity=0.411  Sum_probs=106.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc------ccCHHHHHHHHHHHcCCCcCcccceeEEEEeC--Ceee
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS------KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRA  374 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  374 (436)
                      .+.+.+.||+|+||.||++.. .+++.+|+|.+...      ......+.+|++++++++|+||+++++++...  ...+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            355678999999999999985 46889999987532      11234688999999999999999999988653  4678


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++||+++++|.+++.    +...+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        83 ~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni  137 (264)
T cd06653          83 IFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANI  137 (264)
T ss_pred             EEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHE
Confidence            9999999999999883    234588999999999999999999988   999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.72  E-value=2.8e-17  Score=155.47  Aligned_cols=126  Identities=27%  Similarity=0.504  Sum_probs=101.2

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCC---CcCcccceeEEEEe-----CCe
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRI---HHVNVVQLLGFCSE-----GSK  372 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~~  372 (436)
                      |.+.+.||+|+||.||++... +++.+|+|.++...   .....+.+|+.+++.+   +|+||+++++++..     ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            456788999999999999854 78899999987532   1223466777776655   69999999998754     345


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++|||++ ++|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Ni  139 (288)
T cd07863          82 VTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENI  139 (288)
T ss_pred             EEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            789999997 5888887432  234589999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.72  E-value=4.9e-17  Score=150.47  Aligned_cols=125  Identities=29%  Similarity=0.498  Sum_probs=110.7

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |.+.+.||+|++|.||++... +++.+++|.+.....   ..+.+.+|++++++++|+|++++++++...+..+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            456788999999999999854 678899999876442   3467899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++.    +...+++..+..++.|++.||.|||+.   +|+||||||+||
T Consensus        82 ~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni  130 (254)
T cd06627          82 ENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANI  130 (254)
T ss_pred             CCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHE
Confidence            9999999983    235789999999999999999999988   999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.72  E-value=3.9e-17  Score=152.84  Aligned_cols=130  Identities=26%  Similarity=0.447  Sum_probs=106.9

Q ss_pred             hhhhcccCCCCCeEEEEEEEcC--CCEEEEEEecCcc-----------cCHHHHHHHHHHHcC-CCcCcccceeEEEEeC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLHT--GGLIAVKMLKNSK-----------FSAEEFINEVSTIGR-IHHVNVVQLLGFCSEG  370 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~  370 (436)
                      |++.+.||+|+||.||++....  ++.+|+|.+....           ....++.+|+.++.+ ++|+||+++++.+...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            4567889999999999999653  6789999875321           122457788887765 7899999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..+++|||+++++|.+++.........+++..++.++.|++.||.|||+.  .+++||||||+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~ni  145 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNI  145 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHE
Confidence            999999999999999988744333445689999999999999999999963  2799999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.72  E-value=3.8e-17  Score=152.20  Aligned_cols=125  Identities=30%  Similarity=0.396  Sum_probs=111.3

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      +.+.+.||+|++|.||++... +++.+++|.+.....  ..+.+.+|+..+.+++|+|++++++.+...+..++++||++
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD   82 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence            456688999999999999865 588999999876432  35679999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~iiHrDlkp~NI  436 (436)
                      +++|.+++..    ...+++..+..++.|+++||+|||+ .   +++||||+|+||
T Consensus        83 ~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni  131 (264)
T cd06623          83 GGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNL  131 (264)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHE
Confidence            9999999832    2568999999999999999999998 7   999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.72  E-value=3.8e-17  Score=154.05  Aligned_cols=129  Identities=26%  Similarity=0.419  Sum_probs=109.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEe------CCeee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE------GSKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~  374 (436)
                      ..+.+.+.||+|+||.||++.. .+++.+|+|.+........++..|+.++.++ +|+||+++++++..      ....+
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            4566778999999999999985 4678899999876554556788899999988 69999999998853      45689


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|||+++|+|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        96 iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~ni  152 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNV  152 (282)
T ss_pred             EEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            999999999999988432  234588888999999999999999988   999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.71  E-value=5.4e-17  Score=152.19  Aligned_cols=128  Identities=30%  Similarity=0.502  Sum_probs=104.2

Q ss_pred             hhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCC------e
Q 041073          306 HFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  372 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  372 (436)
                      .+.+.||+|+||.||+|...    ++..+|+|.+.....   ..+++.+|++++++++||||+++++.+....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            45678999999999999743    467899999876432   2456889999999999999999999875432      2


Q ss_pred             eeEEEecCCCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKE--SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++++||+++|+|.+++....  .+...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~ni  144 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNC  144 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhE
Confidence            478899999999988874321  1223578999999999999999999987   999999999996

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.71  E-value=3.6e-17  Score=152.57  Aligned_cols=126  Identities=27%  Similarity=0.425  Sum_probs=110.2

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      +.+.+.||+|++|.||++..+ +++.+|+|.+....  ...+++.+|++.+++++|+||+++++.+...+..++++||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            456688999999999999865 68889999987642  234568899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~iiHrDlkp~NI  436 (436)
                      +++|.+++...   ...+++..+.+++.|+++||+|||+ .   +++||||||+||
T Consensus        83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni  132 (265)
T cd06605          83 GGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNI  132 (265)
T ss_pred             CCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHE
Confidence            99999998432   2578999999999999999999998 6   999999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.71  E-value=5.3e-17  Score=155.57  Aligned_cols=128  Identities=26%  Similarity=0.403  Sum_probs=106.4

Q ss_pred             hhhhcccCCCCCeEEEEEEEc---CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeC--CeeeE
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH---TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAV  375 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  375 (436)
                      |++.+.||+|++|.||+|...   +++.+|+|.+....    ...+.+.+|+.+++.++||||+++++.+...  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            456788999999999999954   47899999987632    2235678899999999999999999999887  78999


Q ss_pred             EEecCCCCChhhhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKES-RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++ +|.+++..... ....+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Ni  139 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANI  139 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHE
Confidence            9999965 67666533222 223789999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.71  E-value=4.5e-17  Score=153.52  Aligned_cols=120  Identities=27%  Similarity=0.373  Sum_probs=98.6

Q ss_pred             ccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC----HHHHHHHHHH---HcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          310 KLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS----AEEFINEVST---IGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       310 ~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .||+|+||.||++.. .+++.+|+|.+......    ...+.+|..+   +...+|+||+++++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999985 46889999998653221    1223444433   334479999999999998899999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Ni  128 (279)
T cd05633          81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANI  128 (279)
T ss_pred             CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHE
Confidence            999999883    235699999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.71  E-value=6.9e-17  Score=150.72  Aligned_cols=129  Identities=26%  Similarity=0.333  Sum_probs=111.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .|++.+.||.|+||.||++.. .++..+++|++....  ...+.+.+|++.++.++|+||+++++.+..++..++++|++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   81 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL   81 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence            356678899999999999985 467789999986533  24467899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++.... ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni  133 (267)
T cd06610          82 SGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNI  133 (267)
T ss_pred             CCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhE
Confidence            9999999984322 124689999999999999999999988   999999999996

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.71  E-value=4.1e-18  Score=150.60  Aligned_cols=125  Identities=26%  Similarity=0.359  Sum_probs=107.2

Q ss_pred             hhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcc-----cCH----HHHHHHHHHHcCC-CcCcccceeEEEEeCCee
Q 041073          305 NHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK-----FSA----EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~-----~~~----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  373 (436)
                      |.-++.||+|..+.|-++. ..+++..|+|++....     .+.    +.-.+|+.+|+++ .||+|+++.+.++.+...
T Consensus        19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~   98 (411)
T KOG0599|consen   19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV   98 (411)
T ss_pred             cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence            3445779999999998887 4578899999986421     122    3456799999988 599999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.|+.|.|.+++    ...-.+++...++|+.|+.+|++|||.+   .|+||||||+||
T Consensus        99 FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENI  154 (411)
T KOG0599|consen   99 FLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENI  154 (411)
T ss_pred             hhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhhe
Confidence            9999999999999999    3446799999999999999999999998   999999999998

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.71  E-value=6.7e-17  Score=153.39  Aligned_cols=121  Identities=29%  Similarity=0.416  Sum_probs=106.5

Q ss_pred             hcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc-CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          308 THKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      ...||+|+||.||++.. .+++.+|+|.+..... ....+.+|+.+++.++|+|++++++.+..++..+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            36799999999999985 4788999998865332 345688999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++.     ...+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus       105 ~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Ni  147 (292)
T cd06657         105 TDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSI  147 (292)
T ss_pred             HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            99872     23588999999999999999999988   999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.71  E-value=7.8e-17  Score=149.28  Aligned_cols=129  Identities=30%  Similarity=0.511  Sum_probs=112.5

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |.+.+.||+|++|.||++... ++..+++|.+....   .....+.+|+++++.++|+|++++.+.+...+..++++||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            456688999999999999954 68899999987643   23456889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++.........+++..+..++.++++||.|||+.   +++|+||+|+||
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~ni  134 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNI  134 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHe
Confidence            99999999854332346799999999999999999999998   999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.71  E-value=2.3e-17  Score=161.10  Aligned_cols=124  Identities=24%  Similarity=0.298  Sum_probs=103.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeC------Ce
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  372 (436)
                      .+|++.+.||+|+||.||++.. ..++.+|+|.+.....   ....+.+|+.+++.++|+||+++++.+...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            4667788999999999999985 4678899999875322   235678899999999999999999987543      34


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++|||+++ +|.+.+.      ..+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        97 ~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Ni  150 (355)
T cd07874          97 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI  150 (355)
T ss_pred             eEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHE
Confidence            6899999965 6777662      2478899999999999999999998   999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.71  E-value=3.4e-17  Score=154.51  Aligned_cols=126  Identities=25%  Similarity=0.444  Sum_probs=108.0

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |+..+.||+|++|.||++... +++.+|+|.++....   ....+.+|++++++++|+||+++++++...+..+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            445678999999999999854 688999998865322   2356889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      + ++|.+++...  ....+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        82 ~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~ni  131 (284)
T cd07860          82 H-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNL  131 (284)
T ss_pred             c-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            5 6898887432  235689999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PTZ00284 protein kinase; Provisional

Probab=99.71  E-value=2.9e-17  Score=166.20  Aligned_cols=127  Identities=20%  Similarity=0.359  Sum_probs=100.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCc------CcccceeEEEEeC-Ceee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH------VNVVQLLGFCSEG-SKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~~~~  374 (436)
                      .+|.+.+.||+|+||+||++.. .+++.||||+++......+....|+.++..++|      .+++++++++... ...+
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            4567778999999999999985 467889999997543333455667777666644      4588888887654 5688


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|||++ +++|.+++.    +...+++..+..++.|++.||+|||++  .+||||||||+||
T Consensus       209 iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NI  263 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENI  263 (467)
T ss_pred             EEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHE
Confidence            999988 778988883    235689999999999999999999963  2899999999997

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.71  E-value=3.6e-17  Score=154.55  Aligned_cols=126  Identities=25%  Similarity=0.379  Sum_probs=108.6

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +|++.+.||+|++|.||++... +++.||+|.++...   ...+.+.+|+++++.++|+||+++++.+..++..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            3567788999999999999865 67889999987532   2346789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++.+..+..    +...+++..+..++.|++.||+|||++   +++||||+|+||
T Consensus        82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni  131 (288)
T cd07833          82 VERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENI  131 (288)
T ss_pred             CCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHe
Confidence            99877766552    234589999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.71  E-value=1.7e-17  Score=154.49  Aligned_cols=129  Identities=24%  Similarity=0.362  Sum_probs=106.7

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecC------cccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKN------SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      |.+.+.||+|+||.||++... .+..+++|+++.      ......++..|+.++++++||||+++++.+.+....++++
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            567789999999999999854 344455666543      1122345778999999999999999999999888999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++.........+++..+..++.|+++||+|||+.   +++|+||||+||
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~ni  137 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNI  137 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhhe
Confidence            99999999988854333446799999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.71  E-value=1e-16  Score=151.51  Aligned_cols=121  Identities=28%  Similarity=0.405  Sum_probs=106.9

Q ss_pred             hcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          308 THKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      .+.||+|++|.||++.. .+++.+++|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..++++||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            46899999999999985 477889999886533 2345688999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++..     ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Ni  146 (285)
T cd06648         104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSI  146 (285)
T ss_pred             HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhE
Confidence            999832     4589999999999999999999998   999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.71  E-value=8.2e-17  Score=152.81  Aligned_cols=127  Identities=27%  Similarity=0.416  Sum_probs=107.0

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +|++.+.||+|++|.||+|... +++.+|+|.+....   ...+.+.+|+++++.++|+||+++++++......++||||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            3556788999999999999854 78899999986532   2235688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++ ++|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        83 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~ni  133 (294)
T PLN00009         83 LD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNL  133 (294)
T ss_pred             cc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceE
Confidence            95 5888877322  223467888899999999999999988   999999999997

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.71  E-value=7e-17  Score=153.79  Aligned_cols=130  Identities=26%  Similarity=0.373  Sum_probs=108.2

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCC----
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----  371 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  371 (436)
                      .....+++.+.||+|+||.||+|..+ +++.+|+|.++...   .....+.+|+++++.++||||+++++.+.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34456777899999999999999965 67889999986532   23356788999999999999999999887654    


Q ss_pred             ------eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 ------KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                            ..++++||+++ ++.+.+..   ....+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~ni  147 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNI  147 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence                  78999999976 77777632   234689999999999999999999998   999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.71  E-value=6.7e-17  Score=154.46  Aligned_cols=127  Identities=25%  Similarity=0.366  Sum_probs=107.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-c---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-F---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|...+.||+|+||.||++... +++.||+|.+.... .   ..+++.+|+++++.++||||+++.+++...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            34667788999999999999854 68899999886422 1   2246889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||++ |++.+++..   ....+++..+..++.|++.||.|||+.   +|+||||+|+||
T Consensus        95 e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nI  146 (307)
T cd06607          95 EYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNI  146 (307)
T ss_pred             HhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccE
Confidence            9996 577776632   234689999999999999999999987   999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.71  E-value=8.8e-17  Score=154.42  Aligned_cols=127  Identities=27%  Similarity=0.397  Sum_probs=107.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..+...+.||+|+||.||++.. .++..+|+|.+.....    ....+.+|+++++.++|+|++++++++..+...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            3455668899999999999985 4678899999865321    2346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||++ |+|.+.+..   ....+++.++..++.|++.||.|||++   +|+||||||+||
T Consensus       105 e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Ni  156 (317)
T cd06635         105 EYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNI  156 (317)
T ss_pred             eCCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccE
Confidence            9996 577777632   235689999999999999999999988   999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.71  E-value=3e-17  Score=152.16  Aligned_cols=129  Identities=28%  Similarity=0.467  Sum_probs=111.2

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      |++.+.||+|++|.||++.. .+++.+++|.+....   ....++.+|+++++.++|+||+++.+.+......++++||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            45678899999999999974 477889999987532   23456788999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++.........+++..+..++.|++.||+|||+.   +++||||+|+||
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni  134 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANI  134 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceE
Confidence            99999999854333346789999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.70  E-value=4.6e-17  Score=159.52  Aligned_cols=124  Identities=24%  Similarity=0.296  Sum_probs=103.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeC------Ce
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  372 (436)
                      .+|.+.+.||+|+||.||++.. ..++.+|||++....   .....+.+|+.+++.++|+||+++++.+...      ..
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            5677789999999999999985 467889999987532   2345688999999999999999999877543      35


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+++ +|.+++.      ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       104 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NI  157 (364)
T cd07875         104 VYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI  157 (364)
T ss_pred             EEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHE
Confidence            7999999965 7777762      2478899999999999999999998   999999999997

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.70  E-value=7.7e-17  Score=149.29  Aligned_cols=125  Identities=30%  Similarity=0.401  Sum_probs=110.2

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeC--CeeeEEEe
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAVVYE  378 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E  378 (436)
                      ++..+.||+|++|.||+|... +++.+++|++....   ...+.+.+|+..+++++|+||+++++.....  ...++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            345678999999999999965 78899999987644   2356789999999999999999999999888  88999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||
T Consensus        82 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni  132 (260)
T cd06606          82 YVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANI  132 (260)
T ss_pred             ecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHE
Confidence            9999999999842    23789999999999999999999997   999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.70  E-value=8.8e-17  Score=151.41  Aligned_cols=125  Identities=26%  Similarity=0.412  Sum_probs=104.1

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc--CHHHHHHHHHHHcCCC-cCcccceeEEEEeC--CeeeEEEe
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF--SAEEFINEVSTIGRIH-HVNVVQLLGFCSEG--SKRAVVYE  378 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E  378 (436)
                      |++.+.||+|+||.||++.. .+++.+|+|.++....  ......+|+..+.++. |+|++++++.+.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            34668899999999999985 4688899999875322  2234557888888885 99999999999887  88999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |++ ++|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni  131 (282)
T cd07831          81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENI  131 (282)
T ss_pred             cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHE
Confidence            996 588887732   224689999999999999999999998   999999999996

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.70  E-value=3e-17  Score=154.29  Aligned_cols=125  Identities=27%  Similarity=0.360  Sum_probs=109.8

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEe
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      |.+.+.||+|++|.||++... +++.+|+|++..+.    ...+.+.+|+.++.+++ |+||+++++.+...+..+++||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE   82 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence            556788999999999999854 78899999987532    22356888999999998 9999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++++|.+++.    +...+++..+..++.|++.||+|||+.   +++|+||||+||
T Consensus        83 ~~~~~~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni  133 (280)
T cd05581          83 YAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENI  133 (280)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHe
Confidence            999999999983    334799999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.70  E-value=7.1e-17  Score=156.30  Aligned_cols=122  Identities=26%  Similarity=0.398  Sum_probs=104.8

Q ss_pred             hhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCH---------------HHHHHHHHHHcCCCcCcccceeEEEEeC
Q 041073          307 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSA---------------EEFINEVSTIGRIHHVNVVQLLGFCSEG  370 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~E~~~l~~l~h~niv~l~~~~~~~  370 (436)
                      +.+.||+|+||.||++... +++.||+|.++......               ..+.+|+++++.++|+||+++++++...
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            4467999999999999854 78899999986532211               1477899999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..+++|||++ |+|.+++.    ....+++.....++.|++.||+|||+.   +|+||||||+||
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~ni  150 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANI  150 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHe
Confidence            99999999996 69999883    335689999999999999999999987   999999999996

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.70  E-value=1.6e-16  Score=149.72  Aligned_cols=120  Identities=28%  Similarity=0.378  Sum_probs=98.8

Q ss_pred             ccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC----HHHHHHHH---HHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          310 KLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS----AEEFINEV---STIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       310 ~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .||+|+||.||++.. .+++.||+|.+......    ...+.+|.   ..++...|++|+++.+.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            479999999999985 46889999998653211    11233343   34455679999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|.+++.    +...+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~ni  128 (278)
T cd05606          81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANI  128 (278)
T ss_pred             CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHE
Confidence            999999883    335699999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.70  E-value=1e-16  Score=153.56  Aligned_cols=123  Identities=18%  Similarity=0.175  Sum_probs=102.3

Q ss_pred             hcccCCCCCeEEEEEEEcCCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCC
Q 041073          308 THKLGQGGFGSVYKGQLHTGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGS  384 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  384 (436)
                      .+.+|.|+++.|+++.. +++.+|+|++...   ....+.+.+|+++++.++|+||+++++.+...+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455555655555544 6889999998754   2234578999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          385 LDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        86 l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Ni  132 (314)
T cd08216          86 CEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHI  132 (314)
T ss_pred             HHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceE
Confidence            99998432  234588999999999999999999998   999999999997

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.69  E-value=7.1e-17  Score=156.82  Aligned_cols=125  Identities=23%  Similarity=0.377  Sum_probs=105.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCC------e
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  372 (436)
                      .+|++.+.||+|+||.||++.. .++..||+|.+.....   ....+.+|+.++++++|+||+++++.+....      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            4566778999999999999984 4788999999865322   2346889999999999999999999886543      3


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+ +++|.+++.     ...+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        95 ~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Ni  149 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNL  149 (343)
T ss_pred             EEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            58999999 779988872     24689999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.69  E-value=1.1e-16  Score=152.86  Aligned_cols=126  Identities=26%  Similarity=0.414  Sum_probs=104.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCC--------
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--------  371 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  371 (436)
                      +|++.+.||+|+||.||++... +++.+|+|.+....   .....+.+|+.++++++||||+++++++...+        
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            5677789999999999999854 68899999886422   12335678999999999999999999886543        


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..+++|||++ ++|.+++..   ....+++..+..++.|+++||+|||++   +++||||||+||
T Consensus        93 ~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~ni  150 (310)
T cd07865          93 SFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANI  150 (310)
T ss_pred             eEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence            3599999996 588887732   234689999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=6e-18  Score=164.65  Aligned_cols=127  Identities=26%  Similarity=0.422  Sum_probs=110.1

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecC-cccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .+.+...||.|+||.||++..+ ++-..|.|++.. +....++++-|+++|....||+||++++.+...+.++|+.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            3455677899999999999865 344456788865 44556789999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||-++..+..   -+..|++.++..++.|++.||.|||++   +|||||||+.||
T Consensus       113 GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNi  161 (1187)
T KOG0579|consen  113 GGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNI  161 (1187)
T ss_pred             CchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccce
Confidence            9999888743   346799999999999999999999998   999999999997

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.69  E-value=1.5e-16  Score=148.13  Aligned_cols=121  Identities=26%  Similarity=0.329  Sum_probs=100.5

Q ss_pred             cccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC----HHHHHHHHHH-HcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS----AEEFINEVST-IGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||++.. .+++.+|+|.++.....    ...+..|... ....+|+|++++++.+..++..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5689999999999985 46789999998753221    1234445444 4455899999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++.    ....+++..+..++.|+++||.|||+.   +++||||+|+||
T Consensus        82 ~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~ni  128 (260)
T cd05611          82 GDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENL  128 (260)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHe
Confidence            99999983    334689999999999999999999987   999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.69  E-value=2.5e-16  Score=145.25  Aligned_cols=126  Identities=33%  Similarity=0.529  Sum_probs=111.3

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc-CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      |...+.||+|++|.||++... ++..+++|+++.... ..+.+.+|+..++.++|+|++++++.+......++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            345678999999999999965 678899999977543 456799999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++...   ...+++..+..++.|+++||+|||+.   +++||||+|+||
T Consensus        82 ~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni  129 (253)
T cd05122          82 GSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANI  129 (253)
T ss_pred             CcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHE
Confidence            9999998432   25789999999999999999999987   999999999997

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=1.5e-17  Score=171.69  Aligned_cols=129  Identities=23%  Similarity=0.236  Sum_probs=113.6

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      .+..+.+.+.||+|+||.|..++. .+++.+|+|++++.    ..+..-|..|-++|..-+.+.|++++-.+.+..++|+
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            456677889999999999999985 47889999999872    3344568889999998889999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||||+||+|-..+    .+...+++..++.++..|+-||.-||+-   |+|||||||+||
T Consensus       153 VMdY~pGGDlltLl----Sk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNv  206 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLL----SKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNV  206 (1317)
T ss_pred             EEecccCchHHHHH----hhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCccee
Confidence            99999999999998    3334799999999999999999999987   999999999997

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.69  E-value=1.2e-16  Score=152.90  Aligned_cols=127  Identities=24%  Similarity=0.384  Sum_probs=105.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeC--CeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  376 (436)
                      ..|++.+.||+|+||.||++... +++.||+|.++....   ....+.+|+.++++++|+||+++++++...  +..++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            34566788999999999999854 688999999865322   123467899999999999999999998654  568999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||++ ++|.+++..   ....+++.++..++.|+++||+|||+.   +++||||||+||
T Consensus        87 ~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~ni  139 (309)
T cd07845          87 MEYCE-QDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNL  139 (309)
T ss_pred             EecCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            99996 488888742   225689999999999999999999998   999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.69  E-value=1e-16  Score=151.66  Aligned_cols=125  Identities=24%  Similarity=0.336  Sum_probs=107.0

Q ss_pred             hhhhcccCCCCCeEEEEEEE----cCCCEEEEEEecCcc-----cCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeee
Q 041073          305 NHFTHKLGQGGFGSVYKGQL----HTGGLIAVKMLKNSK-----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  374 (436)
                      +++.+.||+|++|.||++..    .++..+|+|.++...     ...+.+.+|++++.++ +|+||+++++.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            45668899999999999873    256789999987522     1234688999999999 5999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++|+|.+++.    ....+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        82 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~ni  136 (288)
T cd05583          82 LILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENI  136 (288)
T ss_pred             EEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHe
Confidence            9999999999999883    234688999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.69  E-value=1.6e-16  Score=140.78  Aligned_cols=120  Identities=18%  Similarity=0.192  Sum_probs=92.8

Q ss_pred             hcccCCCCCeEEEEEEEcCCCEEEEEEecCcccC---------------------------HHHHHHHHHHHcCCCcCcc
Q 041073          308 THKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS---------------------------AEEFINEVSTIGRIHHVNV  360 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~ni  360 (436)
                      ...||+|++|.||+|...+|+.||||+++.....                           ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3679999999999999778999999998763210                           1123578899999999987


Q ss_pred             cceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEecCCCCCCC
Q 041073          361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNI  436 (436)
Q Consensus       361 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~iiHrDlkp~NI  436 (436)
                      ..........  .+|||||++++++.....    ....++......++.|++.+|.+||+ .   +|+||||||+||
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NI  149 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNI  149 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhE
Confidence            6554443332  489999998875543321    22457788999999999999999998 7   999999999997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=4e-17  Score=153.11  Aligned_cols=138  Identities=25%  Similarity=0.362  Sum_probs=113.6

Q ss_pred             ccChHHHHHHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcccC--------HHHHHHHHHHHcCCCcCccccee
Q 041073          294 RYSYPEIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS--------AEEFINEVSTIGRIHHVNVVQLL  364 (436)
Q Consensus       294 ~~~~~~i~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~  364 (436)
                      .|........+|-+..+||+|+|+.||++. +...+.||+|+-...+..        .....+|.++.+.+.||.||+++
T Consensus       454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY  533 (775)
T KOG1151|consen  454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY  533 (775)
T ss_pred             hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence            344444556777788999999999999998 445677899975432211        13477899999999999999999


Q ss_pred             EEEEe-CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          365 GFCSE-GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       365 ~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++.- .+..+-|+||++|.+|+-||.    ....+++.+++.|+.||+.||.||.+. +++|||-||||.||
T Consensus       534 DyfslDtdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNI  601 (775)
T KOG1151|consen  534 DYFSLDTDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNI  601 (775)
T ss_pred             eeeeeccccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccE
Confidence            99864 566789999999999999993    446799999999999999999999986 78999999999997

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.69  E-value=1.4e-16  Score=150.33  Aligned_cols=125  Identities=26%  Similarity=0.438  Sum_probs=107.5

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      ++.+.||.|++|.||++... ++..+|+|++....   ...+.+.+|++.++.++|+|++++++.+..++..+++|||++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~   81 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD   81 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence            45678999999999999854 78899999987532   223568899999999999999999999999999999999995


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       ++|.+++...  ....+++..+..++.|+++||+|||++   +++||||+|+||
T Consensus        82 -~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~ni  130 (283)
T cd07835          82 -LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNL  130 (283)
T ss_pred             -cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHE
Confidence             6899988432  224689999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.69  E-value=1.5e-16  Score=150.04  Aligned_cols=124  Identities=28%  Similarity=0.444  Sum_probs=107.0

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeC--CeeeEEEec
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAVVYEY  379 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E~  379 (436)
                      ++.+.||+|++|.||++... +++.+|+|.+....   ...+.+.+|+++++.++|+|++++++.+...  +..++|+||
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   81 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY   81 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence            45678999999999999865 57889999997642   2345688999999999999999999999887  789999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++ +|.+++...   ...+++..+..++.|+++||+|||+.   +++|+||||+||
T Consensus        82 ~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~ni  131 (287)
T cd07840          82 MDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNI  131 (287)
T ss_pred             ccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHe
Confidence            974 898888432   25789999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PRK10345 hypothetical protein; Provisional

Probab=99.68  E-value=1.9e-16  Score=141.37  Aligned_cols=116  Identities=16%  Similarity=0.261  Sum_probs=90.5

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCc-ccCHHHHHHHHHHHcCC-----CcCcccceeEEEEeCC---e-eeEEEe
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRI-----HHVNVVQLLGFCSEGS---K-RAVVYE  378 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lv~E  378 (436)
                      +.||+|+|+.||. ...++. .+||++... ....+.+.+|+.+++.+     .||||++++|++.++.   . ..+|+|
T Consensus         8 ~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            6799999999996 323333 478988653 23456799999999999     5799999999998863   3 347899


Q ss_pred             c--CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCceEecCCCCCCC
Q 041073          379 Y--MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGI-EYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL-~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |  +++|+|.+++..     ..+++.  ..++.|++.++ +|||++   +|+||||||+||
T Consensus        86 ~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NI  136 (210)
T PRK10345         86 FDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNI  136 (210)
T ss_pred             CCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHE
Confidence            9  557999999922     235555  35677888777 999998   999999999997

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.68  E-value=9e-17  Score=155.64  Aligned_cols=125  Identities=24%  Similarity=0.404  Sum_probs=104.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeC-----Ceee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  374 (436)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|.+...  ......+.+|+.++++++|+||+++++.+...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            3566778999999999999984 47889999998642  22345688899999999999999999877543     3578


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++||++ ++|.+.+     ....+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        85 lv~e~~~-~~l~~~~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Ni  137 (336)
T cd07849          85 IVQELME-TDLYKLI-----KTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNL  137 (336)
T ss_pred             EEehhcc-cCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHE
Confidence            9999996 4888877     234689999999999999999999998   999999999996

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.68  E-value=4.5e-17  Score=165.75  Aligned_cols=132  Identities=18%  Similarity=0.274  Sum_probs=99.1

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEcC--CCEEEEE------------------EecCcccCHHHHHHHHHHHcCCCcCcc
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLHT--GGLIAVK------------------MLKNSKFSAEEFINEVSTIGRIHHVNV  360 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~E~~~l~~l~h~ni  360 (436)
                      ....|.+.+.||+|+||+||++..+.  +...+.|                  .+.........+.+|+.+|++++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            34567888999999999999987431  1112222                  111111123458899999999999999


Q ss_pred             cceeEEEEeCCeeeEEEecCCCCChhhhccCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESR-GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       361 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++++...+..++++|++. ++|.+++...... ........+..++.|++.||+|||++   +|+||||||+||
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NI  298 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENI  298 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            999999999999999999984 5777776432211 12334667788999999999999998   999999999997

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.68  E-value=9.4e-17  Score=155.40  Aligned_cols=126  Identities=21%  Similarity=0.366  Sum_probs=105.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEe----CCeee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  374 (436)
                      ..|.+.+.||+|++|.||++.. .++..||+|.+....   .....+.+|+.+++.++|+||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            4556678899999999999984 478899999987532   234567889999999999999999987753    35679


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||++ ++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        85 lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Ni  138 (334)
T cd07855          85 VVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNL  138 (334)
T ss_pred             EEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            9999995 68999883    334589999999999999999999987   999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=5.3e-17  Score=154.10  Aligned_cols=135  Identities=26%  Similarity=0.452  Sum_probs=112.9

Q ss_pred             hHHHHH-HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCC-----c---CcccceeEE
Q 041073          297 YPEIIA-MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-----H---VNVVQLLGF  366 (436)
Q Consensus       297 ~~~i~~-~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~  366 (436)
                      ..|... .+|.+.++||-|.|++||++.. ...+.||+|+.+....-.+..+.||++|++++     |   ..||+|++.
T Consensus        71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            345555 7888899999999999999984 56778999999876655677889999998873     2   379999998


Q ss_pred             EEe----CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          367 CSE----GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       367 ~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..    +.+++||+|++ |-+|..+|..  ...+.++...+.+|+.||+.||.|||++|  +|||-||||+||
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENv  219 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENV  219 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCccee
Confidence            864    45789999999 7788888843  34456899999999999999999999987  999999999997

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.68  E-value=5.5e-17  Score=156.76  Aligned_cols=125  Identities=21%  Similarity=0.275  Sum_probs=106.6

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCH---------HHHHHHHHHHcCCC---cCcccceeEEEEeCC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSA---------EEFINEVSTIGRIH---HVNVVQLLGFCSEGS  371 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~---h~niv~l~~~~~~~~  371 (436)
                      |...+.+|+|+||.|+.+..+ ....|+||++.+.+.-.         .....|+.+|..++   |+||+++++++++++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            445678999999999999865 45679999987643211         12567999999997   999999999999999


Q ss_pred             eeeEEEecC-CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYM-PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..||+||-. ++.+|.++|    .....+++.++..|+.|++.|+++||++   +|||||||-+|+
T Consensus       643 ~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenv  701 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENV  701 (772)
T ss_pred             eeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccE
Confidence            999999976 466999999    3556799999999999999999999998   999999999996

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.68  E-value=3.8e-16  Score=146.24  Aligned_cols=120  Identities=23%  Similarity=0.272  Sum_probs=97.3

Q ss_pred             hhhcc--cCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcC-CCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          306 HFTHK--LGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGR-IHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       306 ~~~~~--lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .+.+.  ||+|+||.||++.. .++..+|+|.+........    |+..... .+|+||+++++.+...+..++||||++
T Consensus        17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~   92 (267)
T PHA03390         17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK   92 (267)
T ss_pred             ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCC
Confidence            34444  59999999999985 4678899999865432221    2222211 269999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|.+++..    ...+++..+..++.|+++||+|||+.   +++||||||+||
T Consensus        93 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~ni  140 (267)
T PHA03390         93 DGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENV  140 (267)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHE
Confidence            9999999832    23789999999999999999999988   899999999996

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.68  E-value=2.1e-16  Score=146.02  Aligned_cols=119  Identities=36%  Similarity=0.486  Sum_probs=105.4

Q ss_pred             cCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          311 LGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       311 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      ||+|+||.||++... +++.+|+|.++....    ....+.+|+.+++.++|+||+++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999864 588999999876332    345688999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++.    ....+++..+..++.|+++||.|||+.   +++|+||||+||
T Consensus        81 ~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni  124 (250)
T cd05123          81 FSHLS----KEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENI  124 (250)
T ss_pred             HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceE
Confidence            99983    334689999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.68  E-value=2.8e-16  Score=150.25  Aligned_cols=129  Identities=25%  Similarity=0.366  Sum_probs=107.7

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      ...++...+.||+|+||.||+|... ++..+|+|.+....    ...+++.+|+++++.++|+|++++.+++......++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            3344666688999999999999954 67789999886421    123467889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+. |++.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||
T Consensus        93 v~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~ni  146 (308)
T cd06634          93 VMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNI  146 (308)
T ss_pred             EEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhE
Confidence            999996 688777632   234589999999999999999999987   999999999996

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.67  E-value=5.5e-16  Score=148.61  Aligned_cols=125  Identities=28%  Similarity=0.426  Sum_probs=105.6

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +...+.||+|+||.||+|.. .++..+++|.+.....    ..+.+.+|+++++.++|+|++++++++.+....+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            33446799999999999985 4678899999865221    224678899999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +. |++.+++..   ....+++.++..++.|++.||+|||+.   +++||||||+||
T Consensus       103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~ni  152 (313)
T cd06633         103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNI  152 (313)
T ss_pred             CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhE
Confidence            95 577777732   235689999999999999999999988   999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.67  E-value=1.3e-16  Score=154.96  Aligned_cols=125  Identities=26%  Similarity=0.347  Sum_probs=105.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeC----------
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG----------  370 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------  370 (436)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|++++++++|+||+++++.+...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            4566778999999999999985 468899999986643 3346688999999999999999998766543          


Q ss_pred             ----CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 ----SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                          ...+++|||++ ++|.+++.     ...+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Ni  145 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANV  145 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHE
Confidence                35789999996 58988872     24689999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.67  E-value=1.8e-16  Score=149.38  Aligned_cols=125  Identities=30%  Similarity=0.543  Sum_probs=106.9

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEecCC
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      ++.+.||+|++|.||+|... +++.+++|.+.....  ......+|+..+++++ |+|++++++.+..++..++||||+ 
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            46688999999999999965 578899999876433  2234567999999999 999999999999999999999999 


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|+|.+++...  ....+++..+..++.|++.+|.|||++   +++|+||||+||
T Consensus        81 ~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni  130 (283)
T cd07830          81 EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENL  130 (283)
T ss_pred             CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhE
Confidence            88999888432  234689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.67  E-value=3.9e-16  Score=151.23  Aligned_cols=126  Identities=25%  Similarity=0.423  Sum_probs=105.6

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc---ccCHHHHHHHHHHHcCC-CcCcccceeEEEEe--CCeee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS---KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE--GSKRA  374 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~~~~~  374 (436)
                      ...+.+.+.||+|+||.||+|... +++.+|+|.+...   ......+.+|+.+++++ +|+||+++++++..  +...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            456778899999999999999864 6788999988542   22234577899999999 99999999998764  34679


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||++ ++|.+++.    . ..+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        86 lv~e~~~-~~L~~~~~----~-~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~ni  138 (337)
T cd07852          86 LVFEYME-TDLHAVIR----A-NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNI  138 (337)
T ss_pred             EEecccc-cCHHHHHh----c-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            9999996 59998882    2 2688999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.67  E-value=2.9e-16  Score=152.63  Aligned_cols=125  Identities=26%  Similarity=0.371  Sum_probs=103.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeC------Ce
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  372 (436)
                      .+|.+.+.||+|+||.||++.. .+++.||+|.+.....   ..+.+.+|+.++++++|+||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            3455668899999999999984 5788999999875322   245688899999999999999999987543      34


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++++|++ +++|.+++.     ...+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        97 ~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NI  151 (345)
T cd07877          97 VYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNL  151 (345)
T ss_pred             EEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHE
Confidence            67888877 789988872     23589999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.67  E-value=2.3e-16  Score=152.86  Aligned_cols=125  Identities=25%  Similarity=0.432  Sum_probs=105.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeC-----Ceee
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  374 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  374 (436)
                      .|.+.+.||+|+||.||++.. .+++.||+|.+...   ......+.+|+.+++.++|+||+++++++...     ...+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            456678899999999999984 47889999998652   22345677899999999999999999987643     3479


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++||+. ++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        86 lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Ni  139 (337)
T cd07858          86 IVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNL  139 (337)
T ss_pred             EEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHE
Confidence            9999995 68988883    335699999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=2.9e-16  Score=151.08  Aligned_cols=119  Identities=20%  Similarity=0.187  Sum_probs=91.8

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc--CCCEEEEEEecCcc------cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCe
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH--TGGLIAVKMLKNSK------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  372 (436)
                      ....|.+.+.||+|+||+||++..+  +++.+|||.+....      ...+.+.+|+++|++++|+|++..+..   .+.
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~   92 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK   92 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence            3455777899999999999999854  56778999875321      123468999999999999999853322   245


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCC-CCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDI-KPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDl-kp~NI  436 (436)
                      .++||||+++++|....    .. .      ...++.|+++||+|||++   +|+|||| ||+||
T Consensus        93 ~~LVmE~~~G~~L~~~~----~~-~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NI  143 (365)
T PRK09188         93 DGLVRGWTEGVPLHLAR----PH-G------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNW  143 (365)
T ss_pred             cEEEEEccCCCCHHHhC----cc-c------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceE
Confidence            79999999999996321    11 1      146788999999999998   9999999 99997

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.66  E-value=4.1e-16  Score=150.52  Aligned_cols=125  Identities=22%  Similarity=0.332  Sum_probs=105.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEe-CCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  377 (436)
                      ..|++.+.||+|+||.||++.. .+++.+|+|.+...   ....+.+.+|+++++.++||||+++.+++.. ....++++
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            3466678999999999999984 47889999987642   2234568899999999999999999998865 56788999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+ +++|.+++.     ...+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        90 e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Ni  139 (328)
T cd07856          90 ELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNI  139 (328)
T ss_pred             ehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHE
Confidence            998 568988872     24578888999999999999999998   999999999996

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.66  E-value=3.9e-16  Score=152.24  Aligned_cols=125  Identities=26%  Similarity=0.320  Sum_probs=104.1

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeC------C
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------S  371 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  371 (436)
                      ..+|+..+.||+|+||.||++.. .+++.+|+|.+....   .....+.+|+.+++.++|+||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            35567778999999999999985 478899999986522   2234677899999999999999999987543      3


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..++||||++ ++|.+.+.      ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        95 ~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Ni  149 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI  149 (353)
T ss_pred             cEEEEEeccC-CCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHE
Confidence            5689999995 58888772      1288999999999999999999998   999999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.66  E-value=5.4e-17  Score=140.21  Aligned_cols=122  Identities=20%  Similarity=0.444  Sum_probs=105.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC-cCcccceeEEEEeC--CeeeEEEe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEG--SKRAVVYE  378 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E  378 (436)
                      ..|++.+++|+|.++.|+.|. ..+.+.++||++++-+  ...+.+|+.+|..+. ||||+++++...++  ....||+|
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE  115 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE  115 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence            457788999999999999998 5677889999997643  356889999999997 99999999988764  34689999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+.+.+....-       ..++..++..++.++++||.|+|+.   ||+|||+||.|+
T Consensus       116 ~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNv  163 (338)
T KOG0668|consen  116 YVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNV  163 (338)
T ss_pred             hhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCccee
Confidence            99998876655       5688889999999999999999998   999999999996

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.66  E-value=2.9e-16  Score=147.83  Aligned_cols=124  Identities=26%  Similarity=0.447  Sum_probs=107.1

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .+.+.||+|++|.||++... +++.+++|.++....   ....+.+|+.++++++|+||+++++.+..+...++++||++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD   81 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence            45678999999999999854 688899999876432   24568899999999999999999999999999999999997


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      + +|.+++..   ....+++..+..++.|+++||+|||+.   +|+|+||||+||
T Consensus        82 ~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~ni  129 (283)
T cd05118          82 T-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENL  129 (283)
T ss_pred             C-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHE
Confidence            5 88888743   225789999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.66  E-value=2.2e-16  Score=152.44  Aligned_cols=124  Identities=27%  Similarity=0.450  Sum_probs=107.0

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCC-----eeeE
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRAV  375 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  375 (436)
                      |++.+.||+|++|.||++... +++.+|+|.+....   ...+.+.+|+.+++.++|+||+++.+++....     ..++
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            556788999999999999964 58899999987632   23457899999999999999999999887765     7899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|||++ ++|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~ni  134 (330)
T cd07834          82 VTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNI  134 (330)
T ss_pred             Eecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            999997 58988883    334799999999999999999999998   999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.65  E-value=2.9e-17  Score=171.63  Aligned_cols=122  Identities=31%  Similarity=0.440  Sum_probs=106.5

Q ss_pred             hcccCCCCCeEEEEEE-EcCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          308 THKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      ...||.|.||.||.+. ..+|...|+|-++...   .......+|..++..++|||+|+++|+-.+++..+|.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            4579999999999998 5688889999876522   22345788999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.+.+    ..++..++.....+..|++.|++|||++   +||||||||+||
T Consensus      1320 sLa~ll----~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI 1365 (1509)
T KOG4645|consen 1320 SLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANI 1365 (1509)
T ss_pred             cHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccce
Confidence            999998    3455677777788899999999999998   999999999998

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.65  E-value=3.4e-16  Score=147.35  Aligned_cols=124  Identities=30%  Similarity=0.473  Sum_probs=107.5

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .+.+.||+|++|.||+|... +++.+|+|.+...   ....+.+.+|+.+++.++|+|++++++++...+..++++||++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            34578999999999999854 5889999998764   2234567889999999999999999999999899999999997


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       ++|.+++...   ...+++..+..++.|++.||+|||++   +|+||||+|+||
T Consensus        82 -~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni  129 (282)
T cd07829          82 -MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNI  129 (282)
T ss_pred             -cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheE
Confidence             5999998432   14689999999999999999999998   999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.65  E-value=1.8e-16  Score=164.90  Aligned_cols=122  Identities=28%  Similarity=0.370  Sum_probs=96.2

Q ss_pred             hcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeC--------------
Q 041073          308 THKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--------------  370 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------------  370 (436)
                      .+.||+||||.||+++.+ +|+.+|||+++...  .....+.+|++.+++++|||||+++..|.+.              
T Consensus       484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~  563 (1351)
T KOG1035|consen  484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS  563 (1351)
T ss_pred             HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence            367999999999999965 89999999997653  3345688999999999999999988643100              


Q ss_pred             --------------------------------------------------------------------------------
Q 041073          371 --------------------------------------------------------------------------------  370 (436)
Q Consensus       371 --------------------------------------------------------------------------------  370 (436)
                                                                                                      
T Consensus       564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d  643 (1351)
T KOG1035|consen  564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD  643 (1351)
T ss_pred             hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence                                                                                            


Q ss_pred             -------------------------CeeeEEEecCCCCChhhhccCCCCCCCCC-CHHHHHHHHHHHHHHHHHHHcCCCC
Q 041073          371 -------------------------SKRAVVYEYMPNGSLDRHIFPKESRGQSF-SWEKLHEVALGTARGIEYLHNGCDV  424 (436)
Q Consensus       371 -------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~i~~gL~yLH~~~~~  424 (436)
                                               ..+||-||||+...|.+++..+    ... .....++++++|++||+|+|++   
T Consensus       644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEGLaYIH~~---  716 (1351)
T KOG1035|consen  644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEGLAYIHDQ---  716 (1351)
T ss_pred             cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHHHHHHHhC---
Confidence                                     1246778888877777766321    111 3667889999999999999998   


Q ss_pred             ceEecCCCCCCC
Q 041073          425 CILHFDIKPHNI  436 (436)
Q Consensus       425 ~iiHrDlkp~NI  436 (436)
                      +||||||||.||
T Consensus       717 giIHRDLKP~NI  728 (1351)
T KOG1035|consen  717 GIIHRDLKPRNI  728 (1351)
T ss_pred             ceeeccCCccee
Confidence            999999999998

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.65  E-value=5.6e-17  Score=145.28  Aligned_cols=119  Identities=27%  Similarity=0.317  Sum_probs=100.1

Q ss_pred             cccCCCCCeEEEEEE-EcCCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEe----CCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE----GSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~E~~~~  382 (436)
                      ++||-|-.|.|..+. .++++.+|+|++..+.    ..++|++..-.. .|+|||+++++++.    ...+.+|||.|+|
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG  143 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG  143 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence            679999999999887 4588899999987643    456778765444 69999999998754    4457899999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |.|...+.++  ..+.+++.++.+|+.||+.|+.|||+.   +|.||||||+|+
T Consensus       144 GeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENL  192 (400)
T KOG0604|consen  144 GELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENL  192 (400)
T ss_pred             hHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhhe
Confidence            9999988443  346799999999999999999999987   999999999996

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.65  E-value=7e-16  Score=149.15  Aligned_cols=124  Identities=24%  Similarity=0.360  Sum_probs=101.9

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-C--CCEEEEEEecCcc---cCHHHHHHHHHHHcCC-CcCcccceeEEEEeC----Cee
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-T--GGLIAVKMLKNSK---FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG----SKR  373 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~  373 (436)
                      |++.+.||+|+||.||++... .  +..+|+|.+....   ...+.+.+|+.+++++ +|+||+++++.....    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            456788999999999999954 4  6789999986521   2245678899999999 599999999875432    456


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++||++ ++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Ni  136 (332)
T cd07857          82 YLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNL  136 (332)
T ss_pred             EEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHe
Confidence            88999985 68998883    335689999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.64  E-value=5.3e-16  Score=148.24  Aligned_cols=127  Identities=30%  Similarity=0.424  Sum_probs=104.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeC--------
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG--------  370 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  370 (436)
                      ..|.+.+.||+|+||.||++... +++.+|+|.+.....   ....+.+|+++++.++|+||+++++.+...        
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            45667789999999999999854 678899998865221   234577899999999999999999877543        


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...++++||+++ +|...+..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        88 ~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~ni  146 (311)
T cd07866          88 GSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANI  146 (311)
T ss_pred             ceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            346899999965 67776632   235699999999999999999999988   999999999996

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.64  E-value=5.2e-16  Score=142.64  Aligned_cols=112  Identities=24%  Similarity=0.177  Sum_probs=95.2

Q ss_pred             CCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCChhhhccCC
Q 041073          314 GGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPK  392 (436)
Q Consensus       314 G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~  392 (436)
                      |.+|.||++.. .+++.+|+|.++...    ...+|...+....||||+++++.+...+..+++|||+++|+|.+++.. 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK-   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-
Confidence            88999999985 478899999987643    223444555556799999999999999999999999999999998842 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          393 ESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       393 ~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                         ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Ni  116 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNI  116 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHE
Confidence               24589999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.64  E-value=7.5e-16  Score=145.67  Aligned_cols=130  Identities=25%  Similarity=0.343  Sum_probs=103.7

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      .+...+.||+|+||.||++... +++.+|+|.+....  .....+.+|+.++.++. |+||+++++.+...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            3445678999999999999854 67899999987532  23356889999999996 99999999999988889999999


Q ss_pred             CCCCChhhhccC-CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFP-KESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++ +++.++... .......+++..+..++.|++.||+|||+.  .+++||||||+||
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Ni  139 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNI  139 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHE
Confidence            85 455443211 111235689999999999999999999963  3899999999996

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=1.5e-16  Score=155.15  Aligned_cols=122  Identities=25%  Similarity=0.322  Sum_probs=106.7

Q ss_pred             hcccCCCCCeEEEEEE-EcCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          308 THKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      .+.||-|+||.|.+++ ..+...+|+|.+++..    ........|-++|.....+.||+|+-.+.+.+.+|+||||++|
T Consensus       634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG  713 (1034)
T KOG0608|consen  634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG  713 (1034)
T ss_pred             EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence            4669999999999987 4567789999998732    2334577888999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |++-.+|.    +-+.+.+..++.++.++..|+++.|.-   ++|||||||+||
T Consensus       714 GDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNI  760 (1034)
T KOG0608|consen  714 GDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNI  760 (1034)
T ss_pred             ccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccce
Confidence            99999884    446789999999999999999999976   999999999998

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=2.1e-16  Score=143.09  Aligned_cols=126  Identities=27%  Similarity=0.335  Sum_probs=110.0

Q ss_pred             hhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .+.+.+.||+|.||+|.+++ ..+++.+|+|++++..    .....-..|-++|...+||.+..+.-.+...+.+++|||
T Consensus       169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe  248 (516)
T KOG0690|consen  169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME  248 (516)
T ss_pred             hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence            35678999999999999998 5589999999998732    233445678899999999999999888999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |..||.|.-++    ++...+++...+.+..+|+.||.|||++   +||.||||.+|+
T Consensus       249 yanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENL  299 (516)
T KOG0690|consen  249 YANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENL  299 (516)
T ss_pred             EccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---Ceeeeechhhhh
Confidence            99999998877    3456799999999999999999999998   999999999985

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.63  E-value=1.3e-15  Score=144.88  Aligned_cols=128  Identities=22%  Similarity=0.372  Sum_probs=104.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ..+.+.+.||+|++|.||++... +++.+|+|.++....  ....+.+|+.++.+.. |+||+++++++......+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            44567789999999999999976 488999999875332  2345667777676665 9999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |++ ++|.+++..   ....+++..+..++.|+++||+|||+.  .+|+||||+|+||
T Consensus        95 ~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~ni  146 (296)
T cd06618          95 LMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNI  146 (296)
T ss_pred             ccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHE
Confidence            985 477776632   224789999999999999999999963  2899999999996

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.63  E-value=1.9e-15  Score=142.65  Aligned_cols=125  Identities=26%  Similarity=0.459  Sum_probs=102.3

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCC---CcCcccceeEEEEeCCe-----e
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRI---HHVNVVQLLGFCSEGSK-----R  373 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----~  373 (436)
                      ++.+.||+|+||.||+++.+ +++.+|+|.++....   ....+.+|+.+++++   .|+|++++++.+...+.     .
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            45678999999999999975 588999999975322   123566787766555   69999999999987776     8


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|||++ ++|.+++...  ....+++..+..++.|+++||+|||+.   +++|+||||+||
T Consensus        82 ~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~ni  138 (287)
T cd07838          82 TLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNI  138 (287)
T ss_pred             EEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhE
Confidence            99999996 5898887432  223589999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.63  E-value=8.9e-16  Score=154.04  Aligned_cols=131  Identities=20%  Similarity=0.318  Sum_probs=96.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-----------------cCCCEEEEEEecCccc-CHHH--------------HHHHHH
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-----------------HTGGLIAVKMLKNSKF-SAEE--------------FINEVS  350 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-----------------~~~~~vavK~~~~~~~-~~~~--------------~~~E~~  350 (436)
                      ..+.+.++||+|+||.||+|..                 ..++.||||.+..... ..++              ...|+.
T Consensus       145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~  224 (507)
T PLN03224        145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY  224 (507)
T ss_pred             cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence            3566778999999999999963                 2345799999865322 1122              334666


Q ss_pred             HHcCCCcCcc-----cceeEEEEe--------CCeeeEEEecCCCCChhhhccCCCC--------------------CCC
Q 041073          351 TIGRIHHVNV-----VQLLGFCSE--------GSKRAVVYEYMPNGSLDRHIFPKES--------------------RGQ  397 (436)
Q Consensus       351 ~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~  397 (436)
                      .+.+++|.++     +++++++..        .+..+|||||+++++|.++++....                    ...
T Consensus       225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~  304 (507)
T PLN03224        225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD  304 (507)
T ss_pred             HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence            6777766544     667776643        3467999999999999998864211                    112


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          398 SFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       398 ~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NI  340 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENL  340 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhE
Confidence            356788899999999999999987   999999999997

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.63  E-value=1.6e-15  Score=153.24  Aligned_cols=128  Identities=29%  Similarity=0.467  Sum_probs=112.1

Q ss_pred             hhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEe-----CCeeeEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE-----GSKRAVV  376 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv  376 (436)
                      +..+.+.||.|.+|.||+++ .++++..|+|++.......++...|..+++.. +|||++.++|++..     ++.+|||
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV   99 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV   99 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence            34567889999999999998 56788899999988776677788888898877 59999999998853     5689999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||.+|+..+.+...  .+..+.|+.+..|++.++.||.+||.+   .+||||||-.||
T Consensus       100 MEfC~gGSVTDLVKn~--~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~Ni  154 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNT--KGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNV  154 (953)
T ss_pred             eeccCCccHHHHHhhh--cccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceE
Confidence            9999999999998543  367899999999999999999999998   899999999987

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.62  E-value=7.5e-16  Score=136.35  Aligned_cols=126  Identities=19%  Similarity=0.340  Sum_probs=107.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeE-EEEeCCeeeEEEec
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLG-FCSEGSKRAVVYEY  379 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lv~E~  379 (436)
                      +.|++.+.||+|.||.+.+++.+ +...+++|.++.......+|.+|...--.+ .|.||+.-++ .+.+.+...+++||
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            45778899999999999999965 667899999988877888999998765555 4889998765 45667788899999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.|+|..-+     ....+.+....+++.|+++|+.|||++   ++||||||.+||
T Consensus       104 aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNi  152 (378)
T KOG1345|consen  104 APRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENI  152 (378)
T ss_pred             Cccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceE
Confidence            9999998877     224578888999999999999999998   999999999997

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.62  E-value=1e-15  Score=158.64  Aligned_cols=137  Identities=30%  Similarity=0.438  Sum_probs=114.9

Q ss_pred             hHHHHHHhhhhhcccCCCCCeEEEEEEEc----C----CCEEEEEEecCcc--cCHHHHHHHHHHHcCCC-cCcccceeE
Q 041073          297 YPEIIAMTNHFTHKLGQGGFGSVYKGQLH----T----GGLIAVKMLKNSK--FSAEEFINEVSTIGRIH-HVNVVQLLG  365 (436)
Q Consensus       297 ~~~i~~~~~~~~~~lg~G~fg~V~~~~~~----~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~  365 (436)
                      ..|+.+....+.+.||+|.||.|++|...    .    ...||||+++...  .+.+.+..|+++|+.+. |+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            44566666667789999999999999732    1    3469999998733  34567999999999985 999999999


Q ss_pred             EEEeCCeeeEEEecCCCCChhhhccCCC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCC
Q 041073          366 FCSEGSKRAVVYEYMPNGSLDRHIFPKE---S-------RG--QSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP  433 (436)
Q Consensus       366 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp  433 (436)
                      ++..++..++|+||++.|+|.++++..+   .       ..  ..++..+.+.++.|||.||+||++.   ++|||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999996544   0       00  2389999999999999999999998   899999999


Q ss_pred             CCC
Q 041073          434 HNI  436 (436)
Q Consensus       434 ~NI  436 (436)
                      +||
T Consensus       447 RNV  449 (609)
T KOG0200|consen  447 RNV  449 (609)
T ss_pred             hhE
Confidence            997

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.62  E-value=8.2e-16  Score=149.38  Aligned_cols=124  Identities=27%  Similarity=0.407  Sum_probs=104.8

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCe------e
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------R  373 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~  373 (436)
                      +|.+.+.||+|++|.||++... +++.+|+|.+....   ...+.+.+|+.+++.++|+|++++.+.+...+.      .
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV   95 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence            4566788999999999999864 67889999986532   223557789999999999999999987765544      8


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+||+ +++|.+++.     ...+++..+..++.|+++||+|||+.   +|+||||||+||
T Consensus        96 ~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Ni  149 (343)
T cd07851          96 YLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNI  149 (343)
T ss_pred             EEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHe
Confidence            9999998 679999883     24689999999999999999999987   999999999996

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.61  E-value=2.1e-15  Score=146.39  Aligned_cols=123  Identities=27%  Similarity=0.451  Sum_probs=102.0

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeC------Cee
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKR  373 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  373 (436)
                      .+...+.||+|+||.||+|.. .+++.+|+|.+....   .....+.+|+.+++.++|+||+++++++...      ...
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   95 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF   95 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence            345568899999999999985 478899999986532   2234688999999999999999999988654      246


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++||+. .+|..++      ...+++..+..++.|++.||+|||++   +++||||||+||
T Consensus        96 ~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NI  148 (342)
T cd07879          96 YLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNL  148 (342)
T ss_pred             EEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            89999996 4777665      13588999999999999999999988   999999999997

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.59  E-value=1.6e-14  Score=128.84  Aligned_cols=120  Identities=34%  Similarity=0.615  Sum_probs=106.3

Q ss_pred             cCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCChhh
Q 041073          311 LGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDR  387 (436)
Q Consensus       311 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~  387 (436)
                      ||+|.+|.||++... +++.+++|++.....  ..+.+.+|++.++.++|++++++++........++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999965 488899999877544  24679999999999999999999999999899999999999999999


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          388 HIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       388 ~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++...   ...+++..+..++.++++++++||+.   +++|+||+|.||
T Consensus        81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni  123 (215)
T cd00180          81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENI  123 (215)
T ss_pred             HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhE
Confidence            98322   14689999999999999999999998   999999999997

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.59  E-value=1e-15  Score=130.39  Aligned_cols=135  Identities=24%  Similarity=0.386  Sum_probs=108.7

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeee
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  374 (436)
                      |+.+....-...||+|++|.|-+-+ ..+|...|+|.++..-.  ...++.+|+.+..+. ..|.+|.++|........+
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw  121 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW  121 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence            3334444445779999999998777 45788999999976433  345688888876554 6999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +.||.| .-||+.+-..--..++.+++..+-+|+..+.+||.|||++  ..+||||+||+||
T Consensus       122 IcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNi  180 (282)
T KOG0984|consen  122 ICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNI  180 (282)
T ss_pred             EeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceE
Confidence            999999 5588776533334667899999999999999999999986  6899999999997

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.58  E-value=7.9e-16  Score=145.02  Aligned_cols=126  Identities=28%  Similarity=0.388  Sum_probs=109.3

Q ss_pred             hhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          306 HFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ..-+.||+|+||.|+-++. .+|+.+|.|.+.+.+.    .....++|-.+|.+++.+.||.+--.+++.+.+++|+..|
T Consensus       188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM  267 (591)
T KOG0986|consen  188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM  267 (591)
T ss_pred             eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence            3447899999999999985 4888999998865322    2344788999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .||+|.-+|....  ...++++.++.++.+|+.||++||+.   +||.|||||+||
T Consensus       268 NGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNI  318 (591)
T KOG0986|consen  268 NGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENI  318 (591)
T ss_pred             cCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhhe
Confidence            9999998885443  25699999999999999999999998   999999999998

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.58  E-value=6.6e-15  Score=139.85  Aligned_cols=130  Identities=23%  Similarity=0.286  Sum_probs=93.1

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcC----CCEEEEEEecCcccC--H----------HHHHHHHHHHcCCCcCcccc
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHT----GGLIAVKMLKNSKFS--A----------EEFINEVSTIGRIHHVNVVQ  362 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~--~----------~~~~~E~~~l~~l~h~niv~  362 (436)
                      ++....|++.+.||+|+||.||+|....    +..+|+|+.......  .          .....+...+..+.|+|+++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            4444567788999999999999998553    345667754332211  1          11223444566788999999


Q ss_pred             eeEEEEeCC----eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          363 LLGFCSEGS----KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       363 l~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++.....    ..++++|++. .++.+.+.    .....++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Ni  157 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFK----RIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENI  157 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhc-cCHHHHHH----hhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            998765543    3467888774 36666552    223457888999999999999999988   999999999997

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.58  E-value=1.2e-14  Score=131.55  Aligned_cols=124  Identities=36%  Similarity=0.546  Sum_probs=108.8

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      .+.+.||+|++|.||++... +++.+++|.+.....  ..+.+.+|++.+++++|+|++++++.+......++++|++++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            45678999999999999966 478899999976443  356788999999999999999999999988899999999999


Q ss_pred             CChhhhccCCCCCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQS-FSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++...    .. +++.....++.+++.++.+||+.   +++|+||+|+||
T Consensus        82 ~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni  129 (225)
T smart00221       82 GDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENI  129 (225)
T ss_pred             CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            9999998432    23 88999999999999999999987   999999999986

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00090 RIO RIO-like kinase

Probab=99.57  E-value=1.5e-14  Score=132.33  Aligned_cols=121  Identities=17%  Similarity=0.183  Sum_probs=91.8

Q ss_pred             hhhhcccCCCCCeEEEEEE--EcCCCEEEEEEecCccc--------------------C-----HHHHHHHHHHHcCCCc
Q 041073          305 NHFTHKLGQGGFGSVYKGQ--LHTGGLIAVKMLKNSKF--------------------S-----AEEFINEVSTIGRIHH  357 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~--~~~~~~vavK~~~~~~~--------------------~-----~~~~~~E~~~l~~l~h  357 (436)
                      +.+.+.||+|++|.||+|.  ..+|+.||+|+++....                    .     ...+..|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            5567889999999999998  56899999999875321                    0     0225679999998875


Q ss_pred             Cc--ccceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc-eEecCCCCC
Q 041073          358 VN--VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC-ILHFDIKPH  434 (436)
Q Consensus       358 ~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~-iiHrDlkp~  434 (436)
                      ..  +.++++.    ...++||||+++++|.....    ....+.......++.|++.++++||++   + |+||||||+
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~  178 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY  178 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence            33  3344432    23589999999988876542    223456666789999999999999998   8 999999999


Q ss_pred             CC
Q 041073          435 NI  436 (436)
Q Consensus       435 NI  436 (436)
                      ||
T Consensus       179 NI  180 (237)
T smart00090      179 NI  180 (237)
T ss_pred             hE
Confidence            97

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=3.2e-16  Score=138.68  Aligned_cols=120  Identities=29%  Similarity=0.469  Sum_probs=100.6

Q ss_pred             cccCCCCCeEEEEEEE-cCCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCC-----eeeEEEec
Q 041073          309 HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRAVVYEY  379 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~E~  379 (436)
                      +.||.|+||.||.+.. ++|+.||+|++..-   -....++.+|+++|.-++|.|++..++.....+     .+|+++|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            5699999999999884 58899999987652   223467889999999999999999988775433     35788999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      | ..+|.+.|.    ..+.++...+.-+..||++||+|||+.   +|+||||||.|+
T Consensus       139 m-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNL  187 (449)
T KOG0664|consen  139 M-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNL  187 (449)
T ss_pred             H-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccE
Confidence            9 458988883    456799999999999999999999998   999999999984

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.55  E-value=2.8e-15  Score=138.72  Aligned_cols=136  Identities=22%  Similarity=0.338  Sum_probs=113.7

Q ss_pred             cChHHHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCc--C----cccceeEEE
Q 041073          295 YSYPEIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH--V----NVVQLLGFC  367 (436)
Q Consensus       295 ~~~~~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~  367 (436)
                      +...|....+|.+.+.+|+|.||.|-.+..+ ++..||+|+++.-..-.+..+-|++++.++.+  |    -++++.+++
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            4455666788888999999999999998743 57889999998755555667789999998842  2    367778888


Q ss_pred             EeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       368 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .-.++.+||+|.+ |-|+.+++..  ++..+++...++.++.|++++++|||+.   +++|-||||+||
T Consensus       161 dyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENI  223 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENI  223 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheE
Confidence            8999999999998 6799999932  3456789999999999999999999988   999999999998

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.54  E-value=8.2e-15  Score=137.34  Aligned_cols=122  Identities=25%  Similarity=0.414  Sum_probs=106.9

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCcccCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .+...++||+|.|+.||++...    ..+.||+|.+.... ...++.+|++.|..+. +.||+++.++...++...+|+|
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp  115 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP  115 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence            3456689999999999999843    46789999987643 4567899999999985 8999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |++.-...++.       ..++..++..++..+..||+++|.+   +||||||||+|+
T Consensus       116 ~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNF  163 (418)
T KOG1167|consen  116 YFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNF  163 (418)
T ss_pred             ccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccc
Confidence            99999988887       4577899999999999999999998   999999999995

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.54  E-value=9.5e-16  Score=150.57  Aligned_cols=127  Identities=28%  Similarity=0.388  Sum_probs=111.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ..|.+...+|.|++|.|||++ .++++..|+|+++... .+..-..+|+-+++..+|+||+.++|.+...+..++.|||+
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            345567889999999999999 5588899999998743 33455778999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+|+|++.-+    -.+.+++.++..++++.++||+|||+.   +-+|||||-.||
T Consensus        95 gggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGani  143 (829)
T KOG0576|consen   95 GGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANI  143 (829)
T ss_pred             CCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---Ccccccccccce
Confidence            9999998763    346899999999999999999999998   889999999997

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.54  E-value=1.9e-14  Score=128.99  Aligned_cols=122  Identities=16%  Similarity=0.118  Sum_probs=97.3

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHH----------HHHHHHHHcCCCcCcccceeEEEE
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE----------FINEVSTIGRIHHVNVVQLLGFCS  368 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~  368 (436)
                      ++...+++..+.+|.|+||.||.... +++.+|+|+++......+.          +.+|+..+.++.|++|..+..+..
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            45566778889999999999999765 5678999999764322222          578999999999999999988755


Q ss_pred             eC--------CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          369 EG--------SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       369 ~~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..        +..+|+|||++|.+|.++.        .+++    ....+++.+|..+|+.   +++|||+||+||
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Ni  166 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNF  166 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHE
Confidence            32        3578999999999998864        1222    2456899999999998   999999999996

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.53  E-value=4.1e-14  Score=127.58  Aligned_cols=116  Identities=19%  Similarity=0.247  Sum_probs=95.6

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCccc---------CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +.||+|++|.||+|.. .+..+++|+......         ....+.+|+.++..++|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5689999999999987 567789998654221         123578899999999999988877777777788999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++..       ..+ ....++.+++.+|.++|+.   +++|||++|+||
T Consensus        81 ~~G~~L~~~~~~-------~~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Ni  126 (211)
T PRK14879         81 IEGEPLKDLINS-------NGM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNM  126 (211)
T ss_pred             eCCcCHHHHHHh-------ccH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccE
Confidence            999999998832       122 7788999999999999998   999999999997

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=2.9e-16  Score=137.53  Aligned_cols=126  Identities=28%  Similarity=0.460  Sum_probs=101.4

Q ss_pred             hhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecC---cccCHHHHHHHHHHHcCCCcCcccceeEEEEe--------CC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKN---SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE--------GS  371 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~  371 (436)
                      .|.-..+||+|.||.||+++ .++++.||+|++-.   ...-.....+|+++|..++|+|++.+++.|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            34445689999999999998 45677788876532   22233557899999999999999999887743        23


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..++|+++++. +|.-.+.   .....++..++.+++.++..||.|+|+.   .|+|||+||+|+
T Consensus        98 t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNv  155 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANV  155 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhE
Confidence            47899999976 8888772   3346799999999999999999999998   999999999996

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.53  E-value=1.5e-14  Score=126.23  Aligned_cols=128  Identities=22%  Similarity=0.377  Sum_probs=106.2

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCc-CcccceeEEEEeCCeeeEEEe
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ....|.+.++||.|+||.+|.|. ...|..||||+-..... ..++.-|.++.+.+++ ..|..+..+..+...-.+|||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            44567888999999999999998 67899999998654332 2357788888888874 577777777788888899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+ +.+|++.+.   -....++..+++.++-|++.-++|+|.+   ++|||||||+|.
T Consensus        92 LL-GPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNF  142 (341)
T KOG1163|consen   92 LL-GPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNF  142 (341)
T ss_pred             cc-CccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccce
Confidence            98 889999873   2345688999999999999999999998   999999999994

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=2.6e-14  Score=137.98  Aligned_cols=130  Identities=18%  Similarity=0.217  Sum_probs=108.2

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecC---cccCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKN---SKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  375 (436)
                      +....|...++||+||-+.||++...+.+.+|+|.+..   +......+.+|+..|.+++ |.+|++++++...++.+||
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            34456778899999999999999987788888887654   3334567999999999996 9999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+= ..+|.++|.++   ...+..-.++.+..|++.++.++|.+   +|||.||||.|.
T Consensus       438 vmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANF  491 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANF  491 (677)
T ss_pred             Eeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccE
Confidence            99976 66999999432   22333237788999999999999998   999999999983

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.51  E-value=1.3e-14  Score=146.03  Aligned_cols=122  Identities=26%  Similarity=0.244  Sum_probs=96.7

Q ss_pred             hcccCCCCCeE-EEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          308 THKLGQGGFGS-VYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       308 ~~~lg~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      .+.+|.|+-|+ ||+|... ++.||||.+-..-  ..-..+|+..|+.-+ |||||++++.-.++...||..|.| ..+|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL  589 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL  589 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence            36789999877 7999876 7799999874432  234678999998874 999999999999999999999999 5699


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++...........-...+.+..|+++||++||+-   +||||||||+||
T Consensus       590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNI  637 (903)
T KOG1027|consen  590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNI  637 (903)
T ss_pred             HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceE
Confidence            999955211111111144578899999999999986   999999999997

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.50  E-value=1e-13  Score=126.80  Aligned_cols=115  Identities=32%  Similarity=0.518  Sum_probs=101.4

Q ss_pred             CCeEEEEEEEc-CCCEEEEEEecCccc-C-HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCChhhhccC
Q 041073          315 GFGSVYKGQLH-TGGLIAVKMLKNSKF-S-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFP  391 (436)
Q Consensus       315 ~fg~V~~~~~~-~~~~vavK~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~  391 (436)
                      +||.||++... +++.+++|++..... . .+.+.+|++.+++++|+|++++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999965 588999999876432 2 57899999999999999999999999998999999999999999999843


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          392 KESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       392 ~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .    ..+++..+..++.++++++.|||+.   +++|+||+|+||
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni  118 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENI  118 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHe
Confidence            2    2388999999999999999999998   999999999996

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.50  E-value=2.9e-14  Score=132.28  Aligned_cols=132  Identities=25%  Similarity=0.306  Sum_probs=106.3

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecC--cccCHHHHHHHHHHHcCCCcCcccceeEEEEe-CC
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GS  371 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  371 (436)
                      .+.+.+....+-+|.||.||+|.++      +.+.|.+|.++.  +......+..|...+..+.|||+.++.+.+.+ ..
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            3445556678999999999999654      334566777765  33345568899999999999999999998865 45


Q ss_pred             eeeEEEecCCCCChhhhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKE----SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      ..++++.++.-|+|..|+...+    ...+.++..+...++.|++.||+|||++   ++||.||.++|
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRN  426 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARN  426 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhc
Confidence            6788999999999999996321    2345688889999999999999999998   99999999998

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.50  E-value=1.2e-13  Score=141.88  Aligned_cols=115  Identities=17%  Similarity=0.245  Sum_probs=91.9

Q ss_pred             hhhcccCCCCCeEEEEEEEcCCCEEEEEE-ecCc-c-------cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKM-LKNS-K-------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~-~~~~-~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ...+.||+|+||.||++...... +++|+ ..+. .       ...+++.+|++++..++|++++....+.......++|
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             CccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            34578999999999999865443 34343 2221 1       1124588999999999999999887777777778999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++++|.+++.            ....++.+++++|.|||+.   +++||||||+||
T Consensus       415 ~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NI  459 (535)
T PRK09605        415 MEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNF  459 (535)
T ss_pred             EEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHE
Confidence            99999999999882            3567999999999999998   999999999997

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.49  E-value=1.1e-13  Score=123.54  Aligned_cols=112  Identities=21%  Similarity=0.250  Sum_probs=88.7

Q ss_pred             ccCCCCCeEEEEEEEcCCCEEEEEEecCcc-c--------CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSK-F--------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       310 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .||+|+||.||+|.. ++..+++|...... .        ...++.+|++++..++|+++.....+....+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 46789999865321 1        1245778999999999887666555556666778999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+.+...    .   .    .++.+++++|.+||+.   +++|||++|+||
T Consensus        80 ~g~~l~~~~~~~----~---~----~~~~~i~~~l~~lH~~---gi~H~Dl~~~Ni  121 (199)
T TIGR03724        80 EGKPLKDVIEEG----N---D----ELLREIGRLVGKLHKA---GIVHGDLTTSNI  121 (199)
T ss_pred             CCccHHHHHhhc----H---H----HHHHHHHHHHHHHHHC---CeecCCCCcceE
Confidence            999999887211    1   0    7899999999999998   999999999996

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=5.2e-15  Score=137.93  Aligned_cols=131  Identities=28%  Similarity=0.291  Sum_probs=109.8

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  372 (436)
                      .+....++|...||+|+||+|.+++.+ +.+.+|||+++++-    .+.+--+.|-++|... +-|.+++++.++.+-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            445567789999999999999999854 67789999998732    2233345677777765 46789999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.||||+.+|+|--.|    +.-+.+.+..+..+|.+||-||-|||++   +||.||||.+||
T Consensus       425 LyFVMEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNv  481 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNV  481 (683)
T ss_pred             eeeEEEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---Ceeeeeccccce
Confidence            99999999999998888    3456788899999999999999999998   999999999996

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.48  E-value=7e-14  Score=143.61  Aligned_cols=128  Identities=24%  Similarity=0.322  Sum_probs=85.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-C----CCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEE------EEeCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-T----GGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF------CSEGS  371 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~~  371 (436)
                      ..|.+.+.||+|+||.||+|... +    +..+|+|.+..... .+...+|  .+....+.++..+...      .....
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence            34667789999999999999964 4    68899998764321 1222222  1111222222222111      23456


Q ss_pred             eeeEEEecCCCCChhhhccCCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKES----------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      ..++|+||+++++|.+++.....                ......+..+..++.|++.||+|||++   +|+||||||+|
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N  285 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN  285 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence            78999999999999998853210                001112344668999999999999988   99999999999


Q ss_pred             C
Q 041073          436 I  436 (436)
Q Consensus       436 I  436 (436)
                      |
T Consensus       286 I  286 (566)
T PLN03225        286 I  286 (566)
T ss_pred             E
Confidence            7

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.46  E-value=1.4e-13  Score=125.43  Aligned_cols=129  Identities=26%  Similarity=0.400  Sum_probs=109.0

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEE-EcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  377 (436)
                      +....|++.++||+|+||.++.|+ +-+++.||||.-.. +.+..++..|.+..+.|. .++|...+-+...+..-.||+
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            455677888999999999999998 56789999996543 344556788888877775 689999988888888889999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |.+ |-+|+|.+   +-.+..++...+..+|.|++.-++|+|++   .+|.|||||+|.
T Consensus       104 dLL-GPSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNF  155 (449)
T KOG1165|consen  104 DLL-GPSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNF  155 (449)
T ss_pred             hhh-CcCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccce
Confidence            998 88999887   33567899999999999999999999998   999999999994

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.46  E-value=1.7e-13  Score=131.75  Aligned_cols=127  Identities=24%  Similarity=0.323  Sum_probs=102.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCC--CEEEEEEecCcc-cCHHHHHHHHHHHcCCCc----CcccceeEEE-EeCCeeeE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTG--GLIAVKMLKNSK-FSAEEFINEVSTIGRIHH----VNVVQLLGFC-SEGSKRAV  375 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~--~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  375 (436)
                      .+.+.++||+|+||.||.+.....  ..+|+|...... .....+..|..++..+..    +++.++++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            567789999999999999996543  478888876532 222267788888888763    5788888888 46778899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+.+ +.+|.++....  ..+.++...+.+++.|++.+|++||+.   +++||||||+|+
T Consensus        99 VM~l~-G~sL~dl~~~~--~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~  153 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRN--PPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENF  153 (322)
T ss_pred             EEecc-CccHHHHHHhC--CCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHe
Confidence            99988 88999977332  246799999999999999999999998   999999999985

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.45  E-value=5.2e-14  Score=128.12  Aligned_cols=125  Identities=21%  Similarity=0.281  Sum_probs=105.6

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc----CHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEe
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF----SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      +++.+.||+|+|++|..+++ ++.+.+|+|++++...    +.+....|-.+.... +||.+|.++.++.+...+++|.|
T Consensus       252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie  331 (593)
T KOG0695|consen  252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE  331 (593)
T ss_pred             ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence            45678999999999999984 5788899999876322    233355566665554 69999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|--.+    ++..+++++.++.+..+|+.||.|||++   +||.||||.+|+
T Consensus       332 yv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnv  382 (593)
T KOG0695|consen  332 YVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNV  382 (593)
T ss_pred             EecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---Ceeeeeccccce
Confidence            99999998777    4556799999999999999999999998   999999999996

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.45  E-value=6.5e-14  Score=124.33  Aligned_cols=124  Identities=22%  Similarity=0.368  Sum_probs=100.9

Q ss_pred             hhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEecCCC
Q 041073          307 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +...||.|+-|.||+.+.+ ++...|||.+++..  .+..+++..++++..-+ .|.||+.+|++..+...++-||.|. 
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-  174 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-  174 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence            4567999999999999955 68899999998743  34456777788776655 8999999999999999999999983 


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .-++..+.   .-.+++++..+-++...+++||.||-++  ++|||||+||+||
T Consensus       175 ~C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNI  223 (391)
T KOG0983|consen  175 TCAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNI  223 (391)
T ss_pred             HHHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccce
Confidence            34445442   1235688888889999999999999876  5999999999998

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.45  E-value=6.4e-15  Score=130.16  Aligned_cols=126  Identities=25%  Similarity=0.371  Sum_probs=100.0

Q ss_pred             hcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc--cCHHHHHHHHHHHc-CCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          308 THKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK--FSAEEFINEVSTIG-RIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      ...||.|+||+|++-.. ..|+..|||.++...  .+..+++.|.+... .-+.||||+++|.+-.++..|+-||.| ..
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence            35799999999999874 478999999998643  34456888887654 446899999999999999999999999 55


Q ss_pred             ChhhhccC-CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFP-KESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+.+-.. .......+++..+-.|....+.||.||-..  ..|||||+||+||
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNI  199 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNI  199 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhhe
Confidence            77554210 012235688888889999999999999875  5899999999998

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.44  E-value=9.2e-14  Score=136.77  Aligned_cols=122  Identities=25%  Similarity=0.354  Sum_probs=99.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEecCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .|.+...+|.|+|+.|-.+.. .+++..++|++.+...   +..+|+.++... +|+||+++.+.+.++...++|||.+.
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD  399 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence            456677899999999998884 4778899999976522   234566555544 69999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++-+.+.+..     .+.....+..|+.+|+.++.|||++   ++|||||||+||
T Consensus       400 g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NI  446 (612)
T KOG0603|consen  400 GGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNI  446 (612)
T ss_pred             ccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhhe
Confidence            9988887732     2223367788999999999999998   999999999998

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.44  E-value=4.6e-13  Score=119.53  Aligned_cols=115  Identities=23%  Similarity=0.223  Sum_probs=88.3

Q ss_pred             hhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccC-----------------------HHHHHHHHHHHcCCCcCc--
Q 041073          305 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS-----------------------AEEFINEVSTIGRIHHVN--  359 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~n--  359 (436)
                      +.+.+.||+|+||.||++...+++.+|||+++.....                       ......|...+..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            5567889999999999999878999999987643210                       112567888888887774  


Q ss_pred             ccceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       360 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++.++    ....+++|||+++++|.+...          ......++.++++++.++|+.   +|+||||||+||
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Ni  156 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNI  156 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccE
Confidence            444443    234589999999999876541          033567889999999999997   999999999997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.43  E-value=1.2e-14  Score=138.67  Aligned_cols=126  Identities=23%  Similarity=0.238  Sum_probs=107.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCC-EEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGG-LIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~-~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ..+....||-|+||.|=++..+... .+|+|.+++.    ....+....|-.+|...+.|.||+++..+.+....|++||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3344567999999999988865333 4888988763    2234568889999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      -|-||.|...++    ..+.++...+..++..+++|++|||++   +||.|||||+|.
T Consensus       501 aClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENl  551 (732)
T KOG0614|consen  501 ACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENL  551 (732)
T ss_pred             hhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhhe
Confidence            999999999994    446789999999999999999999998   999999999995

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.40  E-value=1.4e-12  Score=114.71  Aligned_cols=110  Identities=15%  Similarity=0.133  Sum_probs=85.1

Q ss_pred             hcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCH-----HHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEecCC
Q 041073          308 THKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA-----EEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-----~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      ...|++|+||+|+.+.. .+..++.+.+.......     ..+.+|+++|++++ |+++++++++    +..+++|||++
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            46799999999997765 56777777665533212     24789999999995 5789998875    34689999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCC-CCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDI-KPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDl-kp~NI  436 (436)
                      +.+|.+.+    ..       ....++.|++++|+++|++   +|+|||| ||+||
T Consensus        82 G~~L~~~~----~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NI  123 (218)
T PRK12274         82 GAAMYQRP----PR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANW  123 (218)
T ss_pred             CccHHhhh----hh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceE
Confidence            99987543    11       1135778999999999998   9999999 79997

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.34  E-value=6.4e-12  Score=106.24  Aligned_cols=116  Identities=20%  Similarity=0.167  Sum_probs=95.3

Q ss_pred             hcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCc--CcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          308 THKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      .+.||+|.++.||++.... ..+++|....... ...+.+|+..+..++|  .+++++++.....+..+++|||++++.+
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            3678999999999999754 6789999866443 5678899999999976  5888888888777789999999988776


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..+           +......++.+++++|++||.....+++|+|+||+||
T Consensus        81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Ni  120 (155)
T cd05120          81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNI  120 (155)
T ss_pred             ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceE
Confidence            532           4566778899999999999986445799999999996

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.32  E-value=2e-12  Score=114.20  Aligned_cols=117  Identities=18%  Similarity=0.231  Sum_probs=79.5

Q ss_pred             hcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHH---H----------------------HHHHHHHHcCCCcCc--c
Q 041073          308 THKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAE---E----------------------FINEVSTIGRIHHVN--V  360 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~---~----------------------~~~E~~~l~~l~h~n--i  360 (436)
                      .+.||+|+||.||++...+++.||||+++.......   .                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999977889999999875322111   1                      124555555554332  3


Q ss_pred             cceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEecCCCCCCC
Q 041073          361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNI  436 (436)
Q Consensus       361 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~iiHrDlkp~NI  436 (436)
                      .+.++.    ...+++|||++++.+.......    .... ..+..++.+++.++.++|. .   +|+||||||+||
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~----~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Ni  146 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD----VRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNI  146 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhh----hhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhE
Confidence            344432    2358999999985543211100    0011 5678899999999999998 6   999999999997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.29  E-value=1.7e-12  Score=117.93  Aligned_cols=118  Identities=25%  Similarity=0.363  Sum_probs=93.3

Q ss_pred             hcccCCCCCeEEEEEEE-cCCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeC------CeeeEEE
Q 041073          308 THKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRAVVY  377 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  377 (436)
                      .+.+|.|.- .|-.+-. -.++.||+|.+...   ....++..+|...+..++|+||++++.++...      ...++||
T Consensus        22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~  100 (369)
T KOG0665|consen   22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM  100 (369)
T ss_pred             ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence            355777776 4444432 25778999887542   23456788999999999999999999988543      3468999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+| .++|.+.+.      ..++-+.+..+..|++.|++|||+.   +|+||||||+||
T Consensus       101 e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsni  149 (369)
T KOG0665|consen  101 ELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNI  149 (369)
T ss_pred             Hhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccc
Confidence            999 669998884      3467778889999999999999998   999999999997

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.27  E-value=2.9e-12  Score=134.68  Aligned_cols=129  Identities=26%  Similarity=0.317  Sum_probs=98.1

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC---cCcccceeEEEEeCCeeeE
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  375 (436)
                      ++-...+.+.+.||+|+||+||+|...+++.||+|+-+.....  +|.-=.+++.+|+   -+.|..+..++.-.+.-+|
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            4445566677899999999999999777999999997653221  1111112223333   2345555555566677789


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+||.+.|+|.+++.    ..+.++|.....++.|++.-+++||..   +|||+||||+|.
T Consensus       772 v~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNf  825 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNF  825 (974)
T ss_pred             eeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCccee
Confidence            999999999999993    556799999999999999999999987   999999999993

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.25  E-value=3e-11  Score=110.69  Aligned_cols=115  Identities=15%  Similarity=0.191  Sum_probs=85.5

Q ss_pred             cccC-CCCCeEEEEEEEcCCCEEEEEEecCcc--------------cCHHHHHHHHHHHcCCCcCcc--cceeEEEEeC-
Q 041073          309 HKLG-QGGFGSVYKGQLHTGGLIAVKMLKNSK--------------FSAEEFINEVSTIGRIHHVNV--VQLLGFCSEG-  370 (436)
Q Consensus       309 ~~lg-~G~fg~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~-  370 (436)
                      ..|| .|+.|+||++... +..+++|.+....              .....+.+|++++..++|+++  ++.++..... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4587 8889999998765 6778888875311              123457889999999998875  6666654332 


Q ss_pred             C---eeeEEEecCCC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 S---KRAVVYEYMPN-GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~---~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .   ..++|||++++ .+|.+++..     ..++..    .+.+++.+|.+||+.   +|+||||||+||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NI  173 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNI  173 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhE
Confidence            2   23599999997 699888721     235543    356899999999998   999999999997

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.23  E-value=9.1e-11  Score=111.75  Aligned_cols=126  Identities=31%  Similarity=0.503  Sum_probs=105.2

Q ss_pred             hhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcC-cccceeEEEEeCCeeeEEEec
Q 041073          305 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHV-NVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +.+.+.||.|+|+.||++...  ..+++|.+.....    ....+.+|+..+..+.|+ +++++.+.+......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            345678999999999999866  7789999876332    256789999999999988 799999999777778999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +.++++.+++...... ..+.......+..|++.+++|+|+.   +++|||+||+||
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~ni  132 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENI  132 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHe
Confidence            9999999777321111 2688999999999999999999998   899999999986

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.20  E-value=1.3e-11  Score=118.64  Aligned_cols=137  Identities=18%  Similarity=0.303  Sum_probs=114.1

Q ss_pred             cChHHHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCC------cCcccceeEEE
Q 041073          295 YSYPEIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIH------HVNVVQLLGFC  367 (436)
Q Consensus       295 ~~~~~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~  367 (436)
                      +.+.|+...+|.+....|+|-|++|.+|... .+..||||+++....-...=+.|+++|++|+      .-+.++++..+
T Consensus       424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            4556888888988899999999999999843 5779999999876544445568999999985      23789999999


Q ss_pred             EeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       368 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...++++||+|-+ .-+|.+.+.... +...|....+..++.|+.-||..|-.-   +|+|.||||.||
T Consensus       504 ~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNi  567 (752)
T KOG0670|consen  504 KHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNI  567 (752)
T ss_pred             hhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccce
Confidence            9999999999988 568988885433 345688888999999999999999875   999999999997

>PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal

Probab=99.14  E-value=2.4e-10  Score=88.33  Aligned_cols=86  Identities=23%  Similarity=0.330  Sum_probs=63.8

Q ss_pred             ccCCCCCCCceEEEEEeecccccccCCCCCCcEEEEeeeeccCCC-CCCCHHHHHHHHhcCcEEEEe--cCcccC--cCC
Q 041073          149 VPCLSNNQLNVYVYVGYDLIATSISHLPDSCAFISKVPVVLNRSV-DKLSYEDLRKSLESGFDLTWL--DWSWSL--SMP  223 (436)
Q Consensus       149 ~~C~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~~~vpv~~~~~~-~~~s~~~~~~~l~~gf~l~w~--~~~C~~--~~~  223 (436)
                      |+|.+++.....+|+..+      ..+...|+.++.|||+..... ...+..+++++|++||+|+|.  ..+|..  .+|
T Consensus         1 ~~C~~~~~~~~~~~v~~~------~~~~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C~~C~~Sg   74 (94)
T PF14380_consen    1 INCSINSGNSVSYFVFRS------SDLAGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDCRECEASG   74 (94)
T ss_pred             CccccCCCCceeEEEeCC------cccCCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcCcChhcCC
Confidence            578887644333334431      346789999999999875432 233678899999999999999  458888  889


Q ss_pred             CcccccCccceeEEeccc
Q 041073          224 RYCMYNAGVVATIICYPY  241 (436)
Q Consensus       224 ~~C~~~~~~~~~~~C~~~  241 (436)
                      |+|+|+.. ...+.|+|.
T Consensus        75 G~Cgy~~~-~~~f~C~C~   91 (94)
T PF14380_consen   75 GRCGYDSN-SEQFTCFCS   91 (94)
T ss_pred             CEeCCCCC-CceEEEECC
Confidence            99999955 478899884

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=98.95  E-value=1.2e-10  Score=103.67  Aligned_cols=119  Identities=24%  Similarity=0.407  Sum_probs=98.2

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      +.....++..+|.+...|..|+|+++.+ .+++|+++...   ...++|.+|.-.|+-+.||||..++|.|.....+.++
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence            3344556778899999999999998744 45667775432   2335799999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG  421 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~  421 (436)
                      ..||+.|+|...++..  .+...+..++.+++.++++||+|||+.
T Consensus       266 sq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl  308 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL  308 (448)
T ss_pred             eeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc
Confidence            9999999999999643  445577888999999999999999985

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.93  E-value=2.7e-09  Score=106.38  Aligned_cols=119  Identities=19%  Similarity=0.242  Sum_probs=77.8

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccC---------------------------HH--------------HHHH
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS---------------------------AE--------------EFIN  347 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------------------------~~--------------~~~~  347 (436)
                      +.||.|++|+||+|++++|+.||||+.++....                           ..              ++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            469999999999999999999999998653100                           00              1344


Q ss_pred             HHHHHcCC----CcCcccceeEEE-EeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH-HHHHHHcC
Q 041073          348 EVSTIGRI----HHVNVVQLLGFC-SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR-GIEYLHNG  421 (436)
Q Consensus       348 E~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-gL~yLH~~  421 (436)
                      |++.+.++    +|.+-+.+...+ ......+|||||++|++|.++.....   ...   ...+++.+++. .+..+|..
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC
Confidence            55444444    222222222222 22345689999999999988763211   112   23456666665 46778877


Q ss_pred             CCCceEecCCCCCCC
Q 041073          422 CDVCILHFDIKPHNI  436 (436)
Q Consensus       422 ~~~~iiHrDlkp~NI  436 (436)
                         +++|+|+||.||
T Consensus       277 ---g~~H~D~hPgNi  288 (437)
T TIGR01982       277 ---GFFHADLHPGNI  288 (437)
T ss_pred             ---CceeCCCCcccE
Confidence               999999999997

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.85  E-value=7.6e-09  Score=89.61  Aligned_cols=113  Identities=19%  Similarity=0.148  Sum_probs=80.2

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcc-cceeEEEEeCCeeeEEEecCCCCChhh
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRAVVYEYMPNGSLDR  387 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~  387 (436)
                      +.|+.|.++.||+++.. ++.+++|...........+..|+..+..+.+.++ .+++...  ....++||||+++.++.+
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence            56899999999999865 6789999876543223346788888888865544 4455443  234579999999988754


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceEecCCCCCCC
Q 041073          388 HIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC--DVCILHFDIKPHNI  436 (436)
Q Consensus       388 ~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~--~~~iiHrDlkp~NI  436 (436)
                      ..         .   ....++.+++++|+.||+..  ...++|+|++|.||
T Consensus        81 ~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Ni  119 (170)
T cd05151          81 ED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNF  119 (170)
T ss_pred             cc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcE
Confidence            21         0   11245678999999999872  12369999999996

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.79  E-value=3.6e-09  Score=106.85  Aligned_cols=118  Identities=14%  Similarity=0.199  Sum_probs=71.5

Q ss_pred             cccCCCCCeEEEEEEEcC-CCEEEEEEecCccc---------------------------CH--------H------HHH
Q 041073          309 HKLGQGGFGSVYKGQLHT-GGLIAVKMLKNSKF---------------------------SA--------E------EFI  346 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~---------------------------~~--------~------~~~  346 (436)
                      +.||+|++|+||++++++ |+.||||++++...                           +.        +      ++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            569999999999999876 99999999975310                           00        1      133


Q ss_pred             HHHHHHcCC----CcCcccceeEEEEe-CCeeeEEEecCCCCChhhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHH
Q 041073          347 NEVSTIGRI----HHVNVVQLLGFCSE-GSKRAVVYEYMPNGSLDRHIFPKES--RGQSFSWEKLHEVALGTARGIEYLH  419 (436)
Q Consensus       347 ~E~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~gL~yLH  419 (436)
                      +|+..+.++    .+.+.+.+...+.+ ....+|||||++|+.+.+.-.....  ....+....+..++.|+.       
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence            444433333    23333333333322 4456799999999999874311110  011233333334444443       


Q ss_pred             cCCCCceEecCCCCCCC
Q 041073          420 NGCDVCILHFDIKPHNI  436 (436)
Q Consensus       420 ~~~~~~iiHrDlkp~NI  436 (436)
                      ..   +++|+|+||.||
T Consensus       278 ~~---GffHaDpHPGNI  291 (537)
T PRK04750        278 RD---GFFHADMHPGNI  291 (537)
T ss_pred             hC---CeeeCCCChHHe
Confidence            23   899999999997

>PLN00181 protein SPA1-RELATED; Provisional

Probab=98.78  E-value=2.7e-09  Score=115.12  Aligned_cols=75  Identities=17%  Similarity=0.134  Sum_probs=60.1

Q ss_pred             CCc-CcccceeEEE-------EeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCce
Q 041073          355 IHH-VNVVQLLGFC-------SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI  426 (436)
Q Consensus       355 l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~i  426 (436)
                      ++| .||.++++.+       ........++|++ +++|.+++..   ....+++.+++.++.||++||+|||++   +|
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            445 5777777766       2234567788987 6699999942   235699999999999999999999998   99


Q ss_pred             EecCCCCCCC
Q 041073          427 LHFDIKPHNI  436 (436)
Q Consensus       427 iHrDlkp~NI  436 (436)
                      +||||||+||
T Consensus       102 vHrDlKP~Ni  111 (793)
T PLN00181        102 VVHNVRPSCF  111 (793)
T ss_pred             eeccCCchhE
Confidence            9999999997

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.75  E-value=7.3e-08  Score=87.20  Aligned_cols=107  Identities=19%  Similarity=0.232  Sum_probs=82.2

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCccc--CHHHHHHHHHHHcCCCc--CcccceeEEEEeC---CeeeEEEecCC
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHH--VNVVQLLGFCSEG---SKRAVVYEYMP  381 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~E~~~  381 (436)
                      +.|+.|..+.+|+++..+|+.+++|.......  ....+.+|.++++.+.+  .++.+++.+....   +..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999876667899998765432  34568899999998875  3457777766553   25689999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN  420 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~  420 (436)
                      +.++.+.+.     ...+++.+...++.+++++|..||+
T Consensus        84 G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~  117 (223)
T cd05154          84 GRVLRDRLL-----RPELSPEERRALARALADTLAALHS  117 (223)
T ss_pred             CEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhC
Confidence            988877551     1357778888889999999999985

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.74  E-value=5.3e-08  Score=85.61  Aligned_cols=117  Identities=12%  Similarity=0.198  Sum_probs=81.5

Q ss_pred             cccCCCCCeEEEEEEEcC-------CCEEEEEEecCcc----------------------cCHH-H----HHHHHHHHcC
Q 041073          309 HKLGQGGFGSVYKGQLHT-------GGLIAVKMLKNSK----------------------FSAE-E----FINEVSTIGR  354 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~-~----~~~E~~~l~~  354 (436)
                      ..||.|.-+.||.|...+       +..+|||+.+.+.                      .+.. .    ..+|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997442       4789999875311                      0111 1    2378888888


Q ss_pred             CCc--CcccceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCceEecCC
Q 041073          355 IHH--VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL-HNGCDVCILHFDI  431 (436)
Q Consensus       355 l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yL-H~~~~~~iiHrDl  431 (436)
                      +..  -++.++++.    ...+|||||+.+..+..-..    +...++.++...+..+++.+|..| |..   +++|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            863  456666654    45689999997654422110    112355566778889999999999 776   9999999


Q ss_pred             CCCCC
Q 041073          432 KPHNI  436 (436)
Q Consensus       432 kp~NI  436 (436)
                      ++.||
T Consensus       152 s~~NI  156 (197)
T cd05146         152 SEYNM  156 (197)
T ss_pred             CHHHE
Confidence            99997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.54  E-value=2.3e-08  Score=103.01  Aligned_cols=122  Identities=20%  Similarity=0.241  Sum_probs=87.9

Q ss_pred             hhcccCCCCCeEEEEEEEc-CCCEEEEEEec----CcccCH---HHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          307 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLK----NSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~----~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ....+|.|++|.|+..... .....+.|..+    ......   ..+..|..+-..+.|+|++..+....+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            3467899999977766532 33333444332    211111   125567777778899998877666555555555599


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++ +|...+.    ....++..++..++.|++.|++|||+.   +|.|||+|++|+
T Consensus       402 ~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enl  451 (601)
T KOG0590|consen  402 YCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENL  451 (601)
T ss_pred             cccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccE
Confidence            9999 9999883    334788999999999999999999988   999999999996

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=98.54  E-value=1e-08  Score=107.21  Aligned_cols=123  Identities=20%  Similarity=0.254  Sum_probs=96.1

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCc--ccCHHHHH---HHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNS--KFSAEEFI---NEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .+.+.+.||.+.|=+|.+++.+.|. |+||++-+.  ....+.+.   +|++ ...++|||.+.+.-+.......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            3456688999999999999977665 899998552  23334444   3444 455689999988777777777788989


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |. .-+|.|.+    ..+..+...+.+=|+.|++.||.-+|..   +|.|+|||.+||
T Consensus       102 yv-khnLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENI  151 (1431)
T KOG1240|consen  102 YV-KHNLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENI  151 (1431)
T ss_pred             HH-hhhhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceE
Confidence            98 45999988    3345577777778999999999999988   999999999997

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.42  E-value=1.8e-06  Score=73.77  Aligned_cols=113  Identities=19%  Similarity=0.206  Sum_probs=81.3

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEE-ecCccc--------CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKM-LKNSKF--------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~-~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ..+++|+-+.++.+.+. |..+++|. +++...        ..++-.+|+.++.+++--.|....=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999998764 33455554 222211        124577899999888766665555556677778899999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++..|.+.+...           ...++..+-.-+.-||..   +|+|+||.++||
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNi  123 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNI  123 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceE
Confidence            9999998888321           244566666677789998   999999999996

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.39  E-value=1.1e-06  Score=74.73  Aligned_cols=122  Identities=18%  Similarity=0.229  Sum_probs=87.7

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEE-ecCc--------ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKM-LKNS--------KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~-~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ..|-+|+-+.|+++.+. |+...||. +.+.        +....+..+|++.+.+++--.|.-..-++.+...-.|+|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            56889999999999875 66666664 2221        12335678899999988765665555556677777899999


Q ss_pred             CCC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPN-GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++ .++.+++...-.  .....+....++.+|-+.+.-||.+   +|||+||..+||
T Consensus        92 ~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNi  144 (229)
T KOG3087|consen   92 IDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNI  144 (229)
T ss_pred             ccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---Ceecccccccce
Confidence            966 377777754321  2223333467888999999999998   999999999997

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=98.38  E-value=5.9e-08  Score=96.33  Aligned_cols=120  Identities=23%  Similarity=0.281  Sum_probs=97.0

Q ss_pred             ccCCCCCeEEEEEE----EcCCCEEEEEEecCccc---CHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEecCC
Q 041073          310 KLGQGGFGSVYKGQ----LHTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       310 ~lg~G~fg~V~~~~----~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .+|+|.||.|+.++    ...+..+|+|++++...   .......|-.++...+ ||.++++.-.+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999875    33567789998866211   1124455667778887 9999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.|...+    .....+++.....+...++-+++++|..   +|+|||+|++||
T Consensus        81 gg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~eni  128 (612)
T KOG0603|consen   81 GGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENV  128 (612)
T ss_pred             cchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccce
Confidence            99998776    3445677777888888999999999987   999999999997

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=98.36  E-value=3.4e-07  Score=86.17  Aligned_cols=72  Identities=18%  Similarity=0.235  Sum_probs=58.0

Q ss_pred             CcCcccceeEEEEe---------------------------CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHH
Q 041073          356 HHVNVVQLLGFCSE---------------------------GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVA  408 (436)
Q Consensus       356 ~h~niv~l~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  408 (436)
                      +|||||++.+++.+                           +...|+||.-++ .+|.+++..     ...+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence            59999998876532                           234688998884 489999843     345667777899


Q ss_pred             HHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          409 LGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       409 ~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .|+++|+.|||.+   +|.|||+|++||
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNi  372 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNI  372 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccce
Confidence            9999999999998   999999999997

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.24  E-value=3.9e-07  Score=83.85  Aligned_cols=84  Identities=19%  Similarity=0.375  Sum_probs=69.7

Q ss_pred             HHcCCCcCcccceeEEEEe-----CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 041073          351 TIGRIHHVNVVQLLGFCSE-----GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC  425 (436)
Q Consensus       351 ~l~~l~h~niv~l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~  425 (436)
                      .|-.+-|.|||+++.++.+     .....+++|||+.|+|.++|...+.....+......+++.||..||.|||+ |+|+
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence            3445569999999988854     344678999999999999997655566778888889999999999999999 5899


Q ss_pred             eEecCCCCCC
Q 041073          426 ILHFDIKPHN  435 (436)
Q Consensus       426 iiHrDlkp~N  435 (436)
                      |+|+++.-+-
T Consensus       199 iihgnlTc~t  208 (458)
T KOG1266|consen  199 IIHGNLTCDT  208 (458)
T ss_pred             cccCCcchhh
Confidence            9999987553

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.15  E-value=1.9e-05  Score=73.36  Aligned_cols=114  Identities=16%  Similarity=0.069  Sum_probs=78.4

Q ss_pred             eEEEEEEEcCCCEEEEEEecCcc------------cCHHHHHHHHHHHcCCCcCccc--ceeEEEEe-----CCeeeEEE
Q 041073          317 GSVYKGQLHTGGLIAVKMLKNSK------------FSAEEFINEVSTIGRIHHVNVV--QLLGFCSE-----GSKRAVVY  377 (436)
Q Consensus       317 g~V~~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~h~niv--~l~~~~~~-----~~~~~lv~  377 (436)
                      ..|.+.+. .|+.+.||......            .....+.+|...+.++...+|.  ++.++.+.     ....++||
T Consensus        36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            34566655 46778899764321            0111477888888777544443  44455543     23468999


Q ss_pred             ecCCCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNG-SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |++++. +|.+++....  ....+......++.+++..+.-||..   +|+|+|++++||
T Consensus       115 e~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~Ni  169 (268)
T PRK15123        115 EDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHF  169 (268)
T ss_pred             eeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhE
Confidence            999876 8988873211  13345667778999999999999998   999999999997

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.11  E-value=3.7e-06  Score=78.22  Aligned_cols=126  Identities=22%  Similarity=0.293  Sum_probs=76.4

Q ss_pred             hhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCc----------CcccceeEEE----
Q 041073          307 FTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHH----------VNVVQLLGFC----  367 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h----------~niv~l~~~~----  367 (436)
                      ..+.||.|+++.||.++.. +++.+|+|+.....    ...+++.+|.-....+.+          -.++..++..    
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            4467999999999999965 68899999975422    234556666654444322          1222222222    


Q ss_pred             -----EeC---C-----eeeEEEecCCCCChhhhccC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCC
Q 041073          368 -----SEG---S-----KRAVVYEYMPNGSLDRHIFP---KESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDI  431 (436)
Q Consensus       368 -----~~~---~-----~~~lv~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDl  431 (436)
                           ...   .     +.+++|+-+ .++|.+++..   .......+.......+..|+++.+++||+.   +++|+||
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi  171 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI  171 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence                 111   1     235677777 5688877531   111111233334456678999999999998   9999999


Q ss_pred             CCCCC
Q 041073          432 KPHNI  436 (436)
Q Consensus       432 kp~NI  436 (436)
                      ||+|+
T Consensus       172 ~~~nf  176 (288)
T PF14531_consen  172 KPENF  176 (288)
T ss_dssp             SGGGE
T ss_pred             ceeeE
Confidence            99985

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.09  E-value=6.2e-06  Score=81.77  Aligned_cols=79  Identities=23%  Similarity=0.391  Sum_probs=69.9

Q ss_pred             HcCCCcCcccceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCC
Q 041073          352 IGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDI  431 (436)
Q Consensus       352 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDl  431 (436)
                      |+.+.|.|+.+++|.+..++..++|.+|+..|+|.+.+..   ....+++.....+.++++.||+|||..  +-..|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence            4568899999999999999999999999999999999943   456799999999999999999999985  22399999


Q ss_pred             CCCC
Q 041073          432 KPHN  435 (436)
Q Consensus       432 kp~N  435 (436)
                      +++|
T Consensus        76 ~s~n   79 (484)
T KOG1023|consen   76 KSSN   79 (484)
T ss_pred             cccc
Confidence            9987

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.01  E-value=1.3e-05  Score=80.82  Aligned_cols=100  Identities=18%  Similarity=0.260  Sum_probs=78.8

Q ss_pred             EcCCCEEEEEEecCccc-CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHH
Q 041073          324 LHTGGLIAVKMLKNSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE  402 (436)
Q Consensus       324 ~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~  402 (436)
                      ..++.+|.|...+.+.. ..+...+-++.|+.++||||++++...+..+..|||+|-+.  .|..++       ..++..
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~l-------k~l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVL-------KELGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHH-------HHhHHH
Confidence            44678888888876433 23446777889999999999999999999999999999883  577777       223456


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCceEecCCCCC
Q 041073          403 KLHEVALGTARGIEYLHNGCDVCILHFDIKPH  434 (436)
Q Consensus       403 ~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~  434 (436)
                      ...--+.||+.||.|||+.|  +++|++|.-.
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~  134 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKD  134 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeee
Confidence            66677899999999999764  8999998644

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=97.98  E-value=2.1e-06  Score=85.28  Aligned_cols=126  Identities=21%  Similarity=0.220  Sum_probs=95.8

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc--CCCEEEEEEecCcccC---HHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH--TGGLIAVKMLKNSKFS---AEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      +++....||.|.|+.|+....+  ++..+++|.+......   ...-..|+.+...+ .|.+++.....|......++-.
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~  345 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL  345 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence            3445678999999999988744  6678898887653221   11234455555555 3888888887777777788999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||++++++...+    .-...+.+...+++..|++.++.++|+.   .++|+|+||+||
T Consensus       346 e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni  397 (524)
T KOG0601|consen  346 EFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNI  397 (524)
T ss_pred             hhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccce
Confidence            999999887665    2335678888899999999999999987   999999999997

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.92  E-value=2.5e-05  Score=68.45  Aligned_cols=106  Identities=24%  Similarity=0.250  Sum_probs=66.4

Q ss_pred             EEEEEEEcCCCEEEEEEecCccc-----------------------C----HHHHHHHHHHHcCCCcC--cccceeEEEE
Q 041073          318 SVYKGQLHTGGLIAVKMLKNSKF-----------------------S----AEEFINEVSTIGRIHHV--NVVQLLGFCS  368 (436)
Q Consensus       318 ~V~~~~~~~~~~vavK~~~~~~~-----------------------~----~~~~~~E~~~l~~l~h~--niv~l~~~~~  368 (436)
                      .||.|...++..+|+|+.+....                       .    .....+|.+.|.++...  ++.+++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999888888999998753110                       0    12367899999999755  566666442 


Q ss_pred             eCCeeeEEEecCC--CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCceEecCCCCCCC
Q 041073          369 EGSKRAVVYEYMP--NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL-HNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       369 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yL-H~~~~~~iiHrDlkp~NI  436 (436)
                         ...|||||++  +..+.....      ..++.+....++.+++..+..+ |..   +|+|+||.+.||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~------~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NI  138 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKD------VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNI  138 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHH------CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSE
T ss_pred             ---CCEEEEEecCCCccchhhHHh------ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhE
Confidence               3469999998  544433321      1112344566777888866664 676   999999999996

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=97.82  E-value=4.1e-06  Score=86.56  Aligned_cols=128  Identities=23%  Similarity=0.262  Sum_probs=96.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc--CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH--TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  377 (436)
                      .+.+.+.||+|+|+.|-.....  ....+|+|.+....   ........|..+-+.+. |.|++++++.....+..++.+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            4456677999999999877643  33446666654432   12233445666666676 999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH-~~~~~~iiHrDlkp~NI  436 (436)
                      ||..++++.+.+.  .......+...+..+..|+..++.|+| ..   ++.|||+||+|.
T Consensus       101 ~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~  155 (601)
T KOG0590|consen  101 SYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNS  155 (601)
T ss_pred             Ccccccccccccc--cCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccc
Confidence            9999999988772  112224666777889999999999999 66   999999999984

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.77  E-value=0.00012  Score=66.56  Aligned_cols=115  Identities=23%  Similarity=0.227  Sum_probs=77.6

Q ss_pred             hhhcccCCCCCeEEEEEEEcCCCEEEEEEecCccc-----------------------CHHHHHHHHHHHcCCCcC--cc
Q 041073          306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF-----------------------SAEEFINEVSTIGRIHHV--NV  360 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~--ni  360 (436)
                      .+.++||-|.-+.||.|....|.++|||.=+....                       ......+|.+.|.++...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            45678999999999999988899999997432110                       112367889999988644  66


Q ss_pred             cceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       361 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+.++    -+...+|||++++-.|...-         ++.+....++..|++-+.-+-..   +|||+|+.+=||
T Consensus       174 P~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNI  233 (304)
T COG0478         174 PKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNI  233 (304)
T ss_pred             CCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheE
Confidence            66654    34567999999886664422         12233334444444444444344   899999999886

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=97.73  E-value=2.1e-05  Score=78.29  Aligned_cols=131  Identities=22%  Similarity=0.198  Sum_probs=99.1

Q ss_pred             HHHHHhhhhhcccCC--CCCeEEEEEEE---cCCCEEEEEEecC--c-ccCHHHHHHHHHHHcCCC-cCcccceeEEEEe
Q 041073          299 EIIAMTNHFTHKLGQ--GGFGSVYKGQL---HTGGLIAVKMLKN--S-KFSAEEFINEVSTIGRIH-HVNVVQLLGFCSE  369 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~--G~fg~V~~~~~---~~~~~vavK~~~~--~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  369 (436)
                      +.........+.+|.  |.+|.+|.+..   .++..+|+|.-+.  + .....+=.+|+...++++ |+|.++.+..++.
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            344455556677899  99999999874   3677888887432  1 122223346666666775 9999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCceEecCCCCCCC
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR----GIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++..++-+|++ +.+|.++.+.   ....++...++....+..+    ||.++|+.   .++|-|+||.||
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i  253 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANI  253 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhhe
Confidence            99999999988 5788888743   2344666777777777777    99999998   999999999997

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.58  E-value=0.00022  Score=63.90  Aligned_cols=88  Identities=19%  Similarity=0.260  Sum_probs=65.9

Q ss_pred             HHHHHHHHHHHcCCCcC--cccceeEEEEeCC----eeeEEEecCCCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q 041073          342 AEEFINEVSTIGRIHHV--NVVQLLGFCSEGS----KRAVVYEYMPNG-SLDRHIFPKESRGQSFSWEKLHEVALGTARG  414 (436)
Q Consensus       342 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~g  414 (436)
                      .....+|...+..+...  ..++.+++.....    ..++|+|++++. +|.+++...    ...+......++.++++.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARL  130 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHH
Confidence            34577888877777533  3455566665422    348999999874 899988321    225666778899999999


Q ss_pred             HHHHHcCCCCceEecCCCCCCC
Q 041073          415 IEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       415 L~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++-||+.   +|+|+|+++.||
T Consensus       131 i~~lH~~---gi~H~Dl~~~NI  149 (206)
T PF06293_consen  131 IAKLHDA---GIYHGDLNPSNI  149 (206)
T ss_pred             HHHHHHC---cCCCCCCCcccE
Confidence            9999998   999999999997

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=97.58  E-value=0.0003  Score=69.16  Aligned_cols=117  Identities=19%  Similarity=0.204  Sum_probs=83.6

Q ss_pred             eEEEEEE-EcCCCEEEEEEecCccc-CHHHHHHHHHHHcCCCcCcccceeEEEEe----CCeeeEEEecCCC-CChhhhc
Q 041073          317 GSVYKGQ-LHTGGLIAVKMLKNSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRAVVYEYMPN-GSLDRHI  389 (436)
Q Consensus       317 g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~~~-gsL~~~l  389 (436)
                      .+.|++. ..+|..+++|.++..+. .......-++.++++.|.|+|++.+++..    +..+.+|++|+|+ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            4578887 44888999999854221 11122344678899999999999988763    4457899999985 5776654


Q ss_pred             cCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          390 FPKE-----------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       390 ~~~~-----------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ....           ..+...+++.++.++.|+..||.++|+.   |+.-+-|.+++|
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kI  424 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKI  424 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHe
Confidence            4321           1234578899999999999999999987   666666655544

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.54  E-value=0.00029  Score=71.17  Aligned_cols=120  Identities=16%  Similarity=0.183  Sum_probs=72.7

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccC---------------------------HH--------------HHHH
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS---------------------------AE--------------EFIN  347 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------------------------~~--------------~~~~  347 (436)
                      +.|+.++-|+||+|++++|+.||||+.++.-..                           ..              ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            568899999999999999999999998653110                           00              0334


Q ss_pred             HHHHHcCC----CcCcccceeEEE-EeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 041073          348 EVSTIGRI----HHVNVVQLLGFC-SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC  422 (436)
Q Consensus       348 E~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~  422 (436)
                      |...+.++    +...-+++-..+ +-.+...|+|||++|-.+.+....+.   ..++...+.....++.--.-+-|   
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f~~q~~~d---  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAFLRQLLRD---  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHHHHHHHhc---
Confidence            44444433    222222333333 33566789999999998888742221   33443333333322222222323   


Q ss_pred             CCceEecCCCCCCC
Q 041073          423 DVCILHFDIKPHNI  436 (436)
Q Consensus       423 ~~~iiHrDlkp~NI  436 (436)
                        +++|.|..|.||
T Consensus       285 --gffHaDpHpGNi  296 (517)
T COG0661         285 --GFFHADPHPGNI  296 (517)
T ss_pred             --CccccCCCccce
Confidence              899999999997

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.51  E-value=0.001  Score=58.80  Aligned_cols=114  Identities=18%  Similarity=0.279  Sum_probs=78.8

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcc-----------------cCHHHHHHHHHHHcCCC------cCcccceeE
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSK-----------------FSAEEFINEVSTIGRIH------HVNVVQLLG  365 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~l~~  365 (436)
                      ..||+|+.=.||.  .+......||+.....                 ....+..+|+.....+.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            5689999988885  3445557889886644                 12345667776554444      789999999


Q ss_pred             EEEeCCeeeEEEecCCC------CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          366 FCSEGSKRAVVYEYMPN------GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       366 ~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +.+++.-.-+|+|.+.+      -+|.+++.     ...++. ...+.+.++   .+||-+.   .|+.+|++|+||
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L~~f---~~~l~~~---~Iv~~dl~~~NI  149 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQALDEF---KRYLLDH---HIVIRDLNPHNI  149 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHHHHH---HHHHHHc---CCeecCCCcccE
Confidence            99998888999998743      36777772     234555 344444444   3455555   899999999997

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.36  E-value=0.0026  Score=57.81  Aligned_cols=72  Identities=17%  Similarity=0.358  Sum_probs=53.4

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCc--ccceeEEEEeCCeeeEEEecCCCCC
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVN--VVQLLGFCSEGSKRAVVYEYMPNGS  384 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gs  384 (436)
                      ..||+|..+.||+.   .+..+++|..+... ......+|.+.+..+..-.  +.+.+++....+...++||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            56899999999984   24457788876532 4456788999998876433  4677777777777889999998863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK09902 hypothetical protein; Provisional

Probab=97.31  E-value=0.0036  Score=55.54  Aligned_cols=119  Identities=18%  Similarity=0.118  Sum_probs=82.8

Q ss_pred             CCCCCeEEEEEEEcCCCEEEEEEecC----c---ccCHHHHHHHHHHHcCCCcCc--ccceeEEEEe----CCeeeEEEe
Q 041073          312 GQGGFGSVYKGQLHTGGLIAVKMLKN----S---KFSAEEFINEVSTIGRIHHVN--VVQLLGFCSE----GSKRAVVYE  378 (436)
Q Consensus       312 g~G~fg~V~~~~~~~~~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~----~~~~~lv~E  378 (436)
                      |+||-+-|++-... |..+-+|.-..    +   ......|.+|...+..+...+  +.+.......    .-..+||+|
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            67899999987765 33577776542    1   223456999999988885333  4444422111    123579999


Q ss_pred             cCCC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPN-GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      -+++ -+|.+++...  .....+......+..++++.+.-||+.   ++.|+|+-+.||
T Consensus       106 ~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khI  159 (216)
T PRK09902        106 DMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHI  159 (216)
T ss_pred             eCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhhe
Confidence            7753 5888887321  123457777789999999999999998   999999999987

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.28  E-value=0.0007  Score=68.34  Aligned_cols=118  Identities=17%  Similarity=0.207  Sum_probs=75.2

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCH--------------------------------H------HHHHHHH
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA--------------------------------E------EFINEVS  350 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--------------------------------~------~~~~E~~  350 (436)
                      +.||..+.|.|+++++++|+.||||+.++.-...                                +      +|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5699999999999999999999999976532110                                0      1334443


Q ss_pred             HHcC----CCcCc------ccceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 041073          351 TIGR----IHHVN------VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN  420 (436)
Q Consensus       351 ~l~~----l~h~n------iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~  420 (436)
                      -..+    +.|-+      |.+++-  .-.....|+||||+|..+.+.-.-   ....++...+..-+.++..-+-+-| 
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf~~-  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIFKT-  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHHhc-
Confidence            3222    23444      333332  224467899999999877665321   2234666665555555444444444 


Q ss_pred             CCCCceEecCCCCCCC
Q 041073          421 GCDVCILHFDIKPHNI  436 (436)
Q Consensus       421 ~~~~~iiHrDlkp~NI  436 (436)
                          |++|.|-.|.||
T Consensus       321 ----GffHaDPHPGNi  332 (538)
T KOG1235|consen  321 ----GFFHADPHPGNI  332 (538)
T ss_pred             ----CCccCCCCCCcE
Confidence                899999999997

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.13  E-value=0.0049  Score=54.94  Aligned_cols=117  Identities=15%  Similarity=0.140  Sum_probs=68.6

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHH----------HHHHHHHHcCCC---cCcccceeEEEEe-
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE----------FINEVSTIGRIH---HVNVVQLLGFCSE-  369 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~---h~niv~l~~~~~~-  369 (436)
                      .+...+.+-......|.+-... ++.+++|..+......++          ..+++..+.+++   -.....++.+... 
T Consensus        32 ~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk  110 (229)
T PF06176_consen   32 NYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK  110 (229)
T ss_pred             CceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence            3444455555555566665544 677888987653222221          223333333332   2223332322221 


Q ss_pred             ----CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          370 ----GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                          ....+++|||++|..|.+..        .+++    .++..+.+++.-||..   |+.|+|..|.|+
T Consensus       111 ~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNF  166 (229)
T PF06176_consen  111 IFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNF  166 (229)
T ss_pred             eccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcE
Confidence                23456899999998886654        1232    2456677889999998   999999999995

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.00  E-value=0.0048  Score=54.30  Aligned_cols=122  Identities=24%  Similarity=0.401  Sum_probs=81.3

Q ss_pred             CCCccChHHHHHHhhhhhcccCCCCC-eEEEEEEEcCCCEEEEEEecC-----c-----c------------cCHHHHHH
Q 041073          291 MPKRYSYPEIIAMTNHFTHKLGQGGF-GSVYKGQLHTGGLIAVKMLKN-----S-----K------------FSAEEFIN  347 (436)
Q Consensus       291 ~~~~~~~~~i~~~~~~~~~~lg~G~f-g~V~~~~~~~~~~vavK~~~~-----~-----~------------~~~~~~~~  347 (436)
                      ....|+..   ...+++.+.||.|.- |.||++++. |+.+|+|+++.     .     .            .....|..
T Consensus        28 KL~~F~~h---~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~  103 (207)
T PF13095_consen   28 KLEPFTHH---GDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNC  103 (207)
T ss_pred             CcCCcCCC---CCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHH
Confidence            33445542   256778899999999 999999976 67999999322     0     0            01124788


Q ss_pred             HHHHHcCCC---cCcc--cceeEEEEeC------------------CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHH
Q 041073          348 EVSTIGRIH---HVNV--VQLLGFCSEG------------------SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKL  404 (436)
Q Consensus       348 E~~~l~~l~---h~ni--v~l~~~~~~~------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~  404 (436)
                      |.+...+++   +.++  |+.+|+..-.                  ....||-||.+...             .++    
T Consensus       104 ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----  166 (207)
T PF13095_consen  104 ECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----  166 (207)
T ss_pred             HHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----
Confidence            888777764   4455  8888887322                  11246666654422             122    


Q ss_pred             HHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          405 HEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       405 ~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+-+.+|.+-|..+|..   +|+=+|+|++|.
T Consensus       167 ~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny  195 (207)
T PF13095_consen  167 IRDIPQMLRDLKILHKL---GIVPRDVKPRNY  195 (207)
T ss_pred             hhHHHHHHHHHHHHHHC---CeeeccCccccc
Confidence            23456677778889987   999999999983

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=96.91  E-value=0.0057  Score=55.28  Aligned_cols=117  Identities=18%  Similarity=0.237  Sum_probs=74.9

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCH--------------------HH-----HHHHHHHHcCCC--cCccc
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA--------------------EE-----FINEVSTIGRIH--HVNVV  361 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--------------------~~-----~~~E~~~l~~l~--h~niv  361 (436)
                      -.|.+|.-+.||+|...++..+|+|+++......                    ++     ...|...|+++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            3577888899999998788999999986532111                    11     345666666653  33344


Q ss_pred             ceeEEEEeCCeeeEEEecCCCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          362 QLLGFCSEGSKRAVVYEYMPNG-SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       362 ~l~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +.+++.    .-.|||||+... .-.-.|     +...+...++..+..++++.|.-|-..  -++||+||..=||
T Consensus       134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNi  198 (268)
T COG1718         134 EPIAFR----NNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNI  198 (268)
T ss_pred             Cceeec----CCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhhe
Confidence            444332    346999999653 111112     112334446777888889988888762  2899999988775

>PRK10593 hypothetical protein; Provisional

Probab=96.85  E-value=0.0096  Score=56.49  Aligned_cols=102  Identities=10%  Similarity=0.074  Sum_probs=71.4

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCc---CcccceeEEEEe---CCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH---VNVVQLLGFCSE---GSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~E~~~~  382 (436)
                      +.||.|..+.||+....++ .+.+|..+. ......+..|.+.|+.+..   ..+.++++.+..   .+..+||||++++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            5699999999999875555 466676432 2234578899999888753   357788877754   3568999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG  421 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~  421 (436)
                      +++.+ .        ..+......+..+++++|+-||+.
T Consensus        98 ~~~~~-~--------~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         98 VSVEA-P--------ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EecCC-C--------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            87754 1        122334456667777888888863

>PLN02876 acyl-CoA dehydrogenase

Probab=96.67  E-value=0.014  Score=63.47  Aligned_cols=106  Identities=16%  Similarity=0.251  Sum_probs=75.5

Q ss_pred             cccCCCCCeEEEEEEEcCC---CEEEEEEecCcc--cCHHHHHHHHHHHcCCC-cCcc--cceeEEEEeC---CeeeEEE
Q 041073          309 HKLGQGGFGSVYKGQLHTG---GLIAVKMLKNSK--FSAEEFINEVSTIGRIH-HVNV--VQLLGFCSEG---SKRAVVY  377 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv~  377 (436)
                      +.++.|....+|+.....+   ..+++|+.....  .....+.+|.++|+.+. |.++  .+++..+.+.   +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            5688999999998876543   357777654422  23456889999999885 6654  7777777653   4578999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN  420 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~  420 (436)
                      ||+++..+.+.      ....++..++..++.++++.|+.||+
T Consensus       124 E~v~G~~~~~~------~~~~~~~~~r~~l~~~l~~~La~LH~  160 (822)
T PLN02876        124 EYLEGRIFVDP------KLPGVAPERRRAIYRATAKVLAALHS  160 (822)
T ss_pred             EecCCcccCCc------cCCCCCHHHHHHHHHHHHHHHHHHhC
Confidence            99987544321      11245677778889999999999987

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=96.55  E-value=0.0019  Score=68.70  Aligned_cols=88  Identities=24%  Similarity=0.363  Sum_probs=52.3

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCC
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGS  384 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  384 (436)
                      +..+.|..|++|.||.++.+ +.+.+|+|+ ++...-   +.+   ++.....|.               .|      |+
T Consensus        86 ~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li---lRn---ilt~a~npf---------------vv------gD  137 (1205)
T KOG0606|consen   86 NTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI---LRN---ILTFAGNPF---------------VV------GD  137 (1205)
T ss_pred             ceeEeeccCCCCceeeeeccccccchhhcc-cccchh---hhc---cccccCCcc---------------ee------ch
Confidence            34578999999999999865 556678753 222110   001   111222222               22      34


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          385 LDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      -...+    +.-+.++..        ++.+++|||+.   +|+|||+||+|+
T Consensus       138 c~tll----k~~g~lPvd--------mvla~Eylh~y---givhrdlkpdnl  174 (1205)
T KOG0606|consen  138 CATLL----KNIGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNL  174 (1205)
T ss_pred             hhhhc----ccCCCCcch--------hhHHhHhhccC---CeecCCCCCCcc
Confidence            33333    122333322        27889999987   999999999995

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.50  E-value=0.0079  Score=52.85  Aligned_cols=85  Identities=28%  Similarity=0.304  Sum_probs=62.0

Q ss_pred             HHHHHHcCCCc-CcccceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 041073          347 NEVSTIGRIHH-VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC  425 (436)
Q Consensus       347 ~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~  425 (436)
                      +|.-++..+++ +++++++|.|-    .+++.||.+.+++...-. .-..-..-+|..+.+||.++++.+++|++...-.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            57777888875 59999999983    357899998776532100 0011124689999999999999999999853335


Q ss_pred             eEecCCCCCCC
Q 041073          426 ILHFDIKPHNI  436 (436)
Q Consensus       426 iiHrDlkp~NI  436 (436)
                      +.-.|++++|+
T Consensus        83 ~~lcDv~~~nf   93 (188)
T PF12260_consen   83 FYLCDVSPDNF   93 (188)
T ss_pred             EEEeecchHHe
Confidence            66799999985

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=96.41  E-value=0.001  Score=65.48  Aligned_cols=58  Identities=21%  Similarity=0.326  Sum_probs=49.8

Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..+|.|+++...+|.+||..++ .....++...+.++.|++.|++|   +   +.+|||+||.||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~ni  387 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNI  387 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhcccccc
Confidence            4789999999999999995432 34567788899999999999999   4   899999999997

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.40  E-value=0.023  Score=48.66  Aligned_cols=78  Identities=18%  Similarity=0.322  Sum_probs=56.1

Q ss_pred             hhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCccc-ceeEEEEeCCeeeEEEecCCCCC
Q 041073          306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVV-QLLGFCSEGSKRAVVYEYMPNGS  384 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gs  384 (436)
                      +..+.|++|.+|.||+|.+. +..+|+|+-+.+. ....+..|+++|..+.-.++. +++.+.    ..++.|||+.|..
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS-PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCc-chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence            34577999999999999976 5578888765433 446788999999888755543 334332    2345699998888


Q ss_pred             hhhhc
Q 041073          385 LDRHI  389 (436)
Q Consensus       385 L~~~l  389 (436)
                      |.+.-
T Consensus        99 L~~~~  103 (201)
T COG2112          99 LGKLE  103 (201)
T ss_pred             hhhhh
Confidence            87755

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.06  E-value=0.024  Score=51.13  Aligned_cols=101  Identities=23%  Similarity=0.307  Sum_probs=72.5

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcC--cccceeEEEEe---CCeeeEEEecCCCC
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV--NVVQLLGFCSE---GSKRAVVYEYMPNG  383 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~E~~~~g  383 (436)
                      +.|+.|..+.||+....+ +.+++|..... .....+.+|..++..+...  .+.+++.....   ....+++||++++.
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            467889999999999776 68999987655 3345677888888777533  35566664432   34568999999998


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 041073          384 SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG  421 (436)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~  421 (436)
                      .+..          ..+......++.++++.|.-||+.
T Consensus        81 ~~~~----------~~~~~~~~~~~~~~~~~l~~lh~~  108 (239)
T PF01636_consen   81 PLDD----------ELSPEQRPELLRQLGRALAQLHQV  108 (239)
T ss_dssp             EHHH----------TSTHHHHHHHHHHHHHHHHHHHHS
T ss_pred             cccc----------cccccccccccccchhhhhhcccc
Confidence            8766          245667777888888888888864

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=95.50  E-value=0.075  Score=48.69  Aligned_cols=97  Identities=12%  Similarity=0.170  Sum_probs=61.6

Q ss_pred             cCCCCC-eEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEecCCCCChhhh
Q 041073          311 LGQGGF-GSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRH  388 (436)
Q Consensus       311 lg~G~f-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~  388 (436)
                      |..|.. ..||+.... +..+.+|......  ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|...
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            444544 778998754 3677888775432  335677888887774 34456777777666678899999999887653


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 041073          389 IFPKESRGQSFSWEKLHEVALGTARGIEYLHN  420 (436)
Q Consensus       389 l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~  420 (436)
                      ..       ..   ....++.++++.|+-||+
T Consensus        83 ~~-------~~---~~~~~~~~l~~~l~~lH~  104 (244)
T cd05150          83 WE-------EL---EPERLVDALAEALRRLHA  104 (244)
T ss_pred             hc-------cc---CHHHHHHHHHHHHHHHhc
Confidence            21       01   122345555555555554

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.42  E-value=0.062  Score=51.49  Aligned_cols=120  Identities=18%  Similarity=0.270  Sum_probs=81.8

Q ss_pred             hcccCCCCCeEEEEEEEcCCCEEEEEEecCccc----------------------CHH-----HHHHHHHHHcCCCcCcc
Q 041073          308 THKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF----------------------SAE-----EFINEVSTIGRIHHVNV  360 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~----------------------~~~-----~~~~E~~~l~~l~h~ni  360 (436)
                      ...|..|.-+.||.+.-.+|..+|||+++.+..                      +++     ....|++-|++++...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            356888999999999988899999999754210                      111     14567778888876665


Q ss_pred             cceeEEEEeCCeeeEEEecCCCCC-hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          361 VQLLGFCSEGSKRAVVYEYMPNGS-LDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       361 v~l~~~~~~~~~~~lv~E~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...--....  ...|||+|+..-. ..-.|     +.-.++...+..+-.|++.-|.-|-+.|  ++||.||.-=|+
T Consensus       229 P~PePIlLk--~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~  296 (520)
T KOG2270|consen  229 PCPEPILLK--NHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNL  296 (520)
T ss_pred             CCCCceeee--cceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhh
Confidence            543322222  2469999995321 11112     3346777888888899999999898876  899999975543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=95.35  E-value=0.08  Score=48.26  Aligned_cols=73  Identities=18%  Similarity=0.224  Sum_probs=44.4

Q ss_pred             cccCCCCCe-EEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcC---cccceeEEEEeC---CeeeEEEecCC
Q 041073          309 HKLGQGGFG-SVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV---NVVQLLGFCSEG---SKRAVVYEYMP  381 (436)
Q Consensus       309 ~~lg~G~fg-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~E~~~  381 (436)
                      +.|+.|+.. .||+.    +..+++|..+. ......+.+|.+.+..+...   -+.++++.....   ...+++||+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            346766665 48875    23467776544 22345788999988777532   334444433221   23478999999


Q ss_pred             CCChh
Q 041073          382 NGSLD  386 (436)
Q Consensus       382 ~gsL~  386 (436)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            87764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=93.57  E-value=0.48  Score=46.71  Aligned_cols=79  Identities=14%  Similarity=0.195  Sum_probs=55.3

Q ss_pred             cccCCCCCeEEEEEEEcCC-CEEEEEEecC------c--ccCHHHHHHHHHHHcCCC---cCcccceeEEEEeCCeeeEE
Q 041073          309 HKLGQGGFGSVYKGQLHTG-GLIAVKMLKN------S--KFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~-~~vavK~~~~------~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  376 (436)
                      +.||.|.+..||++...+| +.++||.-.+      .  ....++...|.+.|..+.   ...+++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999998766 4799998542      1  224566777888877653   2456777765  34557899


Q ss_pred             EecCCCCC-hhhhc
Q 041073          377 YEYMPNGS-LDRHI  389 (436)
Q Consensus       377 ~E~~~~gs-L~~~l  389 (436)
                      |||+++.. +.+.+
T Consensus       110 ME~L~~~~~lr~~L  123 (401)
T PRK09550        110 MEDLSDHKILRKGL  123 (401)
T ss_pred             EecCCCccHHHHHH
Confidence            99998754 44444

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=92.76  E-value=0.46  Score=43.07  Aligned_cols=74  Identities=14%  Similarity=0.191  Sum_probs=46.8

Q ss_pred             cccCCCCCeEEEEEEEcC--CCEEEEEEecCcccCHHHHHHHHHHHcCCCcCc-ccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          309 HKLGQGGFGSVYKGQLHT--GGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      +.|..|-...+|+....+  ++.+++|+........-...+|+.++..+...+ .+++++...    ..++|||+++.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            456778888999987653  567889976543221122346888877775333 344444332    2489999988766


Q ss_pred             h
Q 041073          386 D  386 (436)
Q Consensus       386 ~  386 (436)
                      .
T Consensus        80 ~   80 (235)
T cd05157          80 E   80 (235)
T ss_pred             C
Confidence            4

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=92.60  E-value=1.3  Score=40.81  Aligned_cols=72  Identities=8%  Similarity=0.059  Sum_probs=44.7

Q ss_pred             ccCCCCCeEEEEEEEcCCCEEEEEEecCcccCH-HHHHHHHHHHcCCCcCcc-cceeEEEEeCCeeeEEEecCCCCChh
Q 041073          310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRAVVYEYMPNGSLD  386 (436)
Q Consensus       310 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~  386 (436)
                      .+..|-...+|+.. .+++.+++|......... -...+|.++++.+....+ .+++....    ..+||||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            35667778899887 346678888765422111 134678888887764333 34444321    36899999887654

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=92.33  E-value=0.019  Score=61.44  Aligned_cols=121  Identities=18%  Similarity=0.174  Sum_probs=77.2

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      +-+-+|.++.++...-. .+...+.|+....    ....+....+-.++-..++|-+++..-.+.......|+++|..++
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            45777888888876522 3433344433221    111122222222222234566665544445567789999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|...++.    ....+.+-+......+.++++|||..   .++|||++|.|+
T Consensus       890 ~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~  935 (1205)
T KOG0606|consen  890 DLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSL  935 (1205)
T ss_pred             Cchhhhhc----CCCcccccccchhHHHHhhhhccccc---hhhcccccccch
Confidence            99988843    23456666677778899999999986   689999999884

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=90.80  E-value=0.086  Score=42.52  Aligned_cols=43  Identities=19%  Similarity=0.324  Sum_probs=33.0

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHc
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIG  353 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~  353 (436)
                      +.||.|+.|+||+|++++|+.||||+.++.-  .+.+...+.+|+
T Consensus        17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~i--~~~i~~Dl~~l~   59 (119)
T PF03109_consen   17 EPLASASIAQVHRARLKDGEEVAVKVQRPGI--EEQIEADLRILR   59 (119)
T ss_pred             chhhheehhhheeeeecccchhhhhhcchHH--HHHHHHHHHHHH
Confidence            4699999999999999999999999987642  234445555554

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=90.14  E-value=0.066  Score=54.63  Aligned_cols=112  Identities=13%  Similarity=0.116  Sum_probs=74.8

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCc-ccceeEEEEeCCeeeEEEecCCCC-Chh
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRAVVYEYMPNG-SLD  386 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~~g-sL~  386 (436)
                      +..+++++++++|.+-...+....+.+...    ....-++++|.+++||| .+..++-+..+...++.++++..+ +-.
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~  323 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA  323 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence            446888899999877433333334544332    33456788999999999 677777777777889999999776 222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecC
Q 041073          387 RHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFD  430 (436)
Q Consensus       387 ~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrD  430 (436)
                      ..+   ......+...+...+.+.-++++++||+.   .-+|||
T Consensus       324 ~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d  361 (829)
T KOG0576|consen  324 LEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD  361 (829)
T ss_pred             ccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc
Confidence            222   11122345555667778888999999975   347887

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=88.86  E-value=3  Score=39.04  Aligned_cols=44  Identities=11%  Similarity=-0.006  Sum_probs=28.0

Q ss_pred             CCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC
Q 041073          312 GQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH  356 (436)
Q Consensus       312 g~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~  356 (436)
                      ++|--..|+.....+|+.+++|.-+.. .....+.+|.++|+.+.
T Consensus        20 ~~g~~~~v~~i~~~~g~~~VlR~p~~~-~~~~~l~rE~~vL~~L~   63 (276)
T cd05152          20 ESGLDFQVVFAKDTDGVPWVLRIPRRP-DVSERAAAEKRVLALVR   63 (276)
T ss_pred             CCcceeEEEEEEcCCCCeEEEEecCCH-HHHHHHHHHHHHHHHHH
Confidence            444445566554456778888876432 22356788999888775

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=88.82  E-value=1.6  Score=41.11  Aligned_cols=72  Identities=17%  Similarity=0.328  Sum_probs=45.8

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC---cCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      +.++.|....+|+.. .+++.+.||+-...  ....|..|.+-|+.|.   --.+++++++....+..+|+|||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~--~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNSES--GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEEGG--GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecChh--hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            568889899999877 56778899987632  2245778887777763   446778888887777789999999765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=87.70  E-value=4.8  Score=39.82  Aligned_cols=100  Identities=13%  Similarity=0.087  Sum_probs=62.0

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecC-----cc---cCHHHHHHHHHHHcCCC---cCcccceeEEEEeCCeeeEEE
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKN-----SK---FSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~-----~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  377 (436)
                      +.||.|....||+.... ++.++||.-..     +.   ....+-..|...|+.+.   ...+.+++.++.  +...++|
T Consensus        38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM  114 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM  114 (418)
T ss_pred             EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence            56899999999998764 45688998652     11   13344445566665543   347778887776  4467899


Q ss_pred             ecCCC--CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 041073          378 EYMPN--GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIE  416 (436)
Q Consensus       378 E~~~~--gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~  416 (436)
                      |++++  ..+.+.+.    . +......+.++...+++.|-
T Consensus       115 E~L~~~~~ilr~~Ll----~-G~~~p~~a~~ig~~la~tLf  150 (418)
T PLN02756        115 RYLEPPHIILRKGLI----A-GIEYPLLAEHMSDYMAKTLF  150 (418)
T ss_pred             eecCCcceehhhhhc----c-CCCCHHHHHHHHHHHHHHHh
Confidence            99976  34554441    1 22234555566666666643

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=86.58  E-value=2  Score=38.81  Aligned_cols=74  Identities=18%  Similarity=0.315  Sum_probs=48.0

Q ss_pred             ccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC---cCcccceeEEEEeCCeeeEEEecCCCCChh
Q 041073          310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRAVVYEYMPNGSLD  386 (436)
Q Consensus       310 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  386 (436)
                      .+.-|.--..|+... ...++-||.-...  ....|..|+.-|..+.   --.+.+++.........++||||++-|.+.
T Consensus        23 ~v~gG~inea~~v~d-g~~~~FvK~n~~~--~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          23 EVSGGDINEAWRLRD-GTDPFFVKCNQRE--QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             ccCCccccceeEeec-CCcceEEEecchh--hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            344554445555443 2345777764322  2345777877665553   455777888888889999999999987665

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=86.49  E-value=4.6  Score=38.54  Aligned_cols=59  Identities=22%  Similarity=0.263  Sum_probs=35.5

Q ss_pred             CCEEEEEEecC---cccCHHHHHHHHHHHcCCCc--CcccceeEEEEeCC--eeeEEEecCCCCChh
Q 041073          327 GGLIAVKMLKN---SKFSAEEFINEVSTIGRIHH--VNVVQLLGFCSEGS--KRAVVYEYMPNGSLD  386 (436)
Q Consensus       327 ~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~E~~~~gsL~  386 (436)
                      ++.++++ .+.   .........+|..+|+.+.-  .-+...++.+..+.  ..+.||+|.+|..+.
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~  113 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVW  113 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceecc
Confidence            6677777 332   12233456677777776643  22344566665554  679999999885443

>PF02009 Rifin_STEVOR: Rifin/stevor family; InterPro: IPR002858 Malaria is still a major cause of mortality in many areas of the world

Probab=85.38  E-value=0.68  Score=43.48  Aligned_cols=32  Identities=25%  Similarity=0.473  Sum_probs=22.4

Q ss_pred             CchhhhhHHHHHHHHHHHHHHHHhhhccccch
Q 041073          246 PVDVLIIGRFILAPIVFLVFLIHKYRTTLQTV  277 (436)
Q Consensus       246 ~i~viv~~~~~l~~l~~~~~~~~~~~~~~~~~  277 (436)
                      +|...++++++++++++++++++||||+++..
T Consensus       257 ~I~aSiiaIliIVLIMvIIYLILRYRRKKKmk  288 (299)
T PF02009_consen  257 AIIASIIAILIIVLIMVIIYLILRYRRKKKMK  288 (299)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhh
Confidence            45556666677777777888888888766543

Plasmodium falciparum causes the most severe human form of the disease and is responsible for most fatalities. Severe cases of malaria can occur when the parasite invades and then proliferates within red blood cell erythrocytes. The parasite produces many variant antigenic proteins, encoded by multigene families, which are present on the surface of the infected erythrocyte and play important roles in virulence. A crucial survival mechanism for the malaria parasite is its ability to evade the immune response by switching these variant surface antigens. The high virulence of P. falciparum relative to other malarial parasites is in large part due to the fact that in this organism many of these surface antigens mediate the binding of infected erythrocytes to the vascular endothelium (cytoadherence) and non-infected erythrocytes (rosetting). This can lead to the accumulation of infected cells in the vasculature of a variety of organs, blocking the blood flow and reducing the oxygen supply. Clinical symptoms of severe infection can include fever, progressive anaemia, multi-organ dysfunction and coma. For more information see []. Several multicopy gene families have been described in Plasmodium falciparum, including the stevor family of subtelomeric open reading frames and the rif interspersed repetitive elements. Both families contain three predicted transmembrane segments. It has been proposed that stevor and rif are members of a larger superfamily that code for variant surface antigens [].

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=84.01  E-value=2.4  Score=40.07  Aligned_cols=97  Identities=21%  Similarity=0.292  Sum_probs=58.1

Q ss_pred             cccCCCCCeEEEEEEEcC-------CCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcc-cceeEEEEeCCeeeEEEecC
Q 041073          309 HKLGQGGFGSVYKGQLHT-------GGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~  380 (436)
                      +.+..|-...+|+....+       ++.+++|+.........+..+|.+++..+....+ .++++....    .+|+||+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            345566667889887554       4788899876543333345678777777653333 345554432    3578998


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG  421 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~  421 (436)
                      +|..+.....    .    .    ..++.++++.|+-||+.
T Consensus        80 ~G~~l~~~~~----~----~----~~~~~~ia~~L~~lH~~  108 (302)
T cd05156          80 PSRTLTTEEL----R----D----PDISAEIARRMAKLHSI  108 (302)
T ss_pred             CCCcCCHhHc----C----C----cHHHHHHHHHHHHhhCC
Confidence            8866643210    0    0    12556777777778764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=83.86  E-value=5.2  Score=36.84  Aligned_cols=78  Identities=17%  Similarity=0.106  Sum_probs=53.3

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC-CCCChhh
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM-PNGSLDR  387 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~-~~gsL~~  387 (436)
                      ..+..|..+.|+.++..+|...++|+.........+... ...|+..+-...|++++.-  ...-.|++|.+ ++.+|.+
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g-~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~   84 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARG-EAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLAS   84 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhH-HhHhheeCCCCceeeeccc--cccchhhhhhccCCCchhh
Confidence            446778899999999889999999998754322222111 2447777777788888744  33457888998 5557765


Q ss_pred             hc
Q 041073          388 HI  389 (436)
Q Consensus       388 ~l  389 (436)
                      ..
T Consensus        85 ~~   86 (253)
T PF04655_consen   85 LP   86 (253)
T ss_pred             cc
Confidence            54

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=82.70  E-value=6.4  Score=36.98  Aligned_cols=75  Identities=16%  Similarity=0.190  Sum_probs=48.3

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCc--ccceeEE------EEeCCeeeEEEecC
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVN--VVQLLGF------CSEGSKRAVVYEYM  380 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~E~~  380 (436)
                      +.|..|....+|+.... ++.+++|+...  ....++..|++++..+.+.+  +.+++..      ....+..++++|++
T Consensus        20 ~~i~~G~~n~~y~v~~~-~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          20 EGISAGIENTNYFVTTD-SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             ecccCccccceEEEEeC-CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            45677777889988754 34688898764  33455677787777764332  3444331      12345568999999


Q ss_pred             CCCChh
Q 041073          381 PNGSLD  386 (436)
Q Consensus       381 ~~gsL~  386 (436)
                      +|..+.
T Consensus        97 ~G~~~~  102 (296)
T cd05153          97 AGEHLT  102 (296)
T ss_pred             CCCCCC
Confidence            887653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	436
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-26
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-26
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-18
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-18
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-16
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-16
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-16
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-14
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		8e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-07
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-07
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-07
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-07
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-07
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-07
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-07
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-07
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-06
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-06
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-06
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-05
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-05
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-05
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-05
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-05
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-05
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-05
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-05
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-05
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-05
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-05
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-05
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-05
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-05
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-05
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-05
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-05
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-05
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-05
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-05
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-05
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-05
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-05
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-05
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-05
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-05
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-05
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-05
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-05
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-05
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-05
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-04
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-04
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-04
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-04
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-04
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-04
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-04
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-04
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-04
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-04
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-04
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-04
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-04
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-04
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-04
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-04
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-04
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-04
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-04
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-04
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-04
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-04
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-04
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-04
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-04
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-04
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-04
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-04
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-04
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-04
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-04
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-04
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-04
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-04
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-04
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-04
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-04
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-04
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-04
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-04
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-04
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-04
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-04
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-04
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-04
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-04
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-04
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-04
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-04
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-04
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 62/148 (41%), Positives = 88/148 (59%), Gaps = 4/148 (2%)
Query: 293 KRYSYPEIIAMTNHFTHK--LGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE--FINE 348
           KR+S  E+   +++F++K  LG+GGFG VYKG+L  G L+AVK LK  +    E  F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 349 VSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVA 408
           V  I    H N+++L GFC   ++R +VY YM NGS+   +  +        W K   +A
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
           LG+ARG+ YLH+ CD  I+H D+K  NI
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANI 173

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 62/148 (41%), Positives = 87/148 (58%), Gaps = 4/148 (2%)
Query: 293 KRYSYPEIIAMTNHFTHK--LGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE--FINE 348
           KR+S  E+   +++F +K  LG+GGFG VYKG+L  G L+AVK LK  +    E  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 349 VSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVA 408
           V  I    H N+++L GFC   ++R +VY YM NGS+   +  +        W K   +A
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
           LG+ARG+ YLH+ CD  I+H D+K  NI
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANI 165

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/136 (41%), Positives = 80/136 (58%), Gaps = 6/136 (4%)
Query: 304 TNHFTHK--LGQGGFGSVYKGQLHTGGLIAVKM-LKNSKFSAEEFINEVSTIGRIHHVNV 360
           TN+F HK  +G G FG VYKG L  G  +A+K     S    EEF  E+ T+    H ++
Sbjct: 38  TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHL 97
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V L+GFC E ++  ++Y+YM NG+L RH++  +    S SWE+  E+ +G ARG+ YLH 
Sbjct: 98  VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT 157
Query: 421 GCDVCILHFDIKPHNI 436
                I+H D+K  NI
Sbjct: 158 R---AIIHRDVKSINI 170

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/136 (41%), Positives = 80/136 (58%), Gaps = 6/136 (4%)
Query: 304 TNHFTHK--LGQGGFGSVYKGQLHTGGLIAVKM-LKNSKFSAEEFINEVSTIGRIHHVNV 360
           TN+F HK  +G G FG VYKG L  G  +A+K     S    EEF  E+ T+    H ++
Sbjct: 38  TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHL 97
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V L+GFC E ++  ++Y+YM NG+L RH++  +    S SWE+  E+ +G ARG+ YLH 
Sbjct: 98  VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT 157
Query: 421 GCDVCILHFDIKPHNI 436
                I+H D+K  NI
Sbjct: 158 ---RAIIHRDVKSINI 170

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 18/155 (11%)
Query: 295 YSYPEIIAMTNHFT--------HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE-- 344
           +S+ E+  +TN+F         +K+G+GGFG VYKG ++   +   K+      + EE  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 345 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGS-LDRHIFPKESRGQSFSW 401
             F  E+  + +  H N+V+LLGF S+G    +VY YMPNGS LDR            SW
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSW 132
Query: 402 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ++A G A GI +LH    +   H DIK  NI
Sbjct: 133 HMRCKIAQGAANGINFLHENHHI---HRDIKSANI 164

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 18/155 (11%)
Query: 295 YSYPEIIAMTNHFT--------HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE-- 344
           +S+ E+  +TN+F         +K+G+GGFG VYKG ++   +   K+      + EE  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 345 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGS-LDRHIFPKESRGQSFSW 401
             F  E+  + +  H N+V+LLGF S+G    +VY YMPNGS LDR            SW
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSW 126
Query: 402 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ++A G A GI +LH    +   H DIK  NI
Sbjct: 127 HMRCKIAQGAANGINFLHENHHI---HRDIKSANI 158

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 18/155 (11%)
Query: 295 YSYPEIIAMTNHFT--------HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE-- 344
           +S+ E+  +TN+F         +K+G+GGFG VYKG ++   +   K+      + EE  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 345 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGS-LDRHIFPKESRGQSFSW 401
             F  E+  + +  H N+V+LLGF S+G    +VY YMPNGS LDR            SW
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSW 132
Query: 402 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ++A G A GI +LH    +   H DIK  NI
Sbjct: 133 HMRCKIAQGAANGINFLHENHHI---HRDIKSANI 164

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 75/134 (55%), Gaps = 6/134 (4%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAE---EFINEVSTIGRIHHVNVVQ 362
           +   K+G G FG+V++ + H G  +AVK+L    F AE   EF+ EV+ + R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
            +G  ++    ++V EY+  GSL R +    +R Q     +L  +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL-SMAYDVAKGMNYLHNR- 156
Query: 423 DVCILHFDIKPHNI 436
           +  I+H D+K  N+
Sbjct: 157 NPPIVHRDLKSPNL 170

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 86/143 (60%), Gaps = 12/143 (8%)
Query: 297 YPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI---NEVSTIG 353
           Y EI A     + ++G G FG+VYKG+ H  G +AVK+LK    + E+F    NEV+ + 
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 354 RIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR 413
           +  HVN++  +G+ ++ +  A+V ++    SL +H+  +E++ Q F   +L ++A  TA+
Sbjct: 88  KTRHVNILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMF---QLIDIARQTAQ 143
Query: 414 GIEYLHNGCDVCILHFDIKPHNI 436
           G++YLH      I+H D+K +NI
Sbjct: 144 GMDYLHAK---NIIHRDMKSNNI 163

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/155 (34%), Positives = 76/155 (49%), Gaps = 18/155 (11%)
Query: 295 YSYPEIIAMTNHFT--------HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE-- 344
           +S+ E+  +TN+F         +K G+GGFG VYKG ++   +   K+      + EE  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 345 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGS-LDRHIFPKESRGQSFSW 401
             F  E+    +  H N+V+LLGF S+G    +VY Y PNGS LDR            SW
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDR--LSCLDGTPPLSW 123
Query: 402 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ++A G A GI +LH    +   H DIK  NI
Sbjct: 124 HXRCKIAQGAANGINFLHENHHI---HRDIKSANI 155

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/131 (35%), Positives = 78/131 (59%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 18  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + ++  + A+V ++    SL  H+   E++   F  +KL ++A  TARG++YLH      
Sbjct: 76  YSTK-PQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAK---S 128
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 129 IIHRDLKSNNI 139

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/131 (35%), Positives = 77/131 (58%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + S   + A+V ++    SL  H+   E++   F  +KL ++A  TARG++YLH      
Sbjct: 88  Y-STAPQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAK---S 140
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 141 IIHRDLKSNNI 151

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/131 (35%), Positives = 78/131 (59%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + ++  + A+V ++    SL  H+   E++   F  +KL ++A  TARG++YLH      
Sbjct: 88  YSTK-PQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAK---S 140
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 141 IIHRDLKSNNI 151

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 75/134 (55%), Gaps = 6/134 (4%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAE---EFINEVSTIGRIHHVNVVQ 362
           +   K+G G FG+V++ + H G  +AVK+L    F AE   EF+ EV+ + R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
            +G  ++    ++V EY+  GSL R +    +R Q     +L  +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL-SMAYDVAKGMNYLHNR- 156
Query: 423 DVCILHFDIKPHNI 436
           +  I+H ++K  N+
Sbjct: 157 NPPIVHRNLKSPNL 170

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/131 (35%), Positives = 76/131 (58%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + S   + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 72  Y-STAPQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK---S 124
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 125 IIHRDLKSNNI 135

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 77/131 (58%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 16  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 74  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK---S 126
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 127 IIHRDLKSNNI 137

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 77/131 (58%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK---S 124
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 125 IIHRDLKSNNI 135

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 77/131 (58%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK---S 129
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 130 IIHRDLKSNNI 140

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 77/131 (58%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 34  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 92  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK---S 144
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 145 IIHRDLKSNNI 155

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 77/131 (58%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK---S 124
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 125 IIHRDLKSNNI 135

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 77/131 (58%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK---S 129
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 130 IIHRDLKSNNI 140

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 77/131 (58%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 41  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 99  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK---S 151
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 152 IIHRDLKSNNI 162

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 77/131 (58%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK---S 152
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 153 IIHRDLKSNNI 163

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/131 (34%), Positives = 77/131 (58%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           + ++  + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH      
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK---S 152
Query: 426 ILHFDIKPHNI 436
           I+H D+K +NI
Sbjct: 153 IIHRDLKSNNI 163

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  ++G G FG V+ G       +A+K ++    S E+FI E   + ++ H  +VQL G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C E +   +V+E+M +G L  ++  +  RG  F+ E L  + L    G+ YL    + C+
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 122
Query: 427 LHFDIKPHN 435
           +H D+   N
Sbjct: 123 IHRDLAARN 131

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  ++G G FG V+ G       +A+K ++    S E+FI E   + ++ H  +VQL G 
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C E +   +V+E+M +G L  ++  +  RG  F+ E L  + L    G+ YL    + C+
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 124
Query: 427 LHFDIKPHN 435
           +H D+   N
Sbjct: 125 IHRDLAARN 133

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  ++G G FG V+ G       +A+K ++    S E+FI E   + ++ H  +VQL G 
Sbjct: 14  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C E +   +V+E+M +G L  ++  +  RG  F+ E L  + L    G+ YL    + C+
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 127
Query: 427 LHFDIKPHN 435
           +H D+   N
Sbjct: 128 IHRDLAARN 136

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  ++G G FG V+ G       +A+K +K    S ++FI E   + ++ H  +VQL G 
Sbjct: 31  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C E +   +V+E+M +G L  ++  +  RG  F+ E L  + L    G+ YL    + C+
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 144
Query: 427 LHFDIKPHN 435
           +H D+   N
Sbjct: 145 IHRDLAARN 153

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 65/129 (50%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  ++G G FG V+ G       +A+K ++    S E+FI E   + ++ H  +VQL G 
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C E +   +V E+M +G L  ++  +  RG  F+ E L  + L    G+ YL    + C+
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 125
Query: 427 LHFDIKPHN 435
           +H D+   N
Sbjct: 126 IHRDLAARN 134

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 70/133 (52%), Gaps = 13/133 (9%)
Query: 311 LGQGGFGSVYKGQLHTGG-----LIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQL 363
           +G G FG VYKG L T        +A+K LK      +  +F+ E   +G+  H N+++L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G  S+     ++ EYM NG+LD+  F +E  G+ FS  +L  +  G A G++YL N   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDK--FLREKDGE-FSVLQLVGMLRGIAAGMKYLAN--- 165
Query: 424 VCILHFDIKPHNI 436
           +  +H D+   NI
Sbjct: 166 MNYVHRDLAARNI 178

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G FG VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  S   L  +A   +  +EYL        +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 132 HRDLAARN 139

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      +V EYMP G+L  ++  +E   +  +   L  +A   +  +EYL        +
Sbjct: 98  TLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVLLYMATQISSAMEYLEKK---NFI 152
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 153 HRDLAARN 160

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  +LG G FG V  G+      +A+KM+K    S +EFI E   +  + H  +VQL G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 121
Query: 427 LHFDIKPHN 435
           LH D+   N
Sbjct: 122 LHRDLAARN 130

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 65/129 (50%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  ++G G FG V+ G       +A+K ++    S E+FI E   + ++ H  +VQL G 
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C E +   +V+E+M +G L  ++  +  RG  F+ E L  + L    G+ YL    +  +
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EASV 124
Query: 427 LHFDIKPHN 435
           +H D+   N
Sbjct: 125 IHRDLAARN 133

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  +LG G FG V  G+      +A+KM+K    S +EFI E   +  + H  +VQL G 
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 125
Query: 427 LHFDIKPHN 435
           LH D+   N
Sbjct: 126 LHRDLAARN 134

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  S   L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 134 HRDLAARN 141

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  +LG G FG V  G+      +A+KM+K    S +EFI E   +  + H  +VQL G 
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 126
Query: 427 LHFDIKPHN 435
           LH D+   N
Sbjct: 127 LHRDLAARN 135

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  S   L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 134 HRDLAARN 141

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  S   L  +A   +  +EYL        +
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 132 HRDLAARN 139

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  +LG G FG V  G+      +A+KM+K    S +EFI E   +  + H  +VQL G 
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 126
Query: 427 LHFDIKPHN 435
           LH D+   N
Sbjct: 127 LHRDLAARN 135

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  S   L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 139 HRDLAARN 146

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  S   L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 134 HRDLAARN 141

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  S   L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 134 HRDLAARN 141

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 139 HRDLAARN 146

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  S   L  +A   +  +EYL        +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 132 HRDLAARN 139

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 134 HRDLAARN 141

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  +LG G FG V  G+      +A+KM+K    S +EFI E   +  + H  +VQL G 
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 132
Query: 427 LHFDIKPHN 435
           LH D+   N
Sbjct: 133 LHRDLAARN 141

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 72/132 (54%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G L   G     +A+K LK+  ++    +F++E S +G+  H NV+ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++ +   ++ E+M NGSLD   F +++ GQ F+  +L  +  G A G++YL    D+
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---ADM 154
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 155 NYVHRDLAARNI 166

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 139 HRDLAARN 146

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 134 HRDLAARN 141

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  +LG G FG V  G+      +A+KM+K    S +EFI E   +  + H  +VQL G 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 141
Query: 427 LHFDIKPHN 435
           LH D+   N
Sbjct: 142 LHRDLAARN 150

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 6/129 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  +LG G FG V  G+      +A+KM+K    S +EFI E   +  + H  +VQL G 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 141
Query: 427 LHFDIKPHN 435
           LH D+   N
Sbjct: 142 LHRDLAARN 150

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 83  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 137
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 138 HRDLAARN 145

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 80  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 135 HRDLAARN 142

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 139 HRDLAARN 146

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 136 HRDLAARN 143

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 92  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 146
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 147 HRDLAARN 154

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 136 HRDLAARN 143

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 135 HRDLAARN 142

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 139 HRDLAARN 146

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 63/128 (49%), Gaps = 6/128 (4%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +      ++ E+M  G+L  ++  +E   Q  +   L  +A   +  +EYL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 428 HFDIKPHN 435
           H D+   N
Sbjct: 136 HRDLAARN 143

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 12/144 (8%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKMLKN--SKFSAEEFINEVSTI 352
           EI A   H    +G G  G V  G+L   G     +A+K LK   ++    +F++E S +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 353 GRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTA 412
           G+  H N+++L G  + G    +V EYM NGSLD   F +   GQ F+  +L  +  G  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD--TFLRTHDGQ-FTIMQLVGMLRGVG 161
Query: 413 RGIEYLHNGCDVCILHFDIKPHNI 436
            G+ YL    D+  +H D+   N+
Sbjct: 162 AGMRYL---SDLGYVHRDLAARNV 182

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 12/144 (8%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKMLKN--SKFSAEEFINEVSTI 352
           EI A   H    +G G  G V  G+L   G     +A+K LK   ++    +F++E S +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 353 GRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTA 412
           G+  H N+++L G  + G    +V EYM NGSLD   F +   GQ F+  +L  +  G  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD--TFLRTHDGQ-FTIMQLVGMLRGVG 161
Query: 413 RGIEYLHNGCDVCILHFDIKPHNI 436
            G+ YL    D+  +H D+   N+
Sbjct: 162 AGMRYL---SDLGYVHRDLAARNV 182

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 291 MPKRYSYP---------EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKMLK- 336
           MP  Y  P         EI A        +G G FG V  G+L   G     +A+K LK 
Sbjct: 1   MPHTYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKV 60
Query: 337 -NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESR 395
             ++    +F+ E S +G+  H N++ L G  ++     +V EYM NGSLD   F K++ 
Sbjct: 61  GYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD--TFLKKND 118
Query: 396 GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           GQ F+  +L  +  G + G++YL    D+  +H D+   NI
Sbjct: 119 GQ-FTVIQLVGMLRGISAGMKYL---SDMGYVHRDLAARNI 155

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           EI   +     KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H 
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 63
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +VQL    SE     +V EYM  GSL    F K   G+     +L ++A   A G+ Y+
Sbjct: 64  KLVQLYAVVSE-EPIXIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYV 120
Query: 419 HNGCDVCILHFDIKPHNI 436
                +  +H D++  NI
Sbjct: 121 ER---MNYVHRDLRAANI 135

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/127 (33%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + +I H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 139 DLRAANI 145

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 58/112 (51%), Gaps = 3/112 (2%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           +      ++ E+M  G+L  ++  +E   Q  S   L  +A   +  +EYL 
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE 335

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 65/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           EI   +     +LG G FG V+ G  +    +A+K LK    S E F+ E   + ++ H 
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHD 64
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +VQL    SE     +V EYM  GSL    F K+  G++     L ++A   A G+ Y+
Sbjct: 65  KLVQLYAVVSE-EPIYIVTEYMNKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 121
Query: 419 HNGCDVCILHFDIKPHNI 436
                +  +H D++  NI
Sbjct: 122 ER---MNYIHRDLRSANI 136

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           EI   +     KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H 
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 66
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +VQL    SE     +V EYM  GSL    F K   G+     +L ++A   A G+ Y+
Sbjct: 67  KLVQLYAVVSE-EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYV 123
Query: 419 HNGCDVCILHFDIKPHNI 436
                +  +H D++  NI
Sbjct: 124 ER---MNYVHRDLRAANI 138

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           EI   +     KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H 
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 62
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +VQL    SE     +V EYM  GSL    F K   G+     +L ++A   A G+ Y+
Sbjct: 63  KLVQLYAVVSE-EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 119
Query: 419 HNGCDVCILHFDIKPHNI 436
                +  +H D++  NI
Sbjct: 120 ER---MNYVHRDLRAANI 134

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           EI   +     KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H 
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 64
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +VQL    SE     +V EYM  GSL    F K   G+     +L ++A   A G+ Y+
Sbjct: 65  KLVQLYAVVSE-EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 121
Query: 419 HNGCDVCILHFDIKPHNI 436
                +  +H D++  NI
Sbjct: 122 ER---MNYVHRDLRAANI 136

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 251 -EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 305 DLRAANI 311

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 251 -EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 305 DLRAANI 311

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 252 -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 305
Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 306 DLRAANI 312

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 71/132 (53%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G L   G     +A+K LK+  ++    +F++E S +G+  H NV+ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++ +   ++ E+M NGSLD   F +++ GQ F+  +L  +  G A G++YL    D+
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---ADM 128
Query: 425 CILHFDIKPHNI 436
             +H  +   NI
Sbjct: 129 NYVHRALAARNI 140

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVIEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 139 DLRAANI 145

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 139 DLRAANI 145

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 251 -EPIYIVGEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 305 DLRAANI 311

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVIEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 139 DLRAANI 145

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGG----LIAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G+L   G     +A+K LK   ++    +F+ E S +G+  H NVV L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  + G    +V E+M NG+LD   F ++  GQ F+  +L  +  G A G+ YL    D+
Sbjct: 111 GVVTRGKPVMIVIEFMENGALD--AFLRKHDGQ-FTVIQLVGMLRGIAAGMRYL---ADM 164
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 165 GYVHRDLAARNI 176

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/78 (41%), Positives = 44/78 (56%), Gaps = 1/78 (1%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG C
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 368 SEGSKRAVVYEYMPNGSL 385
           +      ++ E+M  G+L
Sbjct: 325 TREPPFYIITEFMTYGNL 342

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           EI   +     KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +VQL    SE     +V EYM  GSL    F K   G+     +L ++A   A G+ Y+
Sbjct: 74  KLVQLYAVVSE-EPIYIVCEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 419 HNGCDVCILHFDIKPHNI 436
                +  +H D++  NI
Sbjct: 131 ER---MNYVHRDLRAANI 145

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 70/132 (53%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V +G+L   G     +A+K LK   ++    EF++E S +G+  H N+++L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  +      ++ E+M NG+LD   F + + GQ F+  +L  +  G A G+ YL    ++
Sbjct: 82  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQ-FTVIQLVGMLRGIASGMRYL---AEM 135
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 136 SYVHRDLAARNI 147

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 70/132 (53%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V +G+L   G     +A+K LK   ++    EF++E S +G+  H N+++L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  +      ++ E+M NG+LD   F + + GQ F+  +L  +  G A G+ YL    ++
Sbjct: 84  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQ-FTVIQLVGMLRGIASGMRYL---AEM 137
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 138 SYVHRDLAARNI 149

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 334 -EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 388 DLRAANI 394

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  GSL    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 430 DIKPHNI 436
           D+   NI
Sbjct: 139 DLAAANI 145

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 12/144 (8%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTI 352
           EI A        +G G FG V  G+L   G     +A+K LK   +     +F++E S +
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 84
Query: 353 GRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTA 412
           G+  H N++ L G  ++     ++ EYM NGSLD  +   + R   F+  +L  +  G  
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIG 141
Query: 413 RGIEYLHNGCDVCILHFDIKPHNI 436
            G++YL    D+  +H D+   NI
Sbjct: 142 SGMKYLS---DMSAVHRDLAARNI 162

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           EI   +     KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H 
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 70
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +VQL    SE     +V EYM  GSL    F K   G+     +L +++   A G+ Y+
Sbjct: 71  KLVQLYAVVSE-EPIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYV 127
Query: 419 HNGCDVCILHFDIKPHNI 436
                +  +H D++  NI
Sbjct: 128 ER---MNYVHRDLRAANI 142

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           EI   +     KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H 
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 70
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +VQL    SE     +V EYM  GSL    F K   G+     +L +++   A G+ Y+
Sbjct: 71  KLVQLYAVVSE-EPIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYV 127
Query: 419 HNGCDVCILHFDIKPHNI 436
                +  +H D++  NI
Sbjct: 128 ER---MNYVHRDLRAANI 142

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  G L    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVMEYMSKGCL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 139 DLRAANI 145

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 12/144 (8%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTI 352
           EI A        +G G FG V  G+L   G     +A+K LK   +     +F++E S +
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 353 GRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTA 412
           G+  H N++ L G  ++     ++ EYM NGSLD  +   + R   F+  +L  +  G  
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIG 126
Query: 413 RGIEYLHNGCDVCILHFDIKPHNI 436
            G++YL    D+  +H D+   NI
Sbjct: 127 SGMKYLS---DMSYVHRDLAARNI 147

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 12/144 (8%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTI 352
           EI A        +G G FG V  G+L   G     +A+K LK   +     +F++E S +
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 353 GRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTA 412
           G+  H N++ L G  ++     ++ EYM NGSLD  +   + R   F+  +L  +  G  
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIG 120
Query: 413 RGIEYLHNGCDVCILHFDIKPHNI 436
            G++YL    D+  +H D+   NI
Sbjct: 121 SGMKYLS---DMSYVHRDLAARNI 141

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EYM  G L    F K   G+     +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVTEYMSKGCL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 430 DIKPHNI 436
           D++  NI
Sbjct: 139 DLRAANI 145

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 287 QQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI 346
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK LK    S + F+
Sbjct: 2   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 58
Query: 347 NEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE 406
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G   +  KL +
Sbjct: 59  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 115
Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           +A   A G+ ++    +   +H D++  NI
Sbjct: 116 MAAQIAEGMAFIE---ERNYIHRDLRAANI 142

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 287 QQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI 346
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK LK    S + F+
Sbjct: 1   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 57
Query: 347 NEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE 406
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G   +  KL +
Sbjct: 58  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 114
Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           +A   A G+ ++    +   +H D++  NI
Sbjct: 115 MAAQIAEGMAFIE---ERNYIHRDLRAANI 141

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 287 QQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI 346
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK LK    S + F+
Sbjct: 5   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 61
Query: 347 NEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE 406
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G   +  KL +
Sbjct: 62  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 118
Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           +A   A G+ ++    +   +H D++  NI
Sbjct: 119 MAAQIAEGMAFIE---ERNYIHRDLRAANI 145

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 287 QQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI 346
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK LK    S + F+
Sbjct: 6   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 62
Query: 347 NEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE 406
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G   +  KL +
Sbjct: 63  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 119
Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           +A   A G+ ++    +   +H D++  NI
Sbjct: 120 MAAQIAEGMAFIE---ERNYIHRDLRAANI 146

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGL----IAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G+L         +A+K LK   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     +V EYM NGSLD  +   +++   F+  +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL---SDM 166
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 167 GFVHRDLAARNI 178

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 71/144 (49%), Gaps = 12/144 (8%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKMLK--NSKFSAEEFINEVSTI 352
           E+ A        +G G FG V  G+L         +A+K LK   ++    +F+ E S +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 353 GRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTA 412
           G+  H N+++L G  ++     +V EYM NGSLD  +   +++   F+  +L  +  G A
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 128
Query: 413 RGIEYLHNGCDVCILHFDIKPHNI 436
            G++YL    D+  +H D+   NI
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNI 149

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 71/144 (49%), Gaps = 12/144 (8%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKMLKN--SKFSAEEFINEVSTI 352
           E+ A        +G G FG V  G+L         +A+K LK   ++    +F+ E S +
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 353 GRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTA 412
           G+  H N+++L G  ++     +V EYM NGSLD  +   +++   F+  +L  +  G A
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 145
Query: 413 RGIEYLHNGCDVCILHFDIKPHNI 436
            G++YL    D+  +H D+   NI
Sbjct: 146 SGMKYL---SDMGYVHRDLAARNI 166

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGL----IAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G+L         +A+K LK   ++    +F+ E S +G+  H N+++L 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     +V EYM NGSLD  +   +++   F+  +L  +  G A G++YL    D+
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL---SDM 164
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 165 GYVHRDLAARNI 176

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 287 QQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI 346
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK LK    S + F+
Sbjct: 9   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 65
Query: 347 NEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE 406
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G   +  KL +
Sbjct: 66  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 122
Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           +A   A G+ ++    +   +H D++  NI
Sbjct: 123 MAAQIAEGMAFIE---ERNYIHRDLRAANI 149

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 287 QQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI 346
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK LK    S + F+
Sbjct: 6   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 62
Query: 347 NEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE 406
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G   +  KL +
Sbjct: 63  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 119
Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           +A   A G+ ++    +   +H D++  NI
Sbjct: 120 MAAQIAEGMAFIE---ERNYIHRDLRAANI 146

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 60/126 (47%), Gaps = 6/126 (4%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           +LG G FG V  G+      +AVKM+K    S +EF  E  T+ ++ H  +V+  G CS+
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF 429
                +V EY+ NG L  ++    S G+     +L E+      G+ +L +      +H 
Sbjct: 75  EYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 430 DIKPHN 435
           D+   N
Sbjct: 129 DLAARN 134

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGL----IAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G+L         +A+K LK   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     +V EYM NGSLD  +   +++   F+  +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL---SDM 166
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 167 GYVHRDLAARNI 178

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGL----IAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G+L         +A+K LK   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     +V EYM NGSLD  +   +++   F+  +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL---SDM 166
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 167 GYVHRDLAARNI 178

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGL----IAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G+L         +A+K LK   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     +V EYM NGSLD  +   +++   F+  +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL---SDM 166
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 167 GYVHRDLAARNI 178

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGL----IAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G+L         +A+K LK   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     +V EYM NGSLD  +   +++   F+  +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL---SDM 166
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 167 GYVHRDLAARNI 178

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGL----IAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G+L         +A+K LK   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     +V EYM NGSLD  +   +++   F+  +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL---SDM 166
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 167 GYVHRDLAARNI 178

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGL----IAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G+L         +A+K LK   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     +V EYM NGSLD  +   +++   F+  +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL---SDM 166
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 167 GYVHRDLAARNI 178

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 287 QQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI 346
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK LK    S + F+
Sbjct: 8   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 64
Query: 347 NEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE 406
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G   +  KL +
Sbjct: 65  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 121
Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           +A   A G+ ++    +   +H D++  NI
Sbjct: 122 MAAQIAEGMAFIE---ERNYIHRDLRAANI 148

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 287 QQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI 346
           Q+ W    +  P     T     +LG G FG V+ G  +    +AVK LK    S + F+
Sbjct: 10  QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 66
Query: 347 NEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE 406
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G   +  KL +
Sbjct: 67  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 123
Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           +A   A G+ ++    +   +H D++  NI
Sbjct: 124 MAAQIAEGMAFIE---ERNYIHRDLRAANI 150

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 66/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           E+   T     +LG G FG V+ G  +    +AVK LK    S + F+ E + + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +V+L    ++     ++ EYM NGSL    F K   G   +  KL ++A   A G+ ++
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 419 HNGCDVCILHFDIKPHNI 436
               +   +H D++  NI
Sbjct: 126 E---ERNYIHRDLRAANI 140

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 66/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           E+   T     +LG G FG V+ G  +    +AVK LK    S + F+ E + + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +V+L    ++     ++ EYM NGSL    F K   G   +  KL ++A   A G+ ++
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 419 HNGCDVCILHFDIKPHNI 436
               +   +H D++  NI
Sbjct: 126 E---ERNYIHRDLRAANI 140

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 66/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           E+   T     +LG G FG V+ G  +    +AVK LK    S + F+ E + + ++ H 
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 63
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +V+L    ++     ++ EYM NGSL    F K   G   +  KL ++A   A G+ ++
Sbjct: 64  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 120
Query: 419 HNGCDVCILHFDIKPHNI 436
               +   +H D++  NI
Sbjct: 121 E---ERNYIHRDLRAANI 135

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 66/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           E+   T     +LG G FG V+ G  +    +AVK LK    S + F+ E + + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +V+L    ++     ++ EYM NGSL    F K   G   +  KL ++A   A G+ ++
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 419 HNGCDVCILHFDIKPHNI 436
               +   +H D++  NI
Sbjct: 126 E---ERNYIHRDLRAANI 140

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG-FC 367
             +G+G FG V  G  + G  +AVK +KN   +A+ F+ E S + ++ H N+VQLLG   
Sbjct: 12  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQS-FSWEKLHEVALGTARGIEYLHNGCDVCI 426
            E     +V EYM  GSL  ++    SRG+S    + L + +L     +EYL        
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 123
Query: 427 LHFDIKPHNI 436
           +H D+   N+
Sbjct: 124 VHRDLAARNV 133

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG-FC 367
             +G+G FG V  G  + G  +AVK +KN   +A+ F+ E S + ++ H N+VQLLG   
Sbjct: 199 QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQS-FSWEKLHEVALGTARGIEYLHNGCDVCI 426
            E     +V EYM  GSL  ++    SRG+S    + L + +L     +EYL        
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 427 LHFDIKPHNI 436
           +H D+   N+
Sbjct: 311 VHRDLAARNV 320

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 66/134 (49%), Gaps = 14/134 (10%)
Query: 308 THKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKF-SAEEFINEVSTIGRIHHVNVVQLLG 365
           T  LG G FG V+K +    GL +A K++K       EE  NE+S + ++ H N++QL  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 366 FCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTA--RGIEYLHNGC 422
                +   +V EY+  G L DR I       +S++  +L  +        GI ++H   
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII------DESYNLTELDTILFMKQICEGIRHMHQ-- 205
Query: 423 DVCILHFDIKPHNI 436
            + ILH D+KP NI
Sbjct: 206 -MYILHLDLKPENI 218

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG-FC 367
             +G+G FG V  G  + G  +AVK +KN   +A+ F+ E S + ++ H N+VQLLG   
Sbjct: 27  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQS-FSWEKLHEVALGTARGIEYLHNGCDVCI 426
            E     +V EYM  GSL  ++    SRG+S    + L + +L     +EYL        
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 427 LHFDIKPHNI 436
           +H D+   N+
Sbjct: 139 VHRDLAARNV 148

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 48/85 (56%), Gaps = 7/85 (8%)
Query: 310 KLGQGGFGSVYKGQLHT------GGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNVVQ 362
           +LG+G FG V+  + H         L+AVK LK +  SA ++F  E   +  + H ++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDR 387
             G C+EG    +V+EYM +G L+R
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNR 109

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG-FC 367
             +G+G FG V  G  + G  +AVK +KN   +A+ F+ E S + ++ H N+VQLLG   
Sbjct: 18  QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQS-FSWEKLHEVALGTARGIEYLHNGCDVCI 426
            E     +V EYM  GSL  ++    SRG+S    + L + +L     +EYL        
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 129
Query: 427 LHFDIKPHNI 436
           +H D+   N+
Sbjct: 130 VHRDLAARNV 139

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 292 PKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGL---IAVKMLKN--SKFSAEEFI 346
           P    YP +      F   +G+G FG V K ++   GL    A+K +K   SK    +F 
Sbjct: 4   PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 63
Query: 347 NEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPNGSL------------DRHIFPKE 393
            E+  + ++ HH N++ LLG C       +  EY P+G+L            D       
Sbjct: 64  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 123
Query: 394 SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           S   + S ++L   A   ARG++YL        +H D+   NI
Sbjct: 124 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 163

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 48/85 (56%), Gaps = 7/85 (8%)
Query: 310 KLGQGGFGSVYKGQLHT------GGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNVVQ 362
           +LG+G FG V+  + H         L+AVK LK +  SA ++F  E   +  + H ++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDR 387
             G C+EG    +V+EYM +G L+R
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNR 103

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 11/131 (8%)
Query: 311 LGQGGFGSVYKGQLHTGGLIAVKMLKNS-----KFSAEEFINEVSTIGRIHHVNVVQLLG 365
           +G GGFG VY+     G  +AVK  ++        + E    E      + H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
            C +     +V E+   G L+R +      G+    + L   A+  ARG+ YLH+   V 
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 426 ILHFDIKPHNI 436
           I+H D+K  NI
Sbjct: 129 IIHRDLKSSNI 139

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 292 PKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGL---IAVKMLKN--SKFSAEEFI 346
           P    YP +      F   +G+G FG V K ++   GL    A+K +K   SK    +F 
Sbjct: 14  PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 73
Query: 347 NEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPNGSL------------DRHIFPKE 393
            E+  + ++ HH N++ LLG C       +  EY P+G+L            D       
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 394 SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           S   + S ++L   A   ARG++YL        +H D+   NI
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 173

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 5/138 (3%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           EI   +     +LG G FG V+ G  +    +AVK LK    S + F+ E + +  + H 
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 68
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +V+L    +      ++ EYM  GSL    F K   G      KL + +   A G+ Y+
Sbjct: 69  KLVRLYAVVTREEPIYIITEYMAKGSL--LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 126
Query: 419 HNGCDVCILHFDIKPHNI 436
                   +H D++  N+
Sbjct: 127 ERK---NYIHRDLRAANV 141

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 15/140 (10%)
Query: 306 HFTHKLGQGGFGSVYKGQL-HTGGLIAVK--MLKNSKFSAE------EFINEVSTIGRIH 356
            +  ++G+GGFG V+KG+L     ++A+K  +L +S+   E      EF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
           H N+V+L G      +  +V E++P G L   +     +     W     + L  A GIE
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIE 136
Query: 417 YLHNGCDVCILHFDIKPHNI 436
           Y+ N  +  I+H D++  NI
Sbjct: 137 YMQN-QNPPIVHRDLRSPNI 155

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 12/144 (8%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGL----IAVKMLKN--SKFSAEEFINEVSTI 352
           E+ A        +G G FG V  G+L         +A+K LK   ++    +F+ E S +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 353 GRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTA 412
           G+  H N+++L G  ++     +V E M NGSLD  +   +++   F+  +L  +  G A
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIA 128
Query: 413 RGIEYLHNGCDVCILHFDIKPHNI 436
            G++YL    D+  +H D+   NI
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNI 149

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 15/140 (10%)
Query: 306 HFTHKLGQGGFGSVYKGQL-HTGGLIAVK--MLKNSKFSAE------EFINEVSTIGRIH 356
            +  ++G+GGFG V+KG+L     ++A+K  +L +S+   E      EF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
           H N+V+L G      +  +V E++P G L   +     +     W     + L  A GIE
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIE 136
Query: 417 YLHNGCDVCILHFDIKPHNI 436
           Y+ N  +  I+H D++  NI
Sbjct: 137 YMQN-QNPPIVHRDLRSPNI 155

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 15/140 (10%)
Query: 306 HFTHKLGQGGFGSVYKGQL-HTGGLIAVK--MLKNSKFSAE------EFINEVSTIGRIH 356
            +  ++G+GGFG V+KG+L     ++A+K  +L +S+   E      EF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
           H N+V+L G      +  +V E++P G L   +     +     W     + L  A GIE
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIE 136
Query: 417 YLHNGCDVCILHFDIKPHNI 436
           Y+ N  +  I+H D++  NI
Sbjct: 137 YMQN-QNPPIVHRDLRSPNI 155

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 48/85 (56%), Gaps = 7/85 (8%)
Query: 310 KLGQGGFGSVYKGQLHT------GGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNVVQ 362
           +LG+G FG V+  + H         L+AVK LK +  SA ++F  E   +  + H ++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDR 387
             G C+EG    +V+EYM +G L+R
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNR 132

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 17/139 (12%)
Query: 311 LGQGGFGSVYKGQLH----TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQL 363
           LG+G FGSV +G L     T   +AVK +K   +S+   EEF++E + +    H NV++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 364 LGFCSEGS-----KRAVVYEYMPNGSLDRHIF--PKESRGQSFSWEKLHEVALGTARGIE 416
           LG C E S     K  V+  +M  G L  ++     E+  +    + L +  +  A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 417 YLHNGCDVCILHFDIKPHN 435
           YL N      LH D+   N
Sbjct: 162 YLSNR---NFLHRDLAARN 177

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 67/132 (50%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGL----IAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G+L         +A+K LK   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     +V E M NGSLD  +   +++   F+  +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL---SDM 166
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 167 GAVHRDLAARNI 178

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 5/138 (3%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           EI   +     KLG G FG V+ G  +    +AVK LK    S + F+ E + +  + H 
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 67
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +V+L    ++     ++ E+M  GSL    F K   G      KL + +   A G+ Y+
Sbjct: 68  KLVRLYAVVTKEEPIYIITEFMAKGSL--LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 125
Query: 419 HNGCDVCILHFDIKPHNI 436
                   +H D++  N+
Sbjct: 126 ERK---NYIHRDLRAANV 140

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           E+   T     +LG G FG V+ G  +    +AVK LK    S + F+ E + + ++ H 
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 64
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +V+L    ++     ++ EYM NGSL    F K   G   +  KL ++A   A G+ ++
Sbjct: 65  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 121
Query: 419 HNGCDVCILHFDIKPHNI 436
               +   +H +++  NI
Sbjct: 122 E---ERNYIHRNLRAANI 136

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 67/132 (50%), Gaps = 12/132 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGL----IAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +G G FG V  G+L         +A+K LK   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G  ++     +V E M NGSLD  +   +++   F+  +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL---SDM 166
Query: 425 CILHFDIKPHNI 436
             +H D+   NI
Sbjct: 167 GYVHRDLAARNI 178

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 15/131 (11%)
Query: 311 LGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 370
           +G+G FG V K +      +A+K ++ S+   + FI E+  + R++H N+V+L G C   
Sbjct: 16  VGRGAFGVVCKAKWRAKD-VAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGACL-- 71
Query: 371 SKRAVVYEYMPNGSL-----DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +   +V EY   GSL          P  +   + SW       L  ++G+ YLH+     
Sbjct: 72  NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPKA 125
Query: 426 ILHFDIKPHNI 436
           ++H D+KP N+
Sbjct: 126 LIHRDLKPPNL 136

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 15/131 (11%)
Query: 311 LGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 370
           +G+G FG V K +      +A+K ++ S+   + FI E+  + R++H N+V+L G C   
Sbjct: 17  VGRGAFGVVCKAKWRAKD-VAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGACL-- 72
Query: 371 SKRAVVYEYMPNGSL-----DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +   +V EY   GSL          P  +   + SW       L  ++G+ YLH+     
Sbjct: 73  NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPKA 126
Query: 426 ILHFDIKPHNI 436
           ++H D+KP N+
Sbjct: 127 LIHRDLKPPNL 137

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 292 PKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGL---IAVKMLKN--SKFSAEEFI 346
           P    YP +      F   +G+G FG V K ++   GL    A+K +K   SK    +F 
Sbjct: 11  PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 70
Query: 347 NEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPNGSL------------DRHIFPKE 393
            E+  + ++ HH N++ LLG C       +  EY P+G+L            D       
Sbjct: 71  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 130
Query: 394 SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           S   + S ++L   A   ARG++YL        +H ++   NI
Sbjct: 131 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNI 170

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           E+   T     +LG G  G V+ G  +    +AVK LK    S + F+ E + + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +V+L    ++     ++ EYM NGSL    F K   G   +  KL ++A   A G+ ++
Sbjct: 69  RLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 419 HNGCDVCILHFDIKPHNI 436
               +   +H D++  NI
Sbjct: 126 E---ERNYIHRDLRAANI 140

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 69/138 (50%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   ++  +     KL +      +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QAHAERIDHIKLLQYTSQICKGMEYL 133
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 134 --GTKRYI-HRDLATRNI 148

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K + +    +AVKMLK+     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE------------V 407
           ++ LLG C++     V+ EY   G+L  ++  +E  G  +S+   H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+EYL      CI H D+   N+
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNV 181

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I +++H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 159 EN---HFIHRDIAARN 171

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 65/132 (49%), Gaps = 21/132 (15%)
Query: 307 FTHKLGQGGFGSVYKGQLHT------GGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVN 359
              +LG+G FG V+  + +         L+AVK LK+   +A ++F  E   +  + H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIF-------------PKESRGQSFSWEKLHE 406
           +V+  G C +G    +V+EYM +G L++ +              P++++G+    + LH 
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH- 137
Query: 407 VALGTARGIEYL 418
           +A   A G+ YL
Sbjct: 138 IASQIASGMVYL 149

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I +++H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 173 EN---HFIHRDIAARN 185

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 129
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 130 --GTKRYI-HRDLATRNI 144

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 130
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 131 --GTKRYI-HRDLATRNI 145

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 134
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 135 --GTKRYI-HRDLATRNI 149

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 128
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 129 --GTKRYI-HRDLATRNI 143

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 136
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 137 --GTKRYI-HRDLATRNI 151

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 161
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 162 --GTKRYI-HRDLATRNI 176

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 130
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 131 --GTKRYI-HRDLATRNI 145

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 133
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 134 --GTKRYI-HRDLATRNI 148

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 130
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 131 --GTKRYI-HRDLATRNI 145

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 165 EN---HFIHRDIAARN 177

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 65/129 (50%), Gaps = 8/129 (6%)
Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           +LG G FG VYK +   TG L A K+++  S+   E++I E+  +    H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
               K  ++ E+ P G++D  I  +  RG   +  ++  V       + +LH+     I+
Sbjct: 78  YHDGKLWIMIEFCPGGAVDA-IMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RII 131
Query: 428 HFDIKPHNI 436
           H D+K  N+
Sbjct: 132 HRDLKAGNV 140

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 135
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 136 --GTKRYI-HRDLATRNI 150

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 65/129 (50%), Gaps = 8/129 (6%)
Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           +LG G FG VYK +   TG L A K+++  S+   E++I E+  +    H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
               K  ++ E+ P G++D  I  +  RG   +  ++  V       + +LH+     I+
Sbjct: 86  YHDGKLWIMIEFCPGGAVD-AIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RII 139
Query: 428 HFDIKPHNI 436
           H D+K  N+
Sbjct: 140 HRDLKAGNV 148

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 175 EN---HFIHRDIAARN 187

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 137
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 138 --GTKRYI-HRDLATRNI 152

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 66/149 (44%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K + +    +AVKMLK+     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE------------V 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  FS+   H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+EYL      CI H D+   N+
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNV 181

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 159 EN---HFIHRDIAARN 171

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 185 EN---HFIHRDIAARN 197

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 148
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 149 --GTKRYI-HRDLATRNI 163

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 159 EN---HFIHRDIAARN 171

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 158 EN---HFIHRDIAARN 170

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 173 EN---HFIHRDIAARN 185

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 158 EN---HFIHRDIAARN 170

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 68/133 (51%), Gaps = 14/133 (10%)
Query: 311 LGQGGFGSVYKGQLHTGG-----LIAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQL 363
           LG G FG+VYKG     G      +A+K+L+   S  + +E ++E   +  +    V +L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
           LG C   S   +V + MP G L  H+  +E+RG+  S + L    +  A+G+ YL    D
Sbjct: 85  LGICLT-STVQLVTQLMPYGCLLDHV--RENRGRLGS-QDLLNWCMQIAKGMSYLE---D 137
Query: 424 VCILHFDIKPHNI 436
           V ++H D+   N+
Sbjct: 138 VRLVHRDLAARNV 150

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 199 EN---HFIHRDIAARN 211

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 62/135 (45%), Gaps = 15/135 (11%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE-----FINEVSTIGRIHHVNVVQLL 364
           KLG G + +VYKG   T G+     LK  K  +EE      I E+S +  + H N+V+L 
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVA--LKEVKLDSEEGTPSTAIREISLMKELKHENIVRLY 69
Query: 365 GFCSEGSKRAVVYEYMPNGS---LDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
                 +K  +V+E+M N     +D        RG   +  K  +  L   +G+ + H  
Sbjct: 70  DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQGLAFCHEN 127
Query: 422 CDVCILHFDIKPHNI 436
               ILH D+KP N+
Sbjct: 128 ---KILHRDLKPQNL 139

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 173 EN---HFIHRDIAARN 185

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 148
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 149 --GTKRYI-HRDLATRNI 163

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 176 EN---HFIHRDIAARN 188

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 311 LGQGGFGSVYKGQLH------TGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQ 362
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 420 NGCDVCILHFDIKPHN 435
                  +H DI   N
Sbjct: 150 EN---HFIHRDIAARN 162

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 67/129 (51%), Gaps = 8/129 (6%)
Query: 309 HKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
            KLG+G +GSVYK     TG ++A+K +   +   +E I E+S + +    +VV+  G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
            + +   +V EY   GS+   I     R ++ + +++  +   T +G+EYLH    +  +
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHF---MRKI 147
Query: 428 HFDIKPHNI 436
           H DIK  NI
Sbjct: 148 HRDIKAGNI 156

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 61/120 (50%), Gaps = 11/120 (9%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ EY+P GSL  ++   + R       KL +      +G+EYL
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 131

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 14/138 (10%)
Query: 307 FTHKLGQGGFGSVY-----KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV        Q +TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 361 VQLLGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R   ++ E++P GSL  ++   + R       KL +      +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHI---KLLQYTSQICKGMEYL 133
Query: 419 HNGCDVCILHFDIKPHNI 436
             G    I H D+   NI
Sbjct: 134 --GTKRYI-HRDLATRNI 148

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K + +    +AVKMLK+     +  + I+E+  +  I  H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE------------V 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S+   H              
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+EYL      CI H D+   N+
Sbjct: 149 AYQVARGMEYL--ASKKCI-HRDLAARNV 174

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K + +    +AVKMLK+     +  + I+E+  +  I  H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE------------V 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S+   H              
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+EYL      CI H D+   N+
Sbjct: 145 AYQVARGMEYL--ASKKCI-HRDLAARNV 170

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K + +    +AVKMLK+     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE------------V 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S+   H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+EYL      CI H D+   N+
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNV 181

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K + +    +AVKMLK+     +  + I+E+  +  I  H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE------------V 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S+   H              
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+EYL      CI H D+   N+
Sbjct: 148 AYQVARGMEYL--ASKKCI-HRDLAARNV 173

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNV 188

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNV 188

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S++             L   
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNV 188

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE-----FINEVSTIGRIH---HVNV 360
           ++G G +G+VYK +  H+G  +A+K ++    + EE      + EV+ + R+    H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 361 VQLLGFCSEGS-----KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGI 415
           V+L+  C+        K  +V+E++     D   +  ++       E + ++     RG+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 416 EYLHNGCDVCILHFDIKPHNI 436
           ++LH  C   I+H D+KP NI
Sbjct: 126 DFLHANC---IVHRDLKPENI 143

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNV 188

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNV 188

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K + +    +AVKMLK+     +  + I+E+  +  I  H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE------------V 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S+   H              
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+EYL      CI H D+   N+
Sbjct: 197 AYQVARGMEYL--ASKKCI-HRDLAARNV 222

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE-----FINEVSTIGRIH---HVNV 360
           ++G G +G+VYK +  H+G  +A+K ++    + EE      + EV+ + R+    H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 361 VQLLGFCSEGS-----KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGI 415
           V+L+  C+        K  +V+E++     D   +  ++       E + ++     RG+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 416 EYLHNGCDVCILHFDIKPHNI 436
           ++LH  C   I+H D+KP NI
Sbjct: 126 DFLHANC---IVHRDLKPENI 143

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 71/141 (50%), Gaps = 22/141 (15%)
Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE-----FINEVSTIGRIH---HVNV 360
           ++G G +G+VYK +  H+G  +A+K ++    + EE      + EV+ + R+    H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 361 VQLLGFCSEGS-----KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGI 415
           V+L+  C+        K  +V+E++     D   +  ++       E + ++     RG+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 416 EYLHNGCDVCILHFDIKPHNI 436
           ++LH  C   I+H D+KP NI
Sbjct: 126 DFLHANC---IVHRDLKPENI 143

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S++             L   
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNV 188

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 21/160 (13%)
Query: 288 QSWMPKRYSYPEIIAMTNHFT-------HKLGQGGFGSVYKGQLHTGGLI-AVKMLKNSK 339
           Q  M      P+I  +T HFT         LG+G FG+VY  +      I A+K+L  S+
Sbjct: 3   QKVMENSSGTPDI--LTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQ 60
Query: 340 FSAE----EFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESR 395
              E    +   E+     +HH N+++L  +  +  +  ++ EY P G L + +     +
Sbjct: 61  IEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL----QK 116
Query: 396 GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN 435
             +F  ++   +    A  + Y H      ++H DIKP N
Sbjct: 117 SCTFDEQRTATIMEELADALMYCHGK---KVIHRDIKPEN 153

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 59/133 (44%), Gaps = 6/133 (4%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKN---SKFSAEEFINEVSTIGRIHHVNVVQL 363
           F  KLG G FG V+  +  + GL  V    N   S+   E+   E+  +  + H N++++
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
                +     +V E    G L   I   ++RG++ S   + E+       + Y H+   
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-- 143
Query: 424 VCILHFDIKPHNI 436
             ++H D+KP NI
Sbjct: 144 -HVVHKDLKPENI 155

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 133 ---LQIAHFDLKPENI 145

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 133 ---LQIAHFDLKPENI 145

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 309 HKLGQGGFGSVYKGQLHTGG-LIAVKMLKNSKFS--AEEFINEVSTIGRIHHVNVVQLLG 365
            ++G+G FG V+ G+L     L+AVK  + +       +F+ E   + +  H N+V+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
            C++     +V E +  G     +    + G     + L ++    A G+EYL + C  C
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESKC--C 234
Query: 426 ILHFDIKPHN 435
           I H D+   N
Sbjct: 235 I-HRDLAARN 243

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 66/142 (46%), Gaps = 21/142 (14%)
Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI---------HHVN 359
           ++G G +G+VYK +  H+G  +A+K ++            +ST+  +          H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 360 VVQLLGFCSEGS-----KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARG 414
           VV+L+  C+        K  +V+E++     D   +  ++       E + ++     RG
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 415 IEYLHNGCDVCILHFDIKPHNI 436
           +++LH  C   I+H D+KP NI
Sbjct: 133 LDFLHANC---IVHRDLKPENI 151

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S++             L   
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 209 TYQLARGMEYL--ASQKCI-HRDLAARNV 234

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 62/130 (47%), Gaps = 9/130 (6%)
Query: 309 HKLGQGGFGSVYKGQLHTGG-LIAVKMLKNSKFS--AEEFINEVSTIGRIHHVNVVQLLG 365
            ++G+G FG V+ G+L     L+AVK  + +       +F+ E   + +  H N+V+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
            C++     +V E +  G     +    + G     + L ++    A G+EYL + C  C
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESKC--C 234
Query: 426 ILHFDIKPHN 435
           I H D+   N
Sbjct: 235 I-HRDLAARN 243

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 63/134 (47%), Gaps = 16/134 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE------FINEVSTIGRIHHVNVVQ 362
            K+G+G +G VYK +   G ++A   LK  +  AE+       I E+S +  +HH N+V 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVA---LKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           L+          +V+E+M      + +  +   G   S  K++   L   RG+ + H   
Sbjct: 84  LIDVIHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQL--LRGVAHCHQH- 138
Query: 423 DVCILHFDIKPHNI 436
              ILH D+KP N+
Sbjct: 139 --RILHRDLKPQNL 150

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 78/149 (52%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 70
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+ VVY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNL 153

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K + +    +AVKMLK+     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRG------------QSFSWEKLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G            +  S + L   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+EYL      CI H D+   N+
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNV 181

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K + +    +AVKMLK+     +  + I+E+  +  I  H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRG------------QSFSWEKLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G            +  S + L   
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG+EYL      CI H D+   N+
Sbjct: 141 AYQVARGMEYL--ASKKCI-HRDLAARNV 166

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 306 HFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKN--SKFSAEEFINEVSTIGRIHH 357
            +   +G+G FG V++ +           ++AVKMLK   S     +F  E + +    +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHI 389
            N+V+LLG C+ G    +++EYM  G L+  +
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 141

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 63/134 (47%), Gaps = 16/134 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE------FINEVSTIGRIHHVNVVQ 362
            K+G+G +G VYK +   G ++A   LK  +  AE+       I E+S +  +HH N+V 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVA---LKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           L+          +V+E+M      + +  +   G   S  K++   L   RG+ + H   
Sbjct: 84  LIDVIHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQL--LRGVAHCHQH- 138
Query: 423 DVCILHFDIKPHNI 436
              ILH D+KP N+
Sbjct: 139 --RILHRDLKPQNL 150

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S++             L   
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 150 TYQLARGMEYL--ASQKCI-HRDLTARNV 175

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 47/101 (46%), Gaps = 8/101 (7%)
Query: 293 KRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKFSA--EE 344
           K+    EI      F  +LG+  FG VYKG L           +A+K LK+       EE
Sbjct: 16  KQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE 75
Query: 345 FINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL 385
           F +E     R+ H NVV LLG  ++    ++++ Y  +G L
Sbjct: 76  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 116

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 48/85 (56%), Gaps = 7/85 (8%)
Query: 310 KLGQGGFGSVYKGQLHT------GGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNVVQ 362
           +LG+G FG V+  + +         L+AVK LK++  +A ++F  E   +  + H ++V+
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDR 387
             G C EG    +V+EYM +G L++
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNK 104

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 26/196 (13%)
Query: 260 IVFLVFLIHKYRTTLQTVDNV------EKFLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQ 313
           +V ++++ H+ R   +  + V       ++      ++P  +   E+       + +LGQ
Sbjct: 1   LVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADVYVPDEW---EVAREKITMSRELGQ 57
Query: 314 GGFGSVYKG------QLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQLLG 365
           G FG VY+G      +      +A+K +  +    E  EF+NE S +   +  +VV+LLG
Sbjct: 58  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 117
Query: 366 FCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSF---SWEKLHEVALGTARGIEYLH 419
             S+G    V+ E M  G L    R + P+          S  K+ ++A   A G+ YL+
Sbjct: 118 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN 177
Query: 420 NGCDVCILHFDIKPHN 435
                  +H D+   N
Sbjct: 178 AN---KFVHRDLAARN 190

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 133 ---LQIAHFDLKPENI 145

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 133 ---LQIAHFDLKPENI 145

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 69/133 (51%), Gaps = 14/133 (10%)
Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLK-NSKFSAEEFIN-----EVSTIGRIHHVNVVQL 363
           LG+G F +VYK +  +T  ++A+K +K   +  A++ IN     E+  +  + H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
           L      S  ++V+++M     D  +  K++     +   +    L T +G+EYLH    
Sbjct: 78  LDAFGHKSNISLVFDFM---ETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 424 VCILHFDIKPHNI 436
             ILH D+KP+N+
Sbjct: 133 --ILHRDLKPNNL 143

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 133 ---LQIAHFDLKPENI 145

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRG------------QSFSWEKLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G            +  +++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNV 188

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S++             L   
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 155 TYQLARGMEYL--ASQKCI-HRDLAARNV 180

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 133 ---LQIAHFDLKPENI 145

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 133 ---LQIAHFDLKPENI 145

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 133 ---LQIAHFDLKPENI 145

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 131
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 132 ---LQIAHFDLKPENI 144

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 131
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 132 ---LQIAHFDLKPENI 144

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 133 ---LQIAHFDLKPENI 145

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+ EY   G+L  ++  +   G  +S++             L   
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 152 TYQLARGMEYL--ASQKCI-HRDLAARNV 177

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 307 FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHV 358
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSF---SWEKLHEVALGTA 412
           +VV+LLG  S+G    V+ E M  G L    R + P+          S  K+ ++A   A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 413 RGIEYLHNGCDVCILHFDIKPHN 435
            G+ YL+       +H D+   N
Sbjct: 142 DGMAYLNAN---KFVHRDLAARN 161

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 307 FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHV 358
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSF---SWEKLHEVALGTA 412
           +VV+LLG  S+G    V+ E M  G L    R + P+          S  K+ ++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 413 RGIEYLHNGCDVCILHFDIKPHN 435
            G+ YL+       +H D+   N
Sbjct: 149 DGMAYLNAN---KFVHRDLAARN 168

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 307 FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHV 358
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSF---SWEKLHEVALGTA 412
           +VV+LLG  S+G    V+ E M  G L    R + P  +        S  K+ ++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 413 RGIEYLHNGCDVCILHFDIKPHN 435
            G+ YL+       +H D+   N
Sbjct: 149 DGMAYLNAN---KFVHRDLAARN 168

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 296 SYPEIIAMTNHFTHK--LGQGGFGSVYK-GQLHTGGLIAVK-MLKNSKFSAEEFINEVST 351
           S P  I   +   H   LG+G FG   K     TG ++ +K +++  + +   F+ EV  
Sbjct: 1   SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKV 60
Query: 352 IGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGT 411
           +  + H NV++ +G   +  +   + EY+  G+L R I   +S    + W +    A   
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL-RGII--KSMDSQYPWSQRVSFAKDI 117
Query: 412 ARGIEYLHNGCDVCILHFDIKPHN 435
           A G+ YLH+   + I+H D+  HN
Sbjct: 118 ASGMAYLHS---MNIIHRDLNSHN 138

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 307 FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHV 358
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSF---SWEKLHEVALGTA 412
           +VV+LLG  S+G    V+ E M  G L    R + P+          S  K+ ++A   A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 413 RGIEYLHNGCDVCILHFDIKPHN 435
            G+ YL+       +H D+   N
Sbjct: 142 DGMAYLNAN---KFVHRDLAARN 161

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 307 FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHV 358
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 20  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 79
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSF---SWEKLHEVALGTA 412
           +VV+LLG  S+G    V+ E M  G L    R + P+          S  K+ ++A   A
Sbjct: 80  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 413 RGIEYLHNGCDVCILHFDIKPHN 435
            G+ YL+       +H D+   N
Sbjct: 140 DGMAYLNAN---KFVHRDLAARN 159

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 45/95 (47%), Gaps = 8/95 (8%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKFSA--EEFINEVS 350
           EI      F  +LG+  FG VYKG L           +A+K LK+       EEF +E  
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 351 TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL 385
              R+ H NVV LLG  ++    ++++ Y  +G L
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 99

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 307 FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHV 358
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSF---SWEKLHEVALGTA 412
           +VV+LLG  S+G    V+ E M  G L    R + P+          S  K+ ++A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 413 RGIEYLHNGCDVCILHFDIKPHN 435
            G+ YL+       +H D+   N
Sbjct: 136 DGMAYLNAN---KFVHRDLAARN 155

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 307 FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHV 358
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 19  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSF---SWEKLHEVALGTA 412
           +VV+LLG  S+G    V+ E M  G L    R + P  +        S  K+ ++A   A
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 413 RGIEYLHNGCDVCILHFDIKPHN 435
            G+ YL+       +H D+   N
Sbjct: 139 DGMAYLNAN---KFVHRDLAARN 158

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 61/136 (44%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYK-GQLHTGGLIAVKMLKNSKFSA-------EEFINEVSTIGRIHHVNV 360
            +LG G F  V K  Q  TG   A K +K  + S+       EE   EV+ +  I H N+
Sbjct: 18  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 77
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + + L ++      G+ YLH+
Sbjct: 78  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----LDGVHYLHS 133
Query: 421 GCDVCILHFDIKPHNI 436
                I HFD+KP NI
Sbjct: 134 K---RIAHFDLKPENI 146

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 307 FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHV 358
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 14  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSF---SWEKLHEVALGTA 412
           +VV+LLG  S+G    V+ E M  G L    R + P+          S  K+ ++A   A
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 413 RGIEYLHNGCDVCILHFDIKPHN 435
            G+ YL+       +H D+   N
Sbjct: 134 DGMAYLNAN---KFVHRDLAARN 153

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 310 KLGQGGFGSV-YKGQLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 367
           K+G+G  G V    + HTG  +AVK +   K    E + NEV  +   HH NVV +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
             G +  VV E++  G+L   +    +R    + E++  V L   R + YLHN     ++
Sbjct: 112 LVGDELWVVMEFLEGGALTDIV--THTR---MNEEQIATVCLSVLRALSYLHNQ---GVI 163
Query: 428 HFDIKPHNI 436
           H DIK  +I
Sbjct: 164 HRDIKSDSI 172

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 307 FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHV 358
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSF---SWEKLHEVALGTA 412
           +VV+LLG  S+G    V+ E M  G L    R + P+          S  K+ ++A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 413 RGIEYLHNGCDVCILHFDIKPHN 435
            G+ YL+       +H D+   N
Sbjct: 143 DGMAYLNAN---KFVHRDLAARN 162

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 307 FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHV 358
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSF---SWEKLHEVALGTA 412
           +VV+LLG  S+G    V+ E M  G L    R + P+          S  K+ ++A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 413 RGIEYLHNGCDVCILHFDIKPHN 435
            G+ YL+       +H D+   N
Sbjct: 143 DGMAYLNAN---KFVHRDLAARN 162

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 133 ---LQIAHFDLKPENI 145

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 61/136 (44%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYK-GQLHTGGLIAVKMLKNSKFSA-------EEFINEVSTIGRIHHVNV 360
            +LG G F  V K  Q  TG   A K +K  + S+       EE   EV+ +  I H N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + + L ++      G+ YLH+
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----LDGVHYLHS 126
Query: 421 GCDVCILHFDIKPHNI 436
                I HFD+KP NI
Sbjct: 127 K---RIAHFDLKPENI 139

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 307 FTHKLGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHV 358
            + +LGQG FG VY+G      +      +A+K +  +    E  EF+NE S +   +  
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSF---SWEKLHEVALGTA 412
           +VV+LLG  S+G    V+ E M  G L    R + P+          S  K+ ++A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 413 RGIEYLHNGCDVCILHFDIKPHN 435
            G+ YL+       +H D+   N
Sbjct: 136 DGMAYLNAN---KFVHRDLAARN 155

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 133 ---LQIAHFDLKPENI 145

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 62/129 (48%), Gaps = 8/129 (6%)
Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           +LG G FG VYK Q   T  L A K++   S+   E+++ E+  +    H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
              +   ++ E+   G++D  +   E   +  +  ++  V   T   + YLH   D  I+
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 428 HFDIKPHNI 436
           H D+K  NI
Sbjct: 158 HRDLKAGNI 166

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 62/129 (48%), Gaps = 8/129 (6%)
Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           +LG G FG VYK Q   T  L A K++   S+   E+++ E+  +    H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
              +   ++ E+   G++D  +   E   +  +  ++  V   T   + YLH   D  I+
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 428 HFDIKPHNI 436
           H D+K  NI
Sbjct: 158 HRDLKAGNI 166

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 62/129 (48%), Gaps = 8/129 (6%)
Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           +LG G FG VYK Q   T  L A K++   S+   E+++ E+  +    H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
              +   ++ E+   G++D  +   E   +  +  ++  V   T   + YLH   D  I+
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 428 HFDIKPHNI 436
           H D+K  NI
Sbjct: 158 HRDLKAGNI 166

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 64/149 (42%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+  Y   G+L  ++  +   G  +S++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNV 188

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 421 GCDVCILHFDIKPHNI 436
              + I HFD+KP NI
Sbjct: 133 ---LQIAHFDLKPENI 145

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 65/132 (49%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++   S+D   F   S         +        +G+ + H+    
Sbjct: 71  DVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 124
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 125 RVLHRDLKPQNL 136

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 65/132 (49%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++   S+D   F   S         +        +G+ + H+    
Sbjct: 72  DVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 125
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 126 RVLHRDLKPQNL 137

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 62/117 (52%), Gaps = 11/117 (9%)
Query: 311 LGQGGFGSVYKGQLHTGG-----LIAVKML--KNSKFSAEEFINEVSTIGRIHHVNVVQL 363
           LG G FG+V+KG     G      + +K++  K+ + S +   + +  IG + H ++V+L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           LG C  GS   +V +Y+P GSL  H+  ++ RG +   + L    +  A+G+ YL  
Sbjct: 99  LGLCP-GSSLQLVTQYLPLGSLLDHV--RQHRG-ALGPQLLLNWGVQIAKGMYYLEE 151

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 309 HKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNV 360
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHE---VALGTARG 414
           V+LLG  S+G    VV E M +G L    R + P+           L E   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 415 IEYLH 419
           + YL+
Sbjct: 143 MAYLN 147

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 62/117 (52%), Gaps = 11/117 (9%)
Query: 311 LGQGGFGSVYKGQLHTGG-----LIAVKML--KNSKFSAEEFINEVSTIGRIHHVNVVQL 363
           LG G FG+V+KG     G      + +K++  K+ + S +   + +  IG + H ++V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           LG C  GS   +V +Y+P GSL  H+  ++ RG +   + L    +  A+G+ YL  
Sbjct: 81  LGLCP-GSSLQLVTQYLPLGSLLDHV--RQHRG-ALGPQLLLNWGVQIAKGMYYLEE 133

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 64/149 (42%), Gaps = 26/149 (17%)
Query: 311 LGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HHVN 359
           LG+G FG V         K +      +AVKMLK+     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE------------KLHEV 407
           ++ LLG C++     V+  Y   G+L  ++  +   G  +S++             L   
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
               ARG+EYL      CI H D+   N+
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNV 188

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 309 HKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNV 360
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHE---VALGTARG 414
           V+LLG  S+G    VV E M +G L    R + P+           L E   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 415 IEYLH 419
           + YL+
Sbjct: 143 MAYLN 147

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 309 HKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNV 360
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHE---VALGTARG 414
           V+LLG  S+G    VV E M +G L    R + P+           L E   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 415 IEYLH 419
           + YL+
Sbjct: 143 MAYLN 147

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 10/134 (7%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQ 362
           H   K+G+G +G VYK Q + G   A+K ++  K         I E+S +  + H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           L        +  +V+E++ +  L + +   E   +S + +      L    GI Y H   
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF---LLQLLNGIAYCH--- 117
Query: 423 DVCILHFDIKPHNI 436
           D  +LH D+KP N+
Sbjct: 118 DRRVLHRDLKPQNL 131

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 10/134 (7%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQ 362
           H   K+G+G +G VYK Q + G   A+K ++  K         I E+S +  + H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           L        +  +V+E++ +  L + +   E   +S + +      L    GI Y H   
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF---LLQLLNGIAYCH--- 117
Query: 423 DVCILHFDIKPHNI 436
           D  +LH D+KP N+
Sbjct: 118 DRRVLHRDLKPQNL 131

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 10/134 (7%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQ 362
           H   K+G+G +G VYK Q + G   A+K ++  K         I E+S +  + H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           L        +  +V+E++ +  L + +   E   +S + +      L    GI Y H   
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF---LLQLLNGIAYCH--- 117
Query: 423 DVCILHFDIKPHNI 436
           D  +LH D+KP N+
Sbjct: 118 DRRVLHRDLKPQNL 131

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 65/132 (49%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++   S+D   F   S         +        +G+ + H+    
Sbjct: 70  DVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 123
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 124 RVLHRDLKPENL 135

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 65/132 (49%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++   S+D   F   S         +        +G+ + H+    
Sbjct: 72  DVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 125
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 126 RVLHRDLKPENL 137

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 309 HKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNV 360
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHE---VALGTARG 414
           V+LLG  S+G    VV E M +G L    R + P+           L E   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 415 IEYLH 419
           + YL+
Sbjct: 143 MAYLN 147

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 309 HKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNV 360
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHE---VALGTARG 414
           V+LLG  S+G    VV E M +G L    R + P+           L E   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 415 IEYLH 419
           + YL+
Sbjct: 143 MAYLN 147

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKL 70
Query: 356 HHVNVVQL-LGFCSEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNL 153

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 60/136 (44%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYK-GQLHTGGLIAVKMLKNSKF-------SAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K  Q  TG   A K +K  +        S EE   EV+ +  I H N+
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L   +  KES  +  + + L ++      G+ YLH+
Sbjct: 92  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----LDGVHYLHS 147
Query: 421 GCDVCILHFDIKPHNI 436
                I HFD+KP NI
Sbjct: 148 K---RIAHFDLKPENI 160

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 9/150 (6%)
Query: 287 QQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI 346
           Q+ W    +  P     +     KLG G FG V+    +    +AVK +K    S E F+
Sbjct: 2   QKPWEKDAWEIPR---ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFL 58
Query: 347 NEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE 406
            E + +  + H  +V+L    ++     ++ E+M  GSL    F K   G      KL +
Sbjct: 59  AEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL--LDFLKSDEGSKQPLPKLID 115
Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            +   A G+ ++        +H D++  NI
Sbjct: 116 FSAQIAEGMAFIEQR---NYIHRDLRAANI 142

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 309 HKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNV 360
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHE---VALGTARG 414
           V+LLG  S+G    VV E M +G L    R + P+           L E   +A   A G
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 415 IEYLH 419
           + YL+
Sbjct: 144 MAYLN 148

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 30  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 83
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 84  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 142
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 143 QL--FRSLAYIHS---FGICHRDIKPQNL 166

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 68/142 (47%), Gaps = 23/142 (16%)
Query: 311 LGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG----- 365
           +G GGFG V+K +    G   V  +K  K++ E+   EV  + ++ HVN+V   G     
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYV--IKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 76
Query: 366 -----FCSEGSKRA------VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARG 414
                  S+ S R+      +  E+   G+L++ I  ++ RG+        E+     +G
Sbjct: 77  DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQITKG 134
Query: 415 IEYLHNGCDVCILHFDIKPHNI 436
           ++Y+H+     +++ D+KP NI
Sbjct: 135 VDYIHSK---KLINRDLKPSNI 153

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 309 HKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNV 360
            +LGQG FG VY+G             +AVK +  S    E  EF+NE S +      +V
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHE---VALGTARG 414
           V+LLG  S+G    VV E M +G L    R + P+           L E   +A   A G
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 415 IEYLH 419
           + YL+
Sbjct: 140 MAYLN 144

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKL 70
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNL 153

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 18  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKL 71
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 130
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 131 QL--FRSLAYIHS---FGICHRDIKPQNL 154

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 36  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 89
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 90  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 148
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 149 QL--FRSLAYIHS---FGICHRDIKPQNL 172

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 25  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 78
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 79  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 137
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 138 QL--FRSLAYIHS---FGICHRDIKPQNL 161

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKL 70
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNL 153

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 29  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 82
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 141
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 142 QL--FRSLAYIHS---FGICHRDIKPQNL 165

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 29  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 82
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 141
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 142 QL--FRSLAYIHS---FGICHRDIKPQNL 165

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 22  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 75
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 134
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 135 QL--FRSLAYIHS---FGICHRDIKPQNL 158

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 45  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 98
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 99  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 157
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 158 QL--FRSLAYIHS---FGICHRDIKPQNL 181

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 6/138 (4%)
Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV 358
           EI   +     KLG G FG V+    +    +AVK +K    S E F+ E + +  + H 
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 237
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +V+L    ++     ++ E+M  GSL    F K   G      KL + +   A G+ ++
Sbjct: 238 KLVKLHAVVTK-EPIYIITEFMAKGSL--LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 294
Query: 419 HNGCDVCILHFDIKPHNI 436
                   +H D++  NI
Sbjct: 295 EQ---RNYIHRDLRAANI 309

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 35/156 (22%)
Query: 311 LGQGGFGSVYKGQ-LHTGG-----LIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQ 362
           LG+G FG V K    H  G      +AVKMLK +   +E  + ++E + + +++H +V++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRG----------------------QSFS 400
           L G CS+     ++ EY   GSL    F +ESR                       ++ +
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSL--RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 401 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
              L   A   ++G++YL    ++ ++H D+   NI
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMSLVHRDLAARNI 181

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 21  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 74
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 75  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 133
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 134 QL--FRSLAYIHS---FGICHRDIKPQNL 157

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 64/150 (42%), Gaps = 9/150 (6%)
Query: 287 QQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI 346
           Q+ W    +   EI   +     KLG G FG V+    +    +AVK +K    S E F+
Sbjct: 175 QKPWEKDAW---EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFL 231
Query: 347 NEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE 406
            E + +  + H  +V+L    ++     ++ E+M  GSL    F K   G      KL +
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL--LDFLKSDEGSKQPLPKLID 288
Query: 407 VALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            +   A G+ ++        +H D++  NI
Sbjct: 289 FSAQIAEGMAFIEQ---RNYIHRDLRAANI 315

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/127 (33%), Positives = 58/127 (45%), Gaps = 18/127 (14%)
Query: 309 HKLGQGGFGSVY--------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHV 358
            +LGQG FG VY        KG+  T   +AVK +  S    E  EF+NE S +      
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAET--RVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHE---VALGTA 412
           +VV+LLG  S+G    VV E M +G L    R + P+           L E   +A   A
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 413 RGIEYLH 419
            G+ YL+
Sbjct: 140 DGMAYLN 146

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 51  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 104
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 163
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 164 QL--FRSLAYIHS---FGICHRDIKPQNL 187

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 286 NQQSW-MPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLK---NSKF 340
           N+ +W +PK Y  P         TH +G G +GSV       +G  +A+K L     S+ 
Sbjct: 34  NKTAWELPKTYVSP---------TH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 83
Query: 341 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY---MPNGSLDRHIFPKESRGQ 397
            A+    E+  +  + H NV+ LL   +  S     Y++   MP    D     ++  G 
Sbjct: 84  FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL----QKIMGM 139
Query: 398 SFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            FS EK+  +     +G++Y+H+     ++H D+KP N+
Sbjct: 140 EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNL 175

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 112 VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 167
Query: 418 L 418
           L
Sbjct: 168 L 168

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 311 LGQGGFGSVYKGQ-LHTGG-----LIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQ 362
           LG+G FG V K    H  G      +AVKMLK +   +E  + ++E + + +++H +V++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESR 395
           L G CS+     ++ EY   GSL    F +ESR
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSL--RGFLRESR 121

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 53  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 106
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 107 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 165
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 166 QL--FRSLAYIHS---FGICHRDIKPQNL 189

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 311 LGQGGFGSVYKGQ-LHTGG-----LIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQ 362
           LG+G FG V K    H  G      +AVKMLK +   +E  + ++E + + +++H +V++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESR 395
           L G CS+     ++ EY   GSL    F +ESR
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSL--RGFLRESR 121

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 51  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 104
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 163
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 164 QL--FRSLAYIHS---FGICHRDIKPQNL 187

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 286 NQQSW-MPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLK---NSKF 340
           N+ +W +PK Y  P         TH +G G +GSV       +G  +A+K L     S+ 
Sbjct: 16  NKTAWELPKTYVSP---------TH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 65
Query: 341 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY---MPNGSLDRHIFPKESRGQ 397
            A+    E+  +  + H NV+ LL   +  S     Y++   MP    D     ++  G 
Sbjct: 66  FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL----QKIMGL 121
Query: 398 SFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            FS EK+  +     +G++Y+H+     ++H D+KP N+
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNL 157

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 111 VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 166
Query: 418 L 418
           L
Sbjct: 167 L 167

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 55  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 108
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 109 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 167
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 168 QL--FRSLAYIHS---FGICHRDIKPQNL 191

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 68/131 (51%), Gaps = 11/131 (8%)
Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKML-KNSKFSA---EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G F  VY+ + +HTG  +A+KM+ K + + A   +   NEV    ++ H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + +   +V E   NG ++R++   ++R + FS  +          G+ YLH+     
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHSH---G 132
Query: 426 ILHFDIKPHNI 436
           ILH D+   N+
Sbjct: 133 ILHRDLTLSNL 143

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 307 FTHKLGQGGFGSV--YKGQLHTGGLIAVK-MLKNSKFSAEEFINEVSTIGRIHHVNVVQL 363
           F  KLG+GGF  V   +G LH G   A+K +L + +   EE   E       +H N+++L
Sbjct: 33  FIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 364 LGFC--SEGSKRA--VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           + +C    G+K    ++  +   G+L   I   + +G   + +++  + LG  RG+E +H
Sbjct: 92  VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 420 NGCDVCILHFDIKPHNI 436
                   H D+KP NI
Sbjct: 152 AK---GYAHRDLKPTNI 165

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 90  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 145
Query: 418 L 418
           L
Sbjct: 146 L 146

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 64/131 (48%), Gaps = 13/131 (9%)
Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKML---KNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           +G+G +G V K +   TG ++A+K      + K   +  + E+  + ++ H N+V LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 367 CSEGSKRAVVYEYMPNGSLDR-HIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           C +  +  +V+E++ +  LD   +FP         ++ + +       GI + H+     
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSH---N 144
Query: 426 ILHFDIKPHNI 436
           I+H DIKP NI
Sbjct: 145 IIHRDIKPENI 155

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 92  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 418 L 418
           L
Sbjct: 148 L 148

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 418 L 418
           L
Sbjct: 149 L 149

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 60/138 (43%), Gaps = 12/138 (8%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-------HHV 358
           H   K+G G FGSV+K      G I    +K SK      ++E + +  +        H 
Sbjct: 12  HELEKIGSGEFGSVFKCVKRLDGCIYA--IKRSKKPLAGSVDEQNALREVYAHAVLGQHS 69
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           +VV+     +E     +  EY   GSL   I         F   +L ++ L   RG+ Y+
Sbjct: 70  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 419 HNGCDVCILHFDIKPHNI 436
           H+   + ++H DIKP NI
Sbjct: 130 HS---MSLVHMDIKPSNI 144

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 85  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 140
Query: 418 L 418
           L
Sbjct: 141 L 141

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 418 L 418
           L
Sbjct: 149 L 149

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+ K+L++ +F       E+  + ++
Sbjct: 96  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKL 149
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 150 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 208
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 209 QL--FRSLAYIHS---FGICHRDIKPQNL 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 92  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 418 L 418
           L
Sbjct: 148 L 148

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 60/138 (43%), Gaps = 12/138 (8%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-------HHV 358
           H   K+G G FGSV+K      G I    +K SK      ++E + +  +        H 
Sbjct: 12  HELEKIGSGEFGSVFKCVKRLDGCIYA--IKRSKKPLAGSVDEQNALREVYAHAVLGQHS 69
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           +VV+     +E     +  EY   GSL   I         F   +L ++ L   RG+ Y+
Sbjct: 70  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 419 HNGCDVCILHFDIKPHNI 436
           H+   + ++H DIKP NI
Sbjct: 130 HS---MSLVHMDIKPSNI 144

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 60/138 (43%), Gaps = 12/138 (8%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-------HHV 358
           H   K+G G FGSV+K      G I    +K SK      ++E + +  +        H 
Sbjct: 14  HELEKIGSGEFGSVFKCVKRLDGCIYA--IKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           +VV+     +E     +  EY   GSL   I         F   +L ++ L   RG+ Y+
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 419 HNGCDVCILHFDIKPHNI 436
           H+   + ++H DIKP NI
Sbjct: 132 HS---MSLVHMDIKPSNI 146

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 88  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 143
Query: 418 L 418
           L
Sbjct: 144 L 144

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 60/138 (43%), Gaps = 12/138 (8%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-------HHV 358
           H   K+G G FGSV+K      G I    +K SK      ++E + +  +        H 
Sbjct: 10  HELEKIGSGEFGSVFKCVKRLDGCIYA--IKRSKKPLAGSVDEQNALREVYAHAVLGQHS 67
Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           +VV+     +E     +  EY   GSL   I         F   +L ++ L   RG+ Y+
Sbjct: 68  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 127
Query: 419 HNGCDVCILHFDIKPHNI 436
           H+   + ++H DIKP NI
Sbjct: 128 HS---MSLVHMDIKPSNI 142

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/137 (22%), Positives = 57/137 (41%), Gaps = 22/137 (16%)
Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI--NEVSTIGRIHHVNVVQLLGF 366
            +LG G FG V++      G + V    N+ +  +++   NE+S + ++HH  ++ L   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV-- 424
             +  +  ++ E++  G L             F      +  +  A  I Y+   C+   
Sbjct: 117 FEDKYEMVLILEFLSGGEL-------------FDRIAAEDYKMSEAEVINYMRQACEGLK 163
Query: 425 -----CILHFDIKPHNI 436
                 I+H DIKP NI
Sbjct: 164 HMHEHSIVHLDIKPENI 180

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G++Y
Sbjct: 91  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKY 146
Query: 418 L 418
           L
Sbjct: 147 L 147

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +  K SR   F  ++       TA  I  L N    C
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-QKLSR---FDEQR-------TATYITELANALSYC 128
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 129 HSKRVIHRDIKPENL 143

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +  K SR   F  ++       TA  I  L N    C
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-QKLSR---FDEQR-------TATYITELANALSYC 128
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 129 HSKRVIHRDIKPENL 143

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++       TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 127
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 128 HSKRVIHRDIKPENL 142

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++       TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 127
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 128 HSKRVIHRDIKPENL 142

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 129
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 130 VIHRDIKPENL 140

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 129
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 130 VIHRDIKPENL 140

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++       TA  I  L N    C
Sbjct: 75  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 123
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 124 HSKRVIHRDIKPENL 138

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 129 VIHRDIKPENL 139

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++       TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 124
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 125 HSKRVIHRDIKPENL 139

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 129 VIHRDIKPENL 139

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 131
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 132 VIHRDIKPENL 142

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 75/149 (50%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFIN-EVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +   K     F N E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK----AFKNRELQIMRKL 70
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNL 153

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++       TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 127
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 128 HSKRVIHRDIKPENL 142

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 75/149 (50%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFIN-EVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +   K     F N E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK----AFKNRELQIMRKL 70
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNL 153

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---K 128
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 129 VIHRDIKPENL 139

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 130
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 131 VIHRDIKPENL 141

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 130
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 131 VIHRDIKPENL 141

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 63/130 (48%), Gaps = 10/130 (7%)
Query: 310 KLGQGGFGSVYKGQLH-TGGLIAVK--MLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           KLG+G + +VYKG+   T  L+A+K   L++ + +    I EVS +  + H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
                   +V+EY+ +  L +++   +  G   +   +        RG+ Y H      +
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 427 LHFDIKPHNI 436
           LH D+KP N+
Sbjct: 122 LHRDLKPQNL 131

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++       TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 124
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 125 HSKRVIHRDIKPENL 139

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 60/133 (45%), Gaps = 11/133 (8%)
Query: 307 FTHKLGQGGFGSVY-KGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNVVQLL 364
           F   LG G F  V+   Q  TG L A+K +K S  F      NE++ + +I H N+V L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGCD 423
                 +   +V + +  G L   I     RG  ++ +    V       ++YLH NG  
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRIL---ERG-VYTEKDASLVIQQVLSAVKYLHENG-- 126
Query: 424 VCILHFDIKPHNI 436
             I+H D+KP N+
Sbjct: 127 --IVHRDLKPENL 137

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 129 VIHRDIKPENL 139

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++       TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 124
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 125 HSKRVIHRDIKPENL 139

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 134 VIHRDIKPENL 144

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +       Q  S  K  E    TA  I  L N    C
Sbjct: 93  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 141
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 142 HSKRVIHRDIKPENL 156

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 128
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 129 VIHRDIKPENL 139

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/172 (22%), Positives = 73/172 (42%), Gaps = 36/172 (20%)
Query: 294 RYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIG 353
           +Y+  +   M       +G GGFG V+K +    G   V  ++  K++ E+   EV  + 
Sbjct: 3   KYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYV--IRRVKYNNEKAEREVKALA 60
Query: 354 RIHHVNVVQLLG--------------------FCSEGSKRA---------VVYEYMPNGS 384
           ++ HVN+V   G                    +  E SK +         +  E+   G+
Sbjct: 61  KLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGT 120
Query: 385 LDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           L++ I  ++ RG+        E+     +G++Y+H+     ++H D+KP NI
Sbjct: 121 LEQWI--EKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNI 167

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 134 VIHRDIKPENL 144

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +       Q  S  K  E    TA  I  L N    C
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 125
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 126 HSKRVIHRDIKPENL 140

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++       TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 127
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 128 HSKRVIHRDIKPENL 142

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +       Q  S  K  E    TA  I  L N    C
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 150
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 151 HSKRVIHRDIKPENL 165

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 154
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 155 VIHRDIKPENL 165

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++       TA  I  L N    C
Sbjct: 73  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 121
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 122 HSKRVIHRDIKPENL 136

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++       TA  I  L N    C
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 128
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 129 HSKRVIHRDIKPENL 143

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 75/149 (50%), Gaps = 22/149 (14%)
Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFIN-EVSTIGRI 355
           P+ ++ T+  T  +G G FG VY+ +L  +G L+A+K +   K     F N E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK----AFKNRELQIMRKL 70
Query: 356 HHVNVVQLLGFC-SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEV 407
            H N+V+L  F  S G K+  VY     +Y+P     + RH + +  +     + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   R + Y+H+     I H DIKP N+
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNL 153

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/121 (35%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 91  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 146
Query: 418 L 418
           L
Sbjct: 147 L 147

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 59/136 (43%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSA-------EEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +  A       EE   EVS + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L    F   ++ +S S E+          G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 421 GCDVCILHFDIKPHNI 436
                I HFD+KP NI
Sbjct: 134 K---KIAHFDLKPENI 146

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 62/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++       TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQR-------TATYITELANALSYC 127
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 128 HSKRVIHRDIKPENL 142

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/131 (23%), Positives = 60/131 (45%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G     ++ +  +   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 134 VIHRDIKPENL 144

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 23/146 (15%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE----------VALG 410
            LLG C++ G    V+ E+   G+L  ++  K +    +  E L++           +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 411 TARGIEYLHNGCDVCILHFDIKPHNI 436
            A+G+E+L        +H D+   NI
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNI 179

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+     
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---R 133
Query: 426 ILHFDIKPHNI 436
           ++H DIKP N+
Sbjct: 134 VIHRDIKPENL 144

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/121 (35%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 418 L 418
           L
Sbjct: 149 L 149

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 61/135 (45%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           +  + ++  ++ EY P G     ++ +  +   F  ++       TA  I  L N    C
Sbjct: 81  YFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQR-------TATYITELANALSYC 129
Query: 426 ----ILHFDIKPHNI 436
               ++H DIKP N+
Sbjct: 130 HSKRVIHRDIKPENL 144

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 50/109 (45%), Gaps = 9/109 (8%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGL------IAVKMLKNSKFSAEE--FINEVSTIGRI-H 356
            F   LG G FG V +      G       +AVKMLK++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLH 405
           H N+V LLG C+ G    V+ EY   G L   +  K   G  +S+   H
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH 157

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 59/136 (43%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S EE   EVS + ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L    F   ++ +S S E+          G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 421 GCDVCILHFDIKPHNI 436
                I HFD+KP NI
Sbjct: 134 K---KIAHFDLKPENI 146

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 66/144 (45%), Gaps = 21/144 (14%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRHIFPKESR--------GQSFSWEKLHEVALGTA 412
            LLG C++ G    V+ E+   G+L  ++  K +             + E L   +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 413 RGIEYLHNGCDVCILHFDIKPHNI 436
           +G+E+L        +H D+   NI
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNI 175

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/121 (35%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 152 VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 207
Query: 418 L 418
           L
Sbjct: 208 L 208

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/121 (35%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 418 L 418
           L
Sbjct: 149 L 149

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 59/136 (43%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S EE   EVS + ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L    F   ++ +S S E+          G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 421 GCDVCILHFDIKPHNI 436
                I HFD+KP NI
Sbjct: 134 K---KIAHFDLKPENI 146

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/121 (35%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 94  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 418 L 418
           L
Sbjct: 150 L 150

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 60/146 (41%), Gaps = 10/146 (6%)
Query: 294 RYSYPEIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE--FINEVS 350
           R+   E I     F   LG G F  V   +   T  L+A+K +       +E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 351 TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALG 410
            + +I H N+V L      G    ++ + +  G L   I  K      ++      +   
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQ 124
Query: 411 TARGIEYLHNGCDVCILHFDIKPHNI 436
               ++YLH   D+ I+H D+KP N+
Sbjct: 125 VLDAVKYLH---DLGIVHRDLKPENL 147

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/121 (35%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 94  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 418 L 418
           L
Sbjct: 150 L 150

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 59/136 (43%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S EE   EVS + ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L    F   ++ +S S E+          G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 421 GCDVCILHFDIKPHNI 436
                I HFD+KP NI
Sbjct: 134 K---KIAHFDLKPENI 146

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 22/136 (16%)
Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKML--KNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           LG+G +G VY G+ L     IA+K +  ++S++S +    E++    + H N+VQ LG  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKL--HEVALG-----TARGIEYLHN 420
           SE     +  E +P GSL   +  K        W  L  +E  +G        G++YLH 
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSK--------WGPLKDNEQTIGFYTKQILEGLKYLH- 139
Query: 421 GCDVCILHFDIKPHNI 436
             D  I+H DIK  N+
Sbjct: 140 --DNQIVHRDIKGDNV 153

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 60/146 (41%), Gaps = 10/146 (6%)
Query: 294 RYSYPEIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE--FINEVS 350
           R+   E I     F   LG G F  V   +   T  L+A+K +       +E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 351 TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALG 410
            + +I H N+V L      G    ++ + +  G L   I  K      ++      +   
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQ 124
Query: 411 TARGIEYLHNGCDVCILHFDIKPHNI 436
               ++YLH   D+ I+H D+KP N+
Sbjct: 125 VLDAVKYLH---DLGIVHRDLKPENL 147

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/121 (35%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 306 HFTHKLGQGGFGSVYKGQL--HTGGLI--AVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L  + G  I  AVK L       E  +F+ E   +    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 360 VVQLLGFC--SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+ LLG C  SEGS   VV  YM +G L R+    E+   +   + L    L  A+G+++
Sbjct: 98  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 153
Query: 418 L 418
           L
Sbjct: 154 L 154

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 59/136 (43%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S EE   EVS + ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L    F   ++ +S S E+          G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 421 GCDVCILHFDIKPHNI 436
                I HFD+KP NI
Sbjct: 134 K---KIAHFDLKPENI 146

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 22/136 (16%)
Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKML--KNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           LG+G +G VY G+ L     IA+K +  ++S++S +    E++    + H N+VQ LG  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKL--HEVALG-----TARGIEYLHN 420
           SE     +  E +P GSL   +  K        W  L  +E  +G        G++YLH 
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSK--------WGPLKDNEQTIGFYTKQILEGLKYLH- 125
Query: 421 GCDVCILHFDIKPHNI 436
             D  I+H DIK  N+
Sbjct: 126 --DNQIVHRDIKGDNV 139

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 60/146 (41%), Gaps = 10/146 (6%)
Query: 294 RYSYPEIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE--FINEVS 350
           R+   E I     F   LG G F  V   +   T  L+A+K +       +E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 351 TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALG 410
            + +I H N+V L      G    ++ + +  G L   I  K      ++      +   
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQ 124
Query: 411 TARGIEYLHNGCDVCILHFDIKPHNI 436
               ++YLH   D+ I+H D+KP N+
Sbjct: 125 VLDAVKYLH---DLGIVHRDLKPENL 147

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 72  DVIHTENKLYLVFEFLHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 125
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 126 RVLHRDLKPQNL 137

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 54/119 (45%), Gaps = 10/119 (8%)
Query: 284 LHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKG------QLHTGGLIAVKMLKN 337
           L  Q   +P   S  E           LG+G FG V +       +  T   +AVKMLK 
Sbjct: 8   LDEQCERLPYDASKWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKE 67
Query: 338 SKFSAE--EFINEVSTIGRI-HHVNVVQLLGFCS-EGSKRAVVYEYMPNGSLDRHIFPK 392
              ++E    + E+  +  I HH+NVV LLG C+ +G    V+ EY   G+L  ++  K
Sbjct: 68  GATASEYKALMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSK 126

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 56/133 (42%), Gaps = 10/133 (7%)
Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQL 363
               LG+G +G V       T   +AVK+  +K +    E    E+     ++H NVV+ 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKF 70
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 123
Query: 424 VCILHFDIKPHNI 436
           + I H DIKP N+
Sbjct: 124 IGITHRDIKPENL 136

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 65/134 (48%), Gaps = 13/134 (9%)
Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLG-FC 367
           +G G +G VYKG+ + TG L A+K++  +    EE   E++ + +  HH N+    G F 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 368 SEG-----SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
            +       +  +V E+   GS+   I  K ++G +   E +  +     RG+ +LH   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQH- 148
Query: 423 DVCILHFDIKPHNI 436
              ++H DIK  N+
Sbjct: 149 --KVIHRDIKGQNV 160

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKML-KNSKFSAEEFINEVSTIGRIH-HVNVVQLLGFC 367
           LG+G +  V     L  G   AVK++ K +  S      EV T+ +   + N+++L+ F 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
            + ++  +V+E +  GS+  HI     + + F+  +   V    A  +++LH      I 
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI----QKQKHFNEREASRVVRDVAAALDFLHTK---GIA 133
Query: 428 HFDIKPHNI 436
           H D+KP NI
Sbjct: 134 HRDLKPENI 142

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH--- 122
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 123 RVLHRDLKPQNL 134

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 310 KLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +K  +V+E++     D   F   S         +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 426 ILHFDIKPHNI 436
           +LH D+KP N+
Sbjct: 124 VLHRDLKPQNL 134

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 310 KLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +K  +V+E++     D   F   S         +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 426 ILHFDIKPHNI 436
           +LH D+KP N+
Sbjct: 123 VLHRDLKPQNL 133

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 122
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 123 RVLHRDLKPQNL 134

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 122
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 123 RVLHRDLKPQNL 134

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 68  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 121
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 122 RVLHRDLKPQNL 133

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 310 KLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +K  +V+E++     D   F   S         +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 426 ILHFDIKPHNI 436
           +LH D+KP N+
Sbjct: 123 VLHRDLKPQNL 133

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 68  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 121
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 122 RVLHRDLKPQNL 133

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 59/136 (43%), Gaps = 15/136 (11%)
Query: 309 HKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNV 360
            +LG G F  V K +  + GL  A K +K  +        S EE   EVS + ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L       +   ++ E +  G L    F   ++ +S S E+          G+ YLH 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 421 GCDVCILHFDIKPHNI 436
                I HFD+KP NI
Sbjct: 134 K---KIAHFDLKPENI 146

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 122
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 123 RVLHRDLKPQNL 134

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 122
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 123 RVLHRDLKPQNL 134

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 310 KLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +K  +V+E++     D   F   S         +        +G+ + H+     
Sbjct: 74  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 127
Query: 426 ILHFDIKPHNI 436
           +LH D+KP N+
Sbjct: 128 VLHRDLKPQNL 138

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 122
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 123 RVLHRDLKPQNL 134

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 25/146 (17%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE----------VALG 410
            LLG C++ G    V+ E+   G+L  ++  +  R +   ++ L++           +  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 411 TARGIEYLHNGCDVCILHFDIKPHNI 436
            A+G+E+L +   +   H D+   NI
Sbjct: 153 VAKGMEFLASRKXI---HRDLAARNI 175

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 310 KLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +K  +V+E++     D   F   S         +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 426 ILHFDIKPHNI 436
           +LH D+KP N+
Sbjct: 124 VLHRDLKPQNL 134

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 25/148 (16%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRH------------IFPKESRGQSFSWEKLHEVA 408
            LLG C++ G    V+ E+   G+L  +            + P++      + E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
              A+G+E+L      CI H D+   NI
Sbjct: 155 FQVAKGMEFL--ASRKCI-HRDLAARNI 179

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 72  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 125
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 126 RVLHRDLKPQNL 137

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 71  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 124
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 125 RVLHRDLKPQNL 136

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 123 ---IGITHRDIKPENL 135

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 70  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 123
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 124 RVLHRDLKPQNL 135

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKD---FMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 122
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 123 RVLHRDLKPENL 134

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 70  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 123
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 124 RVLHRDLKPQNL 135

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 56/133 (42%), Gaps = 10/133 (7%)
Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQL 363
               LG+G +G V       T   +AVK+  +K +    E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 122
Query: 424 VCILHFDIKPHNI 436
           + I H DIKP N+
Sbjct: 123 IGITHRDIKPENL 135

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 71  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 124
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 125 RVLHRDLKPQNL 136

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 56/133 (42%), Gaps = 10/133 (7%)
Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQL 363
               LG+G +G V       T   +AVK+  +K +    E    E+     ++H NVV+ 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 123
Query: 424 VCILHFDIKPHNI 436
           + I H DIKP N+
Sbjct: 124 IGITHRDIKPENL 136

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 25/148 (16%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRH------------IFPKESRGQSFSWEKLHEVA 408
            LLG C++ G    V+ E+   G+L  +            + P++      + E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
              A+G+E+L      CI H D+   NI
Sbjct: 155 FQVAKGMEFL--ASRKCI-HRDLAARNI 179

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 76  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 129
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 130 RVLHRDLKPQNL 141

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 56/133 (42%), Gaps = 10/133 (7%)
Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQL 363
               LG+G +G V       T   +AVK+  +K +    E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 122
Query: 424 VCILHFDIKPHNI 436
           + I H DIKP N+
Sbjct: 123 IGITHRDIKPENL 135

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 310 KLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +K  +V+E++     D   F   S         +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEHVHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 426 ILHFDIKPHNI 436
           +LH D+KP N+
Sbjct: 123 VLHRDLKPQNL 133

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 25/148 (16%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRH------------IFPKESRGQSFSWEKLHEVA 408
            LLG C++ G    V+ E+   G+L  +            + P++      + E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
              A+G+E+L      CI H D+   NI
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNI 170

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 124 ---IGITHRDIKPENL 136

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 310 KLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +K  +V+E++     D   F   S         +        +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 124
Query: 426 ILHFDIKPHNI 436
           +LH D+KP N+
Sbjct: 125 VLHRDLKPQNL 135

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 123 ---IGITHRDIKPENL 135

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 9   LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 121
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 122 ---IGITHRDIKPENL 134

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 70  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 123
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 124 RVLHRDLKPENL 135

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 25/148 (16%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRH------------IFPKESRGQSFSWEKLHEVA 408
            LLG C++ G    V+ E+   G+L  +            + P++      + E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
              A+G+E+L      CI H D+   NI
Sbjct: 155 FQVAKGMEFL--ASRKCI-HRDLAARNI 179

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 60/146 (41%), Gaps = 10/146 (6%)
Query: 294 RYSYPEIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE--FINEVS 350
           R+   E I     F   LG G F  V   +   T  L+A+K +       +E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 68
Query: 351 TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALG 410
            + +I H N+V L      G    ++ + +  G L   I  K      ++      +   
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQ 124
Query: 411 TARGIEYLHNGCDVCILHFDIKPHNI 436
               ++YLH   D+ I+H D+KP N+
Sbjct: 125 VLDAVKYLH---DLGIVHRDLKPENL 147

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 56/133 (42%), Gaps = 10/133 (7%)
Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQL 363
               LG+G +G V       T   +AVK+  +K +    E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 122
Query: 424 VCILHFDIKPHNI 436
           + I H DIKP N+
Sbjct: 123 IGITHRDIKPENL 135

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 71  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 124
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 125 RVLHRDLKPENL 136

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 56/133 (42%), Gaps = 10/133 (7%)
Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQL 363
               LG+G +G V       T   +AVK+  +K +    E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 122
Query: 424 VCILHFDIKPHNI 436
           + I H DIKP N+
Sbjct: 123 IGITHRDIKPENL 135

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 72  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 125
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 126 RVLHRDLKPQNL 137

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 124 ---IGITHRDIKPENL 136

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 24/147 (16%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRHI-----------FPKESRGQSFSWEKLHEVAL 409
            LLG C++ G    V+ E+   G+L  ++            P++      + E L   + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 410 GTARGIEYLHNGCDVCILHFDIKPHNI 436
             A+G+E+L      CI H D+   NI
Sbjct: 156 QVAKGMEFL--ASRKCI-HRDLAARNI 179

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 60/136 (44%), Gaps = 17/136 (12%)
Query: 312 GQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS 371
            +G FG V+K QL     +AVK+       + +   EV ++  + H N++Q +G    G+
Sbjct: 33  ARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 372 KRAV----VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-------N 420
              V    +  +   GSL   +     +    SW +L  +A   ARG+ YLH       +
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 421 GCDVCILHFDIKPHNI 436
           G    I H DIK  N+
Sbjct: 147 GHKPAISHRDIKSKNV 162

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 73  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 126
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 127 RVLHRDLKPQNL 138

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 56/133 (42%), Gaps = 10/133 (7%)
Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQL 363
               LG+G +G V       T   +AVK+  +K +    E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 122
Query: 424 VCILHFDIKPHNI 436
           + I H DIKP N+
Sbjct: 123 IGITHRDIKPENL 135

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 76  DVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 129
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 130 RVLHRDLKPQNL 141

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 123 ---IGITHRDIKPENL 135

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 58/137 (42%), Gaps = 18/137 (13%)
Query: 312 GQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS 371
            +G FG V+K QL     +AVK+       + +   E+ +   + H N++Q +     GS
Sbjct: 24  ARGRFGCVWKAQL-MNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 372 KRAV----VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC-- 425
              V    +  +   GSL  ++     +G   +W +L  VA   +RG+ YLH     C  
Sbjct: 83  NLEVELWLITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 426 ------ILHFDIKPHNI 436
                 I H D K  N+
Sbjct: 138 EGHKPSIAHRDFKSKNV 154

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 25/148 (16%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRH------------IFPKESRGQSFSWEKLHEVA 408
            LLG C++ G    V+ E+   G+L  +            + P++      + E L   +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
              A+G+E+L      CI H D+   NI
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNI 170

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 63/146 (43%), Gaps = 18/146 (12%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGL------IAVKMLKNSKFSAEE--FINEVSTIGRI-H 356
            F   LG G FG V +      G       +AVKMLK++  + E+   ++E+  +  +  
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPK------ESRGQSFSWEKLHEVALG 410
           H N+V LLG C+ G    V+ EY   G L   +  K      +  G+      L   +  
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 411 TARGIEYLHNGCDVCILHFDIKPHNI 436
            A+G+ +L      CI H D+   N+
Sbjct: 161 VAQGMAFL--ASKNCI-HRDVAARNV 183

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 25/148 (16%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRH------------IFPKESRGQSFSWEKLHEVA 408
            LLG C++ G    V+ E+   G+L  +            + P++      + E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
              A+G+E+L      CI H D+   NI
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNI 170

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 25/148 (16%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRH------------IFPKESRGQSFSWEKLHEVA 408
            LLG C++ G    V+ E+   G+L  +            + P++      + E L   +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
              A+G+E+L      CI H D+   NI
Sbjct: 192 FQVAKGMEFL--ASRKCI-HRDLAARNI 216

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 123 ---IGITHRDIKPENL 135

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 25/148 (16%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRH------------IFPKESRGQSFSWEKLHEVA 408
            LLG C++ G    V+ E+   G+L  +            + P++      + E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
              A+G+E+L      CI H D+   NI
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNI 170

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 63/146 (43%), Gaps = 18/146 (12%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGL------IAVKMLKNSKFSAEE--FINEVSTIGRI-H 356
            F   LG G FG V +      G       +AVKMLK++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPK------ESRGQSFSWEKLHEVALG 410
           H N+V LLG C+ G    V+ EY   G L   +  K      +  G+      L   +  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 411 TARGIEYLHNGCDVCILHFDIKPHNI 436
            A+G+ +L      CI H D+   N+
Sbjct: 169 VAQGMAFL--ASKNCI-HRDVAARNV 191

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 44/92 (47%), Gaps = 9/92 (9%)
Query: 307 FTHKLGQGGFGSVYKG---------QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH 357
           F   LGQG F  ++KG         QLH   ++   + K  +  +E F    S + ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHI 389
            ++V   G C  G +  +V E++  GSLD ++
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL 103

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 124 ---IGITHRDIKPENL 136

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 124 ---IGITHRDIKPENL 136

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 124 ---IGITHRDIKPENL 136

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 60/135 (44%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSAE----EFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  S+   E    +   E+     + H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 366 FCSEGSKRAVVYEYMPNG----SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
           +  +  +  ++ E+ P G     L +H    E R  +F  E         A  + Y H  
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCH-- 131
Query: 422 CDVCILHFDIKPHNI 436
            +  ++H DIKP N+
Sbjct: 132 -ERKVIHRDIKPENL 145

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 123 ---IGITHRDIKPENL 135

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 25/148 (16%)
Query: 311 LGQGGFGSVYKG------QLHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRI-HHVNVV 361
           LG+G FG V +       +  T   +AVKMLK     +E    ++E+  +  I HH+NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 362 QLLGFCSE-GSKRAVVYEYMPNGSLDRHI------------FPKESRGQSFSWEKLHEVA 408
            LLG C++ G    V+ E+   G+L  ++             P++      + E L   +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
              A+G+E+L      CI H D+   NI
Sbjct: 157 FQVAKGMEFL--ASRKCI-HRDLAARNI 181

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 16/139 (11%)
Query: 307 FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSKFSAE-EFINEVSTIGRIHHVNV 360
           +  +LG+G FGSV   +      +TG L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 11  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 70
Query: 361 VQLLGFCSEGSKRA---VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+  G  S G  R    +V EY+P+G L   +    +R       +L   +    +G+EY
Sbjct: 71  VKYRGV-SYGPGRPELRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEY 126
Query: 418 LHNGCDVCILHFDIKPHNI 436
           L  G   C+ H D+   NI
Sbjct: 127 L--GSRRCV-HRDLAARNI 142

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 44/92 (47%), Gaps = 9/92 (9%)
Query: 307 FTHKLGQGGFGSVYKG---------QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH 357
           F   LGQG F  ++KG         QLH   ++   + K  +  +E F    S + ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHI 389
            ++V   G C  G +  +V E++  GSLD ++
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYL 103

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 63/132 (47%), Gaps = 10/132 (7%)
Query: 309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
            K+G+G +G VYK +   TG ++A+K ++    ++      I E+S +  ++H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                 +K  +V+E++     D   F   S         +        +G+ + H+    
Sbjct: 72  DVIHTENKLYLVFEHVDQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--- 125
Query: 425 CILHFDIKPHNI 436
            +LH D+KP N+
Sbjct: 126 RVLHRDLKPQNL 137

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 68/142 (47%), Gaps = 28/142 (19%)
Query: 312 GQGGFGSVYKGQLHTGGL-IAVK-MLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF--- 366
           GQG FG+V  G+  + G+ +A+K ++++ +F   E +  +  +  +HH N+VQL  +   
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYT 90
Query: 367 CSEGSKRA----VVYEYMPN-------GSLDRHIFPKESRGQSFSWEKLHEVALGTARGI 415
             E  +R     VV EY+P+           R + P     + F ++ +        R I
Sbjct: 91  LGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI--------RSI 142
Query: 416 EYLH-NGCDVCILHFDIKPHNI 436
             LH    +VC  H DIKPHN+
Sbjct: 143 GCLHLPSVNVC--HRDIKPHNV 162

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 60/135 (44%), Gaps = 20/135 (14%)
Query: 311 LGQGGFGSVYKGQLHTGGLI-AVKMLKNSKFSAE----EFINEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      I A+K+L  S+   E    +   E+     + H N++++  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 366 FCSEGSKRAVVYEYMPNG----SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
           +  +  +  ++ E+ P G     L +H    E R  +F  E         A  + Y H  
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCH-- 132
Query: 422 CDVCILHFDIKPHNI 436
            +  ++H DIKP N+
Sbjct: 133 -ERKVIHRDIKPENL 146

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 124 ---IGITHRDIKPENL 136

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 16/136 (11%)
Query: 307 FTHKLGQGGFGSVYKGQLH----TGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNV 360
               LG+G +G V   QL     T   +AVK+  +K +    E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+  G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 123 ---IGITHRDIKPENL 135

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 64/136 (47%), Gaps = 21/136 (15%)
Query: 311 LGQGGFGSVYKGQLHTGGLIAV-KMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFC- 367
           +G G FG V++ +L     +A+ K+L++ +F   E       I RI  H NVV L  F  
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL-----QIMRIVKHPNVVDLKAFFY 102
Query: 368 SEGSKRAVVY-----EYMPNG--SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           S G K+  V+     EY+P       RH + K  +       KL+   L   R + Y+H+
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRH-YAKLKQTMPMLLIKLYMYQL--LRSLAYIHS 159
Query: 421 GCDVCILHFDIKPHNI 436
              + I H DIKP N+
Sbjct: 160 ---IGICHRDIKPQNL 172

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 16/134 (11%)
Query: 311 LGQGGFGSVYKGQLHTGG-----LIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQL 363
           LG G FG+VYKG     G      +A+K+L  +       EF++E   +  + H ++V+L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFP-KESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           LG C   + + +V + MP+G L  ++   K++ G       L    +  A+G+ YL    
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQL----LLNWCVQIAKGMMYLE--- 134
Query: 423 DVCILHFDIKPHNI 436
           +  ++H D+   N+
Sbjct: 135 ERRLVHRDLAARNV 148

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 16/139 (11%)
Query: 307 FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSKFSAE-EFINEVSTIGRIHHVNV 360
           +  +LG+G FGSV   +      +TG L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 361 VQLLGFCSEGSKRA---VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+  G  S G  R    +V EY+P+G L   +    +R       +L   +    +G+EY
Sbjct: 87  VKYRGV-SYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEY 142
Query: 418 LHNGCDVCILHFDIKPHNI 436
           L  G   C+ H D+   NI
Sbjct: 143 L--GSRRCV-HRDLAARNI 158

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 309 HKLGQGGFGSVYK-GQLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGF 366
            +LG G FG V++  +  TG   A K +     S +E +  E+ T+  + H  +V L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
             + ++  ++YE+M  G L   +  + ++    S ++  E      +G+ ++H       
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHEN---NY 276
Query: 427 LHFDIKPHNI 436
           +H D+KP NI
Sbjct: 277 VHLDLKPENI 286

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 64/137 (46%), Gaps = 23/137 (16%)
Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G V+K +   TG ++A+K    S+      +  + E+  + ++ H N+V LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRG------QSFSWEKLHEVALGTARGIEYLH 419
                 +  +V+EY  +  L  H   +  RG      +S +W+ L  V         + H
Sbjct: 70  VFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQAVNFC------HKH 121
Query: 420 NGCDVCILHFDIKPHNI 436
           N    CI H D+KP NI
Sbjct: 122 N----CI-HRDVKPENI 133

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 61/118 (51%), Gaps = 14/118 (11%)
Query: 311 LGQGGFGSVY------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQ 362
           LG+G FG V       +G  +TG  +AVK LK         +   E+  +  ++H N+V+
Sbjct: 17  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 363 LLGFCSE--GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
             G C+E  G+   ++ E++P+GSL  ++ PK       + ++  + A+   +G++YL
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNK--NKINLKQQLKYAVQICKGMDYL 130

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/129 (24%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 310 KLGQGGFGSVYK-GQLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 367
           +LG G FG V++  +  TG   A K +     S +E +  E+ T+  + H  +V L    
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
            + ++  ++YE+M  G L   +  + ++    S ++  E      +G+ ++H       +
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHEN---NYV 171
Query: 428 HFDIKPHNI 436
           H D+KP NI
Sbjct: 172 HLDLKPENI 180

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 16/139 (11%)
Query: 307 FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSKFSAE-EFINEVSTIGRIHHVNV 360
           +  +LG+G FGSV   +      +TG L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 14  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 73
Query: 361 VQLLGFCSEGSKRA---VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+  G  S G  R    +V EY+P+G L   +    +R       +L   +    +G+EY
Sbjct: 74  VKYRGV-SYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEY 129
Query: 418 LHNGCDVCILHFDIKPHNI 436
           L  G   C+ H D+   NI
Sbjct: 130 L--GSRRCV-HRDLAARNI 145

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 64/131 (48%), Gaps = 11/131 (8%)
Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQLLG- 365
           +LG G  G V K Q    GLI  + L + +       + I E+  +   +   +V   G 
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 82
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
           F S+G + ++  E+M  GSLD+ +  KE++      E L +V++   RG+ YL       
Sbjct: 83  FYSDG-EISICMEHMDGGSLDQVL--KEAK--RIPEEILGKVSIAVLRGLAYLREKHQ-- 135
Query: 426 ILHFDIKPHNI 436
           I+H D+KP NI
Sbjct: 136 IMHRDVKPSNI 146

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 60/132 (45%), Gaps = 9/132 (6%)
Query: 309 HKLGQGGFG-SVYKGQLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQLL 364
            K+G+G FG ++       G    +K +  S+ S+   EE   EV+ +  + H N+VQ  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
               E     +V +Y   G L + I     +G  F  +++ +  +     ++++H   D 
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVH---DR 144
Query: 425 CILHFDIKPHNI 436
            ILH DIK  NI
Sbjct: 145 KILHRDIKSQNI 156

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 9/88 (10%)
Query: 307 FTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HH 357
           F   LG G FG V +   +          +AVKMLK S      E  ++E+  +  + +H
Sbjct: 45  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 104
Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSL 385
           +N+V LLG C+ G    V+ EY   G L
Sbjct: 105 MNIVNLLGACTIGGPTLVITEYCCYGDL 132

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 16/139 (11%)
Query: 307 FTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSKFSAE-EFINEVSTIGRIHHVNV 360
           +  +LG+G FGSV   +      +TG L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 15  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 74
Query: 361 VQLLGFCSEGSKRA---VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           V+  G  S G  R    +V EY+P+G L   +    +R       +L   +    +G+EY
Sbjct: 75  VKYRGV-SYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEY 130
Query: 418 LHNGCDVCILHFDIKPHNI 436
           L  G   C+ H D+   NI
Sbjct: 131 L--GSRRCV-HRDLAARNI 146

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 9/88 (10%)
Query: 307 FTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HH 357
           F   LG G FG V +   +          +AVKMLK S      E  ++E+  +  + +H
Sbjct: 43  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 102
Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSL 385
           +N+V LLG C+ G    V+ EY   G L
Sbjct: 103 MNIVNLLGACTIGGPTLVITEYCCYGDL 130

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 13/90 (14%)
Query: 307 FTHKLGQGGFGSVYKGQLHTGGLI--------AVKMLKNSKF--SAEEFINEVSTIGRI- 355
           F   LG G FG V +   +  GLI        AVKMLK S      E  ++E+  +  + 
Sbjct: 27  FGKTLGAGAFGKVVEATAY--GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 356 HHVNVVQLLGFCSEGSKRAVVYEYMPNGSL 385
           +H+N+V LLG C+ G    V+ EY   G L
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDL 114

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 16/134 (11%)
Query: 311 LGQGGFGSVYKGQLHTGG-----LIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQL 363
           LG G FG+VYKG     G      +A+K+L  +       EF++E   +  + H ++V+L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFP-KESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           LG C   + + +V + MP+G L  ++   K++ G       L    +  A+G+ YL    
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQL----LLNWCVQIAKGMMYLE--- 157
Query: 423 DVCILHFDIKPHNI 436
           +  ++H D+   N+
Sbjct: 158 ERRLVHRDLAARNV 171

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 61/118 (51%), Gaps = 14/118 (11%)
Query: 311 LGQGGFGSVY------KGQLHTGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQ 362
           LG+G FG V       +G  +TG  +AVK LK         +   E+  +  ++H N+V+
Sbjct: 29  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 363 LLGFCSE--GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
             G C+E  G+   ++ E++P+GSL  ++ PK       + ++  + A+   +G++YL
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNK--NKINLKQQLKYAVQICKGMDYL 142

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 9/88 (10%)
Query: 307 FTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HH 357
           F   LG G FG V +   +          +AVKMLK S      E  ++E+  +  + +H
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSL 385
           +N+V LLG C+ G    V+ EY   G L
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDL 137

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 60/143 (41%), Gaps = 22/143 (15%)
Query: 309 HKLGQGGFGSVYKGQLHTG-GLIAVKMLKNSKFSA--------------EEFINEVSTIG 353
            KLG G +G V   +   G    A+K++K S+F                EE  NE+S + 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 354 RIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR 413
            + H N+++L     +     +V E+   G L   I  +    +  +   + ++      
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI----LS 157
Query: 414 GIEYLHNGCDVCILHFDIKPHNI 436
           GI YLH      I+H DIKP NI
Sbjct: 158 GICYLHKH---NIVHRDIKPENI 177

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/131 (23%), Positives = 59/131 (45%), Gaps = 10/131 (7%)
Query: 310 KLGQGGFGSVYKGQLHTGG----LIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G VYK +    G    L  +++   ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +K  +V+E++     D   F   S         +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 426 ILHFDIKPHNI 436
           +LH D+KP N+
Sbjct: 124 VLHRDLKPQNL 134

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/131 (23%), Positives = 59/131 (45%), Gaps = 10/131 (7%)
Query: 310 KLGQGGFGSVYKGQLHTGG----LIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G VYK +    G    L  +++   ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +K  +V+E++     D   F   S         +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 426 ILHFDIKPHNI 436
           +LH D+KP N+
Sbjct: 123 VLHRDLKPQNL 133

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 9/89 (10%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGL------IAVKMLKNSKFSAEE--FINEVSTIGRI-H 356
            F   LG G FG V +      G       +AVKMLK++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSL 385
           H N+V LLG C+ G    V+ EY   G L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDL 137

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 9/88 (10%)
Query: 307 FTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HH 357
           F   LG G FG V +   +          +AVKMLK S      E  ++E+  +  + +H
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSL 385
           +N+V LLG C+ G    V+ EY   G L
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDL 137

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 9/89 (10%)
Query: 306 HFTHKLGQGGFGSVYKGQLHTGGL------IAVKMLKNSKFSAEE--FINEVSTIGRI-H 356
            F   LG G FG V +      G       +AVKMLK++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSL 385
           H N+V LLG C+ G    V+ EY   G L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDL 137

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 55/133 (41%), Gaps = 10/133 (7%)
Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQL 363
               LG+G  G V       T   +AVK+  +K +    E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G   EG+ + +  EY   G L   I P     +  +    H++  G      YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 122
Query: 424 VCILHFDIKPHNI 436
           + I H DIKP N+
Sbjct: 123 IGITHRDIKPENL 135

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 60/131 (45%), Gaps = 12/131 (9%)
Query: 309 HKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGF 366
            K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPK-ESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
              G +  VV EY+  GSL   +       GQ      +  V     + +E+LH+     
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFLHSN---Q 136
Query: 426 ILHFDIKPHNI 436
           ++H DIK  NI
Sbjct: 137 VIHRDIKSDNI 147

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 21/134 (15%)
Query: 311 LGQGGFGSVYKGQLHTGGLIAVKML---KNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           +G+G FG VY G+ H  G +A++++   ++++   + F  EV    +  H NVV  +G C
Sbjct: 41  IGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 368 SEGSKRAVVYEYMPNGSL-----DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
                 A++       +L     D  I             K  ++A    +G+ YLH   
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIV--------LDVNKTRQIAQEIVKGMGYLHAK- 149
Query: 423 DVCILHFDIKPHNI 436
              ILH D+K  N+
Sbjct: 150 --GILHKDLKSKNV 161

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	436
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-61
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-55
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-52
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-37
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-35
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-33
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-33
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-33
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-32
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-31
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-31
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-30
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-28
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-27
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-26
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-26
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-25
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-24
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-24
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-23
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-23
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-23
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-22
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-22
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-22
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-21
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-21
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-21
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-21
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-20
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-19
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-19
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-18
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-18
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-17
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-17
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-17
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-17
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-17
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-16
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-16
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-16
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-16
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-15
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-15
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-15
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-15
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-15
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-15
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-15
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-15
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-14
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-14
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-14
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-14
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-14
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-14
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-14
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-13
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-13
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-13
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-13
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-13
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-13
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-13
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-13
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-13
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-13
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-13
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-13
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-12
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-12
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-12
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-12
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-12
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-12
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-12
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-12
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-12
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-12
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-12
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-12
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-12
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-12
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-12
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-12
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-12
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-12
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-12
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-12
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-11
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-11
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-11
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-11
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-11
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-11
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-11
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-11
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-11
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-11
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-10
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-10
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-10
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-10
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-10
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-09
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-09
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-09
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-09
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-09
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-09
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-09
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-09
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-09
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-09
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-08
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-08
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-08
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-08
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-08
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-08
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-08
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-08
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-08
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-08
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-07
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-07
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-07
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-06
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-06
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-06
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-06
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-05
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-05
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-05
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-05
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-04
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-04
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-04
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-04
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-04
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-04
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  201 bits (514), Expect = 2e-61
 Identities = 60/149 (40%), Positives = 86/149 (57%), Gaps = 4/149 (2%)

Query: 292 PKRYSYPEIIAMTNHF--THKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAE--EFIN 347
            KR+S  E+   +++F   + LG+GGFG VYKG+L  G L+AVK LK  +      +F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 348 EVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEV 407
           EV  I    H N+++L GFC   ++R +VY YM NGS+   +  +        W K   +
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           ALG+ARG+ YLH+ CD  I+H D+K  NI
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANI 165

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  184 bits (470), Expect = 4e-55
 Identities = 55/147 (37%), Positives = 81/147 (55%), Gaps = 6/147 (4%)

Query: 293 KRYSYPEIIAMTNHF--THKLGQGGFGSVYKGQLHTGGLIAVKMLK-NSKFSAEEFINEV 349
            R    ++   TN+F     +G G FG VYKG L  G  +A+K     S    EEF  E+
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 350 STIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVAL 409
            T+    H ++V L+GFC E ++  ++Y+YM NG+L RH++  +    S SWE+  E+ +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 410 GTARGIEYLHNGCDVCILHFDIKPHNI 436
           G ARG+ YLH      I+H D+K  NI
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINI 170

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  176 bits (449), Expect = 3e-52
 Identities = 54/158 (34%), Positives = 80/158 (50%), Gaps = 18/158 (11%)

Query: 292 PKRYSYPEIIAMTNHF--------THKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA- 342
              +S+ E+  +TN+F         +K+G+GGFG VYKG ++    +AVK L        
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITT 70

Query: 343 ----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQS 398
               ++F  E+  + +  H N+V+LLGF S+G    +VY YMPNGSL   +   +     
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PP 129

Query: 399 FSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            SW    ++A G A GI +LH       +H DIK  NI
Sbjct: 130 LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANI 164

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  136 bits (345), Expect = 4e-37
 Identities = 42/134 (31%), Positives = 73/134 (54%), Gaps = 6/134 (4%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQ 362
           +   K+G G FG+V++ + H G  +AVK+L    F A    EF+ EV+ + R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
            +G  ++    ++V EY+  GSL R +    +R +     +   +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHN-R 156

Query: 423 DVCILHFDIKPHNI 436
           +  I+H ++K  N+
Sbjct: 157 NPPIVHRNLKSPNL 170

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  132 bits (335), Expect = 2e-35
 Identities = 38/154 (24%), Positives = 62/154 (40%), Gaps = 19/154 (12%)

Query: 296 SYPEIIAMTNHFT--HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIG 353
               +   +          +G FG V+K QL     +AVK+       + +   EV ++ 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLP 73

Query: 354 RIHHVNVVQLLGFCSEGSKRAV----VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVAL 409
            + H N++Q +G    G+   V    +  +   GSL   +     +    SW +L  +A 
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAE 128

Query: 410 GTARGIEYLH-------NGCDVCILHFDIKPHNI 436
             ARG+ YLH       +G    I H DIK  N+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  128 bits (325), Expect = 1e-34
 Identities = 39/136 (28%), Positives = 59/136 (43%), Gaps = 11/136 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS-----AEEFINEVSTIGRIHHVNV 360
                +G GGFG VY+     G  +AVK  ++          E    E      + H N+
Sbjct: 10  TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           + L G C +     +V E+   G L+R +      G+    + L   A+  ARG+ YLH+
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHD 123

Query: 421 GCDVCILHFDIKPHNI 436
              V I+H D+K  NI
Sbjct: 124 EAIVPIIHRDLKSSNI 139

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  125 bits (316), Expect = 2e-33
 Identities = 35/136 (25%), Positives = 58/136 (42%), Gaps = 9/136 (6%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQ 362
           +F  KL +   G ++KG+   G  I VK+LK   +S     +F  E   +    H NV+ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 363 LLGFCSE--GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           +LG C         ++  +MP GSL   +   E         +  + AL  ARG+ +LH 
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 421 GCDVCILHFDIKPHNI 436
             +  I    +   ++
Sbjct: 130 -LEPLIPRHALNSRSV 144

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  124 bits (313), Expect = 8e-33
 Identities = 38/139 (27%), Positives = 65/139 (46%), Gaps = 15/139 (10%)

Query: 307 FTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA--------EEFINEVSTIGRIHH 357
           +  ++G+GGFG V+KG+ +    ++A+K L               +EF  EV  +  ++H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
            N+V+L G         +V E++P G L   +     +     W     + L  A GIEY
Sbjct: 83  PNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL---LDKAHPIKWSVKLRLMLDIALGIEY 137

Query: 418 LHNGCDVCILHFDIKPHNI 436
           + N  +  I+H D++  NI
Sbjct: 138 MQN-QNPPIVHRDLRSPNI 155

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  124 bits (314), Expect = 9e-33
 Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 5/131 (3%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
                +G+G FG V K +      +A+K +++     + FI E+  + R++H N+V+L G
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER-KAFIVELRQLSRVNHPNIVKLYG 68

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
            C       +V EY   GSL   +   E     ++        L  ++G+ YLH+     
Sbjct: 69  ACLN--PVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 426 ILHFDIKPHNI 436
           ++H D+KP N+
Sbjct: 126 LIHRDLKPPNL 136

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  123 bits (310), Expect = 5e-32
 Identities = 33/134 (24%), Positives = 56/134 (41%), Gaps = 11/134 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQ 362
                +G+G FG VY G+ H  G +A++++   + +    + F  EV    +  H NVV 
Sbjct: 36  EIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
            +G C      A++       +L   +             K  ++A    +G+ YLH   
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEIVKGMGYLHA-- 148

Query: 423 DVCILHFDIKPHNI 436
              ILH D+K  N+
Sbjct: 149 -KGILHKDLKSKNV 161

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  118 bits (299), Expect = 9e-31
 Identities = 45/132 (34%), Positives = 74/132 (56%), Gaps = 14/132 (10%)

Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAE---EFINEVSTIGRIHHVNVVQLLG 365
            ++G G FG+VYKG+ H  G +AVKML  +  + +    F NEV  + +  HVN++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGCDV 424
           + +   + A+V ++    SL  H+    +    F  +KL ++A  TARG++YLH      
Sbjct: 88  YSTAP-QLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHAKS--- 140

Query: 425 CILHFDIKPHNI 436
            I+H D+K +NI
Sbjct: 141 -IIHRDLKSNNI 151

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  117 bits (294), Expect = 9e-30
 Identities = 37/156 (23%), Positives = 65/156 (41%), Gaps = 23/156 (14%)

Query: 296 SYPEIIAMTNHFT--HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINE--VST 351
           +  E     ++      +G+G +G+VYKG L     +AVK+   +  + + FINE  +  
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFA--NRQNFINEKNIYR 60

Query: 352 IGRIHHVNVVQLLGFCSEGSKRA-----VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE 406
           +  + H N+ + +      +        +V EY PNGSL +++        +  W     
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCR 115

Query: 407 VALGTARGIEYLHN------GCDVCILHFDIKPHNI 436
           +A    RG+ YLH            I H D+   N+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  112 bits (283), Expect = 2e-28
 Identities = 35/133 (26%), Positives = 57/133 (42%), Gaps = 8/133 (6%)

Query: 306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNVVQL 363
                LG+G FG   K     TG ++ +K L          F+ EV  +  + H NV++ 
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
           +G   +  +   + EY+  G+L   I   +S    + W +    A   A G+ YLH    
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLH---S 126

Query: 424 VCILHFDIKPHNI 436
           + I+H D+  HN 
Sbjct: 127 MNIIHRDLNSHNC 139

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  110 bits (278), Expect = 2e-27
 Identities = 30/148 (20%), Positives = 64/148 (43%), Gaps = 15/148 (10%)

Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH 357
              IA       ++G+G +G V+ G+   G  +AVK+   ++ ++     E+     + H
Sbjct: 32  QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRH 90

Query: 358 VNVVQLLGFCSEGSKR----AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR 413
            N++  +    +G+       ++ +Y  NGSL  ++     +  +   + + ++A  +  
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVS 145

Query: 414 GIEYLH-----NGCDVCILHFDIKPHNI 436
           G+ +LH           I H D+K  NI
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNI 173

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  107 bits (269), Expect = 2e-26
 Identities = 27/140 (19%), Positives = 50/140 (35%), Gaps = 15/140 (10%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
                +G+G +G V++G    G  +AVK+  +    +     E+     + H N++  + 
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 366 FCSEGSKRAVVY----EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-- 419
                   +        Y   GSL  ++     +  +        + L  A G+ +LH  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 420 ---NGCDVCILHFDIKPHNI 436
                    I H D+K  NI
Sbjct: 125 IFGTQGKPAIAHRDLKSKNI 144

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  106 bits (267), Expect = 6e-26
 Identities = 34/148 (22%), Positives = 64/148 (43%), Gaps = 15/148 (10%)

Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH 357
              IA T      +G+G FG V++G+   G  +AVK+  + +  +     E+     + H
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRH 95

Query: 358 VNVVQLLGFCSEGSKRAVVY----EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR 413
            N++  +   ++ +          +Y  +GSL  ++        + + E + ++AL TA 
Sbjct: 96  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTAS 150

Query: 414 GIEYLH-----NGCDVCILHFDIKPHNI 436
           G+ +LH           I H D+K  NI
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNI 178

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  104 bits (261), Expect = 2e-25
 Identities = 40/114 (35%), Positives = 57/114 (50%), Gaps = 3/114 (2%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLL 364
              HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLL
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           G C+      ++ E+M  G+L    + +E   Q  S   L  +A   +  +EYL
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL 127

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  102 bits (257), Expect = 5e-25
 Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 3/113 (2%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
               +LG G FG V  G+      +AVKM+K    S +EF  E  T+ ++ H  +V+  G
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            CS+     +V EY+ NG L  ++    S G+     +L E+      G+ +L
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFL 120

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  101 bits (253), Expect = 2e-24
 Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 3/113 (2%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
               +LG G FG V+ G  +    +AVK LK    S + F+ E + + ++ H  +V+L  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
             ++     ++ EYM NGSL    F K   G   +  KL ++A   A G+ ++
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  100 bits (251), Expect = 3e-24
 Identities = 35/113 (30%), Positives = 56/113 (49%), Gaps = 3/113 (2%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
            F  ++G G FG V+ G       +A+K ++    S E+FI E   + ++ H  +VQL G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            C E +   +V E+M +G L    + +  RG  F+ E L  + L    G+ YL
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSD--YLRTQRGL-FAAETLLGMCLDVCEGMAYL 120

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 99.6 bits (249), Expect = 6e-24
 Identities = 37/113 (32%), Positives = 57/113 (50%), Gaps = 3/113 (2%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
            F  +LG G FG V  G+      +A+KM+K    S +EFI E   +  + H  +VQL G
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            C++     ++ EYM NG L    + +E R + F  ++L E+       +EYL
Sbjct: 87  VCTKQRPIFIITEYMANGCLLN--YLREMRHR-FQTQQLLEMCKDVCEAMEYL 136

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 37/124 (29%), Positives = 55/124 (44%), Gaps = 11/124 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG------LIAVKMLKN--SKFSAEEFINEVSTIGRIHH 357
                LG G FG VY+GQ+           +AVK L    S+    +F+ E   I + +H
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARG 414
            N+V+ +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 415 IEYL 418
            +YL
Sbjct: 153 CQYL 156

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  101 bits (254), Expect = 2e-23
 Identities = 42/131 (32%), Positives = 62/131 (47%), Gaps = 6/131 (4%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
             HKLG G +G VY+G      L +AVK LK      EEF+ E + +  I H N+VQLLG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
            C+      ++ E+M  G+L    + +E   Q  S   L  +A   +  +EYL       
Sbjct: 284 VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338

Query: 426 ILHFDIKPHNI 436
            +H ++   N 
Sbjct: 339 FIHRNLAARNC 349

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 36/114 (31%), Positives = 54/114 (47%), Gaps = 5/114 (4%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
                +G+G FG V  G    G  +AVK +KN   +A+ F+ E S + ++ H N+VQLLG
Sbjct: 24  KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 366 FCSEGSKRA-VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
              E      +V EYM  GSL    + +         + L + +L     +EYL
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 99.0 bits (247), Expect = 4e-23
 Identities = 37/124 (29%), Positives = 55/124 (44%), Gaps = 11/124 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG------LIAVKMLKN--SKFSAEEFINEVSTIGRIHH 357
                LG G FG VY+GQ+           +AVK L    S+    +F+ E   I + +H
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARG 414
            N+V+ +G   +   R ++ E M  G L    R   P+ S+  S +   L  VA   A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 415 IEYL 418
            +YL
Sbjct: 194 CQYL 197

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 28/117 (23%), Positives = 53/117 (45%), Gaps = 6/117 (5%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGL-IAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQ 362
               ++G+G FG V+ G+L      +AVK  + +       +F+ E   + +  H N+V+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           L+G C++     +V E +  G     +    + G     + L ++    A G+EYL 
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE 230

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 31/132 (23%), Positives = 53/132 (40%), Gaps = 19/132 (14%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG------LIAVKMLKNSKFSAE-EFINEVSTIGRIHHV 358
               +LG+G FG V+  + +         L+AVK LK+   +A  +F  E   +  + H 
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSL------------DRHIFPKESRGQSFSWEKLHE 406
           ++V+  G C +G    +V+EYM +G L                             ++  
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 407 VALGTARGIEYL 418
           +A   A G+ YL
Sbjct: 138 IASQIASGMVYL 149

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 21/169 (12%)

Query: 271 RTTLQTVDNVEKFLHNQQSWMPKRYSY---PEIIAMTNHFTHKLGQGGFGSVYKGQLHTG 327
            ++L   +     L       P+ +S      I         +LG+G FG V+  + H  
Sbjct: 6   GSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65

Query: 328 G------LIAVKMLKNSKFSAE-EFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM 380
                  L+AVK LK +  SA  +F  E   +  + H ++V+  G C+EG    +V+EYM
Sbjct: 66  LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125

Query: 381 PNGSL-----------DRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +G L                 ++         +L  VA   A G+ YL
Sbjct: 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 97.5 bits (243), Expect = 3e-22
 Identities = 30/112 (26%), Positives = 50/112 (44%), Gaps = 3/112 (2%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
              KLG G FG V+    +    +AVK +K    S E F+ E + +  + H  +V+L   
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            ++     ++ E+M  GSL    F K   G      KL + +   A G+ ++
Sbjct: 252 VTK-EPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 95.1 bits (237), Expect = 5e-22
 Identities = 37/127 (29%), Positives = 55/127 (43%), Gaps = 14/127 (11%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG------LIAVKMLKNSKFSAE--EFINEVSTIGRIHH 357
             + +LGQG FG VY+G             +A+K +  +    E  EF+NE S +   + 
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLD------RHIFPKESRGQSFSWEKLHEVALGT 411
            +VV+LLG  S+G    V+ E M  G L       R            S  K+ ++A   
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 412 ARGIEYL 418
           A G+ YL
Sbjct: 148 ADGMAYL 154

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 34/133 (25%), Positives = 52/133 (39%), Gaps = 20/133 (15%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG------LIAVKMLKN--SKFSAEEFINEVSTIGRIHH 357
            F  +LG+  FG VYKG L           +A+K LK+       EEF +E     R+ H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLD------------RHIFPKESRGQSFSWEKLH 405
            NVV LLG  ++    ++++ Y  +G L                    +   +       
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 406 EVALGTARGIEYL 418
            +    A G+EYL
Sbjct: 132 HLVAQIAAGMEYL 144

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 97.3 bits (242), Expect = 6e-22
 Identities = 38/112 (33%), Positives = 54/112 (48%), Gaps = 3/112 (2%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
              KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL   
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            SE     +V EYM  GSL    F K   G+     +L ++A   A G+ Y+
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYV 379

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 11/119 (9%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGL-----IAVKMLKN--SKFSAEEFINEVSTIGRIHHVN 359
               LG G FG+VYKG     G      +A+K L+   S  + +E ++E   +  + + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V +LLG C   S   ++ + MP G L  ++  +E +      + L    +  A+G+ YL
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDN-IGSQYLLNWCVQIAKGMNYL 133

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 94.7 bits (236), Expect = 9e-22
 Identities = 41/158 (25%), Positives = 67/158 (42%), Gaps = 19/158 (12%)

Query: 280 VEKFLHNQQSWM-PKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGL---IAVKML 335
           ++K  H+      P    YP +      F   +G+G FG V K ++   GL    A+K +
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 60

Query: 336 KNSKFSAE--EFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPNGSL------- 385
           K      +  +F  E+  + ++ HH N++ LLG C       +  EY P+G+L       
Sbjct: 61  KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 120

Query: 386 -----DRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
                D       S   + S ++L   A   ARG++YL
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 96.0 bits (239), Expect = 1e-21
 Identities = 38/112 (33%), Positives = 54/112 (48%), Gaps = 3/112 (2%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
              KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL   
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            SE     +V EYM  GSL    F K   G+     +L ++A   A G+ Y+
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYV 296

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 36/120 (30%), Positives = 50/120 (41%), Gaps = 10/120 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L          AVK L          +F+ E   +    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 360 VVQLLGFCSEG-SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+ LLG C        VV  YM +G L   I    +   + + + L    L  A+G++YL
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL 144

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 92.4 bits (230), Expect = 5e-21
 Identities = 34/120 (28%), Positives = 60/120 (50%), Gaps = 11/120 (9%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGL-----IAVKMLKN--SKFSAEEFINEVSTIGRIHHV 358
                LG G FG+V+KG     G      + +K++++   + S +   + +  IG + H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           ++V+LLG C   S   +V +Y+P GSL  H+  ++ RG     + L    +  A+G+ YL
Sbjct: 76  HIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGA-LGPQLLLNWGVQIAKGMYYL 131

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 91.6 bits (228), Expect = 6e-21
 Identities = 28/123 (22%), Positives = 55/123 (44%), Gaps = 12/123 (9%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG-----LIAVKMLK--NSKFSAEEFINEVSTIGRIHHV 358
                LG+G FG V   +    G      +AVK LK  +      +   E+  +  ++H 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 359 NVVQLLGFCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
           N+V+  G C+E     +  + E++P+GSL  ++          + ++  + A+   +G++
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMD 140

Query: 417 YLH 419
           YL 
Sbjct: 141 YLG 143

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 92.8 bits (231), Expect = 6e-21
 Identities = 37/118 (31%), Positives = 60/118 (50%), Gaps = 9/118 (7%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNV 360
               +G G FG V  G+L         +A+K LK   ++    +F+ E S +G+  H N+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           ++L G  ++     +V EYM NGSLD   F ++   Q F+  +L  +  G A G++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIASGMKYL 163

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 92.0 bits (229), Expect = 7e-21
 Identities = 39/119 (32%), Positives = 60/119 (50%), Gaps = 9/119 (7%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVN 359
           H    +G G  G V  G+L   G     +A+K LK   ++    +F++E S +G+  H N
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           +++L G  + G    +V EYM NGSLD   F +   GQ F+  +L  +  G   G+ YL
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQ-FTIMQLVGMLRGVGAGMRYL 167

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 91.2 bits (227), Expect = 8e-21
 Identities = 30/122 (24%), Positives = 52/122 (42%), Gaps = 12/122 (9%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGL--------IAVKMLKNSKFSA-EEFINEVSTIGRIH 356
            F   LGQG F  ++KG     G         + +K+L  +  +  E F    S + ++ 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
           H ++V   G C  G +  +V E++  GSLD ++   +      +     EVA   A  + 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMH 127

Query: 417 YL 418
           +L
Sbjct: 128 FL 129

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 91.2 bits (227), Expect = 8e-21
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 11/121 (9%)

Query: 307 FTHKLGQGGFGSVYKGQLH-----TGGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV   +       TG ++AVK L++S      +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 361 VQLLGFCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R +  + EY+P GSL  ++   +   +     KL +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 130

Query: 419 H 419
            
Sbjct: 131 G 131

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 92.5 bits (230), Expect = 8e-21
 Identities = 35/120 (29%), Positives = 50/120 (41%), Gaps = 10/120 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L          AVK L          +F+ E   +    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 360 VVQLLGFCSEG-SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+ LLG C        VV  YM +G L   I    +   + + + L    L  A+G+++L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL 208

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 91.6 bits (228), Expect = 9e-21
 Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 11/119 (9%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGG-----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVN 359
               LG G FG+VYKG     G      +A+K L+   S  + +E ++E   +  + + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V +LLG C   S   ++ + MP G L  ++  +E +      + L    +  A+G+ YL
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDN-IGSQYLLNWCVQIAKGMNYL 133

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 91.2 bits (227), Expect = 9e-21
 Identities = 37/128 (28%), Positives = 57/128 (44%), Gaps = 16/128 (12%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLKNSKFSAEE---FINEVSTIGRIHHV 358
                LG+G FGSV +G L         +AVK +K    S  E   F++E + +    H 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 359 NVVQLLGFCSEGSKRA-----VVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALG 410
           NV++LLG C E S +      V+  +M  G L     +    E+  +    + L +  + 
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL-ETGPKHIPLQTLLKFMVD 155

Query: 411 TARGIEYL 418
            A G+EYL
Sbjct: 156 IALGMEYL 163

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 34/120 (28%), Positives = 52/120 (43%), Gaps = 10/120 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVN 359
           H    +G+G FG VY G+           A+K L         E F+ E   +  ++H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 360 VVQLLGFCSEGSKRA-VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+ L+G          V+  YM +G L + I    S  ++ + + L    L  ARG+EYL
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYL 140

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 5/113 (4%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
               +G+G FG V  G    G  +AVK +KN   +A+ F+ E S + ++ H N+VQLLG 
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGV 254

Query: 367 CSEGSKRA-VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
             E      +V EYM  GSL    + +         + L + +L     +EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 31/122 (25%), Positives = 51/122 (41%), Gaps = 14/122 (11%)

Query: 307 FTHKLGQGGFGSVYKGQLH-----TGGLIAVKMLK--NSKFSAEEFINEVSTIGRIHHVN 359
               LG+G FG V           TG ++AVK LK          +  E+  +  ++H +
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 360 VVQLLGFCSEGSKRA--VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
           +++  G C +    +  +V EY+P GSL  ++        S    +L   A     G+ Y
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAY 149

Query: 418 LH 419
           LH
Sbjct: 150 LH 151

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 11/121 (9%)

Query: 307 FTHKLGQGGFGSVYKGQLH-----TGGLIAVKMLKNSKFSA-EEFINEVSTIGRIHHVNV 360
           F  +LG+G FGSV   +       TG ++AVK L++S      +F  E+  +  + H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 361 VQLLGFCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G C    +R +  + EY+P GSL  ++   +   +     KL +      +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 161

Query: 419 H 419
            
Sbjct: 162 G 162

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 10/119 (8%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGG-----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVN 359
               +G G FG VYKG L T        +A+K LK   ++    +F+ E   +G+  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           +++L G  S+     ++ EYM NG+LD+  F +E  G+ FS  +L  +  G A G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGE-FSVLQLVGMLRGIAAGMKYL 163

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 34/129 (26%), Positives = 53/129 (41%), Gaps = 17/129 (13%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG----LIAVKMLKNSKFS---AEEFINEVSTIGRIHHV 358
                LG+G FGSV + QL         +AVKMLK    +    EEF+ E + +    H 
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 359 NVVQLLGFCSEGSKRA------VVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVAL 409
           +V +L+G       +       V+  +M +G L          E+   +   + L    +
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN-PFNLPLQTLVRFMV 144

Query: 410 GTARGIEYL 418
             A G+EYL
Sbjct: 145 DIACGMEYL 153

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 88.8 bits (221), Expect = 4e-20
 Identities = 28/118 (23%), Positives = 51/118 (43%), Gaps = 10/118 (8%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNV 360
               +G+G FG V++G   +       +A+K  KN  S    E+F+ E  T+ +  H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+L+G  +E +   ++ E    G L    F +  +        L   A   +  + YL
Sbjct: 79  VKLIGVITE-NPVWIIMELCTLGELRS--FLQVRKYS-LDLASLILYAYQLSTALAYL 132

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 28/114 (24%), Positives = 51/114 (44%), Gaps = 9/114 (7%)

Query: 310 KLGQGGFGSVYKGQLHTGG---LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +LG G FGSV +G          +A+K+LK    K   EE + E   + ++ +  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           G C       +V E    G L + +     + +      + E+    + G++YL
Sbjct: 77  GVCQA-EALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL 126

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 88.6 bits (220), Expect = 9e-20
 Identities = 32/121 (26%), Positives = 58/121 (47%), Gaps = 11/121 (9%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGG-----LIAVKMLKNSKFSAE-EFINEVSTIGRIHHVNV 360
           +  +LG+G FGSV   +    G     L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 361 VQLLGFCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+  G      ++++  V EY+P+G L    F +  R +     +L   +    +G+EYL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRAR-LDASRLLLYSSQICKGMEYL 143

Query: 419 H 419
            
Sbjct: 144 G 144

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 30/119 (25%), Positives = 51/119 (42%), Gaps = 10/119 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGL----IAVKMLKN--SKFSAEEFINEVSTIGRIHHVN 359
                LG+G FG VY+G           +AVK  K   +  + E+F++E   +  + H +
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           +V+L+G   E     ++ E  P G L  ++   E    S     L   +L   + + YL
Sbjct: 75  IVKLIGIIEEEPTW-IIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYL 129

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 32/141 (22%), Positives = 53/141 (37%), Gaps = 28/141 (19%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG------LIAVKMLKN--SKFSAEEFINEVSTIGRIHH 357
            +   +G+G FG V++ +           ++AVKMLK   S     +F  E + +    +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSL--------------------DRHIFPKESRGQ 397
            N+V+LLG C+ G    +++EYM  G L                                
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 398 SFSWEKLHEVALGTARGIEYL 418
             S  +   +A   A G+ YL
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL 190

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 39/131 (29%), Positives = 59/131 (45%), Gaps = 12/131 (9%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKMLK-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 368
           LG+G +G VY G  L     IA+K +       ++    E++    + H N+VQ LG  S
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 369 EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTA---RGIEYLHNGCDVC 425
           E     +  E +P GSL   +  +   G     E+   +   T     G++YLH   D  
Sbjct: 90  ENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNEQT--IGFYTKQILEGLKYLH---DNQ 142

Query: 426 ILHFDIKPHNI 436
           I+H DIK  N+
Sbjct: 143 IVHRDIKGDNV 153

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 38/134 (28%), Positives = 57/134 (42%), Gaps = 22/134 (16%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
            ++G+G FG V++ +   TG   AVK ++   F  EE    +     +    +V L G  
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAV 119

Query: 368 SEGSKRAVVYEYMPNGSLDRHI-----FPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
            EG    +  E +  GSL + I      P E R   +  + L         G+EYLH   
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYYLGQALE--------GLEYLH--- 167

Query: 423 DVCILHFDIKPHNI 436
              ILH D+K  N+
Sbjct: 168 TRRILHGDVKADNV 181

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 85.4 bits (212), Expect = 7e-19
 Identities = 27/115 (23%), Positives = 56/115 (48%), Gaps = 11/115 (9%)

Query: 310 KLGQGGFGSVYKGQLHTGGL---IAVKMLKN---SKFSAEEFINEVSTIGRIHHVNVVQL 363
           +LG G FG+V KG      +   +AVK+LKN        +E + E + + ++ +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           +G C       +V E    G L++++     + +    + + E+    + G++YL
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL 133

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 85.0 bits (211), Expect = 9e-19
 Identities = 36/121 (29%), Positives = 54/121 (44%), Gaps = 12/121 (9%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGL----IAVKMLKNSKFS----AEEFINEVSTIGRIHH 357
               KLG G FG V +G+          +AVK LK    S     ++FI EV+ +  + H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
            N+++L G         +V E  P GSL   +  ++ +G  F    L   A+  A G+ Y
Sbjct: 81  RNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGY 136

Query: 418 L 418
           L
Sbjct: 137 L 137

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 34/132 (25%), Positives = 52/132 (39%), Gaps = 19/132 (14%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG------LIAVKMLKNSKFSAE--EFINEVSTIGRI-H 356
            F   LG G FG V +      G       +AVKMLK++  + E    ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108

Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSL----------DRHIFPKESRGQSFSWEKLHE 406
           H N+V LLG C+ G    V+ EY   G L                      + S   L  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 407 VALGTARGIEYL 418
            +   A+G+ +L
Sbjct: 169 FSSQVAQGMAFL 180

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 29/118 (24%), Positives = 52/118 (44%), Gaps = 10/118 (8%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNV 360
               +G+G FG V++G   +       +A+K  KN  S    E+F+ E  T+ +  H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+L+G  +E +   ++ E    G L   +   + R  S     L   A   +  + YL
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYL 507

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 34/135 (25%), Positives = 59/135 (43%), Gaps = 13/135 (9%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
           ++G+G F +VYKG    T   +A   L++ K +  E   F  E   +  + H N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 366 FCSEGSKRA----VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
                 K      +V E M +G+L  ++     R +    + L        +G+++LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT- 147

Query: 422 CDVCILHFDIKPHNI 436
               I+H D+K  NI
Sbjct: 148 RTPPIIHRDLKCDNI 162

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 85.4 bits (211), Expect = 5e-18
 Identities = 30/114 (26%), Positives = 51/114 (44%), Gaps = 9/114 (7%)

Query: 310 KLGQGGFGSVYKGQLHTGG---LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +LG G FGSV +G          +A+K+LK    K   EE + E   + ++ +  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           G C       +V E    G L +  F    R +      + E+    + G++YL
Sbjct: 403 GVCQA-EALMLVMEMAGGGPLHK--FLVGKREE-IPVSNVAELLHQVSMGMKYL 452

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 31/141 (21%), Positives = 56/141 (39%), Gaps = 28/141 (19%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG------LIAVKMLKNSKFSAE--EFINEVSTIGRIHH 357
                LG+G FG V K              +AVKMLK +   +E  + ++E + + +++H
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSL--------------------DRHIFPKESRGQ 397
            +V++L G CS+     ++ EY   GSL                               +
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 398 SFSWEKLHEVALGTARGIEYL 418
           + +   L   A   ++G++YL
Sbjct: 146 ALTMGDLISFAWQISQGMQYL 166

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 23/136 (16%)

Query: 306 HFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLKNSKFSAE--EFINEVSTIGRI 355
                LG+G FG V   +              +AVKMLK+     +  + ++E+  +  I
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143

Query: 356 -HHVNVVQLLGFCSEGSKRAVVYEYMPNGSL------------DRHIFPKESRGQSFSWE 402
             H N++ LLG C++     V+ EY   G+L            +          +  +++
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 403 KLHEVALGTARGIEYL 418
            L       ARG+EYL
Sbjct: 204 DLVSCTYQLARGMEYL 219

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 23/136 (16%)

Query: 306 HFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLKNSKFSAE--EFINEVSTIGRI 355
                LG+G FG V   +              +AVKMLK+     +  + ++E+  +  I
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97

Query: 356 -HHVNVVQLLGFCSEGSKRAVVYEYMPNGSL------------DRHIFPKESRGQSFSWE 402
             H N++ LLG C++     V+ EY   G+L            +          +  +++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 403 KLHEVALGTARGIEYL 418
            L       ARG+EYL
Sbjct: 158 DLVSCTYQLARGMEYL 173

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 9/133 (6%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVK-MLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG-F 366
           KLG+GGF  V   + LH G   A+K +L + +   EE   E       +H N+++L+   
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 367 CSEGSKRAVVY---EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
             E   +   +    +   G+L   I   + +G   + +++  + LG  RG+E +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 424 VCILHFDIKPHNI 436
               H D+KP NI
Sbjct: 153 KGYAHRDLKPTNI 165

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 38/132 (28%), Positives = 58/132 (43%), Gaps = 8/132 (6%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRI-HHVNVVQLL 364
           K+G G FGSV+K      G + A+K  K     + +    + EV     +  H +VV+  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
              +E     +  EY   GSL   I         F   +L ++ L   RG+ Y+H    +
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134

Query: 425 CILHFDIKPHNI 436
            ++H DIKP NI
Sbjct: 135 SLVHMDIKPSNI 146

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 36/136 (26%), Positives = 56/136 (41%), Gaps = 23/136 (16%)

Query: 306 HFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLKNSKFSAE--EFINEVSTIGRI 355
                LG+G FG V   +              +AVKMLK+     +  + I+E+  +  I
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131

Query: 356 -HHVNVVQLLGFCSEGSKRAVVYEYMPNGSL------------DRHIFPKESRGQSFSWE 402
             H N++ LLG C++     V+ EY   G+L            +    P  +  +  S +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 403 KLHEVALGTARGIEYL 418
            L   A   ARG+EYL
Sbjct: 192 DLVSCAYQVARGMEYL 207

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 35/141 (24%), Positives = 57/141 (40%), Gaps = 28/141 (19%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGG------LIAVKMLKNSKFSAE--EFINEVSTIGRI-H 356
            F   LG G FG V     +          +AVKMLK    S+E    ++E+  + ++  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107

Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSL-------------------DRHIFPKESRGQ 397
           H N+V LLG C+      +++EY   G L                   ++    +E    
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 398 SFSWEKLHEVALGTARGIEYL 418
             ++E L   A   A+G+E+L
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL 188

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 37/135 (27%), Positives = 58/135 (42%), Gaps = 22/135 (16%)

Query: 306 HFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-H 356
                LG+G FG V +          T   +AVKMLK     +E    ++E+  +  I H
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89

Query: 357 HVNVVQLLGFCS-EGSKRAVVYEYMPNGSL------------DRHIFPKESRGQSFSWEK 403
           H+NVV LLG C+  G    V+ E+   G+L               + P++      + E 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 404 LHEVALGTARGIEYL 418
           L   +   A+G+E+L
Sbjct: 150 LICYSFQVAKGMEFL 164

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 9/131 (6%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
           K+G+G FG     +    G    +K +  S+ S++E      EV+ +  + H N+VQ   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
              E     +V +Y   G L + I     +G  F  +++ +  +     ++++H   D  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVH---DRK 145

Query: 426 ILHFDIKPHNI 436
           ILH DIK  NI
Sbjct: 146 ILHRDIKSQNI 156

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 38/138 (27%), Positives = 55/138 (39%), Gaps = 27/138 (19%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLI--------AVKMLKNSKFSAE--EFINEVSTIGRI 355
            F   LG G FG V +   +  GLI        AVKMLK S    E    ++E+  +  +
Sbjct: 26  SFGKTLGAGAFGKVVEATAY--GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 356 -HHVNVVQLLGFCSEGSKRAVVYEYMPNGSL--------------DRHIFPKESRGQSFS 400
            +H+N+V LLG C+ G    V+ EY   G L                     E    +  
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 401 WEKLHEVALGTARGIEYL 418
            E L   +   A+G+ +L
Sbjct: 144 LEDLLSFSYQVAKGMAFL 161

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 79.6 bits (197), Expect = 7e-17
 Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 25/144 (17%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF-- 366
            +G GGFG V+K +    G    +K +K +    E+   EV  + ++ HVN+V   G   
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWD 74

Query: 367 -----------CSEGSKRAVVY---EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTA 412
                       S  SK   ++   E+   G+L++ I  ++ RG+        E+     
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQIT 132

Query: 413 RGIEYLHNGCDVCILHFDIKPHNI 436
           +G++Y+H      +++ D+KP NI
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNI 153

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 11/137 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS--AEEFINEVSTIGRIHHVNVVQ 362
             +  LGQG   +V++G+   TG L A+K+  N  F    +  + E   + +++H N+V+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 363 LLGFCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH- 419
           L     E + R    + E+ P GSL   +             +   V      G+ +L  
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 420 NGCDVCILHFDIKPHNI 436
           NG    I+H +IKP NI
Sbjct: 131 NG----IVHRNIKPGNI 143

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 35/129 (27%), Positives = 63/129 (48%), Gaps = 8/129 (6%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLK-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           +LG G FG VYK +   TG L A K+++  S+   E++I E+  +    H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
               K  ++ E+ P G++D  +       +  +  ++  V       + +LH+     I+
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSK---RII 139

Query: 428 HFDIKPHNI 436
           H D+K  N+
Sbjct: 140 HRDLKAGNV 148

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 77.3 bits (191), Expect = 6e-16
 Identities = 31/137 (22%), Positives = 61/137 (44%), Gaps = 16/137 (11%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQL 363
            K+G+G F  VY+   L  G  +A+K ++           + I E+  + +++H NV++ 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFS----WEKLHEVALGTARGIEYLH 419
                E ++  +V E    G L R I   + + +       W+   ++       +E++H
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS----ALEHMH 153

Query: 420 NGCDVCILHFDIKPHNI 436
                 ++H DIKP N+
Sbjct: 154 ---SRRVMHRDIKPANV 167

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 77.6 bits (191), Expect = 9e-16
 Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 11/137 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS--AEEFINEVSTIGRIHHVNVVQ 362
             +  LGQG   +V++G+   TG L A+K+  N  F    +  + E   + +++H N+V+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 363 LLGFCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH- 419
           L     E + R    + E+ P GSL   +             +   V      G+ +L  
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 420 NGCDVCILHFDIKPHNI 436
           NG    I+H +IKP NI
Sbjct: 131 NG----IVHRNIKPGNI 143

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 29/135 (21%), Positives = 51/135 (37%), Gaps = 8/135 (5%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
            +G G +G   K +    G ++  K L     +  E    ++EV+ +  + H N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 366 -FCSEGSKR-AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH--NG 421
                 +    +V EY   G L   I       Q    E +  V       ++  H  + 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 422 CDVCILHFDIKPHNI 436
               +LH D+KP N+
Sbjct: 133 GGHTVLHRDLKPANV 147

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 29/129 (22%), Positives = 52/129 (40%), Gaps = 12/129 (9%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS 368
            LG G  G++    +     +AVK +    FS  +   EV  +     H NV++      
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIRYFCTEK 88

Query: 369 EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGCDVCIL 427
           +   + +  E     +L  ++   E +  +    +   +   T  G+ +LH       I+
Sbjct: 89  DRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN----IV 140

Query: 428 HFDIKPHNI 436
           H D+KPHNI
Sbjct: 141 HRDLKPHNI 149

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 38/143 (26%), Positives = 60/143 (41%), Gaps = 22/143 (15%)

Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFI------NEVSTIGRIHHVN 359
               +G+G F  V +     TG   AVK++  +KF++   +       E S    + H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTAR----G 414
           +V+LL   S      +V+E+M    L    I  +   G  +S E    VA    R     
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFE-IVKRADAGFVYS-EA---VASHYMRQILEA 142

Query: 415 IEYLH-NGCDVCILHFDIKPHNI 436
           + Y H N     I+H D+KPH +
Sbjct: 143 LRYCHDNN----IIHRDVKPHCV 161

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 74.3 bits (183), Expect = 5e-15
 Identities = 34/146 (23%), Positives = 60/146 (41%), Gaps = 30/146 (20%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF-- 366
            LGQG FG V K +        A+K +++++      ++EV  +  ++H  VV+      
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72

Query: 367 --------CSEGSKRAVVY---EYMPNGSLDRHIFPKESRGQSFS----WEKLHEVALGT 411
                    +   K++ ++   EY  NG+L   I    S   +      W    ++    
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILE-- 127

Query: 412 ARGIEYLH-NGCDVCILHFDIKPHNI 436
              + Y+H  G    I+H D+KP NI
Sbjct: 128 --ALSYIHSQG----IIHRDLKPMNI 147

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 31/143 (21%), Positives = 57/143 (39%), Gaps = 21/143 (14%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
            LG+GGFG V++ +        A+K   L N + + E+ + EV  + ++ H  +V+    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 367 CSEG---------SKRAVVY---EYMPNGSLDRHIFPKESRGQSFSWEKL-HEVALGTAR 413
             E          S +  +Y   +     +L   +              +   + L  A 
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLHIFLQIAE 129

Query: 414 GIEYLHNGCDVCILHFDIKPHNI 436
            +E+LH      ++H D+KP NI
Sbjct: 130 AVEFLH---SKGLMHRDLKPSNI 149

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 73.9 bits (182), Expect = 8e-15
 Identities = 31/136 (22%), Positives = 51/136 (37%), Gaps = 14/136 (10%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
            +G G    V           +A+K   L+  + S +E + E+  + + HH N+V     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALG-----TARGIEYLH-N 420
                +  +V + +  GS+   I              L E  +         G+EYLH N
Sbjct: 82  FVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140

Query: 421 GCDVCILHFDIKPHNI 436
           G     +H D+K  NI
Sbjct: 141 G----QIHRDVKAGNI 152

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 73.9 bits (182), Expect = 8e-15
 Identities = 39/129 (30%), Positives = 65/129 (50%), Gaps = 8/129 (6%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
            KLG+G +GSVYK     TG ++A+K +       +E I E+S + +    +VV+  G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSY 93

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
            + +   +V EY   GS+   I     R ++ + +++  +   T +G+EYLH       +
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFM---RKI 147

Query: 428 HFDIKPHNI 436
           H DIK  NI
Sbjct: 148 HRDIKAGNI 156

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 73.9 bits (182), Expect = 9e-15
 Identities = 34/132 (25%), Positives = 56/132 (42%), Gaps = 12/132 (9%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRI-HHVNVVQLL 364
           +LG G +G V+K +    G L AVK   +     ++    + EV +  ++  H   V+L 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
               EG    +  E     SL +H    E+ G S    ++      T   + +LH     
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176

Query: 425 CILHFDIKPHNI 436
            ++H D+KP NI
Sbjct: 177 GLVHLDVKPANI 188

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 73.9 bits (182), Expect = 9e-15
 Identities = 35/132 (26%), Positives = 58/132 (43%), Gaps = 16/132 (12%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 367
           K+G+G  G V   +  H+G  +AVKM+   K    E + NEV  +    H NVV++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111

Query: 368 SEGSKRAVVYEYMPNGSLD---RHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
             G +  V+ E++  G+L      +   E +  +     L        + + YLH     
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL--------QALAYLHAQ--- 160

Query: 425 CILHFDIKPHNI 436
            ++H DIK  +I
Sbjct: 161 GVIHRDIKSDSI 172

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 36/135 (26%), Positives = 58/135 (42%), Gaps = 20/135 (14%)

Query: 309 HKLGQGGFGSVYKG-QLHTGGLIAVKMLK-NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
            K+GQG  G+VY    + TG  +A++ +    +   E  INE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHE-----VALGTARGIEYLHNG 421
              G +  VV EY+  GSL   +              + E     V     + +E+LH+ 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHSN 135

Query: 422 CDVCILHFDIKPHNI 436
               ++H DIK  NI
Sbjct: 136 ---QVIHRDIKSDNI 147

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 33/133 (24%), Positives = 58/133 (43%), Gaps = 12/133 (9%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE----FINEVSTIGRIHHVNVVQL 363
            ++G G FG+VY  + +    ++A+K +  S   + E     I EV  + ++ H N +Q 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G         +V EY    + D      E   +     ++  V  G  +G+ YLH+   
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLL----EVHKKPLQEVEIAAVTHGALQGLAYLHSH-- 173

Query: 424 VCILHFDIKPHNI 436
             ++H D+K  NI
Sbjct: 174 -NMIHRDVKAGNI 185

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 30/131 (22%), Positives = 61/131 (46%), Gaps = 11/131 (8%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
            K+G+G FG V+KG    T  ++A+K+  L+ ++   E+   E++ + +     V +  G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
              + +K  ++ EY+  GS    +             ++  +     +G++YLH+     
Sbjct: 88  SYLKDTKLWIIMEYLGGGSA-LDLL----EPGPLDETQIATILREILKGLDYLHSE---K 139

Query: 426 ILHFDIKPHNI 436
            +H DIK  N+
Sbjct: 140 KIHRDIKAANV 150

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 36/136 (26%), Positives = 63/136 (46%), Gaps = 13/136 (9%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLG- 365
             +G G +G VYKG+ + TG L A+K++  +    EE   E++ + +  HH N+    G 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 366 -----FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
                      +  +V E+   GS+   I  K ++G +   E +  +     RG+ +LH 
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQ 147

Query: 421 GCDVCILHFDIKPHNI 436
                ++H DIK  N+
Sbjct: 148 H---KVIHRDIKGQNV 160

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 26/134 (19%), Positives = 53/134 (39%), Gaps = 19/134 (14%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 368
            LG+G FG V++  +  +      K +K           E+S +    H N++ L     
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 369 EGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTAR----GIEYLH-NGC 422
              +  +++E++    + +R      +     + E+     +         +++LH +  
Sbjct: 72  SMEELVMIFEFISGLDIFERIN----TSAFELN-ER---EIVSYVHQVCEALQFLHSHN- 122

Query: 423 DVCILHFDIKPHNI 436
              I HFDI+P NI
Sbjct: 123 ---IGHFDIRPENI 133

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 27/139 (19%), Positives = 47/139 (33%), Gaps = 11/139 (7%)

Query: 306 HFTHKLGQGGFGSVYKGQ------LHTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHV 358
           +  H LG+G F  VY+                +K+ K +  +        +  +      
Sbjct: 68  YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQH 127

Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHI-FPKESRGQSFSWEKLHEVALGTARGIEY 417
             ++        +   +V E    G+L   I   K +  +      +   A+     IE 
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187

Query: 418 LHNGCDVCILHFDIKPHNI 436
           +H   D  I+H DIKP N 
Sbjct: 188 VH---DCEIIHGDIKPDNF 203

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 23/137 (16%), Positives = 53/137 (38%), Gaps = 15/137 (10%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRI--HHVNV 360
               ++G GG   V++       + A+K +   +   +    + NE++ + ++  H   +
Sbjct: 12  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH- 419
           ++L  +        +V E   N  L+  +     + +S    +           +  +H 
Sbjct: 72  IRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 420 NGCDVCILHFDIKPHNI 436
           +G    I+H D+KP N 
Sbjct: 127 HG----IVHSDLKPANF 139

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 23/137 (16%), Positives = 53/137 (38%), Gaps = 15/137 (10%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRI--HHVNV 360
               ++G GG   V++       + A+K +   +   +    + NE++ + ++  H   +
Sbjct: 31  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH- 419
           ++L  +        +V E   N  L+  +     + +S    +           +  +H 
Sbjct: 91  IRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 420 NGCDVCILHFDIKPHNI 436
           +G    I+H D+KP N 
Sbjct: 146 HG----IVHSDLKPANF 158

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 37/148 (25%), Positives = 58/148 (39%), Gaps = 29/148 (19%)

Query: 306 HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQ 362
               +LG GGFG V +     TG  +A+K  +      + E +  E+  + +++H NVV 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 363 LLGFCSEGSKRA------VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR--- 413
                    K A      +  EY   G L +++   E+         L E      R   
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC------GLKEG---PIRTLL 127

Query: 414 -----GIEYLHNGCDVCILHFDIKPHNI 436
                 + YLH   +  I+H D+KP NI
Sbjct: 128 SDISSALRYLH---ENRIIHRDLKPENI 152

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 20/137 (14%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLK-NSKFSAEEFIN-----EVSTIGRIHHVNVVQ 362
            LG+G F +VYK +  +T  ++A+K +K   +  A++ IN     E+  +  + H N++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEV---ALGTARGIEYLH 419
           LL      S  ++V+++M    L+  I   +      +      +    L T +G+EYLH
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLT---PSHIKAYMLMTLQGLEYLH 129

Query: 420 NGCDVCILHFDIKPHNI 436
                 ILH D+KP+N+
Sbjct: 130 ---QHWILHRDLKPNNL 143

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 29/134 (21%), Positives = 61/134 (45%), Gaps = 17/134 (12%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN-----EVSTIGRIHHVNVVQL 363
           K+G+G +G V+K +   TG ++A+K    S+   +  I      E+  + ++ H N+V L
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESED--DPVIKKIALREIRMLKQLKHPNLVNL 67

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGC 422
           L       +  +V+EY  + ++   +   +   +      +  +   T + + + H +  
Sbjct: 68  LEVFRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHKHN- 122

Query: 423 DVCILHFDIKPHNI 436
               +H D+KP NI
Sbjct: 123 ---CIHRDVKPENI 133

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 20/137 (14%)

Query: 308 THKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFS-AEEFINEVSTIGRIHHVNVVQLLG 365
           T  LG G FG V+K  +  TG  +A K++K       EE  NE+S + ++ H N++QL  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153

Query: 366 FCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTAR----GIEYLH- 419
                +   +V EY+  G L DR I        + + E      +   +    GI ++H 
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII----DESYNLT-EL---DTILFMKQICEGIRHMHQ 205

Query: 420 NGCDVCILHFDIKPHNI 436
                 ILH D+KP NI
Sbjct: 206 MY----ILHLDLKPENI 218

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 31/134 (23%), Positives = 62/134 (46%), Gaps = 14/134 (10%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQL 363
             LG+G FG+VY  +   +  ++A+K+L  ++        +   EV     + H N+++L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGC 422
            G+  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H    
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR- 129

Query: 423 DVCILHFDIKPHNI 436
              ++H DIKP N+
Sbjct: 130 ---VIHRDIKPENL 140

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 22/137 (16%), Positives = 52/137 (37%), Gaps = 15/137 (10%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHH--VNV 360
               ++G GG   V++       + A+K +   +   +    + NE++ + ++      +
Sbjct: 59  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH- 419
           ++L  +        +V E   N  L+  +     + +S    +           +  +H 
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 420 NGCDVCILHFDIKPHNI 436
           +G    I+H D+KP N 
Sbjct: 174 HG----IVHSDLKPANF 186

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 35/157 (22%), Positives = 65/157 (41%), Gaps = 10/157 (6%)

Query: 285 HNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSA- 342
           H+  S   +   +   I     F  KLG G FG V+   +  +G    +K +   +    
Sbjct: 4   HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63

Query: 343 -EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFS 400
            E+   E+  +  + H N++++     +     +V E    G L +R I   ++RG++ S
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER-IVSAQARGKALS 122

Query: 401 WEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNI 436
              + E+       + Y H       ++H D+KP NI
Sbjct: 123 EGYVAELMKQMMNALAYFHSQH----VVHKDLKPENI 155

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 20/139 (14%)

Query: 306 HFTHKLGQGGFGSVYKG-QLHTGGLIAVKML-KNSKFSAEEFINEVSTIGRIHHVNVVQL 363
               +LG G FG V++  +  TG +   K +            NE+S + ++HH  ++ L
Sbjct: 54  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113

Query: 364 LGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTAR----GIEYL 418
                +  +  ++ E++  G L DR      +     S E      +   R    G++++
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIA----AEDYKMS-EA---EVINYMRQACEGLKHM 165

Query: 419 H-NGCDVCILHFDIKPHNI 436
           H +     I+H DIKP NI
Sbjct: 166 HEHS----IVHLDIKPENI 180

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 35/134 (26%), Positives = 56/134 (41%), Gaps = 15/134 (11%)

Query: 309 HKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLL 364
            +LG+G F  V +     TG   A K++   K SA +      E     ++ H N+V+L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 365 GFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGC 422
               E S   +V++ +  G L +  I  +E     +S              I Y H NG 
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFED-IVARE----FYSEADASHCIQQILESIAYCHSNG- 125

Query: 423 DVCILHFDIKPHNI 436
              I+H ++KP N+
Sbjct: 126 ---IVHRNLKPENL 136

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 42/137 (30%), Positives = 58/137 (42%), Gaps = 19/137 (13%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSA-------EEFINEVSTIGRIHHVNVV 361
           +LG G F  V K  +  TG   A K +K  +  A       EE   EVS + ++ H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH- 419
            L       +   ++ E +  G L D  +  KE    S S E+          G+ YLH 
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDF-LAQKE----SLSEEEATSFIKQILDGVNYLHT 133

Query: 420 NGCDVCILHFDIKPHNI 436
                 I HFD+KP NI
Sbjct: 134 KK----IAHFDLKPENI 146

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 68.3 bits (168), Expect = 4e-13
 Identities = 34/133 (25%), Positives = 58/133 (43%), Gaps = 16/133 (12%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSK------FSAEEFINEVSTIGRIHHVNVVQL 363
           K+G+G +G VYK Q + G   A+K ++  K       +    I E+S +  + H N+V+L
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT---IREISILKELKHSNIVKL 65

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
                   +  +V+E++    L + +   +               L    GI Y H   D
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCH---D 118

Query: 424 VCILHFDIKPHNI 436
             +LH D+KP N+
Sbjct: 119 RRVLHRDLKPQNL 131

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 70.3 bits (172), Expect = 5e-13
 Identities = 34/155 (21%), Positives = 58/155 (37%), Gaps = 34/155 (21%)

Query: 294 RYSYPEIIAMTNHFTHKLGQGGFGSVYKG---QLHTGGLIAVKMLKNSK---FSAEEFIN 347
           +Y   E+          +  GG G +Y      ++ G  + +K L +S          + 
Sbjct: 81  QY---EVKG-------CIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEA-QAMAMA 128

Query: 348 EVSTIGRIHHVNVVQLLGFCSEGSKRAV-----VYEYMPNGSLDRHIFPKESRGQSFSWE 402
           E   +  + H ++VQ+  F     +        V EY+   SL      K S+GQ     
Sbjct: 129 ERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL------KRSKGQKLPVA 182

Query: 403 KLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNI 436
           +     L     + YLH  G    +++ D+KP NI
Sbjct: 183 EAIAYLLEILPALSYLHSIG----LVYNDLKPENI 213

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 31/133 (23%), Positives = 62/133 (46%), Gaps = 15/133 (11%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEF----INEVSTIGRIHHVNVVQLL 364
            +G+G +G V K +   TG ++A+K    S    +      + E+  + ++ H N+V LL
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGCD 423
             C +  +  +V+E++ + ++   +   E       ++ + +       GI + H +   
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHSHN-- 144

Query: 424 VCILHFDIKPHNI 436
             I+H DIKP NI
Sbjct: 145 --IIHRDIKPENI 155

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 35/133 (26%), Positives = 56/133 (42%), Gaps = 15/133 (11%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVVQLLG 365
           +LG+G F  V +     TG   A K++   K SA +      E     ++ H N+V+L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 366 FCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGCD 423
              E S   +V++ +  G L +  I  +E     +S              I Y H NG  
Sbjct: 96  SIQEESFHYLVFDLVTGGELFED-IVARE----FYSEADASHCIQQILESIAYCHSNG-- 148

Query: 424 VCILHFDIKPHNI 436
             I+H ++KP N+
Sbjct: 149 --IVHRNLKPENL 159

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 41/137 (29%), Positives = 58/137 (42%), Gaps = 19/137 (13%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSA-------EEFINEVSTIGRIHHVNVV 361
           +LG G F  V K  +  TG   A K +K  +  A       EE   EVS + ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH- 419
            L       +   ++ E +  G L D  +  KE    S S E+          G+ YLH 
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDF-LAQKE----SLSEEEATSFIKQILDGVNYLHT 133

Query: 420 NGCDVCILHFDIKPHNI 436
                 I HFD+KP NI
Sbjct: 134 KK----IAHFDLKPENI 146

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 33/133 (24%), Positives = 60/133 (45%), Gaps = 16/133 (12%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLK--NSK----FSAEEFINEVSTIGRIHHVNVVQL 363
           K+G+G +G VYK +   G ++A+K ++          +A   I E+S +  +HH N+V L
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA---IREISLLKELHHPNIVSL 84

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
           +          +V+E+M    L + +   +         ++        RG+ + H    
Sbjct: 85  IDVIHSERCLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCH---Q 137

Query: 424 VCILHFDIKPHNI 436
             ILH D+KP N+
Sbjct: 138 HRILHRDLKPQNL 150

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)

Query: 309 HKLGQGGFGSVYKGQL-HTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
            +LG G  G V+K     +G ++A K+  L+       + I E+  +   +   +V   G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 366 -FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
            F S+G + ++  E+M  GSLD+ +     +      + L +V++   +G+ YL      
Sbjct: 99  AFYSDG-EISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE--KH 151

Query: 425 CILHFDIKPHNI 436
            I+H D+KP NI
Sbjct: 152 KIMHRDVKPSNI 163

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 68.0 bits (167), Expect = 9e-13
 Identities = 33/137 (24%), Positives = 60/137 (43%), Gaps = 24/137 (17%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK------FSAEEFINEVSTIGRIHHVNVVQ 362
           KLG+G +G VYK     T   +A+K ++          +A   I EVS +  + H N+++
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA---IREVSLLKELQHRNIIE 97

Query: 363 LLGFCSEGSKRAVVYEYMPN---GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           L        +  +++EY  N     +D++        +SF ++ +         G+ + H
Sbjct: 98  LKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLI--------NGVNFCH 149

Query: 420 NGCDVCILHFDIKPHNI 436
                  LH D+KP N+
Sbjct: 150 ---SRRCLHRDLKPQNL 163

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 28/149 (18%), Positives = 51/149 (34%), Gaps = 25/149 (16%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFI------------------NEVST 351
            L QG F  +   +       A+K  + S    +                     NE+  
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 352 IGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHI----FPKESRGQSFSWEKLHEV 407
           I  I +   +   G  +   +  ++YEYM N S+ +         ++       + +  +
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
                    Y+HN  ++C  H D+KP NI
Sbjct: 157 IKSVLNSFSYIHNEKNIC--HRDVKPSNI 183

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 24/134 (17%), Positives = 49/134 (36%), Gaps = 13/134 (9%)

Query: 310 KLGQG--GFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEF---INEVSTIGRIHHVNVVQL 363
            +G+G     +V   +   TG  + V+ +     S E       E+      +H N+V  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGC 422
                  ++  VV  +M  GS  + +          +   +  +  G  + ++Y+H  G 
Sbjct: 92  RATFIADNELWVVTSFMAYGSA-KDLI-CTHFMDGMNELAIAYILQGVLKALDYIHHMGY 149

Query: 423 DVCILHFDIKPHNI 436
               +H  +K  +I
Sbjct: 150 ----VHRSVKASHI 159

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 36/136 (26%), Positives = 60/136 (44%), Gaps = 17/136 (12%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN-----EVSTIGRIHHVNVVQL 363
           KLG G + +VYKG    TG  +A+K +K     +EE        E+S +  + H N+V+L
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 364 LGFCSEGSKRAVVYEYMPN---GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
                  +K  +V+E+M N     +D       +  +      +        +G+ + H 
Sbjct: 69  YDVIHTENKLTLVFEFMDNDLKKYMDSR--TVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126

Query: 421 GCDVCILHFDIKPHNI 436
                ILH D+KP N+
Sbjct: 127 N---KILHRDLKPQNL 139

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 33/135 (24%), Positives = 60/135 (44%), Gaps = 12/135 (8%)

Query: 306 HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQL 363
               +LG G FG V++  +  TG   A K +     S +E +  E+ T+  + H  +V L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219

Query: 364 LGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NG 421
                + ++  ++YE+M  G L ++            S ++  E      +G+ ++H N 
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVA----DEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 422 CDVCILHFDIKPHNI 436
                +H D+KP NI
Sbjct: 276 ----YVHLDLKPENI 286

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 38/137 (27%), Positives = 61/137 (44%), Gaps = 21/137 (15%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFIN-EVSTIGRIHHVNVVQLLG-FC 367
            +G G FG V++ +L     +A+K +   K     F N E+  +  + H NVV L   F 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFY 102

Query: 368 SEGSKRA-----VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGT---ARGIEYLH 419
           S G K+      +V EY+P  ++ R         Q+     +  + L      R + Y+H
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP---MLLIKLYMYQLLRSLAYIH 158

Query: 420 NGCDVCILHFDIKPHNI 436
           +   + I H DIKP N+
Sbjct: 159 S---IGICHRDIKPQNL 172

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 40/138 (28%), Positives = 65/138 (47%), Gaps = 22/138 (15%)

Query: 310 KLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFIN-EVSTIGRIHHVNVVQLLG-F 366
            +G G FG VY+ +L  +G L+A+K +   K     F N E+  + ++ H N+V+L   F
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFF 116

Query: 367 CSEGSKRA-----VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGT---ARGIEYL 418
            S G K+      +V +Y+P  ++ R         Q+     +  V L      R + Y+
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP---VIYVKLYMYQLFRSLAYI 172

Query: 419 HNGCDVCILHFDIKPHNI 436
           H+     I H DIKP N+
Sbjct: 173 HS---FGICHRDIKPQNL 187

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 32/139 (23%), Positives = 60/139 (43%), Gaps = 14/139 (10%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVK-MLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLG 365
             L +GGF  VY+ Q + +G   A+K +L N +      I EV  + ++  H N+VQ   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 366 FCSEGSKRA--------VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
             S G + +        ++ E      ++     K       S + + ++   T R +++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVE--FLKKMESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 418 LHNGCDVCILHFDIKPHNI 436
           +H      I+H D+K  N+
Sbjct: 152 MHR-QKPPIIHRDLKVENL 169

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 66.4 bits (163), Expect = 2e-12
 Identities = 34/139 (24%), Positives = 65/139 (46%), Gaps = 26/139 (18%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK------FSAEEFINEVSTIGRIHHVNVVQ 362
           K+G+G +G VYK +   TG ++A+K ++          +A   I E+S +  ++H N+V+
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA---IREISLLKELNHPNIVK 66

Query: 363 LLGFCSEGSKRAVVYEYMPN---GSLDRHIFPKESRGQ--SFSWEKLHEVALGTARGIEY 417
           LL      +K  +V+E++       +D             S+ ++ L        +G+ +
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--------QGLAF 118

Query: 418 LHNGCDVCILHFDIKPHNI 436
            H      +LH D+KP N+
Sbjct: 119 CH---SHRVLHRDLKPQNL 134

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 32/131 (24%), Positives = 65/131 (49%), Gaps = 7/131 (5%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAE--EFINEVSTIGR-IHHVNVVQLLG 365
           +LG+G +G V K + + +G ++AVK ++ +  S E    + ++    R +     V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                    +  E M + SLD+       +GQ+   + L ++A+   + +E+LH+   + 
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 130

Query: 426 ILHFDIKPHNI 436
           ++H D+KP N+
Sbjct: 131 VIHRDVKPSNV 141

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 13/134 (9%)

Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFI-NEVSTIGRIHHVNVVQLL 364
           F   LG G F  V+   Q  TG L A+K +K S    +  + NE++ + +I H N+V L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 365 GFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGC 422
                 +   +V + +  G L DR I  +      ++ +    V       ++YLH NG 
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDR-ILERG----VYTEKDASLVIQQVLSAVKYLHENG- 126

Query: 423 DVCILHFDIKPHNI 436
              I+H D+KP N+
Sbjct: 127 ---IVHRDLKPENL 137

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 32/132 (24%), Positives = 61/132 (46%), Gaps = 8/132 (6%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAE--EFINEVSTIGR-IHHVNVVQLLG 365
           ++G+G +GSV K     +G ++AVK ++++    E  + + ++  + R      +VQ  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHI-FPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
                    +  E M + S D+   +           E L ++ L T + + +L    ++
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NL 145

Query: 425 CILHFDIKPHNI 436
            I+H DIKP NI
Sbjct: 146 KIIHRDIKPSNI 157

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 38/172 (22%), Positives = 65/172 (37%), Gaps = 37/172 (21%)

Query: 283 FLHNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQ---LHTGGLIAVKMLKNSK 339
           F     S   +     E          K+G+G +G VYK +          A+K ++ + 
Sbjct: 7   FKVKLSSERERVEDLFEYEGC------KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG 60

Query: 340 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV--VYEYMPN---GSLDRHIFPKES 394
            S      E++ +  + H NV+ L       + R V  +++Y  +     +  H   K +
Sbjct: 61  ISMSA-CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119

Query: 395 RG---------QSFSWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNI 436
           +          +S  ++ L         GI YLH N     +LH D+KP NI
Sbjct: 120 KKPVQLPRGMVKSLLYQIL--------DGIHYLHANW----VLHRDLKPANI 159

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 65.6 bits (161), Expect = 3e-12
 Identities = 30/134 (22%), Positives = 60/134 (44%), Gaps = 17/134 (12%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK------FSAEEFINEVSTIGRIHHVNVVQ 362
           K+G+G +G+V+K +   T  ++A+K ++          SA   + E+  +  + H N+V+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELKHKNIVR 65

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           L        K  +V+E+     L ++    +S       E +        +G+ + H   
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118

Query: 423 DVCILHFDIKPHNI 436
              +LH D+KP N+
Sbjct: 119 SRNVLHRDLKPQNL 132

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 40/150 (26%), Positives = 61/150 (40%), Gaps = 26/150 (17%)

Query: 294 RYSYPEIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE-----FIN 347
           RY   +I+        KLG GG  +VY  +       +A+K +       +E     F  
Sbjct: 12  RY---KIVD-------KLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFER 60

Query: 348 EVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEV 407
           EV    ++ H N+V ++    E     +V EY+   +L  +I   ES G   S +     
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGP-LSVDTAINF 116

Query: 408 ALGTARGIEYLH-NGCDVCILHFDIKPHNI 436
                 GI++ H       I+H DIKP NI
Sbjct: 117 TNQILDGIKHAHDMR----IVHRDIKPQNI 142

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 37/133 (27%), Positives = 60/133 (45%), Gaps = 16/133 (12%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEE-----FINEVSTIGRIHHVNVVQL 363
           KLG+G + +VYKG    T  L+A+K ++      EE      I EVS +  + H N+V L
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVTL 65

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
                      +V+EY+    L +++   +  G   +   +        RG+ Y H    
Sbjct: 66  HDIIHTEKSLTLVFEYLDK-DLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH---R 118

Query: 424 VCILHFDIKPHNI 436
             +LH D+KP N+
Sbjct: 119 QKVLHRDLKPQNL 131

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 42/141 (29%), Positives = 59/141 (41%), Gaps = 27/141 (19%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSA-------EEFINEVSTIGRIHHVNVV 361
           +LG G F  V K  Q  TG   A K +K  + S+       EE   EV+ +  I H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTAR----GIE 416
            L       +   ++ E +  G L D  +  KE    S + E     A    +    G+ 
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDF-LAEKE----SLT-ED---EATQFLKQILDGVH 122

Query: 417 YLH-NGCDVCILHFDIKPHNI 436
           YLH       I HFD+KP NI
Sbjct: 123 YLHSKR----IAHFDLKPENI 139

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 34/137 (24%), Positives = 56/137 (40%), Gaps = 15/137 (10%)

Query: 306 HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVV 361
               KLG G +G V       T    A+K+++ +  S       + EV+ +  + H N++
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH- 419
           +L  F  +     +V E    G L D  I     R   F+      +      G+ YLH 
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEII----HRM-KFNEVDAAVIIKQVLSGVTYLHK 154

Query: 420 NGCDVCILHFDIKPHNI 436
           +     I+H D+KP N+
Sbjct: 155 HN----IVHRDLKPENL 167

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 38/138 (27%), Positives = 57/138 (41%), Gaps = 16/138 (11%)

Query: 306 HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEE----FINEVSTIGRIHHVNV 360
                LG+G FG V       TG   AVK++   +   +      + EV  + ++ H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           ++L  F  +     +V E    G L D  I    SR   FS      +      GI Y+H
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRK-RFSEVDAARIIRQVLSGITYMH 143

Query: 420 -NGCDVCILHFDIKPHNI 436
            N     I+H D+KP N+
Sbjct: 144 KNK----IVHRDLKPENL 157

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 28/136 (20%), Positives = 55/136 (40%), Gaps = 15/136 (11%)

Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQ 362
              +LG+G F  V +  ++  G   A  ++   K SA   ++   E      + H N+V+
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 363 LLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-N 420
           L    SE     ++++ +  G L +  I  +E     +S              + + H  
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFED-IVARE----YYSEADASHCIQQILEAVLHCHQM 129

Query: 421 GCDVCILHFDIKPHNI 436
           G    ++H ++KP N+
Sbjct: 130 G----VVHRNLKPENL 141

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 64.5 bits (158), Expect = 8e-12
 Identities = 36/136 (26%), Positives = 68/136 (50%), Gaps = 21/136 (15%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLG 365
           LG+G F  VY+ + +HTG  +A+KM+           +   NEV    ++ H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK-----LHEVALGTARGIEYLHN 420
           +  + +   +V E   NG ++R++   ++R + FS E      +H++      G+ YLH+
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFS-ENEARHFMHQI----ITGMLYLHS 130

Query: 421 GCDVCILHFDIKPHNI 436
                ILH D+   N+
Sbjct: 131 ---HGILHRDLTLSNL 143

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 65.0 bits (159), Expect = 8e-12
 Identities = 41/141 (29%), Positives = 59/141 (41%), Gaps = 27/141 (19%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSA-------EEFINEVSTIGRIHHVNVV 361
           +LG G F  V K  +  TG   A K +K  +  +       E+   EVS +  I H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTAR----GIE 416
            L       +   ++ E +  G L D  +  KE    S + E+    A    +    G+ 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDF-LAEKE----SLT-EE---EATEFLKQILNGVY 128

Query: 417 YLH-NGCDVCILHFDIKPHNI 436
           YLH       I HFD+KP NI
Sbjct: 129 YLHSLQ----IAHFDLKPENI 145

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 65.0 bits (159), Expect = 9e-12
 Identities = 35/139 (25%), Positives = 52/139 (37%), Gaps = 28/139 (20%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS----AEEFINEVSTIGRIHHVNVVQLLG 365
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR--------GIEY 417
           F  +     VV E     SL       + R        L E     AR        G +Y
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRK------ALTE---PEARYYLRQIVLGCQY 156

Query: 418 LHNGCDVCILHFDIKPHNI 436
           LH      ++H D+K  N+
Sbjct: 157 LHRN---RVIHRDLKLGNL 172

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 33/138 (23%), Positives = 54/138 (39%), Gaps = 22/138 (15%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRI-HHVNVVQLL 364
           +LG+G F  V +     TG   A K LK  +       E ++E++ +        V+ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 365 GFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTAR----GIEYLH 419
                 S+  ++ EY   G +    +       +  S E      +   +    G+ YLH
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCL---PELAEMVS-EN---DVIRLIKQILEGVYYLH 148

Query: 420 -NGCDVCILHFDIKPHNI 436
            N     I+H D+KP NI
Sbjct: 149 QNN----IVHLDLKPQNI 162

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 35/139 (25%), Positives = 52/139 (37%), Gaps = 28/139 (20%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS----AEEFINEVSTIGRIHHVNVVQLLG 365
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR--------GIEY 417
           F  +     VV E     SL       + R        L E     AR        G +Y
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH---KRRK------ALTE---PEARYYLRQIVLGCQY 130

Query: 418 LHNGCDVCILHFDIKPHNI 436
           LH      ++H D+K  N+
Sbjct: 131 LHR---NRVIHRDLKLGNL 146

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 40/158 (25%), Positives = 64/158 (40%), Gaps = 15/158 (9%)

Query: 285 HNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAE 343
           H+  S   +   +    A   +    LG+G FG V K     T    AVK++  +    +
Sbjct: 4   HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63

Query: 344 E---FINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSF 399
           +    + EV  + ++ H N+++L     + S   +V E    G L D  I     R   F
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRK-RF 118

Query: 400 SWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNI 436
           S      +      GI Y+H +     I+H D+KP NI
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHN----IVHRDLKPENI 152

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 33/136 (24%), Positives = 60/136 (44%), Gaps = 22/136 (16%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFI----NEVSTIGRIHHVNVVQLLG 365
           LG+G FG+VY  +      ++A+K+L  S+   E        E+     + H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHI-----FPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           +  +  +  ++ E+ P G L + +     F  E R  +F  E         A  + Y H 
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFMEE--------LADALHYCHE 132

Query: 421 GCDVCILHFDIKPHNI 436
                ++H DIKP N+
Sbjct: 133 ---RKVIHRDIKPENL 145

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 40/158 (25%), Positives = 64/158 (40%), Gaps = 15/158 (9%)

Query: 285 HNQQSWMPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAE 343
           H+  S   +   +    A   +    LG+G FG V K     T    AVK++  +    +
Sbjct: 4   HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63

Query: 344 E---FINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSF 399
           +    + EV  + ++ H N+++L     + S   +V E    G L D  I     R   F
Sbjct: 64  DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRK-RF 118

Query: 400 SWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNI 436
           S      +      GI Y+H +     I+H D+KP NI
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHN----IVHRDLKPENI 152

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 29/145 (20%), Positives = 55/145 (37%), Gaps = 10/145 (6%)

Query: 296 SYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI 355
           ++ + +         LG G  G+V       G  +AVK +       +  + E+  +   
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALMEIKLLTES 65

Query: 356 -HHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVA---LGT 411
             H NV++     +      +  E   N +L   +  K    ++   +K +         
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 412 ARGIEYLHNGCDVCILHFDIKPHNI 436
           A G+ +LH    + I+H D+KP NI
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNI 146

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 35/140 (25%), Positives = 56/140 (40%), Gaps = 21/140 (15%)

Query: 306 HFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-H 356
                LG+G FG V +          T   +AVKMLK     +E    ++E+  +  I H
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 357 HVNVVQLLGFCSEGSKRA-VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGI 415
           H+NVV LLG C++      V+ E+   G+L            ++   K +E      +G 
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNL-----------STYLRSKRNEFVPYKTKGA 133

Query: 416 EYLHNGCDVCILHFDIKPHN 435
            +      V  +  D+K   
Sbjct: 134 RFRQGKDYVGAIPVDLKRRL 153

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 37/134 (27%), Positives = 56/134 (41%), Gaps = 16/134 (11%)

Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGR-IHHVNVVQLL 364
               +G G +    +     T    AVK++  SK    E   E+  + R   H N++ L 
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLK 82

Query: 365 GFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGC 422
               +G    VV E M  G L D+ I  +    + FS  +   V     + +EYLH  G 
Sbjct: 83  DVYDDGKYVYVVTELMKGGELLDK-ILRQ----KFFSEREASAVLFTITKTVEYLHAQG- 136

Query: 423 DVCILHFDIKPHNI 436
              ++H D+KP NI
Sbjct: 137 ---VVHRDLKPSNI 147

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 19/137 (13%), Positives = 37/137 (27%), Gaps = 24/137 (17%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLK----NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
             G       ++         +A+  +           +E ++    + RI    V ++L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 365 GFCSEGSKRAVVYEYMPNGSL----DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH- 419
                 +   VV E++  GSL    D    P  +                 A   +  H 
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAI----------RAMQSLAAAADAAHR 147

Query: 420 NGCDVCILHFDIKPHNI 436
            G    +      P  +
Sbjct: 148 AG----VALSIDHPSRV 160

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 62.2 bits (152), Expect = 5e-11
 Identities = 26/135 (19%), Positives = 48/135 (35%), Gaps = 13/135 (9%)

Query: 306 HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEE-FINEVSTIGRIHHVNVVQL 363
              + +G+G +G V    Q  T    A K +        + F  E+  +  + H N+++L
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 364 LGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NG 421
                + +   +V E    G L +R +     +   F       +       + Y H   
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERVV----HKR-VFRESDAARIMKDVLSAVAYCHKLN 126

Query: 422 CDVCILHFDIKPHNI 436
               + H D+KP N 
Sbjct: 127 ----VAHRDLKPENF 137

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 38/130 (29%), Positives = 57/130 (43%), Gaps = 12/130 (9%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEE-FINEVSTIGRI-HHVNVVQLLGFC 367
           LG+G    V     L T    AVK+++            EV  + +   H NV++L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGCDVCI 426
            E  +  +V+E M  GS+  HI     R   F+  +   V    A  +++LH  G    I
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHI---HKRR-HFNELEASVVVQDVASALDFLHNKG----I 132

Query: 427 LHFDIKPHNI 436
            H D+KP NI
Sbjct: 133 AHRDLKPENI 142

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 61.9 bits (151), Expect = 7e-11
 Identities = 35/155 (22%), Positives = 61/155 (39%), Gaps = 32/155 (20%)

Query: 294 RYSYPEIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE-----FIN 347
           RY   E+          LG GG   V+  + L     +AVK+L+ +  + +      F  
Sbjct: 13  RY---ELGE-------ILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRR 61

Query: 348 EVSTIGRIHHVNVVQLL--GFCSEGSKRAVVY---EYMPNGSLDRHIFPKESRGQSFSWE 402
           E      ++H  +V +   G  +E     + Y   EY+   +L   +          + +
Sbjct: 62  EAQNAAALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPK 116

Query: 403 KLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNI 436
           +  EV     + + + H NG    I+H D+KP NI
Sbjct: 117 RAIEVIADACQALNFSHQNG----IIHRDVKPANI 147

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 39/165 (23%), Positives = 68/165 (41%), Gaps = 29/165 (17%)

Query: 291 MPKRYSYPEIIAMT--NHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVKMLK--NSK---- 339
           M K+Y   E       + +    K+GQG FG V+K +   TG  +A+K +   N K    
Sbjct: 1   MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP 60

Query: 340 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV--------VYEYMPNGSLDRHIFP 391
            +A   + E+  +  + H NVV L+  C   +            V+++  +  L   +  
Sbjct: 61  ITA---LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-- 114

Query: 392 KESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
             +    F+  ++  V      G+ Y+H      ILH D+K  N+
Sbjct: 115 -SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANV 155

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 61.6 bits (150), Expect = 9e-11
 Identities = 28/131 (21%), Positives = 53/131 (40%), Gaps = 10/131 (7%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAE--EFINEVSTIGR-IHHVNVVQLLG 365
           ++G G  G V+K +   TG +IAVK ++ S    E    + ++  + +      +VQ  G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +   +  E M   +       K+          L ++ +   + + YL       
Sbjct: 92  TFITNTDVFIAMELMGTCAEKL----KKRMQGPIPERILGKMTVAIVKALYYLKE--KHG 145

Query: 426 ILHFDIKPHNI 436
           ++H D+KP NI
Sbjct: 146 VIHRDVKPSNI 156

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 39/148 (26%), Positives = 62/148 (41%), Gaps = 26/148 (17%)

Query: 306 HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSA--------------EEFINEVS 350
               KLG G +G V    + +     A+K++K S+F                EE  NE+S
Sbjct: 39  FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 351 TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVAL 409
            +  + H N+++L     +     +V E+   G L ++ I    +R + F       +  
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII----NRHK-FDECDAANIMK 153

Query: 410 GTARGIEYLH-NGCDVCILHFDIKPHNI 436
               GI YLH +     I+H DIKP NI
Sbjct: 154 QILSGICYLHKHN----IVHRDIKPENI 177

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 27/142 (19%), Positives = 54/142 (38%), Gaps = 20/142 (14%)

Query: 306 HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEE---------FINEVSTIGRI 355
             +  LG G  G V    +  T   +A++++   KF+               E+  + ++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 356 HHVNVVQLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARG 414
           +H  ++++  F  +     +V E M  G L D+ +                         
Sbjct: 198 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNK-RLKEATCKLYFYQMLLA 251

Query: 415 IEYLHNGCDVCILHFDIKPHNI 436
           ++YLH   +  I+H D+KP N+
Sbjct: 252 VQYLH---ENGIIHRDLKPENV 270

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 59.1 bits (144), Expect = 4e-10
 Identities = 38/137 (27%), Positives = 55/137 (40%), Gaps = 26/137 (18%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKML-KNSKFSAEEFIN-EVSTIGRIHHVNVVQLLGFC 367
           LG+G +G V       T   +AVK++         E I  E+     ++H NVV+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR--------GIEYLH 419
            EG+ + +  EY   G L   I P            + E     A+        G+ YLH
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPD---------IGMPE---PDAQRFFHQLMAGVVYLH 122

Query: 420 NGCDVCILHFDIKPHNI 436
               + I H DIKP N+
Sbjct: 123 G---IGITHRDIKPENL 136

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 27/134 (20%), Positives = 50/134 (37%), Gaps = 16/134 (11%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE-----FINEVSTIGRIHHVNVVQL 363
            +G+GG G VY+ +      ++A+K++     S++         E  T GR+   +VV +
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGC 422
             F     +  V    +    L   +     R    +  +   +       ++  H  G 
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAAG- 154

Query: 423 DVCILHFDIKPHNI 436
                H D+KP NI
Sbjct: 155 ---ATHRDVKPENI 165

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 59.2 bits (144), Expect = 6e-10
 Identities = 29/129 (22%), Positives = 53/129 (41%), Gaps = 11/129 (8%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFC 367
            LG+G F    K     +    AVK++     +  +   E++ +     H N+V+L    
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVF 75

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
            +     +V E +  G L   I  K+     FS  +   +       + ++H   DV ++
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKKKK----HFSETEASYIMRKLVSAVSHMH---DVGVV 128

Query: 428 HFDIKPHNI 436
           H D+KP N+
Sbjct: 129 HRDLKPENL 137

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 36/133 (27%), Positives = 60/133 (45%), Gaps = 13/133 (9%)

Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
              +LG+G    VY+  Q  T    A+K+LK +    +    E+  + R+ H N+++L  
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 366 FCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGCD 423
                ++ ++V E +  G L DR I  K      +S     +        + YLH NG  
Sbjct: 116 IFETPTEISLVLELVTGGELFDR-IVEKG----YYSERDAADAVKQILEAVAYLHENG-- 168

Query: 424 VCILHFDIKPHNI 436
             I+H D+KP N+
Sbjct: 169 --IVHRDLKPENL 179

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 32/142 (22%), Positives = 56/142 (39%), Gaps = 23/142 (16%)

Query: 309 HKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSA----------EEFINEVSTIGRI-H 356
             LG+G    V +     T    AVK++  +   +          E  + EV  + ++  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGI 415
           H N++QL       +   +V++ M  G L D  +  K     + S ++  ++       I
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDY-LTEK----VTLSEKETRKIMRALLEVI 137

Query: 416 EYLH-NGCDVCILHFDIKPHNI 436
             LH       I+H D+KP NI
Sbjct: 138 CALHKLN----IVHRDLKPENI 155

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 38/137 (27%), Positives = 55/137 (40%), Gaps = 26/137 (18%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKML-KNSKFSAEEFIN-EVSTIGRIHHVNVVQLLGFC 367
           LG+G +G V       T   +AVK++         E I  E+     ++H NVV+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR--------GIEYLH 419
            EG+ + +  EY   G L   I   E          + E     A+        G+ YLH
Sbjct: 75  REGNIQYLFLEYCSGGELFDRI---EPDI------GMPE---PDAQRFFHQLMAGVVYLH 122

Query: 420 NGCDVCILHFDIKPHNI 436
               + I H DIKP N+
Sbjct: 123 G---IGITHRDIKPENL 136

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 37/142 (26%), Positives = 55/142 (38%), Gaps = 30/142 (21%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN-----EVSTIGRIHHVNVVQLL 364
           LG+G +G V +     T    AVK+LK  K             E+  + R+ H NV+QL+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 365 GFCSEGSKRA--VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR--------G 414
                  K+   +V EY   G  +  +             +        A         G
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK------RFPV---CQAHGYFCQLIDG 121

Query: 415 IEYLHNGCDVCILHFDIKPHNI 436
           +EYLH+     I+H DIKP N+
Sbjct: 122 LEYLHS---QGIVHKDIKPGNL 140

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 32/175 (18%), Positives = 52/175 (29%), Gaps = 48/175 (27%)

Query: 306 HFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSA------EEFINEVSTIGRIHHV 358
           H    +GQG +G V    +  T  + A+K++  +K         E    EV  + ++HH 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88

Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR----- 413
           N+ +L     +     +V E    G L   +              + +  +         
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 414 -------------------------------GIEYLH-NGCDVCILHFDIKPHNI 436
                                           + YLH  G    I H DIKP N 
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENF 199

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 32/160 (20%), Positives = 61/160 (38%), Gaps = 36/160 (22%)

Query: 296 SYPEIIAMTNHFTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEE---------F 345
            YP+ +      +  LG G  G V    +  T   +A+K++   KF+             
Sbjct: 3   VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV 62

Query: 346 INEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKL 404
             E+  + +++H  ++++  F  +     +V E M  G L D+ +            E  
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNK-RLK-EA- 114

Query: 405 HEVALGTAR--------GIEYLHNGCDVCILHFDIKPHNI 436
                 T +         ++YLH   +  I+H D+KP N+
Sbjct: 115 ------TCKLYFYQMLLAVQYLH---ENGIIHRDLKPENV 145

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 41/141 (29%), Positives = 65/141 (46%), Gaps = 18/141 (12%)

Query: 308 THKLGQGGFGSVYKGQL-HTGGLIAVK-MLKNSKFSAEEFINEVSTIGRIHHVNVVQLL- 364
               GQG FG+V  G+   TG  +A+K ++++ +F   E +  +  +  +HH N+VQL  
Sbjct: 28  ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQS 86

Query: 365 GFCSEGSKR------AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGT---ARGI 415
            F + G +        VV EY+P+ +L R       R  +        + +      R I
Sbjct: 87  YFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPI---LIKVFLFQLIRSI 142

Query: 416 EYLHNGCDVCILHFDIKPHNI 436
             LH    V + H DIKPHN+
Sbjct: 143 GCLHLPS-VNVCHRDIKPHNV 162

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 31/147 (21%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLK--NSKFSAEEF----INEVSTIGRIH---HVN 359
           ++G G +G+VYK +  H+G  +A+K ++  N            + EV+ + R+    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 360 VVQLLGFCSEGSKRAV-----VYEYMPN---GSLDRHIFPKESRGQ--SFSWEKLHEVAL 409
           VV+L+  C+            V+E++       LD+   P            + L     
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL----- 130

Query: 410 GTARGIEYLHNGCDVCILHFDIKPHNI 436
              RG+++LH     CI+H D+KP NI
Sbjct: 131 ---RGLDFLH---ANCIVHRDLKPENI 151

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 15/159 (9%), Positives = 29/159 (18%), Gaps = 36/159 (22%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFS----AEEFINEVSTIGRIHHVNVVQLLG 365
           L  G    V+    +      A+K+      +     E          R+   +  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 366 FCSEGSKRAV--------------------------VYEYMP--NGSLDRHIFPKESRGQ 397
                                               +          L   +        
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 398 SFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
                 LH +     R    L       ++H    P N+
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNL 225

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 28/138 (20%), Positives = 57/138 (41%), Gaps = 27/138 (19%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN---EVSTIGRIHHVNVVQLLGF 366
           +G+G F  V   + + TG  +A+K++  ++ +         EV  +  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR--------GIEYL 418
                   ++ EY   G +  ++    + G      ++ E     AR         ++Y 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL---VAHG------RMKE---KEARSKFRQIVSAVQYC 130

Query: 419 HNGCDVCILHFDIKPHNI 436
           H      I+H D+K  N+
Sbjct: 131 HQ---KRIVHRDLKAENL 145

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 56.3 bits (136), Expect = 8e-09
 Identities = 29/141 (20%), Positives = 55/141 (39%), Gaps = 22/141 (15%)

Query: 309 HKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSA---------EEFINEVSTIGRIH-H 357
             +G+G    V +     TG   AVK+++ +             E    E   + ++  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
            +++ L+      S   +V++ M  G L D        +  + S ++   +       + 
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKV-ALSEKETRSIMRSLLEAVS 214

Query: 417 YLH-NGCDVCILHFDIKPHNI 436
           +LH N     I+H D+KP NI
Sbjct: 215 FLHANN----IVHRDLKPENI 231

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 32/133 (24%), Positives = 54/133 (40%), Gaps = 15/133 (11%)

Query: 310 KLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLG-F 366
            LG G  G V +     TG   A+K+L +S     +   EV    +     ++V +L  +
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVY 91

Query: 367 CSEGSKRAVVY---EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            +    +  +    E M  G L   I  +    Q+F+  +  E+       I++LH    
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLH---S 146

Query: 424 VCILHFDIKPHNI 436
             I H D+KP N+
Sbjct: 147 HNIAHRDVKPENL 159

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 33/148 (22%), Positives = 63/148 (42%), Gaps = 35/148 (23%)

Query: 310 KLGQGGFGSVYKGQ--LHTGGLIAVKMLK--NSK----FSAEEFINEVST---IGRIHHV 358
           ++G+G +G V+K +   + G  +A+K ++    +     S    I EV+    +    H 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLRHLETFEHP 74

Query: 359 NVVQLL-----GFCSEGSKRAVVYEYMPN---GSLDRH--IFPKESRGQSFSWEKLHEVA 408
           NVV+L            +K  +V+E++       LD+           +   ++ L    
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL---- 130

Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
               RG+++LH      ++H D+KP NI
Sbjct: 131 ----RGLDFLH---SHRVVHRDLKPQNI 151

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 32/135 (23%), Positives = 50/135 (37%), Gaps = 24/135 (17%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
           +G G FG     +   T  L+AVK ++      E    E+     + H N+V+       
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87

Query: 370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR--------GIEYLHNG 421
            +  A++ EY   G L   I    + G      +  E     AR        G+ Y H+ 
Sbjct: 88  PTHLAIIMEYASGGELYERI---CNAG------RFSE---DEARFFFQQLLSGVSYCHS- 134

Query: 422 CDVCILHFDIKPHNI 436
             + I H D+K  N 
Sbjct: 135 --MQICHRDLKLENT 147

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 20/161 (12%), Positives = 45/161 (27%), Gaps = 39/161 (24%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFI----NEVSTIGRI---------- 355
           LGQ    +  +     TG    V +   ++      I     EV  +  +          
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 356 ---------------HHVNVVQLLGFCSEGSKRAVVYEYM----PNGSLDRHIFPKESRG 396
                              ++++     +    +  + Y        +    +    S  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 397 QSFSWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNI 436
           +S       ++ L   R +  LH  G    ++H  ++P +I
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDI 237

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 27/132 (20%), Positives = 57/132 (43%), Gaps = 18/132 (13%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLG-F 366
           KLG+G +  V++   +     + VK+LK      ++   E+  +  +    N++ L    
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIV 100

Query: 367 CSEGSKRAV-VYEYMPNGSLDRHIFP-KESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
               S+    V+E++ N    +      +   + + +E L        + ++Y H+    
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL--------KALDYCHSMG-- 150

Query: 425 CILHFDIKPHNI 436
            I+H D+KPHN+
Sbjct: 151 -IMHRDVKPHNV 161

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 32/137 (23%), Positives = 56/137 (40%), Gaps = 17/137 (12%)

Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLL 364
            +  LG G  G V +     T    A+KML++      +   EV    R     ++V+++
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 121

Query: 365 G-FCSEGSKRAVVY---EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH- 419
             + +  + R  +    E +  G L   I  +    Q+F+  +  E+       I+YLH 
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS 179

Query: 420 NGCDVCILHFDIKPHNI 436
                 I H D+KP N+
Sbjct: 180 IN----IAHRDVKPENL 192

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 21/161 (13%), Positives = 45/161 (27%), Gaps = 39/161 (24%)

Query: 311 LGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFI----NEVSTIGR----------- 354
           LGQ    +  +     TG    V +   ++      I     EV  +             
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 355 -----------IHHVNVVQLLGFCSEGSKRAVVYEY--MP-----NGSLDRHIFPKESRG 396
                      +      +++    +     V+  +   P       +    +    S  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 397 QSFSWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNI 436
           +S       ++ L   R +  LH  G    ++H  ++P +I
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDI 242

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 32/141 (22%), Positives = 51/141 (36%), Gaps = 26/141 (18%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN---------EVSTIGRIHHVNV 360
           LG G FG V+          + VK +K  K   + +I          E++ + R+ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGS-----LDRHIFPKESRGQSFSWEKLHEVALGTARGI 415
           +++L          +V E   +G      +DRH    E        +            +
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ--------LVSAV 143

Query: 416 EYLHNGCDVCILHFDIKPHNI 436
            YL       I+H DIK  NI
Sbjct: 144 GYLRLK---DIIHRDIKDENI 161

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 34/147 (23%), Positives = 58/147 (39%), Gaps = 36/147 (24%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGR-----------IHHV 358
           LG+GGFG+V+ G  L     +A+K++  ++      +++  T                H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 359 NVVQLLGFCSEGSKRAVVYEY-MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR---- 413
            V++LL +        +V E  +P   L  +I     +G       L E   G +R    
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKG------PLGE---GPSRCFFG 146

Query: 414 ----GIEYLHNGCDVCILHFDIKPHNI 436
                I++ H      ++H DIK  NI
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENI 170

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 37/145 (25%), Positives = 55/145 (37%), Gaps = 34/145 (23%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN-------EVSTIGRIHHV--NV 360
           LG GGFGSVY G  +     +A+K ++  + S    +        EV  + ++      V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 361 VQLLGFCSEGSKRAVVYEY-MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR------ 413
           ++LL +        ++ E   P   L   I     RG       L E     AR      
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERG------ALQE---ELARSFFWQV 158

Query: 414 --GIEYLHNGCDVCILHFDIKPHNI 436
              + + HN     +LH DIK  NI
Sbjct: 159 LEAVRHCHN---CGVLHRDIKDENI 180

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 52.2 bits (126), Expect = 8e-08
 Identities = 34/139 (24%), Positives = 59/139 (42%), Gaps = 28/139 (20%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN----EVSTIGRIHHVNVVQLLG 365
           LG G FG V  G+   TG  +AVK+L   K  + + +     E+  +    H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR--------GIEY 417
             S  +   +V EY+  G L  +I             ++ E+    AR         ++Y
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKH---------GRVEEM---EARRLFQQILSAVDY 126

Query: 418 LHNGCDVCILHFDIKPHNI 436
            H      ++H D+KP N+
Sbjct: 127 CHR---HMVVHRDLKPENV 142

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 36/139 (25%), Positives = 59/139 (42%), Gaps = 28/139 (20%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN----EVSTIGRIHHVNVVQLLG 365
           LG G FG V  G+   TG  +AVK+L   K  + + +     E+  +    H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR--------GIEY 417
             S  S   +V EY+  G L  +I             +L E     +R        G++Y
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKN---------GRLDEK---ESRRLFQQILSGVDY 131

Query: 418 LHNGCDVCILHFDIKPHNI 436
            H      ++H D+KP N+
Sbjct: 132 CHR---HMVVHRDLKPENV 147

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 30/143 (20%), Positives = 64/143 (44%), Gaps = 21/143 (14%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV---------- 358
           KLG G F +V+  + +     +A+K+++  K   E   +E+  + R++            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 359 -NVVQLLG-FCSEGSKRA---VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR 413
            ++++LL  F  +G       +V+E +     +     K+   +      + +++     
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVL---GENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 414 GIEYLHNGCDVCILHFDIKPHNI 436
           G++Y+H  C   I+H DIKP N+
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENV 163

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 33/138 (23%), Positives = 57/138 (41%), Gaps = 19/138 (13%)

Query: 307 FTHKLGQGGFGSVYKG-QLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLL 364
            +  LG G  G V +     T    A+KML++      +   EV    R     ++V+++
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 77

Query: 365 G-FCSEGSKRAVVY---EYMPNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
             + +  + R  +    E +  G L  R I  +    Q+F+  +  E+       I+YLH
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSR-IQDR--GDQAFTEREASEIMKSIGEAIQYLH 134

Query: 420 -NGCDVCILHFDIKPHNI 436
                  I H D+KP N+
Sbjct: 135 SIN----IAHRDVKPENL 148

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 36/151 (23%), Positives = 62/151 (41%), Gaps = 38/151 (25%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVN-------- 359
            KLG G F +V+    +     +A+K++K+++   E  ++E+  +  + + +        
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 360 VVQLLG-FCSEGSKRAVVYEYMPNGSLDRHI-------------FPKESRGQSFSWEKLH 405
           VVQLL  F   G           NG    HI             +  +S  Q      + 
Sbjct: 103 VVQLLDDFKISG----------VNG---THICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149

Query: 406 EVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           ++     +G++YLH  C +   H DIKP NI
Sbjct: 150 KIIQQVLQGLDYLHTKCRII--HTDIKPENI 178

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 49.6 bits (119), Expect = 9e-07
 Identities = 34/165 (20%), Positives = 58/165 (35%), Gaps = 56/165 (33%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN---------------------- 347
           +G+G +G V      +     A+K+L   K   +                          
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 348 -----EVSTIGRIHHVNVVQLLGFCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFS 400
                E++ + ++ H NVV+L+    + ++  +  V+E +  G +        +      
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK---- 132

Query: 401 WEKLHEVALGTAR--------GIEYLH-NGCDVCILHFDIKPHNI 436
              L E     AR        GIEYLH       I+H DIKP N+
Sbjct: 133 --PLSED---QARFYFQDLIKGIEYLHYQK----IIHRDIKPSNL 168

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 34/137 (24%), Positives = 59/137 (43%), Gaps = 20/137 (14%)

Query: 311 LGQGGFGSVYKGQLH-TGGLIAVKMLK----NSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           LG+GGFG V+  Q+  TG L A K L       +   +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-- 250

Query: 366 FCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEK----LHEVALGTARGIEYLH 419
             +  +K  +  V   M  G +  HI+  +     F   +      ++      G+E+LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS----GLEHLH 306

Query: 420 NGCDVCILHFDIKPHNI 436
                 I++ D+KP N+
Sbjct: 307 Q---RNIIYRDLKPENV 320

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 35/188 (18%), Positives = 71/188 (37%), Gaps = 64/188 (34%)

Query: 292 PKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN-EV 349
            K+YS  + +          G G FG V +   + +G   A+K +         + N E+
Sbjct: 6   SKKYSLGKTL----------GTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNREL 51

Query: 350 STIGRIHHVNVVQLL-GFCSEGSKRA---------------------------------- 374
             +  + HVN+++L+  F + G +                                    
Sbjct: 52  DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111

Query: 375 ---VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGT---ARGIEYLHNGCDVCILH 428
              V+ EY+P+ +L + +      G+S     ++ +++      R + ++H+   + I H
Sbjct: 112 YLNVIMEYVPD-TLHKVLKSFIRSGRSIP---MNLISIYIYQLFRAVGFIHS---LGICH 164

Query: 429 FDIKPHNI 436
            DIKP N+
Sbjct: 165 RDIKPQNL 172

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 36/136 (26%), Positives = 54/136 (39%), Gaps = 22/136 (16%)

Query: 311 LGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFI----NEVSTIGRIHHVNVVQLLG 365
           LG+G F +V   +   T    A+K+L+      E  +     E   + R+ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK----LHEVALGTARGIEYLH-N 420
              +  K      Y  NG L ++I     +  SF          E+       +EYLH  
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVS----ALEYLHGK 149

Query: 421 GCDVCILHFDIKPHNI 436
           G    I+H D+KP NI
Sbjct: 150 G----IIHRDLKPENI 161

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.5 bits (117), Expect = 2e-06
 Identities = 53/335 (15%), Positives = 97/335 (28%), Gaps = 84/335 (25%)

Query: 18  MFVFSPREIEARKLAVKMCSSSCGDVKNISYPFRLKGDPARCGHPELELS-CESNKTIFE 76
             V   +     + A+     +    KN+     + G     G   + L  C S K   +
Sbjct: 129 YNVSRLQPYLKLRQALLELRPA----KNVL----IDGVLG-SGKTWVALDVCLSYKVQCK 179

Query: 77  FNSGKYYVKRISYDKCTISVVDV--NLAY----GSCSFPSTSFSPP-GLSFSYSFDYNLN 129
            +   +++  +       +V+++   L Y       S    S +    +    +    L 
Sbjct: 180 MDFKIFWLN-LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL 238

Query: 130 SYANYVNC--------SSDIVD--QVSAKVPCLSNNQ-----LNVYVYVGYDLIATSISH 174
               Y NC        ++   +   +S K+   +  +     L+        L   S++ 
Sbjct: 239 KSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL 298

Query: 175 LPD-SCAFISKVPVVLNRSVDKLSYEDLR----------KSLESGFDLTWLDWSWSLSMP 223
            PD   + + K    L+     L  E L           +S+  G   TW +W       
Sbjct: 299 TPDEVKSLLLKY---LDCRPQDLPREVLTTNPRRLSIIAESIRDGLA-TWDNW------- 347

Query: 224 RYCMYNAGVVATII--CY----PYYIR--------FPVDVLIIGRFILAPIVFLVFLIHK 269
           ++   +   + TII        P   R        FP    I       P + L  +   
Sbjct: 348 KHVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI-------PTILLSLIWFD 398

Query: 270 YRTTLQTVDNVEKFLHN----QQSWMPKRYSYPEI 300
                  V  V   LH     ++       S P I
Sbjct: 399 VIK--SDVMVVVNKLHKYSLVEKQPKESTISIPSI 431

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.8 bits (105), Expect = 5e-05
 Identities = 52/409 (12%), Positives = 103/409 (25%), Gaps = 137/409 (33%)

Query: 138 SSDIVDQVSAKVPCLSNNQLN-VYVYVG------YDLIATSISHLP-----DSCAFISKV 185
           S D V         L + Q   V  +V       Y  + + I          +  +I + 
Sbjct: 57  SKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR 116

Query: 186 PVVLN--RSVDKLS------YEDLRKSLES-------------GFDLTWLDWSWSLSMPR 224
             + N  +   K +      Y  LR++L               G   TW+     LS   
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKV 176

Query: 225 YCMYNAGVVATIICYPYYIRF-----PVDVLIIGRFILAPIV------------------ 261
            C  +  +        +++       P  VL + + +L  I                   
Sbjct: 177 QCKMDFKI--------FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228

Query: 262 -----FLVFLIHK-YRTTLQTVDNV------EKFLHNQQ------------SWMPKRYSY 297
                    L  K Y   L  + NV        F  + +                   ++
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTH 288

Query: 298 PEIIAMTNHFTHKLGQGGFGSVYKG-------QLHTGGLIAVKMLKNSKFSAEEFINEVS 350
             +   +   T    +                ++ T     + ++      AE   + ++
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII------AESIRDGLA 342

Query: 351 TIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRH-----IFPKESR--GQSFS--W 401
           T     HVN  +L       +        +      +      +FP  +       S  W
Sbjct: 343 TWDNWKHVNCDKL------TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIW 396

Query: 402 ------------EKLHEVAL---GTARGIEYLHNGCDVCILHFDIKPHN 435
                        KLH+ +L           + +      ++ ++K   
Sbjct: 397 FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS------IYLELKVKL 439

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 32/139 (23%), Positives = 54/139 (38%), Gaps = 29/139 (20%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFIN----EVSTIGRIHHVNVVQLLG 365
           LG+G FG V       T   +A+K +        +       E+S +  + H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTAR--------GIEY 417
             +  +   +V EY   G L  +I  K         +++ E      R         IEY
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEK---------KRMTED---EGRRFFQQIICAIEY 123

Query: 418 LHNGCDVCILHFDIKPHNI 436
            H      I+H D+KP N+
Sbjct: 124 CHR---HKIVHRDLKPENL 139

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 32/140 (22%), Positives = 60/140 (42%), Gaps = 27/140 (19%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV------NVVQL 363
           +G+G FG V K         +A+KM++N K    +   E+  +  +         NV+ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164

Query: 364 LGF-------CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
           L         C       + +E +   S++ +   K+++ Q FS   + + A    + ++
Sbjct: 165 LENFTFRNHIC-------MTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214

Query: 417 YLHNGCDVCILHFDIKPHNI 436
            LH      I+H D+KP NI
Sbjct: 215 ALH---KNRIIHCDLKPENI 231

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 34/137 (24%), Positives = 65/137 (47%), Gaps = 14/137 (10%)

Query: 305 NHF--THKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH-VNV 360
            +F    K+G G FG +  G+ L+T   +A+K+    K  A +   E     ++     +
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM-KSRAPQLHLEYRFYKQLGSGDGI 67

Query: 361 VQLLGFCSEGSKRAVVYEYMPNG-SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
            Q+  F   G   A+V E +  G SL+  +F  +   ++FS + +  +A+     +EY+H
Sbjct: 68  PQVYYFGPCGKYNAMVLELL--GPSLE-DLF--DLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 420 NGCDVCILHFDIKPHNI 436
           +     +++ D+KP N 
Sbjct: 123 S---KNLIYRDVKPENF 136

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 25/132 (18%), Positives = 51/132 (38%), Gaps = 10/132 (7%)

Query: 307 FTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLK-NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
              ++G+G FG +++G  L     +A+K     S             +       +  + 
Sbjct: 14  VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL-LAGCTGIPNVY 72

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
            F  EG    +V + +   SL+  +   +  G+ FS + +   A      ++ +H     
Sbjct: 73  YFGQEGLHNVLVIDLLGP-SLE-DLL--DLCGRKFSVKTVAMAAKQMLARVQSIHE---K 125

Query: 425 CILHFDIKPHNI 436
            +++ DIKP N 
Sbjct: 126 SLVYRDIKPDNF 137

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 33/137 (24%), Positives = 57/137 (41%), Gaps = 14/137 (10%)

Query: 305 NHF--THKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-HVNV 360
           N F    K+G G FG +Y G  + T   +A+K+    K    + + E      +     +
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKIYRILQGGTGI 65

Query: 361 VQLLGFCSEGSKRAVVYEYMPNG-SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
             +  F  EG    +V + +  G SL+  +F      +  S + +  +A      +E++H
Sbjct: 66  PNVRWFGVEGDYNVLVMDLL--GPSLE-DLF--NFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 420 NGCDVCILHFDIKPHNI 436
           +      LH DIKP N 
Sbjct: 121 S---KSFLHRDIKPDNF 134

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 46.7 bits (111), Expect = 8e-06
 Identities = 36/190 (18%), Positives = 64/190 (33%), Gaps = 50/190 (26%)

Query: 268 HKYRTTLQTVDNVEKFLHNQQSW-MPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQ-LH 325
            + R    +             W +P RY             H +G G +G V +     
Sbjct: 27  GQQRKQHHSSKPTASMPRPHSDWQIPDRY----------EIRHLIGTGSYGHVCEAYDKL 76

Query: 326 TGGLIAVKMLKNSKFSAEEF----INEVSTIGRIHHVNVVQLLGFCSEGSKRA-----VV 376
              ++A+K +    F         + E++ + R++H +VV++L               VV
Sbjct: 77  EKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135

Query: 377 YEYMP---------NGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
            E               L + HI       ++  +  L         G++Y+H+     I
Sbjct: 136 LEIADSDFKKLFRTPVYLTELHI-------KTLLYNLL--------VGVKYVHSAG---I 177

Query: 427 LHFDIKPHNI 436
           LH D+KP N 
Sbjct: 178 LHRDLKPANC 187

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 34/137 (24%), Positives = 58/137 (42%), Gaps = 14/137 (10%)

Query: 305 NHF--THKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH-VNV 360
           N +    K+G G FG +Y G  +  G  +A+K+    K    +   E      +   V +
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-KTKHPQLHIESKIYKMMQGGVGI 67

Query: 361 VQLLGFCSEGSKRAVVYEYMPNG-SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
             +    +EG    +V E +  G SL+  +F      + FS + +  +A      IEY+H
Sbjct: 68  PTIRWCGAEGDYNVMVMELL--GPSLE-DLF--NFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 420 NGCDVCILHFDIKPHNI 436
           +      +H D+KP N 
Sbjct: 123 S---KNFIHRDVKPDNF 136

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 34/145 (23%), Positives = 57/145 (39%), Gaps = 26/145 (17%)

Query: 305 NHFT-HK-LGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHH 357
           +HF   + +G+G FG V   Q   T  + A+K +   K            E+  +  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 358 VNVVQLLG-FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK----LHEVALGTA 412
             +V L   F  E     +V + +  G L  H+     +   F  E     + E+ +   
Sbjct: 75  PFLVNLWYSFQDE-EDMFMVVDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMA-- 127

Query: 413 RGIEYLH-NGCDVCILHFDIKPHNI 436
             ++YL        I+H D+KP NI
Sbjct: 128 --LDYLQNQR----IIHRDMKPDNI 146

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 30/154 (19%), Positives = 57/154 (37%), Gaps = 29/154 (18%)

Query: 299 EIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-- 355
           E           +G+G FG V K         +A+K++KN K    +   EV  +  +  
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK 109

Query: 356 ------HHVNVVQLLGF-------CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWE 402
                 +++  V L          C       +V+E +   S + +   + +  +  S  
Sbjct: 110 HDTEMKYYI--VHLKRHFMFRNHLC-------LVFEML---SYNLYDLLRNTNFRGVSLN 157

Query: 403 KLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
              + A      + +L    ++ I+H D+KP NI
Sbjct: 158 LTRKFAQQMCTALLFLATP-ELSIIHCDLKPENI 190

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 23/149 (15%), Positives = 48/149 (32%), Gaps = 29/149 (19%)

Query: 310 KLGQGGFGSVYKGQLHTGGLI---------AVKM-LKNSKFSAE----------EFINEV 349
              +   G +Y+    +             ++K+  K+ +   E            +N+ 
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 350 STIGRIHHVNVVQLLGF-CSEGSKRAVVYEYMPNG-SLDRHIFPKESRGQSFSWEKLHEV 407
             +     + +   +GF   +   R +V   +  G SL        S     S   + +V
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQ-SAL-DVSPKHVLSERSVLQV 164

Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A      +E+LH       +H ++   NI
Sbjct: 165 ACRLLDALEFLHE---NEYVHGNVTAENI 190

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 40/171 (23%), Positives = 71/171 (41%), Gaps = 23/171 (13%)

Query: 278 DNVEKFLHNQQSWMPKRYSYPEIIAMT-NHFTHK--LGQGGFGSVYKGQL-HTGGLIAVK 333
           ++V++FL   +    K++  P       + F     LG G FG V   +   +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 334 MLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHI 389
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 390 FPKESRGQSFSWEK----LHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
                R   FS         ++ L      EYLH    + +++ D+KP N+
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVL----TFEYLH---SLDLIYRDLKPENL 172

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 28/151 (18%), Positives = 56/151 (37%), Gaps = 31/151 (20%)

Query: 309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF------------------SAEEFINEVS 350
             +GQGGFG +Y   +++   +        K                   +  E I +  
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 351 TIGRIHHVNVVQLLGFCSEGSK----RAVVYEYMPNG-SLDRHIFPKESRGQSFSWEKLH 405
              ++ ++ V +  G           R ++ +    G  L   I+  E+  + FS + + 
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQ-KIY--EANAKRFSRKTVL 155

Query: 406 EVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           +++L     +EY+H       +H DIK  N+
Sbjct: 156 QLSLRILDILEYIHE---HEYVHGDIKASNL 183

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 43/192 (22%), Positives = 76/192 (39%), Gaps = 34/192 (17%)

Query: 266 LIHKYRTTLQTVDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFT------HK-LGQGGFGS 318
           L   Y   +      + F    +S    R+   + + +  H T      H+ +G+GGFG 
Sbjct: 145 LFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGE 204

Query: 319 VYKGQL-HTGGLIAVKMLK----NSKFSAEEFINE---VSTIGRIHHVNVVQLLGFCSEG 370
           VY  +   TG + A+K L       K      +NE   +S +       +V +    +  
Sbjct: 205 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM--SYAFH 262

Query: 371 SKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEK----LHEVALGTARGIEYLHNGCDV 424
           +   +  + + M  G L  H+    S+   FS         E+ L    G+E++HN    
Sbjct: 263 TPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIIL----GLEHMHN---R 311

Query: 425 CILHFDIKPHNI 436
            +++ D+KP NI
Sbjct: 312 FVVYRDLKPANI 323

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 36/135 (26%), Positives = 53/135 (39%), Gaps = 18/135 (13%)

Query: 311 LGQGGFGSVYKGQL-HTGGLIAVKMLK----NSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           LG+GGFG V   Q+  TG + A K L+      +      +NE   + +++   VV L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK----LHEVALGTARGIEYLHNG 421
                    +V   M  G L  HI         F   +      E+      G+E LH  
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHI--YHMGQAGFPEARAVFYAAEICC----GLEDLH-- 303

Query: 422 CDVCILHFDIKPHNI 436
               I++ D+KP NI
Sbjct: 304 -RERIVYRDLKPENI 317

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 36/140 (25%), Positives = 59/140 (42%), Gaps = 29/140 (20%)

Query: 311 LGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEV-STIG------RIHHVNVVQ 362
           LG+G FG V   +   TG   A+K+LK     A+   +EV  T+          H  +  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK---DEVAHTLTENRVLQNSRHPFLTA 212

Query: 363 LLGFCS--EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLH----EVALGTARGIE 416
           L    S     +   V EY   G L  H+    SR + FS ++      E+       ++
Sbjct: 213 L--KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVS----ALD 262

Query: 417 YLHNGCDVCILHFDIKPHNI 436
           YLH+  +  +++ D+K  N+
Sbjct: 263 YLHSEKN--VVYRDLKLENL 280

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 23/131 (17%), Positives = 43/131 (32%), Gaps = 9/131 (6%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKM--LKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
             +G+GGFG V++ +        A+K   L N + + E+ + EV  + ++ H  +V+   
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
              E               +D      ES     S     +      R ++       V 
Sbjct: 72  AWLET------PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 426 ILHFDIKPHNI 436
            L        +
Sbjct: 126 QLQPSSPKVYL 136

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 42.1 bits (100), Expect = 2e-04
 Identities = 35/135 (25%), Positives = 59/135 (43%), Gaps = 20/135 (14%)

Query: 311 LGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLG 365
           LG G FG V+  +  H G   A+K+LK          E   +E   +  + H  ++++ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK----LHEVALGTARGIEYLHNG 421
              +  +  ++ +Y+  G L   +     + Q F          EV L     +EYLH+ 
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCL----ALEYLHS- 124

Query: 422 CDVCILHFDIKPHNI 436
            D  I++ D+KP NI
Sbjct: 125 KD--IIYRDLKPENI 137

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 42.2 bits (98), Expect = 2e-04
 Identities = 21/175 (12%), Positives = 44/175 (25%), Gaps = 56/175 (32%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKML---------KNSKFSAEEFINEV---------ST 351
           K+G+G FG V++        +A+K++          + + + EE + E+         S 
Sbjct: 27  KIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 352 IGRIHHVNVVQLLGFC------------------------------SEGSKRAVVYEYMP 381
                    + L                                   +  +  +V E+  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            G     +  K       S      +       +            H D+   N+
Sbjct: 146 GGIDLEQMRTK-----LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 30/137 (21%), Positives = 52/137 (37%), Gaps = 23/137 (16%)

Query: 311 LGQGGFGSVYKGQL-HTGGLIAVKMLKN----SKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           +G+G F  V   ++  TG + A+K++       +     F  E   +       + QL  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL-- 126

Query: 366 FCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEK----LHEVALGTARGIEYLH 419
             +   +  +  V EY   G L   +      G+    E     L E+ +     I+ +H
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLL---SKFGERIPAEMARFYLAEIVMA----IDSVH 179

Query: 420 NGCDVCILHFDIKPHNI 436
               +  +H DIKP NI
Sbjct: 180 R---LGYVHRDIKPDNI 193

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 32/180 (17%), Positives = 54/180 (30%), Gaps = 57/180 (31%)

Query: 286 NQQSW-MPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEE 344
             +   M   Y               +  G +G+V  G    G  +A+K + N+      
Sbjct: 14  IAELHAMQSPY----------TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRT 63

Query: 345 ---FIN---------EVSTIGRIHHVNVVQLLGFCSEGSKRA-----VVYEYM------- 380
                +         E+  +   HH N++ L        + A     +V E M       
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123

Query: 381 ---PNGSL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
                  +  +HI       Q F +  L         G+  LH      ++H D+ P NI
Sbjct: 124 IHDQRIVISPQHI-------QYFMYHIL--------LGLHVLHEA---GVVHRDLHPGNI 165

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 38/157 (24%), Positives = 65/157 (41%), Gaps = 34/157 (21%)

Query: 292 PKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKN---SKFSAEEFIN 347
           PK Y  P  +          G G +GSV       +G  +A+K L     S+  A+    
Sbjct: 23  PKTYVSPTHV----------GSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR 72

Query: 348 EVSTIGRIHHVNVVQLLG-FCSEGSKRA-----VVYEYMPNGSLDRHI--FPKESRGQSF 399
           E+  +  + H NV+ LL  F    S R      +V  +M    L + +     E + Q  
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYL 131

Query: 400 SWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            ++ L        +G++Y+H+     ++H D+KP N+
Sbjct: 132 VYQML--------KGLKYIHSAG---VVHRDLKPGNL 157

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 33/135 (24%), Positives = 56/135 (41%), Gaps = 21/135 (15%)

Query: 311 LGQGGFGSVYKGQL-HTGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLG 365
           +G+G FG V   +   T  + A+K+L       +  +  F  E   +   +   VVQL  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136

Query: 366 FCSEGSKRAVVYEYMPNGSL----DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
              +     +V EYMP G L      +  P E   + +      EV L     ++ +H+ 
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVP-EKWARFY----TAEVVLA----LDAIHS- 186

Query: 422 CDVCILHFDIKPHNI 436
             +  +H D+KP N+
Sbjct: 187 --MGFIHRDVKPDNM 199

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 30/135 (22%), Positives = 51/135 (37%), Gaps = 19/135 (14%)

Query: 311 LGQGGFGSVYKGQL-HTGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLG 365
           +G+G FG V   +L +   + A+K+L       +     F  E   +       +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK----LHEVALGTARGIEYLHNG 421
              + +   +V +Y   G L   +   E R      E     L E+ +     I+ +H  
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDR---LPEEMARFYLAEMVIA----IDSVHQ- 193

Query: 422 CDVCILHFDIKPHNI 436
             +  +H DIKP NI
Sbjct: 194 --LHYVHRDIKPDNI 206

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 41.0 bits (97), Expect = 5e-04
 Identities = 36/143 (25%), Positives = 61/143 (42%), Gaps = 34/143 (23%)

Query: 311 LGQGGFGSVY----KGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIG------RIHHVNV 360
           LGQG FG V+            L A+K+LK +        + V T         ++H  +
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHPFI 88

Query: 361 VQLLGFCS--EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEK----LHEVALGTARG 414
           V+L    +     K  ++ +++  G L   +    S+   F+ E     L E+AL     
Sbjct: 89  VKL--HYAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELAL----A 138

Query: 415 IEYLH-NGCDVCILHFDIKPHNI 436
           +++LH  G    I++ D+KP NI
Sbjct: 139 LDHLHSLG----IIYRDLKPENI 157

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 29/148 (19%), Positives = 56/148 (37%), Gaps = 30/148 (20%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKN-----------SKF----SAEEFINEVSTIG 353
           K+G GGFG +Y     +     A  ++K             KF    + ++ I +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 354 RIHHVNVVQLLGF----CSEGSKRAVVYEYMPNG-SLDRHIFPKESRGQSFSWEKLHEVA 408
           ++ ++ +    G         S R +V E +  G  L   I   ++   +F    + ++ 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ-KIS-GQNG--TFKKSTVLQLG 157

Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
           +     +EY+H       +H DIK  N+
Sbjct: 158 IRMLDVLEYIHE---NEYVHGDIKAANL 182

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 40.5 bits (95), Expect = 8e-04
 Identities = 28/174 (16%), Positives = 57/174 (32%), Gaps = 48/174 (27%)

Query: 283 FLHNQQSW-MPKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKN--- 337
           +    ++  +P  Y             H +G+G +G VY     +T   +A+K +     
Sbjct: 15  YFQGIKNVHVPDNY----------IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE 64

Query: 338 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA-----VVYEYMP---------NG 383
                +  + E++ + R+    +++L                +V E              
Sbjct: 65  DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI 124

Query: 384 SL-DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L + HI       ++  +  L         G  ++H      I+H D+KP N 
Sbjct: 125 FLTEEHI-------KTILYNLL--------LGENFIHESG---IIHRDLKPANC 160

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 29/140 (20%), Positives = 53/140 (37%), Gaps = 26/140 (18%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-----HHVNVVQL 363
           K+G G FG V   Q +      AVK+++N K        E   + +I     ++ N+V+ 
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101

Query: 364 LGF-------CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIE 416
            G        C       +++E +       +     +    F  E +    +   + + 
Sbjct: 102 HGKFMYYDHMC-------LIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 417 YLHNGCDVCILHFDIKPHNI 436
           YL     + + H D+KP NI
Sbjct: 152 YLR---KMSLTHTDLKPENI 168

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	436
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.95
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.95
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.95
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.95
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.94
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.94
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.94
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.94
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.94
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.94
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.94
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.93
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.93
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.93
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.92
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.91
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.91
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.9
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.89
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.87
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.87
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.87
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.87
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.87
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.87
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.87
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.86
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.86
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.86
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.86
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.86
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.86
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.86
3uqc_A	286	Probable conserved transmembrane protein; structur	99.86
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.86
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.86
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.86
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.86
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.86
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.86
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.85
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.85
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.85
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.85
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.85
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.85
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.85
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.85
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.85
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.85
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.85
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.85
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.85
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.85
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.85
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.85
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.85
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.85
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.85
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.84
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.84
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.84
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.84
3niz_A	311	Rhodanese family protein; structural genomics, str	99.84
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.84
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.84
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.84
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.84
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.84
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.84
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.84
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.84
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.84
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.84
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.84
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.84
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.84
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.84
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.84
3bhy_A	283	Death-associated protein kinase 3; death associate	99.84
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.84
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.84
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.84
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.84
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.84
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.84
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.84
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.84
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.84
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.84
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.84
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.83
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.83
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.83
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.83
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.83
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.83
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.83
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.83
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.83
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.83
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.83
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.83
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.83
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.83
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.83
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.83
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.83
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.83
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.83
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.83
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.83
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.83
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.83
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.83
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.83
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.83
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.83
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.83
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.83
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.82
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.82
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.82
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.82
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.82
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.82
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.82
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.82
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.82
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.82
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.82
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.82
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.82
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.82
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.82
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.82
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.82
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.82
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.82
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.82
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.82
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.82
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.82
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.82
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.82
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.82
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.82
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.82
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.82
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.81
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.81
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.81
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.81
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.81
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.81
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.81
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.81
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.81
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.81
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.81
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.81
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.81
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.81
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.81
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.81
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.81
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.81
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.81
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.81
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.81
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.81
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.81
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.81
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.81
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.81
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.81
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.81
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.8
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.8
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.8
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.8
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.8
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.8
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.8
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.8
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.8
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.8
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.8
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.8
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.8
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.8
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.8
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.8
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.8
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.8
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.8
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.8
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.79
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.79
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.79
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.79
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.79
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.79
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.79
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.79
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.79
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.79
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.79
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.79
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.79
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.78
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.78
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.78
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.78
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.78
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.78
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.78
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.78
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.78
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.78
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.78
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.77
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.77
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.77
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.77
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.77
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.77
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.77
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.77
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.77
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.76
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.76
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.76
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.76
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.76
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.76
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.76
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.75
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.75
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.75
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.75
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.75
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.75
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.74
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.74
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.74
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.74
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.74
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.74
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.72
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.72
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.7
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.62
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.59
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.53
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.92
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.64
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.57
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.78
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.61
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.48
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.44
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.38
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.15
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.01
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.64
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.45
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.96
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	95.89
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	93.34
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	89.16
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	87.08
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	86.83
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	86.53
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	86.28
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	85.24
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.13
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	82.07

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.95  E-value=4.6e-29  Score=235.13  Aligned_cols=133  Identities=26%  Similarity=0.477  Sum_probs=112.9

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      .+..+.+.+.||+|+||+||+|++.      ++..||||+++... ...++|.+|+++|++++|||||+++|++.+++..
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            3445667899999999999999853      46789999997632 3346799999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKE---------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|||||+++|+|.++|+...         .....++|.++++++.|+++||+|||++   +||||||||+||
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NI  159 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNC  159 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhE
Confidence            99999999999999996431         2345799999999999999999999998   999999999997

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.95  E-value=6.6e-29  Score=235.07  Aligned_cols=138  Identities=28%  Similarity=0.473  Sum_probs=117.6

Q ss_pred             ChHHHHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEE
Q 041073          296 SYPEIIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFC  367 (436)
Q Consensus       296 ~~~~i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~  367 (436)
                      .+.|+...++++.++||+|+||+||+|.+.      +++.||||+++..  ....++|.+|+.+|++++|||||+++|++
T Consensus        19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            344555567788899999999999999853      4678999999763  33457899999999999999999999999


Q ss_pred             EeCCeeeEEEecCCCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          368 SEGSKRAVVYEYMPNGSLDRHIFPKES------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       368 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      .+++..+|||||+++|+|.++|..+..            ....++|.++.+++.||++||+|||++   +||||||||+|
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~N  175 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRN  175 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccc
Confidence            999999999999999999999964321            124689999999999999999999998   99999999999


Q ss_pred             C
Q 041073          436 I  436 (436)
Q Consensus       436 I  436 (436)
                      |
T Consensus       176 I  176 (308)
T 4gt4_A          176 V  176 (308)
T ss_dssp             E
T ss_pred             e
Confidence            7

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.95  E-value=2.3e-28  Score=233.51  Aligned_cols=132  Identities=29%  Similarity=0.505  Sum_probs=114.0

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCc-ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ...+.+.++||+|+||+||+|+++      ++..||||+++.. ....++|.+|+++|++++|||||+++|++.+.+..+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            344567789999999999999854      4678999999763 333567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKES-----------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||||+++|+|.++++....           ....++|.++++++.|+++||+|||++   +||||||||+||
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NI  189 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNC  189 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhE
Confidence            99999999999999965321           124699999999999999999999998   999999999997

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.95  E-value=6.1e-28  Score=231.01  Aligned_cols=128  Identities=27%  Similarity=0.381  Sum_probs=108.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +|.+.+.||+|+||+||+++. .+++.||||+++.....   .+.+.+|+++|++++|||||++++++.+++..+|||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            577889999999999999985 47899999999764332   45689999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.++|..+  +...+++.+++.++.||+.||+|||++   +||||||||+||
T Consensus       105 ~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NI  156 (350)
T 4b9d_A          105 CEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNI  156 (350)
T ss_dssp             CTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGE
T ss_pred             CCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHE
Confidence            9999999999532  345689999999999999999999998   999999999997

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.94  E-value=6.1e-28  Score=227.32  Aligned_cols=126  Identities=27%  Similarity=0.322  Sum_probs=114.7

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|++.+.||+|+||+||+++. .+++.||+|++++.    ....+.+.+|+++|++++|||||++++++.+.+..+||||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            578889999999999999985 47899999999752    3345779999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++.    +.+.+++..+..++.||+.||+|||++   +|+||||||+||
T Consensus       113 y~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNI  163 (311)
T 4aw0_A          113 YAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENI  163 (311)
T ss_dssp             CCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHe
Confidence            999999999994    335799999999999999999999998   999999999997

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.94  E-value=7e-28  Score=227.26  Aligned_cols=129  Identities=36%  Similarity=0.618  Sum_probs=111.1

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      |+....+.+.++||+|+||+||+|+++  ..||||+++....   ..+.|.+|+.+|++++|||||+++|++.+ +..+|
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            455556678899999999999999865  3599999875333   34579999999999999999999998754 56899


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++|+|.++++..   ...+++.++..++.||++||+|||++   +||||||||+||
T Consensus       109 VmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NI  163 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNI  163 (307)
T ss_dssp             EEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSE
T ss_pred             EEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHE
Confidence            99999999999999532   35699999999999999999999998   999999999997

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.94  E-value=9.3e-28  Score=229.40  Aligned_cols=125  Identities=27%  Similarity=0.377  Sum_probs=112.6

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc-ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .|++.++||+|+||+||+|..+ +|+.||||+++.. ....+.+.+|+.+|+.++|||||++++++.+++..+|||||++
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  154 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  154 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            4667788999999999999964 7899999999763 3344568899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|+|.+++.     ...+++.++..++.||+.||+|||++   +||||||||+||
T Consensus       155 gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NI  201 (346)
T 4fih_A          155 GGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSI  201 (346)
T ss_dssp             TEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHE
Confidence            999999983     24699999999999999999999998   999999999997

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.94  E-value=2.7e-27  Score=221.57  Aligned_cols=126  Identities=26%  Similarity=0.385  Sum_probs=108.5

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEe----CCeeeEEE
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRAVVY  377 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  377 (436)
                      ++.++||+|+||+||+|... ++..||+|++.....   ..+.+.+|+++|++++|||||++++++.+    .+..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            46678999999999999854 788999999976433   34569999999999999999999999865    34579999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++.    +...+++..+..++.||+.||+|||++ .++||||||||+||
T Consensus       109 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NI  162 (290)
T 3fpq_A          109 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNI  162 (290)
T ss_dssp             ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGE
T ss_pred             eCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhhe
Confidence            9999999999994    335799999999999999999999987 22399999999997

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.94  E-value=4.1e-27  Score=230.47  Aligned_cols=126  Identities=27%  Similarity=0.370  Sum_probs=113.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc-ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ..|++.++||+|+||.||+|..+ +|+.||||+++.. ....+.+.+|+.+|+.++|||||++++++.+++..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            34667789999999999999964 7899999999763 334566899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++.     ...+++.++..++.||+.||+|||++   +||||||||+||
T Consensus       231 ~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NI  278 (423)
T 4fie_A          231 EGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSI  278 (423)
T ss_dssp             TTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTE
T ss_pred             CCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHE
Confidence            9999999983     24599999999999999999999998   999999999997

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.94  E-value=5.2e-27  Score=223.52  Aligned_cols=122  Identities=27%  Similarity=0.366  Sum_probs=109.3

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      .+.+.++||+|+||.||+|+. .+++.||||+++.....    .+|+.+|+.++|||||++++++.+++..+|||||+++
T Consensus        59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  134 (336)
T 4g3f_A           59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG  134 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence            345567899999999999995 47899999999765432    4699999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.    +.+.+++..+..++.|++.||+|||++   +||||||||+||
T Consensus       135 g~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NI  181 (336)
T 4g3f_A          135 GSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNV  181 (336)
T ss_dssp             CBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGE
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHE
Confidence            99999994    235799999999999999999999998   999999999997

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.94  E-value=7.2e-27  Score=216.87  Aligned_cols=126  Identities=23%  Similarity=0.338  Sum_probs=108.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      .+|++.+.||+|+||+||++.. .+++.||+|++++..    ...+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            3577889999999999999985 478999999997532    23457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+ +|+|.+++..    ...+++.++..++.|++.||+|||++   +|+||||||+||
T Consensus        93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NI  143 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENL  143 (275)
T ss_dssp             ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTE
T ss_pred             eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHe
Confidence            999 6799999842    35799999999999999999999998   999999999997

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.93  E-value=1e-26  Score=220.10  Aligned_cols=127  Identities=26%  Similarity=0.358  Sum_probs=106.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCC----eeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~E~  379 (436)
                      ++.+.++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++|||||+++|++.+++    ..+|||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            455678999999999999987 4889999999764433333455677777899999999999997654    57999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG-----CDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-----~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++..     ..++|+.+.+++.|+++||+|||++     .+++||||||||+||
T Consensus        83 ~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NI  139 (303)
T 3hmm_A           83 HEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  139 (303)
T ss_dssp             CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGE
T ss_pred             CCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccE
Confidence            999999999942     4589999999999999999999975     245899999999997

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.93  E-value=3e-27  Score=222.45  Aligned_cols=127  Identities=24%  Similarity=0.278  Sum_probs=107.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      ..|++.+.||+|+||+||+++..    +++.||+|+++...   ....++.+|+++|++++|||||++++++.+++..+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            45778899999999999999852    56789999997632   223468889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++|+|.+++.    +...+++.++..++.|++.||+|||++   +|+||||||+||
T Consensus       104 vmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NI  157 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENI  157 (304)
T ss_dssp             EECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGE
T ss_pred             EEEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHe
Confidence            999999999999994    335799999999999999999999998   999999999997

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.93  E-value=3.4e-26  Score=215.75  Aligned_cols=129  Identities=21%  Similarity=0.334  Sum_probs=106.8

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCC---------
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS---------  371 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  371 (436)
                      .|++.+.||+|+||+||+|+.+ +++.||||+++...  ...+.+.+|+++|++++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            4667799999999999999854 78899999987533  23457899999999999999999999987544         


Q ss_pred             ---eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 ---KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                         ..++||||+++|+|.+++..+. .....++..++.++.|+++||+|||++   +||||||||+||
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NI  149 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNI  149 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHe
Confidence               3689999999999999995432 223456777889999999999999998   999999999997

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.92  E-value=4.6e-26  Score=219.38  Aligned_cols=136  Identities=29%  Similarity=0.420  Sum_probs=114.1

Q ss_pred             HHHHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCc-CcccceeEEEE
Q 041073          298 PEIIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHH-VNVVQLLGFCS  368 (436)
Q Consensus       298 ~~i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h-~niv~l~~~~~  368 (436)
                      +|+....+++.+.||+|+||+||+|...      +++.||||+++....  ..+.+.+|+++|+++.| ||||+++|++.
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            3566678888899999999999999854      235799999976432  34579999999999965 89999999987


Q ss_pred             eC-CeeeEEEecCCCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          369 EG-SKRAVVYEYMPNGSLDRHIFPKES------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       369 ~~-~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      +. +..+||||||++|+|.++|+....            ....+++.+++.++.||++||+|||++   +||||||||+|
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N  215 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN  215 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence            64 568999999999999999964321            134589999999999999999999998   99999999999


Q ss_pred             C
Q 041073          436 I  436 (436)
Q Consensus       436 I  436 (436)
                      |
T Consensus       216 I  216 (353)
T 4ase_A          216 I  216 (353)
T ss_dssp             E
T ss_pred             e
Confidence            7

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.91  E-value=6.9e-25  Score=214.72  Aligned_cols=125  Identities=23%  Similarity=0.404  Sum_probs=109.1

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEe------CCee
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKR  373 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  373 (436)
                      +|.+.+.||+|+||+||+|.. .+|+.||||+++.....   .+.+.+|+++|+.++|||||++++++..      .+..
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            477789999999999999985 47899999999764332   3568899999999999999999998764      3568


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|||||++ |+|.+++.    +.+.+++..+..++.||+.||+|||++   +||||||||+||
T Consensus       135 ~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NI  189 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNL  189 (398)
T ss_dssp             EEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGE
T ss_pred             EEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCcccc
Confidence            99999995 68999983    346799999999999999999999998   999999999997

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.91  E-value=2.6e-24  Score=208.27  Aligned_cols=123  Identities=22%  Similarity=0.320  Sum_probs=110.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|++.+.||+|+||+||+|+.+    +++.||+|.+.... ...++.+|+++|+.+ +||||+++++++.+.+..++||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm   99 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM   99 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence            45778899999999999999743    46789999986543 456788999999988 6999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++       ..+++.++..++.|++.||+|||++   +|+||||||+||
T Consensus       100 E~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNi  148 (361)
T 4f9c_A          100 PYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNF  148 (361)
T ss_dssp             ECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             eCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHe
Confidence            999999999998       3589999999999999999999998   999999999997

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.90  E-value=4.3e-24  Score=219.00  Aligned_cols=128  Identities=24%  Similarity=0.400  Sum_probs=114.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .+|.+.+.||+|+||.||++..+ +|+.||+|++.... ...+.+.+|+.+|+.++|||||++++++.+.+..+|||||+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            35778899999999999999854 78999999987643 33567889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++..   +...+++.++..++.||+.||+|||++   +|+||||||+||
T Consensus       237 ~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Ni  286 (573)
T 3uto_A          237 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENI  286 (573)
T ss_dssp             CCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhc
Confidence            99999999842   335799999999999999999999998   999999999997

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.89  E-value=1.2e-23  Score=215.32  Aligned_cols=126  Identities=26%  Similarity=0.336  Sum_probs=108.6

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHH---HHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFIN---EVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      .|.+.+.||+|+||.||+++.+ +++.||+|++++.    ........+   ++.+++.++|||||++++++.+.+.++|
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl  269 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF  269 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence            3567789999999999999954 7899999999752    222333333   4667788899999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||++||+|.++|.    +.+.+++..++.++.||+.||+|||++   +||||||||+||
T Consensus       270 VmEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNI  323 (689)
T 3v5w_A          270 ILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANI  323 (689)
T ss_dssp             EECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGE
T ss_pred             EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHe
Confidence            999999999999994    335799999999999999999999998   999999999997

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.87  E-value=2.2e-22  Score=187.10  Aligned_cols=128  Identities=29%  Similarity=0.553  Sum_probs=117.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      ..+++.+.||+|+||.||++...+++.||+|++.......+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   89 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence            45677899999999999999988888999999988777778899999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        90 ~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Ni  137 (269)
T 4hcu_A           90 GCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNC  137 (269)
T ss_dssp             CBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             CcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheE
Confidence            999999843   335689999999999999999999998   999999999997

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.87  E-value=4.5e-22  Score=190.04  Aligned_cols=130  Identities=38%  Similarity=0.711  Sum_probs=115.7

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      .|++.+.||+|+||.||+|..++++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus        40 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  119 (321)
T 2qkw_B           40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN  119 (321)
T ss_dssp             CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred             ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence            455678899999999999998889999999987643 3356799999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.........+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Ni  170 (321)
T 2qkw_B          120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINI  170 (321)
T ss_dssp             CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTE
T ss_pred             CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHE
Confidence            999999965443445699999999999999999999998   999999999997

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.87  E-value=2.6e-22  Score=194.26  Aligned_cols=133  Identities=25%  Similarity=0.364  Sum_probs=116.7

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc------ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS------KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      ....|.+.+.||+|+||.||++..+ +++.||+|+++..      ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4567888899999999999999854 7889999998642      22467899999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++++|.+++.........+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NI  161 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCV  161 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHe
Confidence            999999999999888754333345689999999999999999999998   999999999997

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.87  E-value=4.3e-22  Score=190.25  Aligned_cols=128  Identities=20%  Similarity=0.285  Sum_probs=114.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      ..|.+.+.||+|+||.||++... +++.+|+|.+.......+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   84 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence            35667789999999999999865 67889999997665555678999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        85 g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NI  133 (321)
T 1tki_A           85 GLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENI  133 (321)
T ss_dssp             CCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHE
Confidence            9999999932   334699999999999999999999998   999999999997

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.87  E-value=1.1e-21  Score=187.53  Aligned_cols=136  Identities=25%  Similarity=0.334  Sum_probs=117.1

Q ss_pred             CccChHHHHHHh------------hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc-ccCHHHHHHHHHHHcCCCcC
Q 041073          293 KRYSYPEIIAMT------------NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHV  358 (436)
Q Consensus       293 ~~~~~~~i~~~~------------~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~  358 (436)
                      ..+++.++...+            ++..+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            446666665544            334568999999999999965 7899999999763 34567799999999999999


Q ss_pred             cccceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       359 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++++...+..++||||+++++|.+++.     ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  172 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI  172 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            99999999999999999999999999999982     24699999999999999999999998   999999999997

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.87  E-value=5.9e-22  Score=188.20  Aligned_cols=128  Identities=27%  Similarity=0.453  Sum_probs=113.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecC-cccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .++.+.+.||+|+||.||++... +++.+|+|.+.. .....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            45667789999999999999964 688999998865 3334567999999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        90 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Ni  139 (310)
T 3s95_A           90 KGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNC  139 (310)
T ss_dssp             TTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             CCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeE
Confidence            99999999943   245699999999999999999999998   999999999997

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.87  E-value=7.6e-22  Score=191.47  Aligned_cols=127  Identities=29%  Similarity=0.405  Sum_probs=114.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc-------CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ..|.+.+.||+|+||.||++... +++.||+|+++....       ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            45677899999999999999965 688999999976322       3567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        92 lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NI  146 (361)
T 2yab_A           92 LILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENI  146 (361)
T ss_dssp             EEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            9999999999999993    345799999999999999999999998   999999999996

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.86  E-value=1.4e-22  Score=188.21  Aligned_cols=130  Identities=28%  Similarity=0.459  Sum_probs=118.1

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ...++.+.+.||+|+||.||++..+++..||+|+++......+++.+|++++++++||||+++++++...+..++||||+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            34567788999999999999999888888999999887777788999999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        86 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Ni  135 (268)
T 3sxs_A           86 SNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNC  135 (268)
T ss_dssp             TTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGE
T ss_pred             CCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceE
Confidence            99999999843   234589999999999999999999998   999999999997

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.86  E-value=2.7e-22  Score=187.92  Aligned_cols=132  Identities=31%  Similarity=0.481  Sum_probs=116.7

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ++...++.+.+.||+|+||.||++...++..||+|+++......+++.+|++++++++|+||+++++++...+..++|||
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            34456777889999999999999998888899999998877777889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Ni  151 (283)
T 3gen_A          100 YMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNC  151 (283)
T ss_dssp             CCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGE
T ss_pred             ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceE
Confidence            99999999999432   34699999999999999999999998   999999999997

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.86  E-value=3.4e-22  Score=191.15  Aligned_cols=145  Identities=41%  Similarity=0.703  Sum_probs=123.6

Q ss_pred             CCccChHHHHHH--hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEE
Q 041073          292 PKRYSYPEIIAM--TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFC  367 (436)
Q Consensus       292 ~~~~~~~~i~~~--~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~  367 (436)
                      ...+++.++...  .|.+.+.||+|+||.||++...+++.||+|++.....  ....+.+|+++++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            345677776654  4555688999999999999987889999999876322  223689999999999999999999999


Q ss_pred             EeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       368 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...+..++||||+++|+|.+++.........+++..+..++.|++.||+|||++++++|+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni  165 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI  165 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence            999999999999999999999976555556799999999999999999999997666899999999997

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.86  E-value=1.3e-22  Score=201.43  Aligned_cols=128  Identities=20%  Similarity=0.210  Sum_probs=111.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..+.+.+.||+|+||+||+++.+ +++.||+|++++.    ....+.+.+|..++..++||||+++++++.+.+..++||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            35666789999999999999965 5788999999652    122234889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       154 Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NI  206 (437)
T 4aw2_A          154 DYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNI  206 (437)
T ss_dssp             CCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             ecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHe
Confidence            99999999999943   235699999999999999999999998   999999999997

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.86  E-value=3.2e-22  Score=191.65  Aligned_cols=126  Identities=19%  Similarity=0.357  Sum_probs=112.9

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      .|.+.+.||+|+||.||++.. .+++.||+|++......   .+.+.+|+++++.++||||+++++++...+..++||||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~   95 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY   95 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence            466779999999999999996 58899999999764333   35688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        96 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NI  145 (328)
T 3fe3_A           96 ASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENL  145 (328)
T ss_dssp             CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHE
Confidence            999999999843    35699999999999999999999998   999999999997

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.86  E-value=6.7e-22  Score=186.81  Aligned_cols=126  Identities=28%  Similarity=0.390  Sum_probs=113.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecC-cccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .+|.+.+.||+|+||.||++.. .+++.||+|++.. .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            3566778999999999999984 5788999999875 3345677899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++..     ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       100 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Ni  147 (297)
T 3fxz_A          100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNI  147 (297)
T ss_dssp             TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHE
Confidence            99999999832     3589999999999999999999998   999999999997

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.86  E-value=1.5e-21  Score=186.95  Aligned_cols=129  Identities=30%  Similarity=0.409  Sum_probs=115.2

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-------cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCe
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  372 (436)
                      ....|.+.+.||+|+||.||++... +++.||+|+++...       ...+.+.+|+.+++.++||||+++++++.....
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3456788899999999999999965 68899999987532       135779999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NI  145 (326)
T 2y0a_A           89 VILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENI  145 (326)
T ss_dssp             EEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             EEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHE
Confidence            999999999999999993    335699999999999999999999998   999999999997

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.86  E-value=7.3e-22  Score=185.52  Aligned_cols=128  Identities=14%  Similarity=0.063  Sum_probs=112.0

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC----HHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      +...+|.+.+.||+|+||.||++... +++.||+|+++.....    .+.+.+|+..+++++|+||+++++++...+..+
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44566888899999999999999965 5889999999764332    267899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++++|.+++.    + . ....++.+++.|++.||+|||++   +|+||||||+||
T Consensus       108 lv~e~~~g~~L~~~l~----~-~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NI  160 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVAD----T-S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRV  160 (286)
T ss_dssp             EEEECCCEEEHHHHHT----T-C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGE
T ss_pred             EEEEecCCCCHHHHHh----c-C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccE
Confidence            9999999999999982    1 2 35667889999999999999998   999999999997

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.86  E-value=5.1e-22  Score=192.87  Aligned_cols=127  Identities=24%  Similarity=0.318  Sum_probs=115.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .+|.+.+.||+|+||.||++... +++.||+|++.......+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            45778899999999999999965 78899999998765555778999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       100 ~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Ni  147 (361)
T 3uc3_A          100 GGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENT  147 (361)
T ss_dssp             SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGE
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            9999999832    34699999999999999999999998   999999999997

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.86  E-value=3.7e-22  Score=191.03  Aligned_cols=132  Identities=31%  Similarity=0.498  Sum_probs=114.4

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  372 (436)
                      ++...+|.+.+.||+|+||.||+|...    .+..||||+++...  ...+.+.+|+.+++.++||||+++++++..++.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            344566778899999999999999964    34459999997632  234568999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+++|+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  182 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNV  182 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceE
Confidence            9999999999999999843   335699999999999999999999998   999999999997

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.86  E-value=3.5e-22  Score=202.10  Aligned_cols=135  Identities=30%  Similarity=0.437  Sum_probs=120.7

Q ss_pred             hHHHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          297 YPEIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       297 ~~~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      ..++....+.+.+.||+|+||.||+|..+ ++..||||.++......+++.+|+.+|++++||||+++++++...+..++
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            34555667788899999999999999976 47889999998876678889999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++|+|.+++...  ....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus       294 v~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NI  349 (495)
T 1opk_A          294 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNC  349 (495)
T ss_dssp             EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhE
Confidence            99999999999999532  235689999999999999999999998   999999999997

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.86  E-value=6.8e-22  Score=190.04  Aligned_cols=127  Identities=25%  Similarity=0.317  Sum_probs=113.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..+++.+.||+|+||.||+++.+ +++.||+|+++..    ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            35667789999999999999865 7889999999752    335567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        85 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NI  136 (337)
T 1o6l_A           85 EYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENL  136 (337)
T ss_dssp             ECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGE
T ss_pred             eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHE
Confidence            9999999999883    235689999999999999999999998   999999999997

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.86  E-value=1.7e-21  Score=186.40  Aligned_cols=130  Identities=19%  Similarity=0.325  Sum_probs=109.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCC--------
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--------  371 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  371 (436)
                      ..|++.+.||+|+||.||+++.+ +++.||||+++...  ...+.+.+|++++++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            45677899999999999999965 78899999997532  23467999999999999999999999886543        


Q ss_pred             -------------------------------------------------eeeEEEecCCCCChhhhccCCCCCCCCCCHH
Q 041073          372 -------------------------------------------------KRAVVYEYMPNGSLDRHIFPKESRGQSFSWE  402 (436)
Q Consensus       372 -------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~  402 (436)
                                                                       ..++||||+++++|.+++.... .....++.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~  164 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG  164 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence                                                             3799999999999999995432 22446777


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          403 KLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       403 ~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++.++.|+++||+|||++   +|+||||||+||
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  195 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNI  195 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccE
Confidence            8899999999999999998   999999999997

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.85  E-value=3e-22  Score=195.38  Aligned_cols=131  Identities=31%  Similarity=0.485  Sum_probs=113.6

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      +....+.+.+.||+|+||.||+|+..    ++..||||.++...  ...+++.+|+.++++++||||+++++++...+..
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            34456777899999999999999854    56679999997632  2345799999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++|+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       122 ~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  178 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNI  178 (373)
T ss_dssp             EEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceE
Confidence            999999999999999943   335699999999999999999999998   999999999997

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.85  E-value=1.3e-21  Score=186.60  Aligned_cols=127  Identities=24%  Similarity=0.342  Sum_probs=113.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|++.+.||+|+||.||+++.. +++.||+|+++..    ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            35667789999999999999865 7889999999753    234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        86 e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NI  137 (318)
T 1fot_A           86 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENI  137 (318)
T ss_dssp             CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGE
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheE
Confidence            9999999999994    235689999999999999999999998   999999999997

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.85  E-value=2.2e-21  Score=188.43  Aligned_cols=129  Identities=24%  Similarity=0.361  Sum_probs=115.2

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ....|.+.+.||+|+||.||++..+ +++.||+|++......   .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567888899999999999999864 6889999999764433   35688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       107 ~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NI  159 (362)
T 2bdw_A          107 FDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENL  159 (362)
T ss_dssp             ECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGE
T ss_pred             EecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHE
Confidence            99999999999883    335689999999999999999999998   999999999997

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.85  E-value=3.6e-22  Score=199.95  Aligned_cols=133  Identities=26%  Similarity=0.416  Sum_probs=118.0

Q ss_pred             HHHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          298 PEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       298 ~~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      .++....+++.+.||+|+||.||+|..+++..||||+++......+.+.+|+.+|+.++||||+++++++. .+..++||
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            34556677888999999999999999888889999999887677889999999999999999999999986 56789999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       262 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Ni  315 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANI  315 (454)
T ss_dssp             CCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGE
T ss_pred             eecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence            999999999999432  123588999999999999999999998   999999999997

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.85  E-value=1e-21  Score=184.26  Aligned_cols=133  Identities=24%  Similarity=0.398  Sum_probs=117.5

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ....|.+.+.||+|+||.||++... ++..+|+|.+...  ....+.+.+|++++++++||||+++++++......++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            3467888899999999999999864 6889999998763  335678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++.........+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NI  155 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENI  155 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGE
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHE
Confidence            99999999998854333346799999999999999999999998   999999999997

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.85  E-value=1.1e-21  Score=187.60  Aligned_cols=126  Identities=27%  Similarity=0.376  Sum_probs=110.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .|++.+.||+|+||.||++... +++.||+|++.....  ..+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   87 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence            4667789999999999999865 788999999865332  2356889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        88 ~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NI  136 (323)
T 3tki_A           88 SGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENL  136 (323)
T ss_dssp             TTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             CCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHE
Confidence            9999999983    345699999999999999999999998   999999999997

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.85  E-value=1.4e-21  Score=183.11  Aligned_cols=132  Identities=30%  Similarity=0.444  Sum_probs=115.2

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc---cCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK---FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ...|.+.+.||+|+||.||++... +++.||+|+++...   ....++.+|+..+..+ +||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            456778899999999999999965 78999999987632   2345688999999988 899999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++++|.+++.........+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NI  146 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNI  146 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHE
Confidence            999999999999954322235689999999999999999999998   999999999997

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.85  E-value=1.8e-21  Score=190.14  Aligned_cols=127  Identities=23%  Similarity=0.344  Sum_probs=114.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|.+.+.||+|+||.||++... +++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46778899999999999999854 6788999998652    334577899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        95 e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NI  146 (384)
T 4fr4_A           95 DLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNI  146 (384)
T ss_dssp             CCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHe
Confidence            9999999999983    345799999999999999999999998   999999999997

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.85  E-value=1.5e-21  Score=181.02  Aligned_cols=128  Identities=29%  Similarity=0.535  Sum_probs=116.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      ..+++.+.||+|+||.||++...+++.||+|.++......+.+.+|+++++.++||||+++++++...+..+++|||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH   87 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence            45677889999999999999988888999999988766778899999999999999999999999999999999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        88 ~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Ni  135 (267)
T 3t9t_A           88 GCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNC  135 (267)
T ss_dssp             CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGE
T ss_pred             CcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheE
Confidence            999999843   235689999999999999999999998   999999999997

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.85  E-value=1.6e-21  Score=190.08  Aligned_cols=132  Identities=27%  Similarity=0.469  Sum_probs=112.8

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc--------CCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEEeC
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEG  370 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  370 (436)
                      ...+.+.+.||+|+||.||+++..        ++..||+|+++....  ..+.+.+|+.+++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            356677899999999999999842        345699999976432  345789999999999 899999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKES------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..++||||+++|+|.+++.....            ....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  234 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  234 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence            999999999999999999864321            124589999999999999999999998   999999999997

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.85  E-value=2.9e-21  Score=189.08  Aligned_cols=128  Identities=23%  Similarity=0.405  Sum_probs=113.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ..|.+.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            45778899999999999999864 78899999987642 23456899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       131 ~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NI  180 (387)
T 1kob_A          131 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENI  180 (387)
T ss_dssp             CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHe
Confidence            99999999842   334689999999999999999999998   999999999997

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.85  E-value=4.9e-22  Score=186.60  Aligned_cols=131  Identities=26%  Similarity=0.411  Sum_probs=113.6

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CC-------CEEEEEEecCc-ccCHHHHHHHHHHHcCCCcCcccceeEEEEeC
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TG-------GLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG  370 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~-------~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  370 (436)
                      +...++.+.+.||+|+||.||++... ++       ..||+|++... ....+.+.+|+.++++++||||+++++++..+
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            34456778899999999999999854 33       46999998763 34457799999999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..++||||+++|+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  144 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNI  144 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             CCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceE
Confidence            999999999999999999943   223489999999999999999999998   999999999997

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.85  E-value=4.6e-22  Score=193.70  Aligned_cols=135  Identities=29%  Similarity=0.442  Sum_probs=115.2

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeC
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG  370 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  370 (436)
                      ++...++.+.+.||+|+||.||+|...      ++..||||+++..  .....++.+|+.++++++||||+++++++...
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            444566778899999999999999843      4568999998753  22345688999999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKE---SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...++||||+++|+|.+++....   .....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  212 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC  212 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhE
Confidence            89999999999999999986432   1224689999999999999999999998   999999999997

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.85  E-value=8.1e-22  Score=194.26  Aligned_cols=126  Identities=22%  Similarity=0.266  Sum_probs=111.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|.+.+.||+|+||.||+++.+ +++.||+|++++.    ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            45667789999999999999965 6889999998652    223345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++..     ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       149 E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NI  199 (410)
T 3v8s_A          149 EYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNM  199 (410)
T ss_dssp             CCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             eCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHe
Confidence            99999999999832     3589999999999999999999998   999999999997

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.85  E-value=1.9e-21  Score=187.93  Aligned_cols=127  Identities=25%  Similarity=0.279  Sum_probs=113.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|.+.+.||+|+||.||+++.. +++.||+|+++..    ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            45667789999999999999965 7889999998653    234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NI  172 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENL  172 (350)
T ss_dssp             ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceE
Confidence            99999999999842    34689999999999999999999998   999999999997

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.85  E-value=1.1e-21  Score=189.78  Aligned_cols=130  Identities=26%  Similarity=0.347  Sum_probs=112.9

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCee
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  373 (436)
                      +....|.+.+.||+|+||.||+++.+ +++.||+|+++..    ....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            33456778899999999999999965 6889999999753    23456688999999987 699999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       100 ~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NI  155 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNV  155 (353)
T ss_dssp             EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGE
T ss_pred             EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHE
Confidence            99999999999999984    235699999999999999999999998   999999999997

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.85  E-value=1.4e-21  Score=184.32  Aligned_cols=128  Identities=26%  Similarity=0.332  Sum_probs=112.9

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ..+|.+.+.||+|+||.||++... ++..||+|.+.....    ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            345778899999999999999854 788999999865322    235688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++++|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        90 ~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Ni  142 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNI  142 (294)
T ss_dssp             EECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             EeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            99999999999983    234699999999999999999999998   999999999997

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.85  E-value=5.4e-22  Score=198.55  Aligned_cols=132  Identities=32%  Similarity=0.482  Sum_probs=117.1

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ++....+.+.+.||+|+||.||+|....+..||||+++......+.+.+|+.+|++++||||+++++++.. +..++|||
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            45556778889999999999999998877889999998766677889999999999999999999999866 67899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       259 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Ni  311 (452)
T 1fmk_A          259 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANI  311 (452)
T ss_dssp             CCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             hhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhE
Confidence            99999999999421  224589999999999999999999998   999999999997

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.85  E-value=5.3e-22  Score=193.93  Aligned_cols=131  Identities=25%  Similarity=0.486  Sum_probs=114.4

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      +....+.+.+.||+|+||.||+|... +++.||+|.++....  ..+++.+|+++|++++||||+++++++...+..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34456778899999999999999975 788999999875322  224588999999999999999999999998899999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       191 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Ni  244 (377)
T 3cbl_A          191 MELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNC  244 (377)
T ss_dssp             EECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHE
Confidence            999999999999843   234589999999999999999999998   999999999997

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.84  E-value=2.6e-21  Score=182.70  Aligned_cols=126  Identities=25%  Similarity=0.403  Sum_probs=106.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---------------------------CHHHHHHHHHHHcC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---------------------------SAEEFINEVSTIGR  354 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~~  354 (436)
                      ..|.+.+.||+|+||.||++... +++.||+|++.....                           ..+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            35667899999999999999854 678899999865321                           12458899999999


Q ss_pred             CCcCcccceeEEEEe--CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCC
Q 041073          355 IHHVNVVQLLGFCSE--GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIK  432 (436)
Q Consensus       355 l~h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlk  432 (436)
                      ++||||+++++++..  ....++||||+++++|.+++     ....+++..+..++.|+++||+|||++   +|+|||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            999999999999986  56789999999999998865     235699999999999999999999998   99999999


Q ss_pred             CCCC
Q 041073          433 PHNI  436 (436)
Q Consensus       433 p~NI  436 (436)
                      |+||
T Consensus       165 p~Ni  168 (298)
T 2zv2_A          165 PSNL  168 (298)
T ss_dssp             GGGE
T ss_pred             HHHE
Confidence            9997

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.84  E-value=3.4e-21  Score=183.72  Aligned_cols=130  Identities=25%  Similarity=0.413  Sum_probs=112.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCC--eeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  377 (436)
                      .+|.+.+.||+|+||.||++... +++.||+|+++..  ....+.+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            34667789999999999999965 5889999999763  234677889999999999999999999988755  679999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++.... ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  143 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNI  143 (319)
T ss_dssp             ECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             eCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHE
Confidence            9999999999995432 223499999999999999999999998   999999999997

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.84  E-value=4e-21  Score=188.49  Aligned_cols=129  Identities=18%  Similarity=0.234  Sum_probs=114.5

Q ss_pred             HhhhhhcccCCC--CCeEEEEEEEc-CCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          303 MTNHFTHKLGQG--GFGSVYKGQLH-TGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G--~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      .+|.+.+.||+|  +||.||+++.. +++.||+|+++.....   .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            467788999999  99999999965 7889999999764333   35688899999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       105 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NI  159 (389)
T 3gni_B          105 TSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHI  159 (389)
T ss_dssp             EECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            9999999999998532  235689999999999999999999998   999999999997

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.84  E-value=4.5e-21  Score=178.91  Aligned_cols=128  Identities=19%  Similarity=0.285  Sum_probs=114.5

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc-ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ...|.+.+.||+|+||.||++... ++..+|+|.+... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            456778899999999999999865 5678999998763 44567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        88 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Ni  137 (277)
T 3f3z_A           88 CTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENF  137 (277)
T ss_dssp             CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHE
Confidence            999999998842    35689999999999999999999998   999999999997

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.84  E-value=2.8e-21  Score=183.75  Aligned_cols=127  Identities=25%  Similarity=0.412  Sum_probs=110.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      .+|.+.+.||+|+||.||++...+++.||+|+++....   ..+.+.+|++++++++||||+++++++......++||||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            45677899999999999999988899999999975332   235688999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++ +|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       101 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NI  150 (311)
T 3niz_A          101 MEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNL  150 (311)
T ss_dssp             CSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhE
Confidence            974 88887743   335699999999999999999999998   999999999997

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.84  E-value=1.9e-21  Score=193.67  Aligned_cols=129  Identities=19%  Similarity=0.294  Sum_probs=112.8

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ....|.+.+.||+|+||.||++.. .+++.+|+|++.....   ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            346678889999999999999985 4788999999876432   335688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NI  141 (444)
T 3soa_A           89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENL  141 (444)
T ss_dssp             ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTE
T ss_pred             EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHE
Confidence            999999999998843    35699999999999999999999998   999999999997

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.84  E-value=1.6e-21  Score=185.28  Aligned_cols=132  Identities=30%  Similarity=0.537  Sum_probs=113.6

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      +...++++.+.||+|+||.||+++. +++.||+|++......   .+++.+|++++++++||||+++++++...+..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            3345677889999999999999986 5788999999764433   34688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++.... ....+++..++.++.|+++||+|||++   +  |+||||||+||
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NI  170 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNL  170 (309)
T ss_dssp             EECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGE
T ss_pred             EecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhE
Confidence            99999999999994321 112389999999999999999999998   7  99999999997

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.84  E-value=2.8e-21  Score=182.58  Aligned_cols=135  Identities=24%  Similarity=0.403  Sum_probs=113.5

Q ss_pred             ChHHHHHHhhhhhcccCCCCCeEEEEEEE-----cCCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEE
Q 041073          296 SYPEIIAMTNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCS  368 (436)
Q Consensus       296 ~~~~i~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  368 (436)
                      ....+....+++.+.||+|+||.||+++.     .+++.||+|+++..  ....+.+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (302)
T 4e5w_A           14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT   93 (302)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            33344455677889999999999999983     36788999999753  334577999999999999999999999998


Q ss_pred             eC--CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          369 EG--SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       369 ~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..  ...++||||+++|+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        94 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Ni  157 (302)
T 4e5w_A           94 EDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNV  157 (302)
T ss_dssp             C---CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cCCCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheE
Confidence            76  668999999999999999843   235689999999999999999999998   999999999997

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.84  E-value=2e-21  Score=186.20  Aligned_cols=128  Identities=25%  Similarity=0.358  Sum_probs=108.3

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE----cCCCEEEEEEecCcc-----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCe
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL----HTGGLIAVKMLKNSK-----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  372 (436)
                      ...|.+.+.||+|+||.||+++.    .+++.+|+|+++...     .....+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35677889999999999999986    478899999997632     233457889999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        96 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Ni  152 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENI  152 (327)
T ss_dssp             EEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTE
T ss_pred             EEEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHe
Confidence            999999999999999984    234689999999999999999999998   999999999997

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.84  E-value=8e-22  Score=185.04  Aligned_cols=135  Identities=31%  Similarity=0.443  Sum_probs=119.7

Q ss_pred             hHHHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          297 YPEIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       297 ~~~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      ..++...++++.+.||+|+||.||++... ++..||+|.+.......+.+.+|+.+++.++||||+++++++...+..++
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            34455667788899999999999999965 57889999998766667789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++++|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        87 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Ni  142 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNC  142 (288)
T ss_dssp             EEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGE
T ss_pred             EEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceE
Confidence            99999999999998432  335689999999999999999999998   999999999997

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.84  E-value=1.8e-21  Score=185.98  Aligned_cols=128  Identities=29%  Similarity=0.454  Sum_probs=110.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCC----eeeEEEe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRAVVYE  378 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~E  378 (436)
                      ..|++.+.||+|+||.||+|+.. ++.||||+++..........+|+.++++++||||+++++++....    ..++|||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e  102 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA  102 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence            46677899999999999999875 789999999765555556778999999999999999999998744    3699999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------CCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC-------DVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~-------~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++..     ..+++..+..++.|+++||+|||+..       .++|+||||||+||
T Consensus       103 ~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Ni  162 (322)
T 3soc_A          103 FHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV  162 (322)
T ss_dssp             CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGE
T ss_pred             cCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhE
Confidence            9999999999932     35899999999999999999999741       23899999999997

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.84  E-value=5.4e-21  Score=191.79  Aligned_cols=127  Identities=26%  Similarity=0.398  Sum_probs=113.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|.+.+.||+|+||.||+|... +++.||||+++...    ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35667789999999999999965 78999999997532    23567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        96 E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NI  147 (476)
T 2y94_A           96 EYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENV  147 (476)
T ss_dssp             ECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGE
T ss_pred             eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHE
Confidence            9999999999993    345699999999999999999999998   999999999997

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.84  E-value=2e-21  Score=187.35  Aligned_cols=127  Identities=24%  Similarity=0.336  Sum_probs=112.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ..+.+.+.||+|+||.||+++.+ +++.||+|+++..    ....+.+.+|..++..+ +||||+++++++.+.+..++|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            45667899999999999999965 6888999999763    33456788899998876 899999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        97 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NI  149 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNI  149 (345)
T ss_dssp             EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGE
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhE
Confidence            999999999999842    34689999999999999999999998   999999999997

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.84  E-value=6.7e-22  Score=186.38  Aligned_cols=131  Identities=29%  Similarity=0.479  Sum_probs=112.0

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEE-----cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEe--CC
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GS  371 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  371 (436)
                      +...++++.+.||+|+||.||+++.     .+++.||+|++.... ...+.+.+|++++++++||||+++++++..  ..
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            3445677889999999999999984     367889999997633 234678999999999999999999999854  35


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..++||||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Ni  145 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNI  145 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             ceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhE
Confidence            589999999999999999432   24589999999999999999999998   999999999997

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.84  E-value=8e-22  Score=201.36  Aligned_cols=132  Identities=32%  Similarity=0.482  Sum_probs=117.3

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ++....+.+.+.||+|+||.||+|....+..||||+++......+++.+|+++|++++|+||+++++++.. +..+||||
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            45566778889999999999999998877889999998766677889999999999999999999999865 67899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++...  ....+++.+++.++.|+++||+|||++   +|+||||||+||
T Consensus       342 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NI  394 (535)
T 2h8h_A          342 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANI  394 (535)
T ss_dssp             CCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             hhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhE
Confidence            99999999999421  224589999999999999999999998   999999999997

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.84  E-value=3.5e-21  Score=180.94  Aligned_cols=126  Identities=27%  Similarity=0.415  Sum_probs=111.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      +|.+.+.||+|+||.||+++..+++.+|+|+++...   ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence            456778999999999999998889999999986532   23467889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++ +|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        83 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  131 (288)
T 1ob3_A           83 DQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNL  131 (288)
T ss_dssp             SE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             CC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            75 99988843   235689999999999999999999998   999999999997

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.84  E-value=2.5e-21  Score=186.84  Aligned_cols=127  Identities=22%  Similarity=0.288  Sum_probs=111.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ..+.+.+.||+|+||.||+++.+ +++.||+|+++....    ..+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            34667789999999999999965 678899999976432    234578899999887 899999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++.    +...+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        89 ~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NI  141 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNV  141 (345)
T ss_dssp             ECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGE
T ss_pred             EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHE
Confidence            99999999999984    234699999999999999999999998   999999999997

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.84  E-value=7.3e-21  Score=181.65  Aligned_cols=128  Identities=30%  Similarity=0.408  Sum_probs=114.8

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc-------CHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      ...|.+.+.||+|+||.||++... +++.||+|.++....       ..+.+.+|+.+++.++||||+++++++......
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            466788899999999999999965 688999999875321       357799999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NI  146 (321)
T 2a2a_A           91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENI  146 (321)
T ss_dssp             EEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHE
Confidence            99999999999999994    335689999999999999999999998   999999999997

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.84  E-value=3e-21  Score=180.35  Aligned_cols=132  Identities=28%  Similarity=0.478  Sum_probs=115.8

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ++...++++.+.||+|+||.||+|...++..||+|.++......+.+.+|+++++.++||||+++++++. .+..++|||
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   87 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE   87 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence            3344677788999999999999999888889999999877667788999999999999999999999876 456889999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Ni  140 (279)
T 1qpc_A           88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI  140 (279)
T ss_dssp             CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhE
Confidence            99999999998321  123689999999999999999999998   999999999997

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.84  E-value=1.9e-21  Score=180.63  Aligned_cols=128  Identities=27%  Similarity=0.440  Sum_probs=111.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeC--CeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  377 (436)
                      .++.+.+.||+|+||.||+|+.. ++.+|+|+++.....   .+.+.+|+.++++++||||+++++++...  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            45677899999999999999975 788999999764332   35689999999999999999999999876  7789999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++...  ....+++..+..++.|+++||+|||++   +  |+||||||+||
T Consensus        89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Ni  144 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSV  144 (271)
T ss_dssp             ECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGE
T ss_pred             cccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceE
Confidence            999999999999532  223689999999999999999999987   6  99999999997

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.84  E-value=6.2e-21  Score=178.51  Aligned_cols=129  Identities=28%  Similarity=0.441  Sum_probs=115.1

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-------cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCe
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  372 (436)
                      ....|.+.+.||+|+||.||++... +++.+|+|+++...       ...+.+.+|+.++++++||||+++++++.....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            3467788899999999999999965 68899999986532       136779999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+++++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Ni  139 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENI  139 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHE
Confidence            9999999999999999842    35689999999999999999999998   999999999997

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.84  E-value=1.8e-21  Score=191.98  Aligned_cols=128  Identities=22%  Similarity=0.206  Sum_probs=111.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..+.+.+.||+|+||.||+++.+ +++.||+|++++..    ...+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            45667789999999999999964 78999999997522    12234788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++...   +..+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus       141 E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NI  193 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNI  193 (412)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             cCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHe
Confidence            999999999999432   24699999999999999999999998   999999999997

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.84  E-value=2.9e-21  Score=185.88  Aligned_cols=132  Identities=26%  Similarity=0.477  Sum_probs=113.3

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      ...+.+.+.||+|+||.||++...      +++.||+|+++....  ..+.+.+|+.++++++||||+++++++...+..
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            356677889999999999999864      347899999976332  245689999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESR--------------------GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP  433 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp  433 (436)
                      ++||||+++|+|.+++......                    ...+++.+++.++.|+++||+|||++   +|+||||||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp  202 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT  202 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCc
Confidence            9999999999999998543211                    25699999999999999999999998   999999999


Q ss_pred             CCC
Q 041073          434 HNI  436 (436)
Q Consensus       434 ~NI  436 (436)
                      +||
T Consensus       203 ~NI  205 (343)
T 1luf_A          203 RNC  205 (343)
T ss_dssp             GGE
T ss_pred             ceE
Confidence            997

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.84  E-value=4e-21  Score=186.88  Aligned_cols=131  Identities=21%  Similarity=0.224  Sum_probs=111.4

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEE------EcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC---cCcccceeEEEEeCC
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQ------LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGS  371 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~  371 (436)
                      ....|.+.+.||+|+||.||+|.      ..+++.||+|+++..  ...++.+|++++..++   |+||+++++.+...+
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            34556778899999999999993      457889999998754  4566778888887776   999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKES-RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..++||||+++|+|.+++..... ....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NI  203 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNF  203 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGE
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHE
Confidence            99999999999999999953221 345699999999999999999999998   999999999997

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.84  E-value=5.1e-21  Score=180.11  Aligned_cols=126  Identities=21%  Similarity=0.402  Sum_probs=108.9

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +|++.+.||+|+||.||++... +++.||+|+++....   ..+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   82 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence            4567789999999999999964 688999999975332   236788999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++ ++.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 ~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Ni  132 (292)
T 3o0g_A           83 CDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNL  132 (292)
T ss_dssp             CSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            975 56565532   335799999999999999999999998   999999999997

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.84  E-value=4e-21  Score=185.70  Aligned_cols=126  Identities=24%  Similarity=0.358  Sum_probs=106.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      ..|.+.+.||+|+||.||++... +++.||+|+++... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            45677789999999999999965 67889999997643 34568899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|+|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       132 ~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI  179 (349)
T 2w4o_A          132 GGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENL  179 (349)
T ss_dssp             SCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccE
Confidence            999999983    335689999999999999999999998   999999999997

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.84  E-value=3.1e-21  Score=189.08  Aligned_cols=127  Identities=21%  Similarity=0.288  Sum_probs=110.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC----HHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS----AEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ..+.+.+.||+|+||.||+++.+ +++.+|+|++++....    .+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            45677899999999999999965 6778999999764322    23578899998876 899999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       132 ~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NI  184 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNV  184 (396)
T ss_dssp             EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGE
T ss_pred             EEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHE
Confidence            99999999999884    235699999999999999999999998   999999999997

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.84  E-value=3e-21  Score=192.99  Aligned_cols=128  Identities=30%  Similarity=0.501  Sum_probs=112.0

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCC-eeeEEEecC
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-KRAVVYEYM  380 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~~  380 (436)
                      ...+++.+.||+|+||.||+|... ++.||||+++... ..+.+.+|+.+|++++||||+++++++.... ..++||||+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            345667789999999999999875 7789999997654 4567999999999999999999999987655 789999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       270 ~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Ni  320 (450)
T 1k9a_A          270 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNV  320 (450)
T ss_dssp             TTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhE
Confidence            999999999532  223479999999999999999999998   999999999997

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.84  E-value=6.1e-21  Score=182.58  Aligned_cols=119  Identities=22%  Similarity=0.329  Sum_probs=107.6

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEecCCCCChh
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYEYMPNGSLD  386 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  386 (436)
                      +.||+|+||.||++... +++.||+|++...  ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+|.
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            67999999999999964 6889999998653  3456789999999997 999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          387 RHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       387 ~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        95 ~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI  137 (325)
T 3kn6_A           95 ERIK----KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENL  137 (325)
T ss_dssp             HHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             HHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHE
Confidence            9994    335799999999999999999999998   999999999997

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.84  E-value=4.5e-21  Score=186.97  Aligned_cols=123  Identities=32%  Similarity=0.437  Sum_probs=104.7

Q ss_pred             hcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          308 THKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      .+.||+|+||.||++.. .+++.||+|+++... ...+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            46799999999999985 478899999997643 3456799999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  218 (373)
T 2x4f_A          174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENI  218 (373)
T ss_dssp             HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHE
Confidence            998843   234689999999999999999999998   999999999997

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.84  E-value=6.4e-21  Score=183.68  Aligned_cols=125  Identities=28%  Similarity=0.390  Sum_probs=110.1

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEec
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ...|.+.+.||+|+||.||++..+ +++.||+|+++.....   ..+|++++.++ +||||+++++++.+++..++||||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            456778899999999999999865 6888999999765432   34688888777 799999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        98 ~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NI  147 (342)
T 2qr7_A           98 MKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNI  147 (342)
T ss_dssp             CCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             CCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHE
Confidence            99999999984    335699999999999999999999998   999999999997

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.84  E-value=1e-20  Score=179.97  Aligned_cols=126  Identities=29%  Similarity=0.392  Sum_probs=110.8

Q ss_pred             hhhhh-cccCCCCCeEEEEEEE-cCCCEEEEEEecCc-ccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFT-HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS-KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~-~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      .|.+. +.||+|+||.||++.. .+++.||||+++.. ....+.+.+|++++.++ +||||+++++++...+..++||||
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   92 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK   92 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence            34453 6799999999999984 47889999999764 33467899999999885 799999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        93 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Ni  142 (316)
T 2ac3_A           93 MRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENI  142 (316)
T ss_dssp             CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             CCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHE
Confidence            999999999843    34689999999999999999999998   999999999997

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.83  E-value=3.8e-21  Score=182.64  Aligned_cols=133  Identities=26%  Similarity=0.423  Sum_probs=113.2

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEE------cCCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCe
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  372 (436)
                      ....|.+.+.||+|+||.||++..      .++..||+|+++...  ...+.+.+|+++++.++||||+++++++...+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            345677789999999999999985      234789999997632  234678999999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKES--------------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIK  432 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlk  432 (436)
                      .++||||+++++|.+++.....                    ....+++..+..++.|+++||+|||++   +|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence            9999999999999999964322                    123489999999999999999999998   99999999


Q ss_pred             CCCC
Q 041073          433 PHNI  436 (436)
Q Consensus       433 p~NI  436 (436)
                      |+||
T Consensus       178 p~NI  181 (314)
T 2ivs_A          178 ARNI  181 (314)
T ss_dssp             GGGE
T ss_pred             hheE
Confidence            9997

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.83  E-value=9.2e-21  Score=180.67  Aligned_cols=130  Identities=26%  Similarity=0.431  Sum_probs=100.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ..|++.+.||+|+||.||+|... +++.||+|.++...  ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   84 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF   84 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence            35667789999999999999854 68899999987532  2346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKE--SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++ |+|.+++....  .....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NI  139 (317)
T 2pmi_A           85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNL  139 (317)
T ss_dssp             CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHe
Confidence            97 69998885321  1224689999999999999999999998   999999999997

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.83  E-value=5.6e-22  Score=190.63  Aligned_cols=128  Identities=15%  Similarity=0.148  Sum_probs=105.6

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcc---------cCHHHHHHHHHHHcCCC---------cCccc
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSK---------FSAEEFINEVSTIGRIH---------HVNVV  361 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~---------h~niv  361 (436)
                      +...+|.+.+.||+|+||.||+|+. +++.||||+++...         ...+.+.+|+.+++.++         |+||+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            3456788899999999999999987 68899999997532         22367889999888875         77777


Q ss_pred             ceeEEEE------------------------------eCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHH
Q 041073          362 QLLGFCS------------------------------EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGT  411 (436)
Q Consensus       362 ~l~~~~~------------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i  411 (436)
                      ++.+.+.                              ..+..++||||+++|++.+.+.     ...+++..++.++.|+
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQL  170 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHH
Confidence            7766543                              2678999999999997766662     2468999999999999


Q ss_pred             HHHHHHHH-cCCCCceEecCCCCCCC
Q 041073          412 ARGIEYLH-NGCDVCILHFDIKPHNI  436 (436)
Q Consensus       412 ~~gL~yLH-~~~~~~iiHrDlkp~NI  436 (436)
                      +.||+||| ++   +|+||||||+||
T Consensus       171 ~~aL~~lH~~~---~ivHrDlKp~NI  193 (336)
T 2vuw_A          171 TASLAVAEASL---RFEHRDLHWGNV  193 (336)
T ss_dssp             HHHHHHHHHHH---CCBCSCCCGGGE
T ss_pred             HHHHHHHHHhC---CEeECCCCHHHE
Confidence            99999999 77   999999999997

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.83  E-value=8.5e-21  Score=192.05  Aligned_cols=129  Identities=25%  Similarity=0.393  Sum_probs=111.5

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ....|.+.+.||+|+||.||++... ++..+|+|+++..   ......+.+|+.+++.++||||+++++++......++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567888899999999999999965 7889999998763   23356789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       115 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  167 (494)
T 3lij_A          115 MECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENL  167 (494)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhE
Confidence            999999999988842    35689999999999999999999998   999999999997

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.83  E-value=1.1e-20  Score=192.05  Aligned_cols=130  Identities=25%  Similarity=0.353  Sum_probs=114.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .+.+.+.||+|+||.||+++.+ +++.||+|++...    ....+.+.+|+.++++++||||+++++++......++|||
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  265 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT  265 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            3455678999999999999965 7899999999653    2345678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++.........+++..+..++.||+.||+|||++   +|+||||||+||
T Consensus       266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NI  320 (543)
T 3c4z_A          266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENV  320 (543)
T ss_dssp             CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHE
Confidence            9999999999865443455799999999999999999999998   999999999997

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.83  E-value=9.8e-21  Score=186.20  Aligned_cols=130  Identities=25%  Similarity=0.413  Sum_probs=112.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCC--eeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  377 (436)
                      .+|.+.+.||+|+||.||+|... +++.||+|+++..  ....+.+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            35667789999999999999965 6889999999763  234577889999999999999999999988755  679999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++.... ....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        89 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  143 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNI  143 (396)
T ss_dssp             CCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             ecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHE
Confidence            9999999999995432 223499999999999999999999998   999999999997

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.83  E-value=1.1e-20  Score=176.36  Aligned_cols=127  Identities=27%  Similarity=0.421  Sum_probs=112.8

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|.+.+.||+|+||.||+++. .+++.||+|++...    ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE   91 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence            466778999999999999986 47889999998653    2234678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        92 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Ni  143 (278)
T 3cok_A           92 MCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNL  143 (278)
T ss_dssp             CCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGE
T ss_pred             cCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence            9999999999843   335689999999999999999999998   999999999997

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.83  E-value=1.5e-20  Score=178.11  Aligned_cols=139  Identities=39%  Similarity=0.671  Sum_probs=120.3

Q ss_pred             CccChHHHHHHhhhhh--------cccCCCCCeEEEEEEEcCCCEEEEEEecCcc-----cCHHHHHHHHHHHcCCCcCc
Q 041073          293 KRYSYPEIIAMTNHFT--------HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSK-----FSAEEFINEVSTIGRIHHVN  359 (436)
Q Consensus       293 ~~~~~~~i~~~~~~~~--------~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~n  359 (436)
                      ..+++.++...+.++.        +.||+|+||.||+|.. +++.+|+|.+....     ...+.+.+|+.+++.++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            5678888888887765        5599999999999986 57889999986521     22467899999999999999


Q ss_pred             ccceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       360 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++++...+..+++|||+++++|.+++.... ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Ni  164 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANI  164 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHE
Confidence            9999999999999999999999999999985432 235699999999999999999999998   999999999997

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.83  E-value=1.3e-20  Score=190.37  Aligned_cols=130  Identities=28%  Similarity=0.408  Sum_probs=116.9

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      +...+|.+.+.||+|+||.||++... +++.||||++...    ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45567888999999999999999965 7889999998653    335678999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       103 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  157 (484)
T 3nyv_A          103 LVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENL  157 (484)
T ss_dssp             EEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHE
Confidence            9999999999999884    335699999999999999999999998   999999999997

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.83  E-value=4.4e-21  Score=185.51  Aligned_cols=127  Identities=27%  Similarity=0.266  Sum_probs=112.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ..+++.+.||+|+||.||+++.+ +++.||+|+++..    ....+.+.+|..++..+ +||||+++++++.+.+..++|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            45677899999999999999965 5778999999753    23456788999999988 799999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++..    ...+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus       100 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NI  152 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNV  152 (353)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGE
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHE
Confidence            999999999999842    24699999999999999999999998   999999999997

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.83  E-value=3.6e-21  Score=188.39  Aligned_cols=135  Identities=29%  Similarity=0.455  Sum_probs=115.4

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc--------CCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEE
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFC  367 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~  367 (436)
                      ++...++.+.+.||+|+||.||+++..        .+..||+|+++....  ..+++.+|+++++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            555677888899999999999999842        234799999976432  335689999999999 899999999999


Q ss_pred             EeCCeeeEEEecCCCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          368 SEGSKRAVVYEYMPNGSLDRHIFPKES------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       368 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      ...+..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||++   +|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            999999999999999999999864321            124699999999999999999999998   99999999999


Q ss_pred             C
Q 041073          436 I  436 (436)
Q Consensus       436 I  436 (436)
                      |
T Consensus       222 I  222 (382)
T 3tt0_A          222 V  222 (382)
T ss_dssp             E
T ss_pred             E
Confidence            7

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.83  E-value=7.7e-21  Score=192.01  Aligned_cols=129  Identities=28%  Similarity=0.416  Sum_probs=116.1

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecC---cccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKN---SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ...+|.+.+.||+|+||.||++... +++.||+|++..   .....+.+.+|+.++++++||||+++++++......++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4577889999999999999999965 788999999865   234567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Ni  152 (486)
T 3mwu_A          100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENI  152 (486)
T ss_dssp             ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHE
Confidence            999999999998843    35689999999999999999999998   999999999997

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.83  E-value=8.7e-21  Score=192.48  Aligned_cols=128  Identities=29%  Similarity=0.401  Sum_probs=111.2

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--------------cCHHHHHHHHHHHcCCCcCcccceeEE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--------------FSAEEFINEVSTIGRIHHVNVVQLLGF  366 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~  366 (436)
                      ...|.+.+.||+|+||.||++... ++..+|+|++....              ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            356778899999999999999965 67889999987532              234678999999999999999999999


Q ss_pred             EEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       367 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +.+....++||||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  177 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENI  177 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHE
Confidence            9999999999999999999998843    35699999999999999999999998   999999999997

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.83  E-value=7.1e-21  Score=182.16  Aligned_cols=138  Identities=30%  Similarity=0.511  Sum_probs=115.0

Q ss_pred             ChHHHHHHhhhhhcccCCCCCeEEEEEEEc-CCCE--EEEEEecCc--ccCHHHHHHHHHHHcCC-CcCcccceeEEEEe
Q 041073          296 SYPEIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGL--IAVKMLKNS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE  369 (436)
Q Consensus       296 ~~~~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~--vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  369 (436)
                      .++.+....+.+.+.||+|+||.||++... ++..  +|+|.++..  ....+.+.+|+++++++ +||||+++++++..
T Consensus        18 ~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   97 (327)
T 1fvr_A           18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   97 (327)
T ss_dssp             CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             ccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence            344455567788899999999999999854 5554  489988752  23345689999999999 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKE------------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+..++||||+++|+|.+++....            .....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NI  173 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI  173 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceE
Confidence            999999999999999999995432            1234799999999999999999999998   999999999997

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.83  E-value=2.8e-21  Score=179.64  Aligned_cols=128  Identities=30%  Similarity=0.505  Sum_probs=107.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcc-----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSK-----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..+++.+.||+|+||.||++... ++.+|+|+++...     ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            45667789999999999999875 7889999986532     23467899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++.     ...+++..+..++.|+++||+|||++...+|+||||||+||
T Consensus        86 e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Ni  139 (271)
T 3dtc_A           86 EFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNI  139 (271)
T ss_dssp             ECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGE
T ss_pred             EcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHE
Confidence            9999999999982     35689999999999999999999998212299999999997

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.83  E-value=1.8e-20  Score=174.64  Aligned_cols=127  Identities=27%  Similarity=0.362  Sum_probs=113.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ..|++.+.||+|+||.||++... +++.||+|++....  ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            56778899999999999999965 78899999987533  2346789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        87 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Ni  136 (276)
T 2yex_A           87 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENL  136 (276)
T ss_dssp             CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHE
Confidence            99999999983    335689999999999999999999998   999999999997

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.83  E-value=6.1e-21  Score=189.04  Aligned_cols=130  Identities=21%  Similarity=0.361  Sum_probs=111.2

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---------CHHHHHHHHHHHcCCCcCcccceeEEEE
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCS  368 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~  368 (436)
                      +.....|.+.+.||+|+||.||+|... +++.||+|++.....         ....+.+|+.+|++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            445667888899999999999999854 678999999875321         1124789999999999999999999975


Q ss_pred             eCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          369 EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       369 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       .+..++||||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NI  270 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENV  270 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             -cCceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhE
Confidence             456899999999999999883    345799999999999999999999998   999999999997

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.83  E-value=7.5e-21  Score=179.51  Aligned_cols=124  Identities=23%  Similarity=0.368  Sum_probs=103.7

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcC--CCcCcccceeEEEEe----CCeeeE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGR--IHHVNVVQLLGFCSE----GSKRAV  375 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~l  375 (436)
                      ...|.+.+.||+|+||.||+|.. +++.||||++....  ...+.+|.+++..  ++||||+++++++..    ....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            34667789999999999999987 58899999986543  3445556555554  899999999998654    245789


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH--------NGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH--------~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++|+|.+++.     ...+++..+..++.|+++||+|||        ++   +|+||||||+||
T Consensus        84 v~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Ni  144 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNI  144 (301)
T ss_dssp             EECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGE
T ss_pred             ehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhE
Confidence            999999999999992     346999999999999999999999        66   999999999997

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.83  E-value=4.4e-21  Score=184.84  Aligned_cols=135  Identities=28%  Similarity=0.443  Sum_probs=112.6

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCcc--cCHHHHHHHHHHHcCC-CcCcccceeEEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSE  369 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  369 (436)
                      ++....+.+.+.||+|+||.||++...      ++..||+|+++...  ...+.+.+|+.+++++ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            445567788899999999999999852      44579999997532  2346789999999999 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecC
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKESR-------------------GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFD  430 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrD  430 (436)
                      .+..++||||+++|+|.+++......                   ...+++..+..++.|++.||+|||++   +|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            99999999999999999999643211                   13489999999999999999999998   999999


Q ss_pred             CCCCCC
Q 041073          431 IKPHNI  436 (436)
Q Consensus       431 lkp~NI  436 (436)
                      |||+||
T Consensus       198 ikp~NI  203 (344)
T 1rjb_A          198 LAARNV  203 (344)
T ss_dssp             CSGGGE
T ss_pred             CChhhE
Confidence            999997

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.83  E-value=6.7e-21  Score=181.37  Aligned_cols=133  Identities=26%  Similarity=0.396  Sum_probs=112.2

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc-ccCHHHHHHHHHHHcCCCcCcccceeEEEEe----CCeee
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRA  374 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  374 (436)
                      ...+|.+.+.||+|+||.||++.. .+++.||+|++... ....+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            345677889999999999999996 57889999988653 3345678999999999999999999999863    34678


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++|+|.+++.........+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NI  165 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNI  165 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHE
Confidence            99999999999999854333456799999999999999999999998   999999999997

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.83  E-value=4e-21  Score=184.57  Aligned_cols=125  Identities=23%  Similarity=0.328  Sum_probs=110.6

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|.+.+.||+|+||.||++.. .+++.||+|++...    ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            566789999999999999995 57889999998652    2233578999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+ +|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        90 ~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NI  139 (336)
T 3h4j_B           90 YA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENL  139 (336)
T ss_dssp             CC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTE
T ss_pred             CC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhE
Confidence            99 7899988843    35699999999999999999999998   999999999997

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.83  E-value=4.3e-21  Score=186.15  Aligned_cols=133  Identities=23%  Similarity=0.307  Sum_probs=115.7

Q ss_pred             HHHHHHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCC-----cCcccceeEEEEeCC
Q 041073          298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-----HVNVVQLLGFCSEGS  371 (436)
Q Consensus       298 ~~i~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~  371 (436)
                      .++....|.+.+.||+|+||.||+++. .+++.||+|+++......+.+..|+.+++.++     ||||+++++++...+
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            344556788889999999999999996 47889999999865555567788999998886     999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..++||||+ +++|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  168 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENI  168 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             eeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccE
Confidence            999999999 99999998532  234589999999999999999999998   999999999997

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.83  E-value=1.4e-21  Score=189.42  Aligned_cols=135  Identities=30%  Similarity=0.457  Sum_probs=112.4

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEE------cCCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSE  369 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  369 (436)
                      ++...++.+.+.||+|+||.||++..      .+++.||||+++....  ..+.+.+|++++.++ +||||+++++++..
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            44456777889999999999999973      2457899999976432  235689999999999 79999999999887


Q ss_pred             CC-eeeEEEecCCCCChhhhccCCCCC-----------------------------------------------------
Q 041073          370 GS-KRAVVYEYMPNGSLDRHIFPKESR-----------------------------------------------------  395 (436)
Q Consensus       370 ~~-~~~lv~E~~~~gsL~~~l~~~~~~-----------------------------------------------------  395 (436)
                      .+ ..++||||+++|+|.+++......                                                     
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            54 489999999999999999654221                                                     


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          396 ---------GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       396 ---------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                               ...+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NI  224 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  224 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhE
Confidence                     12289999999999999999999998   999999999997

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.83  E-value=1.3e-20  Score=192.07  Aligned_cols=129  Identities=29%  Similarity=0.346  Sum_probs=113.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..+.+.+.||+|+||.||+++.. +++.||+|++...    ......+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            34566789999999999999964 7899999999652    234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++...  ....+++..+..++.||+.||+|||++   +|+||||||+||
T Consensus       264 Ey~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNI  317 (576)
T 2acx_A          264 TLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENI  317 (576)
T ss_dssp             CCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             EcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheE
Confidence            999999999988532  224589999999999999999999998   999999999997

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.83  E-value=1.2e-20  Score=178.63  Aligned_cols=129  Identities=29%  Similarity=0.451  Sum_probs=112.6

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ...+|.+.+.||+|+||.||++... +++.||+|.++... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3467778899999999999999965 78899999997643 234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NI  137 (304)
T 2jam_A           87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENL  137 (304)
T ss_dssp             CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGC
T ss_pred             cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHE
Confidence            9999999998842    34689999999999999999999998   999999999997

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.83  E-value=5.8e-21  Score=186.04  Aligned_cols=128  Identities=27%  Similarity=0.368  Sum_probs=104.5

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHHHH-HcCCCcCcccceeEEEEeCCeeeE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEVST-IGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      ...+++.+.||+|+||.||+++.+ +++.+|+|+++....    ....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            356778899999999999999965 678899999976432    23456677776 577899999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++|+|.+++.    +...+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus       117 v~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NI  170 (373)
T 2r5t_A          117 VLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENI  170 (373)
T ss_dssp             EEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             EEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHE
Confidence            999999999999983    235689999999999999999999998   999999999997

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.83  E-value=1.3e-20  Score=179.94  Aligned_cols=130  Identities=22%  Similarity=0.358  Sum_probs=110.7

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---------CHHHHHHHHHHHcCCCcCcccceeEEEE
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCS  368 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~  368 (436)
                      ......|.+.+.||+|+||.||++... +++.||||++.....         ....+.+|++++++++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            445677888999999999999999864 678899999865321         1234889999999999999999999987


Q ss_pred             eCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          369 EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       369 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ... .++||||+++++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NI  145 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENV  145 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence            655 899999999999999883    345799999999999999999999998   999999999997

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.83  E-value=6.7e-21  Score=182.57  Aligned_cols=127  Identities=24%  Similarity=0.394  Sum_probs=109.5

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..+|.+.+.||+|+||.||++.. .+++.||+|+++....   ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            35677889999999999999985 4788999999975332   2345789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||++ |+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       113 e~~~-~~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NI  163 (329)
T 3gbz_A          113 EYAE-NDLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNL  163 (329)
T ss_dssp             ECCS-EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             ecCC-CCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHE
Confidence            9997 59999984    234689999999999999999999998   999999999997

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.83  E-value=1.3e-20  Score=175.95  Aligned_cols=126  Identities=25%  Similarity=0.442  Sum_probs=111.3

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|.+.+.||+|+||.||++... ++..||+|++...    ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (279)
T 3fdn_A           10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   89 (279)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence            4667789999999999999855 6678999998652    2234678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        90 ~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Ni  140 (279)
T 3fdn_A           90 YAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENL  140 (279)
T ss_dssp             CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGE
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhE
Confidence            9999999998832    34689999999999999999999988   999999999997

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.82  E-value=8.5e-21  Score=182.19  Aligned_cols=135  Identities=27%  Similarity=0.467  Sum_probs=113.8

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc--------CCCEEEEEEecCcc--cCHHHHHHHHHHHcCC-CcCcccceeEEE
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH--------TGGLIAVKMLKNSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFC  367 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~  367 (436)
                      ++...+|.+.+.||+|+||.||++...        ++..||+|+++...  ...+.+.+|+.+++++ +||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            445567888899999999999999853        46689999997643  2345688999999999 899999999999


Q ss_pred             EeCCeeeEEEecCCCCChhhhccCCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          368 SEGSKRAVVYEYMPNGSLDRHIFPKESR------------GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       368 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      ...+..++||||+++|+|.+++......            ...+++..++.++.|+++||+|||++   +|+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence            9999999999999999999999643211            23489999999999999999999998   99999999999


Q ss_pred             C
Q 041073          436 I  436 (436)
Q Consensus       436 I  436 (436)
                      |
T Consensus       188 I  188 (334)
T 2pvf_A          188 V  188 (334)
T ss_dssp             E
T ss_pred             E
Confidence            7

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.82  E-value=3.7e-21  Score=192.21  Aligned_cols=127  Identities=24%  Similarity=0.304  Sum_probs=104.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|.+.+.||+|+||.||++.. .+++.||+|+++..    ......+.+|+.+++.++||||+++++++...+..++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            3567778999999999999985 47889999999752    223356788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++.    +...+++..+..++.|++.||+|||+ +   +|+||||||+||
T Consensus       228 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NI  280 (446)
T 4ejn_A          228 EYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENL  280 (446)
T ss_dssp             CCCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGE
T ss_pred             eeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHE
Confidence            9999999999883    23568999999999999999999997 6   899999999997

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.82  E-value=1.3e-20  Score=180.97  Aligned_cols=128  Identities=23%  Similarity=0.299  Sum_probs=112.1

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---------CHHHHHHHHHHHcCCCcCcccceeEEEEeCC
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS  371 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  371 (436)
                      ..+|.+.+.||+|+||.||++.. .+++.||+|+++....         ..+.+.+|+.++++++||||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            45677889999999999999985 4788899999976432         2235778999999999999999999999999


Q ss_pred             eeeEEEecCCCC-ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNG-SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..++||||+..| +|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  161 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENI  161 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHE
Confidence            999999999777 9999983    335699999999999999999999998   999999999997

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.82  E-value=1.1e-20  Score=176.99  Aligned_cols=127  Identities=24%  Similarity=0.364  Sum_probs=112.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ..|.+.+.||+|+||.||++... +++.||+|++......   .+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            35667789999999999999864 6889999999764433   3568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        86 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Ni  136 (284)
T 3kk8_A           86 LVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENL  136 (284)
T ss_dssp             CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHE
Confidence            9999999988842    35689999999999999999999998   999999999997

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.82  E-value=1.7e-20  Score=178.04  Aligned_cols=126  Identities=23%  Similarity=0.386  Sum_probs=111.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +|.+.+.||+|+||.||++... +++.||+|++......   .+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY   83 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence            4667789999999999999965 6889999998764433   35578999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        84 ~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Ni  133 (311)
T 4agu_A           84 CDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENI  133 (311)
T ss_dssp             CSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhE
Confidence            99999998873    335689999999999999999999998   999999999997

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.82  E-value=1.2e-20  Score=179.28  Aligned_cols=133  Identities=25%  Similarity=0.300  Sum_probs=111.4

Q ss_pred             hHHHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC---HHHHHHHHHHHcCC-CcCcccceeEEEEeCC
Q 041073          297 YPEIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS---AEEFINEVSTIGRI-HHVNVVQLLGFCSEGS  371 (436)
Q Consensus       297 ~~~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  371 (436)
                      ..++....|++.++||+|+||+||+|... +++.||||++......   ..+...|+..+.++ +|+||+++++++.+++
T Consensus        51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            34566678888999999999999999965 7889999998664332   23455566555554 8999999999999999


Q ss_pred             eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ..++||||+ +++|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI  188 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANI  188 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHE
Confidence            999999999 77999888432   35699999999999999999999998   999999999997

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.82  E-value=2.3e-21  Score=184.31  Aligned_cols=127  Identities=21%  Similarity=0.295  Sum_probs=109.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc-C---HHHHHHHHHHHcCCCcCcccceeEEEEeCC----ee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF-S---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KR  373 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  373 (436)
                      .+|.+.+.||+|+||.||+++. .+++.||+|+++.... .   ...+.+|+.++++++||||+++++++....    ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            4677889999999999999995 5788999999976432 2   246889999999999999999999887644    34


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        92 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Ni  147 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANI  147 (311)
T ss_dssp             EEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHE
Confidence            999999999999999842    34689999999999999999999998   999999999997

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.82  E-value=5.3e-21  Score=183.03  Aligned_cols=136  Identities=28%  Similarity=0.430  Sum_probs=113.4

Q ss_pred             HHHHHHhhhhhcccCCCCCeEEEEEEE------cCCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEe
Q 041073          298 PEIIAMTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE  369 (436)
Q Consensus       298 ~~i~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  369 (436)
                      .++...+|.+.+.||+|+||.||+|..      .++..||+|.+...  .....++.+|+.++++++||||+++++++..
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            345567788889999999999999983      25678999999653  2234568899999999999999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKES---RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ....++||||+++++|.+++.....   ....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NI  171 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC  171 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHE
Confidence            8899999999999999999964332   124589999999999999999999998   999999999997

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.82  E-value=7.3e-21  Score=183.32  Aligned_cols=132  Identities=23%  Similarity=0.319  Sum_probs=111.5

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc------ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS------KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ..+|.+.+.||+|+||.||++.. .++..+|+|++...      ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            46678889999999999999986 47788999998652      223467899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCC------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 041073          375 VVYEYMPNGSLDRHIFPKES------------------------------------RGQSFSWEKLHEVALGTARGIEYL  418 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~i~~gL~yL  418 (436)
                      +||||+++|+|.+++.....                                    ....+++..+..++.|+++||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999998842100                                    012246778889999999999999


Q ss_pred             HcCCCCceEecCCCCCCC
Q 041073          419 HNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       419 H~~~~~~iiHrDlkp~NI  436 (436)
                      |++   +|+||||||+||
T Consensus       185 H~~---~ivH~Dlkp~NI  199 (345)
T 3hko_A          185 HNQ---GICHRDIKPENF  199 (345)
T ss_dssp             HHT---TEECCCCCGGGE
T ss_pred             HHC---CccccCCChhhE
Confidence            998   999999999997

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.82  E-value=9.7e-21  Score=181.50  Aligned_cols=126  Identities=23%  Similarity=0.299  Sum_probs=110.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ..|.+.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+.+++.+ +|+||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            3466778999999999999995 5788999999875432 24588999999999 8999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       +++|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        88 -~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Ni  136 (330)
T 2izr_A           88 -GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENF  136 (330)
T ss_dssp             -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             -CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHe
Confidence             99999998432   35799999999999999999999998   999999999997

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.82  E-value=1.2e-20  Score=177.99  Aligned_cols=128  Identities=25%  Similarity=0.350  Sum_probs=111.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEe------------
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE------------  369 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------------  369 (436)
                      ..|.+.+.||+|+||.||++... +++.||+|.++......+.+.+|+.+++.++||||+++++++..            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            46777899999999999999964 78899999997655555778999999999999999999998765            


Q ss_pred             -CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          370 -GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       ....++||||+++|+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Ni  147 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNI  147 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             cCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhE
Confidence             3567899999999999999943   234678899999999999999999998   999999999997

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.82  E-value=2.3e-20  Score=175.07  Aligned_cols=127  Identities=31%  Similarity=0.569  Sum_probs=109.0

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc--C------HHHHHHHHHHHcCCCcCcccceeEEEEeCCe
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF--S------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  372 (436)
                      ..+|.+.+.||+|+||.||++.. .+++.||+|++.....  .      .+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            35667789999999999999996 4788999999865221  1      157899999999999999999999986654 


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NI  436 (436)
                       ++||||+++|+|.+++..   ....+++..+..++.|++.||+|||++   +  |+||||||+||
T Consensus        97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Ni  155 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNI  155 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGE
T ss_pred             -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceE
Confidence             699999999999988843   335799999999999999999999998   7  99999999997

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.82  E-value=2.9e-20  Score=174.49  Aligned_cols=132  Identities=27%  Similarity=0.405  Sum_probs=117.4

Q ss_pred             HHHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          298 PEIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       298 ~~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      ++....+|++.+.||+|+||.||++... +++.||+|++...   ....+.+.+|++++++++||||+++++++...+..
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            3455678888999999999999999965 7889999998653   33567899999999999999999999999999999


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NI  152 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENI  152 (287)
T ss_dssp             EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhE
Confidence            999999999999998843    24689999999999999999999998   999999999997

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.82  E-value=6.4e-21  Score=178.42  Aligned_cols=130  Identities=25%  Similarity=0.358  Sum_probs=110.3

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      +...+|.+.+.||+|+||.||+|...    .+..||+|.++...  ...+.+.+|+.++++++||||+++++++. .+..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            34457778899999999999999854    24469999987532  23456899999999999999999999874 5668


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++++|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  147 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNV  147 (281)
T ss_dssp             EEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHE
Confidence            899999999999999843   234689999999999999999999998   999999999997

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.82  E-value=3.5e-20  Score=176.70  Aligned_cols=123  Identities=28%  Similarity=0.459  Sum_probs=108.2

Q ss_pred             hhhcccCCCCCeEEEEEEEc-----CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEe--CCeeeEE
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-----TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAVV  376 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  376 (436)
                      ++.+.||+|+||.||++.+.     +++.||+|+++...  ...+.+.+|++++++++||||+++++++..  ....++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            77899999999999988642     67889999997643  234568999999999999999999999987  4678999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++..     ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       114 ~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Ni  165 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNV  165 (318)
T ss_dssp             ECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheE
Confidence            999999999999932     3489999999999999999999998   999999999997

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.82  E-value=1.1e-20  Score=179.49  Aligned_cols=135  Identities=30%  Similarity=0.474  Sum_probs=114.7

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEE------cCCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSE  369 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  369 (436)
                      ++...++.+.+.||+|+||.||++..      .+++.||+|+++....  ..+.+.+|+.+++++ +||||+++++++..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34446777889999999999999984      2457899999976432  346789999999999 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKES--------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      .+..++||||+++|+|.+++.....              ....+++..+..++.|+++||+|||++   +|+||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence            9999999999999999999854321              123589999999999999999999998   99999999999


Q ss_pred             C
Q 041073          436 I  436 (436)
Q Consensus       436 I  436 (436)
                      |
T Consensus       176 i  176 (313)
T 1t46_A          176 I  176 (313)
T ss_dssp             E
T ss_pred             E
Confidence            7

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.82  E-value=3.6e-20  Score=175.18  Aligned_cols=126  Identities=23%  Similarity=0.368  Sum_probs=113.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      ..|.+.+.||+|+||.||+|.. .+++.||+|++...  ....+.+.+|+.+++.++||||+++++++......++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            3466778999999999999985 47889999999763  33467899999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       102 ~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Ni  150 (303)
T 3a7i_A          102 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANV  150 (303)
T ss_dssp             CTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheE
Confidence            99999999982     35689999999999999999999998   999999999997

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.82  E-value=3.2e-20  Score=174.14  Aligned_cols=126  Identities=24%  Similarity=0.447  Sum_probs=108.3

Q ss_pred             hhhhhc-ccCCCCCeEEEEEEEc---CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          304 TNHFTH-KLGQGGFGSVYKGQLH---TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       304 ~~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ++.+.+ .||+|+||.||+|...   ++..||+|+++...  ...+.+.+|+++++.++||||+++++++ ..+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            344555 8999999999999853   56789999997632  2346789999999999999999999998 556689999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        89 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  141 (287)
T 1u59_A           89 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNV  141 (287)
T ss_dssp             ECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheE
Confidence            99999999999842   345699999999999999999999998   999999999997

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.82  E-value=2e-20  Score=174.94  Aligned_cols=132  Identities=26%  Similarity=0.448  Sum_probs=113.6

Q ss_pred             hHHHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEe------
Q 041073          297 YPEIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE------  369 (436)
Q Consensus       297 ~~~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  369 (436)
                      .++.....|.+.+.||+|+||.||++... +++.||+|.++...   +.+.+|++++++++||||+++++++..      
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            34556677888899999999999999975 78899999987643   356789999999999999999998854      


Q ss_pred             ----------CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          370 ----------GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 ----------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                                ....++||||+++++|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Ni  153 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNI  153 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHE
Confidence                      44578999999999999999532  235689999999999999999999998   999999999997

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.82  E-value=6e-20  Score=175.77  Aligned_cols=138  Identities=25%  Similarity=0.354  Sum_probs=118.0

Q ss_pred             ccChHHHHHHhhhhh-cccCCCCCeEEEEEEEc-CCCEEEEEEecCc---ccCHHHHHHHHHHHcCCC-cCcccceeEEE
Q 041073          294 RYSYPEIIAMTNHFT-HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS---KFSAEEFINEVSTIGRIH-HVNVVQLLGFC  367 (436)
Q Consensus       294 ~~~~~~i~~~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  367 (436)
                      .+...+.....|.+. +.||+|+||.||++... +++.||+|+++..   ......+.+|+.++..++ ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344556666677776 78999999999999865 6889999998763   334678999999999985 69999999999


Q ss_pred             EeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       368 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...+..++||||+++|+|.+++..  .....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NI  162 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNI  162 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHE
Confidence            999999999999999999998843  2345799999999999999999999998   999999999997

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.82  E-value=2.1e-20  Score=177.35  Aligned_cols=131  Identities=22%  Similarity=0.355  Sum_probs=112.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|.+.+.||+|+||.||++.. .+++.||+|+++...    ...+.+.+|+.++++++|+||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            4577889999999999999985 478899999987522    22456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++.........+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NI  167 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANV  167 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHE
Confidence            99999999998854323346689999999999999999999998   999999999997

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.82  E-value=2.2e-20  Score=179.98  Aligned_cols=126  Identities=17%  Similarity=0.249  Sum_probs=111.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCc--CcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|.+.+.||+|+||.||++...+++.||+|++......   .+.+.+|+.++..++|  +||+++++++......++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            346678999999999999999888899999998764333   3568899999999976  99999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      | +.+++|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        89 e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NI  139 (343)
T 3dbq_A           89 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANF  139 (343)
T ss_dssp             C-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             e-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence            9 458899999943    35689999999999999999999998   999999999997

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.82  E-value=1.9e-20  Score=176.30  Aligned_cols=127  Identities=24%  Similarity=0.267  Sum_probs=111.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      .+|.+.+.||+|+||.||++... +++.+|+|++....    ...+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            45667789999999999999965 67889999986532    23456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        95 e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Ni  146 (294)
T 2rku_A           95 ELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNL  146 (294)
T ss_dssp             ECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             ecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhE
Confidence            9999999999883    235689999999999999999999998   999999999997

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.82  E-value=7.2e-21  Score=182.69  Aligned_cols=131  Identities=33%  Similarity=0.502  Sum_probs=111.9

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcC-----CCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCe
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHT-----GGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  372 (436)
                      +....+.+.+.||+|+||.||+|....     +..||+|.++....  ....+.+|+.+++.++||||+++++++...+.
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            334455667899999999999998542     23599999976332  33568899999999999999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+++|+|.+++..   ....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus       121 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI  178 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNI  178 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             cEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheE
Confidence            9999999999999999843   335689999999999999999999998   999999999997

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.82  E-value=1.6e-20  Score=179.70  Aligned_cols=128  Identities=27%  Similarity=0.432  Sum_probs=110.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-----cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEE--eCCeee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  374 (436)
                      .++++.+.||+|+||.||+++.     .+++.||+|++.... ...+.+.+|++++++++|+||+++++++.  .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5667889999999999999984     367889999997643 23456899999999999999999999886  456689


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus       103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NI  158 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNI  158 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhE
Confidence            999999999999998432   24589999999999999999999998   999999999997

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.82  E-value=2.3e-20  Score=173.94  Aligned_cols=127  Identities=24%  Similarity=0.342  Sum_probs=113.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      .+|.+.+.||+|+||.||++... +++.||+|++...    ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            35667789999999999999965 7889999998652    234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        91 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Ni  142 (276)
T 2h6d_A           91 EYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENV  142 (276)
T ss_dssp             ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGE
T ss_pred             eccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhE
Confidence            99999999999842    24689999999999999999999998   999999999997

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.82  E-value=2.2e-20  Score=176.41  Aligned_cols=128  Identities=27%  Similarity=0.479  Sum_probs=111.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc-ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ..|.+.+.||+|+||.||++... +++.+|+|++... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            45677899999999999999965 6889999998763 345678999999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        99 ~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Ni  148 (302)
T 2j7t_A           99 PGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNV  148 (302)
T ss_dssp             TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGE
T ss_pred             CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHE
Confidence            99999998843   235689999999999999999999998   999999999997

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.81  E-value=3.1e-20  Score=178.18  Aligned_cols=133  Identities=23%  Similarity=0.404  Sum_probs=110.1

Q ss_pred             ChHHHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcC--CCcCcccceeEEEEeC---
Q 041073          296 SYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGR--IHHVNVVQLLGFCSEG---  370 (436)
Q Consensus       296 ~~~~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~---  370 (436)
                      ...+.....|++.+.||+|+||.||+|+.. ++.||+|++....  ...+.+|.+++..  ++||||+++++++...   
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            344556678889999999999999999876 8899999986543  2344555555554  4899999999999887   


Q ss_pred             -CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCceEecCCCCCCC
Q 041073          371 -SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC-----DVCILHFDIKPHNI  436 (436)
Q Consensus       371 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~-----~~~iiHrDlkp~NI  436 (436)
                       ...++||||+++|+|.+++..     ..+++..+..++.|++.||+|||++.     .++|+||||||+||
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Ni  173 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI  173 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGE
T ss_pred             CCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHE
Confidence             788999999999999999932     36899999999999999999999741     33899999999997

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.81  E-value=1e-20  Score=189.69  Aligned_cols=126  Identities=21%  Similarity=0.350  Sum_probs=100.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeC-----Cee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKR  373 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  373 (436)
                      .+|.+.+.||+|+||.||++... +++.||||++.....   ..+++.+|+++|+.++|+||+++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            45778899999999999999854 788999999876332   345688999999999999999999998443     568


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+ +++|.+++.    ....+++..+..++.||+.||+|||++   +|+||||||+||
T Consensus       133 ~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NI  187 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANC  187 (458)
T ss_dssp             EEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGE
T ss_pred             EEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhE
Confidence            9999998 579999883    335699999999999999999999998   999999999997

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.81  E-value=2.4e-20  Score=174.72  Aligned_cols=127  Identities=22%  Similarity=0.399  Sum_probs=112.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|.+.+.||+|+||.||++... ++..||+|++...    ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            35667789999999999999865 6778999998652    223567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        94 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Ni  145 (284)
T 2vgo_A           94 EFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENL  145 (284)
T ss_dssp             CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGE
T ss_pred             EeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHE
Confidence            99999999999843    24689999999999999999999998   999999999997

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.81  E-value=1.6e-20  Score=179.25  Aligned_cols=133  Identities=28%  Similarity=0.469  Sum_probs=104.7

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEcC-CC---EEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLHT-GG---LIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~~-~~---~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      ...+|.+.+.||+|+||.||++.... ++   .||+|+++..   ....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34567788999999999999998543 32   7999998763   22346799999999999999999999999876654


Q ss_pred             ------eEEEecCCCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 ------AVVYEYMPNGSLDRHIFPKE--SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ------~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                            +++|||+++|+|.+++....  .....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NI  168 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNC  168 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceE
Confidence                  89999999999999985332  1223689999999999999999999998   999999999997

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.81  E-value=2e-20  Score=179.69  Aligned_cols=127  Identities=24%  Similarity=0.267  Sum_probs=112.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      .+|.+.+.||+|+||.||++... +++.+|+|++....    ...+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            45667899999999999999965 67889999987532    23456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       121 e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NI  172 (335)
T 2owb_A          121 ELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNL  172 (335)
T ss_dssp             CCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             ecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhE
Confidence            9999999999883    235689999999999999999999998   999999999997

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.81  E-value=2.7e-20  Score=179.58  Aligned_cols=130  Identities=22%  Similarity=0.310  Sum_probs=112.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccC------------------HHHHHHHHHHHcCCCcCccccee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS------------------AEEFINEVSTIGRIHHVNVVQLL  364 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~E~~~l~~l~h~niv~l~  364 (436)
                      ..|.+.+.||+|+||.||++.. +++.||+|.+......                  .+.+.+|+.++++++||||++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            4677789999999999999998 8999999998652211                  17799999999999999999999


Q ss_pred             EEEEeCCeeeEEEecCCCCChhhhcc----CCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEecCCCCCCC
Q 041073          365 GFCSEGSKRAVVYEYMPNGSLDRHIF----PKESRGQSFSWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNI  436 (436)
Q Consensus       365 ~~~~~~~~~~lv~E~~~~gsL~~~l~----~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~-~~~~~iiHrDlkp~NI  436 (436)
                      +++...+..++||||+++|+|.+++.    ........+++..+..++.|++.||+|||+ +   +|+||||||+||
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni  183 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI  183 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence            99999999999999999999999831    111224679999999999999999999998 7   999999999997

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.81  E-value=4.9e-20  Score=190.96  Aligned_cols=120  Identities=25%  Similarity=0.472  Sum_probs=106.1

Q ss_pred             ccCCCCCeEEEEEEEc---CCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCC
Q 041073          310 KLGQGGFGSVYKGQLH---TGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGS  384 (436)
Q Consensus       310 ~lg~G~fg~V~~~~~~---~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  384 (436)
                      .||+|+||.||+|..+   ++..||||+++..  ....+++.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999854   4557999999763  3356789999999999999999999999876 56899999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          385 LDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NI  467 (613)
T 2ozo_A          422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNV  467 (613)
T ss_dssp             HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHE
Confidence            9999943   345699999999999999999999998   999999999997

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.81  E-value=8.5e-21  Score=178.35  Aligned_cols=134  Identities=35%  Similarity=0.584  Sum_probs=110.7

Q ss_pred             ccChHHHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeC
Q 041073          294 RYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEG  370 (436)
Q Consensus       294 ~~~~~~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~  370 (436)
                      ..+..|+...++.+.+.||+|+||.||++...  ..+|+|+++.....   .+.+.+|+.+++.++|+||++++++. ..
T Consensus        15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~   91 (289)
T 3og7_A           15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA   91 (289)
T ss_dssp             ---CCBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred             CCCCCccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence            34445666777888899999999999999854  35999999764333   35689999999999999999999965 55


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..++||||+++++|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Ni  151 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNI  151 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             CccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceE
Confidence            668999999999999999843   345699999999999999999999998   999999999997

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.81  E-value=2.3e-20  Score=178.68  Aligned_cols=128  Identities=25%  Similarity=0.456  Sum_probs=105.6

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCC----EEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ...|++.+.||+|+||.||+|... +++    .||+|.++..  ....+++.+|+.++++++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            355677899999999999999853 444    3588887642  334577999999999999999999999998765 77


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++||+++|+|.+++..   ....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus        93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NI  148 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV  148 (327)
T ss_dssp             EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheE
Confidence            89999999999999853   235699999999999999999999998   999999999997

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.81  E-value=3.2e-20  Score=177.55  Aligned_cols=130  Identities=29%  Similarity=0.486  Sum_probs=110.9

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEE-----cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCC--e
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQL-----HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--K  372 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~  372 (436)
                      ....+++.+.||+|+||.||+++.     .+++.||+|.+.... ...+.+.+|++++++++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            345567889999999999999983     367889999997643 33467999999999999999999999886543  6


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+++++|.+++...   ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NI  176 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNI  176 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             eEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceE
Confidence            79999999999999999432   34689999999999999999999998   999999999997

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.81  E-value=2e-20  Score=176.45  Aligned_cols=127  Identities=31%  Similarity=0.468  Sum_probs=107.0

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcC----CCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEE-eCCeeeEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHT----GGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRAVV  376 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv  376 (436)
                      ++++.+.||+|+||.||+|....    ...+|+|.++...  ...+.+.+|+.++++++||||+++++++. .++..++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            35667899999999999998532    2258999987632  23467899999999999999999999864 45678999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       106 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Ni  159 (298)
T 3f66_A          106 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNC  159 (298)
T ss_dssp             EECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheE
Confidence            999999999999943   345689999999999999999999998   999999999997

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.81  E-value=6e-21  Score=183.06  Aligned_cols=135  Identities=29%  Similarity=0.450  Sum_probs=113.4

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc-CC-----CEEEEEEecCcc--cCHHHHHHHHHHHcCC-CcCcccceeEEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH-TG-----GLIAVKMLKNSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSE  369 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~-----~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  369 (436)
                      ++....+.+.+.||+|+||.||++... ++     ..||+|.++...  ...+.+.+|+.+++.+ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            344566778899999999999999854 22     479999997643  2345689999999999 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKES----------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+..++||||+++|+|.+++.....          ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  195 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV  195 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGC
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceE
Confidence            9999999999999999999853210          134689999999999999999999998   999999999997

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.81  E-value=2.8e-20  Score=174.77  Aligned_cols=125  Identities=26%  Similarity=0.392  Sum_probs=108.0

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEe----CCeeeEE
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRAVV  376 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  376 (436)
                      +.+.+.||+|+||.||+|... ++..||+|.+.....   ..+.+.+|+.+++.++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            556788999999999999864 677899999876433   34568999999999999999999998865    3557999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NI  436 (436)
                      |||+++++|.+++.    ....+++..+..++.|++.||+|||++   +  |+||||||+||
T Consensus       108 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Ni  162 (290)
T 1t4h_A          108 TELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNI  162 (290)
T ss_dssp             EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGE
T ss_pred             EEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHE
Confidence            99999999999993    235689999999999999999999997   6  99999999997

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.81  E-value=3.5e-20  Score=178.97  Aligned_cols=127  Identities=25%  Similarity=0.387  Sum_probs=110.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC----HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..+...+.||+|+||.||+|.. .+++.||||++......    .+.+.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4566778899999999999985 57889999998753322    346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||++ |+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  185 (348)
T 1u5q_A          134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNI  185 (348)
T ss_dssp             ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGE
T ss_pred             ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHE
Confidence            9996 688887732   235689999999999999999999998   999999999997

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.81  E-value=1.2e-20  Score=176.24  Aligned_cols=131  Identities=21%  Similarity=0.315  Sum_probs=111.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEe--CCeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  376 (436)
                      ..|++.+.||+|+||.||++... +++.||+|.+.....   ..+.+.+|+.++++++||||+++++++..  ....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            35667789999999999999865 788999999976432   34568899999999999999999998754  6788999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc-----eEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC-----ILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~-----iiHrDlkp~NI  436 (436)
                      |||+++++|.+++.........+++..+..++.|++.||+|||++   +     |+||||||+||
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NI  147 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANV  147 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGE
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhE
Confidence            999999999999864433345699999999999999999999987   6     99999999997

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.81  E-value=1.7e-20  Score=182.89  Aligned_cols=126  Identities=31%  Similarity=0.487  Sum_probs=106.6

Q ss_pred             hhhhcccCCCCCeEEEEEEEc--CC--CEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEe-CCeeeEEE
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH--TG--GLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRAVVY  377 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~--~~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  377 (436)
                      +++.+.||+|+||.||+|...  ++  ..+|+|.++...  ...+++.+|+.++++++||||+++++++.. .+..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            445688999999999999853  22  358999987532  234679999999999999999999998754 55789999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       171 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  223 (373)
T 3c1x_A          171 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNC  223 (373)
T ss_dssp             ECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             ECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheE
Confidence            99999999999943   335689999999999999999999998   999999999997

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.81  E-value=1e-20  Score=183.23  Aligned_cols=127  Identities=25%  Similarity=0.308  Sum_probs=111.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE----cCCCEEEEEEecCcc-----cCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL----HTGGLIAVKMLKNSK-----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  372 (436)
                      ..|.+.+.||+|+||.||+++.    .+++.||||+++...     ...+.+.+|+++++.+ +|+||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            4677889999999999999986    378899999987521     2345577899999999 69999999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+++|+|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       134 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NI  190 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENI  190 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             EEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            9999999999999999843    24689999999999999999999998   999999999997

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.81  E-value=5.6e-20  Score=174.70  Aligned_cols=131  Identities=30%  Similarity=0.436  Sum_probs=109.3

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      +.....|.+.+.||+|+||.||++... +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            344566778899999999999999865 68899999997643 3467899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus       104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Ni  156 (314)
T 3com_A          104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNI  156 (314)
T ss_dssp             ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHE
Confidence            99999999999842   235689999999999999999999998   999999999997

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.81  E-value=7.1e-20  Score=175.23  Aligned_cols=122  Identities=21%  Similarity=0.397  Sum_probs=109.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCC-cCcccceeEEEEe--CCeeeEEEe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSE--GSKRAVVYE  378 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~E  378 (436)
                      ..|++.+.||+|+||.||++.. .+++.||+|+++..  ..+.+.+|+.++++++ |+||+++++++..  ....++|||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            4577789999999999999985 57889999998743  4567899999999997 9999999999987  667899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++       ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       114 ~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Ni  161 (330)
T 3nsz_A          114 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNV  161 (330)
T ss_dssp             CCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             ccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHE
Confidence            99999999988       2489999999999999999999998   999999999997

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.81  E-value=6.8e-20  Score=173.75  Aligned_cols=132  Identities=27%  Similarity=0.507  Sum_probs=106.1

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc------cCHHHHHHHHHHHcCCC---cCcccceeEEEE
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK------FSAEEFINEVSTIGRIH---HVNVVQLLGFCS  368 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  368 (436)
                      ++...+|.+.+.||+|+||.||++.. .+++.||+|+++...      .....+.+|+.+++.++   ||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            44556788889999999999999995 578899999986422      12345677887777664   999999999998


Q ss_pred             eCC-----eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          369 EGS-----KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       369 ~~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...     ..+++|||++ ++|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Ni  151 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENI  151 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTE
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            755     5789999996 6999998532  223499999999999999999999998   999999999997

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.81  E-value=2.3e-20  Score=185.61  Aligned_cols=126  Identities=19%  Similarity=0.318  Sum_probs=109.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeC-----Cee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKR  373 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  373 (436)
                      .+|.+.+.||+|+||.||++... +++.||||+++....   ..+++.+|+++|+.++|+||+++++++...     ...
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            45677899999999999999854 678899999976332   345789999999999999999999998765     568


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||++ ++|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       106 ~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NI  160 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANC  160 (432)
T ss_dssp             EEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             EEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHe
Confidence            99999985 69999983    335699999999999999999999998   999999999997

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.81  E-value=1.3e-20  Score=178.69  Aligned_cols=129  Identities=27%  Similarity=0.462  Sum_probs=108.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      ..+.+.+.||+|+||.||++... ++.||+|.+... ...+.+.+|++++++++||||+++++++.  +..++||||+++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~   83 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG   83 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence            45667789999999999999875 778999998653 23567899999999999999999999876  347899999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.... ....+++..++.++.|+++||+|||+....+|+||||||+||
T Consensus        84 ~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NI  136 (307)
T 2eva_A           84 GSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL  136 (307)
T ss_dssp             CBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGE
T ss_pred             CCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHE
Confidence            99999995432 223578999999999999999999983223899999999997

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.81  E-value=2.7e-20  Score=176.72  Aligned_cols=127  Identities=19%  Similarity=0.292  Sum_probs=112.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc-C---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF-S---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|.+.+.||+|+||.||++... +++.||+|++..... .   .+.+.+|+.++++++||||+++++++...+..+++|
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            45778899999999999999965 688899999876322 2   356889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++++|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       114 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NI  165 (309)
T 2h34_A          114 RLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENI  165 (309)
T ss_dssp             ECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHE
Confidence            99999999999842    34689999999999999999999998   999999999997

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.81  E-value=1.3e-20  Score=179.73  Aligned_cols=135  Identities=29%  Similarity=0.427  Sum_probs=114.5

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeC
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEG  370 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  370 (436)
                      ++...+|.+.+.||+|+||.||+|...      +++.||+|.+.....  ....+.+|+.+++.++|+||+++++++...
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            444567788899999999999999743      367899999876332  334688999999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKE------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..++||||+++|+|.+++....      .....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI  169 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC  169 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence            99999999999999999985321      1124578999999999999999999998   999999999997

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.81  E-value=3.5e-20  Score=181.82  Aligned_cols=126  Identities=17%  Similarity=0.245  Sum_probs=110.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccC---HHHHHHHHHHHcCCC--cCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|.+.+.||+|+||.||++...+++.||||++......   .+.+.+|+.++++++  |+||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            347778999999999999999877899999999764332   356899999999996  599999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      | +.+++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       136 E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NI  186 (390)
T 2zmd_A          136 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANF  186 (390)
T ss_dssp             E-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGE
T ss_pred             e-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHE
Confidence            9 568899999843    34689999999999999999999998   999999999997

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.81  E-value=8.2e-20  Score=177.61  Aligned_cols=128  Identities=22%  Similarity=0.286  Sum_probs=112.4

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--C-------HHHHHHHHHHHcCC-CcCcccceeEEEEeC
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--S-------AEEFINEVSTIGRI-HHVNVVQLLGFCSEG  370 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~-------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  370 (436)
                      ...|.+.+.||+|+||.||++... +|+.||||+++....  .       .+.+.+|+.+++++ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            345677789999999999999975 789999999876331  1       34578999999998 799999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...++||||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NI  231 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENI  231 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             CEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            999999999999999999842    35689999999999999999999998   999999999997

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.81  E-value=1e-19  Score=171.18  Aligned_cols=124  Identities=28%  Similarity=0.372  Sum_probs=107.7

Q ss_pred             cccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCCChh
Q 041073          309 HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLD  386 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  386 (436)
                      ..||+|+||.||+|.. .++..||+|.++... ...+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            4799999999999995 467899999987643 34567899999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          387 RHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       387 ~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++.... ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Ni  153 (295)
T 2clq_A          108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNV  153 (295)
T ss_dssp             HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhE
Confidence            9985432 234567899999999999999999998   999999999997

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.81  E-value=3.6e-20  Score=177.60  Aligned_cols=127  Identities=25%  Similarity=0.438  Sum_probs=111.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .+|.+.+.||+|+||.||++... +++.||+|++......   .+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            35677889999999999999965 6889999998664333   3457899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       105 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Ni  155 (331)
T 4aaa_A          105 FVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENI  155 (331)
T ss_dssp             CCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             cCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheE
Confidence            999999988763    335699999999999999999999998   999999999997

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.80  E-value=1.3e-20  Score=182.74  Aligned_cols=131  Identities=24%  Similarity=0.340  Sum_probs=113.8

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      +....|.+.+.||+|+||.||++... ++..||+|++....  ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            33456777899999999999999965 78899999987642  2345689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++++|.+++..    ...+++..+..++.|++.||+|||++  .+|+||||||+||
T Consensus       110 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Ni  163 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNI  163 (360)
T ss_dssp             ECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGE
T ss_pred             EECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHE
Confidence            999999999999842    34689999999999999999999973  1799999999997

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.80  E-value=5.6e-20  Score=172.90  Aligned_cols=126  Identities=25%  Similarity=0.452  Sum_probs=106.8

Q ss_pred             Hhhhhhc-ccCCCCCeEEEEEEE---cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          303 MTNHFTH-KLGQGGFGSVYKGQL---HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       303 ~~~~~~~-~lg~G~fg~V~~~~~---~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      .++.+.+ .||+|+||.||++..   .+++.||+|+++....   ..+++.+|+.+++.++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4555666 899999999999964   2467899999976422   246789999999999999999999998 5667889


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++++|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        95 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Ni  148 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNV  148 (291)
T ss_dssp             EEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceE
Confidence            9999999999999943    34689999999999999999999998   999999999997

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.80  E-value=1.1e-19  Score=174.71  Aligned_cols=131  Identities=27%  Similarity=0.425  Sum_probs=113.0

Q ss_pred             cChHHHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcC--CCcCcccceeEEEEeCC-
Q 041073          295 YSYPEIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGR--IHHVNVVQLLGFCSEGS-  371 (436)
Q Consensus       295 ~~~~~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~-  371 (436)
                      +...+....+|.+.+.||+|+||.||++.. +++.||+|++...  ..+.+.+|.+++..  ++||||+++++++.... 
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~  110 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNG  110 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence            344566678888999999999999999987 4889999998653  34567788888776  78999999999998765 


Q ss_pred             ---eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCceEecCCCCCCC
Q 041073          372 ---KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH--------NGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH--------~~~~~~iiHrDlkp~NI  436 (436)
                         ..++||||+++|+|.+++..     ..+++..+..++.|++.||+|||        +.   +|+||||||+||
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI  178 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI  178 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred             ccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence               78999999999999999932     35899999999999999999999        66   999999999997

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.80  E-value=3.2e-20  Score=176.36  Aligned_cols=134  Identities=34%  Similarity=0.486  Sum_probs=108.0

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCC-
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS-  371 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  371 (436)
                      +....|.+.+.||+|+||.||+|...    ++..||+|.++.....   .+.+.+|+.++++++||||+++++++.... 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34456778899999999999999854    3447999998764332   356889999999999999999999987654 


Q ss_pred             ----eeeEEEecCCCCChhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          372 ----KRAVVYEYMPNGSLDRHIFPKE--SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       372 ----~~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                          ..++||||+++|+|.+++....  .....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NI  178 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNC  178 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceE
Confidence                3489999999999999984322  2345799999999999999999999998   999999999997

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.80  E-value=2.5e-20  Score=182.44  Aligned_cols=127  Identities=24%  Similarity=0.354  Sum_probs=104.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEe------------
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE------------  369 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------------  369 (436)
                      .+|.+.+.||+|+||.||++.. .+++.||+|++.....   ...+|+++++.++||||+++++++..            
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            4567789999999999999985 5789999999865432   23479999999999999999998844            


Q ss_pred             --------------------------CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 041073          370 --------------------------GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD  423 (436)
Q Consensus       370 --------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~  423 (436)
                                                ....++||||++ |+|.+.+.........+++..+..++.|+++||+|||++  
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  160 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--  160 (383)
T ss_dssp             --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence                                      334789999997 588777643223456799999999999999999999988  


Q ss_pred             CceEecCCCCCCC
Q 041073          424 VCILHFDIKPHNI  436 (436)
Q Consensus       424 ~~iiHrDlkp~NI  436 (436)
                       +|+||||||+||
T Consensus       161 -gi~H~Dikp~Ni  172 (383)
T 3eb0_A          161 -GICHRDIKPQNL  172 (383)
T ss_dssp             -TEECSCCCGGGE
T ss_pred             -cCccCccCHHHE
Confidence             999999999997

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.80  E-value=4.8e-20  Score=173.68  Aligned_cols=125  Identities=29%  Similarity=0.420  Sum_probs=106.4

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCC---EEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCee-eEEEe
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGG---LIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR-AVVYE  378 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~---~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~E  378 (436)
                      ...+.||+|+||.||+|... ++.   .+|+|.+.....  ..+.+.+|+.+++.++||||+++++++...+.. +++||
T Consensus        24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  103 (298)
T 3pls_A           24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP  103 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred             ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence            34588999999999999843 222   699999876332  346789999999999999999999999766554 89999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       104 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Ni  155 (298)
T 3pls_A          104 YMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNC  155 (298)
T ss_dssp             CCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceE
Confidence            9999999999943   345689999999999999999999998   999999999997

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.80  E-value=2.6e-20  Score=178.03  Aligned_cols=126  Identities=29%  Similarity=0.458  Sum_probs=107.3

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCH--HHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSA--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      +|.+.+.||+|+||.||++... +++.||+|+++......  ..+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   82 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence            4567789999999999999965 78899999987533221  23567999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      + |+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        83 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NI  131 (324)
T 3mtl_A           83 D-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNL  131 (324)
T ss_dssp             S-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGE
T ss_pred             c-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHE
Confidence            6 589888843   335689999999999999999999998   999999999997

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.80  E-value=4.1e-20  Score=174.22  Aligned_cols=127  Identities=24%  Similarity=0.241  Sum_probs=111.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----------cCHHHHHHHHHHHcCCC-cCcccceeEEEEeC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----------FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEG  370 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  370 (436)
                      .+|.+.+.||+|+||.||++... +++.||+|+++...          ...+.+.+|+++++++. ||||+++++++...
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (298)
T 1phk_A           17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   96 (298)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence            45667789999999999999965 67899999987532          11345789999999996 99999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..++||||+++++|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        97 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Ni  155 (298)
T 1phk_A           97 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENI  155 (298)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceE
Confidence            999999999999999999842    35689999999999999999999998   999999999997

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.80  E-value=5.9e-20  Score=192.18  Aligned_cols=128  Identities=27%  Similarity=0.260  Sum_probs=112.4

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  375 (436)
                      ...+++.+.||+|+||.||+++.. +++.||||+++..    ....+.+..|..++..+ +|++|+++++++.+.+..+|
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            345677889999999999999954 6788999999752    23446688899999987 69999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++|+|.+++..    ...+++..++.++.||+.||+|||++   +|+||||||+||
T Consensus       420 V~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NI  473 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNV  473 (674)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTE
T ss_pred             EEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhE
Confidence            9999999999999842    24699999999999999999999998   999999999997

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.80  E-value=4.3e-20  Score=174.38  Aligned_cols=132  Identities=20%  Similarity=0.284  Sum_probs=99.6

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ...|.+.+.||+|+||.||++.. .+++.||+|.+...  ....+++.+|+.++++++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            34567789999999999999984 47889999998653  2334568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPK----ESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++...    ......+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Ni  152 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNI  152 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGE
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhE
Confidence            99999999988421    11245689999999999999999999998   999999999997

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.80  E-value=7.9e-20  Score=173.82  Aligned_cols=125  Identities=26%  Similarity=0.358  Sum_probs=102.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEE------------
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCS------------  368 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~------------  368 (436)
                      .+|.+.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|++++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            35667789999999999999965 58899999987533 33467899999999999999999998873            


Q ss_pred             --eCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          369 --EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       369 --~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                        .....++||||++ |+|.+++.     ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  151 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANL  151 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGE
T ss_pred             ccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHE
Confidence              3467899999997 69999982     35689999999999999999999998   999999999997

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.80  E-value=6.7e-20  Score=178.14  Aligned_cols=130  Identities=22%  Similarity=0.319  Sum_probs=106.1

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcC------CCEEEEEEecCcccC------------HHHHHHHHHHHcCCCcCccc
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHT------GGLIAVKMLKNSKFS------------AEEFINEVSTIGRIHHVNVV  361 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv  361 (436)
                      +....|.+.+.||+|+||.||+|....      ++.||+|++......            ......|+..+..++|+||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            344577888999999999999998653      468999998654311            12245566778888999999


Q ss_pred             ceeEEEEeC----CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          362 QLLGFCSEG----SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       362 ~l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++++...    ...++||||+ +++|.+++..   ....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Ni  183 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNL  183 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHE
Confidence            999998764    4579999999 9999999843   335799999999999999999999998   999999999997

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.80  E-value=6.4e-20  Score=190.62  Aligned_cols=120  Identities=25%  Similarity=0.482  Sum_probs=105.0

Q ss_pred             cccCCCCCeEEEEEEEc---CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH---TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||+|...   .++.||||+++....   ..+++.+|+++|++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999643   457899999976332   35789999999999999999999999864 457899999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.    ....+++..+..++.||+.||+|||++   +|+||||||+||
T Consensus       454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NI  500 (635)
T 4fl3_A          454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNV  500 (635)
T ss_dssp             EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhE
Confidence            99999993    335689999999999999999999998   999999999997

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.80  E-value=5.5e-20  Score=180.29  Aligned_cols=127  Identities=29%  Similarity=0.453  Sum_probs=101.3

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCC-cCcccceeEEEEeCC--ee
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGS--KR  373 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~  373 (436)
                      ...+|.+.+.||+|+||.||++.. .+++.||+|++.....   ..+++.+|+.+++.+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            445677889999999999999985 4788999999865322   3456789999999997 999999999997544  68


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||++ ++|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        87 ~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NI  140 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNI  140 (388)
T ss_dssp             EEEEECCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             EEEecccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHe
Confidence            99999997 68999883     24689999999999999999999998   999999999997

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.80  E-value=2.7e-20  Score=178.07  Aligned_cols=127  Identities=28%  Similarity=0.497  Sum_probs=105.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCE----EEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGL----IAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~----vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      ..+++.+.||+|+||.||+|... +++.    +|+|.+...  ....+.+.+|+.+++.++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            34567789999999999999854 4443    788877542  222345778999999999999999999886 456889


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++|+|.+++...   ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Ni  146 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNV  146 (325)
T ss_dssp             EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTE
T ss_pred             EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheE
Confidence            99999999999998432   34688999999999999999999998   999999999997

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.80  E-value=5.2e-20  Score=175.90  Aligned_cols=129  Identities=27%  Similarity=0.430  Sum_probs=113.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEe------CCeee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE------GSKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~  374 (436)
                      ..|.+.+.||+|+||.||+|.. .+++.||+|++.......+.+.+|+.+++++ +||||+++++++..      .+..+
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            4566779999999999999996 4788999999987665667899999999998 79999999999976      46789


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       104 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NI  160 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNV  160 (326)
T ss_dssp             EEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGE
T ss_pred             EEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHE
Confidence            999999999999998532  235689999999999999999999998   999999999997

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.80  E-value=1.2e-19  Score=171.17  Aligned_cols=127  Identities=24%  Similarity=0.442  Sum_probs=108.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      .|++.+.||+|+||.||++... +++.||+|.++....   ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (299)
T 2r3i_A            4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   83 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEEc
Confidence            4567789999999999999965 788999999875332   235788999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++ ++|.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        84 ~~-~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Ni  134 (299)
T 2r3i_A           84 LH-QDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNL  134 (299)
T ss_dssp             CS-EEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             cc-CCHHHHHHhh--hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHe
Confidence            97 6999988432  224689999999999999999999998   999999999997

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.80  E-value=2.3e-20  Score=177.45  Aligned_cols=134  Identities=29%  Similarity=0.451  Sum_probs=111.5

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEE------cCCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEEeC
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEG  370 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  370 (436)
                      +...+|.+.+.||+|+||.||++..      .+++.||+|+++....  ..+.+.+|+.++.++ +||||+++++++...
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            3446777889999999999999973      2457899999976432  235688999999999 699999999998765


Q ss_pred             C-eeeEEEecCCCCChhhhccCCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 S-KRAVVYEYMPNGSLDRHIFPKESR------------GQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~-~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      + ..++||||+++|+|.+++......            ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Ni  179 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  179 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceE
Confidence            4 589999999999999999543221            12389999999999999999999998   999999999997

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.80  E-value=1.1e-19  Score=174.02  Aligned_cols=127  Identities=26%  Similarity=0.463  Sum_probs=108.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCE----EEEEEecC--cccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGL----IAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~----vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      ..|++.+.||+|+||.||+|... +++.    +|+|.+..  .....+.+.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            45677899999999999999854 4443    57777754  3345678999999999999999999999998765 789


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||+++|+|.+++..   ....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        94 v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI  148 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV  148 (327)
T ss_dssp             EECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHE
Confidence            9999999999999843   235699999999999999999999998   999999999997

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.79  E-value=1.9e-19  Score=174.02  Aligned_cols=127  Identities=25%  Similarity=0.391  Sum_probs=107.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEe--------C
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--------G  370 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  370 (436)
                      .+|.+.+.||+|+||.||++.. .+++.||+|++....   .....+.+|+.+++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            4677889999999999999996 578899999986532   224568899999999999999999999877        4


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..++||||+++ +|.+.+..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI  155 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANV  155 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             ceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHE
Confidence            468999999975 77777632   335699999999999999999999998   999999999997

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.79  E-value=8.4e-20  Score=179.69  Aligned_cols=119  Identities=26%  Similarity=0.323  Sum_probs=101.3

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHH-cCCCcCcccceeEEEEe----CCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTI-GRIHHVNVVQLLGFCSE----GSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~E~~~~  382 (436)
                      +.||+|+||.||++... +++.||||+++..    ..+.+|+.++ +..+||||+++++++..    ....++||||+++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            67999999999999864 7889999998643    3567888876 44589999999998875    5668999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       144 g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Ni  192 (400)
T 1nxk_A          144 GELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL  192 (400)
T ss_dssp             EEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceE
Confidence            9999999532  234699999999999999999999998   999999999997

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.79  E-value=4.3e-20  Score=179.68  Aligned_cols=125  Identities=23%  Similarity=0.392  Sum_probs=102.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCC------e
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  372 (436)
                      .+|.+.+.||+|+||.||++.. .+++.||+|++......   .+++.+|+++++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            3566778999999999999986 47889999998653322   356889999999999999999999987653      4


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+ +++|.+++..     ..+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       105 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NI  159 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNL  159 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             EEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHE
Confidence            59999999 8899999832     4689999999999999999999998   999999999997

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.79  E-value=1.1e-19  Score=171.31  Aligned_cols=126  Identities=21%  Similarity=0.346  Sum_probs=110.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.+++.+ +|+|++++++++......++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            4567788999999999999995 578899999986533 224578899999999 7999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       +++|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        89 -~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NI  137 (298)
T 1csn_A           89 -GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNF  137 (298)
T ss_dssp             -CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGE
T ss_pred             -CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHE
Confidence             9999999943   234699999999999999999999988   999999999997

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.79  E-value=6.4e-20  Score=177.00  Aligned_cols=127  Identities=28%  Similarity=0.453  Sum_probs=106.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC------HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      .+|.+.+.||+|+||.||++... +++.||+|+++.....      .+.+.+|+.+++.++||||+++++++...+..++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            45777899999999999999954 6889999998753211      2357899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++ +|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        90 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  143 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNL  143 (346)
T ss_dssp             EEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             EEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHE
Confidence            9999975 89888832   335688999999999999999999998   999999999997

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.79  E-value=4.5e-20  Score=178.03  Aligned_cols=132  Identities=19%  Similarity=0.238  Sum_probs=105.7

Q ss_pred             hHHHHHHhhhhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCccc------------CHHHHHHHHHHHcCCCcCcc
Q 041073          297 YPEIIAMTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSKF------------SAEEFINEVSTIGRIHHVNV  360 (436)
Q Consensus       297 ~~~i~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~ni  360 (436)
                      ..++...+|.+.+.||+|+||.||+|...    ++..+|+|++.....            ....+.+|+..++.++||||
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni  110 (345)
T 2v62_A           31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI  110 (345)
T ss_dssp             EECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred             eccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence            34455567888899999999999999964    567899999875421            11246788889999999999


Q ss_pred             cceeEEEEe----CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          361 VQLLGFCSE----GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       361 v~l~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++++..    ....++||||+ +++|.+++..    ...+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus       111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  182 (345)
T 2v62_A          111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANL  182 (345)
T ss_dssp             CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             ceeecccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHE
Confidence            999999987    67889999999 9999999843    23799999999999999999999998   999999999997

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.79  E-value=8.2e-20  Score=170.78  Aligned_cols=128  Identities=27%  Similarity=0.371  Sum_probs=108.3

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEcC----CCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLHT----GGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      ..++.+.+.||+|+||.||+|....    +..||+|.++...  ...+.+.+|+.+++.++||||+++++++.. +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            3456778999999999999998542    2359999987642  234678999999999999999999998765 45689


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++++|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        90 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Ni  144 (281)
T 3cc6_A           90 IMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNI  144 (281)
T ss_dssp             EEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGE
T ss_pred             EEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceE
Confidence            9999999999999843   234689999999999999999999998   999999999997

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.79  E-value=1.6e-19  Score=170.46  Aligned_cols=123  Identities=26%  Similarity=0.317  Sum_probs=105.4

Q ss_pred             hhhh-cccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHH-cCCCcCcccceeEEEEe----CCeeeEEE
Q 041073          305 NHFT-HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTI-GRIHHVNVVQLLGFCSE----GSKRAVVY  377 (436)
Q Consensus       305 ~~~~-~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~  377 (436)
                      |.+. +.||+|+||.||++.. .+++.||+|+++..    ..+.+|+.++ +..+||||+++++++..    ....++||
T Consensus        19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~   94 (299)
T 3m2w_A           19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM   94 (299)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence            4444 6799999999999986 47889999998643    4567888887 56689999999999876    66789999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        95 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Ni  148 (299)
T 3m2w_A           95 ECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL  148 (299)
T ss_dssp             CCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             eecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHE
Confidence            999999999999542  234699999999999999999999998   999999999997

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.79  E-value=9e-20  Score=176.95  Aligned_cols=127  Identities=22%  Similarity=0.311  Sum_probs=108.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccC------------HHHHHHHHHHHcCCCcCcccceeEEEEe-
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS------------AEEFINEVSTIGRIHHVNVVQLLGFCSE-  369 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~~~~-  369 (436)
                      ..|.+.+.||+|+||.||++...++..||||++......            .+.+.+|+.++++++||||+++++++.. 
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            456677899999999999999888999999998652211            2678999999999999999999999854 


Q ss_pred             ----CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          370 ----GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                          ....++||||++ |+|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  165 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI  165 (362)
T ss_dssp             CTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             cCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence                336799999997 688888843   335699999999999999999999998   999999999997

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.79  E-value=1.4e-19  Score=171.11  Aligned_cols=128  Identities=30%  Similarity=0.378  Sum_probs=106.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-----cCHHHHHHHHHHHcCCCcCcccceeEEEE--eCCeee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-----FSAEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  374 (436)
                      .+|.+.+.||+|+||.||++.. .+++.+|+|+++...     ...+.+.+|+.+++.++|+||+++++++.  .....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            3567788999999999999995 477899999987532     23467899999999999999999999984  455789


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||++++ |.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        85 lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NI  140 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNL  140 (305)
T ss_dssp             EEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccE
Confidence            999999876 76766432  235689999999999999999999998   999999999997

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.79  E-value=6.3e-20  Score=183.94  Aligned_cols=124  Identities=24%  Similarity=0.301  Sum_probs=105.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeC------Ce
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  372 (436)
                      .+|.+.+.||+|+||.||++... +++.||||++.....   ..+++.+|+.+++.++||||+++++++...      ..
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            45677899999999999999854 688999999976322   345688999999999999999999998654      45


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+++ +|.+.+.      ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       142 ~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NI  195 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI  195 (464)
T ss_dssp             EEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             EEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhE
Confidence            7999999965 5666662      2489999999999999999999998   999999999997

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.79  E-value=6.3e-20  Score=171.28  Aligned_cols=128  Identities=30%  Similarity=0.502  Sum_probs=108.6

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeC-CeeeEEEecC
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-SKRAVVYEYM  380 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~~  380 (436)
                      ...+++.+.||+|+||.||++... ++.||+|.++... ..+.+.+|+.++++++||||+++++++... +..++||||+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            356778899999999999999875 7889999987643 456799999999999999999999987554 4689999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++++|.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        98 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Ni  148 (278)
T 1byg_A           98 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNV  148 (278)
T ss_dssp             TTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceE
Confidence            999999998432  112378999999999999999999998   999999999997

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.79  E-value=5.4e-20  Score=180.49  Aligned_cols=136  Identities=26%  Similarity=0.442  Sum_probs=111.9

Q ss_pred             ChHHHHHHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCC--------cCcccceeEE
Q 041073          296 SYPEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH--------HVNVVQLLGF  366 (436)
Q Consensus       296 ~~~~i~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~  366 (436)
                      ...++...+|.+.+.||+|+||.||++.. .+++.||+|+++......+.+.+|+.+++.++        |+||+++++.
T Consensus        30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            34455556788889999999999999985 46788999999876555567889999998885        7889999998


Q ss_pred             EE----eCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          367 CS----EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       367 ~~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +.    .....++||||+ +++|.+++...  ....+++..++.++.|+++||+|||+++  +|+||||||+||
T Consensus       110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NI  178 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENI  178 (397)
T ss_dssp             EEEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGE
T ss_pred             eeecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHe
Confidence            87    456789999999 56666666432  2356999999999999999999999852  799999999997

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.78  E-value=1.1e-19  Score=191.04  Aligned_cols=126  Identities=24%  Similarity=0.321  Sum_probs=107.2

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc--CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCe-----
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH--TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-----  372 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  372 (436)
                      ..+|.+.+.||+|+||.||++...  +++.||||++....  ...+.+.+|+.++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            356778899999999999999965  68899999986532  223568899999999999999999999987655     


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+|||||+++++|.+++.      ..+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus       159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NI  213 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENI  213 (681)
T ss_dssp             EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHe
Confidence            699999999999988762      2689999999999999999999998   999999999997

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.78  E-value=7.2e-20  Score=171.79  Aligned_cols=132  Identities=23%  Similarity=0.333  Sum_probs=107.1

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..++++.+.||+|+||.||++.. .+++.||+|+++.....   .+.+.++...++.++||||+++++++..++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            35667789999999999999996 47889999999764222   223445555688899999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||++ |+|.+++.........+++..+..++.|++.||+|||++  .+|+||||||+||
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Ni  141 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNV  141 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGC
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHE
Confidence            9997 588877743223456799999999999999999999974  2899999999997

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.78  E-value=3.2e-20  Score=176.76  Aligned_cols=129  Identities=26%  Similarity=0.416  Sum_probs=111.2

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      +....+++.+.||+|+||.||+|....  .+|+|+++...   ...+.+.+|+.++++++|+||+++++++...+..+++
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            344566778999999999999998653  48999987532   2234577899999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++++|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       108 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NI  161 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNV  161 (319)
T ss_dssp             CBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTE
T ss_pred             eecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhE
Confidence            999999999999943   234689999999999999999999998   999999999997

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.78  E-value=1.9e-19  Score=178.80  Aligned_cols=129  Identities=26%  Similarity=0.380  Sum_probs=110.2

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCC------CcCcccceeEEEEeCCeee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRI------HHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~  374 (436)
                      ..+|.+.+.||+|+||.||+|... +++.||||+++......+.+.+|+.+++.+      +|+||+++++.+......+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            345778899999999999999854 678999999987554456677888877766      5779999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||++ ++|.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       176 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NI  231 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENI  231 (429)
T ss_dssp             EEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGE
T ss_pred             EEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHe
Confidence            9999995 6999988532  234589999999999999999999998   999999999997

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.78  E-value=1.9e-19  Score=172.54  Aligned_cols=130  Identities=24%  Similarity=0.400  Sum_probs=111.9

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEE--cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCc------ccceeEEEEeCCe
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQL--HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVN------VVQLLGFCSEGSK  372 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  372 (436)
                      ...+|.+.+.||+|+||.||++..  .+++.||+|+++......+.+.+|+++++.++|++      ++++++++...+.
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            345677889999999999999985  36788999999765545567889999998887664      9999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+ +++|.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  149 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENI  149 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHE
Confidence            99999999 88999998432  224689999999999999999999998   999999999997

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.78  E-value=2.5e-19  Score=171.82  Aligned_cols=126  Identities=29%  Similarity=0.488  Sum_probs=100.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHH--HHcCCCcCcccceeEEEEe-----CCeeeE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVS--TIGRIHHVNVVQLLGFCSE-----GSKRAV  375 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~~-----~~~~~l  375 (436)
                      ..+.+.+.||+|+||.||+|+. +++.||+|++....  .+.+..|.+  .+..++|+||+++++.+..     ....++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            4566789999999999999976 57899999987543  233444444  4556899999999986543     235689


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC------DVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~------~~~iiHrDlkp~NI  436 (436)
                      ||||+++|+|.+++..     ...++..+..++.|+++||+|||++.      .++|+||||||+||
T Consensus        90 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Ni  151 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV  151 (336)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGE
T ss_pred             EEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceE
Confidence            9999999999999932     34589999999999999999999752      23899999999997

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.78  E-value=1.2e-19  Score=176.62  Aligned_cols=125  Identities=26%  Similarity=0.371  Sum_probs=100.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeC------Ce
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  372 (436)
                      .+|.+.+.||+|+||.||+|.. .+++.||||++.....   ..+.+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4567788999999999999985 4788999999876332   345688999999999999999999998653      55


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++++|++ +++|.+++.     ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       109 ~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NI  163 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNL  163 (367)
T ss_dssp             CEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             EEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhE
Confidence            79999999 789998882     25699999999999999999999998   999999999997

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.78  E-value=3.9e-20  Score=180.67  Aligned_cols=130  Identities=18%  Similarity=0.147  Sum_probs=102.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc----ccCHHHHHHHH---HHHcCCCcCccccee-------EEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS----KFSAEEFINEV---STIGRIHHVNVVQLL-------GFC  367 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~  367 (436)
                      ..|.+.+.||+|+||.||+|.. .+++.||||++...    ....+.+.+|+   +.+++++||||++++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            3456678999999999999995 57899999998742    22346788999   556666899999998       666


Q ss_pred             EeCC-----------------eeeEEEecCCCCChhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceE
Q 041073          368 SEGS-----------------KRAVVYEYMPNGSLDRHIFPKES---RGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL  427 (436)
Q Consensus       368 ~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~ii  427 (436)
                      ...+                 ..+++|||+ +|+|.+++.....   ....+++..+..++.|+++||+|||++   +|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            5543                 278999999 6899999853211   112344688889999999999999998   999


Q ss_pred             ecCCCCCCC
Q 041073          428 HFDIKPHNI  436 (436)
Q Consensus       428 HrDlkp~NI  436 (436)
                      ||||||+||
T Consensus       229 HrDikp~NI  237 (377)
T 3byv_A          229 HTYLRPVDI  237 (377)
T ss_dssp             CSCCCGGGE
T ss_pred             cCCCCHHHE
Confidence            999999997

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.78  E-value=4.5e-19  Score=174.84  Aligned_cols=127  Identities=24%  Similarity=0.383  Sum_probs=98.8

Q ss_pred             hhh-hcccCCCCCeEEEEEEEc---CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEe--CCeeeEEEe
Q 041073          305 NHF-THKLGQGGFGSVYKGQLH---TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAVVYE  378 (436)
Q Consensus       305 ~~~-~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E  378 (436)
                      |.+ .++||+|+||.||+|..+   +++.||+|++...... ..+.+|+.+|++++||||+++++++..  ....++|||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e  100 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD  100 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence            444 357999999999999855   5778999999764433 468899999999999999999999954  678899999


Q ss_pred             cCCCCChhhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKE-----SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |++ ++|.+++....     .....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus       101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NI  159 (405)
T 3rgf_A          101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANI  159 (405)
T ss_dssp             CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHe
Confidence            996 58877774211     1223599999999999999999999998   999999999997

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.78  E-value=1.9e-19  Score=178.33  Aligned_cols=126  Identities=27%  Similarity=0.391  Sum_probs=102.6

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeC------CeeeEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRAVV  376 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv  376 (436)
                      .|.+.+.||+|+||.||++... +++.||||++.....   ...+|+++|+.++|+||+++++++...      ...++|
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            4667789999999999999965 688999999865332   234799999999999999999988542      235799


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++ +|.+.+.........+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NI  187 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNL  187 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGE
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhE
Confidence            999975 66665532222346799999999999999999999998   999999999997

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.77  E-value=1.8e-19  Score=169.12  Aligned_cols=128  Identities=30%  Similarity=0.468  Sum_probs=102.0

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc--CCC--EEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH--TGG--LIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~--~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      ...|++.+.||+|+||.||+++..  +++  .||+|+++...    ...+.+.+|+++++.++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            356778899999999999999853  333  58999987532    23467899999999999999999999987655 8


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++++|.+++...   ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Ni  152 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNL  152 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheE
Confidence            8999999999999998432   24589999999999999999999998   999999999997

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.77  E-value=2.1e-19  Score=174.59  Aligned_cols=125  Identities=20%  Similarity=0.320  Sum_probs=107.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeC-----Ceee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  374 (436)
                      .+|.+.+.||+|+||.||++... ++..||+|++.....  ..+.+.+|++++++++||||+++++++...     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            35677899999999999999854 678899999975322  235688999999999999999999998654     3689


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||++ |+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       107 iv~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI  159 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNL  159 (364)
T ss_dssp             EEEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             EEEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhE
Confidence            9999996 59999883     24599999999999999999999998   999999999997

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.77  E-value=2.7e-19  Score=170.03  Aligned_cols=128  Identities=16%  Similarity=0.240  Sum_probs=111.7

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCccc---CHHHHHHHHHHHcCCC--cCcccceeEEEEeCCeeeE
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l  375 (436)
                      ....|.+.+.||+|+||.||++...+++.||+|++.....   ..+.+.+|+.++++++  |+||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            3445777899999999999999988889999999976433   3456889999999997  5999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|| +.+++|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       106 v~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NI  158 (313)
T 3cek_A          106 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANF  158 (313)
T ss_dssp             EEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             EEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccE
Confidence            999 568899999843    35689999999999999999999998   999999999997

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.77  E-value=2e-19  Score=173.82  Aligned_cols=125  Identities=23%  Similarity=0.392  Sum_probs=107.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeC-----Ceee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  374 (436)
                      ..|.+.+.||+|+||.||++... +++.||||.++....  ....+.+|+.+++.++||||+++++++...     ...+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            35667789999999999999965 688999999975322  235688999999999999999999987654     6789


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|||++ ++|.+++..     ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        91 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Ni  143 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNL  143 (353)
T ss_dssp             EEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             EEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHe
Confidence            9999996 699998832     4689999999999999999999998   999999999997

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.77  E-value=2e-19  Score=172.29  Aligned_cols=132  Identities=24%  Similarity=0.338  Sum_probs=109.4

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc-cCHHHHHHHHHHHcCCC-cCcccceeEEEE--------
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK-FSAEEFINEVSTIGRIH-HVNVVQLLGFCS--------  368 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------  368 (436)
                      +...+|++.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++.++. ||||+++++++.        
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            33456778899999999999999954 78899999885532 33456889999999996 999999999984        


Q ss_pred             eCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEecCCCCCCC
Q 041073          369 EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNI  436 (436)
Q Consensus       369 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~--iiHrDlkp~NI  436 (436)
                      .....+++|||++ |+|.+++.... ....+++..++.++.|++.||+|||++   +  |+||||||+||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NI  169 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENL  169 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccE
Confidence            3345789999995 79988884321 235699999999999999999999987   6  99999999998

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.77  E-value=5.8e-20  Score=177.69  Aligned_cols=125  Identities=18%  Similarity=0.201  Sum_probs=106.7

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEcC---------CCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccc----------
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLHT---------GGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQ----------  362 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------  362 (436)
                      ...|.+.+.||+|+||.||++....         ++.||+|++...    +.+.+|++++++++||||++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            4567788999999999999998653         788999998754    35789999999999999987          


Q ss_pred             -----eeEEEEe-CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          363 -----LLGFCSE-GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       363 -----l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                           +++++.. +...++||||+ +++|.+++...  ....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI  190 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI  190 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence                 6677766 77889999999 99999999532  135799999999999999999999998   999999999997

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.77  E-value=2.1e-19  Score=187.40  Aligned_cols=130  Identities=25%  Similarity=0.358  Sum_probs=110.1

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc----CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      +...++.+.+.||+|+||.||+|...    .+..+|+|.++...  ...+.+.+|+.++++++||||+++++++. .+..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            44556777889999999999999864    24569999987532  22367899999999999999999999984 4568


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++|+|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       466 ~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NI  522 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNV  522 (656)
T ss_dssp             EEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhE
Confidence            999999999999999843   234689999999999999999999998   999999999997

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.77  E-value=4.1e-19  Score=172.07  Aligned_cols=133  Identities=27%  Similarity=0.317  Sum_probs=97.8

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCe------
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------  372 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  372 (436)
                      ....+|.+.+.||+|+||.||++... +++.||||++...........+|++.++.++||||+++++++...+.      
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   99 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI   99 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence            33456777899999999999999964 68899999987654444567788888888999999999999865433      


Q ss_pred             -eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCceEecCCCCCCC
Q 041073          373 -RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH--NGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 -~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH--~~~~~~iiHrDlkp~NI  436 (436)
                       .++||||+++ +|.+.+.........+++..+..++.|++.||.|||  ++   +|+||||||+||
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NI  162 (360)
T 3e3p_A          100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNV  162 (360)
T ss_dssp             EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGE
T ss_pred             eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHE
Confidence             7899999976 555444322234567899999999999999999999  66   999999999997

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.77  E-value=7.6e-20  Score=173.69  Aligned_cols=132  Identities=23%  Similarity=0.297  Sum_probs=103.9

Q ss_pred             HHHHHHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc-------CHHHHHHHHHHHcCC----CcCcccceeE
Q 041073          298 PEIIAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF-------SAEEFINEVSTIGRI----HHVNVVQLLG  365 (436)
Q Consensus       298 ~~i~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l----~h~niv~l~~  365 (436)
                      .+....+|.+.+.||+|+||.||++.. .+++.||+|+++....       ....+.+|+.++.++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            345567788889999999999999985 4788999999976432       122356788888888    8999999999


Q ss_pred             EEEeCCeeeEEEec-CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          366 FCSEGSKRAVVYEY-MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       366 ~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++...+..++|||+ +++++|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  170 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENI  170 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhE
Confidence            99988899999999 789999999843    34689999999999999999999998   999999999997

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.76  E-value=4.7e-19  Score=172.65  Aligned_cols=124  Identities=24%  Similarity=0.301  Sum_probs=106.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCC------e
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  372 (436)
                      .+|.+.+.||+|+||.||++... +++.||||++.....   ..+.+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            35667789999999999999854 688899999976332   2356889999999999999999999987654      7


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||++ ++|.+++.      ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       105 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NI  158 (371)
T 2xrw_A          105 VYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI  158 (371)
T ss_dssp             EEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             eEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHE
Confidence            899999996 57888872      3489999999999999999999998   999999999997

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.76  E-value=3.6e-19  Score=174.85  Aligned_cols=127  Identities=25%  Similarity=0.350  Sum_probs=101.9

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCe------eeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------RAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv  376 (436)
                      .+|.+.+.||+|+||.||++....+..+|+|++.....   ...+|+++++.++||||+++++++...+.      .++|
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            45777899999999999999987677799988755322   12369999999999999999999865432      7899


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||++++ +.+.+.........+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Ni  172 (394)
T 4e7w_A          117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNL  172 (394)
T ss_dssp             EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHE
Confidence            9999764 4333322112345799999999999999999999998   999999999997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.76  E-value=5.3e-19  Score=172.26  Aligned_cols=124  Identities=27%  Similarity=0.423  Sum_probs=107.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCee-----
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR-----  373 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  373 (436)
                      .+|.+.+.||+|+||.||++... +++.||+|++......   .+.+.+|+.+++.++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            35667789999999999999854 7889999999764332   35688999999999999999999999876654     


Q ss_pred             -eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 -AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 -~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       ++||||++ ++|.+++.      ..+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       122 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI  175 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNL  175 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHe
Confidence             99999996 68988872      3489999999999999999999998   999999999997

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.76  E-value=1.4e-18  Score=166.99  Aligned_cols=126  Identities=24%  Similarity=0.272  Sum_probs=102.1

Q ss_pred             Hhhhhh-cccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEe----CCeeeEE
Q 041073          303 MTNHFT-HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRAVV  376 (436)
Q Consensus       303 ~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  376 (436)
                      ..|.+. +.||+|+||.||++... +++.||+|++.....   ...+....++.++|+||+++++++..    ....++|
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            356664 46999999999999965 788999999876432   22222334566789999999999876    4457999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       105 ~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NI  159 (336)
T 3fhr_A          105 MECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENL  159 (336)
T ss_dssp             EECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            9999999999999532  234699999999999999999999998   999999999997

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.76  E-value=1.4e-18  Score=163.51  Aligned_cols=126  Identities=24%  Similarity=0.358  Sum_probs=106.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEE-EeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E~~  380 (436)
                      .+|.+.+.||+|+||.||++.. .+++.||+|++..... .+++.+|+.+++.++|++++..+..+ ......++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            3566778999999999999995 5788999999876432 24688999999999988876665555 5677889999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       +++|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        88 -~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NI  136 (296)
T 3uzp_A           88 -GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNF  136 (296)
T ss_dssp             -CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             -CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHe
Confidence             9999999842   235699999999999999999999998   999999999997

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.76  E-value=3.3e-19  Score=170.06  Aligned_cols=129  Identities=23%  Similarity=0.306  Sum_probs=110.6

Q ss_pred             HHHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc-------CHHHHHHHHHHHcCCC--cCcccceeEEEEeC
Q 041073          301 IAMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF-------SAEEFINEVSTIGRIH--HVNVVQLLGFCSEG  370 (436)
Q Consensus       301 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  370 (436)
                      ...+|.+.+.||+|+||.||+|.. .+++.||+|.++....       ..+.+.+|+.++++++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            345677889999999999999985 4788899999876322       2245678999999886  59999999999999


Q ss_pred             CeeeEEEecCCC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPN-GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..+++||++.+ ++|.+++..    ...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  180 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENI  180 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHE
Confidence            999999999976 899999842    35689999999999999999999998   999999999997

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.76  E-value=6.8e-19  Score=170.22  Aligned_cols=123  Identities=28%  Similarity=0.425  Sum_probs=105.9

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCe------e
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------R  373 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~  373 (436)
                      +|.+.+.||+|+||.||+|... +++.||||.+......   .+.+.+|+.+++.++||||+++++++.....      .
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  104 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  104 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence            4667789999999999999864 7889999999764332   3568899999999999999999999977653      4


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|||++ ++|.+++.      ..+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus       105 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NI  157 (353)
T 3coi_A          105 YLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNL  157 (353)
T ss_dssp             EEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGE
T ss_pred             EEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            99999996 68888772      2489999999999999999999998   999999999997

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.75  E-value=1.1e-18  Score=168.52  Aligned_cols=132  Identities=20%  Similarity=0.343  Sum_probs=110.9

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc-CC-CEEEEEEecCcccCHHHHHHHHHHHcCCCcCc------ccceeEEEEeC
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH-TG-GLIAVKMLKNSKFSAEEFINEVSTIGRIHHVN------VVQLLGFCSEG  370 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~  370 (436)
                      +....+|.+.+.||+|+||.||++... ++ ..||+|+++......+.+.+|+.+++.++|++      ++.+.+++...
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            334467788899999999999999864 44 68999999865545567889999999887766      89999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..++||||+ +++|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NI  154 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENI  154 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGE
T ss_pred             CeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            9999999999 66777776432  234689999999999999999999998   999999999997

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.75  E-value=1.1e-18  Score=164.22  Aligned_cols=126  Identities=24%  Similarity=0.358  Sum_probs=104.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEE-EeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E~~  380 (436)
                      .+|.+.+.||+|+||.||++.. .+++.||+|++..... .+++.+|+.+++.++|++++..++.+ ...+..+++|||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            5677889999999999999995 5788999998765322 23478899999999988877766655 6677889999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       +++|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        88 -~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI  136 (296)
T 4hgt_A           88 -GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNF  136 (296)
T ss_dssp             -CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             -CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHe
Confidence             9999999842   235699999999999999999999998   999999999997

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.75  E-value=6.5e-19  Score=168.17  Aligned_cols=128  Identities=25%  Similarity=0.470  Sum_probs=104.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE--cCCCEEEEEEecCccc---CHHHHHHHHHHHcCC---CcCcccceeEEEE-----e
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL--HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRI---HHVNVVQLLGFCS-----E  369 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  369 (436)
                      ..|.+.+.||+|+||.||++..  .+++.||+|+++....   ....+.+|+.+++.+   +||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            3566788999999999999996  3677899999865321   223466777776655   8999999999987     4


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ....++||||++ |+|.+++...  ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Ni  151 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNI  151 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             CceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHe
Confidence            567899999997 6999998432  234589999999999999999999998   999999999997

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.75  E-value=5.2e-19  Score=175.64  Aligned_cols=124  Identities=23%  Similarity=0.235  Sum_probs=102.9

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      ++...+.||+|+||+|+.....+++.||||++.....  ..+.+|+.+++.+ +||||+++++.+.+....++||||++ 
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence            4556688999999997655566789999999865322  2356899999998 79999999999999999999999995 


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++....   ..+.+..+..++.|+++||+|||++   +|+||||||+||
T Consensus       102 g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NI  149 (432)
T 3p23_A          102 ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNI  149 (432)
T ss_dssp             EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSE
T ss_pred             CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHE
Confidence            69999985432   3345556678999999999999998   999999999997

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.75  E-value=8.7e-19  Score=174.33  Aligned_cols=124  Identities=22%  Similarity=0.192  Sum_probs=99.8

Q ss_pred             hhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      ..+.||+|+||+||.+...+++.||||++....  .+.+.+|+.++.++ +||||+++++.+.+.+..++||||++ |+|
T Consensus        19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL   95 (434)
T 2rio_A           19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL   95 (434)
T ss_dssp             EEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred             ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence            357799999999987766789999999986532  35678999999876 89999999999999999999999995 699


Q ss_pred             hhhccCCCCCCCC---CCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          386 DRHIFPKESRGQS---FSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       386 ~~~l~~~~~~~~~---l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++.........   .++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NI  146 (434)
T 2rio_A           96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNI  146 (434)
T ss_dssp             HHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhE
Confidence            9999543221111   13334678999999999999998   999999999997

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.75  E-value=1.4e-18  Score=178.01  Aligned_cols=118  Identities=16%  Similarity=0.179  Sum_probs=91.6

Q ss_pred             cccCCCCCeEEEEEE-EcCCCEEEEEEecCcc-----------cCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeE
Q 041073          309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK-----------FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  375 (436)
                      ...+.|+.|.+..++ ...|+.+++|++....           .+.+++.+|+++|+++ .|+||+++++++++++..||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            345677777666554 3468889999986531           1235699999999999 69999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||++|++|.++|.    +.+.++..   +|+.||+.||+|+|++   +||||||||+||
T Consensus       320 VMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNI  370 (569)
T 4azs_A          320 VMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNV  370 (569)
T ss_dssp             EEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGE
T ss_pred             EEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhE
Confidence            999999999999993    33566654   5889999999999998   999999999997

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.74  E-value=5e-19  Score=172.43  Aligned_cols=124  Identities=10%  Similarity=0.026  Sum_probs=88.9

Q ss_pred             hhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc----CHHHHHHHH---HHHcCCCcCccccee-------EEEEe
Q 041073          305 NHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF----SAEEFINEV---STIGRIHHVNVVQLL-------GFCSE  369 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~---~~l~~l~h~niv~l~-------~~~~~  369 (436)
                      |.+.+.||+|+||.||+|... +++.||+|++.....    ..+.+.+|+   ..|+. +||||++++       +.+..
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEE
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheec
Confidence            567789999999999999964 788999999987432    234577784   55555 799987754       44443


Q ss_pred             C-----------------CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCce
Q 041073          370 G-----------------SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKL------HEVALGTARGIEYLHNGCDVCI  426 (436)
Q Consensus       370 ~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~gL~yLH~~~~~~i  426 (436)
                      .                 ...++||||++ |+|.+++...   ...+.+..+      ..++.|+++||+|||++   +|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i  215 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GL  215 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence            2                 33799999998 8999999532   123444555      67889999999999998   99


Q ss_pred             EecCCCCCCC
Q 041073          427 LHFDIKPHNI  436 (436)
Q Consensus       427 iHrDlkp~NI  436 (436)
                      +||||||+||
T Consensus       216 vHrDikp~NI  225 (371)
T 3q60_A          216 VHGHFTPDNL  225 (371)
T ss_dssp             EETTCSGGGE
T ss_pred             ccCcCCHHHE
Confidence            9999999997

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.74  E-value=1.7e-18  Score=169.25  Aligned_cols=131  Identities=22%  Similarity=0.287  Sum_probs=109.0

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCC-cC-----cccceeEEEEeCCeee
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-HV-----NVVQLLGFCSEGSKRA  374 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~  374 (436)
                      ..+|.+.+.||+|+||.||+|... +++.||||+++......+++.+|+.+++.++ |+     +|+++++.+...+..+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            356778899999999999999865 6788999999865544566778888887764 44     5999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||++ ++|.+++...  ....+++..+..++.|++.||+|||++ +.+|+||||||+||
T Consensus       133 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NI  190 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENI  190 (382)
T ss_dssp             EEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGE
T ss_pred             EEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccE
Confidence            9999995 5999998543  224589999999999999999999963 34899999999997

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.74  E-value=2.9e-19  Score=184.18  Aligned_cols=130  Identities=25%  Similarity=0.370  Sum_probs=110.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEe------CCee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKR  373 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  373 (436)
                      .+|.+.+.||+|+||.||++.. .+++.||+|+++...  ...+.+.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            5688889999999999999985 468899999987532  234568999999999999999999998754      6677


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++|+|.+++.... ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NI  152 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENI  152 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTE
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHe
Confidence            99999999999999985432 234689999999999999999999998   999999999997

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.74  E-value=2.6e-18  Score=172.62  Aligned_cols=126  Identities=22%  Similarity=0.339  Sum_probs=106.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCc-CcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ..|.+.+.||+|+||.||++.. .+++.||||++..... .+++.+|+++++.++| +++..+..+....+..+|||||+
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            3567789999999999999995 5788999998865332 2357889999999986 55666666777888899999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       +++|.+++..   ....+++..++.++.||+.||+|||++   +|+||||||+||
T Consensus        86 -g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NI  134 (483)
T 3sv0_A           86 -GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNF  134 (483)
T ss_dssp             -CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             -CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceE
Confidence             9999999842   235699999999999999999999998   999999999997

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.74  E-value=8.8e-18  Score=171.18  Aligned_cols=113  Identities=12%  Similarity=0.174  Sum_probs=89.0

Q ss_pred             hcccCCCCCeEEEEEEEcCCCEEEEEEecCccc---------CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          308 THKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .+.||+|+||.||++.. .++.+++|.......         ..+++.+|++++++++||||+++..+....+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            46899999999999954 467889888654221         12348999999999999999976666667778899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|.+++..            +..++.|+++||+|||++   +|+||||||+||
T Consensus       420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NI  462 (540)
T 3en9_A          420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNF  462 (540)
T ss_dssp             CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSE
T ss_pred             CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHE
Confidence            9999999999931            568999999999999998   999999999997

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.74  E-value=1.3e-18  Score=169.30  Aligned_cols=130  Identities=22%  Similarity=0.367  Sum_probs=110.4

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCC-----------cCcccceeEEEEe
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-----------HVNVVQLLGFCSE  369 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  369 (436)
                      ..+|.+.+.||+|+||.||++.. .+++.||+|+++......+.+.+|+.++++++           |+||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            35677889999999999999995 47889999999865555567889999988876           8999999999876


Q ss_pred             CC----eeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          370 GS----KRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 ~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+    ..+++||++ +++|.+++...  ....+++..+..++.|++.||+|||++  .+|+||||||+||
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NI  163 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENV  163 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGE
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHe
Confidence            44    689999999 88999998532  234589999999999999999999984  2899999999997

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.72  E-value=5e-18  Score=162.23  Aligned_cols=131  Identities=23%  Similarity=0.318  Sum_probs=105.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc--CHHHHHHHHH-HHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF--SAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ..+.+.+.||+|+||.||++... +++.||+|+++....  ...++..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            45567789999999999999964 788999999976432  2334556665 7788899999999999999999999999


Q ss_pred             cCCCCChhhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPK-ESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++ +|.+++... ......+++..+..++.|++.||.|||++  .+|+||||||+||
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NI  157 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNI  157 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGE
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHE
Confidence            9975 887776321 11245789999999999999999999974  3799999999997

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.72  E-value=5.2e-18  Score=161.20  Aligned_cols=128  Identities=20%  Similarity=0.272  Sum_probs=97.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ..|.+.+.||+|+||.||++... +++.||+|++......   .+.+.++..+++.++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            45667789999999999999965 7889999999764322   2234455567888899999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+ ++.+..+..   .....+++..+..++.|+++||+|||++  .+|+||||||+||
T Consensus       105 ~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Ni  156 (318)
T 2dyl_A          105 LM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNI  156 (318)
T ss_dssp             CC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGE
T ss_pred             cc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHE
Confidence            99 555555542   1235689999999999999999999972  1799999999997

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.70  E-value=1.4e-17  Score=155.83  Aligned_cols=112  Identities=19%  Similarity=0.183  Sum_probs=90.2

Q ss_pred             hhcccCCCCCeEEEEEEEcCCCEEEEEEecCccc-------------------CHHHHHHHHHHHcCCCcCcccceeEEE
Q 041073          307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF-------------------SAEEFINEVSTIGRIHHVNVVQLLGFC  367 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~~~~  367 (436)
                      +.+.||+|+||.||+|...+++.||+|.++....                   ....+.+|+.++++++  | +++.+++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            4488999999999999987788999999964221                   2345889999999998  4 6666655


Q ss_pred             EeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       368 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .. +..++||||+++++|.+ +..          .....++.|+++||+|||++   +|+||||||+||
T Consensus       171 ~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI  224 (282)
T 1zar_A          171 AW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV  224 (282)
T ss_dssp             EE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             ec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence            43 45699999999999988 511          12447999999999999998   999999999997

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.62  E-value=2.6e-16  Score=145.26  Aligned_cols=117  Identities=15%  Similarity=0.152  Sum_probs=88.7

Q ss_pred             hhhcccCCCCCeEEEEEEE-cCCCE--EEEEEecCcccC-------------------------HHHHHHHHHHHcCCCc
Q 041073          306 HFTHKLGQGGFGSVYKGQL-HTGGL--IAVKMLKNSKFS-------------------------AEEFINEVSTIGRIHH  357 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h  357 (436)
                      .+.+.||+|+||.||+|.. .+|+.  ||||+++.....                         ...+.+|+..|..++|
T Consensus        50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  129 (258)
T 1zth_A           50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE  129 (258)
T ss_dssp             EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence            3567899999999999997 67888  999997543111                         1257899999999988


Q ss_pred             Ccc--cceeEEEEeCCeeeEEEecCCC-C----ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCceEec
Q 041073          358 VNV--VQLLGFCSEGSKRAVVYEYMPN-G----SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH-NGCDVCILHF  429 (436)
Q Consensus       358 ~ni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH-~~~~~~iiHr  429 (436)
                      +++  +.+++.    ...+|||||+.+ |    +|.+....       .++..+..++.|++.||.||| +.   +|+||
T Consensus       130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHr  195 (258)
T 1zth_A          130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHA  195 (258)
T ss_dssp             TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred             CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence            864  334432    246899999942 4    67665521       234567789999999999999 87   99999


Q ss_pred             CCCCCCC
Q 041073          430 DIKPHNI  436 (436)
Q Consensus       430 Dlkp~NI  436 (436)
                      ||||+||
T Consensus       196 Dlkp~NI  202 (258)
T 1zth_A          196 DLSEYNI  202 (258)
T ss_dssp             SCSTTSE
T ss_pred             CCCHHHE
Confidence            9999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.59  E-value=4.1e-16  Score=153.95  Aligned_cols=128  Identities=17%  Similarity=0.112  Sum_probs=92.7

Q ss_pred             hhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc----cCHHHHHHHHHHHcCCCc-Cccc---------ceeEE---
Q 041073          305 NHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK----FSAEEFINEVSTIGRIHH-VNVV---------QLLGF---  366 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h-~niv---------~l~~~---  366 (436)
                      +...+.||+|+||.||+|.. .+++.||||+++...    ...+.+.+|+.+++.++| +|..         .....   
T Consensus        80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  159 (413)
T 3dzo_A           80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  159 (413)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred             EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence            34557899999999999994 578899999987422    234678999999999977 2211         11111   


Q ss_pred             ---------EEe-----CCeeeEEEecCCCCChhhhccCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEec
Q 041073          367 ---------CSE-----GSKRAVVYEYMPNGSLDRHIFPK---ESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHF  429 (436)
Q Consensus       367 ---------~~~-----~~~~~lv~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHr  429 (436)
                               ...     ....+++|+++ +++|.+++...   ......+++..++.++.|+++||+|||++   +|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHr  235 (413)
T 3dzo_A          160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT  235 (413)
T ss_dssp             CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence                     111     12356777765 78999888311   12234578889999999999999999998   99999


Q ss_pred             CCCCCCC
Q 041073          430 DIKPHNI  436 (436)
Q Consensus       430 Dlkp~NI  436 (436)
                      ||||+||
T Consensus       236 DiKp~NI  242 (413)
T 3dzo_A          236 YLRPVDI  242 (413)
T ss_dssp             CCCGGGE
T ss_pred             CcccceE
Confidence            9999997

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.53  E-value=1.5e-15  Score=146.21  Aligned_cols=117  Identities=12%  Similarity=0.082  Sum_probs=82.8

Q ss_pred             hhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCccc---------------CHHH--------HHHHHHHHcCCCcCccc
Q 041073          305 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKF---------------SAEE--------FINEVSTIGRIHHVNVV  361 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---------------~~~~--------~~~E~~~l~~l~h~niv  361 (436)
                      |.+...||+|++|.||+|...+|+.||||+++....               ....        ...|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            456788999999999999988899999999764211               1111        23456666666544432


Q ss_pred             ceeEEEEeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          362 QLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       362 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...-+...  ..+|||||+++++|.++..        .  .....++.|++.+|.|||+.   +||||||||.||
T Consensus       177 vp~p~~~~--~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NI  236 (397)
T 4gyi_A          177 VPEPIAQS--RHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNI  236 (397)
T ss_dssp             CCCEEEEE--TTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             CCeeeecc--CceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHE
Confidence            22111122  2369999999988876541        1  13456889999999999998   999999999997

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.92  E-value=2.2e-09  Score=98.67  Aligned_cols=106  Identities=11%  Similarity=-0.001  Sum_probs=81.9

Q ss_pred             hhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEecCCC
Q 041073          305 NHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       305 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      +.+...++.|+.+.||+.... ++.+++|...... .....+.+|+.+++.+. +..+.+++++....+..++||||++|
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   94 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG   94 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred             ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence            445667888888999998754 6789999986521 22345888999988874 67788999999888899999999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN  420 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~  420 (436)
                      .+|.+.+.         +......++.+++++|+.||+
T Consensus        95 ~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           95 VLCSEEYE---------DEQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             EEHHHHCC---------TTTCHHHHHHHHHHHHHHHHH
T ss_pred             eehhhccC---------CcccHHHHHHHHHHHHHHHhC
Confidence            99987641         112234688899999999998

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.64  E-value=5.3e-08  Score=88.92  Aligned_cols=96  Identities=14%  Similarity=0.112  Sum_probs=70.2

Q ss_pred             CCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCc--ccceeEEEEeCCeeeEEEecCCCCChhhhc
Q 041073          312 GQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVN--VVQLLGFCSEGSKRAVVYEYMPNGSLDRHI  389 (436)
Q Consensus       312 g~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l  389 (436)
                      +.|..+.||+....++..+++|.....  ....+.+|+.+++.+.+.+  +.++++....++..++||||+++.+|.  .
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~  104 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S  104 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence            455669999998766778999997654  2245778888888875434  567888888777889999999998884  3


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 041073          390 FPKESRGQSFSWEKLHEVALGTARGIEYLHNG  421 (436)
Q Consensus       390 ~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~  421 (436)
                      .       ..+   ...++.++++.|..||+.
T Consensus       105 ~-------~~~---~~~~~~~l~~~l~~lh~~  126 (264)
T 1nd4_A          105 S-------HLA---PAEKVSIMADAMRRLHTL  126 (264)
T ss_dssp             S-------CCC---HHHHHHHHHHHHHHHTTS
T ss_pred             C-------cCC---HhHHHHHHHHHHHHHhCC
Confidence            1       112   235777888888888874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.57  E-value=1.2e-07  Score=91.32  Aligned_cols=105  Identities=16%  Similarity=0.190  Sum_probs=77.5

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEec--Ccc--cCHHHHHHHHHHHcCCC--cCcccceeEEEEeC---CeeeEEEec
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLK--NSK--FSAEEFINEVSTIGRIH--HVNVVQLLGFCSEG---SKRAVVYEY  379 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~E~  379 (436)
                      +.|+.|.++.+|+.... ++.+++|+..  ...  .....+.+|..+++.+.  +..+++++..+.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            56899999999998865 4678888776  322  12346788999998886  45678888888765   347899999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN  420 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~  420 (436)
                      +++..+.+..      ...++..+...++.++++.|+.||+
T Consensus       123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A          123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhC
Confidence            9988775422      1347788889999999999999997

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.61  E-value=4.5e-05  Score=71.26  Aligned_cols=101  Identities=18%  Similarity=0.190  Sum_probs=69.8

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC-cCc--ccceeEEEEeCC---eeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-HVN--VVQLLGFCSEGS---KRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~E~~~~  382 (436)
                      +.++.|....||+..    ..+++|+.... .....+.+|.++|+.+. +..  +.+++......+   ..++|||+++|
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            457889999998753    45888886533 23456889999988773 332  344544433332   35899999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN  420 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~  420 (436)
                      .+|.+...      ..++.++...++.++++.|+.||+
T Consensus       101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~  132 (304)
T 3sg8_A          101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHS  132 (304)
T ss_dssp             EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHc
Confidence            88865331      346777888888889988888885

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.48  E-value=0.00025  Score=66.34  Aligned_cols=101  Identities=17%  Similarity=0.127  Sum_probs=67.4

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcC---cccceeEEEE-eCCeeeEEEecCCCCC
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV---NVVQLLGFCS-EGSKRAVVYEYMPNGS  384 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~~~~gs  384 (436)
                      +.++.|....||+.    ++.+++|+-+. ......+.+|.++|+.+.+.   .+.+.+.+.. ..+..+++||+++|.+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            45678888889987    46688887532 22345688999999988642   3556666664 3455789999999988


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 041073          385 LDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN  420 (436)
Q Consensus       385 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~  420 (436)
                      +.+...      ..++..+...++.++++.|+.||+
T Consensus       100 l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~  129 (306)
T 3tdw_A          100 LGEDGM------AVLPDDAKDRLALQLAEFMNELSA  129 (306)
T ss_dssp             CHHHHH------TTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             Cchhhh------hhCCHHHHHHHHHHHHHHHHHHhc
Confidence            876321      224555556666666666666664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.44  E-value=0.0004  Score=63.43  Aligned_cols=100  Identities=13%  Similarity=0.097  Sum_probs=67.1

Q ss_pred             cCCCCCe-EEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEecCCCCChhh
Q 041073          311 LGQGGFG-SVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDR  387 (436)
Q Consensus       311 lg~G~fg-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~  387 (436)
                      +..|..+ .||+.... .+..+.+|+-...  ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            3444443 68987754 4567888986543  2356788988887764 3447788888888899999999999988876


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 041073          388 HIFPKESRGQSFSWEKLHEVALGTARGIEYLHN  420 (436)
Q Consensus       388 ~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~  420 (436)
                      ....        .......+..++++.|.-||+
T Consensus       110 ~~~~--------~~~~~~~~~~~l~~~L~~Lh~  134 (272)
T 4gkh_A          110 VLEE--------YPDSGENIVDALAVFLRRLHS  134 (272)
T ss_dssp             HHHH--------CGGGHHHHHHHHHHHHHHHHT
T ss_pred             cccC--------CHHHHHHHHHHHHHHHHHhcC
Confidence            5411        112233456666666666664

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.15  E-value=0.00052  Score=65.47  Aligned_cols=79  Identities=8%  Similarity=0.047  Sum_probs=54.4

Q ss_pred             ccc-CCCCCeEEEEEEEc-------CCCEEEEEEecCcc---c-CHHHHHHHHHHHcCCCc---CcccceeEEEEeC---
Q 041073          309 HKL-GQGGFGSVYKGQLH-------TGGLIAVKMLKNSK---F-SAEEFINEVSTIGRIHH---VNVVQLLGFCSEG---  370 (436)
Q Consensus       309 ~~l-g~G~fg~V~~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---  370 (436)
                      +.| +.|....+|+....       +++.+++|......   . ....+.+|+.+++.+..   ..+.+++....+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78888999988754       25678888865432   1 12457788888887752   3567778776554   


Q ss_pred             CeeeEEEecCCCCChhh
Q 041073          371 SKRAVVYEYMPNGSLDR  387 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~  387 (436)
                      +..++|||++++..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            34689999999877654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.64  E-value=0.0026  Score=58.63  Aligned_cols=73  Identities=19%  Similarity=0.260  Sum_probs=52.2

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCc---CcccceeEEEEeCCeeeEEEecCCCCC
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHH---VNVVQLLGFCSEGSKRAVVYEYMPNGS  384 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~E~~~~gs  384 (436)
                      +.+|.|..+.||+.+..+|+.+.+|+..... .....+..|...|+.+..   .-++++++.  .  ..+++|||++.+.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence            5689999999999999999999999876532 223457889888877742   234455543  2  2478999998764


Q ss_pred             h
Q 041073          385 L  385 (436)
Q Consensus       385 L  385 (436)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.45  E-value=0.0073  Score=58.38  Aligned_cols=73  Identities=14%  Similarity=0.102  Sum_probs=48.1

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--------cCHHHHHHHHHHHcCCCc---CcccceeEEEEeCCeeeEE
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--------FSAEEFINEVSTIGRIHH---VNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv  376 (436)
                      +.||.|..+.||++... +++.+++|......        ...+++..|.++++.+..   ..+.+++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            56899999999999743 46789999865321        123456778888876632   334466643  34456899


Q ss_pred             EecCCCC
Q 041073          377 YEYMPNG  383 (436)
Q Consensus       377 ~E~~~~g  383 (436)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.96  E-value=0.024  Score=53.17  Aligned_cols=73  Identities=16%  Similarity=0.310  Sum_probs=41.6

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCc--CcccceeE------EEEeCCeeeEEEecC
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH--VNVVQLLG------FCSEGSKRAVVYEYM  380 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~E~~  380 (436)
                      +.|+.|..+.+|+....++ .+++|+....   ..++..|..++..+..  -.+.+++.      +....+..+++|||+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            3466677889999886544 5889988753   2344455555544431  12333332      123466789999999


Q ss_pred             CCCCh
Q 041073          381 PNGSL  385 (436)
Q Consensus       381 ~~gsL  385 (436)
                      +|..+
T Consensus       114 ~G~~~  118 (346)
T 2q83_A          114 EGRPF  118 (346)
T ss_dssp             CCBCC
T ss_pred             cCccC
Confidence            98654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=95.89  E-value=0.032  Score=52.02  Aligned_cols=92  Identities=17%  Similarity=0.148  Sum_probs=70.2

Q ss_pred             cccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC---cCcccceeEEEEeCCeeeEEEecCCCCCh
Q 041073          309 HKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRAVVYEYMPNGSL  385 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~gsL  385 (436)
                      +.|+.|....+|+... +++.+++|+....  ....+..|...|+.+.   ...+++++......+..++||||+++..+
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            4589999999999875 4667888987543  3566888988888774   35678888888877889999999988754


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 041073          386 DRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG  421 (436)
Q Consensus       386 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~  421 (436)
                      ..                  ..+.++.+.|+-||+.
T Consensus       119 ~~------------------~~~~~lG~~LA~LH~~  136 (312)
T 3jr1_A          119 KQ------------------SSFTIFAEKIAQLHQI  136 (312)
T ss_dssp             CT------------------THHHHHHHHHHHHHHC
T ss_pred             Cc------------------hhHHHHHHHHHHHHcC
Confidence            11                  2456788888999985

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=93.34  E-value=0.1  Score=48.09  Aligned_cols=71  Identities=13%  Similarity=0.145  Sum_probs=42.2

Q ss_pred             hcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcc-cceeEEEEeCCeeeEEEecC-CCCCh
Q 041073          308 THKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRAVVYEYM-PNGSL  385 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~~gsL  385 (436)
                      .+.|+.|....+|+.     +.+++|+........-...+|...++.+...++ .++++.  ..+.-++++||+ ++.++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence            356888888999988     457888876421111123457777666543223 455543  333457899999 55444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=89.16  E-value=0.85  Score=42.17  Aligned_cols=75  Identities=15%  Similarity=0.151  Sum_probs=49.2

Q ss_pred             ccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcC--cccceeEE-----EEeCCeeeEEEecCCC
Q 041073          310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHV--NVVQLLGF-----CSEGSKRAVVYEYMPN  382 (436)
Q Consensus       310 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~E~~~~  382 (436)
                      .++ |....||+....+|+.+++|..+......+.+..|..++..+...  .+++++..     ....+..+++||++++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G  111 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  111 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence            355 777789988766676799999875444566777788877766422  23444432     1234566889999987


Q ss_pred             CCh
Q 041073          383 GSL  385 (436)
Q Consensus       383 gsL  385 (436)
                      ..+
T Consensus       112 ~~~  114 (328)
T 1zyl_A          112 RQF  114 (328)
T ss_dssp             EEC
T ss_pred             CCC
Confidence            543

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=87.08  E-value=0.66  Score=28.85  Aligned_cols=9  Identities=11%  Similarity=0.353  Sum_probs=3.9

Q ss_pred             chhhhhHHH
Q 041073          247 VDVLIIGRF  255 (436)
Q Consensus       247 i~viv~~~~  255 (436)
                      ++.++++++
T Consensus        14 Ia~~vVGvl   22 (44)
T 2jwa_A           14 IISAVVGIL   22 (44)
T ss_dssp             HHHHHHHHH
T ss_pred             hHHHHHHHH
Confidence            344444433

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=86.83  E-value=1.4  Score=42.02  Aligned_cols=97  Identities=12%  Similarity=0.154  Sum_probs=56.0

Q ss_pred             cccCCCCCeEEEEEEEc--------CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCc-ccceeEEEEeCCeeeEEEec
Q 041073          309 HKLGQGGFGSVYKGQLH--------TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~  379 (436)
                      +.|..|-...+|+....        +++.+++|+..........+.+|..+++.+...+ ..++++.+..    .+||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            45666777888988754        2467889886443334566778998887775222 3566665543    299999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG  421 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~  421 (436)
                      +++..|..--         +..   ..+..++++.|+-||+.
T Consensus       132 i~G~~l~~~~---------l~~---p~~~~~ia~~La~LH~~  161 (379)
T 3feg_A          132 IPSRPLKTQE---------LRE---PVLSAAIATKMAQFHGM  161 (379)
T ss_dssp             CSEEECCGGG---------GGC---HHHHHHHHHHHHHHHTC
T ss_pred             ecCccCChhH---------hCC---HHHHHHHHHHHHHHhCC
Confidence            9986653211         100   13456677777777763

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=86.53  E-value=1  Score=28.12  Aligned_cols=25  Identities=16%  Similarity=0.297  Sum_probs=10.6

Q ss_pred             chhhhhH-HHHHHHHHHHHHHHHhhh
Q 041073          247 VDVLIIG-RFILAPIVFLVFLIHKYR  271 (436)
Q Consensus       247 i~viv~~-~~~l~~l~~~~~~~~~~~  271 (436)
                      |+..+++ ++++++++++++++.|+|
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr   38 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRR   38 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhh
Confidence            4444444 333344444444444433

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=86.28  E-value=1.2  Score=43.14  Aligned_cols=72  Identities=15%  Similarity=0.266  Sum_probs=48.8

Q ss_pred             cccCCCCCeEEEEEEEcC--------CCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcc-cceeEEEEeCCeeeEEEec
Q 041073          309 HKLGQGGFGSVYKGQLHT--------GGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~  379 (436)
                      +.|+.|-...+|+....+        ++.+++|+.... ...+.+.+|..+++.+...++ .++++.+..    .+|+||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            457888889999998653        467889987432 222566789888887753333 566665432    389999


Q ss_pred             CCCCCh
Q 041073          380 MPNGSL  385 (436)
Q Consensus       380 ~~~gsL  385 (436)
                      +++.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986554

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=85.24  E-value=0.87  Score=28.33  Aligned_cols=18  Identities=17%  Similarity=0.279  Sum_probs=7.4

Q ss_pred             HHHHHHHHHHHHHHhhhc
Q 041073          255 FILAPIVFLVFLIHKYRT  272 (436)
Q Consensus       255 ~~l~~l~~~~~~~~~~~~  272 (436)
                      +++++++++++++.|+|+
T Consensus        21 ~~v~ii~~~~~~~~RRRr   38 (44)
T 2l2t_A           21 FILVIVGLTFAVYVRRKS   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhhhhh
Confidence            333334444444444433

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.13  E-value=0.18  Score=49.73  Aligned_cols=60  Identities=3%  Similarity=0.004  Sum_probs=18.4

Q ss_pred             hhcccCCCCCeEEEEEEEcC-CCEEEE------EEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEe
Q 041073          307 FTHKLGQGGFGSVYKGQLHT-GGLIAV------KMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE  369 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~~~~-~~~vav------K~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  369 (436)
                      +.+.||   ||.||+|.+.. ..+||+      |..+...   .....+.+|..+++..+|+|+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            446676   99999998653 356888      6655422   223457888899999999999999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=82.07  E-value=1.6  Score=42.78  Aligned_cols=97  Identities=12%  Similarity=0.092  Sum_probs=59.6

Q ss_pred             cccCCCCCeEEEEEEEcC-CCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcc-cceeEEEEeCCeeeEEEecCCCCChh
Q 041073          309 HKLGQGGFGSVYKGQLHT-GGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRAVVYEYMPNGSLD  386 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~  386 (436)
                      +.|+.|-...+|+....+ +..+++|+........-...+|..++..+...++ .++++.+.  +  .+||||+++.+|.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l~  189 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYALS  189 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccCC
Confidence            457888889999998764 4678888875422111112478888877754444 56776652  2  2599999875543


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 041073          387 RHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG  421 (436)
Q Consensus       387 ~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~  421 (436)
                      .         ..+..   ..++.++++.|+-||+.
T Consensus       190 ~---------~~l~~---~~~~~~ia~~La~LH~~  212 (458)
T 2qg7_A          190 R---------EDIKN---PKFQKLIAKNLKLLHDI  212 (458)
T ss_dssp             T---------TTTTS---HHHHHHHHHHHHHHHTC
T ss_pred             h---------hhcCC---HHHHHHHHHHHHHHhcC
Confidence            1         11111   24677888999999975

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	436
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-35
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-34
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-33
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-32
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-31
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-30
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-30
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-30
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-30
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-29
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-29
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-29
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-29
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-29
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-27
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-27
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-27
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-27
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-27
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-26
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-26
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-26
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-26
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-26
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-26
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-25
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-25
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-25
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-25
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-25
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-24
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-24
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-24
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-23
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-23
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-23
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-23
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-22
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-22
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-22
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-22
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-22
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-22
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-21
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-21
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-21
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-21
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-20
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-20
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-20
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-19
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-19
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-19
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-19
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-18
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-18
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-17
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-16
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-16
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-16
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-15
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-13

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 8e-35
 Identities = 36/131 (27%), Positives = 62/131 (47%), Gaps = 6/131 (4%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
               +LG G FG V+ G  +    +AVK LK    S + F+ E + + ++ H  +V+L  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
             ++     ++ EYM NGSL   +  K   G   +  KL ++A   A G+ ++       
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---N 129

Query: 426 ILHFDIKPHNI 436
            +H D++  NI
Sbjct: 130 YIHRDLRAANI 140

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 6e-34
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 6/131 (4%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
            F  +LG G FG V  G+      +A+KM+K    S +EFI E   +  + H  +VQL G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
            C++     ++ EYM NG L  ++     R   F  ++L E+       +EYL +     
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESK---Q 120

Query: 426 ILHFDIKPHNI 436
            LH D+   N 
Sbjct: 121 FLHRDLAARNC 131

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-33
 Identities = 44/134 (32%), Positives = 74/134 (55%), Gaps = 12/134 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQ 362
               ++G G FG+VYKG+ H    +AVKML  +  +    + F NEV  + +  HVN++ 
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
            +G+ +   + A+V ++    SL  H+   E++   F   KL ++A  TA+G++YLH   
Sbjct: 69  FMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAK- 123

Query: 423 DVCILHFDIKPHNI 436
              I+H D+K +NI
Sbjct: 124 --SIIHRDLKSNNI 135

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 4e-33
 Identities = 35/130 (26%), Positives = 63/130 (48%), Gaps = 6/130 (4%)

Query: 307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGF 366
           F  ++G G FG V+ G       +A+K ++    S E+FI E   + ++ H  +VQL G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
           C E +   +V+E+M +G L  ++    ++   F+ E L  + L    G   +    + C+
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEG---MAYLEEACV 122

Query: 427 LHFDIKPHNI 436
           +H D+   N 
Sbjct: 123 IHRDLAARNC 132

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 5e-32
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 8/132 (6%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
                +G+G FG V  G  + G  +AVK +KN   +A+ F+ E S + ++ H N+VQLLG
Sbjct: 10  KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLG 67

Query: 366 FCSEGSKR-AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
              E      +V EYM  GSL  ++  +         + L + +L     +EYL      
Sbjct: 68  VIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 122

Query: 425 CILHFDIKPHNI 436
             +H D+   N+
Sbjct: 123 NFVHRDLAARNV 134

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  120 bits (301), Expect = 1e-31
 Identities = 45/148 (30%), Positives = 66/148 (44%), Gaps = 8/148 (5%)

Query: 292 PKRYSYPEIIAMTNHFT--HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINE 348
           P   +Y +        T  HKLG G +G VY+G        +AVK LK      EEF+ E
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63

Query: 349 VSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVA 408
            + +  I H N+VQLLG C+      ++ E+M  G+L  ++   E   Q  S   L  +A
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMA 121

Query: 409 LGTARGIEYLHNGCDVCILHFDIKPHNI 436
              +  +EYL        +H D+   N 
Sbjct: 122 TQISSAMEYLE---KKNFIHRDLAARNC 146

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-30
 Identities = 40/131 (30%), Positives = 62/131 (47%), Gaps = 6/131 (4%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
               KLGQG FG V+ G  +    +A+K LK    S E F+ E   + ++ H  +VQL  
Sbjct: 20  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
             SE     +V EYM  GSL   +  +   G+     +L ++A   A G+ Y+     + 
Sbjct: 80  VVSEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MN 133

Query: 426 ILHFDIKPHNI 436
            +H D++  NI
Sbjct: 134 YVHRDLRAANI 144

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 2e-30
 Identities = 33/138 (23%), Positives = 61/138 (44%), Gaps = 11/138 (7%)

Query: 304 TNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA--EEFINEVSTIGRIHHV 358
            + F    +LG G  G V+K     +G ++A K++      A   + I E+  +   +  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            +V   G      + ++  E+M  GSLD+ +     +      + L +V++   +G+ YL
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 419 HNGCDVCILHFDIKPHNI 436
                  I+H D+KP NI
Sbjct: 121 REKHK--IMHRDVKPSNI 136

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  117 bits (293), Expect = 2e-30
 Identities = 32/132 (24%), Positives = 56/132 (42%), Gaps = 12/132 (9%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE----FINEVSTIGRIHHVNVVQLL 364
           ++G G FG+VY  + +    ++A+K +  S   + E     I EV  + ++ H N +Q  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G         +V EY    + D          +     ++  V  G  +G+ YLH     
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH---SH 134

Query: 425 CILHFDIKPHNI 436
            ++H D+K  NI
Sbjct: 135 NMIHRDVKAGNI 146

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 4e-30
 Identities = 40/154 (25%), Positives = 62/154 (40%), Gaps = 26/154 (16%)

Query: 306 HFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKFSA--EEFINEVSTIGRI-H 356
            F   LG G FG V +   +          +AVKMLK S      E  ++E+  +  + +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 357 HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPK--------------ESRGQSFSWE 402
           H+N+V LLG C+ G    V+ EY   G L   +  K              E    +   E
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 403 KLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            L   +   A+G+ +L +      +H D+   NI
Sbjct: 146 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-29
 Identities = 31/132 (23%), Positives = 58/132 (43%), Gaps = 12/132 (9%)

Query: 310 KLGQGGFGSVYKGQLH---TGGLIAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQLL 364
           +LG G FGSV +G          +A+K+LK    K   EE + E   + ++ +  +V+L+
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G C +     +V E    G L + +     + +      + E+    + G++YL      
Sbjct: 76  GVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE---K 128

Query: 425 CILHFDIKPHNI 436
             +H D+   N+
Sbjct: 129 NFVHRDLAARNV 140

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 3e-29
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 8/129 (6%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKML-KNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           +LG G FG VYK Q   T  L A K++   S+   E+++ E+  +    H N+V+LL   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
              +   ++ E+   G++D  +       +  +  ++  V   T   + YLH   D  I+
Sbjct: 79  YYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH---DNKII 132

Query: 428 HFDIKPHNI 436
           H D+K  NI
Sbjct: 133 HRDLKAGNI 141

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 5e-29
 Identities = 32/136 (23%), Positives = 64/136 (47%), Gaps = 15/136 (11%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 369
            +G+G FG V++G+   G  +AVK+  + +  +     E+     + H N++  +   ++
Sbjct: 10  SIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 370 G----SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                ++  +V +Y  +GSL  ++        + + E + ++AL TA G+ +LH      
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 426 -----ILHFDIKPHNI 436
                I H D+K  NI
Sbjct: 124 QGKPAIAHRDLKSKNI 139

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 5e-29
 Identities = 29/139 (20%), Positives = 53/139 (38%), Gaps = 8/139 (5%)

Query: 306 HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE---FINEVSTIGRIHHVNVV 361
              + +G G +G   K +    G ++  K L     +  E    ++EV+ +  + H N+V
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 362 QLLGFCSEGSKRAV--VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           +      + +   +  V EY   G L   I       Q    E +  V       ++  H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 420 --NGCDVCILHFDIKPHNI 436
             +     +LH D+KP N+
Sbjct: 127 RRSDGGHTVLHRDLKPANV 145

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (282), Expect = 6e-29
 Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 23/159 (14%)

Query: 295 YSYPEIIAMTNHFT-----------HKLGQGGFGSVYKGQLHTGG----LIAVKMLKN-- 337
           +++ +       F              +G G FG V  G L   G     +A+K LK+  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 338 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQ 397
           ++    +F++E S +G+  H NV+ L G  ++ +   ++ E+M NGSLD  +   + +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-- 124

Query: 398 SFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            F+  +L  +  G A G++YL +   +  +H D+   NI
Sbjct: 125 -FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNI 159

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (272), Expect = 1e-27
 Identities = 34/138 (24%), Positives = 60/138 (43%), Gaps = 13/138 (9%)

Query: 307 FTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQ 362
           F  ++G+G F +VYKG    T   +A   L++ K +    + F  E   +  + H N+V+
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 363 LLGFCSEGSKR----AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
                    K      +V E M +G+L  ++     R +    + L        +G+++L
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128

Query: 419 HNGCDVCILHFDIKPHNI 436
           H      I+H D+K  NI
Sbjct: 129 HTRT-PPIIHRDLKCDNI 145

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  110 bits (276), Expect = 1e-27
 Identities = 32/133 (24%), Positives = 56/133 (42%), Gaps = 8/133 (6%)

Query: 306 HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS-AEEFINEVSTIGRIHHVNVVQL 363
               +LG G FG V++     TG   A K +     S  E    E+ T+  + H  +V L
Sbjct: 29  DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
                + ++  ++YE+M  G L   +          S ++  E      +G+ ++H   +
Sbjct: 89  HDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMH---E 142

Query: 424 VCILHFDIKPHNI 436
              +H D+KP NI
Sbjct: 143 NNYVHLDLKPENI 155

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 3e-27
 Identities = 38/139 (27%), Positives = 59/139 (42%), Gaps = 15/139 (10%)

Query: 306 HFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSKFS----AEEFINEVSTIGRIHH 357
               KLG G FG V +G+          +AVK LK    S     ++FI EV+ +  + H
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 70

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
            N+++L G       + +V E  P GSL   +   +     F    L   A+  A G+ Y
Sbjct: 71  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGY 126

Query: 418 LHNGCDVCILHFDIKPHNI 436
           L +      +H D+   N+
Sbjct: 127 LESK---RFIHRDLAARNL 142

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 3e-27
 Identities = 31/136 (22%), Positives = 63/136 (46%), Gaps = 12/136 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS----AEEFINEVSTIGRIHHVNV 360
                LG+G FG+VY  +   +  ++A+K+L  ++        +   EV     + H N+
Sbjct: 9   EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           ++L G+  + ++  ++ EY P G++ R +     +   F  ++        A  + Y H+
Sbjct: 69  LRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS 124

Query: 421 GCDVCILHFDIKPHNI 436
                ++H DIKP N+
Sbjct: 125 K---RVIHRDIKPENL 137

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  108 bits (270), Expect = 7e-27
 Identities = 32/164 (19%), Positives = 70/164 (42%), Gaps = 10/164 (6%)

Query: 277 VDNVEKFLHNQQSWMPKRYSYPEIIAMTNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVK 333
           +++ +KF  +       +    +  ++ +++    +LG G FG V++     TG +   K
Sbjct: 1   INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60

Query: 334 MLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPK 392
            +            NE+S + ++HH  ++ L     +  +  ++ E++  G L   I   
Sbjct: 61  FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--- 117

Query: 393 ESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            +     S  ++         G++++H   +  I+H DIKP NI
Sbjct: 118 AAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENI 158

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 1e-26
 Identities = 31/133 (23%), Positives = 62/133 (46%), Gaps = 14/133 (10%)

Query: 310 KLGQGGFGSVYKGQLH---TGGLIAVKMLKNSKFSA---EEFINEVSTIGRIHHVNVVQL 363
           +LG G FG+V KG          +AVK+LKN        +E + E + + ++ +  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
           +G C E     +V E    G L++++     + +    + + E+    + G++YL     
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES-- 126

Query: 424 VCILHFDIKPHNI 436
              +H D+   N+
Sbjct: 127 -NFVHRDLAARNV 138

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 2e-26
 Identities = 25/128 (19%), Positives = 49/128 (38%), Gaps = 7/128 (5%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 368
            LG+G FG V++     +      K +K           E+S +    H N++ L     
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 369 EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILH 428
              +  +++E++    +   I    +     +  ++          +++LH      I H
Sbjct: 72  SMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH---SHNIGH 125

Query: 429 FDIKPHNI 436
           FDI+P NI
Sbjct: 126 FDIRPENI 133

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 2e-26
 Identities = 35/136 (25%), Positives = 51/136 (37%), Gaps = 12/136 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE----FINEVSTIGRIHHVNV 360
            F   LG+G F +V   + L T    A+K+L+      E        E   + R+ H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
           V+L     +  K      Y  NG L ++I     +  SF           TA  +  L  
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDET---CTRFYTAEIVSALEY 123

Query: 421 GCDVCILHFDIKPHNI 436
                I+H D+KP NI
Sbjct: 124 LHGKGIIHRDLKPENI 139

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 3e-26
 Identities = 35/129 (27%), Positives = 57/129 (44%), Gaps = 10/129 (7%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKML-KNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
           K+GQG  G+VY    + TG  +A++ +    +   E  INE+  +    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
             G +  VV EY+  GSL   +             ++  V     + +E+LH      ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVI 138

Query: 428 HFDIKPHNI 436
           H DIK  NI
Sbjct: 139 HRDIKSDNI 147

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 3e-26
 Identities = 36/134 (26%), Positives = 52/134 (38%), Gaps = 10/134 (7%)

Query: 306 HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKML--KNSKFSAEEFINEVSTIGRIHHVNVVQ 362
                LG+G +G V       T   +AVK++  K +    E    E+     ++H NVV+
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
             G   EG+ + +  EY   G L   I P                      G+ YLH   
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 423 DVCILHFDIKPHNI 436
            + I H DIKP N+
Sbjct: 121 GIGITHRDIKPENL 134

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 5e-26
 Identities = 39/158 (24%), Positives = 63/158 (39%), Gaps = 31/158 (19%)

Query: 307 FTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-HH 357
           F   LG G FG V     +          +AVKMLK    S+E    ++E+  + ++  H
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPK-------------------ESRGQS 398
            N+V LLG C+      +++EY   G L  ++  K                   E     
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 399 FSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
            ++E L   A   A+G+E+L        +H D+   N+
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNV 195

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 2e-25
 Identities = 32/137 (23%), Positives = 55/137 (40%), Gaps = 13/137 (9%)

Query: 306 HFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSKFSA--EEFINEVSTIGRIHHVN 359
                +G+G FG V++G           +A+K  KN    +  E+F+ E  T+ +  H +
Sbjct: 10  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           +V+L+G  +E     ++ E    G L   +     R  S     L   A   +  + YL 
Sbjct: 70  IVKLIGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLE 125

Query: 420 NGCDVCILHFDIKPHNI 436
                  +H DI   N+
Sbjct: 126 ---SKRFVHRDIAARNV 139

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 3e-25
 Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 21/149 (14%)

Query: 306 HFTHKLGQGGFGSVYKGQLHTGGL---IAVKMLK--NSKFSAEEFINEVSTIGRI-HHVN 359
            F   +G+G FG V K ++   GL    A+K +K   SK    +F  E+  + ++ HH N
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIF------------PKESRGQSFSWEKLHEV 407
           ++ LLG C       +  EY P+G+L   +                S   + S ++L   
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 408 ALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           A   ARG++YL        +H D+   NI
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNI 158

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  102 bits (254), Expect = 5e-25
 Identities = 34/159 (21%), Positives = 60/159 (37%), Gaps = 31/159 (19%)

Query: 306 HFTHKLGQGGFGSVYKGQL------HTGGLIAVKMLKNSKFS--AEEFINEVSTIGRIHH 357
            +   +G+G FG V++ +           ++AVKMLK    +    +F  E + +    +
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIF--------------------PKESRGQ 397
            N+V+LLG C+ G    +++EYM  G L+  +                            
Sbjct: 76  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135

Query: 398 SFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
             S  +   +A   A G+ YL        +H D+   N 
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC 171

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (253), Expect = 7e-25
 Identities = 31/133 (23%), Positives = 54/133 (40%), Gaps = 10/133 (7%)

Query: 307 FTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE--FINEVSTIGRIHHVNVVQL 363
           F   LG G F  V   +   T  L+A+K +       +E    NE++ + +I H N+V L
Sbjct: 13  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
                 G    ++ + +  G L   I         ++      +       ++YL    D
Sbjct: 73  DDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYL---HD 125

Query: 424 VCILHFDIKPHNI 436
           + I+H D+KP N+
Sbjct: 126 LGIVHRDLKPENL 138

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  102 bits (255), Expect = 9e-25
 Identities = 31/135 (22%), Positives = 57/135 (42%), Gaps = 15/135 (11%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE-------FINEVSTIGRIHHVNVV 361
            +G+GGFG VY  +   TG + A+K L   +   ++           +S +       +V
Sbjct: 11  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
            +        K + + + M  G L  H+    S+   FS   +   A     G+E++H  
Sbjct: 71  CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMH-- 124

Query: 422 CDVCILHFDIKPHNI 436
            +  +++ D+KP NI
Sbjct: 125 -NRFVVYRDLKPANI 138

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 2e-24
 Identities = 39/145 (26%), Positives = 62/145 (42%), Gaps = 17/145 (11%)

Query: 306 HFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHH 357
             + +LGQG FG VY+G             +A+K +  +    E  EF+NE S +   + 
Sbjct: 23  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPK------ESRGQSFSWEKLHEVALGT 411
            +VV+LLG  S+G    V+ E M  G L  ++                S  K+ ++A   
Sbjct: 83  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142

Query: 412 ARGIEYLHNGCDVCILHFDIKPHNI 436
           A G+ YL+       +H D+   N 
Sbjct: 143 ADGMAYLNA---NKFVHRDLAARNC 164

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 2e-24
 Identities = 38/138 (27%), Positives = 52/138 (37%), Gaps = 13/138 (9%)

Query: 306 HFTHKLGQGGFGSVYKGQLH----TGGLIAVKMLKNSKFSAE--EFINEVSTIGRIHHVN 359
           HF   +G+G FG VY G L          AVK L       E  +F+ E   +    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 360 VVQLLGFCSEGSKRA-VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
           V+ LLG C        VV  YM +G L   I        + + + L    L  A+G   +
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKG---M 143

Query: 419 HNGCDVCILHFDIKPHNI 436
                   +H D+   N 
Sbjct: 144 KFLASKKFVHRDLAARNC 161

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 8e-24
 Identities = 39/153 (25%), Positives = 63/153 (41%), Gaps = 26/153 (16%)

Query: 307 FTHKLGQGGFGSVYKGQL--------HTGGLIAVKMLKNSKFS--AEEFINEVSTIGRI- 355
               LG+G FG V   +         +    +AVKMLK+        + I+E+  +  I 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 356 HHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRG------------QSFSWEK 403
            H N++ LLG C++     V+ EY   G+L  ++  +   G            +  S + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 404 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           L   A   ARG+EYL        +H D+   N+
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNV 166

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 2e-23
 Identities = 42/133 (31%), Positives = 67/133 (50%), Gaps = 13/133 (9%)

Query: 311 LGQGGFGSVYKGQLHTGG-----LIAVKMLKNSKFSAE--EFINEVSTIGRIHHVNVVQL 363
           +G G FG VYKG L T        +A+K LK      +  +F+ E   +G+  H N+++L
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
            G  S+     ++ EYM NG+LD+ +     +   FS  +L  +  G A G++YL N   
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN--- 128

Query: 424 VCILHFDIKPHNI 436
           +  +H D+   NI
Sbjct: 129 MNYVHRDLAARNI 141

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 95.6 bits (237), Expect = 6e-23
 Identities = 28/139 (20%), Positives = 49/139 (35%), Gaps = 16/139 (11%)

Query: 307 FTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS----AEEFINEVSTIGRIHHVNVV 361
               LG GG   V+  + L     +AVK+L+            F  E      ++H  +V
Sbjct: 11  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70

Query: 362 QLLGFC----SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
            +          G    +V EY+   +L   +          + ++  EV     + + +
Sbjct: 71  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNF 126

Query: 418 LHNGCDVCILHFDIKPHNI 436
                   I+H D+KP NI
Sbjct: 127 S---HQNGIIHRDVKPANI 142

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 6e-23
 Identities = 24/130 (18%), Positives = 53/130 (40%), Gaps = 7/130 (5%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS--AEEFINEVSTIGRIHHVNVVQLLGF 366
            +G+G +G V           +A+K +   +     +  + E+  + R  H N++ +   
Sbjct: 15  YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
               +   +   Y+    +   ++ K  + Q  S + +        RG++Y+H      +
Sbjct: 75  IRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130

Query: 427 LHFDIKPHNI 436
           LH D+KP N+
Sbjct: 131 LHRDLKPSNL 140

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.3 bits (239), Expect = 8e-23
 Identities = 32/132 (24%), Positives = 55/132 (41%), Gaps = 15/132 (11%)

Query: 311 LGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQLLGFC- 367
           LG G  G V +     T    A+KML++      +   EV    R     ++V+++    
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYE 75

Query: 368 ---SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
              +      +V E +  G L   I  ++   Q+F+  +  E+       I+YLH    +
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 425 CILHFDIKPHNI 436
            I H D+KP N+
Sbjct: 131 NIAHRDVKPENL 142

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (238), Expect = 1e-22
 Identities = 36/152 (23%), Positives = 61/152 (40%), Gaps = 22/152 (14%)

Query: 292 PKRYSYPEIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVS 350
           P+  SY +           +G G FG VY+ +L  +G L+A+K +   K        E+ 
Sbjct: 17  PQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQ 65

Query: 351 TIGRIHHVNVVQLLGFCSEGSKR------AVVYEYMPNGSLDRHIFPKESRGQSFSWEKL 404
            + ++ H N+V+L  F     ++       +V +Y+P     R         Q+     +
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYV 124

Query: 405 HEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
                   R + Y+H      I H DIKP N+
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNL 153

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.6 bits (234), Expect = 2e-22
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 25/153 (16%)

Query: 306 HFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKFSAE--EFINEVSTIGRI-H 356
                LG+G FG V +          T   +AVKMLK     +E    ++E+  +  I H
Sbjct: 16  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75

Query: 357 HVNVVQLLGFCSE-GSKRAVVYEYMPNGSLDRHIF------------PKESRGQSFSWEK 403
           H+NVV LLG C++ G    V+ E+   G+L  ++             P++      + E 
Sbjct: 76  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 404 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           L   +   A+G+E+L +      +H D+   NI
Sbjct: 136 LICYSFQVAKGMEFLAS---RKCIHRDLAARNI 165

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 94.0 bits (233), Expect = 2e-22
 Identities = 30/139 (21%), Positives = 57/139 (41%), Gaps = 19/139 (13%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA----------EEFINEVSTIGRIH-H 357
            LG+G    V +     T    AVK++  +   +          E  + EV  + ++  H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 358 VNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
            N++QL       +   +V++ M  G L  ++    +   + S ++  ++       I  
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICA 125

Query: 418 LHNGCDVCILHFDIKPHNI 436
           LH    + I+H D+KP NI
Sbjct: 126 LH---KLNIVHRDLKPENI 141

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 94.9 bits (235), Expect = 4e-22
 Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 15/167 (8%)

Query: 278 DNVEKFLHNQQSWMPKRYSYP-EIIAMTNHFT--HKLGQGGFGSVYKGQ-LHTGGLIAVK 333
           ++V++FL   +    K++  P +  A  + F     LG G FG V   +   +G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 334 MLKNSKFSA----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHI 389
           +L   K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 390 FPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
                R   FS       A       EYLH    + +++ D+KP N+
Sbjct: 133 R----RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 92.6 bits (229), Expect = 9e-22
 Identities = 33/130 (25%), Positives = 54/130 (41%), Gaps = 10/130 (7%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGF 366
           K+G+G +G VYK Q + G   A+K ++  K         I E+S +  + H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 367 CSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCI 426
                +  +V+E++           +                L    GI Y H   D  +
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRV 121

Query: 427 LHFDIKPHNI 436
           LH D+KP N+
Sbjct: 122 LHRDLKPQNL 131

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.9 bits (230), Expect = 9e-22
 Identities = 33/134 (24%), Positives = 63/134 (47%), Gaps = 14/134 (10%)

Query: 310 KLGQGGFGSVYKGQLHTGG-----LIAVKMLK--NSKFSAEEFINEVSTIGRIHHVNVVQ 362
            LG G FG+VYKG     G      +A+K L+   S  + +E ++E   +  + + +V +
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           LLG C   + + ++ + MP G L  ++        +   + L    +  A+G+ YL +  
Sbjct: 76  LLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130

Query: 423 DVCILHFDIKPHNI 436
              ++H D+   N+
Sbjct: 131 --RLVHRDLAARNV 142

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 92.6 bits (229), Expect = 1e-21
 Identities = 31/129 (24%), Positives = 52/129 (40%), Gaps = 10/129 (7%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC- 367
           K+G G FG +Y G  +  G  +A+K+    K    +   E      +     +  + +C 
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECV-KTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72

Query: 368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCIL 427
           +EG    +V E +     D   F      + FS + +  +A      IEY+H       +
Sbjct: 73  AEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIH---SKNFI 125

Query: 428 HFDIKPHNI 436
           H D+KP N 
Sbjct: 126 HRDVKPDNF 134

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 92.5 bits (229), Expect = 2e-21
 Identities = 29/132 (21%), Positives = 52/132 (39%), Gaps = 12/132 (9%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS----AEEFINEVSTIGRIHHVNVVQLL 364
            LG G FG V+  +  H G   A+K+LK          E   +E   +  + H  ++++ 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 365 GFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDV 424
           G   +  +  ++ +Y+  G L   +   +      +     EV L        L      
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------ALEYLHSK 123

Query: 425 CILHFDIKPHNI 436
            I++ D+KP NI
Sbjct: 124 DIIYRDLKPENI 135

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.1 bits (225), Expect = 3e-21
 Identities = 34/134 (25%), Positives = 60/134 (44%), Gaps = 14/134 (10%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSA------EEFINEVSTIGRIHHVNVVQ 362
            LG+G F +VYK +  +T  ++A+K +K    S          + E+  +  + H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 363 LLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC 422
           LL      S  ++V+++M                   +   +    L T +G+EYLH   
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 423 DVCILHFDIKPHNI 436
              ILH D+KP+N+
Sbjct: 120 --WILHRDLKPNNL 131

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.3 bits (226), Expect = 4e-21
 Identities = 30/136 (22%), Positives = 46/136 (33%), Gaps = 13/136 (9%)

Query: 307 FTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS----AEEFINEVSTIGR-IHHVNV 360
               LG+G FG V+  +   T    A+K LK          E  + E   +     H  +
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
             +            V EY+  G L  HI         F   +    A     G+++L  
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFL-- 119

Query: 421 GCDVCILHFDIKPHNI 436
                I++ D+K  NI
Sbjct: 120 -HSKGIVYRDLKLDNI 134

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.4 bits (218), Expect = 3e-20
 Identities = 31/131 (23%), Positives = 59/131 (45%), Gaps = 10/131 (7%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G VYK +   TG ++A+K ++    +       I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                +K  +V+E++         F   S         +        +G+ +        
Sbjct: 69  VIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHR 122

Query: 426 ILHFDIKPHNI 436
           +LH D+KP N+
Sbjct: 123 VLHRDLKPQNL 133

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.6 bits (216), Expect = 5e-20
 Identities = 27/137 (19%), Positives = 58/137 (42%), Gaps = 13/137 (9%)

Query: 310 KLGQGGFGSVYKGQ--LHTGGLIAVKMLKNSK------FSAEEFINEVSTIGRIHHVNVV 361
           ++G+G +G V+K +   + G  +A+K ++          S    +  +  +    H NVV
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSLDRHI--FPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           +L   C+           +    +D+ +  +  +        E + ++     RG+++LH
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 420 NGCDVCILHFDIKPHNI 436
                 ++H D+KP NI
Sbjct: 134 ---SHRVVHRDLKPQNI 147

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.1 bits (215), Expect = 7e-20
 Identities = 36/135 (26%), Positives = 55/135 (40%), Gaps = 15/135 (11%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNVV 361
           +LG G F  V K +   TG   A K +K  +        S E+   EVS +  I H NV+
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 362 QLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
            L       +   ++ E +  G L   +       +S + E+  E       G   ++  
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNG---VYYL 129

Query: 422 CDVCILHFDIKPHNI 436
             + I HFD+KP NI
Sbjct: 130 HSLQIAHFDLKPENI 144

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 85.2 bits (210), Expect = 3e-19
 Identities = 26/133 (19%), Positives = 53/133 (39%), Gaps = 10/133 (7%)

Query: 306 HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQL 363
               ++G+G FG +++G  L     +A+K        A +  +E  T   +     +  +
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 364 LGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCD 423
             F  EG    +V + +     D      +  G+ FS + +   A      ++ +H   +
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIH---E 119

Query: 424 VCILHFDIKPHNI 436
             +++ DIKP N 
Sbjct: 120 KSLVYRDIKPDNF 132

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.0 bits (212), Expect = 3e-19
 Identities = 31/136 (22%), Positives = 52/136 (38%), Gaps = 12/136 (8%)

Query: 306 HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEE----FINEVSTIGRIHHVNV 360
            +   LG+G FG V   +   TG   A+K+L+     A++     + E   +    H  +
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 361 VQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHN 420
             L        +   V EY   G L  H+    SR + F+ E+        A  +  L  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYG---AEIVSALEY 120

Query: 421 GCDVCILHFDIKPHNI 436
                +++ DIK  N+
Sbjct: 121 LHSRDVVYRDIKLENL 136

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.6 bits (211), Expect = 4e-19
 Identities = 27/131 (20%), Positives = 53/131 (40%), Gaps = 7/131 (5%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
            +G G +G+V       TG  +A+K L     S+  A+    E+  +  + H NV+ LL 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
             +         ++            K  + +    +++  +     +G+ Y+H      
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141

Query: 426 ILHFDIKPHNI 436
           I+H D+KP N+
Sbjct: 142 IIHRDLKPGNL 152

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 84.5 bits (208), Expect = 9e-19
 Identities = 28/135 (20%), Positives = 58/135 (42%), Gaps = 16/135 (11%)

Query: 306 HFTHKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRI-HHVNVVQL 363
               KLG+G +  V++   +     + VK+LK  K   ++   E+  +  +    N++ L
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITL 95

Query: 364 LGFCSEGSKR--AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG 421
                +   R  A+V+E++ N    +         Q+ +   +        + ++Y H  
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH-- 146

Query: 422 CDVCILHFDIKPHNI 436
             + I+H D+KPHN+
Sbjct: 147 -SMGIMHRDVKPHNV 160

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.2 bits (205), Expect = 1e-18
 Identities = 27/137 (19%), Positives = 47/137 (34%), Gaps = 16/137 (11%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS-------AEEFINEVSTIGRIH--HVN 359
            LG GGFGSVY G  +     +A+K ++  + S             EV  + ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 360 VVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
           V++LL +        ++ E               +   +   E            + +  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHC- 126

Query: 420 NGCDVCILHFDIKPHNI 436
              +  +LH DIK  NI
Sbjct: 127 --HNCGVLHRDIKDENI 141

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.2 bits (199), Expect = 8e-18
 Identities = 25/131 (19%), Positives = 53/131 (40%), Gaps = 11/131 (8%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLK---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 365
           K+G+G +G+V+K +   T  ++A+K ++   + +      + E+  +  + H N+V+L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
                 K  +V+E+                           V     + ++ L       
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 426 ILHFDIKPHNI 436
           +LH D+KP N+
Sbjct: 122 VLHRDLKPQNL 132

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.3 bits (197), Expect = 3e-17
 Identities = 34/151 (22%), Positives = 59/151 (39%), Gaps = 18/151 (11%)

Query: 297 YPEIIAMTN-HFTHKLGQGGFGSVYKGQL----HTGGLIAVKMLKNSKFS-----AEEFI 346
           + E + + N      LG G +G V+  +      TG L A+K+LK +         E   
Sbjct: 17  HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 76

Query: 347 NEVSTIGRI-HHVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLH 405
            E   +  I     +V L       +K  ++ +Y+  G L  H+  +E   +      + 
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG 136

Query: 406 EVALGTARGIEYLHNGCDVCILHFDIKPHNI 436
           E+ L        L +   + I++ DIK  NI
Sbjct: 137 EIVLA-------LEHLHKLGIIYRDIKLENI 160

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.4 bits (192), Expect = 1e-16
 Identities = 28/139 (20%), Positives = 51/139 (36%), Gaps = 19/139 (13%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLG 365
           K+GQG FG V+K +   TG  +A+K +             + E+  +  + H NVV L+ 
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 366 FCSEGSKRA--------VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEY 417
            C   +           +V+++  +               S     +  +       +  
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-------LNG 129

Query: 418 LHNGCDVCILHFDIKPHNI 436
           L+      ILH D+K  N+
Sbjct: 130 LYYIHRNKILHRDMKAANV 148

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 77.4 bits (189), Expect = 3e-16
 Identities = 27/141 (19%), Positives = 57/141 (40%), Gaps = 15/141 (10%)

Query: 309 HKLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 367
            KLG G F +V+  + +     +A+K+++  K   E   +E+  + R++  +  +     
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 368 SEGSKR--AVVYEYMPNGSLDRHI----------FPKESRGQSFSWEKLHEVALGTARGI 415
           +    +         PNG     +            K+   +      + +++     G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 416 EYLHNGCDVCILHFDIKPHNI 436
           +Y+H  C   I+H DIKP N+
Sbjct: 139 DYMHRRC--GIIHTDIKPENV 157

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.9 bits (188), Expect = 4e-16
 Identities = 28/136 (20%), Positives = 49/136 (36%), Gaps = 20/136 (14%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLG 365
            +G G  G V           +A+K L     +   A+    E+  +  ++H N++ LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 366 FCS------EGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLH 419
             +      E     +V E M                     E++  +      GI++LH
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQME-------LDHERMSYLLYQMLCGIKHLH 136

Query: 420 NGCDVCILHFDIKPHN 435
           +     I+H D+KP N
Sbjct: 137 S---AGIIHRDLKPSN 149

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.3 bits (184), Expect = 1e-15
 Identities = 31/131 (23%), Positives = 52/131 (39%), Gaps = 7/131 (5%)

Query: 310 KLGQGGFGSVYKGQ-LHTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLG 365
            +G G +GSV       TG  +AVK L     S   A+    E+  +  + H NV+ LL 
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 366 FCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVC 425
             +         +      L         + Q  + + +  +     RG++Y+H      
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 141

Query: 426 ILHFDIKPHNI 436
           I+H D+KP N+
Sbjct: 142 IIHRDLKPSNL 152

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 65.2 bits (158), Expect = 6e-13
 Identities = 25/138 (18%), Positives = 39/138 (28%), Gaps = 21/138 (15%)

Query: 310 KLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSA-----------EEFINEVSTIGRIHHV 358
            +G+G   +V+       G   VK  K    S              F        R    
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 359 NVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYL 418
            + +L G          VY +  N  L   I  KE            EV       +   
Sbjct: 67  ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD--EVLDMILEEVAKF 119

Query: 419 HNGCDVCILHFDIKPHNI 436
           ++     I+H D+  +N+
Sbjct: 120 YH---RGIVHGDLSQYNV 134

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	436
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.94
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.94
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.94
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.94
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.94
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.93
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.93
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.93
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.93
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.93
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.93
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.93
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.93
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.93
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.93
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.93
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.93
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.93
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.93
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.92
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.92
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.92
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.92
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.92
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.92
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.92
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.92
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.91
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.91
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.91
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.91
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.9
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.9
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.9
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.9
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.9
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.9
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.9
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.89
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.89
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.89
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.89
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.89
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.89
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.89
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.89
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.89
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.89
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.89
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.88
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.88
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.87
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.87
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.87
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.87
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.87
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.86
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.85
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.85
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.85
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.84
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.72
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.72
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.21
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.24
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	94.77
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	83.46

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.94  E-value=3.2e-28  Score=226.49  Aligned_cols=134  Identities=31%  Similarity=0.451  Sum_probs=121.1

Q ss_pred             HHHHHHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          298 PEIIAMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       298 ~~i~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      +|+....+.+.+.||+|+||+||+|..+ +++.||||+++.+....+++.+|+++|++++|||||++++++.+++..++|
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            4555667788899999999999999965 688899999988777788999999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++...  ....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus        92 ~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NI  146 (287)
T d1opja_          92 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNC  146 (287)
T ss_dssp             EECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             eecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeE
Confidence            9999999999998532  345789999999999999999999998   999999999997

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.3e-27  Score=219.72  Aligned_cols=127  Identities=29%  Similarity=0.561  Sum_probs=116.7

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      .+++.+.||+|+||.||+|...+++.||||+++......+++.+|++++++++||||++++|++...+..++||||+++|
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g   85 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG   85 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence            35577899999999999999888889999999887777888999999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        86 ~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Ni  132 (263)
T d1sm2a_          86 CLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNC  132 (263)
T ss_dssp             BHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGE
T ss_pred             cHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhhe
Confidence            99999843   335689999999999999999999998   999999999997

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.9e-27  Score=219.09  Aligned_cols=126  Identities=27%  Similarity=0.371  Sum_probs=111.3

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .|++.+.||+|+||+||+|+.+ +++.||||+++...  ...+.+.+|+++|++++||||+++++++.+++..+|||||+
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~   85 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   85 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence            4667899999999999999964 78899999987632  23456899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++.    +...+++.++..++.|+++||+|||++   +|+||||||+||
T Consensus        86 ~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NI  134 (271)
T d1nvra_          86 SGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENL  134 (271)
T ss_dssp             TTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             CCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHE
Confidence            9999999983    345799999999999999999999998   999999999997

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=9.1e-28  Score=221.76  Aligned_cols=132  Identities=28%  Similarity=0.485  Sum_probs=116.9

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      |+....+++.+.||+|+||.||+|..++++.||||+++......+.+.+|++++++++|||||+++|++.+ +..++|||
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence            34456778889999999999999999888899999998877778889999999999999999999998754 56789999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++...  ....+++..+++++.||++||+|||++   +|+||||||+||
T Consensus        88 y~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NI  140 (272)
T d1qpca_          88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI  140 (272)
T ss_dssp             CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             eCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhhe
Confidence            99999999987432  224589999999999999999999998   999999999997

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=7e-27  Score=217.59  Aligned_cols=125  Identities=28%  Similarity=0.396  Sum_probs=113.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc-ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      +|.+.+.||+|+||+||+|.. .+++.||||+++.. ....+.+.+|+++|++++||||+++++++.+.+..++||||++
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence            467778999999999999985 57899999998763 3456779999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|+|.+++.     ...+++.++..++.|++.||+|||++   +|+||||||+||
T Consensus       101 gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NI  147 (293)
T d1yhwa1         101 GGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNI  147 (293)
T ss_dssp             TCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHe
Confidence            999999873     24699999999999999999999998   999999999997

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=6.6e-27  Score=214.03  Aligned_cols=127  Identities=31%  Similarity=0.492  Sum_probs=116.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPNG  383 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  383 (436)
                      .+++.++||+|+||+||+|+.++++.||||+++......+++.+|+.++++++||||++++|++.+.+..++||||+++|
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g   84 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG   84 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred             HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence            34577899999999999999988889999999987778889999999999999999999999999999999999999999


Q ss_pred             ChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          384 SLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       384 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|.+++..   ....+++..+.+++.|+++||+|||++   +|+||||||+||
T Consensus        85 ~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Ni  131 (258)
T d1k2pa_          85 CLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNC  131 (258)
T ss_dssp             EHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGE
T ss_pred             cHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeE
Confidence            99998743   335689999999999999999999998   999999999997

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=8.9e-27  Score=220.03  Aligned_cols=128  Identities=20%  Similarity=0.285  Sum_probs=115.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      ++|.+.+.||+|+||+||+|... +++.||+|+++....+...+.+|+++|+.++||||+++++++.+++..+|||||++
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence            35678899999999999999864 78899999998766556678899999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|+|.+++..   ....+++.++..++.||++||+|||++   +|+||||||+||
T Consensus        85 gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NI  133 (321)
T d1tkia_          85 GLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENI  133 (321)
T ss_dssp             CCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccce
Confidence            9999999932   334699999999999999999999998   999999999997

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=8e-27  Score=213.98  Aligned_cols=126  Identities=25%  Similarity=0.451  Sum_probs=113.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|.+.+.||+|+||+||+|+.+ +++.||+|++.+.    ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            4677899999999999999964 7889999998642    3345678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++.    +...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        87 y~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Ni  137 (263)
T d2j4za1          87 YAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENL  137 (263)
T ss_dssp             CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             ecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeeeeeccccc
Confidence            999999999983    335699999999999999999999998   999999999997

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.6e-27  Score=217.93  Aligned_cols=127  Identities=27%  Similarity=0.436  Sum_probs=113.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc-ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  381 (436)
                      .|++.+.||+|+||.||+|+.+ ++..||+|+++.. ....+.+.+|+++|++++|||||++++++.+.+..++||||++
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            4667889999999999999964 7889999999763 3344678999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|+|.+++..   ....+++.++..++.|+++||+|||++   +|+||||||+||
T Consensus        93 ~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NI  141 (288)
T d2jfla1          93 GGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNI  141 (288)
T ss_dssp             TEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhhe
Confidence            9999998742   235699999999999999999999998   999999999997

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.93  E-value=1.5e-26  Score=216.37  Aligned_cols=127  Identities=31%  Similarity=0.543  Sum_probs=109.0

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCC---EEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGG---LIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~---~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      .+++.+.||+|+||+||+|..+ +++   .||||.+....  ...++|.+|+++|++++|||||+++|++..++..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            4556688999999999999864 232   58899886532  23457999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++..   ....+++.+++.++.|+++||+|||++   +|+||||||+||
T Consensus       107 Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NI  159 (299)
T d1jpaa_         107 EFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNI  159 (299)
T ss_dssp             ECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceE
Confidence            99999999998843   335699999999999999999999998   999999999997

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.4e-27  Score=215.97  Aligned_cols=134  Identities=21%  Similarity=0.304  Sum_probs=106.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEe--CCeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  376 (436)
                      +.|++.+.||+|+||+||+|+. .+++.||+|.++.....   .+.+.+|+++|++++||||+++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            3567789999999999999985 47889999999764333   3568899999999999999999998864  4567999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGC--DVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~--~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++.........+++..++.++.|+++||+|||++.  ..+|+||||||+||
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NI  145 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV  145 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGE
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhc
Confidence            9999999999998543333467999999999999999999999851  12499999999997

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.1e-27  Score=223.59  Aligned_cols=129  Identities=24%  Similarity=0.347  Sum_probs=113.7

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ...|++.+.||+|+||+||+|+. .+++.||+|+++...  ...+++.+|+.+|++++|||||++++++.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            45677789999999999999996 478899999997632  234678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++.    +...+++..+..++.|+++||+|||++  .+|+||||||+||
T Consensus        85 y~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NI  136 (322)
T d1s9ja_          85 HMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNI  136 (322)
T ss_dssp             CCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGE
T ss_pred             cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHe
Confidence            999999999984    235699999999999999999999963  1799999999997

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.9e-26  Score=214.06  Aligned_cols=127  Identities=31%  Similarity=0.404  Sum_probs=114.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-------cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      .+|++.+.||+|+||+||+|+. .+|+.||||++++..       ...+.+.+|+.+|++++|||||++++++.+.+..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4678889999999999999996 478899999986421       23577999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||||+++|+|.+++..    ...+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        90 iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Ni  144 (293)
T d1jksa_          90 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENI  144 (293)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceE
Confidence            99999999999999842    35699999999999999999999998   999999999997

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.2e-26  Score=211.89  Aligned_cols=126  Identities=26%  Similarity=0.385  Sum_probs=108.1

Q ss_pred             hhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEe----CCeeeEEE
Q 041073          306 HFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRAVVY  377 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  377 (436)
                      ++.++||+|+||+||+|... ++..||+|.+.....   ..+.+.+|+++|++++||||+++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            46678999999999999964 688999999876433   34568999999999999999999999865    34579999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++.    +...+++..++.++.|+++||+|||++ .++|+||||||+||
T Consensus        92 E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NI  145 (270)
T d1t4ha_          92 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNI  145 (270)
T ss_dssp             ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGE
T ss_pred             eCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhc
Confidence            9999999999983    335799999999999999999999987 22399999999997

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.93  E-value=1.6e-26  Score=216.87  Aligned_cols=128  Identities=23%  Similarity=0.379  Sum_probs=110.7

Q ss_pred             HHhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          302 AMTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       302 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      ...|++.+.||+|+||+||+|+.+ +++.||||++....  .....+.+|+.+|++++||||+++++++.+++..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            355778899999999999999964 78899999997633  233568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        88 ~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Ni  138 (307)
T d1a06a_          88 LVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENL  138 (307)
T ss_dssp             CCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             ccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccce
Confidence            999999999994    345799999999999999999999998   999999999997

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.93  E-value=3.7e-26  Score=218.17  Aligned_cols=128  Identities=23%  Similarity=0.403  Sum_probs=114.3

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      ..|++.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.+|++++||||+++++++.+++..+|||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            3578889999999999999995 478999999987643 33456889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++.   .....+++.+++.++.||+.||+|||++   +|+||||||+||
T Consensus       109 ~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NI  158 (352)
T d1koba_         109 SGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENI  158 (352)
T ss_dssp             CCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccccc
Confidence            9999998873   2345699999999999999999999998   999999999997

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.93  E-value=2.7e-26  Score=218.96  Aligned_cols=128  Identities=24%  Similarity=0.397  Sum_probs=114.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc-cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .+|++.+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+.+|++++||||+++++++.+.+..++||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            3678889999999999999986 478899999997643 33467899999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++|+|.+++..   ....+++..+..++.||+.||+|||++   +||||||||+||
T Consensus       106 ~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NI  155 (350)
T d1koaa2         106 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENI  155 (350)
T ss_dssp             CSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHe
Confidence            99999999842   335699999999999999999999998   999999999997

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=7.9e-27  Score=215.64  Aligned_cols=128  Identities=35%  Similarity=0.598  Sum_probs=109.5

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCc---ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      +....+.+.+.||+|+||+||+|+.+  ..||||+++..   ....+.|.+|+.+|++++||||+++++++.. +..++|
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            33455667889999999999999854  36999999753   2234679999999999999999999998754 568999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++..   ....+++..+..++.|+++||+|||++   +||||||||+||
T Consensus        82 ~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~Ni  135 (276)
T d1uwha_          82 TQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNI  135 (276)
T ss_dssp             EECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHE
Confidence            999999999999853   235699999999999999999999998   999999999997

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=9.7e-27  Score=215.86  Aligned_cols=131  Identities=31%  Similarity=0.476  Sum_probs=116.7

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +....+++.+.||+|+||.||+|..++++.||||+++......+.|.+|+.++++++|+|||+++|++.+ +..++||||
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            3345788889999999999999998888889999998877778889999999999999999999999854 567899999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|+|..++...  ....++|.+++.++.||++||+|||++   +|+||||||+||
T Consensus        93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NI  144 (285)
T d1fmka3          93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANI  144 (285)
T ss_dssp             CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEE
Confidence            9999999988532  234699999999999999999999998   999999999997

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.1e-26  Score=213.85  Aligned_cols=126  Identities=27%  Similarity=0.322  Sum_probs=113.8

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|++.+.||+|+||+||+|+. .+++.||||+++..    ....+.+.+|+++|++++||||+++++++.+.+..++|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            477889999999999999996 47889999998752    3345679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++.    ..+.+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        89 y~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NI  139 (288)
T d1uu3a_          89 YAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENI  139 (288)
T ss_dssp             CCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             ccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCcccc
Confidence            999999999883    335799999999999999999999998   999999999997

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=4.3e-26  Score=213.97  Aligned_cols=127  Identities=24%  Similarity=0.373  Sum_probs=112.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC----HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|...+.||+|+||.||+|+. .+++.||||+++.....    .+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4577788999999999999985 47888999999764332    246889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|..++.    ....+++.++..++.||++||+|||++   +|+||||||+||
T Consensus        95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NI  146 (309)
T d1u5ra_          95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNI  146 (309)
T ss_dssp             ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGE
T ss_pred             EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceE
Confidence            9999999977663    335799999999999999999999998   999999999997

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=4.6e-26  Score=211.37  Aligned_cols=125  Identities=24%  Similarity=0.444  Sum_probs=106.4

Q ss_pred             hhhhc-ccCCCCCeEEEEEEEc---CCCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          305 NHFTH-KLGQGGFGSVYKGQLH---TGGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       305 ~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      +.+.+ +||+|+||.||+|..+   ++..||||+++...  ...++|.+|+++|++++|||||+++|++.+ +..++|||
T Consensus        10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE   88 (285)
T d1u59a_          10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME   88 (285)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEE
Confidence            33445 4999999999999753   34479999997632  234679999999999999999999999865 45789999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++..   ....+++.++..++.|+++||+|||++   +|+||||||+||
T Consensus        89 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Ni  140 (285)
T d1u59a_          89 MAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNV  140 (285)
T ss_dssp             CCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             eCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhhe
Confidence            9999999998732   335799999999999999999999998   999999999997

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=8.9e-26  Score=208.71  Aligned_cols=120  Identities=25%  Similarity=0.482  Sum_probs=102.8

Q ss_pred             cccCCCCCeEEEEEEEc---CCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecCCC
Q 041073          309 HKLGQGGFGSVYKGQLH---TGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYMPN  382 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  382 (436)
                      ++||+|+||+||+|.++   +++.||||+++....   ..+++.+|+++|++++|||||+++|++.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999854   345799999975322   24579999999999999999999999865 457899999999


Q ss_pred             CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          383 GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+|.+++.    +...+++..++.++.||++||+|||++   +|+||||||+||
T Consensus        92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Ni  138 (277)
T d1xbba_          92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNV  138 (277)
T ss_dssp             EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhh
Confidence            99999984    335699999999999999999999998   999999999997

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.5e-25  Score=212.52  Aligned_cols=126  Identities=25%  Similarity=0.322  Sum_probs=113.9

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|.+.+.||+|+||.||+++. .+++.||+|++++.    ....+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            467789999999999999995 57899999999752    3356778999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++.    +...+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        86 y~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NI  136 (337)
T d1o6la_          86 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENL  136 (337)
T ss_dssp             CCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGE
T ss_pred             ccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHe
Confidence            999999999984    345789999999999999999999998   999999999997

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1e-25  Score=213.24  Aligned_cols=135  Identities=28%  Similarity=0.434  Sum_probs=111.6

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEcC-C-----CEEEEEEecCc--ccCHHHHHHHHHHHcCC-CcCcccceeEEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLHT-G-----GLIAVKMLKNS--KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE  369 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~~-~-----~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  369 (436)
                      |+....+.+.+.||+|+||+||+|+... +     ..||+|.+...  ......+.+|+.+|.++ +|||||++++++.+
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            4455677888999999999999998542 2     26899998653  22345789999999998 89999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecC
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKES-------------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFD  430 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrD  430 (436)
                      .+..++||||+++|+|.+++..++.                   ....+++..++.++.|+++||+|||++   +|||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence            9999999999999999999965431                   123589999999999999999999998   999999


Q ss_pred             CCCCCC
Q 041073          431 IKPHNI  436 (436)
Q Consensus       431 lkp~NI  436 (436)
                      |||+||
T Consensus       190 lKp~Ni  195 (325)
T d1rjba_         190 LAARNV  195 (325)
T ss_dssp             CSGGGE
T ss_pred             Cchhcc
Confidence            999997

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.92  E-value=2.9e-25  Score=208.98  Aligned_cols=126  Identities=25%  Similarity=0.361  Sum_probs=113.1

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEe
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYE  378 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  378 (436)
                      .|++.+.||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|+.+|+.++||||+++++++.+.+..++|||
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   84 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   84 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence            466789999999999999996 47899999999752    3346779999999999999999999999999999999999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|..++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        85 ~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NI  135 (316)
T d1fota_          85 YIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENI  135 (316)
T ss_dssp             CCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGE
T ss_pred             ecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchhe
Confidence            999999999883    345688999999999999999999998   999999999997

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.92  E-value=1.3e-25  Score=207.42  Aligned_cols=127  Identities=24%  Similarity=0.247  Sum_probs=112.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---C-------HHHHHHHHHHHcCCC-cCcccceeEEEEeC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---S-------AEEFINEVSTIGRIH-HVNVVQLLGFCSEG  370 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~-------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  370 (436)
                      .+|++.+.||+|+||+||+|+. .+++.+|||+++....   .       .+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            3567789999999999999985 4788999999876321   1       235889999999997 99999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..+|||||+++|+|.+++.    ....+++.+++.++.||++||+|||++   +|+||||||+||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Ni  141 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENI  141 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceE
Confidence            99999999999999999994    235799999999999999999999998   999999999997

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.91  E-value=1e-25  Score=208.55  Aligned_cols=127  Identities=21%  Similarity=0.282  Sum_probs=110.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc----CHHHHHHHHHHHcCCCcCcccceeEEEEeCC----ee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KR  373 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  373 (436)
                      .+|.+.+.||+|+||.||+|+. .+++.||||+++....    ..+.+.+|+++++.++||||+++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            3577889999999999999985 5788999999976332    2346899999999999999999999987643    37


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++++|.+++.    ..+.+++.+++.++.|+++||+|||++   +|+||||||+||
T Consensus        87 ~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NI  142 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANI  142 (277)
T ss_dssp             EEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCccc
Confidence            89999999999999883    335799999999999999999999998   999999999997

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.9e-25  Score=207.40  Aligned_cols=127  Identities=33%  Similarity=0.519  Sum_probs=109.6

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCC-----CEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTG-----GLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~-----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      .+...+.||+|+||.||+|.++..     ..||||.++....  ...+|.+|++++++++|||||+++|++.+.+..++|
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v   87 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII   87 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence            345668899999999999986532     3699999876332  335689999999999999999999999999999999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||++++++.+++..   ....+++.++..++.|++.||+|||++   +|+||||||+||
T Consensus        88 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NI  141 (283)
T d1mqba_          88 TEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNI  141 (283)
T ss_dssp             EECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceE
Confidence            999999999988743   335799999999999999999999998   999999999997

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=5.5e-25  Score=206.79  Aligned_cols=131  Identities=31%  Similarity=0.526  Sum_probs=110.4

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCC--EEEEEEecC--cccCHHHHHHHHHHHcCC-CcCcccceeEEEEeCCeeeEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGG--LIAVKMLKN--SKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~--~vavK~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  376 (436)
                      ..+++.+.||+|+||.||+|..+ ++.  .||||.++.  .....+.+.+|+++|.++ +||||++++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            45667789999999999999865 444  477888754  223445799999999998 799999999999999999999


Q ss_pred             EecCCCCChhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKE------------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.++++...            .....+++..+.+++.||++||.|||++   +|+||||||+||
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NI  158 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI  158 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceE
Confidence            99999999999985431            2346799999999999999999999998   999999999997

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=6.7e-25  Score=205.21  Aligned_cols=127  Identities=25%  Similarity=0.445  Sum_probs=107.6

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      .|++.++||+|+||+||+|.. .+++.||||+++....   ..+++.+|+++|++++||||+++++++.+++..++||||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~   82 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   82 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence            466778999999999999995 5789999999965322   346789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +.++ +.+++..  .....+++..+..++.|++.||+|||++   +||||||||+||
T Consensus        83 ~~~~-~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNI  133 (298)
T d1gz8a_          83 LHQD-LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNL  133 (298)
T ss_dssp             CSEE-HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             cCCc-hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchhe
Confidence            9654 4444422  2345699999999999999999999998   999999999997

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.90  E-value=7.2e-25  Score=203.85  Aligned_cols=126  Identities=26%  Similarity=0.376  Sum_probs=112.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      +|++.++||+|+||+||+|+.++++.||||+++...   ...+++.+|+.+|++++||||+++++.+...+..++++|++
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~   82 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence            466778999999999999998889999999997632   23467999999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++.+..+.    .....+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        83 ~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NI  131 (286)
T d1ob3a_          83 DQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNL  131 (286)
T ss_dssp             SEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             hhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCcee
Confidence            887776665    3346799999999999999999999998   999999999997

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.90  E-value=1.4e-24  Score=207.06  Aligned_cols=127  Identities=26%  Similarity=0.293  Sum_probs=114.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEE
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      ..|++.+.||+|+||.||+|+.+ +|+.||||++...    ....+.+.+|+++|+.++||||+++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            35778899999999999999864 7899999998642    234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+.+|+|.+++.    +...+++..++.++.||+.||+|||++   +||||||||+||
T Consensus       121 e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NI  172 (350)
T d1rdqe_         121 EYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENL  172 (350)
T ss_dssp             ECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             ccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHc
Confidence            9999999999984    235699999999999999999999998   999999999997

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.3e-25  Score=205.72  Aligned_cols=127  Identities=31%  Similarity=0.507  Sum_probs=108.6

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEe-CCeeeEEEecCC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRAVVYEYMP  381 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~~~  381 (436)
                      ..+++.+.||+|+||.||+|..+ +..||||+++.+. ..+.+.+|++++++++||||++++|++.+ .+..++||||++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            34567789999999999999985 7789999997643 45779999999999999999999998865 456799999999


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|+|.+++..+  ....+++..+++++.||+.||+|||++   +|+||||||+||
T Consensus        85 ~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Ni  134 (262)
T d1byga_          85 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNV  134 (262)
T ss_dssp             TEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhh
Confidence            99999998432  223589999999999999999999998   999999999997

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=5.1e-25  Score=207.22  Aligned_cols=135  Identities=30%  Similarity=0.467  Sum_probs=114.9

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSE  369 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  369 (436)
                      |+....+.+.+.||+|+||.||+|+..      +++.||||+++....  ....+.+|+.+++++ +|||||++++++.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            455567888899999999999999852      456899999976432  345689999999998 69999999999999


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCC
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKES--------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  435 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~N  435 (436)
                      .+..+++|||+++|+|.+++.....              ....+++..+.+++.||++||+|||++   +|+||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence            9999999999999999999864321              223689999999999999999999998   99999999999


Q ss_pred             C
Q 041073          436 I  436 (436)
Q Consensus       436 I  436 (436)
                      |
T Consensus       176 I  176 (311)
T d1t46a_         176 I  176 (311)
T ss_dssp             E
T ss_pred             c
Confidence            7

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=9e-25  Score=205.98  Aligned_cols=126  Identities=25%  Similarity=0.344  Sum_probs=110.5

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCc----ccCHHHHHHHHHHHc-CCCcCcccceeEEEEeCCeeeEEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS----KFSAEEFINEVSTIG-RIHHVNVVQLLGFCSEGSKRAVVY  377 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~  377 (436)
                      .|.+.+.||+|+||+||+|..+ +++.||||++++.    ....+.+..|..++. .++||||+++++++.+++..++||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            4667899999999999999964 7889999999752    334566777777665 689999999999999999999999


Q ss_pred             ecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          378 EYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       378 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||+++|+|.+++.    ....+++.++..++.||+.||+|||++   +|+||||||+||
T Consensus        83 Ey~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~Ni  134 (320)
T d1xjda_          83 EYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNI  134 (320)
T ss_dssp             ECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGE
T ss_pred             eecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccce
Confidence            9999999999994    335689999999999999999999998   999999999997

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=5.8e-25  Score=203.01  Aligned_cols=130  Identities=25%  Similarity=0.362  Sum_probs=110.4

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcC----CCEEEEEEecCcc--cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCee
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHT----GGLIAVKMLKNSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  373 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  373 (436)
                      +.+..+.+.+.||+|+||.||+|....    +..||||.++...  ...+.+.+|+.+|++++||||++++|++. .+..
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            345677888999999999999998542    3468899886532  23456999999999999999999999985 4678


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+++|+|.+++..   ....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus        83 ~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NI  139 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNV  139 (273)
T ss_dssp             EEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---Ceeccccchhhe
Confidence            999999999999998743   335789999999999999999999998   999999999997

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=8.5e-25  Score=201.61  Aligned_cols=127  Identities=30%  Similarity=0.468  Sum_probs=101.1

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc--CC--CEEEEEEecCcc----cCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH--TG--GLIAVKMLKNSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~--~~--~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ..+++.+.||+|+||.||+|+..  ++  ..||||+++...    ...+++.+|+.+|++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            34677899999999999999853  22  368999987532    223579999999999999999999999965 4678


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||||+++|++.+++..   +...+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus        87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NI  142 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNL  142 (273)
T ss_dssp             EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHh
Confidence            99999999999988743   235699999999999999999999998   999999999997

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.89  E-value=3.1e-24  Score=205.81  Aligned_cols=126  Identities=25%  Similarity=0.334  Sum_probs=108.3

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcc----cCHHHHHH---HHHHHcCCCcCcccceeEEEEeCCeeeE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSK----FSAEEFIN---EVSTIGRIHHVNVVQLLGFCSEGSKRAV  375 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~l  375 (436)
                      .|.+.+.||+|+||.||+|+.. +|+.||||++....    .....+.+   |+.+++.++||||+++++++.+.+..++
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            4667789999999999999964 78999999986422    22233444   4777888899999999999999999999


Q ss_pred             EEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          376 VYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       376 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ||||+++|+|.+++.    +...+++..+..++.||+.||+|||++   +|+||||||+||
T Consensus        85 vmE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NI  138 (364)
T d1omwa3          85 ILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANI  138 (364)
T ss_dssp             EECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EEEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHC---Cccceeecccee
Confidence            999999999999984    335689999999999999999999998   999999999997

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=4.2e-24  Score=200.60  Aligned_cols=125  Identities=30%  Similarity=0.474  Sum_probs=106.7

Q ss_pred             hhhcccCCCCCeEEEEEEEcCC----CEEEEEEecCc--ccCHHHHHHHHHHHcCCCcCcccceeEEEEe-CCeeeEEEe
Q 041073          306 HFTHKLGQGGFGSVYKGQLHTG----GLIAVKMLKNS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRAVVYE  378 (436)
Q Consensus       306 ~~~~~lg~G~fg~V~~~~~~~~----~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E  378 (436)
                      +|.++||+|+||+||+|.+..+    ..||||.++..  ....++|.+|+++|++++||||++++|++.. ++..++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            4567899999999999986432    25899998752  2234679999999999999999999999876 568899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++|+|.+++..   ....+++..+++++.|+++||.|||+.   +|+||||||+||
T Consensus       110 ~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NI  161 (311)
T d1r0pa_         110 YMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNC  161 (311)
T ss_dssp             CCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhE
Confidence            9999999998843   345678899999999999999999998   999999999997

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=2.1e-24  Score=201.89  Aligned_cols=122  Identities=28%  Similarity=0.443  Sum_probs=104.2

Q ss_pred             hcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC------HHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEecC
Q 041073          308 THKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       308 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .+.||+|+||+||+|+. .+++.||||+++.....      .+.+.+|+.+|++++||||+++++++..++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            36799999999999995 47889999998753221      235889999999999999999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++++....    .....+++..+..++.||+.||+|||++   +|+||||||+||
T Consensus        83 ~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NI  131 (299)
T d1ua2a_          83 ETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNL  131 (299)
T ss_dssp             SEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             cchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceE
Confidence            888776665    3446789999999999999999999998   999999999997

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.89  E-value=2.3e-24  Score=201.76  Aligned_cols=131  Identities=26%  Similarity=0.478  Sum_probs=112.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeee
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  374 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  374 (436)
                      ..+++.+.||+|+||+||+|+.+      +++.||||+++....  ..+++.+|+++|++++||||+++++++...+..+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            45677899999999999999854      346899999876332  2456999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhccCCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKE--------------------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPH  434 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~  434 (436)
                      ++|||+++|+|.+++....                    .....+++..++.++.|++.||+|||++   +||||||||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~  169 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR  169 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEccc
Confidence            9999999999999985321                    1123589999999999999999999998   9999999999


Q ss_pred             CC
Q 041073          435 NI  436 (436)
Q Consensus       435 NI  436 (436)
                      ||
T Consensus       170 NI  171 (301)
T d1lufa_         170 NC  171 (301)
T ss_dssp             GE
T ss_pred             ce
Confidence            97

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=5.6e-24  Score=199.18  Aligned_cols=127  Identities=26%  Similarity=0.358  Sum_probs=104.8

Q ss_pred             hhhhhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeCC----eeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~E~  379 (436)
                      ++.+.+.||+|+||.||+|+. +|+.||||+++...........|+..+..++||||+++++++.+.+    ..++||||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey   82 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence            455678899999999999986 5789999999765433233445666667889999999999997654    57899999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNG-----CDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~-----~~~~iiHrDlkp~NI  436 (436)
                      +++|+|.+++..     ..++|..+.+++.|++.||+|||+.     .+++|+||||||+||
T Consensus        83 ~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NI  139 (303)
T d1vjya_          83 HEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  139 (303)
T ss_dssp             CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGE
T ss_pred             ccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccce
Confidence            999999999942     3589999999999999999999973     135999999999997

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=2.2e-24  Score=201.69  Aligned_cols=134  Identities=28%  Similarity=0.447  Sum_probs=108.3

Q ss_pred             HHHHhhhhhcccCCCCCeEEEEEEEcC--------CCEEEEEEecCccc--CHHHHHHHHHHHcCC-CcCcccceeEEEE
Q 041073          300 IIAMTNHFTHKLGQGGFGSVYKGQLHT--------GGLIAVKMLKNSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCS  368 (436)
Q Consensus       300 i~~~~~~~~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~  368 (436)
                      +....+.+.+.||+|+||.||+|+...        +..||||+++....  ...++.+|+..+.++ +|||||++++++.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            445677788999999999999998431        23699999976433  335688898888888 7999999999999


Q ss_pred             eCCeeeEEEecCCCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          369 EGSKRAVVYEYMPNGSLDRHIFPKES------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       369 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++..++||||+++|+|.+++..+..            ....+++..++.++.|++.||+|||++   +||||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence            99999999999999999999965431            134689999999999999999999998   999999999996

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=4.7e-24  Score=202.31  Aligned_cols=124  Identities=27%  Similarity=0.321  Sum_probs=105.5

Q ss_pred             hhhhh-cccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcC-CCcCcccceeEEEEe----CCeeeEE
Q 041073          304 TNHFT-HKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGR-IHHVNVVQLLGFCSE----GSKRAVV  376 (436)
Q Consensus       304 ~~~~~-~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~lv  376 (436)
                      .|.+. +.||+|+||.||+|.. .+++.||||+++..    ..+.+|+.++.+ .+||||+++++++.+    ....++|
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv   87 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   87 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence            45555 4599999999999985 57899999998653    457789988655 589999999999865    4568999


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||+++|+|.+++..+  ....+++.++..++.|++.||+|||++   +|+||||||+||
T Consensus        88 mEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NI  142 (335)
T d2ozaa1          88 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENL  142 (335)
T ss_dssp             EECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccc
Confidence            9999999999999532  235699999999999999999999998   999999999997

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=9.4e-24  Score=199.03  Aligned_cols=126  Identities=26%  Similarity=0.464  Sum_probs=106.1

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCC----EEEEEEecC--cccCHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGG----LIAVKMLKN--SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  376 (436)
                      .|++.+.||+|+||+||+|... +++    .||+|.++.  .....+++.+|++++++++|||||+++|++.++ ..+++
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v   88 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   88 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence            3667799999999999999854 443    588998865  334567899999999999999999999999765 56788


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +||+++|+|.+++..   ....+++..+++++.||++||+|||++   +|+||||||+||
T Consensus        89 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NI  142 (317)
T d1xkka_          89 TQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV  142 (317)
T ss_dssp             EECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcc
Confidence            899999999998843   346799999999999999999999998   999999999997

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=2.7e-24  Score=201.85  Aligned_cols=135  Identities=29%  Similarity=0.427  Sum_probs=114.4

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeC
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEG  370 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  370 (436)
                      |+....+++.+.||+|+||.||+|..+      ++..||||+++....  ....+.+|+.++++++||||++++|.+...
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            444567778899999999999999853      356899999976332  234589999999999999999999999999


Q ss_pred             CeeeEEEecCCCCChhhhccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKE------SRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +..++||||+++|+|.+++...+      .....+++..+.+++.|+++||.|||++   +|+||||||+||
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~Ni  164 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC  164 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCce
Confidence            99999999999999999885321      1224579999999999999999999998   999999999997

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.2e-23  Score=195.93  Aligned_cols=126  Identities=21%  Similarity=0.363  Sum_probs=112.2

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc---CHHHHHHHHHHHcCCCcCcccceeEEEEeCCeeeEEEec
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAVVYEY  379 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  379 (436)
                      +|++.+.||+|+||+||+|+. .+++.||||+++....   ..+++.+|+.+|+.++||||+++++++......++++|+
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            466778999999999999995 4788999999975332   246789999999999999999999999999999999999


Q ss_pred             CCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          380 MPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +.+++|..++.    ..+.+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        83 ~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NI  132 (292)
T d1unla_          83 CDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNL  132 (292)
T ss_dssp             CSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             ccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCccc
Confidence            99999888773    446789999999999999999999998   999999999997

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.89  E-value=1.7e-23  Score=198.28  Aligned_cols=122  Identities=21%  Similarity=0.392  Sum_probs=108.2

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCC-cCcccceeEEEEeC--CeeeEEEe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEG--SKRAVVYE  378 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E  378 (436)
                      .+|++.++||+|+||+||+|+. .+++.||||+++..  ..+++.+|+++|+.++ ||||+++++++...  ...++|||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            4678889999999999999996 57889999998753  4567899999999995 99999999998753  46899999


Q ss_pred             cCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          379 YMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |+++++|..+.       +.+++..++.++.||+.||+|||++   +|+||||||+||
T Consensus       113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NI  160 (328)
T d3bqca1         113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNV  160 (328)
T ss_dssp             CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccce
Confidence            99999997765       4589999999999999999999998   999999999997

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=5.7e-24  Score=198.97  Aligned_cols=135  Identities=30%  Similarity=0.452  Sum_probs=107.3

Q ss_pred             HHHHHhhhhhcccCCCCCeEEEEEEEc------CCCEEEEEEecCcc--cCHHHHHHHHHHHcCC-CcCcccceeEEEEe
Q 041073          299 EIIAMTNHFTHKLGQGGFGSVYKGQLH------TGGLIAVKMLKNSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSE  369 (436)
Q Consensus       299 ~i~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  369 (436)
                      |+.+..+++.+.||+|+||.||+|...      +++.||||+++...  ...+.+.+|...+.++ +|+||+.+++++..
T Consensus         9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1           9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            344567888899999999999999853      34579999987532  2345677888887776 68999999998865


Q ss_pred             C-CeeeEEEecCCCCChhhhccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          370 G-SKRAVVYEYMPNGSLDRHIFPKES------------RGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 ~-~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      . ...++||||+++|+|.+++..+..            ....+++.+++.++.|+++||+|||++   +|+||||||+||
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI  165 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  165 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence            4 467999999999999999864321            134589999999999999999999998   999999999997

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=6.5e-24  Score=195.81  Aligned_cols=127  Identities=24%  Similarity=0.306  Sum_probs=108.7

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc-------CHHHHHHHHHHHcCCC--cCcccceeEEEEeCCe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF-------SAEEFINEVSTIGRIH--HVNVVQLLGFCSEGSK  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  372 (436)
                      .+|++.+.||+|+||.||+|.. .+++.||||+++....       ...++.+|+.+|++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            3567789999999999999995 4789999999875321       1234678999999886  8999999999999999


Q ss_pred             eeEEEecCCC-CChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPN-GSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+.+ +++.+++.    +...+++..+..++.|+++||+|||++   +|+||||||+||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NI  141 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENI  141 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccce
Confidence            9999999975 67777773    335799999999999999999999998   999999999997

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2.6e-23  Score=198.32  Aligned_cols=125  Identities=19%  Similarity=0.309  Sum_probs=102.8

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCccc--CHHHHHHHHHHHcCCCcCcccceeEEEEeCC----eeeEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRAVV  376 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  376 (436)
                      +|++.+.||+|+||+||+|.. .+++.||||+++....  ..+++.+|+.+|+.++||||+++++++....    ..+++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            467789999999999999985 5889999999976332  2457889999999999999999999986543    23445


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +|++.+|+|.+++.     ...+++..++.++.|++.||+|||++   +||||||||+||
T Consensus        89 ~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NI  140 (345)
T d1pmea_          89 VTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNL  140 (345)
T ss_dssp             EEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             EEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceE
Confidence            55667999999983     24699999999999999999999998   999999999997

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2.8e-23  Score=198.46  Aligned_cols=125  Identities=25%  Similarity=0.357  Sum_probs=107.4

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeC-----Ceee
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  374 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  374 (436)
                      +|++.+.||+|+||+||+|+. .+++.||||+++....+   .+++.+|+++|+.++||||+++++++...     ...+
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            577789999999999999985 57899999999764333   34688999999999999999999998643     3346


Q ss_pred             EEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          375 VVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       375 lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++||+.+|+|.+++.     .+.+++..++.++.||+.||+|||++   +|+||||||+||
T Consensus        99 ~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NI  152 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNL  152 (348)
T ss_dssp             EEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             EEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccc
Confidence            6777888999999982     24699999999999999999999998   999999999997

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2.9e-23  Score=198.45  Aligned_cols=126  Identities=26%  Similarity=0.374  Sum_probs=102.3

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCcccceeEEEEeC------CeeeEE
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRAVV  376 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv  376 (436)
                      +|+..++||+|+||+||+|+.. +++.||||+++.....   ..+|+++|++++|+||+++++++...      ...+||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            4556688999999999999964 7899999999764322   34799999999999999999998542      347899


Q ss_pred             EecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          377 YEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       377 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      |||++++.+. .+.........+++.+++.++.|+++||+|||++   +|+||||||+||
T Consensus        98 ~Ey~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NI  153 (350)
T d1q5ka_          98 LDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNL  153 (350)
T ss_dssp             EECCSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGE
T ss_pred             EeccCCccHH-HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceE
Confidence            9999765433 3322112345799999999999999999999998   999999999997

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=3.3e-23  Score=197.83  Aligned_cols=125  Identities=23%  Similarity=0.391  Sum_probs=101.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEeCC------e
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  372 (436)
                      .+|++.+.||+|+||+||+|.. .+++.||||+++.....   .+.+.+|+++|+.++|||||++++++...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            4577789999999999999995 47899999999764333   356889999999999999999999997654      4


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .++||||+ +.+|..++.     ...+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        98 ~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NI  152 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNL  152 (346)
T ss_dssp             CEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             EEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchh
Confidence            69999999 667877762     34699999999999999999999998   999999999997

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.2e-22  Score=191.49  Aligned_cols=127  Identities=24%  Similarity=0.369  Sum_probs=105.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcc---cCHHHHHHHHHHHcCCCcCcccceeEEEEe--------C
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE--------G  370 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  370 (436)
                      .+|++.+.||+|+||+||+|+. .+++.||||++....   ....++.+|+++|++++|+||+++++.+..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            5677889999999999999996 478999999986532   234678899999999999999999998755        3


Q ss_pred             CeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          371 SKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       371 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ...+++|||++++.+....    .....+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NI  148 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANV  148 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             ceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchhe
Confidence            4578999999887776554    3446789999999999999999999998   999999999997

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=1.3e-22  Score=194.18  Aligned_cols=123  Identities=24%  Similarity=0.286  Sum_probs=102.8

Q ss_pred             hhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccC---HHHHHHHHHHHcCCCcCcccceeEEEEe------CCee
Q 041073          304 TNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKR  373 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  373 (436)
                      +|++.++||+|+||+||+|... +++.||||+++....+   ..++.+|+.+++.++||||+++++++..      ....
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~   97 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV   97 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence            4667789999999999999964 7899999999764333   3468899999999999999999999863      3678


Q ss_pred             eEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          374 AVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       374 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ++||||+.++.+ +.+.      ..+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        98 ~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Ni  150 (355)
T d2b1pa1          98 YLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI  150 (355)
T ss_dssp             EEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             EEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCcccc
Confidence            999999976544 4441      3589999999999999999999998   999999999997

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=1.9e-22  Score=189.06  Aligned_cols=128  Identities=24%  Similarity=0.437  Sum_probs=101.8

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE-cC-CCEEEEEEecCcc---cCHHHHHHHHHHHcCC---CcCcccceeEEEEe-----
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL-HT-GGLIAVKMLKNSK---FSAEEFINEVSTIGRI---HHVNVVQLLGFCSE-----  369 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~-~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  369 (436)
                      .+|++.+.||+|+||+||+|+. ++ ++.||||+++...   .....+.+|+.+|+.+   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            4577789999999999999986 34 5579999986522   1223466777776655   79999999998853     


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      ....+++|||++++.+.....   .....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NI  147 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNI  147 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             CceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEE
Confidence            346789999998877654442   2345689999999999999999999998   999999999997

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=1.6e-22  Score=190.73  Aligned_cols=127  Identities=25%  Similarity=0.315  Sum_probs=111.0

Q ss_pred             HhhhhhcccCCCCCeEEEEEEE----cCCCEEEEEEecCcc-----cCHHHHHHHHHHHcCCCc-CcccceeEEEEeCCe
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQL----HTGGLIAVKMLKNSK-----FSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSK  372 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  372 (436)
                      ..|++.+.||+|+||+||+|..    .+|+.||||++++..     ...+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            4578889999999999999984    257899999986522     234568899999999976 899999999999999


Q ss_pred             eeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          373 RAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       373 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .+++|||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus       104 ~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Ni  160 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENI  160 (322)
T ss_dssp             EEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             eeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccce
Confidence            999999999999999983    335678999999999999999999998   999999999997

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.85  E-value=2.8e-22  Score=186.64  Aligned_cols=126  Identities=21%  Similarity=0.347  Sum_probs=108.5

Q ss_pred             HhhhhhcccCCCCCeEEEEEEEc-CCCEEEEEEecCcccCHHHHHHHHHHHcCCCc-CcccceeEEEEeCCeeeEEEecC
Q 041073          303 MTNHFTHKLGQGGFGSVYKGQLH-TGGLIAVKMLKNSKFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRAVVYEYM  380 (436)
Q Consensus       303 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~  380 (436)
                      .+|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+|++.++.++| +|++.++++...+...++||||+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            45778899999999999999954 78899999986532 22346788888888875 89999999999999999999999


Q ss_pred             CCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          381 PNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                       +++|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        84 -~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Ni  132 (293)
T d1csna_          84 -GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNF  132 (293)
T ss_dssp             -CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGE
T ss_pred             -CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccce
Confidence             7899998843   335689999999999999999999998   999999999997

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.84  E-value=1.7e-21  Score=181.88  Aligned_cols=125  Identities=23%  Similarity=0.309  Sum_probs=103.1

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCccc-ceeEEEEeCCeeeEEEecCC
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVV-QLLGFCSEGSKRAVVYEYMP  381 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~  381 (436)
                      +|++.+.||+|+||.||+|+. .+++.||||++..... .+++..|+++++.++|+|++ .+.++....+..++||||+ 
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            477889999999999999985 4788999999876432 23578899999999877655 4556667788899999999 


Q ss_pred             CCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          382 NGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      +++|.+.+..   ....+++..+..++.|++.||+|||++   +|+||||||+||
T Consensus        86 ~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NI  134 (299)
T d1ckia_          86 GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNF  134 (299)
T ss_dssp             CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhc
Confidence            5567666532   345799999999999999999999998   999999999997

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.72  E-value=3.3e-18  Score=148.50  Aligned_cols=112  Identities=21%  Similarity=0.211  Sum_probs=87.7

Q ss_pred             hhcccCCCCCeEEEEEEEcCCCEEEEEEecCcccC-------------------HHHHHHHHHHHcCCCcCcccceeEEE
Q 041073          307 FTHKLGQGGFGSVYKGQLHTGGLIAVKMLKNSKFS-------------------AEEFINEVSTIGRIHHVNVVQLLGFC  367 (436)
Q Consensus       307 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~E~~~l~~l~h~niv~l~~~~  367 (436)
                      +.++||+|+||.||+|...+|+.||||+++.....                   .....+|...+.++.|.+++..++..
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            45789999999999999888999999987642110                   12245688889999999999887653


Q ss_pred             EeCCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          368 SEGSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       368 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                          ..+++|||+++..+.+           +++..+.+++.|++++|+|||++   +|+||||||+||
T Consensus        84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NI  134 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV  134 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             ----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhhe
Confidence                2379999998765543           22334567999999999999998   999999999997

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.72  E-value=2e-18  Score=165.27  Aligned_cols=130  Identities=22%  Similarity=0.350  Sum_probs=101.0

Q ss_pred             hhhhhcccCCCCCeEEEEEEE-cCCCEEEEEEecCcccCHHHHHHHHHHHcCCC-----------cCcccceeEEEEe--
Q 041073          304 TNHFTHKLGQGGFGSVYKGQL-HTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH-----------HVNVVQLLGFCSE--  369 (436)
Q Consensus       304 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~--  369 (436)
                      +|++.++||+|+||+||+|+. .+|+.||||+++......+.+.+|+++++.++           |+||+++++++..  
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            478889999999999999996 47899999999876555567888998887764           5789999988754  


Q ss_pred             CCeeeEEEecCCCCChhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEecCCCCCCC
Q 041073          370 GSKRAVVYEYMPNGSLDRHIFPKESRGQSFSWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  436 (436)
Q Consensus       370 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~gL~yLH~~~~~~iiHrDlkp~NI  436 (436)
                      .....++++++..+....... .......+++..+..++.|++.||+|||+.  .+|+||||||+||
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NI  157 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENV  157 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGE
T ss_pred             ccceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHe
Confidence            345666666665443222211 113446789999999999999999999973  2899999999997

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.21  E-value=0.00056  Score=59.85  Aligned_cols=97  Identities=14%  Similarity=0.032  Sum_probs=62.8

Q ss_pred             CCCeEEEEEEEcCCCEEEEEEecCc-ccCHHHHHHHHHHHcCCC-cCcccceeEEEEeCCeeeEEEecCCCCChhhhccC
Q 041073          314 GGFGSVYKGQLHTGGLIAVKMLKNS-KFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDRHIFP  391 (436)
Q Consensus       314 G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~  391 (436)
                      ++.+.||+... +++.+.+|..... ......+.+|...+..+. +--+.+++.....++..++|||++++.++.+....
T Consensus        25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~  103 (263)
T d1j7la_          25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED  103 (263)
T ss_dssp             CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred             CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence            34468998764 4556778877542 223344677887776553 44467788888888899999999999888665411


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 041073          392 KESRGQSFSWEKLHEVALGTARGIEYLHN  420 (436)
Q Consensus       392 ~~~~~~~l~~~~~~~i~~~i~~gL~yLH~  420 (436)
                            ...   ...++.++++.++.||+
T Consensus       104 ------~~~---~~~~~~~l~~~l~~lH~  123 (263)
T d1j7la_         104 ------EQS---PEKIIELYAECIRLFHS  123 (263)
T ss_dssp             ------CSC---HHHHHHHHHHHHHHHHT
T ss_pred             ------ccc---HHHHHHHHHHHHHHHhc
Confidence                  011   23345566666666664

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.24  E-value=0.0077  Score=51.85  Aligned_cols=75  Identities=15%  Similarity=0.185  Sum_probs=52.0

Q ss_pred             cCCCC-CeEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCC--cCcccceeEEEEeCCeeeEEEecCCCCChhh
Q 041073          311 LGQGG-FGSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRAVVYEYMPNGSLDR  387 (436)
Q Consensus       311 lg~G~-fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~  387 (436)
                      +..|. -+.||+....++..+++|.......  ..+..|...++.+.  .-.+.+++.....++..+++||++++.++.+
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence            34444 3678998877777788898655322  23566777666553  3346778888888888899999998866543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=94.77  E-value=0.024  Score=52.30  Aligned_cols=74  Identities=14%  Similarity=0.094  Sum_probs=47.2

Q ss_pred             cccCCCCCeEEEEEEEc-CCCEEEEEEecCc--------ccCHHHHHHHHHHHcCCC---cCcccceeEEEEeCCeeeEE
Q 041073          309 HKLGQGGFGSVYKGQLH-TGGLIAVKMLKNS--------KFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRAVV  376 (436)
Q Consensus       309 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  376 (436)
                      +.||.|....||+.... +++.+++|.-...        ....++...|.+.|+.+.   ...+++++.+  +.+...+|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            46899999999999854 4567889975431        112344556777776542   2345666654  44556799


Q ss_pred             EecCCCCC
Q 041073          377 YEYMPNGS  384 (436)
Q Consensus       377 ~E~~~~gs  384 (436)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=83.46  E-value=1.6  Score=38.11  Aligned_cols=68  Identities=13%  Similarity=0.146  Sum_probs=47.8

Q ss_pred             eEEEEEEEcCCCEEEEEEecCcccCHHHHHHHHHHHcCCCcCccc-----ce--eEEEEeCCeeeEEEecCCCCC
Q 041073          317 GSVYKGQLHTGGLIAVKMLKNSKFSAEEFINEVSTIGRIHHVNVV-----QL--LGFCSEGSKRAVVYEYMPNGS  384 (436)
Q Consensus       317 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-----~l--~~~~~~~~~~~lv~E~~~~gs  384 (436)
                      -.||+++..+|..+++|+.+....+.+++..|...+..+....+.     ..  -......+..+.++++++|..
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            479999988899999999987766777888898887766422221     11  112244667788999997743